data_2lui_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lui _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 19.8 ptpt . . . . . 0 C--O 1.232 0.16 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.67 136.42 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -110.72 129.45 55.83 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.78 0.8 . . . . 0.0 110.72 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.19 -160.2 1.03 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.01 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -140.3 149.05 42.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.117 0.484 . . . . 0.0 110.104 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 3.3 mmmm -45.39 151.45 0.37 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.578 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -84.37 172.61 11.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.169 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.02 41.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 110.828 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.575 ' NE2' HD22 ' A' ' 32' ' ' LEU . 3.9 tt0 -92.47 8.43 38.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.982 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 40.1 t30 69.35 34.75 2.8 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.901 0.858 . . . . 0.0 110.583 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.575 HD22 ' NE2' ' A' ' 30' ' ' GLN . 1.5 pp -147.07 -164.4 1.99 Allowed 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.273 -0.571 . . . . 0.0 112.002 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -104.07 -30.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 101.56 32.52 5.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.194 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.488 ' CD1' HG23 ' A' ' 128' ' ' VAL . 2.8 pp -126.83 -179.48 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.613 0.721 . . . . 0.0 112.61 -175.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 39.8 m -137.6 128.73 27.64 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.506 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.494 ' HB ' ' CG ' ' A' ' 126' ' ' LEU . 48.0 mm -111.04 125.43 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.649 0.738 . . . . 0.0 111.988 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.925 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 170.563 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.684 HG23 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.303 0 CA-C-O 122.128 0.966 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -94.27 -31.78 4.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.12 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -161.0 154.15 21.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.13 0.491 . . . . 0.0 110.088 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 9.8 p -143.45 160.77 16.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.922 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.479 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 80.4 m-85 -112.74 124.97 53.78 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 20.6 t70 -54.19 -27.36 33.58 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -165.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -101.0 6.93 43.69 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.184 0.516 . . . . 0.0 110.492 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.479 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 30.9 p -87.55 153.9 53.32 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.32 -40.2 78.69 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.211 1.274 . . . . 0.0 110.905 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -55.68 -49.49 72.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.803 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -77.68 -56.29 4.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.848 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.628 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.3 pp -52.74 -74.12 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -170.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.628 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 37.2 t70 -94.13 -9.11 37.58 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.563 1.173 . . . . 0.0 107.938 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -82.94 -51.73 4.11 Favored Glycine 0 C--N 1.311 -0.816 0 CA-C-N 113.093 -1.867 . . . . 0.0 113.458 -171.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 p 64.57 22.55 12.68 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.699 1.2 . . . . 0.0 111.143 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.467 HG11 HG13 ' A' ' 99' ' ' ILE . 9.9 m -92.1 53.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 122.959 1.361 . . . . 0.0 109.74 172.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.6 179.81 7.04 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.552 -2.113 . . . . 0.0 111.736 -171.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.37 122.71 11.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.991 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.86 1.07 34.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.71 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.684 ' O ' HG23 ' A' ' 49' ' ' ILE . 51.5 t0 -98.48 152.73 19.22 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 33.6 tt0 -101.44 82.31 2.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.896 0.379 . . . . 0.0 110.692 -174.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.497 ' N ' HD13 ' A' ' 70' ' ' ILE . 2.0 mp -74.18 101.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.679 0.752 . . . . 0.0 109.362 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.407 HG23 HD22 ' A' ' 102' ' ' ASN . 7.5 t -100.76 -15.8 17.54 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.649 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -147.78 148.03 19.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.6 -1.285 . . . . 0.0 113.457 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.76 115.31 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.475 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 9.7 t-20 52.21 37.17 21.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.218 0.532 . . . . 0.0 111.311 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.69 -22.45 39.66 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.833 -0.621 . . . . 0.0 113.927 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -106.13 129.29 54.24 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 117.726 0.763 . . . . 0.0 111.245 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.489 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 46.4 m -61.63 148.67 41.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.536 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.477 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -90.68 -25.52 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.265 0.555 . . . . 0.0 109.598 177.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -73.09 86.5 1.36 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.262 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.65 -25.7 0.17 Allowed Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.07 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -111.12 -117.04 0.3 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.942 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.439 ' O ' HG12 ' A' ' 86' ' ' VAL . 4.9 m -149.61 148.93 29.91 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.236 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.57 ' O ' HG22 ' A' ' 86' ' ' VAL . 5.5 mttt -47.81 -55.69 9.12 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.253 0.549 . . . . 0.0 111.976 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.06 -36.91 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.697 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 89' ' ' MET . 37.1 mt-10 -74.36 -37.21 63.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.261 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 83' ' ' LYS . 27.3 m -67.35 -43.09 88.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.888 0.375 . . . . 0.0 111.087 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.07 73.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.203 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 59.8 tttm -61.48 -45.89 92.34 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.583 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 82.5 mtp -53.7 -37.21 63.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.402 0.62 . . . . 0.0 110.723 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.468 HD12 HD13 ' A' ' 33' ' ' ILE . 97.1 mt -77.23 -38.53 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.21 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -70.68 -29.33 65.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.625 0.25 . . . . 0.0 110.86 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -62.48 -48.73 78.31 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.628 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 93' ' ' VAL . 13.3 m -69.75 82.5 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 122.772 1.272 . . . . 0.0 110.08 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -67.34 123.08 19.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.407 -173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.539 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 95.9 -21.17 46.43 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.431 169.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.472 ' O ' HG21 ' A' ' 97' ' ' VAL . 9.2 pt-20 -124.28 169.17 12.04 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.079 0.466 . . . . 0.0 109.885 -174.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 96' ' ' GLU . 2.8 t -159.15 125.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.501 -173.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.475 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 99.5 m -141.58 131.9 25.07 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 122.171 -0.33 . . . . 0.0 110.143 172.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.552 HD11 ' N ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -120.36 132.65 69.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.429 -176.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -100.46 129.42 46.41 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 69' ' ' GLU . 27.5 p90 -136.85 165.82 25.06 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.745 0.307 . . . . 0.0 111.341 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.407 HD22 HG23 ' A' ' 71' ' ' THR . 62.1 m-20 . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 . . . . . 0 C--O 1.215 -0.73 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -31.55 -55.88 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.752 2.968 . . . . 0.0 114.138 -172.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.0 ptpt -58.0 -45.9 86.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 71.0 mm-40 -86.57 -17.63 33.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.488 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.3 tm? -74.26 -44.26 53.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.161 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -70.11 -26.58 64.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.484 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.4 t -72.53 -41.72 63.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.028 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.7 tp -72.41 -23.09 61.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.822 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.8 t80 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.308 -178.546 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.494 ' CG ' ' HB ' ' A' ' 37' ' ' ILE . 1.4 pp . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 10.9 ptmm? -150.98 145.85 25.84 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.357 0.599 . . . . 0.0 110.478 176.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.573 ' OXT' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 168.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 64.4 pttt . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.538 0.209 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 62' ' ' GLY . 9.7 p -142.95 138.78 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.461 ' O ' HD11 ' A' ' 25' ' ' LEU . 12.0 t -110.89 127.36 55.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.445 0.64 . . . . 0.0 110.768 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 24' ' ' THR . 2.6 mm? -127.51 -170.39 2.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.432 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 80.5 mt-30 -129.98 136.55 49.56 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.238 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.602 ' NZ ' ' HA ' ' A' ' 91' ' ' GLN . 22.3 mmtp -45.16 149.27 0.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.712 1.258 . . . . 0.0 112.009 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 4.5 p-10 -89.89 -162.88 0.93 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.489 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.09 65.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.755 0.312 . . . . 0.0 111.555 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.448 ' O ' ' HB3' ' A' ' 31' ' ' ASN . 36.5 mt-30 -88.43 0.84 55.82 Favored 'General case' 0 N--CA 1.425 -1.722 0 C-N-CA 122.931 0.492 . . . . 0.0 112.245 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 50.7 t30 71.3 18.47 5.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.51 0.671 . . . . 0.0 110.943 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.447 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 2.0 pp -126.58 -165.26 1.43 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.092 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.82 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -109.03 -22.27 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.674 -177.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 98.48 35.05 5.08 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.878 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.544 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.7 pp -123.2 171.21 12.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.463 0.649 . . . . 0.0 110.698 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 46.2 m -130.72 131.92 45.06 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.375 175.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.482 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 41.2 mm -100.44 141.29 17.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.152 -176.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.806 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.117 -176.714 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.52 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 122.468 1.127 . . . . 0.0 110.369 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 m -108.73 -19.12 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.123 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 13.9 tp60 -157.3 143.55 17.88 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-O 121.023 0.439 . . . . 0.0 110.222 -171.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.5 p -145.31 160.93 12.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.015 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' H ' HG22 ' A' ' 52' ' ' VAL . 30.2 m-85 -98.64 -131.15 0.21 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.119 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -138.2 -44.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.484 ' HA ' HD23 ' A' ' 60' ' ' LEU . 46.7 m-80 -100.62 8.33 43.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.334 0.588 . . . . 0.0 109.78 -170.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.422 ' CB ' ' HA3' ' A' ' 34' ' ' GLY . 31.0 p -92.19 143.66 27.85 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.51 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 3.6 Cg_endo -44.96 -41.92 15.59 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 C-N-CA 122.551 2.167 . . . . 0.0 111.776 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -58.1 -54.76 43.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.419 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -71.8 -55.0 8.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.73 0.776 . . . . 0.0 109.807 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.3 tm? -42.45 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.235 -1.802 . . . . 0.0 113.273 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -98.8 -39.54 8.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.152 0.501 . . . . 0.0 111.914 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -62.89 -27.33 70.04 Favored Glycine 0 C--O 1.228 -0.226 0 CA-C-N 115.14 -0.936 . . . . 0.0 114.631 -165.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 t 50.71 35.84 12.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.312 1.053 . . . . 0.0 111.39 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.535 HG11 HG13 ' A' ' 99' ' ' ILE . 20.6 m -100.14 51.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.345 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.33 177.77 8.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.222 -168.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.26 136.21 25.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.992 -170.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.82 56.32 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.6 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' O ' HG21 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -104.12 165.49 11.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.025 0.44 . . . . 0.0 110.438 176.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -108.63 99.93 9.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.173 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.421 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 28.7 mm -83.66 105.43 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 77' ' ' SER . 4.2 t -101.49 -15.26 17.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.315 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -139.93 136.36 7.73 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 119.762 -1.209 . . . . 0.0 113.655 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.672 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -103.97 120.54 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 123.376 0.67 . . . . 0.0 109.379 177.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.511 ' ND2' HG11 ' A' ' 93' ' ' VAL . 66.0 t30 54.1 29.91 11.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.481 0.658 . . . . 0.0 110.719 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.15 -21.35 44.92 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.755 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 2.7 ptp180 -104.22 131.2 51.79 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 117.874 0.837 . . . . 0.0 110.602 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' THR . 62.6 m -47.8 136.11 11.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.201 0.525 . . . . 0.0 112.151 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.481 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -76.1 -19.75 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.76 -174.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.04 -12.21 59.26 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.121 -173.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.58 -20.87 61.03 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.377 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 2.6 mptp? -107.67 -131.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.845 0.831 . . . . 0.0 110.275 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 86' ' ' VAL . 5.5 m -158.13 160.12 36.95 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.616 ' O ' HG23 ' A' ' 86' ' ' VAL . 12.8 mttt -47.01 -60.8 2.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.335 0.588 . . . . 0.0 111.756 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -55.0 -34.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.076 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.588 ' O ' ' HG2' ' A' ' 89' ' ' MET . 33.2 mt-10 -77.52 -43.47 31.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.679 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 83' ' ' LYS . 19.7 m -58.42 -47.6 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 126' ' ' LEU . . . -57.16 -38.75 74.03 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 25.6 ttpp -60.88 -56.92 15.45 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.588 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 16.5 mmt -48.63 -43.2 36.22 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.63 0.581 . . . . 0.0 111.146 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.451 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 64.2 mt -62.45 -55.12 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.465 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.602 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 10.4 pt20 -76.94 -22.12 53.78 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.985 -0.447 . . . . 0.0 111.459 -174.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.58 -52.68 23.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.411 0.684 . . . . 0.0 111.732 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.511 HG11 ' ND2' ' A' ' 74' ' ' ASN . 31.8 m -49.42 -36.26 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.543 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 67.62 134.55 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.464 0.649 . . . . 0.0 112.493 171.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.415 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 102.27 -48.25 1.08 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.938 172.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.0 pt-20 -146.03 178.79 7.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.058 0.456 . . . . 0.0 110.144 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.413 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 5.4 m -145.39 154.69 13.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.621 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.3 m -140.71 99.78 3.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 172.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.535 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -93.45 120.63 43.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.112 -175.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -94.39 129.06 41.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 171.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -139.04 163.98 30.97 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.157 0.503 . . . . 0.0 111.815 -172.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 C--N 1.32 -0.707 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 175.489 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 20.2 t70 . . . . . 0 C--O 1.21 -1.021 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.454 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 13.6 Cg_exo -29.26 -51.48 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.251 3.301 . . . . 0.0 115.16 -173.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.485 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.1 pttp -59.51 -45.63 91.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.379 0.609 . . . . 0.0 111.759 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.485 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 15.1 mm100 -85.76 -17.81 34.79 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.838 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.418 HD11 ' C ' ' A' ' 111' ' ' LEU . 3.2 tm? -73.25 -43.73 60.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.485 -175.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -69.18 -35.47 76.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.119 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 109' ' ' LYS . 81.0 t -64.71 -41.11 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.223 0.535 . . . . 0.0 109.991 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.85 -23.79 61.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.84 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 85.4 t80 . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.041 178.701 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' A' ' 127' ' ' LYS . 61.6 tp . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 120.669 0.271 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.521 ' N ' ' HG ' ' A' ' 126' ' ' LEU . 13.8 ptmm? -169.38 151.79 4.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.696 0.398 . . . . 0.0 110.69 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.82 ' OXT' HG13 ' A' ' 33' ' ' ILE . 14.5 p . . . . . 0 C--O 1.238 0.491 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.048 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 12.0 ptmm? . . . . . 0 CA--C 1.517 -0.319 0 CA-C-O 120.82 0.343 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 62' ' ' GLY . 14.6 m -128.16 154.19 38.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.938 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.7 t -116.35 123.6 48.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.546 0.689 . . . . 0.0 110.219 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.8 mt -122.34 -168.43 1.72 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.402 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 93.6 mt-30 -133.89 140.14 46.63 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.215 0.531 . . . . 0.0 110.642 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 10.0 mmtp -45.79 144.02 1.88 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.067 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -83.63 -179.39 7.31 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.439 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.77 -24.24 61.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 118.084 0.402 . . . . 0.0 111.363 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.477 HE21 HD22 ' A' ' 32' ' ' LEU . 6.1 tt0 -96.56 21.13 9.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 110.202 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 1.7 p-10 57.17 23.45 8.63 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.121 1.369 . . . . 0.0 113.173 174.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.477 HD22 HE21 ' A' ' 30' ' ' GLN . 0.8 OUTLIER -128.72 -165.43 1.5 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.797 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.769 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.7 -26.58 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.635 -178.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 98.28 41.9 3.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.093 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.509 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -130.06 172.6 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.947 0.879 . . . . 0.0 111.488 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m -141.41 129.41 21.96 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.712 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 35' ' ' ILE . 6.9 pt -119.41 137.97 51.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.896 0.855 . . . . 0.0 111.022 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.221 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.853 -179.587 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.6 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.475 0.655 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 m -117.66 -22.21 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.397 -175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -155.07 138.61 15.97 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.585 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 59' ' ' ALA . 6.2 p -139.91 160.89 26.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.855 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -97.93 -137.79 0.28 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.429 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.44 -34.66 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -101.72 -0.56 34.28 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.998 0.428 . . . . 0.0 110.174 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 80.2 p -84.04 148.54 53.86 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 10.2 Cg_endo -52.06 -41.16 66.04 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.484 1.456 . . . . 0.0 110.991 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.569 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.52 -45.71 88.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.827 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 52' ' ' VAL . . . -72.38 -59.56 2.67 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.411 0.624 . . . . 0.0 110.525 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.636 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.6 pp -54.87 -75.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.636 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 31.4 t70 -94.6 -13.06 26.33 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 122.581 1.181 . . . . 0.0 108.24 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -61.55 -40.34 98.57 Favored Glycine 0 C--N 1.314 -0.687 0 CA-C-N 112.464 -2.153 . . . . 0.0 114.804 -166.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.2 p 52.31 35.29 16.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.455 1.121 . . . . 0.0 111.197 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.434 HG11 HG13 ' A' ' 99' ' ' ILE . 15.9 m -122.79 53.66 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.174 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.62 179.67 7.33 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 112.649 -2.069 . . . . 0.0 111.319 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.34 123.05 15.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.696 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.64 -18.6 8.64 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.522 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.6 ' O ' HG21 ' A' ' 49' ' ' ILE . 11.9 m-20 -83.33 144.51 29.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.524 0.662 . . . . 0.0 110.532 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 41.9 mt-10 -94.52 97.0 9.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.924 -174.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.475 HD13 ' HB ' ' A' ' 49' ' ' ILE . 2.1 mp -76.01 138.26 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -127.89 -25.03 3.13 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.963 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.15 146.81 16.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.536 -1.316 . . . . 0.0 113.772 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.675 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -117.52 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.491 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 5.4 m-20 56.24 22.17 5.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.95 0.405 . . . . 0.0 111.786 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.83 -12.21 59.25 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.451 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 9.7 ptp180 -105.76 131.72 52.76 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 117.922 0.861 . . . . 0.0 110.861 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 p -61.06 138.08 58.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.133 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.504 HD12 ' H ' ' A' ' 79' ' ' LYS . 1.1 pp -77.56 -24.16 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-O 122.391 1.091 . . . . 0.0 109.883 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.504 ' H ' HD12 ' A' ' 78' ' ' ILE . 3.5 tppp? -69.63 -19.27 63.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.068 -1.878 . . . . 0.0 109.878 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.56 -15.61 75.47 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.019 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.518 ' HB3' ' HZ3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.73 -142.26 0.17 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.662 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 86' ' ' VAL . 29.7 p -136.35 169.79 17.08 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.177 -0.209 . . . . 0.0 111.105 -169.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.461 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -49.02 -53.99 17.7 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.81 0.693 . . . . 0.0 112.443 -176.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.06 -39.82 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.624 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.07 -35.32 66.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 82' ' ' THR . 32.3 m -68.54 -46.1 80.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.209 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.411 ' HB1' HD11 ' A' ' 126' ' ' LEU . . . -58.33 -37.82 75.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.971 0.415 . . . . 0.0 110.171 172.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -63.26 -53.13 57.8 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.847 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.475 ' O ' HG13 ' A' ' 93' ' ' VAL . 24.8 mmt -51.86 -42.48 62.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.25 0.548 . . . . 0.0 111.386 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.586 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 62.5 mt -64.78 -47.96 86.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.675 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.436 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 7.1 pt20 -73.78 -35.36 64.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.159 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -58.95 -50.1 75.35 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.526 0.516 . . . . 0.0 111.981 -173.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 89' ' ' MET . 17.8 m -52.99 -35.29 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.566 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 98.5 mttt 65.16 151.32 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.824 0.821 . . . . 0.0 112.802 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 88.3 -53.52 4.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.214 168.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.1 pt-20 -137.33 178.01 7.42 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.8 150.67 14.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.846 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 34.3 m -137.97 103.61 5.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.043 0.449 . . . . 0.0 110.182 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -94.45 129.81 44.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.338 -175.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -114.72 119.86 38.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.258 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -142.04 154.1 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.003 0.43 . . . . 0.0 110.893 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 17.3 m120 . . . . . 0 C--N 1.323 -0.563 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.586 ' OD2' ' HG2' ' A' ' 109' ' ' LYS . 10.5 t70 . . . . . 0 C--O 1.21 -1.007 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 9.2 Cg_exo -29.9 -47.77 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.693 2.929 . . . . 0.0 114.087 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.586 ' HG2' ' OD2' ' A' ' 107' ' ' ASP . 9.2 ptpp? -58.25 -49.61 76.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.232 0.539 . . . . 0.0 111.831 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.482 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 26.3 mm-40 -85.95 -11.59 52.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.714 0.769 . . . . 0.0 110.872 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.42 -43.89 22.47 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.142 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 115' ' ' PHE . 8.2 pt-20 -69.56 -22.07 63.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.191 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 109' ' ' LYS . 82.0 t -64.02 -35.24 72.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.403 0.62 . . . . 0.0 109.583 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.07 -27.66 54.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.81 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.408 ' HB3' ' HA ' ' A' ' 112' ' ' GLU . 13.7 t80 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.149 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.411 HD11 ' HB1' ' A' ' 87' ' ' ALA . 1.6 pp . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 121.503 0.668 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -151.43 114.55 4.75 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.634 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.769 ' OXT' HG13 ' A' ' 33' ' ' ILE . 13.8 p . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 118.011 -0.995 . . . . 0.0 108.699 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 63.8 mttm . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 99' ' ' ILE . 32.7 m -140.26 161.35 25.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.138 0.494 . . . . 0.0 112.152 -162.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 t -122.91 123.87 41.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.389 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' CD2' HD13 ' A' ' 99' ' ' ILE . 2.4 mm? -118.15 -166.68 1.24 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.805 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 93.1 mt-30 -127.67 149.67 50.1 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.908 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 23.9 mmtp -52.14 146.26 9.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.749 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.46 179.93 7.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.807 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.99 -22.2 60.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.119 0.485 . . . . 0.0 111.044 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.514 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -92.18 8.7 36.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.033 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 38.6 t30 72.61 11.72 5.52 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.335 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.573 HD23 ' OXT' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -127.13 -168.07 1.83 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.945 -0.472 . . . . 0.0 111.887 -174.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.83 -26.87 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 99.08 33.41 5.49 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.144 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 128' ' ' VAL . 2.8 pp -125.72 172.38 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.692 0.758 . . . . 0.0 112.126 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 40.0 m -139.14 127.65 23.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.24 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.549 ' HB ' ' HG ' ' A' ' 126' ' ' LEU . 66.0 mt -106.56 120.23 57.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.891 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.673 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.434 177.583 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 122.124 0.964 . . . . 0.0 110.048 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.6 t -111.79 -23.36 4.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.942 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -147.5 143.4 27.81 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.663 0.744 . . . . 0.0 112.402 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.487 ' CG2' ' HB1' ' A' ' 59' ' ' ALA . 6.5 p -143.05 160.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.758 -1.564 . . . . 0.0 109.395 174.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.539 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 22.8 m-85 -116.86 126.06 52.45 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 34.9 t70 -57.46 -21.99 40.69 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -164.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.468 ' HA ' HD22 ' A' ' 60' ' ' LEU . 42.5 m-80 -101.38 6.17 42.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.228 0.537 . . . . 0.0 110.23 -173.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.539 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 28.3 p -96.98 149.12 35.35 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -48.28 -40.08 35.27 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.183 1.922 . . . . 0.0 111.804 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -57.54 -54.16 50.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.967 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HB1' ' CG2' ' A' ' 52' ' ' VAL . . . -73.95 -54.82 7.08 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.036 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -42.85 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.831 -177.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -95.6 -36.27 11.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.329 0.585 . . . . 0.0 111.026 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.46 -38.61 95.02 Favored Glycine 0 CA--C 1.517 0.159 0 CA-C-N 115.211 -0.904 . . . . 0.0 114.39 -167.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.11 56.19 4.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.049 0.928 . . . . 0.0 110.819 -174.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.544 HG12 HG13 ' A' ' 99' ' ' ILE . 16.3 m -128.39 49.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.581 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.92 179.28 7.58 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.295 -167.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.19 123.56 7.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.036 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.96 20.5 11.29 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.63 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.454 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.2 t0 -107.97 161.77 14.64 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.491 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 4.2 mp0 -101.98 124.51 47.73 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.031 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.3 mm -113.31 141.89 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.465 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.747 HG22 ' CG ' ' A' ' 101' ' ' TYR . 12.0 t -137.44 -18.57 1.27 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.706 -0.621 . . . . 0.0 112.262 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -131.9 136.68 8.91 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.032 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.466 HG12 HG23 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -101.15 121.86 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 124.011 0.925 . . . . 0.0 109.156 175.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.487 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 9.2 t-20 57.01 25.51 10.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.542 0.687 . . . . 0.0 110.355 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.87 -21.15 43.12 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.027 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -107.45 140.31 40.6 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 118.206 1.003 . . . . 0.0 111.024 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' THR . 23.1 t -52.93 137.12 33.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 111.755 -174.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.489 ' HB ' HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -80.94 -17.83 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 109.499 -177.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -64.67 -13.58 54.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.523 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.71 -19.57 78.08 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.815 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.94 -130.7 0.14 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.732 0.766 . . . . 0.0 111.653 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.473 ' O ' HG11 ' A' ' 86' ' ' VAL . 2.8 m -139.11 156.09 47.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.565 -168.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.547 ' O ' HG21 ' A' ' 86' ' ' VAL . 3.5 mtpt -47.85 -49.11 30.35 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.292 0.637 . . . . 0.0 111.676 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -58.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 122.454 1.121 . . . . 0.0 110.537 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 41.2 mt-10 -61.93 -30.95 71.25 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 112.94 -1.936 . . . . 0.0 112.615 -171.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.547 HG21 ' O ' ' A' ' 83' ' ' LYS . 30.5 m -71.17 -42.26 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.17 -41.18 68.2 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 28.5 ttpp -59.38 -48.48 81.48 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.616 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 89.0 mtp -51.97 -41.16 61.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.138 0.495 . . . . 0.0 110.866 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.6 mt -72.21 -41.28 66.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.231 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -76.05 -25.0 55.18 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.176 -0.327 . . . . 0.0 111.792 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.03 -51.66 65.91 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.52 151.2 8.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -132.05 144.42 50.74 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.151 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.1 -47.27 1.08 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.639 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 10.5 pt-20 -138.59 176.45 8.68 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.568 0.699 . . . . 0.0 111.182 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.526 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 5.5 m -149.65 158.29 6.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.06 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 24.7 m -142.41 125.08 15.87 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 170.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.544 HG13 HG12 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -102.9 139.22 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.539 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 0.7 OUTLIER -134.56 124.42 25.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.67 -179.464 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.747 ' CG ' HG22 ' A' ' 71' ' ' THR . 1.0 OUTLIER 169.98 -130.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 O-C-N 124.426 1.079 . . . . 0.0 110.014 166.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.539 ' HB2' ' CD1' ' A' ' 101' ' ' TYR . 4.5 m120 . . . . . 0 N--CA 1.443 -0.812 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -158.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 111' ' ' LEU . 8.4 m-20 . . . . . 0 C--O 1.213 -0.821 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -31.36 -48.79 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.68 2.92 . . . . 0.0 114.032 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.427 ' HZ1' ' HG2' ' A' ' 110' ' ' GLN . 13.2 ptmm? -57.08 -48.95 77.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.57 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.468 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 61.9 mm-40 -90.42 -13.42 34.96 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.677 0.751 . . . . 0.0 110.327 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.4 tm? -76.21 -38.21 56.74 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.238 -175.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.53 -25.89 63.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.394 0.616 . . . . 0.0 109.528 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 110' ' ' GLN . 96.5 t -67.02 -44.18 88.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.572 173.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.71 -21.67 62.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.758 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 77.2 t80 . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.493 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.549 ' HG ' ' HB ' ' A' ' 37' ' ' ILE . 1.2 pp . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 13.7 ptmm? -152.56 129.72 11.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.394 0.616 . . . . 0.0 110.918 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.649 ' O ' HG13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.016 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 167.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.71 0.767 . . . . 0.0 110.007 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 99' ' ' ILE . 34.8 m -122.06 145.97 27.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.306 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.1 t -117.47 110.9 18.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.721 0.772 . . . . 0.0 110.312 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.49 -164.72 0.97 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.371 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 92.3 mt-30 -131.04 144.36 51.39 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.363 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 29.5 mmtm -47.91 149.65 1.3 Allowed 'General case' 0 C--N 1.316 -0.878 0 O-C-N 124.641 1.213 . . . . 0.0 111.841 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -83.04 -178.59 7.17 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.94 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.77 -19.24 49.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.422 0.63 . . . . 0.0 110.647 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.532 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 3.9 mt-30 -92.8 11.38 27.18 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.626 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 1.2 p-10 56.82 24.07 8.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.013 1.325 . . . . 0.0 112.498 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.545 HD23 ' OXT' ' A' ' 128' ' ' VAL . 1.2 pp -130.57 -165.47 1.55 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.182 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.703 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.75 -29.47 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 100.36 30.86 6.07 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.221 -0.514 . . . . 0.0 113.226 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' CD1' HG22 ' A' ' 128' ' ' VAL . 2.8 pp -122.85 179.71 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.061 0.457 . . . . 0.0 111.592 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 51.5 m -138.16 129.67 27.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.095 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.469 ' HB ' HD11 ' A' ' 126' ' ' LEU . 61.6 mt -97.46 139.47 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.854 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA2' ' HZ3' ' A' ' 83' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.338 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.049 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 122.083 0.944 . . . . 0.0 110.503 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.9 t -105.03 -30.26 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.258 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.441 ' HG2' ' HB2' ' A' ' 36' ' ' SER . 3.8 pt20 -157.05 152.54 26.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 6.7 p -141.84 160.54 20.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.845 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 97.3 m-85 -114.51 125.92 54.35 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.675 0.75 . . . . 0.0 108.978 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -53.07 -27.59 20.84 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 125.143 1.377 . . . . 0.0 114.566 -165.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.508 ' HA ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -100.85 4.14 42.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.26 0.552 . . . . 0.0 110.463 -171.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.485 ' CB ' ' HA3' ' A' ' 34' ' ' GLY . 30.4 p -91.3 146.82 34.18 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -47.41 -39.11 28.07 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.255 1.97 . . . . 0.0 111.659 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.49 -54.26 49.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.256 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -75.14 -52.97 9.67 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.388 0.614 . . . . 0.0 110.138 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.1 tm? -43.09 -75.62 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.502 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -96.83 -43.95 7.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.185 0.517 . . . . 0.0 111.479 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.3 -27.75 60.86 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 115.019 -0.992 . . . . 0.0 114.822 -164.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.48 48.31 19.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.868 0.842 . . . . 0.0 111.449 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.405 HG11 HG13 ' A' ' 99' ' ' ILE . 6.1 m -123.8 53.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 CA-C-O 122.936 1.351 . . . . 0.0 109.481 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.8 173.95 10.25 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 112.485 -2.143 . . . . 0.0 111.2 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.25 122.36 7.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.889 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.06 -4.97 16.01 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.71 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.615 ' O ' HG22 ' A' ' 49' ' ' ILE . 76.1 m-20 -98.85 172.81 7.2 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.548 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 30.7 tt0 -130.72 145.7 52.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.932 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.432 ' N ' HD11 ' A' ' 70' ' ' ILE . 4.2 mp -114.12 128.5 71.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.316 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.657 HG23 ' CG ' ' A' ' 101' ' ' TYR . 7.3 t -109.03 -4.81 16.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.054 0.454 . . . . 0.0 110.586 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.76 133.43 3.41 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.459 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.477 HG11 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -103.15 120.81 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.426 HD22 ' HA ' ' A' ' 90' ' ' ILE . 96.3 m-20 53.78 29.92 10.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.238 0.542 . . . . 0.0 111.704 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.57 -21.59 41.98 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.914 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -101.27 137.34 39.74 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 118.061 0.93 . . . . 0.0 110.789 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m -65.91 151.39 46.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.063 0.458 . . . . 0.0 111.228 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.884 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -93.47 3.48 8.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 122.455 1.121 . . . . 0.0 108.685 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -78.94 80.88 5.26 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.549 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.59 -30.49 0.41 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.688 -1.244 . . . . 0.0 115.012 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.884 ' HE2' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -112.35 -145.05 0.39 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.844 1.322 . . . . 0.0 112.088 -172.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.557 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -134.71 151.8 51.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.14 -178.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HA ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -45.44 -54.68 7.04 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.159 0.583 . . . . 0.0 112.341 175.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 p -51.69 -31.67 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.166 0.508 . . . . 0.0 111.981 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 89' ' ' MET . 32.4 mt-10 -81.89 -40.22 22.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.005 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' A' ' 83' ' ' LYS . 29.9 m -70.55 -38.25 72.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.538 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.17 -42.37 66.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.173 169.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -64.76 -50.77 65.51 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.717 175.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 62.4 mtt -50.74 -41.31 56.28 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.569 0.543 . . . . 0.0 111.045 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.497 HD13 HD11 ' A' ' 33' ' ' ILE . 74.4 mt -65.11 -56.42 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.254 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.521 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 10.3 pt20 -73.12 -24.59 60.64 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.713 -175.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 32.2 tt0 -58.7 -53.25 60.48 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.713 0.805 . . . . 0.0 111.976 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 90' ' ' ILE . 12.4 m -56.33 -29.02 27.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.292 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 92' ' ' GLU . 57.4 mttp 61.25 148.73 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.613 0.72 . . . . 0.0 112.609 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.55 -53.45 4.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.407 169.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 10.0 pt-20 -129.06 175.08 8.98 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.158 0.504 . . . . 0.0 110.19 -172.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.493 HG12 HG21 ' A' ' 33' ' ' ILE . 5.7 m -151.37 151.9 11.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.648 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.8 m -141.44 117.51 10.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.798 0.332 . . . . 0.0 110.741 170.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -98.63 148.74 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.17 176.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 1.1 m-70 -143.54 116.39 8.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.657 ' CG ' HG23 ' A' ' 71' ' ' THR . 1.3 t80 178.63 -116.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.615 0.572 . . . . 0.0 111.139 162.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.443 -0.78 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.135 -163.901 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.441 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 15.2 t70 . . . . . 0 C--O 1.205 -1.237 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 15.6 Cg_exo -29.3 -51.74 0.17 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 124.537 3.491 . . . . 0.0 115.424 -174.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.7 pttm -57.77 -48.15 80.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.356 0.598 . . . . 0.0 111.716 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.52 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.9 mm100 -83.37 -17.8 41.06 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.519 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.424 HD11 ' C ' ' A' ' 111' ' ' LEU . 2.4 tm? -64.74 -48.36 74.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.076 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -70.54 -25.24 63.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.794 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.8 t -69.6 -45.62 77.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.435 0.636 . . . . 0.0 109.787 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.53 -17.28 58.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.137 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.393 -177.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 127' ' ' LYS . 1.5 tm? . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 21.8 ptmt -167.0 127.13 1.5 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.532 0.682 . . . . 0.0 111.422 176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.703 ' O ' HG13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.845 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 163.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 62' ' ' GLY . 20.7 m -126.54 146.9 31.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.864 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 t -110.95 116.04 30.52 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.726 0.774 . . . . 0.0 110.77 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mt -123.32 -166.89 1.52 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.646 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.652 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 2.0 pt20 -144.01 142.6 30.78 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.766 174.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -32.87 149.74 0.01 OUTLIER 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 177.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.46 -179.25 6.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.655 -1.612 . . . . 0.0 108.385 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.58 -29.04 61.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.59 0.632 . . . . 0.0 111.499 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.53 ' HB3' HD21 ' A' ' 32' ' ' LEU . 3.2 mt-30 -88.05 5.36 41.35 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.043 0.449 . . . . 0.0 110.603 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.9 t30 70.28 28.22 3.92 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.349 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.712 ' HB2' ' OXT' ' A' ' 128' ' ' VAL . 1.8 pt? -128.19 -171.26 2.41 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.785 175.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.842 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -104.58 -26.21 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.715 179.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' N ' ' HG ' ' A' ' 32' ' ' LEU . . . 96.17 40.43 4.01 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.386 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.4 HG22 HG21 ' A' ' 52' ' ' VAL . 2.9 pp -129.64 176.74 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.968 0.89 . . . . 0.0 112.305 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 24.0 m -144.72 126.87 15.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.731 172.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.5 mt -103.32 119.9 52.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.246 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.093 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.824 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.7 m -94.31 -20.51 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.691 -170.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -157.07 136.24 11.92 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.505 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 59' ' ' ALA . 6.7 p -139.88 160.28 26.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.16 -138.55 0.2 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -138.24 -39.37 0.54 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.765 0.711 . . . . 0.0 112.145 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -101.32 4.09 41.3 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.762 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 59.9 p -84.14 148.04 52.27 Favored Pre-proline 0 N--CA 1.433 -1.285 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.0 Cg_endo -49.7 -42.18 43.93 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.764 1.643 . . . . 0.0 111.22 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.574 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.6 -46.48 84.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.019 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 52' ' ' VAL . . . -74.76 -59.13 2.87 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.346 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.614 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.6 pp -51.16 -74.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -171.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.614 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 21.7 t70 -93.74 -15.4 25.23 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.544 1.164 . . . . 0.0 108.081 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -64.39 -48.39 74.51 Favored Glycine 0 C--N 1.313 -0.704 0 CA-C-N 112.818 -1.992 . . . . 0.0 114.524 -166.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.1 p 63.64 15.78 9.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.078 0.951 . . . . 0.0 111.006 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG13 HG13 ' A' ' 99' ' ' ILE . 16.7 m -96.92 53.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-O 123.0 1.381 . . . . 0.0 110.028 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.21 168.52 14.69 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 112.512 -2.131 . . . . 0.0 111.39 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.66 122.54 6.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.832 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.64 -14.64 11.65 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.009 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.699 ' O ' HG22 ' A' ' 49' ' ' ILE . 43.4 m-20 -90.55 146.15 24.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.2 0.5 . . . . 0.0 110.167 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -89.4 126.48 35.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.682 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.5 mm -94.42 120.27 43.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -110.97 -21.68 11.88 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.832 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.78 156.06 27.72 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.398 -1.382 . . . . 0.0 113.869 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.9 124.63 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 C-N-CA 123.573 0.749 . . . . 0.0 109.186 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.467 ' HA ' ' OG1' ' A' ' 98' ' ' THR . 6.9 t-20 58.28 22.57 9.43 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.583 0.706 . . . . 0.0 111.192 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.44 -20.01 50.23 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.109 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -101.99 130.17 48.46 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 117.292 0.546 . . . . 0.0 110.619 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.6 m -63.66 153.52 35.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.021 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.501 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -93.08 -30.93 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 110.417 -178.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -71.44 91.26 1.02 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.552 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.54 -21.51 0.33 Allowed Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.799 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -125.83 -131.08 0.25 Allowed 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.245 177.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -137.48 147.36 45.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.927 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.471 ' HA ' HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -46.32 -49.49 17.55 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.598 0.759 . . . . 0.0 112.527 176.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -57.26 -39.9 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.831 0.348 . . . . 0.0 111.623 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.46 -41.48 66.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.943 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG12 ' HB ' ' A' ' 78' ' ' ILE . 32.8 m -67.63 -45.21 85.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.897 0.38 . . . . 0.0 110.815 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.25 -34.59 75.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.261 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.61 -51.16 68.39 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.424 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.2 mmt -53.04 -36.65 60.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.62 0.724 . . . . 0.0 111.416 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.469 ' CD1' HG13 ' A' ' 128' ' ' VAL . 44.6 mt -72.64 -31.86 38.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.753 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -90.37 -23.51 21.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.8 -49.45 62.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.946 0.499 . . . . 0.0 111.097 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.88 -32.32 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.718 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 62.32 119.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.652 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 96.97 -33.22 5.9 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.194 173.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.3 pt-20 -134.86 178.76 6.77 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 117.177 0.489 . . . . 0.0 110.501 -171.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.498 HG12 HG21 ' A' ' 33' ' ' ILE . 1.2 m -152.48 148.74 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.159 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -141.27 106.93 5.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.469 172.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.412 HG13 HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -100.0 141.99 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.051 0.453 . . . . 0.0 111.705 -178.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -118.5 121.36 40.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -136.52 174.73 10.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.053 0.454 . . . . 0.0 111.614 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--N 1.325 -0.472 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -177.001 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 C--O 1.215 -0.761 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -30.66 -55.39 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.915 3.077 . . . . 0.0 114.721 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.531 ' O ' HG22 ' A' ' 113' ' ' VAL . 5.9 ptpp? -56.48 -47.12 79.9 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.242 0.544 . . . . 0.0 112.311 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.479 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.3 mm100 -87.84 -17.02 32.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.895 -175.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -77.8 -45.32 24.79 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.021 -177.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.92 -27.27 69.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.215 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 109' ' ' LYS . 77.0 t -61.0 -41.38 88.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.14 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.79 -24.61 41.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.544 0.688 . . . . 0.0 109.802 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.9 t80 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.413 -176.899 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.448 ' HB3' ' HE3' ' A' ' 83' ' ' LYS . 1.6 pp . . . . . 0 C--O 1.227 -0.113 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.449 ' C ' ' HD2' ' A' ' 127' ' ' LYS . 0.1 OUTLIER -143.49 154.49 43.7 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.842 ' OXT' HG13 ' A' ' 33' ' ' ILE . 7.1 p . . . . . 0 C--O 1.247 0.93 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.315 0 CA-C-O 120.634 0.254 . . . . 0.0 110.352 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.406 HG22 HD12 ' A' ' 99' ' ' ILE . 27.2 m -128.71 158.65 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.152 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.9 t -132.72 117.32 17.7 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.652 0.739 . . . . 0.0 110.656 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.11 -159.25 0.9 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.875 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 96' ' ' GLU . 31.9 mm-40 -122.57 158.26 30.31 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.625 0.726 . . . . 0.0 110.114 175.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.569 ' NZ ' ' HA ' ' A' ' 91' ' ' GLN . 11.4 mmmm -54.4 156.69 3.17 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.082 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.57 174.97 7.47 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.3 -15.56 36.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.224 0.535 . . . . 0.0 110.556 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.469 ' NE2' HD22 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -91.38 -0.49 57.65 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.746 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.492 ' C ' ' HE2' ' A' ' 27' ' ' LYS . 31.1 t30 70.06 38.05 1.59 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.427 1.108 . . . . 0.0 109.897 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.518 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -154.57 -167.35 2.59 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.572 175.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.743 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.26 -28.93 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.945 -177.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.442 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 100.4 35.11 4.52 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.608 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.5 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.7 pp -126.92 177.96 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.269 0.557 . . . . 0.0 111.633 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -134.76 128.19 32.39 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.626 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.517 ' HB ' ' CD1' ' A' ' 126' ' ' LEU . 56.2 mt -107.47 140.79 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.469 0.652 . . . . 0.0 111.912 -173.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.978 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.523 ' HB ' ' CG1' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 122.531 1.158 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -95.62 -30.55 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.206 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -155.49 139.87 16.75 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.453 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 59' ' ' ALA . 5.2 p -138.33 161.2 31.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -99.33 -135.05 0.28 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -138.4 -33.41 0.68 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -101.61 1.82 38.19 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.062 0.458 . . . . 0.0 110.366 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 77.9 p -85.33 150.18 53.92 Favored Pre-proline 0 N--CA 1.44 -0.956 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.16 -40.39 77.31 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.295 1.33 . . . . 0.0 111.197 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.46 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.42 -46.28 86.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.741 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HB3' HG21 ' A' ' 52' ' ' VAL . . . -73.62 -58.4 3.33 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.672 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.57 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 2.1 pp -52.95 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -170.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.57 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 24.0 t70 -95.99 -16.32 21.75 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.262 1.029 . . . . 0.0 108.487 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -61.21 -38.71 96.09 Favored Glycine 0 C--N 1.315 -0.586 0 CA-C-N 113.019 -1.901 . . . . 0.0 113.594 -169.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p 52.31 38.38 24.76 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.415 1.102 . . . . 0.0 111.774 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 m -118.17 54.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.832 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.49 168.64 15.27 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 112.716 -2.038 . . . . 0.0 111.778 -170.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.89 132.09 26.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.669 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.0 2.64 57.03 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.648 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' OD1' ' HB2' ' A' ' 101' ' ' TYR . 1.7 t70 -90.77 167.89 12.14 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.97 89.52 3.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.523 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 25.0 mm -78.34 110.0 13.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.893 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -102.3 -7.57 21.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.129 -175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -151.88 135.37 4.99 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.384 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.45 ' CG1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -103.57 120.83 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 123.615 0.766 . . . . 0.0 109.217 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.3 t30 55.1 32.81 19.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.952 0.882 . . . . 0.0 110.472 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.83 -21.29 44.39 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.405 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -108.17 138.58 44.2 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 117.132 0.466 . . . . 0.0 110.484 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.438 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 17.7 t -59.58 142.51 52.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.89 0.376 . . . . 0.0 111.892 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.45 HG21 ' CG1' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -74.89 -22.71 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HB3' ' HZ3' ' A' ' 79' ' ' LYS . 7.8 ttpm? -64.38 99.35 0.29 Allowed 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.814 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.2 -30.63 1.75 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.942 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.623 ' HE3' ' SD ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -125.26 -139.27 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.795 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -141.25 159.88 41.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.896 -169.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.47 ' O ' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -49.38 -52.79 26.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.503 0.502 . . . . 0.0 110.865 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -53.94 -38.71 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.893 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 34.2 mt-10 -76.28 -39.58 53.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.567 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.492 ' HA ' ' SD ' ' A' ' 89' ' ' MET . 34.7 m -69.61 -39.31 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.299 . . . . 0.0 111.389 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.54 -43.64 62.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.326 168.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 28.5 ttpp -61.59 -46.58 89.25 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.495 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.623 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 74.1 mtp -56.3 -35.14 67.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.43 0.633 . . . . 0.0 110.482 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.476 ' O ' HG21 ' A' ' 93' ' ' VAL . 27.9 mm -73.7 -32.3 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.387 177.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.569 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 56.0 mt-30 -82.74 -24.67 33.44 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.754 -0.591 . . . . 0.0 111.899 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -64.25 -39.49 94.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.286 0.634 . . . . 0.0 111.895 -171.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 94' ' ' LYS . 3.7 m -35.48 -47.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.114 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.562 ' N ' HG23 ' A' ' 93' ' ' VAL . 55.4 mtmt 57.08 83.29 0.1 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.496 -162.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.438 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 115.47 -36.73 3.75 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 118.785 -1.674 . . . . 0.0 113.675 164.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 93' ' ' VAL . 11.7 pt-20 -106.13 172.35 6.86 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 117.716 0.758 . . . . 0.0 110.127 -173.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 t -153.4 127.87 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.448 -171.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.0 m -141.04 135.75 31.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.455 HD13 ' N ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -130.87 140.67 48.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.801 0.334 . . . . 0.0 111.808 -177.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -116.99 122.57 44.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.404 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 40.2 p90 -138.85 157.16 46.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.073 0.463 . . . . 0.0 111.582 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m120 . . . . . 0 C--N 1.325 -0.475 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.19 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 16.7 m-20 . . . . . 0 C--O 1.215 -0.746 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 107' ' ' ASP . 12.8 Cg_exo -31.51 -46.86 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.904 2.403 . . . . 0.0 113.959 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.1 ptpt -68.83 -48.23 64.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.511 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.489 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.5 mm100 -84.92 -11.77 54.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.438 0.637 . . . . 0.0 110.968 -174.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.1 tm? -70.02 -43.37 71.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.339 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.16 -30.72 63.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.271 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.3 t -63.71 -36.1 75.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.473 0.654 . . . . 0.0 109.902 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.6 tp -77.86 -27.02 49.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.244 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.8 t80 . . . . . 0 N--CA 1.465 0.275 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.075 -177.315 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.517 ' CD1' ' HB ' ' A' ' 37' ' ' ILE . 2.0 mt . . . . . 0 CA--C 1.497 -1.085 0 CA-C-O 121.291 0.567 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -157.51 80.75 0.89 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.194 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.743 ' OXT' HG13 ' A' ' 33' ' ' ILE . 9.1 p . . . . . 0 N--CA 1.438 -1.068 0 CA-C-O 117.575 -1.203 . . . . 0.0 108.724 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 62' ' ' GLY . 29.8 m -128.04 152.93 36.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.5 t -118.41 123.07 44.33 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.631 0.729 . . . . 0.0 110.571 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -130.51 -165.22 1.52 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.536 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -133.28 142.93 48.75 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.326 0.584 . . . . 0.0 110.513 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 2.5 mmmm -43.09 146.95 0.37 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.487 -1.688 . . . . 0.0 112.637 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -85.09 177.8 7.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.798 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.14 -21.77 48.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.909 0.385 . . . . 0.0 111.45 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.539 ' NE2' HD21 ' A' ' 32' ' ' LEU . 5.0 tt0 -92.88 15.11 15.56 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.123 0.487 . . . . 0.0 110.231 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 1.2 p-10 54.5 35.31 23.05 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.527 1.131 . . . . 0.0 111.583 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.707 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -140.76 -171.16 3.18 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.376 174.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.812 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -97.96 -31.07 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-O 120.682 0.277 . . . . 0.0 111.039 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' N ' HD12 ' A' ' 32' ' ' LEU . . . 102.5 37.64 3.22 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.324 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 2.3 pp -126.91 173.37 12.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.131 0.491 . . . . 0.0 110.72 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.4 m -134.86 130.55 36.16 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.782 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.507 ' HB ' HD13 ' A' ' 126' ' ' LEU . 40.7 mm -114.15 128.91 70.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.73 0.776 . . . . 0.0 111.838 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.995 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.582 179.556 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.496 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.02 -34.6 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.833 -170.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -155.84 144.41 20.25 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 120.764 0.316 . . . . 0.0 110.487 -171.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.495 HG22 ' HB3' ' A' ' 59' ' ' ALA . 5.7 p -139.14 160.18 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -92.02 -136.19 0.15 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.73 -38.26 0.47 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.617 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -100.91 3.87 42.15 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.036 0.446 . . . . 0.0 110.324 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 61.7 p -82.62 151.26 64.62 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.5 -40.75 71.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.299 1.333 . . . . 0.0 111.269 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.572 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -59.16 -44.31 92.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.255 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -78.33 -55.94 4.85 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.836 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.619 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.7 pp -52.66 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -171.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.619 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 29.4 t70 -95.78 -12.73 24.89 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.441 1.115 . . . . 0.0 108.12 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -65.36 -45.46 90.54 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 112.969 -1.923 . . . . 0.0 113.497 -170.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p 62.93 9.51 3.77 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.069 0.948 . . . . 0.0 111.498 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.42 HG13 HG13 ' A' ' 99' ' ' ILE . 19.1 m -89.68 53.53 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 CA-C-O 123.001 1.382 . . . . 0.0 110.166 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.29 169.99 14.13 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.622 -2.081 . . . . 0.0 111.459 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.48 129.87 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.143 -174.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.7 -22.24 10.11 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.673 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.496 ' O ' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -80.4 161.48 24.95 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.339 -177.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -110.44 120.89 43.88 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.8 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.0 mm -89.63 123.75 41.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.588 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.6 t -103.15 -29.77 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.51 151.16 20.54 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.905 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -107.72 122.53 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.429 ' ND2' HG13 ' A' ' 93' ' ' VAL . 5.2 m-20 50.62 31.6 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.66 -20.66 45.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.637 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 18.8 ptp180 -100.23 124.39 45.61 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 117.502 0.651 . . . . 0.0 110.279 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.1 m -61.15 149.83 36.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.999 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.474 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -81.76 -17.55 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.567 0.698 . . . . 0.0 109.55 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.69 -24.14 66.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.636 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.45 -12.69 80.0 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.182 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.595 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -137.35 -131.51 0.14 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.531 0.666 . . . . 0.0 110.619 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.3 p -146.8 166.09 27.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.364 0.126 . . . . 0.0 111.046 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.449 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -49.72 -53.33 25.4 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.662 0.601 . . . . 0.0 112.406 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -56.08 -37.73 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.66 -38.86 58.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.529 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.474 HG11 ' HB ' ' A' ' 78' ' ' ILE . 26.6 m -71.13 -44.03 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.955 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.21 62.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.289 170.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.21 -52.48 63.59 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.284 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.8 mmt -54.06 -43.23 70.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 0.0 112.02 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.95 -39.59 82.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.067 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.82 -36.16 57.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 122.362 -0.211 . . . . 0.0 111.443 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.83 -44.08 90.84 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.308 0.643 . . . . 0.0 110.892 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 93' ' ' VAL . 13.8 m -70.18 71.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 122.878 1.323 . . . . 0.0 110.203 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 96.8 mttt -60.34 126.3 26.97 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.596 -173.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.562 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 100.66 -27.16 21.8 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.515 170.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 97' ' ' VAL . 8.5 pt-20 -124.16 171.87 9.48 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 117.39 0.595 . . . . 0.0 110.083 -174.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 96' ' ' GLU . 2.1 t -157.19 128.17 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.742 -171.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.4 m -140.32 106.47 5.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.038 0.447 . . . . 0.0 110.908 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -97.18 147.81 6.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.064 -177.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -130.88 123.38 28.86 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -133.65 144.76 49.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 0.0 111.421 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 . . . . . 0 C--N 1.326 -0.417 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 . . . . . 0 C--O 1.216 -0.692 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.527 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 22.4 Cg_exo -31.8 -52.57 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.678 2.919 . . . . 0.0 114.07 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.468 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.0 ptmt -62.25 -48.51 79.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.015 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.468 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 71.6 mm-40 -81.4 -19.45 42.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.712 0.768 . . . . 0.0 110.153 -174.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.31 -51.17 13.86 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.204 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 4.7 pt-20 -70.77 -34.6 71.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.879 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.468 ' N ' ' HG3' ' A' ' 112' ' ' GLU . 2.9 p -65.14 -38.37 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.283 -176.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.75 -28.04 36.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.511 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 56.2 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.508 -176.839 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.507 HD13 ' HB ' ' A' ' 37' ' ' ILE . 12.2 mt . . . . . 0 CA--C 1.489 -1.388 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -165.78 85.62 0.35 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 110.996 -2.82 . . . . 0.0 109.057 175.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.812 ' OXT' HG13 ' A' ' 33' ' ' ILE . 6.0 p . . . . . 0 C--O 1.246 0.872 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.287 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.6 pttm . . . . . 0 CA--C 1.518 -0.264 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.435 HG21 HD13 ' A' ' 99' ' ' ILE . 29.2 m -140.53 158.72 24.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 t -124.37 125.79 44.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.163 0.506 . . . . 0.0 110.751 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.44 -169.28 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.763 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 91.0 mt-30 -132.9 149.21 52.27 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.417 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.615 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 8.6 mmtp -47.24 146.37 1.93 Allowed 'General case' 0 C--N 1.313 -1.004 0 O-C-N 124.629 1.206 . . . . 0.0 112.344 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.88 177.94 8.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.115 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.03 -19.78 61.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.185 0.517 . . . . 0.0 110.419 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.451 ' NE2' HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -89.49 3.84 51.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.241 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.9 15.72 5.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.68 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.508 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -131.43 -163.69 1.36 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.642 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.862 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.51 -23.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.8 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.86 36.13 4.87 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.918 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.495 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.6 pp -125.91 168.53 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.903 0.859 . . . . 0.0 111.564 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 44.9 m -134.43 131.77 38.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.499 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.672 ' O ' ' HB3' ' A' ' 126' ' ' LEU . 76.3 mt -117.75 130.67 72.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.57 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.439 ' HA2' ' HZ2' ' A' ' 83' ' ' LYS . . . . . . . . 0 N--CA 1.436 -1.323 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.633 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.347 0 CA-C-O 122.282 1.039 . . . . 0.0 109.497 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -98.43 -25.73 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.229 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.76 145.23 12.33 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.946 -172.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 59' ' ' ALA . 7.5 p -140.25 161.12 25.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -87.81 -138.03 0.1 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -137.48 -38.94 0.59 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 119.152 0.887 . . . . 0.0 112.641 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.539 ' HA ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -101.45 10.86 40.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.455 0.645 . . . . 0.0 109.854 -171.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 42.9 p -93.82 147.87 34.3 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 8.5 Cg_endo -48.48 -39.97 36.74 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.215 1.943 . . . . 0.0 111.631 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.8 -53.57 56.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.141 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB2' HG21 ' A' ' 52' ' ' VAL . . . -74.98 -55.04 6.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.513 0.673 . . . . 0.0 109.946 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.539 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.1 tm? -42.73 -76.22 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.171 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -96.45 -38.3 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.052 0.453 . . . . 0.0 111.514 -177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.508 ' O ' HG23 ' A' ' 63' ' ' THR . . . -66.49 -27.29 73.04 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.746 -168.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 62' ' ' GLY . 5.8 t 52.44 25.44 3.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.456 1.103 . . . . 0.0 111.645 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.546 HG13 HG13 ' A' ' 99' ' ' ILE . 29.9 m -88.93 50.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 122.068 0.937 . . . . 0.0 109.761 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.01 175.27 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.204 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.43 118.53 3.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.527 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.93 5.59 8.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.82 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.692 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -107.3 161.75 14.51 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 110.431 174.665 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.572 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 18.0 mm-40 -104.05 138.24 40.87 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.6 mm -118.55 134.01 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 123.104 0.252 . . . . 0.0 110.379 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.486 HG23 ' HA ' ' A' ' 101' ' ' TYR . 14.9 t -132.74 -18.97 2.37 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.127 -0.358 . . . . 0.0 111.844 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -139.16 138.32 9.25 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.744 -1.217 . . . . 0.0 113.635 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.401 HG13 HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -105.53 123.15 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.518 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 17.4 t-20 59.1 23.23 11.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.914 0.864 . . . . 0.0 109.965 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.93 -20.24 48.67 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.552 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -105.32 136.58 44.58 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 117.888 0.844 . . . . 0.0 111.095 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 71' ' ' THR . 19.3 t -55.88 140.63 42.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.678 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.54 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -74.68 -17.57 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.731 0.777 . . . . 0.0 109.127 -177.03 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -63.47 -20.57 65.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.633 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.4 -17.32 76.32 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.365 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.631 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 1.7 mptp? -120.42 -136.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.914 0.864 . . . . 0.0 109.635 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.9 p -151.31 163.49 38.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.525 -1.671 . . . . 0.0 107.838 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.524 ' O ' HG21 ' A' ' 86' ' ' VAL . 1.5 mtpt -48.02 -52.75 18.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.316 0.579 . . . . 0.0 111.793 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -56.67 -35.11 44.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.362 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 89' ' ' MET . 34.1 mt-10 -77.13 -46.54 23.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.614 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.54 HG11 ' HB ' ' A' ' 78' ' ' ILE . 24.0 m -59.05 -43.7 89.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HB1' HD13 ' A' ' 126' ' ' LEU . . . -59.51 -35.59 74.45 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 173.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 38.8 ttpt -64.34 -51.26 64.25 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.476 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 82.2 mtp -48.15 -52.24 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.737 0.648 . . . . 0.0 111.136 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.615 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 62.6 mt -61.78 -46.69 95.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.029 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.418 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 8.7 pt20 -77.39 -29.03 53.0 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.211 -0.306 . . . . 0.0 111.564 -177.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -68.23 -48.0 66.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.3 m -50.31 -33.48 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.86 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt 67.15 137.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.669 0.747 . . . . 0.0 112.282 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.513 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 90.59 -50.07 3.2 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.404 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.3 pt-20 -125.82 176.49 6.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 117.256 0.528 . . . . 0.0 110.409 -172.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.441 HG23 ' CG2' ' A' ' 33' ' ' ILE . 14.2 m -150.88 150.85 13.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.804 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.518 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 1.7 m -141.83 107.58 5.12 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.904 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.546 HG13 HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -90.8 138.87 18.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.902 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.61 124.42 15.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -174.66 -113.17 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.168 161.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 N--CA 1.444 -0.764 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.878 -169.336 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.212 -0.883 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -32.08 -52.6 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.818 3.012 . . . . 0.0 114.443 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.2 ptmt -55.82 -46.08 78.17 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.426 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.3 mm100 -89.63 -13.41 37.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.892 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.2 tm? -70.79 -40.95 72.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.313 -177.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.7 -24.38 62.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.258 0.552 . . . . 0.0 110.46 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.08 -45.54 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.042 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.2 mt -82.61 -3.42 56.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.365 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 9.4 t80 . . . . . 0 C--N 1.321 -0.66 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.36 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.672 ' HB3' ' O ' ' A' ' 37' ' ' ILE . 40.5 tp . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 120.99 0.424 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 22.9 pttp -156.82 139.75 15.3 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.635 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.862 ' OXT' HG13 ' A' ' 33' ' ' ILE . 14.4 p . . . . . 0 C--N 1.313 -1.003 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.5 m -138.35 147.72 25.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.815 0.34 . . . . 0.0 110.195 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -110.39 101.12 9.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.279 0.561 . . . . 0.0 110.465 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.412 HD11 ' HA3' ' A' ' 62' ' ' GLY . 10.6 mt -111.88 -170.22 1.61 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.736 -174.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 88.6 mt-30 -132.54 144.38 50.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.239 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 28.5 mmtm -50.25 158.37 0.57 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.676 -175.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 5.4 p-10 -89.82 -163.64 1.04 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.92 67.24 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.477 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.445 HE21 HD21 ' A' ' 32' ' ' LEU . 9.2 tt0 -92.56 9.46 34.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.663 0.268 . . . . 0.0 111.082 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 51.9 t30 66.66 30.0 8.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.75 0.786 . . . . 0.0 110.905 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 1.3 pp -133.05 -171.24 2.63 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 121.821 -0.55 . . . . 0.0 111.202 172.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.709 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.71 -27.96 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.973 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.68 28.39 6.0 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.942 -0.646 . . . . 0.0 113.046 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.559 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -121.65 174.12 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.762 0.791 . . . . 0.0 112.074 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 23.0 m -137.28 126.09 24.03 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.229 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.441 ' HB ' HD12 ' A' ' 126' ' ' LEU . 68.7 mt -98.46 140.16 18.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.72 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.926 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.24 -176.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.601 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -97.03 -21.38 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -168.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.48 141.93 10.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.182 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' CG2' ' HB1' ' A' ' 59' ' ' ALA . 6.1 p -141.16 160.75 22.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.994 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.521 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 92.5 m-85 -113.96 124.67 52.73 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.432 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 30.7 t70 -58.33 -23.4 56.55 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -165.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.445 ' HA ' HD23 ' A' ' 60' ' ' LEU . 46.7 m-80 -101.77 9.84 40.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.49 0.662 . . . . 0.0 110.09 -172.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 31.6 p -98.66 149.24 35.55 Favored Pre-proline 0 CA--C 1.502 -0.877 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -48.55 -38.63 36.18 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 121.946 1.764 . . . . 0.0 111.374 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.22 5.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.065 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HB1' ' CG2' ' A' ' 52' ' ' VAL . . . -72.15 -53.2 13.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.453 0.644 . . . . 0.0 110.227 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -45.13 -74.3 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.629 -178.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -95.54 -35.5 11.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.611 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.412 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -74.79 -31.49 58.2 Favored Glycine 0 C--O 1.228 -0.26 0 CA-C-N 115.523 -0.762 . . . . 0.0 114.245 -168.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p 66.05 15.38 10.05 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.851 0.86 . . . . 0.0 110.674 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.78 53.98 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 CA-C-O 122.748 1.261 . . . . 0.0 110.518 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.89 176.39 8.51 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.942 -172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.94 104.34 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.716 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.06 -10.33 3.06 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.962 -175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.601 ' O ' HG21 ' A' ' 49' ' ' ILE . 2.4 t70 -89.32 164.95 14.69 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.724 ' HB3' ' CD2' ' A' ' 101' ' ' TYR . 5.5 mp0 -107.89 134.85 50.23 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.492 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 5.4 mm -122.97 122.29 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.691 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 7.6 t -129.85 -10.19 4.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.72 0.295 . . . . 0.0 111.699 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.3 151.52 23.1 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.711 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.546 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 4.4 m -117.85 147.36 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 114.355 -0.923 . . . . 0.0 109.02 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.405 ' ND2' HG13 ' A' ' 93' ' ' VAL . 5.5 t-20 60.92 19.53 9.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.425 0.631 . . . . 0.0 110.508 171.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.01 -10.33 70.08 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.12 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 14.9 ptp180 -121.27 143.73 49.01 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 117.156 0.478 . . . . 0.0 111.238 -174.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 m -52.49 146.39 9.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.525 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.523 HG21 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -76.09 -13.19 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 121.695 0.759 . . . . 0.0 109.2 -176.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -58.61 -17.33 21.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.074 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.91 67.78 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.982 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -142.45 -119.73 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.966 -0.138 . . . . 0.0 111.061 178.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.469 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 14.9 t -158.1 174.77 14.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.566 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -47.32 -60.02 2.79 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -175.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -54.51 -34.62 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 121.258 0.551 . . . . 0.0 111.779 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 40.0 mt-10 -78.68 -35.08 45.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.809 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 83' ' ' LYS . 34.4 m -73.42 -38.94 54.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.539 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.96 -36.41 59.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.003 169.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 60.7 tttm -64.66 -50.08 68.46 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 84.5 mtp -53.99 -44.66 71.04 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.204 0.525 . . . . 0.0 111.237 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 93' ' ' VAL . 29.6 mm -55.28 -56.87 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.631 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.506 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 8.6 pt20 -76.07 -22.86 55.16 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -58.59 -50.65 73.02 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.032 0.533 . . . . 0.0 110.959 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 90' ' ' ILE . 13.2 m -60.1 -29.66 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.941 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp 63.45 143.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.001 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.486 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 87.94 -48.81 3.72 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.876 170.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.7 pt-20 -127.24 175.65 8.0 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 117.398 0.599 . . . . 0.0 110.125 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.487 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 9.2 m -147.92 155.54 9.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.838 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -142.37 99.87 3.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.712 0.292 . . . . 0.0 111.203 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.95 144.6 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -147.72 131.16 16.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.724 ' CD2' ' HB3' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -177.97 -114.62 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.172 162.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 1.4 t-20 . . . . . 0 N--CA 1.442 -0.865 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.583 -171.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.526 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 9.8 m-20 . . . . . 0 C--O 1.216 -0.661 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.618 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 37.7 Cg_exo -29.09 -60.61 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.899 3.066 . . . . 0.0 115.107 -167.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.6 pttp -65.54 -50.07 66.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.238 0.542 . . . . 0.0 111.866 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.526 ' CG ' ' H ' ' A' ' 107' ' ' ASP . 12.4 pt20 -80.11 -7.94 59.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.853 0.835 . . . . 0.0 111.827 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.43 HD11 ' C ' ' A' ' 111' ' ' LEU . 1.8 tm? -90.04 -48.4 7.22 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.922 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 6.0 pt-20 -71.45 -24.86 62.09 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 110.864 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.1 p -68.15 -32.64 56.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.483 0.659 . . . . 0.0 109.708 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.43 -24.9 39.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.471 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 58.7 t80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.408 -179.206 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.518 HD11 ' N ' ' A' ' 127' ' ' LYS . 0.4 OUTLIER . . . . . 0 CA--C 1.509 -0.604 0 CA-C-O 121.351 0.596 . . . . 0.0 111.964 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.518 ' N ' HD11 ' A' ' 126' ' ' LEU . 19.2 ptmt -167.87 111.09 0.63 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.728 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.709 ' OXT' HG13 ' A' ' 33' ' ' ILE . 12.6 p . . . . . 0 N--CA 1.441 -0.896 0 CA-C-O 118.08 -0.962 . . . . 0.0 108.909 170.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.69 157.43 42.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 t -124.58 118.61 26.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.384 0.611 . . . . 0.0 110.563 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.448 ' CD2' HD12 ' A' ' 99' ' ' ILE . 2.3 mm? -119.92 -169.6 1.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.645 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 87.8 mt-30 -129.28 140.31 51.48 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.821 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HG2' ' C ' ' A' ' 95' ' ' GLY . 25.4 mmtp -45.9 148.79 0.74 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.336 -176.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -82.7 -179.01 7.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.585 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.64 55.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.192 0.52 . . . . 0.0 110.875 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.546 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.7 mt-30 -91.12 4.1 53.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.948 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 37.8 t30 71.04 16.71 6.35 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.036 0.922 . . . . 0.0 111.133 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.598 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -128.31 -171.1 2.37 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.769 -0.582 . . . . 0.0 111.275 -179.45 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.734 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.37 -29.23 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.604 -177.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.26 27.18 5.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.745 . . . . 0.0 113.125 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pp -119.17 173.85 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.333 0.587 . . . . 0.0 111.839 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 36.3 m -134.65 129.92 35.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.517 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.454 ' HB ' HD12 ' A' ' 126' ' ' LEU . 63.3 mt -104.03 145.07 13.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.518 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.031 -179.85 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.658 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 122.215 1.007 . . . . 0.0 109.856 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.3 -29.98 4.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.257 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.463 ' HG2' ' HB2' ' A' ' 36' ' ' SER . 4.0 pt20 -164.31 156.29 16.43 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.477 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 9.3 p -141.99 161.67 20.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.263 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.526 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 89.9 m-85 -113.67 123.63 50.38 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -55.23 -25.81 35.62 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.115 -165.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.489 ' HA ' HD23 ' A' ' 60' ' ' LEU . 47.8 m-80 -102.41 8.39 40.16 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.169 0.509 . . . . 0.0 110.616 -172.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.526 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 32.0 p -96.72 150.32 36.81 Favored Pre-proline 0 CA--C 1.503 -0.844 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.51 -37.67 42.73 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 121.789 1.659 . . . . 0.0 111.396 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -57.36 -57.35 13.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.108 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.477 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -73.61 -52.6 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.451 0.643 . . . . 0.0 110.121 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -45.39 -75.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.806 -1.543 . . . . 0.0 112.743 -177.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -96.59 -33.12 11.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.157 0.503 . . . . 0.0 111.5 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.25 -28.77 63.39 Favored Glycine 0 C--O 1.228 -0.275 0 CA-C-N 115.663 -0.699 . . . . 0.0 114.236 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p 64.57 14.41 8.95 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.994 0.917 . . . . 0.0 111.403 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.44 HG12 HG13 ' A' ' 99' ' ' ILE . 6.9 m -84.98 54.56 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 CA-C-O 122.578 1.18 . . . . 0.0 111.284 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.17 173.2 10.6 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.469 -172.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.8 113.41 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.163 -173.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.12 -16.37 4.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.446 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.658 ' O ' HG21 ' A' ' 49' ' ' ILE . 1.7 m-20 -96.86 154.62 17.19 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 117.597 0.698 . . . . 0.0 110.746 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 38.3 tt0 -90.7 80.86 5.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.529 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.489 HD12 ' HB ' ' A' ' 49' ' ' ILE . 1.8 mp -68.85 92.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 77' ' ' SER . 9.0 t -96.08 -14.05 23.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.595 -170.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -143.83 137.27 7.35 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 119.367 -1.397 . . . . 0.0 113.629 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -104.79 119.02 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.526 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 16.9 t-20 55.03 32.18 17.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.413 0.625 . . . . 0.0 110.613 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.86 -21.28 46.73 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.643 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -102.76 126.91 50.06 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 117.725 0.762 . . . . 0.0 110.991 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 71' ' ' THR . 29.9 m -57.79 145.81 33.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.72 -176.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.442 ' HB ' HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -81.32 -18.51 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.546 0.689 . . . . 0.0 109.602 -179.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -63.04 -24.19 67.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.877 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.44 -14.85 81.72 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.936 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.595 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.22 -132.31 0.15 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.409 0.604 . . . . 0.0 110.718 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -143.64 152.26 41.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.112 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.4 ptpt -43.43 -59.36 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.96 0.504 . . . . 0.0 112.272 176.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.5 p -53.97 -34.87 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.842 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 89' ' ' MET . 33.7 mt-10 -76.93 -42.44 39.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.557 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 83' ' ' LYS . 33.6 m -66.8 -40.11 85.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.643 -175.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.57 -41.42 63.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.429 170.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -66.44 -45.94 78.13 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.197 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 59.4 mtt -54.62 -35.17 63.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.398 0.618 . . . . 0.0 110.765 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 93' ' ' VAL . 65.3 mt -75.33 -48.84 29.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.186 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.406 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 86.4 mt-30 -63.6 -41.06 98.36 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.03 -45.44 85.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.441 -169.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 90' ' ' ILE . 25.9 m -54.63 -31.42 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.295 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? 65.93 130.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 170.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.479 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 97.77 -47.91 1.51 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.517 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.0 pt-20 -136.48 176.83 8.34 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.188 0.518 . . . . 0.0 110.406 -172.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.442 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 5.4 m -147.43 153.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.862 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.526 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 30.8 m -142.4 115.77 9.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -111.1 123.63 67.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.269 -175.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -98.67 123.69 43.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 69' ' ' GLU . 17.0 p90 -141.96 139.95 32.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.577 0.703 . . . . 0.0 112.006 -173.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.127 -179.601 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 C--O 1.211 -0.926 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.52 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 19.4 Cg_exo -29.97 -51.99 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.009 3.14 . . . . 0.0 114.958 -171.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.52 ' HG3' ' HG3' ' A' ' 110' ' ' GLN . 59.3 pttt -57.16 -44.48 83.53 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.517 0.675 . . . . 0.0 112.285 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.52 ' HG3' ' HG3' ' A' ' 109' ' ' LYS . 96.9 mt-30 -85.98 -27.74 24.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.632 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.5 tm? -66.55 -49.52 66.18 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.221 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 5.2 pt-20 -60.07 -31.68 70.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.1 0.476 . . . . 0.0 110.69 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 109' ' ' LYS . 68.8 t -64.52 -47.41 89.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.512 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.01 -13.61 57.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.496 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 20.9 t80 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.859 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.498 HD11 ' N ' ' A' ' 127' ' ' LYS . 1.1 tm? . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.498 ' N ' HD11 ' A' ' 126' ' ' LEU . 19.8 ptmt -161.94 112.98 1.64 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.143 0.497 . . . . 0.0 110.429 -174.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.734 ' O ' HG13 ' A' ' 33' ' ' ILE . 13.1 p . . . . . 0 N--CA 1.437 -1.122 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.009 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 99' ' ' ILE . 7.7 p -147.57 158.46 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -170.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.461 HG23 HG23 ' A' ' 98' ' ' THR . 24.5 p -124.52 121.78 35.76 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 122.2 -0.313 . . . . 0.0 111.083 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.457 HD22 ' CA ' ' A' ' 62' ' ' GLY . 2.7 mm? -121.16 -165.78 1.27 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.7 pt20 -141.23 158.19 44.23 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.081 174.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 31' ' ' ASN . 31.1 mmtm -52.77 155.86 2.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.955 -1.02 . . . . 0.0 113.129 -172.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -85.57 -179.53 6.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.794 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.97 -21.01 60.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.619 0.645 . . . . 0.0 111.095 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.479 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -91.22 2.28 56.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.101 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 54.8 t30 70.55 35.7 1.85 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.247 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.604 HD22 ' OXT' ' A' ' 128' ' ' VAL . 2.1 pp -140.56 -170.66 3.05 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.841 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.469 HG21 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -104.78 -25.45 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.981 -175.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 92.78 35.4 6.46 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.511 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.508 HD12 HG23 ' A' ' 128' ' ' VAL . 2.9 pp -123.01 178.96 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.738 0.304 . . . . 0.0 110.617 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 64.4 m -128.47 135.29 49.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.085 0.469 . . . . 0.0 111.135 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.9 mm -102.29 138.77 25.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.144 -176.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.45 178.6 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.571 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 122.456 1.122 . . . . 0.0 109.615 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.0 t -86.84 -35.54 8.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.408 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.487 ' HG2' ' HB2' ' A' ' 36' ' ' SER . 11.3 pt20 -165.57 163.53 19.36 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -173.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.472 HG22 ' HB1' ' A' ' 59' ' ' ALA . 9.5 p -141.29 159.82 22.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.132 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.498 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 50.1 m-85 -116.09 122.97 46.72 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.74 0.781 . . . . 0.0 108.907 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.407 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 7.5 m-20 -58.2 -18.94 29.57 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.324 1.45 . . . . 0.0 114.641 -164.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -102.89 6.06 38.87 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.97 0.414 . . . . 0.0 110.513 -174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.498 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 13.1 p -102.59 151.53 38.26 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -176.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.18 -39.94 42.27 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.086 1.857 . . . . 0.0 111.779 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.02 -54.02 49.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.027 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB1' HG22 ' A' ' 52' ' ' VAL . . . -76.6 -53.03 8.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.497 0.665 . . . . 0.0 110.277 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER -44.22 -75.01 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.522 -176.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -96.66 -32.06 12.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.14 0.495 . . . . 0.0 111.637 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.457 ' CA ' HD22 ' A' ' 25' ' ' LEU . . . -72.84 -38.97 56.07 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.923 -0.656 . . . . 0.0 114.542 -167.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p 64.77 21.72 12.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 122.0 0.905 . . . . 0.0 110.897 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.592 ' HA ' ' OH ' ' A' ' 101' ' ' TYR . 3.8 m -88.02 56.43 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.193 176.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.64 -179.76 7.2 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.786 -168.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' A' ' 51' ' ' GLN . . . -57.43 139.46 53.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.722 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.89 -9.51 29.67 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.51 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.571 ' O ' HG21 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -96.8 174.81 6.61 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.584 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -123.13 95.19 4.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.466 0.651 . . . . 0.0 110.377 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.42 ' O ' HD11 ' A' ' 78' ' ' ILE . 9.9 mm -69.96 114.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.587 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 102' ' ' ASN . 6.4 t -88.11 -34.84 17.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.42 156.63 26.81 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.468 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.621 ' CG1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -131.1 129.4 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 59.64 26.29 15.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.639 0.733 . . . . 0.0 110.037 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.55 -20.1 50.14 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.256 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -107.93 135.04 49.98 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 117.092 0.446 . . . . 0.0 111.732 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m -63.49 148.15 49.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.472 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.621 HG21 ' CG1' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -93.0 -25.67 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 CA-C-O 122.93 1.347 . . . . 0.0 109.625 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.483 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -57.88 -24.46 57.75 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.189 -2.278 . . . . 0.0 110.339 -178.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.8 -17.64 76.91 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.642 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.483 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -129.53 -134.87 0.22 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.062 0.931 . . . . 0.0 112.079 -176.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.581 ' O ' HG11 ' A' ' 86' ' ' VAL . 60.5 p -135.89 166.13 24.03 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.573 -0.079 . . . . 0.0 110.839 -169.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' HG23 ' A' ' 86' ' ' VAL . 16.6 mttt -49.1 -57.69 6.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.542 0.687 . . . . 0.0 111.919 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.47 -39.68 54.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.828 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 89' ' ' MET . 34.6 mt-10 -75.29 -37.91 60.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.581 HG11 ' O ' ' A' ' 82' ' ' THR . 30.0 m -67.05 -45.39 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.61 -176.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.671 ' O ' ' HG3' ' A' ' 91' ' ' GLN . . . -58.9 -43.05 90.91 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 172.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -61.63 -45.63 93.24 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.199 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 86.4 mmm -51.6 -42.33 61.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.43 HD12 HD12 ' A' ' 33' ' ' ILE . 85.9 mt -65.64 -46.89 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.609 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 59.5 mt-30 -60.45 -46.77 88.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.117 0.484 . . . . 0.0 110.979 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -61.71 -50.91 70.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.498 -167.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 89' ' ' MET . 14.8 m -52.99 -32.92 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm 61.79 137.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 95.03 -51.78 1.91 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.741 167.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.6 pt-20 -133.83 178.71 6.73 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -174.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.469 HG12 HG21 ' A' ' 33' ' ' ILE . 9.5 m -150.05 148.23 15.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.784 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.461 HG23 HG23 ' A' ' 24' ' ' THR . 12.9 p -134.51 109.46 8.72 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.506 HD11 ' N ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -102.15 126.82 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.31 0.576 . . . . 0.0 111.524 -173.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -108.17 117.16 33.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.182 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.592 ' OH ' ' HA ' ' A' ' 64' ' ' VAL . 1.1 m-30 -74.0 162.2 29.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.318 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.412 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 O-C-N 124.624 1.202 . . . . 0.0 108.464 175.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.485 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 10.4 t70 . . . . . 0 C--O 1.216 -0.667 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 16.6 Cg_exo -29.45 -49.84 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.902 3.068 . . . . 0.0 114.269 -176.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.501 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.1 ptpt -57.99 -47.65 82.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.239 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.538 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 14.9 mm100 -87.02 -19.96 27.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.449 0.642 . . . . 0.0 110.355 -176.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -73.0 -43.12 62.54 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.276 -175.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -66.36 -31.43 72.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.889 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 109' ' ' LYS . 74.3 t -66.59 -39.77 84.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.205 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 110' ' ' GLN . 76.1 mt -70.65 -24.05 62.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.759 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 27.6 t80 . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.125 178.952 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' A' ' 127' ' ' LYS . 51.5 tp . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 4.9 pttp -166.26 161.99 17.1 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.239 0.542 . . . . 0.0 110.862 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.604 ' OXT' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.778 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 165.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 25.7 pttm . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.09 146.74 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.5 t -103.8 98.88 8.66 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.788 0.804 . . . . 0.0 110.378 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.406 HD11 ' HA2' ' A' ' 62' ' ' GLY . 16.6 mt -110.48 -163.83 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.753 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.655 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 2.2 pt20 -150.53 156.3 41.15 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.176 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HE2' ' C ' ' A' ' 31' ' ' ASN . 10.0 mmmm -52.4 146.77 9.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.639 0.733 . . . . 0.0 111.938 -174.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -85.65 173.67 9.96 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.355 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.2 -20.79 56.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.118 0.485 . . . . 0.0 110.453 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.465 ' NE2' HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -85.59 -1.26 56.94 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.032 -177.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' C ' ' HE2' ' A' ' 27' ' ' LYS . 15.4 t30 69.01 37.52 2.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.734 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.478 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -154.22 -163.31 1.59 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.897 173.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.736 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.55 -24.27 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.494 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.44 40.71 3.6 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.761 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.512 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.6 pp -131.89 171.95 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.855 0.836 . . . . 0.0 111.633 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.1 m -140.59 126.5 19.41 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.161 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.607 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 26.3 mt -122.72 -168.64 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -176.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.607 ' H ' ' CG2' ' A' ' 37' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.814 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.616 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 121.915 0.864 . . . . 0.0 109.27 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.18 -30.65 5.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.739 -171.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.64 142.77 15.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.976 0.417 . . . . 0.0 111.401 -172.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.475 HG21 ' HB1' ' A' ' 59' ' ' ALA . 6.4 p -140.56 160.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.011 173.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -97.34 -133.8 0.23 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -141.15 -33.3 0.53 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -101.24 0.93 38.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.971 0.415 . . . . 0.0 110.347 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 68.0 p -84.17 151.54 60.17 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 8.4 Cg_endo -53.28 -41.27 73.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.239 1.292 . . . . 0.0 111.024 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.516 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.48 -47.58 81.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.996 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.475 ' HB1' HG21 ' A' ' 52' ' ' VAL . . . -72.69 -56.81 4.74 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.68 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.598 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.8 pp -55.77 -75.7 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -171.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.598 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 37.5 t70 -94.76 -13.38 25.74 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 122.546 1.165 . . . . 0.0 108.37 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -64.57 -51.16 54.54 Favored Glycine 0 C--N 1.312 -0.785 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.038 -169.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.4 p 56.95 42.76 25.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.731 1.253 . . . . 0.0 110.321 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.53 HG13 HG13 ' A' ' 99' ' ' ILE . 29.5 m -119.23 47.81 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 112.684 -2.053 . . . . 0.0 108.789 173.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.13 173.71 10.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.569 -170.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.77 108.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.674 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.92 -17.75 3.41 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.68 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.616 ' O ' HG21 ' A' ' 49' ' ' ILE . 18.3 m-20 -90.54 156.88 17.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.081 0.441 . . . . 0.0 110.928 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -114.9 98.26 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.365 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.82 114.67 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.076 0.465 . . . . 0.0 110.38 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -97.5 -12.42 22.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.551 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -161.17 144.75 10.15 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 119.529 -1.319 . . . . 0.0 114.143 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 78' ' ' ILE . 5.0 m -100.79 140.56 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 CA-C-N 114.533 -0.833 . . . . 0.0 109.809 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.2 t30 53.89 29.17 9.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.826 0.822 . . . . 0.0 111.173 164.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.24 59.19 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.392 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -126.73 149.38 49.63 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.132 0.966 . . . . 0.0 111.903 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 m -57.1 148.46 21.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.454 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.525 HG23 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -85.6 -19.03 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.281 0.562 . . . . 0.0 111.076 -172.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -67.73 -7.53 27.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.301 -170.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.58 -27.95 73.57 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.224 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.443 ' NZ ' ' HE3' ' A' ' 89' ' ' MET . 0.0 OUTLIER -139.14 -139.77 0.14 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 117.234 0.517 . . . . 0.0 111.847 -177.065 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.83 160.73 33.55 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -168.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.415 ' O ' HG21 ' A' ' 86' ' ' VAL . 2.5 pttt -46.87 -52.65 13.89 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.59 -35.09 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 121.047 0.451 . . . . 0.0 111.564 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 89' ' ' MET . 29.7 mt-10 -79.9 -40.33 28.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.553 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 89' ' ' MET . 27.7 m -63.41 -40.03 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.606 0.241 . . . . 0.0 111.44 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 91' ' ' GLN . . . -56.3 -45.16 80.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.437 171.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.74 -40.3 96.4 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 120.75 0.31 . . . . 0.0 110.7 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 24.9 mmt -51.22 -32.92 25.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.57 0.7 . . . . 0.0 110.927 174.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 90' ' ' ILE . 88.6 mt -90.42 -18.44 7.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.077 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 50.4 mt-30 -87.6 -14.78 39.17 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.901 -0.499 . . . . 0.0 111.546 173.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.27 -40.53 15.44 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.12 0.962 . . . . 0.0 108.969 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -43.44 120.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.932 169.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -82.66 86.48 6.84 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.655 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 108.91 -25.16 19.72 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 118.575 -1.774 . . . . 0.0 113.923 162.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 8.6 pt-20 -125.57 173.4 8.98 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 117.947 0.874 . . . . 0.0 110.332 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.3 m -155.8 154.92 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.861 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.13 117.12 11.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.072 0.463 . . . . 0.0 110.367 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.53 HG13 HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -106.25 115.49 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.902 -176.138 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -102.11 121.95 43.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -146.65 160.79 41.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.729 0.776 . . . . 0.0 112.595 -173.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.422 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 111' ' ' LEU . 7.5 m-20 . . . . . 0 C--O 1.207 -1.135 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -31.31 -60.33 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.955 3.103 . . . . 0.0 114.529 -171.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.502 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.2 ptmt -61.35 -44.95 96.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.676 0.75 . . . . 0.0 111.716 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.502 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 70.2 mm-40 -80.39 -9.62 59.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.844 -175.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.1 tm? -90.5 -51.74 5.25 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.471 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.5 -30.85 70.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.485 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.404 HG11 ' C ' ' A' ' 110' ' ' GLN . 4.1 p -69.1 -31.97 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.561 0.696 . . . . 0.0 109.817 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.414 HD11 ' O ' ' A' ' 114' ' ' LEU . 3.2 tm? -75.08 -28.73 60.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.547 176.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.6 t80 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.648 -178.983 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 127' ' ' LYS . 8.6 tt . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.555 ' N ' HD22 ' A' ' 126' ' ' LEU . 22.0 ptmt -150.54 123.73 8.87 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.353 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.736 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.8 p . . . . . 0 N--CA 1.437 -1.085 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.318 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 62' ' ' GLY . 7.7 p -132.72 143.72 38.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.456 ' O ' HD12 ' A' ' 25' ' ' LEU . 11.6 t -113.78 130.49 56.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.437 0.637 . . . . 0.0 110.935 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.457 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.8 mm? -132.56 -167.5 1.91 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.561 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 57' ' ' PRO . 97.0 mt-30 -132.29 155.98 47.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 37.0 mmtt -46.54 145.15 1.92 Allowed 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.762 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.06 -178.87 5.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.262 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.2 -22.13 65.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.439 0.637 . . . . 0.0 110.306 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.482 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -93.12 11.22 28.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.72 0.772 . . . . 0.0 109.607 178.026 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.44 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 1.1 p-10 60.28 16.1 5.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.311 -1.768 . . . . 0.0 113.049 176.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -115.93 -159.98 0.74 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.507 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.71 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -110.93 -22.89 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 118.755 0.707 . . . . 0.0 111.596 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 96.17 38.54 4.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.744 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.481 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -130.76 173.89 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.844 0.83 . . . . 0.0 112.122 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 126' ' ' LEU . 20.7 m -138.81 125.78 21.16 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.262 -1.335 . . . . 0.0 109.742 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.474 HG13 HD11 ' A' ' 35' ' ' ILE . 61.1 mt -124.94 131.01 73.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.504 0.668 . . . . 0.0 112.716 -173.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.05 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.572 172.603 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.645 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 122.175 0.988 . . . . 0.0 110.719 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.6 t -102.31 -30.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.305 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -150.32 138.66 20.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 120.84 0.352 . . . . 0.0 110.926 -170.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 59' ' ' ALA . 5.3 p -141.34 161.24 22.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.221 174.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 96.6 m-85 -99.57 -140.88 0.32 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -133.8 -28.52 1.39 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -101.53 -2.1 31.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.058 0.456 . . . . 0.0 110.297 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 47.9 p -84.93 146.43 45.84 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 9.8 Cg_endo -51.12 -41.83 55.8 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.729 1.619 . . . . 0.0 111.251 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.466 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.81 -43.48 85.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.799 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.475 ' HB2' HG21 ' A' ' 52' ' ' VAL . . . -74.85 -58.28 3.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.36 0.6 . . . . 0.0 110.902 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.561 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 2.2 pp -55.02 -75.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -170.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.561 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 32.8 t70 -95.69 -13.83 23.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 122.367 1.08 . . . . 0.0 108.702 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.596 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -65.51 -33.25 85.85 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 113.315 -1.766 . . . . 0.0 113.964 -169.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 62' ' ' GLY . 5.3 t 51.2 21.58 1.13 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.497 1.119 . . . . 0.0 112.516 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -101.58 54.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-O 123.001 1.381 . . . . 0.0 110.038 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.31 171.35 12.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 112.455 -2.157 . . . . 0.0 111.386 -171.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.49 112.02 1.15 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.175 -175.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.3 -0.24 5.97 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.574 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.645 ' O ' HG21 ' A' ' 49' ' ' ILE . 1.1 m-20 -99.35 149.16 23.44 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.216 0.532 . . . . 0.0 110.916 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -99.05 97.57 8.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.108 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.8 mm -69.72 139.43 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.888 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -124.91 -17.88 5.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.08 163.41 34.29 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.126 -1.512 . . . . 0.0 114.094 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.62 125.9 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 123.497 0.719 . . . . 0.0 109.267 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 54.2 30.26 11.97 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.52 -20.15 49.57 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.331 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -106.05 125.48 51.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 117.406 0.603 . . . . 0.0 111.226 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m -59.21 146.01 40.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.594 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.545 ' HB ' HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -84.38 -25.61 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.452 0.644 . . . . 0.0 110.18 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -60.36 -24.12 64.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.536 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.97 -22.09 77.02 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.984 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -124.02 -120.43 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.287 -176.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' HG11 ' A' ' 86' ' ' VAL . 7.3 m -148.91 150.08 32.33 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.49 -173.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.564 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -46.54 -56.66 5.68 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.378 0.671 . . . . 0.0 111.944 -177.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.84 -37.99 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.831 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 89' ' ' MET . 38.1 mt-10 -71.57 -36.4 70.89 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 83' ' ' LYS . 19.9 m -71.54 -42.62 72.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.137 -175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' A' ' 91' ' ' GLN . . . -51.73 -42.33 62.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.826 169.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 37.5 ttpt -60.85 -49.67 76.54 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.824 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.48 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 40.3 mtm -52.12 -39.09 59.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 110.431 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.457 HD12 HD12 ' A' ' 33' ' ' ILE . 68.1 mt -71.73 -39.17 68.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.441 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 6.7 mm-40 -71.33 -29.41 64.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.081 0.467 . . . . 0.0 110.505 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -72.15 -47.01 54.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.692 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.58 ' O ' HG21 ' A' ' 93' ' ' VAL . 16.8 m -71.51 51.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.793 0.806 . . . . 0.0 111.025 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -44.33 134.14 5.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.853 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.604 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 107.48 -36.88 4.11 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.438 171.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.27 147.39 32.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.737 0.779 . . . . 0.0 112.866 -168.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.536 HG12 ' HZ2' ' A' ' 27' ' ' LYS . 3.9 m -131.67 146.8 32.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.715 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.0 m -140.17 109.4 6.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 172.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -100.66 130.9 49.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.693 -174.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -106.1 123.11 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.917 173.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -137.14 146.19 44.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.273 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 . . . . . 0 C--N 1.321 -0.637 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -178.866 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.496 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 21.7 Cg_exo -32.36 -48.43 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.796 2.997 . . . . 0.0 113.761 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 0.6 OUTLIER -59.04 -49.58 77.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.684 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.538 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 24.1 mm-40 -88.9 -15.82 33.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.437 0.636 . . . . 0.0 111.026 -175.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.417 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -78.7 -39.33 36.88 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.998 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 7.3 pt-20 -68.98 -31.71 70.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.176 0.512 . . . . 0.0 109.924 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.5 t -61.71 -41.18 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.982 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 98.0 mt -76.2 -22.46 55.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.806 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.5 t80 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.861 -175.142 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 36' ' ' SER . 2.4 pp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.449 ' HB3' ' HZ3' ' A' ' 127' ' ' LYS . 7.4 mtpm? -141.91 93.9 2.61 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.17 -172.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.71 ' OXT' HG13 ' A' ' 33' ' ' ILE . 12.0 p . . . . . 0 N--CA 1.438 -1.029 0 CA-C-O 117.853 -1.07 . . . . 0.0 109.302 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HG2' ' CE1' ' A' ' 100' ' ' HIS . 2.3 mppt? . . . . . 0 CA--C 1.518 -0.287 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.27 152.27 35.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.839 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -122.11 126.95 49.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.461 0.648 . . . . 0.0 110.529 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 2.4 mm? -122.44 -171.13 2.2 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.084 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 87.7 mt-30 -131.97 137.58 47.96 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.642 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.63 ' NZ ' ' HA ' ' A' ' 91' ' ' GLN . 25.0 mmtp -44.11 148.0 0.46 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 124.679 1.237 . . . . 0.0 112.663 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.75 -172.19 3.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.294 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -22.02 65.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.231 0.538 . . . . 0.0 110.816 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.442 ' NE2' HD23 ' A' ' 32' ' ' LEU . 7.1 tt0 -96.35 11.07 36.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.231 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.8 t30 70.26 15.23 7.49 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.389 0.614 . . . . 0.0 111.506 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.649 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.5 pp -128.57 -173.07 2.86 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 121.958 -0.464 . . . . 0.0 111.588 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.85 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.0 -24.37 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.474 -176.294 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.12 41.24 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.486 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.45 HD11 HG12 ' A' ' 37' ' ' ILE . 2.8 pp -129.24 176.6 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.403 0.62 . . . . 0.0 111.71 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 32.1 m -140.59 128.1 21.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.389 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.457 ' HB ' HD23 ' A' ' 126' ' ' LEU . 49.6 mm -114.48 143.24 24.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.421 -174.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.277 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.102 175.29 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.631 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 122.453 1.121 . . . . 0.0 109.96 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.79 -25.37 3.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.63 -171.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.87 144.19 20.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.908 0.385 . . . . 0.0 110.817 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.6 p -140.43 161.11 24.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' H ' HG22 ' A' ' 52' ' ' VAL . 80.9 m-85 -94.43 -137.17 0.21 Allowed 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.303 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -137.27 -36.4 0.66 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.447 ' HA ' HD21 ' A' ' 60' ' ' LEU . 32.8 m-80 -100.6 -0.38 37.73 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.435 0.636 . . . . 0.0 109.495 -171.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 44.6 p -87.99 144.74 35.1 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 6.5 Cg_endo -47.04 -40.35 26.08 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.291 1.994 . . . . 0.0 111.689 -174.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -59.02 -52.26 66.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.229 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.77 -55.61 6.48 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.898 0.856 . . . . 0.0 109.524 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -43.69 -76.17 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.186 -1.825 . . . . 0.0 113.081 -178.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.14 -39.58 9.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.211 0.529 . . . . 0.0 111.872 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.74 -20.34 74.09 Favored Glycine 0 N--CA 1.458 0.162 0 CA-C-N 115.447 -0.797 . . . . 0.0 114.28 -166.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 t 47.23 33.48 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.194 0.998 . . . . 0.0 111.761 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 99' ' ' ILE . 11.9 m -94.6 55.22 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 CA-C-O 122.871 1.32 . . . . 0.0 109.697 175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.77 165.36 18.91 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.42 -2.173 . . . . 0.0 111.049 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.64 104.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.124 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.39 -8.88 2.14 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.478 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.631 ' O ' HG21 ' A' ' 49' ' ' ILE . 22.6 m-20 -98.69 177.05 5.42 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.702 ' HB2' ' OD1' ' A' ' 102' ' ' ASN . 41.5 mt-10 -120.97 143.02 49.24 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.039 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.2 mm -119.12 119.39 60.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.723 HG23 ' CB ' ' A' ' 101' ' ' TYR . 5.5 t -105.25 -26.85 11.86 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.533 -177.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.71 155.46 26.15 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 118.875 -1.631 . . . . 0.0 114.448 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.559 HG12 HG22 ' A' ' 78' ' ' ILE . 6.7 m -110.02 142.59 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.291 176.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.57 ' HA ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER 61.17 19.34 9.95 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.94 0.4 . . . . 0.0 110.719 171.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.17 -15.37 60.47 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 116.11 -0.495 . . . . 0.0 113.403 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -118.56 139.18 51.87 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 117.124 0.462 . . . . 0.0 112.012 -174.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 71' ' ' THR . 35.6 m -50.15 141.6 10.96 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.559 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -83.8 -25.71 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.169 -175.301 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -63.48 -13.69 43.19 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.349 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.35 -30.08 76.47 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.636 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.571 ' HG2' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -119.33 -117.17 0.32 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.77 0.785 . . . . 0.0 112.069 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.605 ' O ' ' HB ' ' A' ' 86' ' ' VAL . 3.2 m -161.5 151.14 16.64 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -168.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.525 ' HA ' HD22 ' A' ' 126' ' ' LEU . 2.6 mttm -39.96 -57.32 1.64 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.98 -32.33 32.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.456 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 89' ' ' MET . 30.9 mt-10 -90.56 -25.93 19.97 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 123.048 1.404 . . . . 0.0 108.318 -175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 82' ' ' THR . 1.0 OUTLIER -75.21 -42.86 44.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.797 -2.456 . . . . 0.0 110.778 -175.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.55 73.21 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -61.0 -52.7 63.89 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.157 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 88.2 mmm -45.44 -50.37 12.61 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.495 0.497 . . . . 0.0 112.004 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 93' ' ' VAL . 25.3 mm -60.09 -53.51 47.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.236 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.63 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -75.31 -25.34 57.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 122.205 -0.309 . . . . 0.0 111.483 -173.034 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.51 -52.51 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.564 0.345 . . . . 0.0 111.707 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 90' ' ' ILE . 20.5 m -49.45 -36.52 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 O-C-N 123.462 0.476 . . . . 0.0 110.95 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 95' ' ' GLY . 4.4 tmmm? 67.5 138.08 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.723 0.773 . . . . 0.0 112.196 169.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 94' ' ' LYS . . . 89.71 -33.05 4.54 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.505 171.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.6 pt-20 -145.3 177.24 8.96 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.413 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 10.4 m -146.98 153.48 12.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.975 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.57 ' OG1' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -141.21 106.62 5.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 176.005 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.488 HG13 HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -100.07 140.19 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.536 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 1.3 t60 -135.67 127.48 29.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.187 -174.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.723 ' CB ' HG23 ' A' ' 71' ' ' THR . 0.9 OUTLIER 171.28 -99.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.301 1.001 . . . . 0.0 111.912 162.283 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.702 ' OD1' ' HB2' ' A' ' 69' ' ' GLU . 29.2 p-10 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.74 -162.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.588 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 41.5 m-20 . . . . . 0 CA--C 1.508 -0.671 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.469 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 17.5 Cg_exo -29.89 -52.59 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.008 3.139 . . . . 0.0 114.499 -172.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.491 ' HB2' ' HZ2' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -60.32 -50.37 73.91 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.588 ' CG ' ' H ' ' A' ' 107' ' ' ASP . 21.2 pt20 -90.7 -9.62 46.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.9 0.857 . . . . 0.0 111.911 -173.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.407 ' C ' HD12 ' A' ' 111' ' ' LEU . 1.9 tm? -86.21 -41.39 14.69 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.384 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 8.0 pt-20 -64.89 -21.05 66.74 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 110' ' ' GLN . 61.1 t -58.04 -38.53 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.436 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.5 mp -81.0 -22.74 39.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.662 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.1 t80 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -175.741 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 83' ' ' LYS . 1.8 pp . . . . . 0 CA--C 1.519 -0.24 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 15.1 ptmm? -149.89 134.69 17.72 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.811 0.338 . . . . 0.0 110.221 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.85 ' OXT' HG13 ' A' ' 33' ' ' ILE . 7.7 p . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.775 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 21.2 ptmt . . . . . 0 C--O 1.231 0.103 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 99' ' ' ILE . 24.8 m -127.64 149.21 32.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 168.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -120.98 126.31 49.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.684 0.754 . . . . 0.0 110.448 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' HB2' ' CG2' ' A' ' 97' ' ' VAL . 5.2 mt -132.64 -167.62 1.93 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.359 -175.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.1 mt-30 -134.37 142.56 47.24 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.019 0.438 . . . . 0.0 110.158 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 27.9 mmtp -48.74 152.55 0.97 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.841 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 4.0 p-10 -85.74 -164.55 1.04 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.3 -24.64 67.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.855 0.359 . . . . 0.0 111.615 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.9 mt-30 -92.21 4.65 52.8 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.104 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 36.5 t30 71.15 24.9 3.75 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.121 0.962 . . . . 0.0 110.831 176.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.541 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.7 pp -131.05 -170.15 2.3 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.721 -0.612 . . . . 0.0 111.277 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.77 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.02 -21.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.152 -176.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.81 30.08 6.61 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.969 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.482 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.9 pp -124.33 175.62 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.711 0.767 . . . . 0.0 112.43 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -136.25 126.42 26.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.056 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.452 ' H ' ' HB3' ' A' ' 126' ' ' LEU . 46.7 mm -97.66 146.84 7.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.404 0.621 . . . . 0.0 111.071 -176.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.781 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.635 178.002 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.83 -31.9 12.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.851 -170.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -165.5 152.05 9.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.932 0.396 . . . . 0.0 110.213 -175.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.465 ' CG2' ' HB1' ' A' ' 59' ' ' ALA . 9.7 p -142.02 161.66 20.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.317 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.505 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 90.5 m-85 -110.99 123.69 50.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 59' ' ' ALA . 28.2 t70 -58.81 -19.88 45.15 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.675 -1.148 . . . . 0.0 113.869 -164.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.85 2.95 38.79 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.79 -175.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.505 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 20.7 p -89.08 153.58 49.15 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.418 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 6.5 Cg_endo -49.44 -43.18 39.5 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.801 1.667 . . . . 0.0 111.532 -176.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.444 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -54.33 -50.69 66.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.029 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . . . -76.11 -54.01 7.46 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.067 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.7 pp -53.67 -74.68 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -170.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.601 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 38.7 t70 -94.24 -14.62 25.32 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.405 1.097 . . . . 0.0 108.305 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -72.08 -51.55 13.84 Favored Glycine 0 C--N 1.312 -0.779 0 CA-C-N 113.259 -1.792 . . . . 0.0 113.129 -170.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.11 47.45 5.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.298 1.047 . . . . 0.0 111.119 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.446 HG12 HG13 ' A' ' 99' ' ' ILE . 19.5 m -124.86 49.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.3 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.38 -179.57 7.21 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.31 -1.313 . . . . 0.0 112.348 -169.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.61 118.03 2.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.568 -172.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.91 -16.97 20.47 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.384 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 49' ' ' ILE . 6.7 m-20 -81.97 157.02 24.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.949 0.404 . . . . 0.0 110.808 -178.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -101.04 124.54 46.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.037 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.44 98.69 7.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -80.87 -15.01 57.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.25 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.77 152.27 22.91 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 119.119 -1.515 . . . . 0.0 114.562 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.553 HG12 HG21 ' A' ' 78' ' ' ILE . 5.9 m -99.81 140.76 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 114.312 -0.944 . . . . 0.0 108.803 176.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.479 ' ND2' HG12 ' A' ' 93' ' ' VAL . 4.9 t-20 58.13 19.1 5.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.976 0.417 . . . . 0.0 111.618 170.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.36 -20.34 48.96 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.174 -0.467 . . . . 0.0 113.259 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -105.01 134.19 48.54 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 117.143 0.472 . . . . 0.0 110.663 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -52.09 138.62 25.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 0.0 111.724 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.553 HG21 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -77.7 -13.43 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.877 0.846 . . . . 0.0 109.056 -176.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -59.76 -13.42 10.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.907 -173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.76 -24.14 76.47 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.671 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.581 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -143.14 -137.89 0.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.357 0.578 . . . . 0.0 111.238 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.6 p -139.86 170.83 15.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.612 0.244 . . . . 0.0 111.598 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.48 ' HA ' HG23 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -50.19 -54.16 22.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.743 -175.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.73 -35.46 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.152 0.501 . . . . 0.0 111.426 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.483 ' OE2' ' HB2' ' A' ' 81' ' ' LYS . 31.8 mt-10 -80.54 -35.86 33.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.768 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.503 HG13 ' HB ' ' A' ' 78' ' ' ILE . 33.7 m -71.04 -41.38 76.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.584 0.23 . . . . 0.0 111.269 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.54 -39.59 61.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.027 0.441 . . . . 0.0 109.931 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 61.5 tttm -64.64 -49.49 70.84 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.519 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 87.6 mtp -50.37 -41.93 52.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.418 0.628 . . . . 0.0 110.473 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.438 HD11 HD12 ' A' ' 33' ' ' ILE . 63.4 mt -70.26 -47.26 67.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.389 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -65.02 -32.52 74.28 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.801 -0.562 . . . . 0.0 111.569 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.06 -46.9 88.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.706 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.507 ' O ' HG21 ' A' ' 93' ' ' VAL . 9.9 m -75.89 41.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.228 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -45.88 137.52 5.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.802 0.811 . . . . 0.0 111.844 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.461 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 107.61 -32.91 6.71 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.01 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.7 pt-20 -143.87 176.6 9.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.067 0.461 . . . . 0.0 110.799 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.51 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 6.1 m -152.21 150.57 12.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.043 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.459 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 40.7 m -141.29 117.6 10.74 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 170.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -104.92 129.04 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.12 -177.371 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.88 116.27 32.36 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -120.25 160.98 21.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.563 0.697 . . . . 0.0 112.486 -170.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.444 -0.755 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.502 176.633 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.578 ' OD1' ' HG2' ' A' ' 109' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.211 -0.939 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 1.4 Cg_exo -29.88 -41.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.309 2.673 . . . . 0.0 113.858 173.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.578 ' HG2' ' OD1' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -62.82 -49.76 73.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.727 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.48 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 76.3 mm-40 -87.35 -13.12 44.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.491 0.662 . . . . 0.0 110.597 -177.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 107' ' ' ASP . 2.7 tm? -75.65 -44.03 44.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.368 -176.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -68.62 -30.89 69.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.029 0.442 . . . . 0.0 109.981 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 109' ' ' LYS . 88.4 t -69.54 -29.8 42.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.59 0.709 . . . . 0.0 109.758 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 114' ' ' LEU . 8.0 tt -73.3 -27.47 61.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.1 t80 . . . . . 0 N--CA 1.446 -0.632 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.562 -179.462 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 127' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.577 ' N ' HD13 ' A' ' 126' ' ' LEU . 21.8 pttp -156.21 121.78 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.466 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.77 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.2 p . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 117.957 -1.021 . . . . 0.0 108.638 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 51.8 pttt . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.023 0.439 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -137.44 147.02 26.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.3 t -112.59 123.13 49.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.489 0.661 . . . . 0.0 110.965 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.495 HD22 ' HA2' ' A' ' 62' ' ' GLY . 9.6 mt -127.13 -168.96 1.95 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.589 -176.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.2 mt-30 -132.89 142.05 48.71 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.827 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HZ2' ' CA ' ' A' ' 94' ' ' LYS . 29.9 mmtm -48.38 153.42 0.74 Allowed 'General case' 0 C--N 1.32 -0.711 0 O-C-N 124.631 1.207 . . . . 0.0 113.013 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -86.55 -178.66 6.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.521 173.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.68 -21.76 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 111.364 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.461 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -94.64 6.5 48.69 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.307 -177.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 47.3 t30 67.33 32.01 6.17 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.36 1.076 . . . . 0.0 110.613 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 1.4 pp -136.93 -169.51 2.49 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.041 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.735 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.1 -26.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.685 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.2 29.18 6.15 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.299 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 2.8 pp -118.21 172.3 5.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.668 0.747 . . . . 0.0 111.555 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.483 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 60.0 m -139.1 127.31 22.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.541 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.3 130.09 47.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.274 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.005 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.11 179.213 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.9 t -79.03 -29.36 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.018 -168.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.483 ' HG2' ' HB2' ' A' ' 36' ' ' SER . 2.6 pt20 -161.03 152.42 19.09 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.221 0.534 . . . . 0.0 110.112 -173.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 59' ' ' ALA . 8.5 p -142.13 160.94 20.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.326 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 97.8 m-85 -111.63 125.97 54.52 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.691 0.758 . . . . 0.0 109.217 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -51.36 -29.16 14.53 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.803 -1.544 . . . . 0.0 114.136 -166.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.492 ' HA ' HD21 ' A' ' 60' ' ' LEU . 51.3 m-80 -102.18 9.14 40.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.864 0.364 . . . . 0.0 110.729 -172.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 32.7 p -95.55 147.72 33.46 Favored Pre-proline 0 CA--C 1.501 -0.936 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.3 Cg_endo -47.32 -39.65 27.71 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.111 1.874 . . . . 0.0 111.235 -175.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -55.89 -57.2 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.201 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 52' ' ' VAL . . . -72.96 -54.62 8.18 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.458 0.647 . . . . 0.0 110.026 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -44.15 -75.52 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.783 -178.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HB3' HD21 ' A' ' 25' ' ' LEU . 22.0 t70 -97.48 -31.66 12.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.035 0.445 . . . . 0.0 111.942 -174.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.495 ' HA2' HD22 ' A' ' 25' ' ' LEU . . . -72.4 -36.67 59.22 Favored Glycine 0 C--O 1.227 -0.281 0 N-CA-C 115.127 0.811 . . . . 0.0 115.127 -166.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.9 p 65.06 24.02 12.5 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.181 0.991 . . . . 0.0 110.788 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.533 HG13 HG13 ' A' ' 99' ' ' ILE . 31.2 m -94.82 49.0 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.646 174.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.74 -179.43 7.11 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.949 -170.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.0 135.18 37.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.934 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.81 -11.1 20.93 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.888 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.617 ' O ' HG23 ' A' ' 49' ' ' ILE . 13.8 m-20 -101.23 178.09 4.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.905 0.353 . . . . 0.0 110.515 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -120.9 143.4 48.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.1 mm -104.94 115.85 47.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -113.87 1.39 14.75 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -173.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.1 145.71 10.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.208 -1.473 . . . . 0.0 114.296 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.521 HG11 HG23 ' A' ' 78' ' ' ILE . 6.0 m -110.88 143.45 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.532 -0.834 . . . . 0.0 109.73 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 55.9 26.58 9.93 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.623 0.725 . . . . 0.0 111.608 164.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.48 -14.57 64.47 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.525 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -109.46 172.42 6.87 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 123.084 0.554 . . . . 0.0 110.291 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 t -74.13 174.96 7.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.97 0.414 . . . . 0.0 110.47 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.521 HG23 HG11 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -109.15 -14.04 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.485 0.659 . . . . 0.0 109.328 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.647 ' HD2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -64.25 -19.14 65.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.855 -169.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.01 -20.84 76.62 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.619 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.578 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -142.51 -145.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.275 0.538 . . . . 0.0 110.655 -178.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.3 t -140.78 173.38 11.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.55 0.214 . . . . 0.0 110.564 -169.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.495 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -41.14 -61.27 1.03 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.556 1.143 . . . . 0.0 113.843 -175.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -57.31 -36.38 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 120.976 0.417 . . . . 0.0 111.503 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 89' ' ' MET . 34.3 mt-10 -80.62 -33.11 36.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.016 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 83' ' ' LYS . 35.1 m -70.09 -45.63 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.453 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.11 -37.6 83.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -61.08 -52.27 65.63 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.236 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 21.1 mmt -50.02 -40.34 44.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.23 0.538 . . . . 0.0 111.686 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.499 HD11 HD12 ' A' ' 33' ' ' ILE . 44.1 mt -65.77 -53.05 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.113 178.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.526 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 4.1 pt20 -80.29 -18.54 48.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.42 -53.05 60.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.951 0.5 . . . . 0.0 111.098 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 90' ' ' ILE . 12.6 m -56.42 -27.68 25.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.978 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.464 ' CA ' ' HZ2' ' A' ' 27' ' ' LYS . 25.0 pttm 48.98 157.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.113 1.365 . . . . 0.0 113.439 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.37 -50.81 4.29 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.117 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.4 pt-20 -132.9 177.2 7.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.021 0.438 . . . . 0.0 109.936 -173.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 25' ' ' LEU . 8.8 m -151.04 153.54 9.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.685 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.5 m -140.89 100.09 3.75 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.533 HG13 HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -90.64 138.07 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.71 -172.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -116.36 117.73 30.78 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -125.59 154.96 41.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.461 0.648 . . . . 0.0 111.926 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 . . . . . 0 N--CA 1.441 -0.884 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.652 -179.135 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.569 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 24.8 t70 . . . . . 0 C--O 1.214 -0.805 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 6.3 Cg_exo -29.34 -50.63 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.016 3.144 . . . . 0.0 115.073 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.0 ptpt -58.08 -49.1 78.1 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.569 ' CG ' ' H ' ' A' ' 107' ' ' ASP . 3.7 pt20 -90.15 -13.53 35.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.845 0.831 . . . . 0.0 111.76 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.436 HD11 ' C ' ' A' ' 111' ' ' LEU . 1.7 tm? -79.35 -40.77 29.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.495 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 6.7 pt-20 -65.97 -29.14 69.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.204 0.526 . . . . 0.0 109.72 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.2 t -58.88 -45.46 91.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.556 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.403 ' HA ' ' CG ' ' A' ' 79' ' ' LYS . 10.9 mp -80.7 -16.68 53.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.533 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 42.4 t80 . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.706 -176.751 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.0 tp . . . . . 0 N--CA 1.45 -0.43 0 CA-C-O 120.828 0.347 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 10.4 ptmm? -167.27 162.74 15.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.335 173.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.735 ' O ' HG13 ' A' ' 33' ' ' ILE . 5.0 p . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 170.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 99' ' ' ILE . 25.3 m -125.55 160.7 31.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 118.096 -1.442 . . . . 0.0 112.583 -164.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -135.6 118.05 15.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.525 0.678 . . . . 0.0 110.539 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.411 ' C ' ' HB ' ' A' ' 97' ' ' VAL . 3.3 mm? -113.58 -159.4 0.69 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.055 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 2.0 pt20 -142.39 149.31 39.18 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 31' ' ' ASN . 36.1 mmtm -37.19 151.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.67 177.67 8.29 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.034 -1.894 . . . . 0.0 109.126 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.57 -25.37 62.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.103 0.41 . . . . 0.0 111.404 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.425 HE21 HD23 ' A' ' 32' ' ' LEU . 7.2 tt0 -94.2 20.33 8.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.39 0.614 . . . . 0.0 110.336 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 2.4 p-10 54.35 30.04 11.94 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.938 1.295 . . . . 0.0 112.629 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 0.9 OUTLIER -128.05 -166.5 1.63 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.561 175.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.755 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.97 -25.98 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.545 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.7 39.68 3.82 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.526 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.562 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.9 pp -131.44 172.48 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.822 0.82 . . . . 0.0 111.854 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 m -138.16 127.86 25.14 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.193 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.649 ' HB ' ' CD2' ' A' ' 126' ' ' LEU . 49.7 mm -106.44 119.87 56.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.423 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.01 178.114 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.711 HG21 ' O ' ' A' ' 68' ' ' ASP . 2.3 tt . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.558 0.694 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.25 -21.12 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.583 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.64 143.6 18.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.454 -173.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.461 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.9 p -139.1 160.35 29.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 173.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -94.73 -140.81 0.24 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -130.0 -43.05 1.22 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.937 0.79 . . . . 0.0 112.408 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.495 ' HA ' HD22 ' A' ' 60' ' ' LEU . 1.0 OUTLIER -99.29 13.7 32.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.387 0.613 . . . . 0.0 110.067 -172.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 65.7 p -91.95 141.1 25.02 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.7 Cg_endo -48.06 -38.22 31.67 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 121.935 1.756 . . . . 0.0 111.413 -173.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 64' ' ' VAL . . . -54.33 -56.56 17.24 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.762 175.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.74 -56.95 4.25 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.472 0.653 . . . . 0.0 110.187 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.495 HD22 ' HA ' ' A' ' 55' ' ' ASN . 1.2 tm? -42.28 -76.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.675 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 60' ' ' LEU . 28.2 t70 -96.15 -37.88 10.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.819 -171.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.546 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . -64.3 -74.55 0.45 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.261 -168.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.546 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 6.0 t 130.86 0.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.195 1.398 . . . . 0.0 108.853 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.598 ' CG2' HD11 ' A' ' 70' ' ' ILE . 0.6 OUTLIER -75.96 58.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 124.651 2.167 . . . . 0.0 111.849 -175.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.73 173.0 10.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 113.633 -1.622 . . . . 0.0 110.19 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.78 124.85 20.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.165 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.67 -15.99 6.25 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.923 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.711 ' O ' HG21 ' A' ' 49' ' ' ILE . 2.2 m-20 -89.66 146.45 24.52 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.028 0.442 . . . . 0.0 110.688 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -89.58 88.76 7.54 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.598 HD11 ' CG2' ' A' ' 64' ' ' VAL . 40.6 mt -87.26 94.66 4.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.496 -176.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' SER . 11.1 t -102.35 1.79 35.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.545 -171.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -134.3 130.61 5.63 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.777 -1.201 . . . . 0.0 113.923 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -99.63 125.4 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 123.939 0.896 . . . . 0.0 108.938 177.423 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 59.53 21.62 10.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.075 0.464 . . . . 0.0 110.947 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.438 ' HA2' ' ND1' ' A' ' 100' ' ' HIS . . . 101.4 -19.02 52.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.562 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -112.33 141.22 46.32 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 117.656 0.728 . . . . 0.0 111.148 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 71' ' ' THR . 51.0 m -48.81 143.45 5.33 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.486 ' HB ' HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -83.93 -18.3 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.266 -176.469 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -61.56 -25.36 67.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.964 -170.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.25 -15.27 78.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.782 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.636 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 5.7 mptt -108.98 -119.43 0.27 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.71 0.767 . . . . 0.0 109.882 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.414 ' O ' HG11 ' A' ' 86' ' ' VAL . 10.2 t -179.7 167.17 1.38 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.803 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.502 ' O ' HD21 ' A' ' 126' ' ' LEU . 1.0 OUTLIER -50.12 -53.03 30.27 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.8 0.687 . . . . 0.0 112.431 -171.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.24 -39.72 85.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.983 0.42 . . . . 0.0 111.761 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -74.19 -42.6 59.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 83' ' ' LYS . 27.7 m -57.91 -43.15 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.39 -42.99 67.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.832 174.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -64.59 -49.95 69.15 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.306 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.9 mmt -49.84 -46.22 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.274 0.559 . . . . 0.0 110.904 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 93' ' ' VAL . 20.4 mm -59.18 -56.9 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.873 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.67 -24.81 67.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.07 -46.18 88.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.142 0.496 . . . . 0.0 111.361 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.574 ' O ' HG21 ' A' ' 93' ' ' VAL . 13.2 m -72.88 55.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.104 0.954 . . . . 0.0 110.581 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -43.35 131.84 4.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.677 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 107.32 -35.47 5.0 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.072 170.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.56 177.81 7.33 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.102 0.477 . . . . 0.0 110.903 -171.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.411 ' HB ' ' C ' ' A' ' 25' ' ' LEU . 16.9 t -152.28 133.64 5.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.314 -170.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.4 m -132.45 116.25 16.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 174.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.58 HD13 ' N ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -107.47 124.2 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 121.128 0.489 . . . . 0.0 111.602 -176.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.438 ' ND1' ' HA2' ' A' ' 75' ' ' GLY . 0.3 OUTLIER -112.96 103.14 11.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.734 173.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -128.55 162.9 26.17 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 . . . . . 0 C--N 1.317 -0.826 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.892 -177.196 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 C--O 1.208 -1.089 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 27.4 Cg_exo -31.45 -54.83 0.27 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.254 3.303 . . . . 0.0 114.905 -172.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 0.5 OUTLIER -57.59 -43.57 84.71 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.724 0.773 . . . . 0.0 111.884 178.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 19.9 mt-30 -82.33 -26.56 32.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.514 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.425 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.2 tm? -69.55 -48.12 61.41 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.782 -175.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 5.1 pt-20 -64.78 -31.35 72.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.528 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 109' ' ' LYS . 75.1 t -64.55 -41.14 91.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.291 0.567 . . . . 0.0 109.797 175.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 tp -70.54 -32.71 70.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.584 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.7 t80 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.252 -178.585 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.649 ' CD2' ' HB ' ' A' ' 37' ' ' ILE . 2.1 pp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -144.98 95.6 2.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.226 0.536 . . . . 0.0 110.396 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.755 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.1 p . . . . . 0 N--CA 1.443 -0.809 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.343 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 60.7 pttt . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 120.914 0.387 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.507 HG21 ' O ' ' A' ' 62' ' ' GLY . 10.1 m -131.68 157.32 43.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -126.77 131.79 51.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.36 0.6 . . . . 0.0 110.914 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.473 HD23 ' HA2' ' A' ' 62' ' ' GLY . 2.9 mm? -127.35 -171.55 2.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.41 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.559 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 89.5 mt-30 -129.81 136.88 50.11 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.94 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.463 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 25.8 mmtp -40.14 146.27 0.13 Allowed 'General case' 0 C--N 1.321 -0.644 0 O-C-N 124.814 1.321 . . . . 0.0 113.354 -176.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -79.55 179.6 7.38 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.382 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.85 -32.22 63.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.775 0.321 . . . . 0.0 110.691 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -92.68 16.93 11.12 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.088 0.47 . . . . 0.0 111.018 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.456 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 63.5 t30 71.75 12.54 6.27 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.765 173.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 pp -121.95 -170.31 2.03 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 121.397 -0.815 . . . . 0.0 112.091 -174.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.9 -29.6 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.881 -178.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.78 40.26 4.72 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.413 -0.898 . . . . 0.0 113.427 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 2.7 pp -123.95 177.79 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.567 0.698 . . . . 0.0 112.197 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.55 ' HG ' ' CB ' ' A' ' 127' ' ' LYS . 23.1 m -148.92 116.17 6.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.077 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 5.0 tt -105.0 125.61 59.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.449 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.694 -176.697 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.41 0.624 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.7 t -100.06 -20.55 5.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.37 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -151.15 133.11 15.12 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.356 -173.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 59' ' ' ALA . 9.8 p -135.66 159.96 39.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -90.91 -137.87 0.15 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -138.89 -38.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.733 0.697 . . . . 0.0 112.321 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -101.73 4.06 40.21 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.956 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 70.0 p -82.9 146.61 52.62 Favored Pre-proline 0 N--CA 1.433 -1.294 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 9.1 Cg_endo -50.13 -40.5 50.89 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.911 1.741 . . . . 0.0 111.204 -176.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.88 84.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.814 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.491 ' HB2' HG23 ' A' ' 52' ' ' VAL . . . -74.94 -59.02 2.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.167 0.508 . . . . 0.0 110.573 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.572 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 2.0 pp -50.03 -76.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -171.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.572 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 35.7 t70 -95.56 -19.12 20.05 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.616 1.198 . . . . 0.0 108.511 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.535 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -64.25 -32.47 84.3 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 112.512 -2.131 . . . . 0.0 114.164 -167.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 t 48.01 32.1 2.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 112.255 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.645 ' HB ' ' OH ' ' A' ' 101' ' ' TYR . 22.8 m -105.1 51.37 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-O 123.483 1.611 . . . . 0.0 109.288 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.35 166.77 18.17 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.04 -2.345 . . . . 0.0 111.242 -172.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.02 119.09 2.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.175 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.87 -28.3 3.55 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.307 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.691 ' HB3' ' CD1' ' A' ' 101' ' ' TYR . 1.1 m-20 -73.7 144.29 45.82 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 102' ' ' ASN . 17.1 tt0 -101.59 122.89 44.68 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.728 HG12 ' CE1' ' A' ' 101' ' ' TYR . 3.2 mt -108.48 101.17 12.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.329 0.585 . . . . 0.0 111.205 -170.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -92.41 -15.17 27.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.069 -175.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.03 148.73 18.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.572 -1.299 . . . . 0.0 113.847 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.402 HG11 HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -110.01 122.25 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 123.407 0.683 . . . . 0.0 109.457 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 53.2 28.36 6.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.94 -20.15 46.76 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.639 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -103.51 134.58 46.63 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 117.854 0.827 . . . . 0.0 110.52 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.2 m -66.68 152.37 45.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.692 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.404 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -88.48 6.02 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 122.396 1.093 . . . . 0.0 108.447 178.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.515 ' HE2' ' O ' ' A' ' 115' ' ' PHE . 39.3 tptt -76.05 96.19 3.77 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.254 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.49 -30.25 2.8 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.107 -1.044 . . . . 0.0 114.28 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.595 ' CG ' HG11 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -89.92 -151.32 0.23 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 117.989 0.895 . . . . 0.0 112.242 -172.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.495 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 2.7 m -132.91 141.19 48.24 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.413 ' O ' HG21 ' A' ' 86' ' ' VAL . 9.5 mtmm -37.63 -54.59 1.17 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.354 0.662 . . . . 0.0 112.715 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -51.64 -31.63 12.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.85 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 89' ' ' MET . 34.0 mt-10 -80.77 -34.92 33.85 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.849 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.595 HG11 ' CG ' ' A' ' 81' ' ' LYS . 20.3 m -73.48 -42.86 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.84 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' A' ' 91' ' ' GLN . . . -61.69 -34.65 76.13 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 171.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 38.1 ttpt -63.61 -48.33 77.79 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.727 175.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 65.6 mtt -45.38 -46.96 13.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.365 0.602 . . . . 0.0 110.275 175.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.412 HG23 ' CG2' ' A' ' 128' ' ' VAL . 34.8 mm -63.69 -54.43 32.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.973 176.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 11.9 mm-40 -61.39 -35.69 78.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -67.03 -55.16 15.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -172.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -54.42 -40.18 47.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.582 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 64.6 pttt 48.38 161.62 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.227 1.411 . . . . 0.0 113.702 -178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.67 -46.07 3.12 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.235 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.1 pt-20 -146.54 178.39 8.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.095 0.474 . . . . 0.0 110.11 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -147.48 151.04 14.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.55 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.6 m -140.35 105.49 5.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.265 0.555 . . . . 0.0 110.595 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.686 ' HB ' ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -92.61 149.67 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.077 -176.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -128.03 129.13 46.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.784 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.728 ' CE1' HG12 ' A' ' 70' ' ' ILE . 97.5 m-85 -123.46 153.61 40.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.584 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 11.1 p-10 . . . . . 0 N--CA 1.44 -0.946 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.178 171.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 111' ' ' LEU . 12.6 m-20 . . . . . 0 C--O 1.21 -1.013 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -32.59 -49.03 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.693 2.929 . . . . 0.0 113.743 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.471 ' O ' HG21 ' A' ' 113' ' ' VAL . 21.3 ptmt -60.7 -49.38 77.73 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.587 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.47 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.8 mm100 -90.09 -11.25 41.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.535 0.683 . . . . 0.0 111.206 -173.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.4 tm? -84.91 -40.12 17.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.493 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -66.25 -21.85 66.3 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.851 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 109' ' ' LYS . 76.0 t -64.21 -36.34 76.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.922 174.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.425 ' O ' HD22 ' A' ' 114' ' ' LEU . 7.1 tt -79.63 -30.36 41.31 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.515 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 9.8 t80 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.609 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.55 ' CB ' ' HG ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -144.32 148.81 35.26 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.313 0.578 . . . . 0.0 111.23 -178.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 33' ' ' ILE . 4.1 p . . . . . 0 C--N 1.315 -0.899 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 21.3 pttm . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.538 0.209 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.55 141.07 43.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -109.5 119.66 40.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.808 0.814 . . . . 0.0 111.186 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 25' ' ' LEU . 2.9 mm? -124.41 -167.01 1.59 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.045 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.0 mt-30 -132.12 139.67 48.53 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.014 0.435 . . . . 0.0 109.948 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 5.3 mmtp -45.03 145.27 1.02 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.86 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.25 179.1 8.0 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.421 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.92 -21.35 64.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.169 0.509 . . . . 0.0 110.658 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.543 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 2.5 mt-30 -89.74 11.34 20.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.907 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 1.8 p-10 55.33 29.18 12.52 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.136 1.374 . . . . 0.0 112.136 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.543 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 0.9 OUTLIER -131.65 -165.74 1.62 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.639 177.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.73 -28.57 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.67 38.02 4.31 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.267 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.429 HD11 HG13 ' A' ' 37' ' ' ILE . 2.6 pp -128.82 177.51 6.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.868 0.842 . . . . 0.0 111.954 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 11.7 m -138.41 125.18 20.99 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.397 173.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 38' ' ' GLY . 22.5 mt -110.47 -168.18 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.604 ' H ' HG22 ' A' ' 37' ' ' ILE . . . . . . . . 0 C--N 1.308 -0.984 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.31 0 CA-C-O 121.53 0.681 . . . . 0.0 109.285 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 37.4 t -92.3 -38.32 10.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.937 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.96 150.15 20.3 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.682 -174.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' A' ' 59' ' ' ALA . 8.1 p -141.33 159.98 22.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.567 173.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -95.91 -139.18 0.25 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -136.06 -33.41 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.783 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -102.38 4.49 38.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.166 0.508 . . . . 0.0 110.564 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 82.5 p -86.3 144.16 37.84 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.793 ' HA ' ' CD1' ' A' ' 60' ' ' LEU . 10.2 Cg_endo -52.25 -38.99 73.06 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.428 1.418 . . . . 0.0 111.704 -172.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.661 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.05 -45.36 87.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.543 175.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 52' ' ' VAL . . . -72.4 -60.95 1.98 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.095 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.793 ' CD1' ' HA ' ' A' ' 57' ' ' PRO 0.268 0.0 OUTLIER -61.41 -71.43 0.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -166.895 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.696 ' H ' ' CD1' ' A' ' 60' ' ' LEU . 23.7 t70 -92.84 -4.31 53.15 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -71.71 -62.28 3.48 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 112.613 -2.085 . . . . 0.0 113.648 -171.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p 74.31 23.18 2.07 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.933 1.293 . . . . 0.0 110.574 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.531 HG13 HG13 ' A' ' 99' ' ' ILE . 31.2 m -100.21 50.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.564 172.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.73 174.91 10.07 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.138 -170.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.91 132.43 52.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.607 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.15 -13.58 19.19 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.628 ' O ' HG23 ' A' ' 49' ' ' ILE . 57.8 m-20 -95.86 -175.99 3.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.026 0.441 . . . . 0.0 110.72 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . 50.9 mt-10 -132.09 154.24 49.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.101 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 mm -122.83 140.29 47.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 t -131.07 -0.88 4.11 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.56 142.16 7.94 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.22 -1.467 . . . . 0.0 113.952 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.613 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -104.0 117.3 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 123.632 0.773 . . . . 0.0 109.767 -179.059 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.566 ' ND2' HG13 ' A' ' 93' ' ' VAL . 64.9 t30 53.71 29.95 10.32 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.536 0.684 . . . . 0.0 111.016 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.614 ' HA2' ' CD2' ' A' ' 100' ' ' HIS . . . 100.66 -21.52 43.61 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.917 177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 5.8 ptm180 -100.59 142.97 31.32 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 117.801 0.8 . . . . 0.0 110.529 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.7 m -59.42 149.87 28.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.188 0.518 . . . . 0.0 111.332 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.46 HD11 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -90.62 -20.96 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.166 -179.01 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.24 -25.78 68.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.123 -170.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.99 -17.71 77.24 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.863 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -135.01 -139.27 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.321 0.56 . . . . 0.0 110.215 -176.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.433 ' OG1' ' HG3' ' A' ' 85' ' ' GLU . 47.1 p -137.67 157.89 45.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.628 -172.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.465 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -48.04 -54.94 11.38 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.774 0.671 . . . . 0.0 112.588 -178.424 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.93 -39.67 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 120.895 0.378 . . . . 0.0 111.974 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.564 ' O ' ' HG3' ' A' ' 89' ' ' MET . 39.8 mt-10 -72.7 -36.62 67.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.934 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 83' ' ' LYS . 29.1 m -72.48 -41.36 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.347 -176.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.65 -37.01 67.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.027 170.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 57.1 tttm -64.76 -48.98 72.56 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.828 173.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.564 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 58.3 mtt -54.69 -40.56 69.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.107 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.565 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 20.1 mm -61.26 -55.48 24.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.087 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.51 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 10.4 pt20 -72.34 -23.13 61.1 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -176.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -67.45 -53.75 26.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.566 HG13 ' ND2' ' A' ' 74' ' ' ASN . 33.6 m -46.59 -32.33 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 23.9 tptm 70.87 123.88 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.292 0.568 . . . . 0.0 112.073 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.514 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 105.8 -59.16 0.42 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.151 -1.024 . . . . 0.0 113.588 172.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.5 pt-20 -135.47 178.72 6.82 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.149 0.5 . . . . 0.0 110.566 -170.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 m -148.38 151.09 13.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.0 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 p -139.73 99.98 3.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.33 0.586 . . . . 0.0 109.99 170.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -86.26 115.51 27.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.82 -176.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.614 ' CD2' ' HA2' ' A' ' 75' ' ' GLY . 4.7 m-70 -91.99 119.71 31.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -132.2 -170.16 2.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.61 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.514 ' ND2' ' HB2' ' A' ' 69' ' ' GLU . 4.0 p-10 . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.319 173.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 C--O 1.21 -1.013 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.543 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 36.3 Cg_exo -32.76 -52.89 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.582 2.855 . . . . 0.0 113.965 -174.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.7 ptpt -55.97 -51.06 69.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.387 0.613 . . . . 0.0 111.978 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.527 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.3 mm100 -88.16 -3.9 58.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.729 0.776 . . . . 0.0 111.343 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.72 -49.11 6.65 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.622 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 7.4 pt-20 -68.73 -23.43 64.34 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.514 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 110' ' ' GLN . 3.9 p -69.54 -31.74 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.589 0.709 . . . . 0.0 110.101 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.84 -34.02 45.49 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.283 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.6 t80 . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.529 -178.27 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.613 HD21 ' N ' ' A' ' 127' ' ' LYS . 9.1 tt . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.613 ' N ' HD21 ' A' ' 126' ' ' LEU . 19.8 pttp -155.13 120.88 5.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.478 0.656 . . . . 0.0 111.575 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.605 ' O ' HG13 ' A' ' 33' ' ' ILE . 12.5 p . . . . . 0 N--CA 1.446 -0.651 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.344 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -147.27 102.71 3.78 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.37 5.18 6.45 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.621 2.214 . . . . 0.0 113.305 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.5 63.07 2.18 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.253 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.508 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 2.7 pt -79.07 157.09 76.36 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.508 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 36.1 Cg_endo -66.26 -87.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.377 2.051 . . . . 0.0 113.393 -171.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.11 96.09 48.44 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 120.766 0.317 . . . . 0.0 110.978 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.76 144.39 31.12 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.576 2.184 . . . . 0.0 112.487 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -154.7 172.5 33.13 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 19.8 ptpt -148.63 141.72 24.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.815 0.308 . . . . 0.0 110.558 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.67 136.42 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -110.72 129.45 55.83 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.78 0.8 . . . . 0.0 110.72 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.19 -160.2 1.03 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.01 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -140.3 149.05 42.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.117 0.484 . . . . 0.0 110.104 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 3.3 mmmm -45.39 151.45 0.37 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.578 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -84.37 172.61 11.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.169 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.02 41.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 110.828 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.575 ' NE2' HD22 ' A' ' 32' ' ' LEU . 3.9 tt0 -92.47 8.43 38.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.982 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 40.1 t30 69.35 34.75 2.8 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.901 0.858 . . . . 0.0 110.583 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.575 HD22 ' NE2' ' A' ' 30' ' ' GLN . 1.5 pp -147.07 -164.4 1.99 Allowed 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.273 -0.571 . . . . 0.0 112.002 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -104.07 -30.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 101.56 32.52 5.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.194 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.488 ' CD1' HG23 ' A' ' 128' ' ' VAL . 2.8 pp -126.83 -179.48 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.613 0.721 . . . . 0.0 112.61 -175.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 39.8 m -137.6 128.73 27.64 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.506 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.614 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 48.0 mm -111.04 125.43 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.649 0.738 . . . . 0.0 111.988 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 48' ' ' TYR . . . -132.62 126.59 4.54 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 170.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.07 61.74 2.17 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.888 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.82 149.94 7.69 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.456 ' HB2' ' NE2' ' A' ' 116' ' ' GLN . . . -117.63 -76.43 0.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.798 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 113' ' ' VAL . 18.0 pt20 -77.62 104.75 8.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.034 0.445 . . . . 0.0 109.974 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 74.17 4.79 4.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.927 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.467 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 69.1 m 57.66 58.9 7.15 Favored Pre-proline 0 C--O 1.231 0.095 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.995 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.47 ' HB2' ' H ' ' A' ' 46' ' ' CYS . 21.8 Cg_exo -65.63 -86.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.493 2.128 . . . . 0.0 112.609 -173.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.727 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 93.8 m -151.72 -97.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 46' ' ' CYS . 0.4 OUTLIER 50.62 -66.89 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.201 1.4 . . . . 0.0 114.136 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 87.9 m-85 68.6 -57.15 0.5 Allowed 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.262 0.625 . . . . 0.0 112.515 -174.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.684 HG23 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -86.57 115.85 28.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 118.509 -1.277 . . . . 0.0 110.32 -179.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -94.27 -31.78 4.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.12 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -161.0 154.15 21.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.13 0.491 . . . . 0.0 110.088 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 9.8 p -143.45 160.77 16.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.922 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.479 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 80.4 m-85 -112.74 124.97 53.78 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 20.6 t70 -54.19 -27.36 33.58 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -165.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -101.0 6.93 43.69 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.184 0.516 . . . . 0.0 110.492 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.479 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 30.9 p -87.55 153.9 53.32 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.32 -40.2 78.69 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.211 1.274 . . . . 0.0 110.905 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -55.68 -49.49 72.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.803 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -77.68 -56.29 4.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.848 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.628 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.3 pp -52.74 -74.12 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -170.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.628 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 37.2 t70 -94.13 -9.11 37.58 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.563 1.173 . . . . 0.0 107.938 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -82.94 -51.73 4.11 Favored Glycine 0 C--N 1.311 -0.816 0 CA-C-N 113.093 -1.867 . . . . 0.0 113.458 -171.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 p 64.57 22.55 12.68 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.699 1.2 . . . . 0.0 111.143 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.467 HG11 HG13 ' A' ' 99' ' ' ILE . 9.9 m -92.1 53.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 122.959 1.361 . . . . 0.0 109.74 172.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.6 179.81 7.04 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.552 -2.113 . . . . 0.0 111.736 -171.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.37 122.71 11.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.991 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.86 1.07 34.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.71 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.684 ' O ' HG23 ' A' ' 49' ' ' ILE . 51.5 t0 -98.48 152.73 19.22 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 33.6 tt0 -101.44 82.31 2.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.896 0.379 . . . . 0.0 110.692 -174.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.497 ' N ' HD13 ' A' ' 70' ' ' ILE . 2.0 mp -74.18 101.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.679 0.752 . . . . 0.0 109.362 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.407 HG23 HD22 ' A' ' 102' ' ' ASN . 7.5 t -100.76 -15.8 17.54 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.649 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -147.78 148.03 19.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.6 -1.285 . . . . 0.0 113.457 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.76 115.31 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.475 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 9.7 t-20 52.21 37.17 21.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.218 0.532 . . . . 0.0 111.311 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.69 -22.45 39.66 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.833 -0.621 . . . . 0.0 113.927 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -106.13 129.29 54.24 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 117.726 0.763 . . . . 0.0 111.245 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.489 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 46.4 m -61.63 148.67 41.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.536 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.477 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -90.68 -25.52 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.265 0.555 . . . . 0.0 109.598 177.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -73.09 86.5 1.36 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.262 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.65 -25.7 0.17 Allowed Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.07 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -111.12 -117.04 0.3 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.942 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.439 ' O ' HG12 ' A' ' 86' ' ' VAL . 4.9 m -149.61 148.93 29.91 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.236 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.57 ' O ' HG22 ' A' ' 86' ' ' VAL . 5.5 mttt -47.81 -55.69 9.12 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.253 0.549 . . . . 0.0 111.976 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.06 -36.91 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.697 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 89' ' ' MET . 37.1 mt-10 -74.36 -37.21 63.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.261 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 83' ' ' LYS . 27.3 m -67.35 -43.09 88.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.888 0.375 . . . . 0.0 111.087 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.07 73.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.203 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 59.8 tttm -61.48 -45.89 92.34 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.583 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 82.5 mtp -53.7 -37.21 63.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.402 0.62 . . . . 0.0 110.723 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.468 HD12 HD13 ' A' ' 33' ' ' ILE . 97.1 mt -77.23 -38.53 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.21 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -70.68 -29.33 65.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.625 0.25 . . . . 0.0 110.86 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -62.48 -48.73 78.31 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.628 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 93' ' ' VAL . 13.3 m -69.75 82.5 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 122.772 1.272 . . . . 0.0 110.08 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -67.34 123.08 19.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.407 -173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.539 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 95.9 -21.17 46.43 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.431 169.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.472 ' O ' HG21 ' A' ' 97' ' ' VAL . 9.2 pt-20 -124.28 169.17 12.04 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.079 0.466 . . . . 0.0 109.885 -174.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 96' ' ' GLU . 2.8 t -159.15 125.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.501 -173.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.475 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 99.5 m -141.58 131.9 25.07 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 122.171 -0.33 . . . . 0.0 110.143 172.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.552 HD11 ' N ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -120.36 132.65 69.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.429 -176.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -100.46 129.42 46.41 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 69' ' ' GLU . 27.5 p90 -136.85 165.82 25.06 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.745 0.307 . . . . 0.0 111.341 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.602 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 62.1 m-20 -142.58 172.25 12.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 13.1 mptt -148.57 99.44 3.01 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -174.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.557 HD11 ' N ' ' A' ' 105' ' ' GLN . 0.1 OUTLIER -97.83 125.98 42.96 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.518 -171.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.557 ' N ' HD11 ' A' ' 104' ' ' LEU . 23.1 mp0 -81.61 -22.84 37.41 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.194 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.48 ' H ' HD11 ' A' ' 104' ' ' LEU . . . 52.31 -155.46 0.17 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.199 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.5 152.1 79.76 Favored Pre-proline 0 C--O 1.215 -0.73 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -31.55 -55.88 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.752 2.968 . . . . 0.0 114.138 -172.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.0 ptpt -58.0 -45.9 86.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 71.0 mm-40 -86.57 -17.63 33.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.488 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.3 tm? -74.26 -44.26 53.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.161 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -70.11 -26.58 64.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.484 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.544 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 79.4 t -72.53 -41.72 63.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.028 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.7 tp -72.41 -23.09 61.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.822 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -61.5 -42.0 98.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.308 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.495 ' OE1' ' HG2' ' A' ' 42' ' ' GLN . 12.4 mm100 63.07 94.82 0.05 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.702 0.763 . . . . 0.0 110.778 -173.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.44 ' H ' ' HD2' ' A' ' 118' ' ' PRO . . . -126.52 -57.64 0.14 Allowed Glycine 0 C--N 1.309 -0.97 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.48 ' HG2' ' OE1' ' A' ' 42' ' ' GLN . 10.3 Cg_endo -50.5 123.93 12.28 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.397 2.731 . . . . 0.0 111.311 165.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -115.86 42.87 2.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.467 0.651 . . . . 0.0 110.471 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -79.59 -24.56 41.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.884 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 p -84.76 106.76 16.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.799 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.6 tp -86.22 -71.19 0.55 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 62.01 178.41 0.13 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.436 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -118.0 103.31 9.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.485 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -92.71 -179.19 5.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.494 ' CG ' ' HB ' ' A' ' 37' ' ' ILE . 1.4 pp -117.71 168.96 9.97 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 10.9 ptmm? -150.98 145.85 25.84 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.357 0.599 . . . . 0.0 110.478 176.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.573 ' OXT' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 168.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 p -76.95 129.85 77.47 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.988 0.394 . . . . 0.0 110.357 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.93 46.72 2.13 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.935 2.423 . . . . 0.0 112.359 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.3 -178.15 41.83 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.038 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.467 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 10.5 pt -106.85 156.06 37.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 29.7 Cg_endo -62.68 -91.03 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.348 2.032 . . . . 0.0 112.931 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.1 112.68 15.85 Favored Pre-proline 0 N--CA 1.438 -1.027 0 O-C-N 122.161 -0.337 . . . . 0.0 110.678 174.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.17 144.39 10.58 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.848 2.365 . . . . 0.0 112.996 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.25 -176.86 42.97 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 64.4 pttt -141.95 161.32 38.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.14 0.47 . . . . 0.0 110.633 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 62' ' ' GLY . 9.7 p -142.95 138.78 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.461 ' O ' HD11 ' A' ' 25' ' ' LEU . 12.0 t -110.89 127.36 55.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.445 0.64 . . . . 0.0 110.768 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 24' ' ' THR . 2.6 mm? -127.51 -170.39 2.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.432 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 80.5 mt-30 -129.98 136.55 49.56 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.238 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.602 ' NZ ' ' HA ' ' A' ' 91' ' ' GLN . 22.3 mmtp -45.16 149.27 0.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.712 1.258 . . . . 0.0 112.009 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 4.5 p-10 -89.89 -162.88 0.93 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.489 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.09 65.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.755 0.312 . . . . 0.0 111.555 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.448 ' O ' ' HB3' ' A' ' 31' ' ' ASN . 36.5 mt-30 -88.43 0.84 55.82 Favored 'General case' 0 N--CA 1.425 -1.722 0 C-N-CA 122.931 0.492 . . . . 0.0 112.245 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 50.7 t30 71.3 18.47 5.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.51 0.671 . . . . 0.0 110.943 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.447 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 2.0 pp -126.58 -165.26 1.43 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.092 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.82 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -109.03 -22.27 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.674 -177.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 98.48 35.05 5.08 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.878 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.544 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.7 pp -123.2 171.21 12.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.463 0.649 . . . . 0.0 110.698 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 46.2 m -130.72 131.92 45.06 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.375 175.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 41.2 mm -100.44 141.29 17.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.152 -176.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.29 -158.81 8.03 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.117 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' HA3' HD12 ' A' ' 47' ' ' LEU . . . -12.39 -102.15 0.0 OUTLIER Glycine 0 C--N 1.34 0.784 0 N-CA-C 115.83 1.092 . . . . 0.0 115.83 -159.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 45' ' ' PRO . . . 55.29 80.65 0.07 OUTLIER Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.769 -172.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.62 ' N ' ' HA ' ' A' ' 45' ' ' PRO . . . -173.54 -153.28 0.06 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.992 0.396 . . . . 0.0 110.808 -166.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -50.66 129.95 23.57 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.559 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 76.68 -21.53 0.32 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.949 0.9 . . . . 0.0 112.904 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 38.3 t -162.63 80.8 1.72 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.948 0.404 . . . . 0.0 111.26 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.62 ' HA ' ' N ' ' A' ' 41' ' ' ALA . 17.1 Cg_exo -75.4 23.07 0.43 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.63 2.887 . . . . 0.0 112.954 174.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 80.9 m -95.54 -141.79 0.26 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.429 HD12 ' HA3' ' A' ' 39' ' ' GLY . 40.2 mt 76.0 -103.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.377 0.608 . . . . 0.0 110.809 177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 26.6 m-85 68.75 -77.78 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.778 -176.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.52 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -82.2 109.84 16.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 118.066 -1.454 . . . . 0.0 110.369 -172.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 m -108.73 -19.12 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.123 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 13.9 tp60 -157.3 143.55 17.88 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-O 121.023 0.439 . . . . 0.0 110.222 -171.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.5 p -145.31 160.93 12.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.015 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' H ' HG22 ' A' ' 52' ' ' VAL . 30.2 m-85 -98.64 -131.15 0.21 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.119 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -138.2 -44.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.484 ' HA ' HD23 ' A' ' 60' ' ' LEU . 46.7 m-80 -100.62 8.33 43.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.334 0.588 . . . . 0.0 109.78 -170.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.422 ' CB ' ' HA3' ' A' ' 34' ' ' GLY . 31.0 p -92.19 143.66 27.85 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.51 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 3.6 Cg_endo -44.96 -41.92 15.59 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 C-N-CA 122.551 2.167 . . . . 0.0 111.776 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -58.1 -54.76 43.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.419 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -71.8 -55.0 8.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.73 0.776 . . . . 0.0 109.807 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.3 tm? -42.45 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.235 -1.802 . . . . 0.0 113.273 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -98.8 -39.54 8.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.152 0.501 . . . . 0.0 111.914 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -62.89 -27.33 70.04 Favored Glycine 0 C--O 1.228 -0.226 0 CA-C-N 115.14 -0.936 . . . . 0.0 114.631 -165.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 t 50.71 35.84 12.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.312 1.053 . . . . 0.0 111.39 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.535 HG11 HG13 ' A' ' 99' ' ' ILE . 20.6 m -100.14 51.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.345 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.33 177.77 8.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.222 -168.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.26 136.21 25.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.992 -170.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.82 56.32 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.6 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' O ' HG21 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -104.12 165.49 11.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.025 0.44 . . . . 0.0 110.438 176.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -108.63 99.93 9.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.173 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.421 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 28.7 mm -83.66 105.43 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 77' ' ' SER . 4.2 t -101.49 -15.26 17.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.315 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -139.93 136.36 7.73 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 119.762 -1.209 . . . . 0.0 113.655 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.672 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -103.97 120.54 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 123.376 0.67 . . . . 0.0 109.379 177.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.511 ' ND2' HG11 ' A' ' 93' ' ' VAL . 66.0 t30 54.1 29.91 11.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.481 0.658 . . . . 0.0 110.719 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.15 -21.35 44.92 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.755 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 2.7 ptp180 -104.22 131.2 51.79 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 117.874 0.837 . . . . 0.0 110.602 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' THR . 62.6 m -47.8 136.11 11.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.201 0.525 . . . . 0.0 112.151 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.528 HG13 ' CE2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -76.1 -19.75 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.76 -174.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.04 -12.21 59.26 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.121 -173.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.58 -20.87 61.03 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.377 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 2.6 mptp? -107.67 -131.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.845 0.831 . . . . 0.0 110.275 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 86' ' ' VAL . 5.5 m -158.13 160.12 36.95 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.616 ' O ' HG23 ' A' ' 86' ' ' VAL . 12.8 mttt -47.01 -60.8 2.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.335 0.588 . . . . 0.0 111.756 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -55.0 -34.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.076 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.588 ' O ' ' HG2' ' A' ' 89' ' ' MET . 33.2 mt-10 -77.52 -43.47 31.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.679 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 83' ' ' LYS . 19.7 m -58.42 -47.6 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 126' ' ' LEU . . . -57.16 -38.75 74.03 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 25.6 ttpp -60.88 -56.92 15.45 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.588 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 16.5 mmt -48.63 -43.2 36.22 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.63 0.581 . . . . 0.0 111.146 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.451 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 64.2 mt -62.45 -55.12 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.465 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.602 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 10.4 pt20 -76.94 -22.12 53.78 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.985 -0.447 . . . . 0.0 111.459 -174.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.58 -52.68 23.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.411 0.684 . . . . 0.0 111.732 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.511 HG11 ' ND2' ' A' ' 74' ' ' ASN . 31.8 m -49.42 -36.26 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.543 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 67.62 134.55 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.464 0.649 . . . . 0.0 112.493 171.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.415 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 102.27 -48.25 1.08 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.938 172.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.0 pt-20 -146.03 178.79 7.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.058 0.456 . . . . 0.0 110.144 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.413 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 5.4 m -145.39 154.69 13.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.621 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.3 m -140.71 99.78 3.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 172.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.535 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -93.45 120.63 43.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.112 -175.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -94.39 129.06 41.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 171.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -139.04 163.98 30.97 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.157 0.503 . . . . 0.0 111.815 -172.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -133.75 103.13 5.73 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 18' ' ' PRO . 11.0 mtpt -93.58 139.55 30.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.28 0.562 . . . . 0.0 111.607 -165.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 106' ' ' ALA . 1.0 OUTLIER -157.99 -52.82 0.07 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.057 -175.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.433 ' O ' HD23 ' A' ' 111' ' ' LEU . 2.7 mp0 59.37 18.61 6.91 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -170.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.521 ' H ' ' HG ' ' A' ' 104' ' ' LEU . . . 58.77 -166.32 0.17 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.643 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 20.2 t70 -125.53 144.95 49.58 Favored Pre-proline 0 C--O 1.21 -1.021 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.454 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 13.6 Cg_exo -29.26 -51.48 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.251 3.301 . . . . 0.0 115.16 -173.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.485 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.1 pttp -59.51 -45.63 91.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.379 0.609 . . . . 0.0 111.759 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.485 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 15.1 mm100 -85.76 -17.81 34.79 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.838 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 105' ' ' GLN . 3.2 tm? -73.25 -43.73 60.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.485 -175.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -69.18 -35.47 76.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.119 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 109' ' ' LYS . 81.0 t -64.71 -41.11 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.223 0.535 . . . . 0.0 109.991 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.85 -23.79 61.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.84 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -76.08 -49.64 16.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.041 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -85.09 42.43 0.94 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.208 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -122.29 -61.5 0.21 Allowed Glycine 0 C--N 1.312 -0.792 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -38.62 86.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.195 3.263 . . . . 0.0 112.752 158.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -151.73 21.81 0.7 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.845 0.831 . . . . 0.0 109.402 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -125.61 124.03 40.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.12 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.07 -20.76 17.16 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.393 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.1 mt -80.52 76.0 7.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.174 0.511 . . . . 0.0 110.597 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.2 166.79 28.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.926 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -82.39 109.34 16.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.928 0.394 . . . . 0.0 110.325 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 51.2 t90 -85.13 153.18 22.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.246 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' A' ' 127' ' ' LYS . 61.6 tp -143.36 167.97 20.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.669 0.271 . . . . 0.0 111.333 -173.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.521 ' N ' ' HG ' ' A' ' 126' ' ' LEU . 13.8 ptmm? -169.38 151.79 4.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.696 0.398 . . . . 0.0 110.69 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.82 ' OXT' HG13 ' A' ' 33' ' ' ILE . 14.5 p . . . . . 0 C--O 1.238 0.491 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.048 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -77.06 112.92 26.08 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.35 65.47 8.87 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.587 2.191 . . . . 0.0 112.409 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.65 -23.25 40.01 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.535 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 5.2 pt -113.01 166.92 10.06 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 60.0 Cg_endo -75.08 -161.71 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.523 1.482 . . . . 0.0 112.066 -177.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -41.94 113.69 1.22 Allowed Pre-proline 0 C--O 1.234 0.265 0 O-C-N 123.459 0.474 . . . . 0.0 111.485 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.482 ' HA ' ' ND2' ' A' ' 102' ' ' ASN . 9.8 Cg_endo -88.27 126.22 1.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.162 2.575 . . . . 0.0 113.1 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.15 134.16 8.77 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 12.0 ptmm? -159.78 114.62 2.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.82 0.343 . . . . 0.0 110.596 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 62' ' ' GLY . 14.6 m -128.16 154.19 38.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.938 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.7 t -116.35 123.6 48.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.546 0.689 . . . . 0.0 110.219 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.8 mt -122.34 -168.43 1.72 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.402 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 93.6 mt-30 -133.89 140.14 46.63 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.215 0.531 . . . . 0.0 110.642 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 10.0 mmtp -45.79 144.02 1.88 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.067 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -83.63 -179.39 7.31 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.439 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.77 -24.24 61.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 118.084 0.402 . . . . 0.0 111.363 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.477 HE21 HD22 ' A' ' 32' ' ' LEU . 6.1 tt0 -96.56 21.13 9.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 110.202 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 1.7 p-10 57.17 23.45 8.63 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.121 1.369 . . . . 0.0 113.173 174.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.477 HD22 HE21 ' A' ' 30' ' ' GLN . 0.8 OUTLIER -128.72 -165.43 1.5 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.797 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.769 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.7 -26.58 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.635 -178.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 98.28 41.9 3.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.093 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.509 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -130.06 172.6 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.947 0.879 . . . . 0.0 111.488 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m -141.41 129.41 21.96 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.712 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 35' ' ' ILE . 6.9 pt -119.41 137.97 51.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.896 0.855 . . . . 0.0 111.022 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.465 ' HA2' ' CD1' ' A' ' 125' ' ' TRP . . . -109.93 -157.81 16.84 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.853 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -14.09 -69.78 0.01 OUTLIER Glycine 0 C--N 1.343 0.921 0 O-C-N 124.929 1.017 . . . . 0.0 115.508 -163.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 46' ' ' CYS . . . 69.35 30.3 71.48 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.653 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 64.08 5.82 2.61 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -71.05 -28.37 64.33 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -106.44 -56.87 2.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.897 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.451 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 47.6 m -162.76 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.767 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 44' ' ' CYS . 40.3 Cg_endo -77.57 138.65 17.45 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.601 2.201 . . . . 0.0 112.934 -167.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.548 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 79.7 m -59.62 -94.98 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.275 -0.393 . . . . 0.0 111.18 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.592 HD11 ' N ' ' A' ' 48' ' ' TYR . 1.2 pp 47.74 -70.67 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.592 ' N ' HD11 ' A' ' 47' ' ' LEU . 49.1 m-85 70.22 -88.21 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.377 0.671 . . . . 0.0 110.592 -170.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.6 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -71.54 128.74 34.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 119.373 0.988 . . . . 0.0 110.647 -172.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 m -117.66 -22.21 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.397 -175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -155.07 138.61 15.97 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.585 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 59' ' ' ALA . 6.2 p -139.91 160.89 26.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.855 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -97.93 -137.79 0.28 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.429 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.44 -34.66 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -101.72 -0.56 34.28 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.998 0.428 . . . . 0.0 110.174 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 80.2 p -84.04 148.54 53.86 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 10.2 Cg_endo -52.06 -41.16 66.04 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.484 1.456 . . . . 0.0 110.991 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.569 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.52 -45.71 88.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.827 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 52' ' ' VAL . . . -72.38 -59.56 2.67 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.411 0.624 . . . . 0.0 110.525 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.636 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.6 pp -54.87 -75.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.636 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 31.4 t70 -94.6 -13.06 26.33 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 122.581 1.181 . . . . 0.0 108.24 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -61.55 -40.34 98.57 Favored Glycine 0 C--N 1.314 -0.687 0 CA-C-N 112.464 -2.153 . . . . 0.0 114.804 -166.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.2 p 52.31 35.29 16.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.455 1.121 . . . . 0.0 111.197 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.434 HG11 HG13 ' A' ' 99' ' ' ILE . 15.9 m -122.79 53.66 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.174 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.62 179.67 7.33 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 112.649 -2.069 . . . . 0.0 111.319 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.34 123.05 15.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.696 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.64 -18.6 8.64 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.522 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.6 ' O ' HG21 ' A' ' 49' ' ' ILE . 11.9 m-20 -83.33 144.51 29.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.524 0.662 . . . . 0.0 110.532 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 41.9 mt-10 -94.52 97.0 9.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.924 -174.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.475 HD13 ' HB ' ' A' ' 49' ' ' ILE . 2.1 mp -76.01 138.26 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -127.89 -25.03 3.13 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.963 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.15 146.81 16.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.536 -1.316 . . . . 0.0 113.772 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.675 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -117.52 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.491 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 5.4 m-20 56.24 22.17 5.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.95 0.405 . . . . 0.0 111.786 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.83 -12.21 59.25 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.451 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 9.7 ptp180 -105.76 131.72 52.76 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 117.922 0.861 . . . . 0.0 110.861 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 p -61.06 138.08 58.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.133 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.504 HD12 ' H ' ' A' ' 79' ' ' LYS . 1.1 pp -77.56 -24.16 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-O 122.391 1.091 . . . . 0.0 109.883 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.504 ' H ' HD12 ' A' ' 78' ' ' ILE . 3.5 tppp? -69.63 -19.27 63.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.068 -1.878 . . . . 0.0 109.878 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.56 -15.61 75.47 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.019 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.518 ' HB3' ' HZ3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.73 -142.26 0.17 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.662 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 86' ' ' VAL . 29.7 p -136.35 169.79 17.08 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.177 -0.209 . . . . 0.0 111.105 -169.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.461 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -49.02 -53.99 17.7 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.81 0.693 . . . . 0.0 112.443 -176.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.06 -39.82 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.624 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.07 -35.32 66.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 82' ' ' THR . 32.3 m -68.54 -46.1 80.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.209 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.411 ' HB1' HD11 ' A' ' 126' ' ' LEU . . . -58.33 -37.82 75.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.971 0.415 . . . . 0.0 110.171 172.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -63.26 -53.13 57.8 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.847 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.475 ' O ' HG13 ' A' ' 93' ' ' VAL . 24.8 mmt -51.86 -42.48 62.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.25 0.548 . . . . 0.0 111.386 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.586 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 62.5 mt -64.78 -47.96 86.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.675 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.436 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 7.1 pt20 -73.78 -35.36 64.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.159 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -58.95 -50.1 75.35 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.526 0.516 . . . . 0.0 111.981 -173.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 89' ' ' MET . 17.8 m -52.99 -35.29 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.566 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 98.5 mttt 65.16 151.32 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.824 0.821 . . . . 0.0 112.802 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 88.3 -53.52 4.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.214 168.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.1 pt-20 -137.33 178.01 7.42 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.8 150.67 14.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.846 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 34.3 m -137.97 103.61 5.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.043 0.449 . . . . 0.0 110.182 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -94.45 129.81 44.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.338 -175.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -114.72 119.86 38.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.258 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -142.04 154.1 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.003 0.43 . . . . 0.0 110.893 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 20' ' ' PRO . 17.3 m120 -141.7 -172.25 3.5 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 9.1 mptt -148.24 98.58 2.93 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -173.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.53 HD12 ' H ' ' A' ' 105' ' ' GLN . 0.3 OUTLIER -112.13 -178.66 3.47 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.277 -169.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.53 ' H ' HD12 ' A' ' 104' ' ' LEU . 14.7 mm100 -104.9 -84.33 0.49 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.981 0.42 . . . . 0.0 111.123 -173.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 58.82 -177.35 0.08 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.527 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.586 ' OD2' ' HG2' ' A' ' 109' ' ' LYS . 10.5 t70 -172.54 151.21 2.35 Favored Pre-proline 0 C--O 1.21 -1.007 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 9.2 Cg_exo -29.9 -47.77 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.693 2.929 . . . . 0.0 114.087 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.586 ' HG2' ' OD2' ' A' ' 107' ' ' ASP . 9.2 ptpp? -58.25 -49.61 76.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.232 0.539 . . . . 0.0 111.831 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.482 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 26.3 mm-40 -85.95 -11.59 52.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.714 0.769 . . . . 0.0 110.872 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.42 -43.89 22.47 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.142 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 115' ' ' PHE . 8.2 pt-20 -69.56 -22.07 63.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.191 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 109' ' ' LYS . 82.0 t -64.02 -35.24 72.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.403 0.62 . . . . 0.0 109.583 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.07 -27.66 54.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.81 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 118' ' ' PRO . 13.7 t80 -89.38 36.62 0.84 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.149 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -71.64 81.59 0.84 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.08 0.943 . . . . 0.0 111.27 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.461 ' H ' ' CD ' ' A' ' 118' ' ' PRO . . . 148.22 50.16 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.512 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 11.2 Cg_endo -51.43 110.25 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.713 2.942 . . . . 0.0 113.718 -167.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -134.31 138.74 45.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.719 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -128.62 96.92 4.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.095 0.474 . . . . 0.0 110.873 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 29.0 p -97.5 92.59 6.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.67 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.5 tp -59.11 107.3 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 110.075 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.82 147.87 23.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.343 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -58.58 145.44 39.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.784 0.326 . . . . 0.0 110.415 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.465 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 11.6 m-90 -75.98 147.76 38.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.411 HD11 ' HB1' ' A' ' 87' ' ' ALA . 1.6 pp -89.27 169.0 11.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.503 0.668 . . . . 0.0 112.069 -165.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -151.43 114.55 4.75 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.634 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.769 ' OXT' HG13 ' A' ' 33' ' ' ILE . 13.8 p . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 118.011 -0.995 . . . . 0.0 108.699 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 p -62.99 134.74 95.89 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.479 0.181 . . . . 0.0 110.537 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.66 63.88 3.04 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.959 2.439 . . . . 0.0 112.631 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.57 82.07 0.3 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.656 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.684 ' HB ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -92.39 154.93 42.79 Favored Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 122.102 0.161 . . . . 0.0 111.338 -177.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.461 ' HD3' HD12 ' A' ' 104' ' ' LEU . 38.3 Cg_endo -68.83 -86.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.457 2.105 . . . . 0.0 113.407 -172.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.86 107.4 54.65 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-O 121.392 0.615 . . . . 0.0 110.708 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.36 165.61 23.13 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 124.652 3.568 . . . . 0.0 113.257 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 100' ' ' HIS . . . 85.05 -63.54 4.37 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.578 169.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 63.8 mttm 83.03 -136.35 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.418 1.087 . . . . 0.0 111.546 -174.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 99' ' ' ILE . 32.7 m -140.26 161.35 25.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.138 0.494 . . . . 0.0 112.152 -162.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 t -122.91 123.87 41.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.389 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' CD2' HD13 ' A' ' 99' ' ' ILE . 2.4 mm? -118.15 -166.68 1.24 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.805 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 93.1 mt-30 -127.67 149.67 50.1 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.908 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 23.9 mmtp -52.14 146.26 9.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.749 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.46 179.93 7.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.807 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.99 -22.2 60.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.119 0.485 . . . . 0.0 111.044 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.514 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -92.18 8.7 36.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.033 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 38.6 t30 72.61 11.72 5.52 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.335 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.573 HD23 ' OXT' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -127.13 -168.07 1.83 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.945 -0.472 . . . . 0.0 111.887 -174.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.83 -26.87 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 99.08 33.41 5.49 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.144 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 128' ' ' VAL . 2.8 pp -125.72 172.38 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.692 0.758 . . . . 0.0 112.126 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 40.0 m -139.14 127.65 23.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.24 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 66.0 mt -106.56 120.23 57.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.891 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.15 -160.21 9.42 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.434 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.32 143.09 17.48 Favored Glycine 0 C--N 1.319 -0.372 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.508 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 42' ' ' GLN . . . -70.86 -121.31 0.05 OUTLIER Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.621 169.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.659 ' H ' ' HA ' ' A' ' 45' ' ' PRO . . . 69.05 -18.67 0.18 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' C ' ' H ' ' A' ' 44' ' ' CYS . 28.0 mm-40 -75.09 56.99 0.8 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 67.73 -7.01 0.62 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.726 0.81 . . . . 0.0 110.808 -174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' H ' ' C ' ' A' ' 42' ' ' GLN . 59.6 m -137.78 92.24 13.04 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.345 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.659 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 52.6 Cg_exo -63.23 -153.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 123.914 3.076 . . . . 0.0 114.045 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 45' ' ' PRO . 76.5 m 70.68 122.98 0.03 OUTLIER 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -163.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -131.97 178.83 6.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.162 0.982 . . . . 0.0 113.067 -170.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 83.7 m-85 67.01 -80.82 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.657 -1.611 . . . . 0.0 110.71 -163.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.37 115.52 28.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.048 -177.21 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.6 t -111.79 -23.36 4.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.942 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -147.5 143.4 27.81 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.663 0.744 . . . . 0.0 112.402 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.487 ' CG2' ' HB1' ' A' ' 59' ' ' ALA . 6.5 p -143.05 160.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.758 -1.564 . . . . 0.0 109.395 174.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.539 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 22.8 m-85 -116.86 126.06 52.45 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 34.9 t70 -57.46 -21.99 40.69 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -164.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.468 ' HA ' HD22 ' A' ' 60' ' ' LEU . 42.5 m-80 -101.38 6.17 42.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.228 0.537 . . . . 0.0 110.23 -173.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.539 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 28.3 p -96.98 149.12 35.35 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -48.28 -40.08 35.27 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.183 1.922 . . . . 0.0 111.804 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -57.54 -54.16 50.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.967 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HB1' ' CG2' ' A' ' 52' ' ' VAL . . . -73.95 -54.82 7.08 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.036 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -42.85 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.831 -177.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -95.6 -36.27 11.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.329 0.585 . . . . 0.0 111.026 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.46 -38.61 95.02 Favored Glycine 0 CA--C 1.517 0.159 0 CA-C-N 115.211 -0.904 . . . . 0.0 114.39 -167.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.11 56.19 4.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.049 0.928 . . . . 0.0 110.819 -174.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.544 HG12 HG13 ' A' ' 99' ' ' ILE . 16.3 m -128.39 49.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.581 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.92 179.28 7.58 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.295 -167.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.19 123.56 7.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.036 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.96 20.5 11.29 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.63 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.454 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.2 t0 -107.97 161.77 14.64 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.491 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 4.2 mp0 -101.98 124.51 47.73 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.031 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.3 mm -113.31 141.89 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.465 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.747 HG22 ' CG ' ' A' ' 101' ' ' TYR . 12.0 t -137.44 -18.57 1.27 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.706 -0.621 . . . . 0.0 112.262 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -131.9 136.68 8.91 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.032 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.466 HG12 HG23 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -101.15 121.86 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 124.011 0.925 . . . . 0.0 109.156 175.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.487 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 9.2 t-20 57.01 25.51 10.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.542 0.687 . . . . 0.0 110.355 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.87 -21.15 43.12 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.027 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -107.45 140.31 40.6 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 118.206 1.003 . . . . 0.0 111.024 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' THR . 23.1 t -52.93 137.12 33.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 111.755 -174.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.489 ' HB ' HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -80.94 -17.83 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 109.499 -177.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -64.67 -13.58 54.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.523 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.71 -19.57 78.08 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.815 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.94 -130.7 0.14 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.732 0.766 . . . . 0.0 111.653 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.473 ' O ' HG11 ' A' ' 86' ' ' VAL . 2.8 m -139.11 156.09 47.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.565 -168.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.547 ' O ' HG21 ' A' ' 86' ' ' VAL . 3.5 mtpt -47.85 -49.11 30.35 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.292 0.637 . . . . 0.0 111.676 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -58.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 122.454 1.121 . . . . 0.0 110.537 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 41.2 mt-10 -61.93 -30.95 71.25 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 112.94 -1.936 . . . . 0.0 112.615 -171.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.547 HG21 ' O ' ' A' ' 83' ' ' LYS . 30.5 m -71.17 -42.26 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.17 -41.18 68.2 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 28.5 ttpp -59.38 -48.48 81.48 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.616 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 89.0 mtp -51.97 -41.16 61.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.138 0.495 . . . . 0.0 110.866 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.6 mt -72.21 -41.28 66.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.231 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -76.05 -25.0 55.18 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.176 -0.327 . . . . 0.0 111.792 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.03 -51.66 65.91 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.52 151.2 8.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -132.05 144.42 50.74 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.151 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.1 -47.27 1.08 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.639 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 10.5 pt-20 -138.59 176.45 8.68 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.568 0.699 . . . . 0.0 111.182 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.526 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 5.5 m -149.65 158.29 6.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.06 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 24.7 m -142.41 125.08 15.87 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 170.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.544 HG13 HG12 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -102.9 139.22 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 0.7 OUTLIER -134.56 124.42 25.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.67 -179.464 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.747 ' CG ' HG22 ' A' ' 71' ' ' THR . 1.0 OUTLIER 169.98 -130.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 O-C-N 124.426 1.079 . . . . 0.0 110.014 166.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.684 ' ND2' ' HB ' ' A' ' 17' ' ' ILE . 4.5 m120 -172.66 -172.33 0.88 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -158.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.626 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 4.1 mptt -124.34 167.37 14.45 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 169.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 103' ' ' LYS . 4.1 pp 54.28 -150.12 0.41 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.112 0.883 . . . . 0.0 113.031 171.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.483 ' NE2' HG21 ' A' ' 17' ' ' ILE . 35.3 tt0 80.32 71.76 0.03 OUTLIER 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.432 1.093 . . . . 0.0 109.537 -175.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.02 165.44 11.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.628 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 111' ' ' LEU . 8.4 m-20 -145.23 161.62 41.06 Favored Pre-proline 0 C--O 1.213 -0.821 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -31.36 -48.79 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.68 2.92 . . . . 0.0 114.032 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.427 ' HZ1' ' HG2' ' A' ' 110' ' ' GLN . 13.2 ptmm? -57.08 -48.95 77.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.57 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.468 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 61.9 mm-40 -90.42 -13.42 34.96 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.677 0.751 . . . . 0.0 110.327 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.4 tm? -76.21 -38.21 56.74 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.238 -175.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.53 -25.89 63.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.394 0.616 . . . . 0.0 109.528 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 110' ' ' GLN . 96.5 t -67.02 -44.18 88.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.572 173.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.457 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 4.1 mm? -70.71 -21.67 62.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.758 176.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.9 -39.58 61.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.493 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -143.12 -65.82 0.38 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.308 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.728 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . 175.44 -46.6 0.13 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.124 -174.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.728 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 29.2 Cg_exo -9.08 77.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.297 1 C-N-CA 127.171 5.247 . . . . 0.0 116.832 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -176.55 40.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -77.8 63.87 2.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.678 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 m -90.05 131.19 36.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.296 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.71 103.35 2.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.881 0.372 . . . . 0.0 110.417 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -130.05 142.43 50.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.626 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.52 162.46 28.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.734 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -119.08 142.11 48.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.994 0.426 . . . . 0.0 110.366 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.549 ' HG ' ' HB ' ' A' ' 37' ' ' ILE . 1.2 pp -113.47 168.57 9.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 13.7 ptmm? -152.56 129.72 11.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.394 0.616 . . . . 0.0 110.918 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.649 ' O ' HG13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.016 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 167.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.3 t -137.75 89.53 15.2 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.761 0.315 . . . . 0.0 110.374 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.58 -32.2 39.41 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.84 2.36 . . . . 0.0 112.618 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.38 -87.09 0.73 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.345 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 pt -71.4 150.92 94.1 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 123.107 -0.055 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.565 ' HG3' HD23 ' A' ' 104' ' ' LEU . 34.3 Cg_endo -65.15 -78.4 0.01 OUTLIER 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.313 2.009 . . . . 0.0 112.571 -172.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.09 115.02 61.88 Favored Pre-proline 0 N--CA 1.427 -1.584 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.33 130.63 30.96 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.105 2.536 . . . . 0.0 112.204 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.36 91.82 0.58 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.728 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -138.33 100.49 4.13 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.71 0.767 . . . . 0.0 110.007 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 99' ' ' ILE . 34.8 m -122.06 145.97 27.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.306 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.1 t -117.47 110.9 18.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.721 0.772 . . . . 0.0 110.312 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.49 -164.72 0.97 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.371 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 92.3 mt-30 -131.04 144.36 51.39 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.363 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 29.5 mmtm -47.91 149.65 1.3 Allowed 'General case' 0 C--N 1.316 -0.878 0 O-C-N 124.641 1.213 . . . . 0.0 111.841 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -83.04 -178.59 7.17 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.94 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.77 -19.24 49.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.422 0.63 . . . . 0.0 110.647 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.532 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 3.9 mt-30 -92.8 11.38 27.18 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.626 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 1.2 p-10 56.82 24.07 8.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.013 1.325 . . . . 0.0 112.498 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.545 HD23 ' OXT' ' A' ' 128' ' ' VAL . 1.2 pp -130.57 -165.47 1.55 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.182 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.703 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.75 -29.47 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 100.36 30.86 6.07 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.221 -0.514 . . . . 0.0 113.226 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' CD1' HG22 ' A' ' 128' ' ' VAL . 2.8 pp -122.85 179.71 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.061 0.457 . . . . 0.0 111.592 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 51.5 m -138.16 129.67 27.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.095 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.83 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 61.6 mt -97.46 139.47 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.854 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA2' ' HZ3' ' A' ' 83' ' ' LYS . . . -173.74 -175.13 41.2 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.049 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.77 108.01 2.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.311 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.563 ' H ' ' HB3' ' A' ' 47' ' ' LEU . . . 97.74 106.39 2.48 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.51 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.483 ' HB3' ' HG2' ' A' ' 45' ' ' PRO . . . -59.65 -67.07 0.42 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.661 0.267 . . . . 0.0 110.862 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -94.42 -71.33 0.67 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -107.96 -59.84 1.79 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 170.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.509 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 47.3 t -171.5 61.77 0.34 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.12 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 0.9 OUTLIER -82.96 -50.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.323 2.015 . . . . 0.0 110.246 173.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 82.5 m -144.43 173.61 11.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.762 175.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -140.81 -172.94 3.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.023 0.916 . . . . 0.0 112.812 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.83 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 5.3 m-85 68.48 -37.86 0.36 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.222 -1.354 . . . . 0.0 114.034 -172.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -112.44 114.69 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 118.207 -1.397 . . . . 0.0 110.503 169.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.9 t -105.03 -30.26 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.258 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.441 ' HG2' ' HB2' ' A' ' 36' ' ' SER . 3.8 pt20 -157.05 152.54 26.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 6.7 p -141.84 160.54 20.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.845 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 97.3 m-85 -114.51 125.92 54.35 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.675 0.75 . . . . 0.0 108.978 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -53.07 -27.59 20.84 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 125.143 1.377 . . . . 0.0 114.566 -165.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.508 ' HA ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -100.85 4.14 42.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.26 0.552 . . . . 0.0 110.463 -171.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.485 ' CB ' ' HA3' ' A' ' 34' ' ' GLY . 30.4 p -91.3 146.82 34.18 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -47.41 -39.11 28.07 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.255 1.97 . . . . 0.0 111.659 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.49 -54.26 49.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.256 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -75.14 -52.97 9.67 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.388 0.614 . . . . 0.0 110.138 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.1 tm? -43.09 -75.62 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.502 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -96.83 -43.95 7.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.185 0.517 . . . . 0.0 111.479 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.3 -27.75 60.86 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 115.019 -0.992 . . . . 0.0 114.822 -164.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.48 48.31 19.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.868 0.842 . . . . 0.0 111.449 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.405 HG11 HG13 ' A' ' 99' ' ' ILE . 6.1 m -123.8 53.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 CA-C-O 122.936 1.351 . . . . 0.0 109.481 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.8 173.95 10.25 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 112.485 -2.143 . . . . 0.0 111.2 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.25 122.36 7.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.889 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.06 -4.97 16.01 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.71 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.615 ' O ' HG22 ' A' ' 49' ' ' ILE . 76.1 m-20 -98.85 172.81 7.2 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 30.7 tt0 -130.72 145.7 52.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.932 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.432 ' N ' HD11 ' A' ' 70' ' ' ILE . 4.2 mp -114.12 128.5 71.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.316 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.657 HG23 ' CG ' ' A' ' 101' ' ' TYR . 7.3 t -109.03 -4.81 16.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.054 0.454 . . . . 0.0 110.586 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.76 133.43 3.41 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.459 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.477 HG11 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -103.15 120.81 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.426 HD22 ' HA ' ' A' ' 90' ' ' ILE . 96.3 m-20 53.78 29.92 10.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.238 0.542 . . . . 0.0 111.704 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.57 -21.59 41.98 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.914 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -101.27 137.34 39.74 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 118.061 0.93 . . . . 0.0 110.789 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m -65.91 151.39 46.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.063 0.458 . . . . 0.0 111.228 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.884 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -93.47 3.48 8.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 122.455 1.121 . . . . 0.0 108.685 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -78.94 80.88 5.26 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.549 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.59 -30.49 0.41 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.688 -1.244 . . . . 0.0 115.012 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.884 ' HE2' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -112.35 -145.05 0.39 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.844 1.322 . . . . 0.0 112.088 -172.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.557 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -134.71 151.8 51.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.14 -178.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HA ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -45.44 -54.68 7.04 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.159 0.583 . . . . 0.0 112.341 175.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 p -51.69 -31.67 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.166 0.508 . . . . 0.0 111.981 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 89' ' ' MET . 32.4 mt-10 -81.89 -40.22 22.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.005 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' A' ' 83' ' ' LYS . 29.9 m -70.55 -38.25 72.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.538 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.17 -42.37 66.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.173 169.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -64.76 -50.77 65.51 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.717 175.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 62.4 mtt -50.74 -41.31 56.28 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.569 0.543 . . . . 0.0 111.045 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.497 HD13 HD11 ' A' ' 33' ' ' ILE . 74.4 mt -65.11 -56.42 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.254 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.521 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 10.3 pt20 -73.12 -24.59 60.64 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.713 -175.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 32.2 tt0 -58.7 -53.25 60.48 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.713 0.805 . . . . 0.0 111.976 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 90' ' ' ILE . 12.4 m -56.33 -29.02 27.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.292 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 92' ' ' GLU . 57.4 mttp 61.25 148.73 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.613 0.72 . . . . 0.0 112.609 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.55 -53.45 4.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.407 169.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 10.0 pt-20 -129.06 175.08 8.98 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.158 0.504 . . . . 0.0 110.19 -172.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.493 HG12 HG21 ' A' ' 33' ' ' ILE . 5.7 m -151.37 151.9 11.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.648 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.8 m -141.44 117.51 10.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.798 0.332 . . . . 0.0 110.741 170.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -98.63 148.74 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.17 176.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 1.1 m-70 -143.54 116.39 8.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.657 ' CG ' HG23 ' A' ' 71' ' ' THR . 1.3 t80 178.63 -116.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.615 0.572 . . . . 0.0 111.139 162.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.456 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 1.1 p-10 -161.47 175.68 11.9 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.135 -163.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 102' ' ' ASN . 53.0 mmtt -120.45 35.6 4.82 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.565 HD23 ' HG3' ' A' ' 18' ' ' PRO . 4.3 pp -178.89 157.07 0.86 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.176 0.512 . . . . 0.0 111.629 175.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 15.6 mm-40 -123.54 16.45 9.62 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.66 0.743 . . . . 0.0 109.245 171.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 73.52 -101.94 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.155 -1.384 . . . . 0.0 113.265 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.441 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 15.2 t70 -154.11 146.78 17.63 Favored Pre-proline 0 C--O 1.205 -1.237 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.031 -169.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 15.6 Cg_exo -29.3 -51.74 0.17 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 124.537 3.491 . . . . 0.0 115.424 -174.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.7 pttm -57.77 -48.15 80.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.356 0.598 . . . . 0.0 111.716 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.52 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.9 mm100 -83.37 -17.8 41.06 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.519 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.424 HD11 ' C ' ' A' ' 111' ' ' LEU . 2.4 tm? -64.74 -48.36 74.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.076 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -70.54 -25.24 63.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.794 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.8 t -69.6 -45.62 77.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.435 0.636 . . . . 0.0 109.787 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.53 -17.28 58.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.137 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.412 ' HZ ' ' CD1' ' A' ' 120' ' ' PHE . 43.4 t80 -91.74 9.36 32.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.393 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -77.78 10.53 2.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.212 0.529 . . . . 0.0 110.481 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -141.54 -63.33 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -30.16 108.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 124.579 3.519 . . . . 0.0 113.546 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -96.73 105.65 17.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.565 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.412 ' CD1' ' HZ ' ' A' ' 115' ' ' PHE . 3.1 p90 -69.58 118.78 12.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.436 0.636 . . . . 0.0 110.053 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.43 76.63 1.87 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.95 77.97 8.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 17.6 ptp180 -166.48 107.03 0.67 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.76 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 123' ' ' ARG . 63.0 m-70 70.29 143.35 0.05 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.408 0.623 . . . . 0.0 111.406 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -82.21 137.29 34.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.106 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 127' ' ' LYS . 1.5 tm? -111.33 161.21 16.29 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 21.8 ptmt -167.0 127.13 1.5 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.532 0.682 . . . . 0.0 111.422 176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.703 ' O ' HG13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.845 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 163.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 112.009 -0.436 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 m 57.94 70.13 1.36 Allowed Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 122.817 0.447 . . . . 0.0 111.114 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.45 53.57 4.27 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.84 2.36 . . . . 0.0 112.465 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.63 -62.08 3.55 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.062 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 8.5 pt -110.36 152.71 43.44 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 51.0 Cg_endo -70.1 -61.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.714 1.609 . . . . 0.0 112.105 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.3 93.98 7.53 Favored Pre-proline 0 N--CA 1.441 -0.922 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 173.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HA ' ' CD1' ' A' ' 17' ' ' ILE . 44.6 Cg_endo -67.21 138.22 46.33 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.699 2.266 . . . . 0.0 112.557 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.93 144.82 12.06 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.274 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -157.54 129.84 7.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 62' ' ' GLY . 20.7 m -126.54 146.9 31.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.864 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 t -110.95 116.04 30.52 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.726 0.774 . . . . 0.0 110.77 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mt -123.32 -166.89 1.52 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.646 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.652 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 2.0 pt20 -144.01 142.6 30.78 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.766 174.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -32.87 149.74 0.01 OUTLIER 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 177.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.46 -179.25 6.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.655 -1.612 . . . . 0.0 108.385 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.58 -29.04 61.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.59 0.632 . . . . 0.0 111.499 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.53 ' HB3' HD21 ' A' ' 32' ' ' LEU . 3.2 mt-30 -88.05 5.36 41.35 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.043 0.449 . . . . 0.0 110.603 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.9 t30 70.28 28.22 3.92 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.349 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.712 ' HB2' ' OXT' ' A' ' 128' ' ' VAL . 1.8 pt? -128.19 -171.26 2.41 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.785 175.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.842 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -104.58 -26.21 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.715 179.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' N ' ' HG ' ' A' ' 32' ' ' LEU . . . 96.17 40.43 4.01 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.386 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.4 HG22 HG21 ' A' ' 52' ' ' VAL . 2.9 pp -129.64 176.74 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.968 0.89 . . . . 0.0 112.305 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 24.0 m -144.72 126.87 15.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.731 172.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.5 mt -103.32 119.9 52.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.246 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.39 134.99 11.89 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.824 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.08 162.31 12.68 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.623 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.444 ' N ' ' HG ' ' A' ' 47' ' ' LEU . . . -70.05 -143.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.799 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.686 ' HA ' ' O ' ' A' ' 121' ' ' THR . . . -174.71 -84.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.66 0.267 . . . . 0.0 110.596 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -97.54 -14.62 20.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 110.201 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -87.74 -73.58 0.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 p -158.05 97.72 1.85 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.177 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.55 ' HG2' ' O ' ' A' ' 119' ' ' GLN . 81.8 Cg_exo -49.57 146.62 14.52 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.221 2.614 . . . . 0.0 112.725 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 84.3 m 70.37 125.95 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 O-C-N 124.261 0.976 . . . . 0.0 109.598 -165.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' A' ' 69' ' ' GLU . 13.2 mt -140.16 -93.44 0.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.652 0.739 . . . . 0.0 110.888 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.526 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 49.2 p90 -144.01 174.58 10.73 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.347 -168.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -77.63 121.01 29.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.23 178.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.7 m -94.31 -20.51 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.691 -170.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -157.07 136.24 11.92 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.505 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 59' ' ' ALA . 6.7 p -139.88 160.28 26.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.16 -138.55 0.2 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -138.24 -39.37 0.54 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.765 0.711 . . . . 0.0 112.145 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -101.32 4.09 41.3 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.762 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 59.9 p -84.14 148.04 52.27 Favored Pre-proline 0 N--CA 1.433 -1.285 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.0 Cg_endo -49.7 -42.18 43.93 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.764 1.643 . . . . 0.0 111.22 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.574 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.6 -46.48 84.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.019 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 52' ' ' VAL . . . -74.76 -59.13 2.87 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.346 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.614 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.6 pp -51.16 -74.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -171.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.614 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 21.7 t70 -93.74 -15.4 25.23 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.544 1.164 . . . . 0.0 108.081 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -64.39 -48.39 74.51 Favored Glycine 0 C--N 1.313 -0.704 0 CA-C-N 112.818 -1.992 . . . . 0.0 114.524 -166.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.1 p 63.64 15.78 9.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.078 0.951 . . . . 0.0 111.006 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG13 HG13 ' A' ' 99' ' ' ILE . 16.7 m -96.92 53.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-O 123.0 1.381 . . . . 0.0 110.028 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.21 168.52 14.69 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 112.512 -2.131 . . . . 0.0 111.39 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.66 122.54 6.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.832 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.64 -14.64 11.65 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.009 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.699 ' O ' HG22 ' A' ' 49' ' ' ILE . 43.4 m-20 -90.55 146.15 24.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.2 0.5 . . . . 0.0 110.167 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 47' ' ' LEU . 33.1 tt0 -89.4 126.48 35.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.682 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.5 mm -94.42 120.27 43.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -110.97 -21.68 11.88 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.832 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.78 156.06 27.72 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.398 -1.382 . . . . 0.0 113.869 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.9 124.63 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 C-N-CA 123.573 0.749 . . . . 0.0 109.186 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.467 ' HA ' ' OG1' ' A' ' 98' ' ' THR . 6.9 t-20 58.28 22.57 9.43 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.583 0.706 . . . . 0.0 111.192 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.44 -20.01 50.23 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.109 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -101.99 130.17 48.46 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 117.292 0.546 . . . . 0.0 110.619 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.6 m -63.66 153.52 35.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.021 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.501 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -93.08 -30.93 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 110.417 -178.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -71.44 91.26 1.02 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.552 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.54 -21.51 0.33 Allowed Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.799 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -125.83 -131.08 0.25 Allowed 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.245 177.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -137.48 147.36 45.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.927 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.471 ' HA ' HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -46.32 -49.49 17.55 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.598 0.759 . . . . 0.0 112.527 176.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -57.26 -39.9 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.831 0.348 . . . . 0.0 111.623 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.46 -41.48 66.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.943 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG12 ' HB ' ' A' ' 78' ' ' ILE . 32.8 m -67.63 -45.21 85.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.897 0.38 . . . . 0.0 110.815 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.25 -34.59 75.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.261 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.61 -51.16 68.39 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.424 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.2 mmt -53.04 -36.65 60.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.62 0.724 . . . . 0.0 111.416 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.469 ' CD1' HG13 ' A' ' 128' ' ' VAL . 44.6 mt -72.64 -31.86 38.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.753 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -90.37 -23.51 21.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.8 -49.45 62.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.946 0.499 . . . . 0.0 111.097 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.88 -32.32 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.718 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 62.32 119.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.652 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 96.97 -33.22 5.9 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.194 173.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.3 pt-20 -134.86 178.76 6.77 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 117.177 0.489 . . . . 0.0 110.501 -171.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.498 HG12 HG21 ' A' ' 33' ' ' ILE . 1.2 m -152.48 148.74 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.159 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -141.27 106.93 5.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.469 172.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.412 HG13 HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -100.0 141.99 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.051 0.453 . . . . 0.0 111.705 -178.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -118.5 121.36 40.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -136.52 174.73 10.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.053 0.454 . . . . 0.0 111.614 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -166.47 -169.8 1.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -144.4 97.34 3.02 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HG ' ' HG3' ' A' ' 18' ' ' PRO . 5.7 mt -127.91 134.91 49.38 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -172.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -140.99 98.64 3.42 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.788 164.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.83 163.95 8.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.075 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -125.65 155.87 71.72 Favored Pre-proline 0 C--O 1.215 -0.761 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -30.66 -55.39 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.915 3.077 . . . . 0.0 114.721 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.531 ' O ' HG22 ' A' ' 113' ' ' VAL . 5.9 ptpp? -56.48 -47.12 79.9 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.242 0.544 . . . . 0.0 112.311 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.479 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.3 mm100 -87.84 -17.02 32.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.895 -175.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -77.8 -45.32 24.79 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.021 -177.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.92 -27.27 69.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.215 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 109' ' ' LYS . 77.0 t -61.0 -41.38 88.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.14 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.79 -24.61 41.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.544 0.688 . . . . 0.0 109.802 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -92.69 30.38 1.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.413 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -89.75 11.49 19.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.017 0.437 . . . . 0.0 110.648 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.436 ' H ' ' HD3' ' A' ' 118' ' ' PRO . . . 151.5 51.87 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.436 ' HD3' ' H ' ' A' ' 117' ' ' GLY . 38.4 Cg_endo -61.64 -17.96 57.37 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.419 2.746 . . . . 0.0 113.478 -169.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.55 ' O ' ' HG2' ' A' ' 45' ' ' PRO . 35.0 tt0 67.71 87.81 0.12 Allowed 'General case' 0 N--CA 1.462 0.168 0 O-C-N 123.75 0.656 . . . . 0.0 110.131 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.79 91.79 0.2 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.964 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 3.5 p -140.61 134.73 30.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.962 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.96 106.04 4.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.395 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.433 ' HE ' ' HA ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -102.05 103.3 13.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.17 0.509 . . . . 0.0 111.166 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -71.68 168.46 17.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.898 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -80.38 115.95 20.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.448 ' HB3' ' HE3' ' A' ' 83' ' ' LYS . 1.6 pp -89.12 168.56 12.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.043 175.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.449 ' C ' ' HD2' ' A' ' 127' ' ' LYS . 0.1 OUTLIER -143.49 154.49 43.7 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.842 ' OXT' HG13 ' A' ' 33' ' ' ILE . 7.1 p . . . . . 0 C--O 1.247 0.93 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.804 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.7 t -121.44 127.47 26.09 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.08 10.31 1.78 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.714 2.276 . . . . 0.0 112.541 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.31 -61.44 4.71 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -107.01 150.95 40.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.822 0.344 . . . . 0.0 110.359 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 30.9 Cg_endo -86.7 -152.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.384 2.723 . . . . 0.0 111.843 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 1.5 t -34.08 122.55 0.51 Allowed Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.864 0.866 . . . . 0.0 112.67 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 19' ' ' VAL . 10.6 Cg_endo -90.95 128.74 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 123.528 2.819 . . . . 0.0 112.243 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.07 143.68 17.46 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -155.48 127.63 7.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.77 0.285 . . . . 0.0 110.352 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.406 HG22 HD12 ' A' ' 99' ' ' ILE . 27.2 m -128.71 158.65 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.152 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.9 t -132.72 117.32 17.7 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.652 0.739 . . . . 0.0 110.656 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.11 -159.25 0.9 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.875 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 96' ' ' GLU . 31.9 mm-40 -122.57 158.26 30.31 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.625 0.726 . . . . 0.0 110.114 175.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.569 ' NZ ' ' HA ' ' A' ' 91' ' ' GLN . 11.4 mmmm -54.4 156.69 3.17 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.082 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.57 174.97 7.47 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.3 -15.56 36.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.224 0.535 . . . . 0.0 110.556 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.469 ' NE2' HD22 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -91.38 -0.49 57.65 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.746 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.492 ' C ' ' HE2' ' A' ' 27' ' ' LYS . 31.1 t30 70.06 38.05 1.59 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.427 1.108 . . . . 0.0 109.897 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.518 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -154.57 -167.35 2.59 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.572 175.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.743 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.26 -28.93 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.945 -177.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.442 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 100.4 35.11 4.52 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.608 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.5 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.7 pp -126.92 177.96 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.269 0.557 . . . . 0.0 111.633 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -134.76 128.19 32.39 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.626 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.758 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 56.2 mt -107.47 140.79 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.469 0.652 . . . . 0.0 111.912 -173.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 48' ' ' TYR . . . 177.94 -170.51 42.8 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.978 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.28 153.48 17.01 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.94 -72.76 0.44 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.386 -0.912 . . . . 0.0 112.697 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -83.0 81.07 8.83 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 10.5 pt20 55.84 -70.38 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.401 1.48 . . . . 0.0 113.826 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 123' ' ' ARG . 54.9 p90 -154.53 16.97 0.46 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.778 0.717 . . . . 0.0 111.595 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.525 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 56.4 m -91.07 -49.21 0.34 Allowed Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.978 -174.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 44' ' ' CYS . 94.8 Cg_endo -99.7 -163.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.09 1.86 . . . . 0.0 111.972 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.6 m -117.79 -179.74 3.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.389 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 48' ' ' TYR . 4.2 pp 149.27 -40.51 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.134 2.173 . . . . 0.0 107.262 171.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.758 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 78.8 m-85 62.69 -22.33 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 174.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.523 ' HB ' ' CG1' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -110.85 109.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 120.338 1.426 . . . . 0.0 110.218 171.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -95.62 -30.55 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.206 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -155.49 139.87 16.75 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.453 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 59' ' ' ALA . 5.2 p -138.33 161.2 31.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -99.33 -135.05 0.28 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -138.4 -33.41 0.68 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -101.61 1.82 38.19 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.062 0.458 . . . . 0.0 110.366 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 77.9 p -85.33 150.18 53.92 Favored Pre-proline 0 N--CA 1.44 -0.956 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.16 -40.39 77.31 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.295 1.33 . . . . 0.0 111.197 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.46 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.42 -46.28 86.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.741 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HB3' HG21 ' A' ' 52' ' ' VAL . . . -73.62 -58.4 3.33 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.672 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.57 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 2.1 pp -52.95 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -170.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.57 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 24.0 t70 -95.99 -16.32 21.75 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.262 1.029 . . . . 0.0 108.487 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -61.21 -38.71 96.09 Favored Glycine 0 C--N 1.315 -0.586 0 CA-C-N 113.019 -1.901 . . . . 0.0 113.594 -169.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p 52.31 38.38 24.76 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.415 1.102 . . . . 0.0 111.774 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 m -118.17 54.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.832 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.49 168.64 15.27 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 112.716 -2.038 . . . . 0.0 111.778 -170.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.89 132.09 26.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.669 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.0 2.64 57.03 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.648 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.434 ' CG ' ' HZ2' ' A' ' 103' ' ' LYS . 1.7 t70 -90.77 167.89 12.14 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.97 89.52 3.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.523 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 25.0 mm -78.34 110.0 13.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.893 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -102.3 -7.57 21.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.129 -175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -151.88 135.37 4.99 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.384 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.45 ' CG1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -103.57 120.83 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 123.615 0.766 . . . . 0.0 109.217 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.3 t30 55.1 32.81 19.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.952 0.882 . . . . 0.0 110.472 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.83 -21.29 44.39 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.405 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -108.17 138.58 44.2 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 117.132 0.466 . . . . 0.0 110.484 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.438 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 17.7 t -59.58 142.51 52.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.89 0.376 . . . . 0.0 111.892 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.505 HG13 ' CE2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -74.89 -22.71 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HB3' ' HZ3' ' A' ' 79' ' ' LYS . 7.8 ttpm? -64.38 99.35 0.29 Allowed 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.814 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.2 -30.63 1.75 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.942 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.623 ' HE3' ' SD ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -125.26 -139.27 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.795 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -141.25 159.88 41.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.896 -169.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.47 ' O ' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -49.38 -52.79 26.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.503 0.502 . . . . 0.0 110.865 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -53.94 -38.71 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.893 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 34.2 mt-10 -76.28 -39.58 53.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.567 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.492 ' HA ' ' SD ' ' A' ' 89' ' ' MET . 34.7 m -69.61 -39.31 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.299 . . . . 0.0 111.389 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.54 -43.64 62.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.326 168.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 28.5 ttpp -61.59 -46.58 89.25 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.495 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.623 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 74.1 mtp -56.3 -35.14 67.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.43 0.633 . . . . 0.0 110.482 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.476 ' O ' HG21 ' A' ' 93' ' ' VAL . 27.9 mm -73.7 -32.3 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.387 177.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.569 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 56.0 mt-30 -82.74 -24.67 33.44 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.754 -0.591 . . . . 0.0 111.899 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -64.25 -39.49 94.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.286 0.634 . . . . 0.0 111.895 -171.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 94' ' ' LYS . 3.7 m -35.48 -47.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.114 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.562 ' N ' HG23 ' A' ' 93' ' ' VAL . 55.4 mtmt 57.08 83.29 0.1 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.496 -162.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.438 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 115.47 -36.73 3.75 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 118.785 -1.674 . . . . 0.0 113.675 164.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 93' ' ' VAL . 11.7 pt-20 -106.13 172.35 6.86 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 117.716 0.758 . . . . 0.0 110.127 -173.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 t -153.4 127.87 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.448 -171.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.0 m -141.04 135.75 31.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.455 HD13 ' N ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -130.87 140.67 48.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.801 0.334 . . . . 0.0 111.808 -177.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -116.99 122.57 44.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.404 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 40.2 p90 -138.85 157.16 46.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.073 0.463 . . . . 0.0 111.582 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -139.83 -179.23 5.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -107.69 166.96 10.3 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.0 -177.148 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.607 ' O ' HD13 ' A' ' 104' ' ' LEU . 4.0 pp 56.66 115.2 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.87 1.356 . . . . 0.0 114.506 170.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.49 30.37 0.75 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.019 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -100.06 148.63 24.34 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.122 0.963 . . . . 0.0 112.299 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 16.7 m-20 -151.65 168.62 10.8 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 107' ' ' ASP . 12.8 Cg_exo -31.51 -46.86 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.904 2.403 . . . . 0.0 113.959 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.1 ptpt -68.83 -48.23 64.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.511 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.489 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.5 mm100 -84.92 -11.77 54.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.438 0.637 . . . . 0.0 110.968 -174.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.1 tm? -70.02 -43.37 71.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.339 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.16 -30.72 63.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.271 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.424 ' HA ' ' HD2' ' A' ' 118' ' ' PRO . 84.3 t -63.71 -36.1 75.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.473 0.654 . . . . 0.0 109.902 175.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.6 tp -77.86 -27.02 49.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.244 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -58.77 -40.9 85.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.075 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -141.57 -67.57 0.4 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.222 0.534 . . . . 0.0 109.876 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.706 ' H ' ' CD ' ' A' ' 118' ' ' PRO . . . 147.06 39.3 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.246 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.706 ' CD ' ' H ' ' A' ' 117' ' ' GLY . 18.6 Cg_endo -54.65 114.35 1.8 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.964 2.443 . . . . 0.0 112.579 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -88.88 62.05 6.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.669 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -77.42 -23.39 50.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.937 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 p -99.2 129.32 45.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.124 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.4 tp -98.17 -85.2 0.38 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.391 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.551 ' HG2' ' H ' ' A' ' 124' ' ' HIS . 44.9 ttt180 60.85 179.73 0.1 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.003 0.43 . . . . 0.0 110.6 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.551 ' H ' ' HG2' ' A' ' 123' ' ' ARG . 62.9 t60 -102.36 109.68 21.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 173.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -81.23 -179.35 7.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.262 0.554 . . . . 0.0 111.139 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.517 ' CD1' ' HB ' ' A' ' 37' ' ' ILE . 2.0 mt -95.6 169.03 10.32 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.972 172.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -157.51 80.75 0.89 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.194 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.743 ' OXT' HG13 ' A' ' 33' ' ' ILE . 9.1 p . . . . . 0 N--CA 1.438 -1.068 0 CA-C-O 117.575 -1.203 . . . . 0.0 108.724 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.802 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.9 t -75.6 118.36 70.36 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.69 99.18 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.482 2.121 . . . . 0.0 111.792 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 151.25 -23.34 0.97 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.651 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 pt -90.16 151.55 44.96 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HD3' ' CD1' ' A' ' 104' ' ' LEU . 46.3 Cg_endo -76.93 -75.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.973 1.782 . . . . 0.0 112.708 -171.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.7 93.9 15.49 Favored Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.293 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -83.05 130.68 5.69 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.755 2.303 . . . . 0.0 112.407 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.53 152.22 20.85 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.101 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -160.09 137.19 9.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 62' ' ' GLY . 29.8 m -128.04 152.93 36.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.5 t -118.41 123.07 44.33 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.631 0.729 . . . . 0.0 110.571 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -130.51 -165.22 1.52 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.536 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -133.28 142.93 48.75 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.326 0.584 . . . . 0.0 110.513 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 2.5 mmmm -43.09 146.95 0.37 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.487 -1.688 . . . . 0.0 112.637 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -85.09 177.8 7.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.798 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.14 -21.77 48.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.909 0.385 . . . . 0.0 111.45 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.539 ' NE2' HD21 ' A' ' 32' ' ' LEU . 5.0 tt0 -92.88 15.11 15.56 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.123 0.487 . . . . 0.0 110.231 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 1.2 p-10 54.5 35.31 23.05 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.527 1.131 . . . . 0.0 111.583 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.707 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -140.76 -171.16 3.18 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.376 174.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.812 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -97.96 -31.07 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-O 120.682 0.277 . . . . 0.0 111.039 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' N ' HD12 ' A' ' 32' ' ' LEU . . . 102.5 37.64 3.22 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.324 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 2.3 pp -126.91 173.37 12.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.131 0.491 . . . . 0.0 110.72 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.4 m -134.86 130.55 36.16 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.782 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.507 ' HB ' HD13 ' A' ' 126' ' ' LEU . 40.7 mm -114.15 128.91 70.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.73 0.776 . . . . 0.0 111.838 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 47' ' ' LEU . . . -138.42 168.27 24.72 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.582 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 47' ' ' LEU . . . -73.27 143.97 33.83 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.411 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 47' ' ' LEU . . . -60.92 -52.36 52.79 Favored Glycine 0 CA--C 1.502 -0.742 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 174.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HB1' ' HD3' ' A' ' 45' ' ' PRO . . . -124.04 -163.38 1.14 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 166.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -80.9 -46.04 15.84 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.361 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -154.86 46.16 0.53 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.567 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 3.7 m -138.23 -74.03 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 44' ' ' CYS . 43.4 Cg_endo -95.42 -164.92 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.215 1.943 . . . . 0.0 113.333 -169.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.478 ' SG ' ' HG3' ' A' ' 105' ' ' GLN . 61.8 m -76.32 -175.31 3.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.954 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.489 ' HB3' ' H ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -134.48 179.41 6.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.568 0.699 . . . . 0.0 112.093 -174.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 48.4 p90 -145.19 174.74 10.82 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.579 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.496 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -88.03 118.83 34.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.02 -34.6 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.833 -170.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -155.84 144.41 20.25 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 120.764 0.316 . . . . 0.0 110.487 -171.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.495 HG22 ' HB3' ' A' ' 59' ' ' ALA . 5.7 p -139.14 160.18 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -92.02 -136.19 0.15 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.73 -38.26 0.47 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.617 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -100.91 3.87 42.15 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.036 0.446 . . . . 0.0 110.324 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 61.7 p -82.62 151.26 64.62 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.5 -40.75 71.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.299 1.333 . . . . 0.0 111.269 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.572 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -59.16 -44.31 92.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.255 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -78.33 -55.94 4.85 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.836 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.619 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.7 pp -52.66 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -171.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.619 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 29.4 t70 -95.78 -12.73 24.89 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.441 1.115 . . . . 0.0 108.12 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -65.36 -45.46 90.54 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 112.969 -1.923 . . . . 0.0 113.497 -170.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p 62.93 9.51 3.77 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.069 0.948 . . . . 0.0 111.498 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.42 HG13 HG13 ' A' ' 99' ' ' ILE . 19.1 m -89.68 53.53 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 CA-C-O 123.001 1.382 . . . . 0.0 110.166 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.29 169.99 14.13 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.622 -2.081 . . . . 0.0 111.459 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.48 129.87 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.143 -174.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.7 -22.24 10.11 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.673 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.496 ' O ' HG21 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -80.4 161.48 24.95 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.339 -177.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.452 ' OE2' ' HA ' ' A' ' 104' ' ' LEU . 27.4 tt0 -110.44 120.89 43.88 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.8 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.0 mm -89.63 123.75 41.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.588 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.462 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 7.6 t -103.15 -29.77 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -175.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.51 151.16 20.54 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.905 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -107.72 122.53 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.429 ' ND2' HG13 ' A' ' 93' ' ' VAL . 5.2 m-20 50.62 31.6 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.66 -20.66 45.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.637 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 18.8 ptp180 -100.23 124.39 45.61 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 117.502 0.651 . . . . 0.0 110.279 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.1 m -61.15 149.83 36.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.999 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.474 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -81.76 -17.55 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.567 0.698 . . . . 0.0 109.55 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.434 ' HE2' ' SG ' ' A' ' 46' ' ' CYS . 37.9 ttmt -61.69 -24.14 66.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.636 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.45 -12.69 80.0 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.182 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.595 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -137.35 -131.51 0.14 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.531 0.666 . . . . 0.0 110.619 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.3 p -146.8 166.09 27.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.364 0.126 . . . . 0.0 111.046 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -49.72 -53.33 25.4 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.662 0.601 . . . . 0.0 112.406 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -56.08 -37.73 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.66 -38.86 58.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.529 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.474 HG11 ' HB ' ' A' ' 78' ' ' ILE . 26.6 m -71.13 -44.03 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.955 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.21 62.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.289 170.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.21 -52.48 63.59 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.284 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.8 mmt -54.06 -43.23 70.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 0.0 112.02 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.95 -39.59 82.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.067 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.82 -36.16 57.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 122.362 -0.211 . . . . 0.0 111.443 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.83 -44.08 90.84 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.308 0.643 . . . . 0.0 110.892 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 93' ' ' VAL . 13.8 m -70.18 71.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 122.878 1.323 . . . . 0.0 110.203 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 96.8 mttt -60.34 126.3 26.97 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.596 -173.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.562 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 100.66 -27.16 21.8 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.515 170.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 97' ' ' VAL . 8.5 pt-20 -124.16 171.87 9.48 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 117.39 0.595 . . . . 0.0 110.083 -174.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 96' ' ' GLU . 2.1 t -157.19 128.17 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.742 -171.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.4 m -140.32 106.47 5.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.038 0.447 . . . . 0.0 110.908 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -97.18 147.81 6.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.064 -177.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -130.88 123.38 28.86 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -133.65 144.76 49.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 0.0 111.421 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 24.6 m-20 -135.26 -172.19 3.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -101.62 -4.82 25.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.239 0.542 . . . . 0.0 109.66 174.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.464 ' CD1' ' HD3' ' A' ' 18' ' ' PRO . 4.3 pp -177.25 163.01 2.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.873 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.478 ' HG3' ' SG ' ' A' ' 46' ' ' CYS . 13.0 pt20 -155.3 66.48 0.64 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.267 0.555 . . . . 0.0 111.498 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.45 156.59 39.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.522 0.677 . . . . 0.0 111.454 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -133.95 158.7 74.78 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.527 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 22.4 Cg_exo -31.8 -52.57 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.678 2.919 . . . . 0.0 114.07 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.468 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.0 ptmt -62.25 -48.51 79.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.015 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.468 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 71.6 mm-40 -81.4 -19.45 42.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.712 0.768 . . . . 0.0 110.153 -174.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.31 -51.17 13.86 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.204 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 4.7 pt-20 -70.77 -34.6 71.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.879 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.525 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 2.9 p -65.14 -38.37 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.283 -176.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.75 -28.04 36.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.511 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -58.68 -45.88 88.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.508 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -67.07 -33.1 74.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.608 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.77 62.59 0.54 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 113' ' ' VAL . 18.0 Cg_endo -56.86 -69.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.418 2.745 . . . . 0.0 112.988 -173.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -144.67 -78.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.503 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.472 ' CZ ' HD21 ' A' ' 47' ' ' LEU . 8.0 t80 45.45 73.02 0.18 Allowed 'General case' 0 CA--C 1.53 0.198 0 O-C-N 124.254 0.971 . . . . 0.0 111.629 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.8 p -87.55 119.79 28.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.829 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.7 mt -94.81 138.57 32.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -146.95 111.58 5.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.759 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 76.1 t60 72.16 126.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.986 0.804 . . . . 0.0 112.164 174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -72.54 137.43 46.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.507 HD13 ' HB ' ' A' ' 37' ' ' ILE . 12.2 mt -91.21 168.75 11.38 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -167.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -165.78 85.62 0.35 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 110.996 -2.82 . . . . 0.0 109.057 175.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.812 ' OXT' HG13 ' A' ' 33' ' ' ILE . 6.0 p . . . . . 0 C--O 1.246 0.872 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.287 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 t -154.92 91.85 2.91 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.55 -14.46 19.98 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.586 2.191 . . . . 0.0 112.342 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.7 -90.07 0.95 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.437 HG13 ' OD1' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -73.69 157.57 87.34 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.562 ' HG3' HD21 ' A' ' 104' ' ' LEU . 51.2 Cg_endo -68.5 -101.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.192 1.928 . . . . 0.0 114.528 -164.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.467 ' N ' HD22 ' A' ' 102' ' ' ASN . 49.3 t -86.61 107.55 14.27 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 118.553 0.615 . . . . 0.0 110.422 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -48.84 123.21 9.35 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 124.343 3.362 . . . . 0.0 114.549 -167.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.09 110.82 2.15 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.155 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -168.36 138.26 2.48 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.435 HG21 HD13 ' A' ' 99' ' ' ILE . 29.2 m -140.53 158.72 24.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 t -124.37 125.79 44.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.163 0.506 . . . . 0.0 110.751 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.44 -169.28 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.763 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 91.0 mt-30 -132.9 149.21 52.27 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.417 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.615 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 8.6 mmtp -47.24 146.37 1.93 Allowed 'General case' 0 C--N 1.313 -1.004 0 O-C-N 124.629 1.206 . . . . 0.0 112.344 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.88 177.94 8.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.115 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.03 -19.78 61.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.185 0.517 . . . . 0.0 110.419 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.451 ' NE2' HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -89.49 3.84 51.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.241 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.9 15.72 5.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.68 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.508 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -131.43 -163.69 1.36 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.642 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.862 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.51 -23.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.8 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.86 36.13 4.87 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.918 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.495 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.6 pp -125.91 168.53 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.903 0.859 . . . . 0.0 111.564 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 44.9 m -134.43 131.77 38.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.499 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.672 ' O ' ' HB3' ' A' ' 126' ' ' LEU . 76.3 mt -117.75 130.67 72.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.57 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.439 ' HA2' ' HZ2' ' A' ' 83' ' ' LYS . . . -136.89 125.32 3.38 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.633 175.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.73 116.26 4.8 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.07 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.37 -167.12 4.21 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.435 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.6 -19.15 64.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.466 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 13.4 mm-40 68.88 -46.17 0.55 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.655 0.782 . . . . 0.0 111.362 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -55.53 -16.04 3.46 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.822 0.849 . . . . 0.0 111.097 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.58 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 29.8 m -146.62 -68.05 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 44' ' ' CYS . 66.4 Cg_endo -95.09 -37.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.698 1.599 . . . . 0.0 115.878 -165.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.717 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 64.5 m 70.51 -66.58 0.28 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.562 0.745 . . . . 0.0 112.731 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 46' ' ' CYS . 0.1 OUTLIER 55.96 -75.05 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.381 1.472 . . . . 0.0 114.511 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 30.2 m-85 70.23 -74.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -169.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -79.11 109.5 13.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 118.344 -1.342 . . . . 0.0 109.497 -176.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -98.43 -25.73 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.229 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.76 145.23 12.33 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.946 -172.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 59' ' ' ALA . 7.5 p -140.25 161.12 25.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -87.81 -138.03 0.1 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -137.48 -38.94 0.59 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 119.152 0.887 . . . . 0.0 112.641 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.539 ' HA ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -101.45 10.86 40.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.455 0.645 . . . . 0.0 109.854 -171.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 42.9 p -93.82 147.87 34.3 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 8.5 Cg_endo -48.48 -39.97 36.74 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.215 1.943 . . . . 0.0 111.631 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.8 -53.57 56.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.141 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB2' HG21 ' A' ' 52' ' ' VAL . . . -74.98 -55.04 6.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.513 0.673 . . . . 0.0 109.946 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.539 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.1 tm? -42.73 -76.22 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.171 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -96.45 -38.3 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.052 0.453 . . . . 0.0 111.514 -177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.508 ' O ' HG23 ' A' ' 63' ' ' THR . . . -66.49 -27.29 73.04 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.746 -168.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 62' ' ' GLY . 5.8 t 52.44 25.44 3.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.456 1.103 . . . . 0.0 111.645 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.546 HG13 HG13 ' A' ' 99' ' ' ILE . 29.9 m -88.93 50.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 122.068 0.937 . . . . 0.0 109.761 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.01 175.27 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.204 -171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.43 118.53 3.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.527 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.93 5.59 8.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.82 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.692 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -107.3 161.75 14.51 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 110.431 174.665 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.572 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 18.0 mm-40 -104.05 138.24 40.87 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.6 mm -118.55 134.01 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 123.104 0.252 . . . . 0.0 110.379 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.486 HG23 ' HA ' ' A' ' 101' ' ' TYR . 14.9 t -132.74 -18.97 2.37 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.127 -0.358 . . . . 0.0 111.844 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -139.16 138.32 9.25 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.744 -1.217 . . . . 0.0 113.635 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.401 HG13 HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -105.53 123.15 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.518 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 17.4 t-20 59.1 23.23 11.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.914 0.864 . . . . 0.0 109.965 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.93 -20.24 48.67 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.552 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -105.32 136.58 44.58 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 117.888 0.844 . . . . 0.0 111.095 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 71' ' ' THR . 19.3 t -55.88 140.63 42.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.678 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.54 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -74.68 -17.57 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.731 0.777 . . . . 0.0 109.127 -177.03 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -63.47 -20.57 65.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.633 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.4 -17.32 76.32 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.365 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.631 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 1.7 mptp? -120.42 -136.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.914 0.864 . . . . 0.0 109.635 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.9 p -151.31 163.49 38.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.525 -1.671 . . . . 0.0 107.838 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.524 ' O ' HG21 ' A' ' 86' ' ' VAL . 1.5 mtpt -48.02 -52.75 18.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.316 0.579 . . . . 0.0 111.793 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -56.67 -35.11 44.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.362 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 89' ' ' MET . 34.1 mt-10 -77.13 -46.54 23.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.614 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.54 HG11 ' HB ' ' A' ' 78' ' ' ILE . 24.0 m -59.05 -43.7 89.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HB1' HD13 ' A' ' 126' ' ' LEU . . . -59.51 -35.59 74.45 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 173.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 38.8 ttpt -64.34 -51.26 64.25 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.476 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 82.2 mtp -48.15 -52.24 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.737 0.648 . . . . 0.0 111.136 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.615 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 62.6 mt -61.78 -46.69 95.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.029 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.418 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 8.7 pt20 -77.39 -29.03 53.0 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.211 -0.306 . . . . 0.0 111.564 -177.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -68.23 -48.0 66.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.3 m -50.31 -33.48 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.86 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt 67.15 137.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.669 0.747 . . . . 0.0 112.282 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.513 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 90.59 -50.07 3.2 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.404 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.3 pt-20 -125.82 176.49 6.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 117.256 0.528 . . . . 0.0 110.409 -172.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.441 HG23 ' CG2' ' A' ' 33' ' ' ILE . 14.2 m -150.88 150.85 13.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.804 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.518 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 1.7 m -141.83 107.58 5.12 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.904 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.546 HG13 HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -90.8 138.87 18.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.902 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.61 124.42 15.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -174.66 -113.17 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.168 161.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.56 ' ND2' ' HG2' ' A' ' 18' ' ' PRO . 1.5 t30 -179.03 -173.55 0.3 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.878 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.781 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 8.7 mmpt? -93.22 171.13 9.12 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 172.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.781 ' HG ' ' O ' ' A' ' 103' ' ' LYS . 3.6 pp 52.93 154.27 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 O-C-N 124.594 1.184 . . . . 0.0 112.358 -173.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 0.2 OUTLIER -91.1 -13.19 33.56 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.578 -178.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -178.85 165.12 1.57 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.394 0.616 . . . . 0.0 112.58 -173.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -125.73 148.81 63.45 Favored Pre-proline 0 C--O 1.212 -0.883 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 168.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -32.08 -52.6 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.818 3.012 . . . . 0.0 114.443 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.2 ptmt -55.82 -46.08 78.17 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.426 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.3 mm100 -89.63 -13.41 37.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.892 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.2 tm? -70.79 -40.95 72.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.313 -177.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.7 -24.38 62.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.258 0.552 . . . . 0.0 110.46 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.08 -45.54 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.042 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 116' ' ' GLN . 74.2 mt -82.61 -3.42 56.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.365 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 9.4 t80 -64.69 38.52 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.36 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 114' ' ' LEU . 41.7 mt-30 -61.26 98.4 0.08 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.567 0.698 . . . . 0.0 110.322 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.572 ' H ' ' HD2' ' A' ' 118' ' ' PRO . . . -94.5 -50.67 2.14 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HD2' ' H ' ' A' ' 117' ' ' GLY . 5.6 Cg_exo -34.9 -53.64 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.738 3.625 . . . . 0.0 112.984 164.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -78.78 113.77 17.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.046 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -78.18 -26.54 47.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.791 0.329 . . . . 0.0 110.725 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 122' ' ' LEU . 1.1 m 60.8 -143.96 0.49 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.926 175.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.564 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 96.5 mt 62.06 -167.68 0.2 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.653 0.381 . . . . 0.0 111.347 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 122' ' ' LEU . 18.0 ptp180 57.7 165.34 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.088 1.355 . . . . 0.0 113.201 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 36.5 m80 62.69 92.88 0.06 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.628 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.452 ' CZ3' ' HD3' ' A' ' 127' ' ' LYS . 22.2 t90 -70.49 107.19 3.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.309 0.576 . . . . 0.0 109.967 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.672 ' HB3' ' O ' ' A' ' 37' ' ' ILE . 40.5 tp -93.94 142.41 27.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.243 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 22.9 pttp -156.82 139.75 15.3 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.635 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.862 ' OXT' HG13 ' A' ' 33' ' ' ILE . 14.4 p . . . . . 0 C--N 1.313 -1.003 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.8 m 59.16 87.88 0.13 Allowed Pre-proline 0 CA--C 1.532 0.26 0 O-C-N 123.751 0.324 . . . . 0.0 110.75 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.11 107.0 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.63 2.22 . . . . 0.0 112.294 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.24 69.68 2.92 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.039 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.647 HG13 ' ND2' ' A' ' 102' ' ' ASN . 1.6 pt -86.54 165.68 31.7 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.671 -0.265 . . . . 0.0 110.428 -177.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HG2' HD21 ' A' ' 104' ' ' LEU . 12.4 Cg_exo -64.48 -141.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.028 3.152 . . . . 0.0 114.433 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.3 t -50.21 109.74 1.41 Allowed Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 123.546 0.738 . . . . 0.0 111.164 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -52.44 126.82 21.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.549 2.833 . . . . 0.0 113.501 -170.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.47 109.25 1.16 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.634 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -170.29 139.78 1.78 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.5 m -138.35 147.72 25.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.815 0.34 . . . . 0.0 110.195 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -110.39 101.12 9.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.279 0.561 . . . . 0.0 110.465 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.412 HD11 ' HA3' ' A' ' 62' ' ' GLY . 10.6 mt -111.88 -170.22 1.61 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.736 -174.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 88.6 mt-30 -132.54 144.38 50.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.239 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 28.5 mmtm -50.25 158.37 0.57 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.676 -175.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 5.4 p-10 -89.82 -163.64 1.04 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.92 67.24 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.477 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.445 HE21 HD21 ' A' ' 32' ' ' LEU . 9.2 tt0 -92.56 9.46 34.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.663 0.268 . . . . 0.0 111.082 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 51.9 t30 66.66 30.0 8.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.75 0.786 . . . . 0.0 110.905 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 1.3 pp -133.05 -171.24 2.63 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 121.821 -0.55 . . . . 0.0 111.202 172.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.709 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.71 -27.96 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.973 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.68 28.39 6.0 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.942 -0.646 . . . . 0.0 113.046 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.559 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -121.65 174.12 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.762 0.791 . . . . 0.0 112.074 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 23.0 m -137.28 126.09 24.03 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.229 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.441 ' HB ' HD12 ' A' ' 126' ' ' LEU . 68.7 mt -98.46 140.16 18.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.72 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.23 99.88 0.46 Allowed Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.24 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.34 124.29 6.99 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.86 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.56 -43.54 67.59 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 114.321 0.488 . . . . 0.0 114.321 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.503 ' H ' ' HA ' ' A' ' 45' ' ' PRO . . . 79.74 -77.11 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.308 0.643 . . . . 0.0 111.607 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.99 -49.98 65.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.153 0.502 . . . . 0.0 110.393 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -78.75 -40.65 32.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.951 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 53.8 t 176.89 117.84 0.16 Allowed Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.617 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.503 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 17.0 Cg_exo -68.57 52.38 0.67 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.585 2.857 . . . . 0.0 112.914 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 71' ' ' THR . 42.2 t -150.64 -89.61 0.07 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.1 mt 53.59 -100.72 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -172.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 54.1 p90 -148.69 -179.86 7.3 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -163.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.601 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -93.57 128.5 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.336 178.529 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -97.03 -21.38 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -168.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.48 141.93 10.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.182 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' CG2' ' HB1' ' A' ' 59' ' ' ALA . 6.1 p -141.16 160.75 22.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.994 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.521 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 92.5 m-85 -113.96 124.67 52.73 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.432 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 30.7 t70 -58.33 -23.4 56.55 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -165.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.445 ' HA ' HD23 ' A' ' 60' ' ' LEU . 46.7 m-80 -101.77 9.84 40.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.49 0.662 . . . . 0.0 110.09 -172.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 31.6 p -98.66 149.24 35.55 Favored Pre-proline 0 CA--C 1.502 -0.877 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -48.55 -38.63 36.18 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 121.946 1.764 . . . . 0.0 111.374 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.22 5.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.065 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HB1' ' CG2' ' A' ' 52' ' ' VAL . . . -72.15 -53.2 13.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.453 0.644 . . . . 0.0 110.227 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -45.13 -74.3 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.629 -178.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -95.54 -35.5 11.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.611 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -74.79 -31.49 58.2 Favored Glycine 0 C--O 1.228 -0.26 0 CA-C-N 115.523 -0.762 . . . . 0.0 114.245 -168.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p 66.05 15.38 10.05 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.851 0.86 . . . . 0.0 110.674 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.78 53.98 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 CA-C-O 122.748 1.261 . . . . 0.0 110.518 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.89 176.39 8.51 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.942 -172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.94 104.34 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.716 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.06 -10.33 3.06 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.962 -175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.601 ' O ' HG21 ' A' ' 49' ' ' ILE . 2.4 t70 -89.32 164.95 14.69 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.724 ' HB3' ' CD2' ' A' ' 101' ' ' TYR . 5.5 mp0 -107.89 134.85 50.23 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.492 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 5.4 mm -122.97 122.29 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.691 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 7.6 t -129.85 -10.19 4.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.72 0.295 . . . . 0.0 111.699 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.3 151.52 23.1 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.711 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.546 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 4.4 m -117.85 147.36 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 114.355 -0.923 . . . . 0.0 109.02 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.405 ' ND2' HG13 ' A' ' 93' ' ' VAL . 5.5 t-20 60.92 19.53 9.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.425 0.631 . . . . 0.0 110.508 171.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.01 -10.33 70.08 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.12 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 14.9 ptp180 -121.27 143.73 49.01 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 117.156 0.478 . . . . 0.0 111.238 -174.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 m -52.49 146.39 9.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.525 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.523 HG21 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -76.09 -13.19 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 121.695 0.759 . . . . 0.0 109.2 -176.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -58.61 -17.33 21.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.074 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.91 67.78 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.982 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -142.45 -119.73 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.966 -0.138 . . . . 0.0 111.061 178.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.469 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 14.9 t -158.1 174.77 14.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.566 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -47.32 -60.02 2.79 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -175.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -54.51 -34.62 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 121.258 0.551 . . . . 0.0 111.779 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 40.0 mt-10 -78.68 -35.08 45.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.809 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 83' ' ' LYS . 34.4 m -73.42 -38.94 54.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.539 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.96 -36.41 59.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.003 169.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 60.7 tttm -64.66 -50.08 68.46 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 84.5 mtp -53.99 -44.66 71.04 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.204 0.525 . . . . 0.0 111.237 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 93' ' ' VAL . 29.6 mm -55.28 -56.87 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.631 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.506 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 8.6 pt20 -76.07 -22.86 55.16 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -58.59 -50.65 73.02 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.032 0.533 . . . . 0.0 110.959 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 90' ' ' ILE . 13.2 m -60.1 -29.66 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.941 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp 63.45 143.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.001 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.486 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 87.94 -48.81 3.72 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.876 170.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.7 pt-20 -127.24 175.65 8.0 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 117.398 0.599 . . . . 0.0 110.125 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.487 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 9.2 m -147.92 155.54 9.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.838 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -142.37 99.87 3.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.712 0.292 . . . . 0.0 111.203 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.95 144.6 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -147.72 131.16 16.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.724 ' CD2' ' HB3' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -177.97 -114.62 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.172 162.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.647 ' ND2' HG13 ' A' ' 17' ' ' ILE . 1.4 t-20 -174.43 -169.17 0.43 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.583 -171.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HZ2' ' CG ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -105.28 32.93 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -171.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.499 HD21 ' HG2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -164.85 157.01 15.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 0.0 111.0 175.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -97.84 25.03 6.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.714 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.463 ' HB3' ' HG3' ' A' ' 110' ' ' GLN . . . 70.78 -174.66 0.18 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.427 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.526 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 9.8 m-20 -137.06 158.36 72.86 Favored Pre-proline 0 C--O 1.216 -0.661 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.618 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 37.7 Cg_exo -29.09 -60.61 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.899 3.066 . . . . 0.0 115.107 -167.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.6 pttp -65.54 -50.07 66.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.238 0.542 . . . . 0.0 111.866 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.526 ' CG ' ' H ' ' A' ' 107' ' ' ASP . 12.4 pt20 -80.11 -7.94 59.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.853 0.835 . . . . 0.0 111.827 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.43 HD11 ' C ' ' A' ' 111' ' ' LEU . 1.8 tm? -90.04 -48.4 7.22 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.922 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 6.0 pt-20 -71.45 -24.86 62.09 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 110.864 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.1 p -68.15 -32.64 56.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.483 0.659 . . . . 0.0 109.708 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.43 -24.9 39.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.471 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -63.94 -47.33 80.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.408 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 70.5 -70.19 0.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.203 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.615 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . -166.34 -49.54 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.28 -175.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 1.1 Cg_endo -41.48 116.82 0.54 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.999 3.133 . . . . 0.0 113.341 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -129.66 -45.78 1.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.229 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -88.04 5.38 41.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.992 0.425 . . . . 0.0 110.728 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.4 m -78.99 69.49 5.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.754 0.788 . . . . 0.0 110.353 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.467 ' HG ' ' HB1' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.02 116.14 4.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.24 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 20.4 ptt180 -148.02 128.7 14.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.186 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.449 ' O ' ' HD3' ' A' ' 83' ' ' LYS . 12.9 m-70 73.57 139.11 0.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.146 0.904 . . . . 0.0 111.939 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -71.24 132.64 45.25 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.518 HD11 ' N ' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -92.17 153.51 19.27 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.964 -167.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.518 ' N ' HD11 ' A' ' 126' ' ' LEU . 19.2 ptmt -167.87 111.09 0.63 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.728 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.709 ' OXT' HG13 ' A' ' 33' ' ' ILE . 12.6 p . . . . . 0 N--CA 1.441 -0.896 0 CA-C-O 118.08 -0.962 . . . . 0.0 108.909 170.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.601 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.496 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 13.4 m -71.94 -49.78 10.03 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 14' ' ' SER . 22.1 Cg_endo -61.86 156.63 47.6 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.759 1.639 . . . . 0.0 111.654 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.28 -30.08 8.23 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.631 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.51 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 5.9 pt -70.68 155.84 92.82 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 20.2 Cg_endo -59.26 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.273 1.982 . . . . 0.0 113.025 -168.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 17.6 t -116.52 106.11 49.07 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.9 141.98 67.12 Favored 'Trans proline' 0 C--N 1.329 -0.452 0 C-N-CA 123.422 2.748 . . . . 0.0 112.459 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.42 155.63 27.12 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.005 -0.616 . . . . 0.0 111.63 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -166.49 137.91 3.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.69 157.43 42.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 t -124.58 118.61 26.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.384 0.611 . . . . 0.0 110.563 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.448 ' CD2' HD12 ' A' ' 99' ' ' ILE . 2.3 mm? -119.92 -169.6 1.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.645 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 87.8 mt-30 -129.28 140.31 51.48 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.821 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HG2' ' C ' ' A' ' 95' ' ' GLY . 25.4 mmtp -45.9 148.79 0.74 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.336 -176.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -82.7 -179.01 7.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.585 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.64 55.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.192 0.52 . . . . 0.0 110.875 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.546 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.7 mt-30 -91.12 4.1 53.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.948 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 37.8 t30 71.04 16.71 6.35 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.036 0.922 . . . . 0.0 111.133 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.598 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -128.31 -171.1 2.37 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.769 -0.582 . . . . 0.0 111.275 -179.45 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.734 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.37 -29.23 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.604 -177.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.26 27.18 5.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.745 . . . . 0.0 113.125 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pp -119.17 173.85 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.333 0.587 . . . . 0.0 111.839 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 36.3 m -134.65 129.92 35.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.517 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 63.3 mt -104.03 145.07 13.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.518 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.89 150.97 11.65 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.031 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.7 109.75 3.81 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.589 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 45' ' ' PRO . . . 96.04 129.46 6.0 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.408 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.467 ' H ' ' HD2' ' A' ' 45' ' ' PRO . . . -98.16 -87.75 0.33 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -99.02 -42.01 7.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.71 0.291 . . . . 0.0 110.342 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -88.99 -88.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.625 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 22.6 p 178.79 49.57 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.417 0 O-C-N 123.302 0.376 . . . . 0.0 111.83 173.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.625 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 4.9 Cg_exo -82.3 -179.53 4.74 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.136 1.891 . . . . 0.0 111.542 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.7 p -74.61 -78.95 0.09 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.296 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 69' ' ' GLU . 1.5 pp 50.67 -49.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.539 1.936 . . . . 0.0 115.51 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.672 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 18.6 m-85 69.01 -51.72 0.59 Allowed 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 118.596 0.635 . . . . 0.0 112.682 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.658 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -88.13 111.72 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 119.419 1.009 . . . . 0.0 109.856 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.3 -29.98 4.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.257 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.463 ' HG2' ' HB2' ' A' ' 36' ' ' SER . 4.0 pt20 -164.31 156.29 16.43 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.477 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 9.3 p -141.99 161.67 20.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.263 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.526 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 89.9 m-85 -113.67 123.63 50.38 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -55.23 -25.81 35.62 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.115 -165.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.489 ' HA ' HD23 ' A' ' 60' ' ' LEU . 47.8 m-80 -102.41 8.39 40.16 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.169 0.509 . . . . 0.0 110.616 -172.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.526 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 32.0 p -96.72 150.32 36.81 Favored Pre-proline 0 CA--C 1.503 -0.844 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.51 -37.67 42.73 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 121.789 1.659 . . . . 0.0 111.396 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -57.36 -57.35 13.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.108 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.477 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -73.61 -52.6 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.451 0.643 . . . . 0.0 110.121 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -45.39 -75.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.806 -1.543 . . . . 0.0 112.743 -177.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -96.59 -33.12 11.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.157 0.503 . . . . 0.0 111.5 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.25 -28.77 63.39 Favored Glycine 0 C--O 1.228 -0.275 0 CA-C-N 115.663 -0.699 . . . . 0.0 114.236 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p 64.57 14.41 8.95 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.994 0.917 . . . . 0.0 111.403 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.44 HG12 HG13 ' A' ' 99' ' ' ILE . 6.9 m -84.98 54.56 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 CA-C-O 122.578 1.18 . . . . 0.0 111.284 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.17 173.2 10.6 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.469 -172.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.8 113.41 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.163 -173.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.12 -16.37 4.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.446 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.658 ' O ' HG21 ' A' ' 49' ' ' ILE . 1.7 m-20 -96.86 154.62 17.19 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 117.597 0.698 . . . . 0.0 110.746 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 38.3 tt0 -90.7 80.86 5.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.529 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.489 HD12 ' HB ' ' A' ' 49' ' ' ILE . 1.8 mp -68.85 92.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 77' ' ' SER . 9.0 t -96.08 -14.05 23.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.595 -170.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -143.83 137.27 7.35 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 119.367 -1.397 . . . . 0.0 113.629 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -104.79 119.02 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.526 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 16.9 t-20 55.03 32.18 17.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.413 0.625 . . . . 0.0 110.613 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.86 -21.28 46.73 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.643 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -102.76 126.91 50.06 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 117.725 0.762 . . . . 0.0 110.991 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 71' ' ' THR . 29.9 m -57.79 145.81 33.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.72 -176.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.442 ' HB ' HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -81.32 -18.51 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.546 0.689 . . . . 0.0 109.602 -179.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -63.04 -24.19 67.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.877 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.44 -14.85 81.72 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.936 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.595 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.22 -132.31 0.15 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.409 0.604 . . . . 0.0 110.718 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -143.64 152.26 41.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.112 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.4 ptpt -43.43 -59.36 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.96 0.504 . . . . 0.0 112.272 176.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.5 p -53.97 -34.87 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.842 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 89' ' ' MET . 33.7 mt-10 -76.93 -42.44 39.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.557 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 83' ' ' LYS . 33.6 m -66.8 -40.11 85.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.643 -175.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.57 -41.42 63.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.429 170.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -66.44 -45.94 78.13 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.197 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 59.4 mtt -54.62 -35.17 63.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.398 0.618 . . . . 0.0 110.765 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 93' ' ' VAL . 65.3 mt -75.33 -48.84 29.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.186 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.406 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 86.4 mt-30 -63.6 -41.06 98.36 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.03 -45.44 85.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.441 -169.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 90' ' ' ILE . 25.9 m -54.63 -31.42 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.295 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? 65.93 130.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 170.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.479 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 97.77 -47.91 1.51 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.517 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.0 pt-20 -136.48 176.83 8.34 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.188 0.518 . . . . 0.0 110.406 -172.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.442 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 5.4 m -147.43 153.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.862 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.526 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 30.8 m -142.4 115.77 9.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -111.1 123.63 67.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.269 -175.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -98.67 123.69 43.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 69' ' ' GLU . 17.0 p90 -141.96 139.95 32.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.577 0.703 . . . . 0.0 112.006 -173.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.4 m-20 -115.55 169.59 9.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.127 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 103' ' ' LYS . 2.6 mptt -115.11 82.43 1.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.95 -0.7 . . . . 0.0 112.797 -168.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.491 HD23 ' HG3' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -178.62 167.73 1.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.772 170.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 45' ' ' PRO . 15.9 pt20 -107.48 13.12 27.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.834 171.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 70.51 162.68 0.24 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.152 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -134.18 156.84 78.72 Favored Pre-proline 0 C--O 1.211 -0.926 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.52 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 19.4 Cg_exo -29.97 -51.99 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.009 3.14 . . . . 0.0 114.958 -171.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.52 ' HG3' ' HG3' ' A' ' 110' ' ' GLN . 59.3 pttt -57.16 -44.48 83.53 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.517 0.675 . . . . 0.0 112.285 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.52 ' HG3' ' HG3' ' A' ' 109' ' ' LYS . 96.9 mt-30 -85.98 -27.74 24.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.632 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.5 tm? -66.55 -49.52 66.18 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.221 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 5.2 pt-20 -60.07 -31.68 70.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.1 0.476 . . . . 0.0 110.69 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 109' ' ' LYS . 68.8 t -64.52 -47.41 89.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.512 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.01 -13.61 57.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.496 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 20.9 t80 -87.66 37.91 0.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.859 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -58.65 -24.4 61.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.247 0.546 . . . . 0.0 110.185 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.565 ' H ' ' CD ' ' A' ' 118' ' ' PRO . . . 154.86 47.74 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.585 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.565 ' CD ' ' H ' ' A' ' 117' ' ' GLY . 38.0 Cg_endo -64.92 5.73 0.44 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.292 2.661 . . . . 0.0 113.15 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' A' ' 117' ' ' GLY . 16.0 mm100 -77.38 -154.76 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.686 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.3 t80 65.92 33.33 7.95 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 122.339 1.066 . . . . 0.0 108.712 -173.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 m -85.87 95.86 9.59 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.203 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 pp -80.04 9.6 5.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.431 0.634 . . . . 0.0 110.378 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 73.32 64.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.489 169.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -130.58 126.43 36.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.45 0.643 . . . . 0.0 109.648 166.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -83.87 158.29 21.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.709 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.498 HD11 ' N ' ' A' ' 127' ' ' LYS . 1.1 tm? -101.08 158.84 15.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.498 ' N ' HD11 ' A' ' 126' ' ' LEU . 19.8 ptmt -161.94 112.98 1.64 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.143 0.497 . . . . 0.0 110.429 -174.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.734 ' O ' HG13 ' A' ' 33' ' ' ILE . 13.1 p . . . . . 0 N--CA 1.437 -1.122 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.726 -0.549 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -147.83 72.29 11.43 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.764 0.316 . . . . 0.0 111.405 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -92.13 -166.6 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.157 2.572 . . . . 0.0 111.763 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.58 -51.87 9.07 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.325 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 14.7 pt -113.06 159.8 33.36 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 26.7 Cg_endo -67.95 -70.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.657 1.572 . . . . 0.0 112.571 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.8 t -124.73 110.22 27.91 Favored Pre-proline 0 N--CA 1.439 -1.017 0 CA-C-O 120.982 0.42 . . . . 0.0 110.095 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.66 145.37 18.2 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 124.62 3.547 . . . . 0.0 114.486 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 100' ' ' HIS . . . 83.98 164.27 36.89 Favored Glycine 0 N--CA 1.461 0.321 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.349 168.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -160.86 -74.87 0.06 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 117.023 0.412 . . . . 0.0 111.457 174.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 99' ' ' ILE . 7.7 p -147.57 158.46 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -170.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.461 HG23 HG23 ' A' ' 98' ' ' THR . 24.5 p -124.52 121.78 35.76 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 122.2 -0.313 . . . . 0.0 111.083 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.457 HD22 ' CA ' ' A' ' 62' ' ' GLY . 2.7 mm? -121.16 -165.78 1.27 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.7 pt20 -141.23 158.19 44.23 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.081 174.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 31' ' ' ASN . 31.1 mmtm -52.77 155.86 2.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.955 -1.02 . . . . 0.0 113.129 -172.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -85.57 -179.53 6.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.794 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.97 -21.01 60.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.619 0.645 . . . . 0.0 111.095 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.479 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -91.22 2.28 56.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.101 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 54.8 t30 70.55 35.7 1.85 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.247 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.604 HD22 ' OXT' ' A' ' 128' ' ' VAL . 2.1 pp -140.56 -170.66 3.05 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.841 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.469 HG21 HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -104.78 -25.45 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.981 -175.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 92.78 35.4 6.46 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.511 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.508 HD12 HG23 ' A' ' 128' ' ' VAL . 2.9 pp -123.01 178.96 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.738 0.304 . . . . 0.0 110.617 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 64.4 m -128.47 135.29 49.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.085 0.469 . . . . 0.0 111.135 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 34.9 mm -102.29 138.77 25.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.144 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.74 123.97 1.22 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.45 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.66 101.6 2.81 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.638 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 45' ' ' PRO . . . 94.33 118.82 3.04 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.371 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HB3' HD22 ' A' ' 47' ' ' LEU . . . -95.07 -78.43 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.744 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -95.33 48.63 1.16 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.198 0.523 . . . . 0.0 109.944 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.8 t80 56.91 27.1 12.54 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.438 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.412 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 32.5 m -143.28 -69.88 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.533 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 73.3 Cg_endo -73.61 124.74 9.53 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.113 1.209 . . . . 0.0 111.095 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.739 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 71.2 m -69.11 -51.63 36.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.524 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.799 ' O ' ' HA ' ' A' ' 69' ' ' GLU . 1.6 pp 56.74 -56.98 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.83 1.652 . . . . 0.0 114.648 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.714 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 17.4 m-85 71.68 -36.3 0.36 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.165 0.586 . . . . 0.0 112.505 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.571 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.94 108.18 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 122.456 1.122 . . . . 0.0 109.615 176.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.0 t -86.84 -35.54 8.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.408 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.487 ' HG2' ' HB2' ' A' ' 36' ' ' SER . 11.3 pt20 -165.57 163.53 19.36 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -173.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.472 HG22 ' HB1' ' A' ' 59' ' ' ALA . 9.5 p -141.29 159.82 22.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.132 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.498 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 50.1 m-85 -116.09 122.97 46.72 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.74 0.781 . . . . 0.0 108.907 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.407 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 7.5 m-20 -58.2 -18.94 29.57 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.324 1.45 . . . . 0.0 114.641 -164.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -102.89 6.06 38.87 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.97 0.414 . . . . 0.0 110.513 -174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.498 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 13.1 p -102.59 151.53 38.26 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -176.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.18 -39.94 42.27 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.086 1.857 . . . . 0.0 111.779 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.02 -54.02 49.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.027 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB1' HG22 ' A' ' 52' ' ' VAL . . . -76.6 -53.03 8.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.497 0.665 . . . . 0.0 110.277 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER -44.22 -75.01 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.522 -176.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -96.66 -32.06 12.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.14 0.495 . . . . 0.0 111.637 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' CA ' HD22 ' A' ' 25' ' ' LEU . . . -72.84 -38.97 56.07 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.923 -0.656 . . . . 0.0 114.542 -167.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p 64.77 21.72 12.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 122.0 0.905 . . . . 0.0 110.897 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.592 ' HA ' ' OH ' ' A' ' 101' ' ' TYR . 3.8 m -88.02 56.43 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.193 176.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.64 -179.76 7.2 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.786 -168.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' A' ' 51' ' ' GLN . . . -57.43 139.46 53.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.722 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.89 -9.51 29.67 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.51 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.571 ' O ' HG21 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -96.8 174.81 6.61 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.584 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.799 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 25.0 tt0 -123.13 95.19 4.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.466 0.651 . . . . 0.0 110.377 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.42 ' O ' HD11 ' A' ' 78' ' ' ILE . 9.9 mm -69.96 114.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.587 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 102' ' ' ASN . 6.4 t -88.11 -34.84 17.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.42 156.63 26.81 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.468 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.621 ' CG1' HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -131.1 129.4 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 59.64 26.29 15.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.639 0.733 . . . . 0.0 110.037 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.55 -20.1 50.14 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.256 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -107.93 135.04 49.98 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 117.092 0.446 . . . . 0.0 111.732 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m -63.49 148.15 49.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.472 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.621 HG21 ' CG1' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -93.0 -25.67 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 CA-C-O 122.93 1.347 . . . . 0.0 109.625 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.483 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -57.88 -24.46 57.75 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.189 -2.278 . . . . 0.0 110.339 -178.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.8 -17.64 76.91 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.642 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.483 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -129.53 -134.87 0.22 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.062 0.931 . . . . 0.0 112.079 -176.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.581 ' O ' HG11 ' A' ' 86' ' ' VAL . 60.5 p -135.89 166.13 24.03 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.573 -0.079 . . . . 0.0 110.839 -169.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' HG23 ' A' ' 86' ' ' VAL . 16.6 mttt -49.1 -57.69 6.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.542 0.687 . . . . 0.0 111.919 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.47 -39.68 54.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.828 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 89' ' ' MET . 34.6 mt-10 -75.29 -37.91 60.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.581 HG11 ' O ' ' A' ' 82' ' ' THR . 30.0 m -67.05 -45.39 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.61 -176.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.671 ' O ' ' HG3' ' A' ' 91' ' ' GLN . . . -58.9 -43.05 90.91 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 172.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -61.63 -45.63 93.24 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.199 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 86.4 mmm -51.6 -42.33 61.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.43 HD12 HD12 ' A' ' 33' ' ' ILE . 85.9 mt -65.64 -46.89 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.609 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.671 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 59.5 mt-30 -60.45 -46.77 88.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.117 0.484 . . . . 0.0 110.979 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -61.71 -50.91 70.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.498 -167.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 89' ' ' MET . 14.8 m -52.99 -32.92 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm 61.79 137.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 95.03 -51.78 1.91 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.741 167.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.6 pt-20 -133.83 178.71 6.73 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -174.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.469 HG12 HG21 ' A' ' 33' ' ' ILE . 9.5 m -150.05 148.23 15.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.784 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.461 HG23 HG23 ' A' ' 24' ' ' THR . 12.9 p -134.51 109.46 8.72 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.506 HD11 ' N ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -102.15 126.82 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.31 0.576 . . . . 0.0 111.524 -173.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.438 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 35.0 m170 -108.17 117.16 33.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.182 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.592 ' OH ' ' HA ' ' A' ' 64' ' ' VAL . 1.1 m-30 -74.0 162.2 29.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.318 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.412 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -175.68 155.51 1.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 O-C-N 124.624 1.202 . . . . 0.0 108.464 175.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HZ3' ' CG ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -99.16 -32.59 11.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -152.55 134.85 15.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.738 0.78 . . . . 0.0 112.121 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -92.11 -19.47 22.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.173 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.09 159.07 42.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.994 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 10.4 t70 -135.12 149.43 70.15 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 16.6 Cg_exo -29.45 -49.84 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.902 3.068 . . . . 0.0 114.269 -176.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.501 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.1 ptpt -57.99 -47.65 82.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.239 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.538 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 14.9 mm100 -87.02 -19.96 27.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.449 0.642 . . . . 0.0 110.355 -176.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -73.0 -43.12 62.54 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.276 -175.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -66.36 -31.43 72.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.889 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 109' ' ' LYS . 74.3 t -66.59 -39.77 84.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.205 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 110' ' ' GLN . 76.1 mt -70.65 -24.05 62.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.759 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.422 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 27.6 t80 -84.04 -7.56 59.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.125 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -87.61 29.62 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.385 0.612 . . . . 0.0 110.27 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.431 ' H ' ' HD3' ' A' ' 118' ' ' PRO . . . 159.45 50.76 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.431 ' HD3' ' H ' ' A' ' 117' ' ' GLY . 28.9 Cg_endo -58.93 -56.46 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.249 2.633 . . . . 0.0 113.068 -170.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 48.27 49.91 17.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.137 0.494 . . . . 0.0 112.092 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -86.47 73.93 10.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.471 ' O ' ' HE3' ' A' ' 83' ' ' LYS . 13.5 t -84.36 175.05 9.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.83 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.0 mt 64.03 60.54 1.0 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.515 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -69.78 85.3 0.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.499 0.666 . . . . 0.0 111.298 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -165.94 159.96 16.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -74.15 144.56 44.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.013 0.435 . . . . 0.0 110.59 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' A' ' 127' ' ' LYS . 51.5 tp -117.51 168.43 10.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.483 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 4.9 pttp -166.26 161.99 17.1 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.239 0.542 . . . . 0.0 110.862 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.604 ' OXT' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.778 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 165.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 112.211 -0.356 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 p -142.13 87.92 9.44 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.947 0.403 . . . . 0.0 110.295 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.73 6.53 5.42 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.12 2.547 . . . . 0.0 112.859 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.69 35.71 24.63 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.62 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.554 HD12 ' ND2' ' A' ' 102' ' ' ASN . 2.9 pt -69.11 140.67 91.01 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.964 0.411 . . . . 0.0 111.26 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.52 -100.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.323 2.682 . . . . 0.0 113.826 -171.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 29.5 t -84.51 130.51 53.3 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 120.466 0.174 . . . . 0.0 111.189 -173.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 19' ' ' VAL . 6.6 Cg_endo -82.21 134.59 8.06 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.248 2.632 . . . . 0.0 111.453 -175.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.59 148.87 20.39 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.293 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 25.7 pttm -172.32 136.49 0.81 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.09 146.74 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.5 t -103.8 98.88 8.66 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.788 0.804 . . . . 0.0 110.378 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.406 HD11 ' HA2' ' A' ' 62' ' ' GLY . 16.6 mt -110.48 -163.83 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.753 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.655 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 2.2 pt20 -150.53 156.3 41.15 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.176 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HE2' ' C ' ' A' ' 31' ' ' ASN . 10.0 mmmm -52.4 146.77 9.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.639 0.733 . . . . 0.0 111.938 -174.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -85.65 173.67 9.96 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.355 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.2 -20.79 56.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.118 0.485 . . . . 0.0 110.453 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.465 ' NE2' HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -85.59 -1.26 56.94 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.032 -177.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' C ' ' HE2' ' A' ' 27' ' ' LYS . 15.4 t30 69.01 37.52 2.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.734 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.478 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -154.22 -163.31 1.59 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.897 173.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.736 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.55 -24.27 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.494 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.44 40.71 3.6 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.761 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.512 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.6 pp -131.89 171.95 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.855 0.836 . . . . 0.0 111.633 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.1 m -140.59 126.5 19.41 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.161 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.607 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 26.3 mt -122.72 -168.64 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -176.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.607 ' H ' ' CG2' ' A' ' 37' ' ' ILE . . . -166.19 155.51 26.8 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 46' ' ' CYS . . . -70.12 118.5 8.1 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.928 -177.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.21 -17.0 9.13 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.93 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.36 -172.26 2.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.143 0.472 . . . . 0.0 110.314 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 14.9 mm100 -62.08 144.01 55.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.504 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 87.4 t80 77.29 -0.33 2.89 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.772 0.796 . . . . 0.0 110.484 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.458 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 28.0 p 51.88 60.01 14.25 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.106 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 2.5 Cg_endo -78.66 -71.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 122.191 1.927 . . . . 0.0 111.968 -173.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.511 ' N ' ' HA2' ' A' ' 39' ' ' GLY . 9.3 t -177.13 157.08 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.634 HD11 ' N ' ' A' ' 48' ' ' TYR . 3.5 pp 172.3 -51.43 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.154 0.909 . . . . 0.0 112.1 162.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.634 ' N ' HD11 ' A' ' 47' ' ' LEU . 6.3 p90 -80.43 115.71 20.1 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.335 -174.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.616 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -75.74 117.5 20.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.915 0.864 . . . . 0.0 109.27 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.18 -30.65 5.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.739 -171.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.64 142.77 15.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.976 0.417 . . . . 0.0 111.401 -172.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.475 HG21 ' HB1' ' A' ' 59' ' ' ALA . 6.4 p -140.56 160.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.011 173.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -97.34 -133.8 0.23 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -141.15 -33.3 0.53 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -101.24 0.93 38.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.971 0.415 . . . . 0.0 110.347 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 68.0 p -84.17 151.54 60.17 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 8.4 Cg_endo -53.28 -41.27 73.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.239 1.292 . . . . 0.0 111.024 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.516 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.48 -47.58 81.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.996 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.475 ' HB1' HG21 ' A' ' 52' ' ' VAL . . . -72.69 -56.81 4.74 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.68 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.598 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.8 pp -55.77 -75.7 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -171.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.598 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 37.5 t70 -94.76 -13.38 25.74 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 122.546 1.165 . . . . 0.0 108.37 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -64.57 -51.16 54.54 Favored Glycine 0 C--N 1.312 -0.785 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.038 -169.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.4 p 56.95 42.76 25.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.731 1.253 . . . . 0.0 110.321 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.53 HG13 HG13 ' A' ' 99' ' ' ILE . 29.5 m -119.23 47.81 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 112.684 -2.053 . . . . 0.0 108.789 173.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.13 173.71 10.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.569 -170.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.77 108.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.674 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.92 -17.75 3.41 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.68 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.616 ' O ' HG21 ' A' ' 49' ' ' ILE . 18.3 m-20 -90.54 156.88 17.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.081 0.441 . . . . 0.0 110.928 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -114.9 98.26 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.365 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 2.8 mp -72.82 114.67 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.076 0.465 . . . . 0.0 110.38 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -97.5 -12.42 22.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.551 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -161.17 144.75 10.15 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 119.529 -1.319 . . . . 0.0 114.143 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 78' ' ' ILE . 5.0 m -100.79 140.56 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 CA-C-N 114.533 -0.833 . . . . 0.0 109.809 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.2 t30 53.89 29.17 9.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.826 0.822 . . . . 0.0 111.173 164.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.24 59.19 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.392 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -126.73 149.38 49.63 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.132 0.966 . . . . 0.0 111.903 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 m -57.1 148.46 21.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.454 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.525 HG23 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -85.6 -19.03 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.281 0.562 . . . . 0.0 111.076 -172.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -67.73 -7.53 27.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.301 -170.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.58 -27.95 73.57 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.224 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.443 ' NZ ' ' HE3' ' A' ' 89' ' ' MET . 0.0 OUTLIER -139.14 -139.77 0.14 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 117.234 0.517 . . . . 0.0 111.847 -177.065 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.83 160.73 33.55 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -168.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.415 ' O ' HG21 ' A' ' 86' ' ' VAL . 2.5 pttt -46.87 -52.65 13.89 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.59 -35.09 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 121.047 0.451 . . . . 0.0 111.564 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 89' ' ' MET . 29.7 mt-10 -79.9 -40.33 28.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.553 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 89' ' ' MET . 27.7 m -63.41 -40.03 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.606 0.241 . . . . 0.0 111.44 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 91' ' ' GLN . . . -56.3 -45.16 80.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.437 171.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.74 -40.3 96.4 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 120.75 0.31 . . . . 0.0 110.7 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 24.9 mmt -51.22 -32.92 25.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.57 0.7 . . . . 0.0 110.927 174.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 90' ' ' ILE . 88.6 mt -90.42 -18.44 7.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.077 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 50.4 mt-30 -87.6 -14.78 39.17 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.901 -0.499 . . . . 0.0 111.546 173.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.27 -40.53 15.44 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.12 0.962 . . . . 0.0 108.969 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -43.44 120.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.932 169.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -82.66 86.48 6.84 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.655 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 108.91 -25.16 19.72 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 118.575 -1.774 . . . . 0.0 113.923 162.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 8.6 pt-20 -125.57 173.4 8.98 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 117.947 0.874 . . . . 0.0 110.332 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.3 m -155.8 154.92 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.861 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.13 117.12 11.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.072 0.463 . . . . 0.0 110.367 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.53 HG13 HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -106.25 115.49 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.902 -176.138 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -102.11 121.95 43.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -146.65 160.79 41.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.729 0.776 . . . . 0.0 112.595 -173.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.554 ' ND2' HD12 ' A' ' 17' ' ' ILE . 28.7 m-80 -137.91 -166.2 1.92 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.626 ' C ' HD13 ' A' ' 104' ' ' LEU . 1.2 mptt -123.2 143.81 49.78 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.137 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.626 HD13 ' C ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER 41.18 178.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -176.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -156.34 25.32 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.7 172.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -169.49 -165.5 0.52 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.583 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 111' ' ' LEU . 7.5 m-20 -111.24 149.91 41.25 Favored Pre-proline 0 C--O 1.207 -1.135 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -31.31 -60.33 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.955 3.103 . . . . 0.0 114.529 -171.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.502 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.2 ptmt -61.35 -44.95 96.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.676 0.75 . . . . 0.0 111.716 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.502 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 70.2 mm-40 -80.39 -9.62 59.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.844 -175.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.1 tm? -90.5 -51.74 5.25 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.471 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.5 -30.85 70.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.485 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.404 HG11 ' C ' ' A' ' 110' ' ' GLN . 4.1 p -69.1 -31.97 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.561 0.696 . . . . 0.0 109.817 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.414 HD11 ' O ' ' A' ' 114' ' ' LEU . 3.2 tm? -75.08 -28.73 60.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.547 176.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -75.44 -3.13 32.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.648 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -80.04 58.66 3.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.607 0.717 . . . . 0.0 110.149 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.5 ' H ' ' HD2' ' A' ' 118' ' ' PRO . . . -148.17 -53.04 0.02 OUTLIER Glycine 0 C--N 1.312 -0.755 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.29 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HD2' ' H ' ' A' ' 117' ' ' GLY . 99.0 Cg_exo -29.66 117.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.526 3.484 . . . . 0.0 114.097 168.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 73.51 -15.59 0.55 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.466 0.706 . . . . 0.0 112.441 175.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 118' ' ' PRO . 43.7 t80 -89.21 -71.63 0.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -85.26 -34.96 21.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.64 55.9 3.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.12 172.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -61.88 -30.41 70.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.923 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -96.63 89.93 5.14 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -82.62 173.31 12.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.839 -176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 127' ' ' LYS . 8.6 tt -90.27 146.07 24.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.497 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.555 ' N ' HD22 ' A' ' 126' ' ' LEU . 22.0 ptmt -150.54 123.73 8.87 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.353 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.736 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.8 p . . . . . 0 N--CA 1.437 -1.085 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.318 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 112.004 -0.438 . . . . 0.0 112.004 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.2 m -97.72 103.63 17.58 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 13' ' ' GLY . 37.4 Cg_exo -59.05 -38.37 87.82 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.137 2.558 . . . . 0.0 113.349 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 179.97 136.58 2.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.457 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.528 HD12 ' ND2' ' A' ' 102' ' ' ASN . 3.0 pt -114.64 151.05 44.94 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.28 -62.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.378 2.052 . . . . 0.0 113.235 -174.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.11 96.33 34.5 Favored Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 122.577 0.351 . . . . 0.0 111.101 -177.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.645 ' HA ' ' OD1' ' A' ' 102' ' ' ASN . 3.0 Cg_exo -68.35 112.81 2.9 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.416 2.077 . . . . 0.0 111.55 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -118.83 149.01 18.31 Favored Glycine 0 C--N 1.312 -0.791 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.956 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -149.71 134.32 17.6 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.209 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 62' ' ' GLY . 7.7 p -132.72 143.72 38.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.456 ' O ' HD12 ' A' ' 25' ' ' LEU . 11.6 t -113.78 130.49 56.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.437 0.637 . . . . 0.0 110.935 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.457 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.8 mm? -132.56 -167.5 1.91 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.561 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 57' ' ' PRO . 97.0 mt-30 -132.29 155.98 47.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 37.0 mmtt -46.54 145.15 1.92 Allowed 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.762 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.06 -178.87 5.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.262 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.2 -22.13 65.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.439 0.637 . . . . 0.0 110.306 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.482 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -93.12 11.22 28.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.72 0.772 . . . . 0.0 109.607 178.026 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.44 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 1.1 p-10 60.28 16.1 5.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.311 -1.768 . . . . 0.0 113.049 176.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -115.93 -159.98 0.74 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.507 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.71 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -110.93 -22.89 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 118.755 0.707 . . . . 0.0 111.596 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 96.17 38.54 4.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.744 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.481 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -130.76 173.89 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.844 0.83 . . . . 0.0 112.122 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.506 ' HB3' ' CD1' ' A' ' 125' ' ' TRP . 20.7 m -138.81 125.78 21.16 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.262 -1.335 . . . . 0.0 109.742 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.474 HG13 HD11 ' A' ' 35' ' ' ILE . 61.1 mt -124.94 131.01 73.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.504 0.668 . . . . 0.0 112.716 -173.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.95 116.2 0.78 Allowed Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.572 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.68 99.7 0.62 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.655 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.474 ' H ' ' HG ' ' A' ' 47' ' ' LEU . . . 76.7 171.83 34.58 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.126 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.52 -43.48 0.07 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.515 0.674 . . . . 0.0 109.771 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 20.1 mp0 -75.59 84.85 2.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.185 175.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.439 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 73.5 t80 77.22 -0.93 2.84 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.712 0.768 . . . . 0.0 109.735 -172.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.568 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 61.5 m 71.21 56.57 0.42 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.51 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 12.6 Cg_exo -73.48 -86.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.338 2.025 . . . . 0.0 112.537 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.421 ' H ' ' HB2' ' A' ' 45' ' ' PRO . 70.9 m -158.28 168.59 26.61 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 48' ' ' TYR . 4.6 pp 154.12 -38.57 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.35 1.46 . . . . 0.0 108.281 168.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.528 ' N ' HD11 ' A' ' 47' ' ' LEU . 83.2 m-85 66.39 -85.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.219 -1.355 . . . . 0.0 113.344 176.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.645 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -75.56 116.56 18.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 120.037 1.29 . . . . 0.0 110.719 -171.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.6 t -102.31 -30.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.305 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -150.32 138.66 20.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 120.84 0.352 . . . . 0.0 110.926 -170.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 59' ' ' ALA . 5.3 p -141.34 161.24 22.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.221 174.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 96.6 m-85 -99.57 -140.88 0.32 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -133.8 -28.52 1.39 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -101.53 -2.1 31.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.058 0.456 . . . . 0.0 110.297 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 47.9 p -84.93 146.43 45.84 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 9.8 Cg_endo -51.12 -41.83 55.8 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.729 1.619 . . . . 0.0 111.251 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.466 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.81 -43.48 85.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.799 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.475 ' HB2' HG21 ' A' ' 52' ' ' VAL . . . -74.85 -58.28 3.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.36 0.6 . . . . 0.0 110.902 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.561 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 2.2 pp -55.02 -75.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -170.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.561 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 32.8 t70 -95.69 -13.83 23.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 122.367 1.08 . . . . 0.0 108.702 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.596 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -65.51 -33.25 85.85 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 113.315 -1.766 . . . . 0.0 113.964 -169.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 62' ' ' GLY . 5.3 t 51.2 21.58 1.13 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.497 1.119 . . . . 0.0 112.516 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -101.58 54.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-O 123.001 1.381 . . . . 0.0 110.038 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.31 171.35 12.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 112.455 -2.157 . . . . 0.0 111.386 -171.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.49 112.02 1.15 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.175 -175.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.3 -0.24 5.97 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.574 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.645 ' O ' HG21 ' A' ' 49' ' ' ILE . 1.1 m-20 -99.35 149.16 23.44 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.216 0.532 . . . . 0.0 110.916 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HG2' ' H ' ' A' ' 105' ' ' GLN . 5.4 mp0 -99.05 97.57 8.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.108 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.8 mm -69.72 139.43 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.888 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -124.91 -17.88 5.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.08 163.41 34.29 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.126 -1.512 . . . . 0.0 114.094 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.62 125.9 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 123.497 0.719 . . . . 0.0 109.267 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 54.2 30.26 11.97 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.52 -20.15 49.57 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.331 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -106.05 125.48 51.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 117.406 0.603 . . . . 0.0 111.226 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m -59.21 146.01 40.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.594 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.545 ' HB ' HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -84.38 -25.61 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.452 0.644 . . . . 0.0 110.18 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -60.36 -24.12 64.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.536 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.97 -22.09 77.02 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.984 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -124.02 -120.43 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.287 -176.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' HG11 ' A' ' 86' ' ' VAL . 7.3 m -148.91 150.08 32.33 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.49 -173.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.564 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -46.54 -56.66 5.68 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.378 0.671 . . . . 0.0 111.944 -177.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.84 -37.99 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.831 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 89' ' ' MET . 38.1 mt-10 -71.57 -36.4 70.89 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 83' ' ' LYS . 19.9 m -71.54 -42.62 72.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.137 -175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' A' ' 91' ' ' GLN . . . -51.73 -42.33 62.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.826 169.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 37.5 ttpt -60.85 -49.67 76.54 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.824 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.48 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 40.3 mtm -52.12 -39.09 59.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 110.431 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.457 HD12 HD12 ' A' ' 33' ' ' ILE . 68.1 mt -71.73 -39.17 68.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.441 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 6.7 mm-40 -71.33 -29.41 64.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.081 0.467 . . . . 0.0 110.505 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -72.15 -47.01 54.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.692 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.58 ' O ' HG21 ' A' ' 93' ' ' VAL . 16.8 m -71.51 51.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.793 0.806 . . . . 0.0 111.025 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -44.33 134.14 5.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.853 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.604 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 107.48 -36.88 4.11 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.438 171.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.27 147.39 32.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.737 0.779 . . . . 0.0 112.866 -168.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.536 HG12 ' HZ2' ' A' ' 27' ' ' LYS . 3.9 m -131.67 146.8 32.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.715 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.0 m -140.17 109.4 6.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 172.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -100.66 130.9 49.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.693 -174.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -106.1 123.11 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.917 173.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -137.14 146.19 44.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.273 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.645 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 54.2 m-20 -132.94 173.2 11.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.499 ' HB3' HD13 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -102.08 161.59 13.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 174.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER 30.57 58.25 0.22 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.902 1.281 . . . . 0.0 114.246 -177.195 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.443 ' H ' ' HG2' ' A' ' 69' ' ' GLU . 9.4 tt0 -80.28 52.96 1.68 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.1 0.952 . . . . 0.0 109.703 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.45 179.06 8.91 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.078 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -133.98 155.12 80.46 Favored Pre-proline 0 CA--C 1.505 -0.769 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.496 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 21.7 Cg_exo -32.36 -48.43 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.796 2.997 . . . . 0.0 113.761 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 0.6 OUTLIER -59.04 -49.58 77.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.684 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.538 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 24.1 mm-40 -88.9 -15.82 33.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.437 0.636 . . . . 0.0 111.026 -175.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.417 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -78.7 -39.33 36.88 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.998 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 7.3 pt-20 -68.98 -31.71 70.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.176 0.512 . . . . 0.0 109.924 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.5 t -61.71 -41.18 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.982 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 98.0 mt -76.2 -22.46 55.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.806 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.7 -52.77 40.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.861 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -103.77 -61.04 1.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.98 0.419 . . . . 0.0 110.374 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.48 ' HA2' ' HG2' ' A' ' 42' ' ' GLN . . . 118.87 58.5 0.27 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.409 ' HD2' ' O ' ' A' ' 113' ' ' VAL . 11.7 Cg_endo -52.77 -40.29 74.81 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.596 2.864 . . . . 0.0 112.924 -176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -154.3 135.59 14.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.527 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -148.02 154.26 40.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.7 t -164.99 -34.09 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.77 0.319 . . . . 0.0 111.019 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 41.1 tp -104.66 104.51 14.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.496 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -130.17 88.38 2.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.652 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -147.54 121.9 9.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 173.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.506 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 4.5 p90 -112.99 179.11 4.06 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.1 0.476 . . . . 0.0 111.581 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 36' ' ' SER . 2.4 pp -96.18 168.81 10.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.136 175.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.449 ' HB3' ' HZ3' ' A' ' 127' ' ' LYS . 7.4 mtpm? -141.91 93.9 2.61 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.17 -172.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.71 ' OXT' HG13 ' A' ' 33' ' ' ILE . 12.0 p . . . . . 0 N--CA 1.438 -1.029 0 CA-C-O 117.853 -1.07 . . . . 0.0 109.302 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.805 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.8 m -147.43 69.66 11.49 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.776 0.322 . . . . 0.0 110.286 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.92 66.84 7.11 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 122.781 2.321 . . . . 0.0 112.403 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.21 81.12 0.26 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.516 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 18.2 pt -64.57 154.7 83.81 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HD2' HD21 ' A' ' 102' ' ' ASN . 20.4 Cg_endo -55.23 -84.4 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.626 2.884 . . . . 0.0 112.029 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -130.9 148.71 71.33 Favored Pre-proline 0 N--CA 1.431 -1.408 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 172.109 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.42 124.12 13.26 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.405 2.07 . . . . 0.0 111.542 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA3' ' HG2' ' A' ' 103' ' ' LYS . . . -116.31 110.54 2.18 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.568 -176.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HG2' ' CE1' ' A' ' 100' ' ' HIS . 2.3 mppt? -143.1 110.65 5.82 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.27 152.27 35.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.839 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -122.11 126.95 49.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.461 0.648 . . . . 0.0 110.529 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 2.4 mm? -122.44 -171.13 2.2 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.084 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 87.7 mt-30 -131.97 137.58 47.96 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.642 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.63 ' NZ ' ' HA ' ' A' ' 91' ' ' GLN . 25.0 mmtp -44.11 148.0 0.46 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 124.679 1.237 . . . . 0.0 112.663 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.75 -172.19 3.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.294 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -22.02 65.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.231 0.538 . . . . 0.0 110.816 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.442 ' NE2' HD23 ' A' ' 32' ' ' LEU . 7.1 tt0 -96.35 11.07 36.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.231 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.8 t30 70.26 15.23 7.49 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.389 0.614 . . . . 0.0 111.506 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.649 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.5 pp -128.57 -173.07 2.86 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 121.958 -0.464 . . . . 0.0 111.588 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.85 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.0 -24.37 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.474 -176.294 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.12 41.24 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.486 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.45 HD11 HG12 ' A' ' 37' ' ' ILE . 2.8 pp -129.24 176.6 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.403 0.62 . . . . 0.0 111.71 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 32.1 m -140.59 128.1 21.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.389 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 49.6 mm -114.48 143.24 24.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.421 -174.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' HA3' ' CE3' ' A' ' 125' ' ' TRP . . . 179.41 124.11 0.86 Allowed Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.102 175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 44' ' ' CYS . . . -78.88 149.84 33.47 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.045 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.02 44.72 0.6 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.49 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.557 ' H ' ' HD2' ' A' ' 45' ' ' PRO . . . -90.72 -20.23 22.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 109.949 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -174.49 -63.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.656 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -103.98 -71.14 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.455 173.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.72 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 83.9 m -148.33 30.79 0.06 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.72 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 6.8 Cg_endo -93.29 160.82 2.5 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.639 1.559 . . . . 0.0 112.39 174.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.713 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 69.4 m 66.95 169.62 0.25 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.327 0.651 . . . . 0.0 112.505 175.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 46' ' ' CYS . 0.1 OUTLIER 54.08 -75.86 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.175 1.39 . . . . 0.0 112.895 -178.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 37.7 m-85 66.05 -65.78 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.631 HG21 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -85.01 109.76 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 118.014 -1.474 . . . . 0.0 109.96 -174.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.79 -25.37 3.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.63 -171.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.87 144.19 20.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.908 0.385 . . . . 0.0 110.817 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.6 p -140.43 161.11 24.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' H ' HG22 ' A' ' 52' ' ' VAL . 80.9 m-85 -94.43 -137.17 0.21 Allowed 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.303 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -137.27 -36.4 0.66 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.447 ' HA ' HD21 ' A' ' 60' ' ' LEU . 32.8 m-80 -100.6 -0.38 37.73 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.435 0.636 . . . . 0.0 109.495 -171.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 44.6 p -87.99 144.74 35.1 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 6.5 Cg_endo -47.04 -40.35 26.08 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.291 1.994 . . . . 0.0 111.689 -174.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -59.02 -52.26 66.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.229 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.77 -55.61 6.48 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.898 0.856 . . . . 0.0 109.524 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -43.69 -76.17 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.186 -1.825 . . . . 0.0 113.081 -178.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.14 -39.58 9.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.211 0.529 . . . . 0.0 111.872 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.74 -20.34 74.09 Favored Glycine 0 N--CA 1.458 0.162 0 CA-C-N 115.447 -0.797 . . . . 0.0 114.28 -166.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 t 47.23 33.48 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.194 0.998 . . . . 0.0 111.761 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 99' ' ' ILE . 11.9 m -94.6 55.22 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 CA-C-O 122.871 1.32 . . . . 0.0 109.697 175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.77 165.36 18.91 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.42 -2.173 . . . . 0.0 111.049 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.64 104.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.124 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.39 -8.88 2.14 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.478 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.631 ' O ' HG21 ' A' ' 49' ' ' ILE . 22.6 m-20 -98.69 177.05 5.42 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.702 ' HB2' ' OD1' ' A' ' 102' ' ' ASN . 41.5 mt-10 -120.97 143.02 49.24 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.039 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.471 ' H ' ' HB2' ' A' ' 48' ' ' TYR . 18.2 mm -119.12 119.39 60.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.723 HG23 ' CB ' ' A' ' 101' ' ' TYR . 5.5 t -105.25 -26.85 11.86 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.533 -177.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.71 155.46 26.15 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 118.875 -1.631 . . . . 0.0 114.448 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.559 HG12 HG22 ' A' ' 78' ' ' ILE . 6.7 m -110.02 142.59 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.291 176.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.57 ' HA ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER 61.17 19.34 9.95 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.94 0.4 . . . . 0.0 110.719 171.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.17 -15.37 60.47 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 116.11 -0.495 . . . . 0.0 113.403 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -118.56 139.18 51.87 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 117.124 0.462 . . . . 0.0 112.012 -174.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 71' ' ' THR . 35.6 m -50.15 141.6 10.96 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.559 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -83.8 -25.71 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.169 -175.301 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -63.48 -13.69 43.19 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.349 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.35 -30.08 76.47 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.636 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.571 ' HG2' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -119.33 -117.17 0.32 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.77 0.785 . . . . 0.0 112.069 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.605 ' O ' ' HB ' ' A' ' 86' ' ' VAL . 3.2 m -161.5 151.14 16.64 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -168.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.548 ' HE3' ' O ' ' A' ' 123' ' ' ARG . 2.6 mttm -39.96 -57.32 1.64 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.98 -32.33 32.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.456 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 89' ' ' MET . 30.9 mt-10 -90.56 -25.93 19.97 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 123.048 1.404 . . . . 0.0 108.318 -175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 82' ' ' THR . 1.0 OUTLIER -75.21 -42.86 44.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.797 -2.456 . . . . 0.0 110.778 -175.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.55 73.21 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -61.0 -52.7 63.89 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.157 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 88.2 mmm -45.44 -50.37 12.61 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.495 0.497 . . . . 0.0 112.004 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 93' ' ' VAL . 25.3 mm -60.09 -53.51 47.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.236 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.63 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -75.31 -25.34 57.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 122.205 -0.309 . . . . 0.0 111.483 -173.034 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.51 -52.51 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.564 0.345 . . . . 0.0 111.707 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 90' ' ' ILE . 20.5 m -49.45 -36.52 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 O-C-N 123.462 0.476 . . . . 0.0 110.95 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 95' ' ' GLY . 4.4 tmmm? 67.5 138.08 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.723 0.773 . . . . 0.0 112.196 169.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 94' ' ' LYS . . . 89.71 -33.05 4.54 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.505 171.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.6 pt-20 -145.3 177.24 8.96 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.413 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 10.4 m -146.98 153.48 12.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.975 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.57 ' OG1' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -141.21 106.62 5.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 176.005 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.488 HG13 HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -100.07 140.19 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.536 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 1.3 t60 -135.67 127.48 29.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.187 -174.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.723 ' CB ' HG23 ' A' ' 71' ' ' THR . 0.9 OUTLIER 171.28 -99.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.301 1.001 . . . . 0.0 111.912 162.283 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.702 ' OD1' ' HB2' ' A' ' 69' ' ' GLU . 29.2 p-10 -155.89 159.18 39.09 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.74 -162.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.46 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 23.5 mmtt -128.0 119.54 25.69 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.425 0.631 . . . . 0.0 112.539 -170.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.473 HD11 ' HG3' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -168.49 36.66 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.664 -177.166 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -40.19 96.12 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 124.982 1.426 . . . . 0.0 111.994 -173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.476 ' HB1' ' HG3' ' A' ' 110' ' ' GLN . . . -75.87 172.13 13.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.974 -174.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.588 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 41.5 m-20 -127.16 152.89 76.59 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.469 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 17.5 Cg_exo -29.89 -52.59 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.008 3.139 . . . . 0.0 114.499 -172.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.491 ' HB2' ' HZ2' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -60.32 -50.37 73.91 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.588 ' CG ' ' H ' ' A' ' 107' ' ' ASP . 21.2 pt20 -90.7 -9.62 46.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.9 0.857 . . . . 0.0 111.911 -173.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.407 ' C ' HD12 ' A' ' 111' ' ' LEU . 1.9 tm? -86.21 -41.39 14.69 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.384 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 8.0 pt-20 -64.89 -21.05 66.74 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 110' ' ' GLN . 61.1 t -58.04 -38.53 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.436 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.5 mp -81.0 -22.74 39.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.662 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -110.52 36.14 3.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 71.41 -79.11 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.959 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.552 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . -177.54 -55.27 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 12.1 Cg_endo -53.77 139.98 67.7 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 123.817 3.012 . . . . 0.0 112.931 171.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -108.74 118.63 37.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -160.59 168.45 24.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.126 -174.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.43 ' HB ' ' NE1' ' A' ' 125' ' ' TRP . 7.5 t -134.8 124.62 25.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.227 0.537 . . . . 0.0 110.59 174.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 98.1 mt -119.08 -39.38 2.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.148 176.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.548 ' O ' ' HE3' ' A' ' 83' ' ' LYS . 3.6 tpm_? -89.94 2.49 55.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.951 -175.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 123' ' ' ARG . 89.8 m-70 72.99 145.16 0.07 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.506 0.67 . . . . 0.0 112.222 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.445 ' CE3' ' HA3' ' A' ' 38' ' ' GLY . 7.6 m95 -104.23 154.17 20.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.712 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 83' ' ' LYS . 1.8 pp -112.37 168.71 9.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 15.1 ptmm? -149.89 134.69 17.72 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.811 0.338 . . . . 0.0 110.221 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.85 ' OXT' HG13 ' A' ' 33' ' ' ILE . 7.7 p . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.775 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 112.307 -0.317 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.6 m -89.62 129.4 47.06 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.583 0.23 . . . . 0.0 110.441 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.94 63.42 6.77 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.625 2.217 . . . . 0.0 111.855 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.21 128.71 11.87 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.209 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.492 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 6.1 pt -123.04 161.06 46.75 Favored Pre-proline 0 C--N 1.321 -0.636 0 O-C-N 122.951 -0.146 . . . . 0.0 111.101 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.677 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 18.8 Cg_endo -53.63 -82.67 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.558 2.839 . . . . 0.0 112.272 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.0 t -133.6 121.2 16.06 Favored Pre-proline 0 N--CA 1.434 -1.27 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -60.47 120.78 8.72 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.977 2.451 . . . . 0.0 112.196 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.505 ' HA3' ' CE1' ' A' ' 101' ' ' TYR . . . -129.32 163.68 22.47 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.559 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 21.2 ptmt -157.27 136.84 12.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.834 0.317 . . . . 0.0 111.828 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 99' ' ' ILE . 24.8 m -127.64 149.21 32.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 168.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -120.98 126.31 49.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.684 0.754 . . . . 0.0 110.448 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' HB2' ' CG2' ' A' ' 97' ' ' VAL . 5.2 mt -132.64 -167.62 1.93 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.359 -175.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.1 mt-30 -134.37 142.56 47.24 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.019 0.438 . . . . 0.0 110.158 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 27.9 mmtp -48.74 152.55 0.97 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.841 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 4.0 p-10 -85.74 -164.55 1.04 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.3 -24.64 67.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.855 0.359 . . . . 0.0 111.615 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.9 mt-30 -92.21 4.65 52.8 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.104 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 36.5 t30 71.15 24.9 3.75 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.121 0.962 . . . . 0.0 110.831 176.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.541 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.7 pp -131.05 -170.15 2.3 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.721 -0.612 . . . . 0.0 111.277 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.77 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.02 -21.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.152 -176.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.81 30.08 6.61 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.969 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.482 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.9 pp -124.33 175.62 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.711 0.767 . . . . 0.0 112.43 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -136.25 126.42 26.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.056 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.452 ' H ' ' HB3' ' A' ' 126' ' ' LEU . 46.7 mm -97.66 146.84 7.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.404 0.621 . . . . 0.0 111.071 -176.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.83 161.68 28.07 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.635 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.506 ' HA2' ' CA ' ' A' ' 46' ' ' CYS . . . -90.35 137.97 14.23 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.006 -175.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.489 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -143.93 17.57 2.17 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 119.032 -1.556 . . . . 0.0 114.235 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.9 -78.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.35 0.575 . . . . 0.0 110.268 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -148.78 -46.69 0.15 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.68 0.276 . . . . 0.0 110.514 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -92.21 4.31 53.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.196 0.522 . . . . 0.0 110.266 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.514 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 46.5 t 73.79 61.66 0.32 Allowed Pre-proline 0 C--N 1.333 -0.109 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.077 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 4.7 Cg_exo -80.26 -80.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.316 2.01 . . . . 0.0 111.571 176.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.613 ' O ' HD22 ' A' ' 47' ' ' LEU . 69.3 m -157.8 156.77 32.1 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 46' ' ' CYS . 1.1 pp 160.49 -42.72 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.67 1.232 . . . . 0.0 110.734 158.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.489 ' CD2' ' HA3' ' A' ' 40' ' ' GLY . 90.5 m-85 -76.57 146.48 38.3 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.239 0.542 . . . . 0.0 111.406 176.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -96.84 120.47 46.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.868 171.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.83 -31.9 12.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.851 -170.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -165.5 152.05 9.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.932 0.396 . . . . 0.0 110.213 -175.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.465 ' CG2' ' HB1' ' A' ' 59' ' ' ALA . 9.7 p -142.02 161.66 20.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.317 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.505 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 90.5 m-85 -110.99 123.69 50.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 59' ' ' ALA . 28.2 t70 -58.81 -19.88 45.15 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.675 -1.148 . . . . 0.0 113.869 -164.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.85 2.95 38.79 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.79 -175.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.505 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 20.7 p -89.08 153.58 49.15 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.418 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 6.5 Cg_endo -49.44 -43.18 39.5 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.801 1.667 . . . . 0.0 111.532 -176.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.444 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -54.33 -50.69 66.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.029 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . . . -76.11 -54.01 7.46 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.067 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.7 pp -53.67 -74.68 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -170.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.601 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 38.7 t70 -94.24 -14.62 25.32 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.405 1.097 . . . . 0.0 108.305 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -72.08 -51.55 13.84 Favored Glycine 0 C--N 1.312 -0.779 0 CA-C-N 113.259 -1.792 . . . . 0.0 113.129 -170.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.11 47.45 5.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.298 1.047 . . . . 0.0 111.119 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.446 HG12 HG13 ' A' ' 99' ' ' ILE . 19.5 m -124.86 49.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.3 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.38 -179.57 7.21 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.31 -1.313 . . . . 0.0 112.348 -169.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.61 118.03 2.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.568 -172.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.91 -16.97 20.47 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.384 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 49' ' ' ILE . 6.7 m-20 -81.97 157.02 24.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.949 0.404 . . . . 0.0 110.808 -178.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -101.04 124.54 46.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.037 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.44 98.69 7.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -80.87 -15.01 57.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.25 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.77 152.27 22.91 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 119.119 -1.515 . . . . 0.0 114.562 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.553 HG12 HG21 ' A' ' 78' ' ' ILE . 5.9 m -99.81 140.76 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 114.312 -0.944 . . . . 0.0 108.803 176.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.479 ' ND2' HG12 ' A' ' 93' ' ' VAL . 4.9 t-20 58.13 19.1 5.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.976 0.417 . . . . 0.0 111.618 170.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.36 -20.34 48.96 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.174 -0.467 . . . . 0.0 113.259 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -105.01 134.19 48.54 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 117.143 0.472 . . . . 0.0 110.663 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -52.09 138.62 25.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 0.0 111.724 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.553 HG21 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -77.7 -13.43 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.877 0.846 . . . . 0.0 109.056 -176.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -59.76 -13.42 10.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.907 -173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.76 -24.14 76.47 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.671 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.581 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -143.14 -137.89 0.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.357 0.578 . . . . 0.0 111.238 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.6 p -139.86 170.83 15.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.612 0.244 . . . . 0.0 111.598 -170.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.48 ' HA ' HG23 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -50.19 -54.16 22.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.743 -175.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.73 -35.46 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.152 0.501 . . . . 0.0 111.426 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.483 ' OE2' ' HB2' ' A' ' 81' ' ' LYS . 31.8 mt-10 -80.54 -35.86 33.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.768 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.503 HG13 ' HB ' ' A' ' 78' ' ' ILE . 33.7 m -71.04 -41.38 76.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.584 0.23 . . . . 0.0 111.269 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.54 -39.59 61.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.027 0.441 . . . . 0.0 109.931 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 61.5 tttm -64.64 -49.49 70.84 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.519 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 87.6 mtp -50.37 -41.93 52.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.418 0.628 . . . . 0.0 110.473 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.438 HD11 HD12 ' A' ' 33' ' ' ILE . 63.4 mt -70.26 -47.26 67.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.389 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -65.02 -32.52 74.28 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.801 -0.562 . . . . 0.0 111.569 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.06 -46.9 88.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.706 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.507 ' O ' HG21 ' A' ' 93' ' ' VAL . 9.9 m -75.89 41.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.228 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -45.88 137.52 5.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.802 0.811 . . . . 0.0 111.844 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.461 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 107.61 -32.91 6.71 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.01 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.7 pt-20 -143.87 176.6 9.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.067 0.461 . . . . 0.0 110.799 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.51 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 6.1 m -152.21 150.57 12.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.043 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.459 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 40.7 m -141.29 117.6 10.74 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 170.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -104.92 129.04 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.12 -177.371 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.88 116.27 32.36 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.609 ' CD1' ' HE2' ' A' ' 103' ' ' LYS . 17.9 p90 -120.25 160.98 21.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.563 0.697 . . . . 0.0 112.486 -170.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.466 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . 2.1 p-10 -135.5 145.82 47.48 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.502 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.635 ' O ' HD13 ' A' ' 104' ' ' LEU . 63.4 mmtt -122.38 -62.68 1.35 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -167.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.677 ' HG ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 34.92 -98.96 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.665 0.786 . . . . 0.0 112.509 -168.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -166.33 72.24 0.14 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.367 0.603 . . . . 0.0 109.916 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.15 166.73 24.57 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.951 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.578 ' OD1' ' HG2' ' A' ' 109' ' ' LYS . 1.0 OUTLIER 173.27 158.78 0.28 Allowed Pre-proline 0 C--O 1.211 -0.939 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -172.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 1.4 Cg_exo -29.88 -41.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.309 2.673 . . . . 0.0 113.858 173.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.578 ' HG2' ' OD1' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -62.82 -49.76 73.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.727 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.48 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 76.3 mm-40 -87.35 -13.12 44.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.491 0.662 . . . . 0.0 110.597 -177.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 107' ' ' ASP . 2.7 tm? -75.65 -44.03 44.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.368 -176.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -68.62 -30.89 69.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.029 0.442 . . . . 0.0 109.981 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 109' ' ' LYS . 88.4 t -69.54 -29.8 42.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.59 0.709 . . . . 0.0 109.758 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 114' ' ' LEU . 8.0 tt -73.3 -27.47 61.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -103.44 35.45 2.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.562 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 71.48 -70.42 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.362 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.609 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . -166.41 -51.34 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 10.1 Cg_endo -48.74 108.56 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.711 2.941 . . . . 0.0 113.019 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -83.76 177.06 8.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.807 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -147.84 126.22 12.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.281 0.563 . . . . 0.0 111.297 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.2 t -160.5 87.56 0.76 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.977 0.894 . . . . 0.0 109.328 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 122' ' ' LEU . 6.2 mp -76.06 -80.02 0.1 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.677 -174.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -172.07 3.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -88.2 87.54 7.35 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.65 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -104.4 161.8 13.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.605 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -129.71 162.54 28.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.219 -177.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.577 ' N ' HD13 ' A' ' 126' ' ' LEU . 21.8 pttp -156.21 121.78 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.466 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.77 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.2 p . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 117.957 -1.021 . . . . 0.0 108.638 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.0 p -125.83 91.71 47.78 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.775 0.321 . . . . 0.0 110.478 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.72 -25.13 5.57 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.281 1.987 . . . . 0.0 112.35 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.75 127.43 7.69 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.469 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.517 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 16.3 pt -92.15 153.71 43.17 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.517 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 20.8 Cg_endo -57.87 -71.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.001 2.467 . . . . 0.0 112.687 -169.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.06 89.47 9.78 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 172.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.4 126.86 21.93 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.299 2.666 . . . . 0.0 113.18 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -141.21 139.78 9.81 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 51.8 pttt -159.13 130.83 6.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.023 0.439 . . . . 0.0 111.134 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -137.44 147.02 26.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.3 t -112.59 123.13 49.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.489 0.661 . . . . 0.0 110.965 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.495 HD22 ' HA2' ' A' ' 62' ' ' GLY . 9.6 mt -127.13 -168.96 1.95 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.589 -176.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.2 mt-30 -132.89 142.05 48.71 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.827 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HZ2' ' CA ' ' A' ' 94' ' ' LYS . 29.9 mmtm -48.38 153.42 0.74 Allowed 'General case' 0 C--N 1.32 -0.711 0 O-C-N 124.631 1.207 . . . . 0.0 113.013 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -86.55 -178.66 6.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.521 173.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.68 -21.76 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 111.364 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.461 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -94.64 6.5 48.69 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.307 -177.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 47.3 t30 67.33 32.01 6.17 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.36 1.076 . . . . 0.0 110.613 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 1.4 pp -136.93 -169.51 2.49 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.041 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.735 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.1 -26.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.685 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.2 29.18 6.15 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.299 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 2.8 pp -118.21 172.3 5.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.668 0.747 . . . . 0.0 111.555 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.483 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 60.0 m -139.1 127.31 22.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.541 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.3 130.09 47.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.274 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.01 129.1 9.73 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.11 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.514 ' HA2' ' C ' ' A' ' 45' ' ' PRO . . . -68.3 125.5 21.15 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.093 -176.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.561 ' HA3' ' CD1' ' A' ' 47' ' ' LEU . . . -78.92 -9.95 86.63 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 119.887 -1.149 . . . . 0.0 114.477 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.531 ' H ' ' HA ' ' A' ' 45' ' ' PRO . . . -149.58 -171.54 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.121 0.96 . . . . 0.0 111.674 -174.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -90.75 -49.6 6.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.027 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 119' ' ' GLN . 83.1 m-85 -80.27 -42.74 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.187 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 118' ' ' PRO . 63.2 m -120.55 66.58 12.98 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.819 0.342 . . . . 0.0 111.22 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.551 ' HD3' ' C ' ' A' ' 43' ' ' TYR . 7.6 Cg_exo -78.69 83.05 2.32 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.813 2.342 . . . . 0.0 113.294 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.553 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 64.1 m -148.14 126.26 12.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 168.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.561 ' CD1' ' HA3' ' A' ' 40' ' ' GLY . 47.6 mt -164.64 -92.77 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.598 1.19 . . . . 0.0 111.224 172.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -59.45 150.16 27.42 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.064 -2.334 . . . . 0.0 112.208 -172.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.81 104.19 15.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 163.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.9 t -79.03 -29.36 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.018 -168.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.483 ' HG2' ' HB2' ' A' ' 36' ' ' SER . 2.6 pt20 -161.03 152.42 19.09 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.221 0.534 . . . . 0.0 110.112 -173.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 59' ' ' ALA . 8.5 p -142.13 160.94 20.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.326 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 97.8 m-85 -111.63 125.97 54.52 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.691 0.758 . . . . 0.0 109.217 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -51.36 -29.16 14.53 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.803 -1.544 . . . . 0.0 114.136 -166.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.492 ' HA ' HD21 ' A' ' 60' ' ' LEU . 51.3 m-80 -102.18 9.14 40.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.864 0.364 . . . . 0.0 110.729 -172.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 32.7 p -95.55 147.72 33.46 Favored Pre-proline 0 CA--C 1.501 -0.936 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.3 Cg_endo -47.32 -39.65 27.71 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.111 1.874 . . . . 0.0 111.235 -175.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -55.89 -57.2 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.201 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 52' ' ' VAL . . . -72.96 -54.62 8.18 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.458 0.647 . . . . 0.0 110.026 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -44.15 -75.52 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.783 -178.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HB3' HD21 ' A' ' 25' ' ' LEU . 22.0 t70 -97.48 -31.66 12.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.035 0.445 . . . . 0.0 111.942 -174.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.495 ' HA2' HD22 ' A' ' 25' ' ' LEU . . . -72.4 -36.67 59.22 Favored Glycine 0 C--O 1.227 -0.281 0 N-CA-C 115.127 0.811 . . . . 0.0 115.127 -166.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.9 p 65.06 24.02 12.5 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.181 0.991 . . . . 0.0 110.788 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.533 HG13 HG13 ' A' ' 99' ' ' ILE . 31.2 m -94.82 49.0 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.646 174.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.74 -179.43 7.11 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.949 -170.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.0 135.18 37.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.934 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.81 -11.1 20.93 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.888 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.617 ' O ' HG23 ' A' ' 49' ' ' ILE . 13.8 m-20 -101.23 178.09 4.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.905 0.353 . . . . 0.0 110.515 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 104' ' ' LEU . 15.5 mm-40 -120.9 143.4 48.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.1 mm -104.94 115.85 47.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -113.87 1.39 14.75 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -173.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.1 145.71 10.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.208 -1.473 . . . . 0.0 114.296 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.521 HG11 HG23 ' A' ' 78' ' ' ILE . 6.0 m -110.88 143.45 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.532 -0.834 . . . . 0.0 109.73 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 55.9 26.58 9.93 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.623 0.725 . . . . 0.0 111.608 164.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.48 -14.57 64.47 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.525 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -109.46 172.42 6.87 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 123.084 0.554 . . . . 0.0 110.291 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 t -74.13 174.96 7.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.97 0.414 . . . . 0.0 110.47 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.521 HG23 HG11 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -109.15 -14.04 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.485 0.659 . . . . 0.0 109.328 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.647 ' HD2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -64.25 -19.14 65.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.855 -169.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.01 -20.84 76.62 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.619 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.578 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -142.51 -145.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.275 0.538 . . . . 0.0 110.655 -178.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.3 t -140.78 173.38 11.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.55 0.214 . . . . 0.0 110.564 -169.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.495 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -41.14 -61.27 1.03 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.556 1.143 . . . . 0.0 113.843 -175.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -57.31 -36.38 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 120.976 0.417 . . . . 0.0 111.503 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 89' ' ' MET . 34.3 mt-10 -80.62 -33.11 36.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.016 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 83' ' ' LYS . 35.1 m -70.09 -45.63 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.453 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.11 -37.6 83.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -61.08 -52.27 65.63 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.236 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 21.1 mmt -50.02 -40.34 44.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.23 0.538 . . . . 0.0 111.686 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.499 HD11 HD12 ' A' ' 33' ' ' ILE . 44.1 mt -65.77 -53.05 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.113 178.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.526 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 4.1 pt20 -80.29 -18.54 48.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.42 -53.05 60.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.951 0.5 . . . . 0.0 111.098 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 90' ' ' ILE . 12.6 m -56.42 -27.68 25.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.978 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.464 ' CA ' ' HZ2' ' A' ' 27' ' ' LYS . 25.0 pttm 48.98 157.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.113 1.365 . . . . 0.0 113.439 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.37 -50.81 4.29 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.117 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.4 pt-20 -132.9 177.2 7.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.021 0.438 . . . . 0.0 109.936 -173.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 25' ' ' LEU . 8.8 m -151.04 153.54 9.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.685 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.5 m -140.89 100.09 3.75 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.533 HG13 HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -90.64 138.07 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.71 -172.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -116.36 117.73 30.78 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -125.59 154.96 41.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.461 0.648 . . . . 0.0 111.926 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -140.05 176.84 8.42 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.652 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -132.39 80.63 1.91 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.455 ' O ' ' HG3' ' A' ' 69' ' ' GLU . 0.8 OUTLIER -176.62 157.8 1.64 Allowed 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.378 0.671 . . . . 0.0 110.52 170.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -97.1 15.03 23.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.434 ' HB2' ' HG3' ' A' ' 110' ' ' GLN . . . 68.07 -179.15 0.22 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.253 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.569 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 24.8 t70 -135.88 143.65 45.28 Favored Pre-proline 0 C--O 1.214 -0.805 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 6.3 Cg_exo -29.34 -50.63 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.016 3.144 . . . . 0.0 115.073 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.0 ptpt -58.08 -49.1 78.1 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.569 ' CG ' ' H ' ' A' ' 107' ' ' ASP . 3.7 pt20 -90.15 -13.53 35.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.845 0.831 . . . . 0.0 111.76 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.436 HD11 ' C ' ' A' ' 111' ' ' LEU . 1.7 tm? -79.35 -40.77 29.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.495 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 6.7 pt-20 -65.97 -29.14 69.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.204 0.526 . . . . 0.0 109.72 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.2 t -58.88 -45.46 91.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.556 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.403 ' HA ' ' CG ' ' A' ' 79' ' ' LYS . 10.9 mp -80.7 -16.68 53.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.533 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -74.24 -42.61 59.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.706 -176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -78.73 60.61 2.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.452 0.644 . . . . 0.0 111.747 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 79' ' ' LYS . . . -159.87 -61.8 0.01 OUTLIER Glycine 0 C--N 1.309 -0.952 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 171.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.471 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 10.4 Cg_exo -40.61 -142.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 1 C-N-CA 125.552 4.168 . . . . 0.0 115.958 164.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.68 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 9.3 tt0 70.21 -119.1 0.11 Allowed 'General case' 0 C--O 1.237 0.417 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.687 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 119' ' ' GLN . 84.3 m-85 69.29 -60.06 0.47 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.319 0.647 . . . . 0.0 110.759 -172.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.7 p -135.85 133.63 37.99 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 pp -85.32 168.5 14.62 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.708 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 124' ' ' HIS . 12.5 tpp180 69.97 -163.77 0.17 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -174.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.429 ' H ' ' HG3' ' A' ' 123' ' ' ARG . 10.7 m-70 64.52 125.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.556 0.693 . . . . 0.0 112.589 177.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -89.82 172.13 9.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.064 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.0 tp -124.03 149.62 45.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 10.4 ptmm? -167.27 162.74 15.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.335 173.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.735 ' O ' HG13 ' A' ' 33' ' ' ILE . 5.0 p . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 170.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.6 m -127.92 83.91 64.76 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.62 0.248 . . . . 0.0 110.581 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.46 151.0 32.72 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.393 2.062 . . . . 0.0 112.088 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.09 64.46 3.94 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.563 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.481 HD12 ' ND2' ' A' ' 102' ' ' ASN . 5.3 pt -117.21 138.8 25.23 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.465 ' HD3' HD12 ' A' ' 104' ' ' LEU . 29.3 Cg_endo -65.23 -80.91 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.932 2.421 . . . . 0.0 114.091 -163.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.9 t -109.89 101.35 46.74 Favored Pre-proline 0 N--CA 1.442 -0.861 0 CA-C-O 121.369 0.604 . . . . 0.0 110.475 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 18' ' ' PRO . 4.2 Cg_endo -85.78 121.1 2.09 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 124.089 3.193 . . . . 0.0 113.136 -176.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.614 ' HA2' ' CG ' ' A' ' 100' ' ' HIS . . . 126.64 -105.5 0.78 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.044 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 13.9 mmmm 99.92 -90.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.067 1.347 . . . . 0.0 113.221 174.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 99' ' ' ILE . 25.3 m -125.55 160.7 31.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 118.096 -1.442 . . . . 0.0 112.583 -164.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -135.6 118.05 15.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.525 0.678 . . . . 0.0 110.539 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.411 ' C ' ' HB ' ' A' ' 97' ' ' VAL . 3.3 mm? -113.58 -159.4 0.69 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.055 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 2.0 pt20 -142.39 149.31 39.18 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 31' ' ' ASN . 36.1 mmtm -37.19 151.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -83.67 177.67 8.29 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.034 -1.894 . . . . 0.0 109.126 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.57 -25.37 62.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.103 0.41 . . . . 0.0 111.404 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.425 HE21 HD23 ' A' ' 32' ' ' LEU . 7.2 tt0 -94.2 20.33 8.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.39 0.614 . . . . 0.0 110.336 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 2.4 p-10 54.35 30.04 11.94 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.938 1.295 . . . . 0.0 112.629 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 0.9 OUTLIER -128.05 -166.5 1.63 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.561 175.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.755 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.97 -25.98 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.545 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.7 39.68 3.82 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.526 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.562 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.9 pp -131.44 172.48 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.822 0.82 . . . . 0.0 111.854 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 m -138.16 127.86 25.14 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.193 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.649 ' HB ' ' CD2' ' A' ' 126' ' ' LEU . 49.7 mm -106.44 119.87 56.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.423 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.5 -163.31 9.63 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.01 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.2 125.98 7.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.428 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 45' ' ' PRO . . . -83.96 -171.27 47.64 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.958 169.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.18 -86.73 0.11 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -130.77 -67.75 0.71 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.908 0.385 . . . . 0.0 111.352 -177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -135.66 40.65 2.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.258 -175.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.537 ' CB ' ' HD3' ' A' ' 45' ' ' PRO . 2.6 m -146.78 -71.29 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 44' ' ' CYS . 39.2 Cg_endo -90.47 146.68 4.17 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.487 1.458 . . . . 0.0 111.882 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.416 ' SG ' ' HA2' ' A' ' 67' ' ' GLY . 56.3 m -80.36 150.82 29.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 0.0 110.884 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.15 130.73 34.96 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.53 1.157 . . . . 0.0 112.862 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.639 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 25.0 m-85 66.94 -78.03 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.041 -1.89 . . . . 0.0 111.183 -172.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.711 HG21 ' O ' ' A' ' 68' ' ' ASP . 2.3 tt -85.4 122.91 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 118.549 -1.261 . . . . 0.0 111.166 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.25 -21.12 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.583 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.64 143.6 18.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.454 -173.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.461 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.9 p -139.1 160.35 29.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 173.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -94.73 -140.81 0.24 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -130.0 -43.05 1.22 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.937 0.79 . . . . 0.0 112.408 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.495 ' HA ' HD22 ' A' ' 60' ' ' LEU . 1.0 OUTLIER -99.29 13.7 32.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.387 0.613 . . . . 0.0 110.067 -172.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 65.7 p -91.95 141.1 25.02 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.7 Cg_endo -48.06 -38.22 31.67 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 121.935 1.756 . . . . 0.0 111.413 -173.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 64' ' ' VAL . . . -54.33 -56.56 17.24 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.762 175.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.74 -56.95 4.25 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.472 0.653 . . . . 0.0 110.187 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.495 HD22 ' HA ' ' A' ' 55' ' ' ASN . 1.2 tm? -42.28 -76.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.675 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 60' ' ' LEU . 28.2 t70 -96.15 -37.88 10.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.819 -171.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.546 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . -64.3 -74.55 0.45 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.261 -168.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.546 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 6.0 t 130.86 0.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.195 1.398 . . . . 0.0 108.853 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.598 ' CG2' HD11 ' A' ' 70' ' ' ILE . 0.6 OUTLIER -75.96 58.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 124.651 2.167 . . . . 0.0 111.849 -175.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.73 173.0 10.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 113.633 -1.622 . . . . 0.0 110.19 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.78 124.85 20.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.165 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.416 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . 127.67 -15.99 6.25 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.923 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.711 ' O ' HG21 ' A' ' 49' ' ' ILE . 2.2 m-20 -89.66 146.45 24.52 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.028 0.442 . . . . 0.0 110.688 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -89.58 88.76 7.54 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.598 HD11 ' CG2' ' A' ' 64' ' ' VAL . 40.6 mt -87.26 94.66 4.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.496 -176.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' SER . 11.1 t -102.35 1.79 35.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.545 -171.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -134.3 130.61 5.63 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.777 -1.201 . . . . 0.0 113.923 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -99.63 125.4 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 123.939 0.896 . . . . 0.0 108.938 177.423 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 59.53 21.62 10.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.075 0.464 . . . . 0.0 110.947 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.438 ' HA2' ' ND1' ' A' ' 100' ' ' HIS . . . 101.4 -19.02 52.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.562 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -112.33 141.22 46.32 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 117.656 0.728 . . . . 0.0 111.148 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 71' ' ' THR . 51.0 m -48.81 143.45 5.33 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.486 ' HB ' HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -83.93 -18.3 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.266 -176.469 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -61.56 -25.36 67.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.964 -170.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.25 -15.27 78.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.782 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.636 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 5.7 mptt -108.98 -119.43 0.27 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.71 0.767 . . . . 0.0 109.882 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.414 ' O ' HG11 ' A' ' 86' ' ' VAL . 10.2 t -179.7 167.17 1.38 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.803 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.502 ' O ' HD21 ' A' ' 126' ' ' LEU . 1.0 OUTLIER -50.12 -53.03 30.27 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.8 0.687 . . . . 0.0 112.431 -171.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.24 -39.72 85.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.983 0.42 . . . . 0.0 111.761 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -74.19 -42.6 59.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 83' ' ' LYS . 27.7 m -57.91 -43.15 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.39 -42.99 67.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.832 174.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -64.59 -49.95 69.15 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.306 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.9 mmt -49.84 -46.22 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.274 0.559 . . . . 0.0 110.904 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 93' ' ' VAL . 20.4 mm -59.18 -56.9 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.873 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.67 -24.81 67.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.07 -46.18 88.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.142 0.496 . . . . 0.0 111.361 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.574 ' O ' HG21 ' A' ' 93' ' ' VAL . 13.2 m -72.88 55.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.104 0.954 . . . . 0.0 110.581 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -43.35 131.84 4.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.677 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 107.32 -35.47 5.0 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.072 170.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.56 177.81 7.33 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.102 0.477 . . . . 0.0 110.903 -171.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.411 ' HB ' ' C ' ' A' ' 25' ' ' LEU . 16.9 t -152.28 133.64 5.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.314 -170.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.4 m -132.45 116.25 16.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 174.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.58 HD13 ' N ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -107.47 124.2 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 121.128 0.489 . . . . 0.0 111.602 -176.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.614 ' CG ' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -112.96 103.14 11.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.734 173.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -128.55 162.9 26.17 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.481 ' ND2' HD12 ' A' ' 17' ' ' ILE . 31.3 m-80 -136.66 163.55 30.31 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.892 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.674 ' C ' ' HG ' ' A' ' 104' ' ' LEU . 11.2 mmpt? -94.02 166.06 12.34 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.621 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.674 ' HG ' ' C ' ' A' ' 103' ' ' LYS . 0.5 OUTLIER 57.16 -66.08 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 174.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.611 ' O ' HD22 ' A' ' 111' ' ' LEU . 0.3 OUTLIER 56.45 56.18 5.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -166.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 71.27 -150.65 0.09 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.477 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -130.68 152.1 79.89 Favored Pre-proline 0 C--O 1.208 -1.089 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.436 -176.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 27.4 Cg_exo -31.45 -54.83 0.27 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.254 3.303 . . . . 0.0 114.905 -172.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 0.5 OUTLIER -57.59 -43.57 84.71 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.724 0.773 . . . . 0.0 111.884 178.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 19.9 mt-30 -82.33 -26.56 32.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.514 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.611 HD22 ' O ' ' A' ' 105' ' ' GLN . 3.2 tm? -69.55 -48.12 61.41 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.782 -175.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 5.1 pt-20 -64.78 -31.35 72.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.528 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 109' ' ' LYS . 75.1 t -64.55 -41.14 91.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.291 0.567 . . . . 0.0 109.797 175.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 tp -70.54 -32.71 70.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.584 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.402 ' O ' ' HB3' ' A' ' 116' ' ' GLN . 43.7 t80 -79.52 -10.85 59.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.252 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 115' ' ' PHE . 28.2 tt0 74.03 -66.58 0.3 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.823 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.98 59.7 0.23 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.15 134.49 56.52 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.792 2.995 . . . . 0.0 113.575 -173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -95.49 4.62 53.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.464 0.649 . . . . 0.0 109.479 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -124.67 82.33 2.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.989 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.9 m -114.64 108.69 17.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.597 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.402 ' N ' HD13 ' A' ' 122' ' ' LEU . 7.1 mp -107.78 122.4 46.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -81.3 90.46 6.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.3 0.571 . . . . 0.0 110.718 -177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -144.39 123.07 12.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.274 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -115.97 148.9 39.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.898 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.649 ' CD2' ' HB ' ' A' ' 37' ' ' ILE . 2.1 pp -90.63 169.2 11.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.861 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -144.98 95.6 2.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.226 0.536 . . . . 0.0 110.396 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.755 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.1 p . . . . . 0 N--CA 1.443 -0.809 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.343 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.5 m -144.02 159.2 53.85 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.02 -46.24 33.73 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.129 1.886 . . . . 0.0 111.152 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.57 68.84 1.52 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.126 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 20.8 pt -80.25 150.68 71.46 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.2 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 102' ' ' ASN . 28.3 Cg_endo -61.27 -78.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.006 2.471 . . . . 0.0 112.18 -170.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.8 119.31 37.62 Favored Pre-proline 0 N--CA 1.432 -1.333 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.77 135.09 37.15 Favored 'Trans proline' 0 C--N 1.33 -0.4 0 C-N-CA 123.445 2.764 . . . . 0.0 112.291 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.13 143.41 11.31 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -160.85 136.96 8.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.914 0.387 . . . . 0.0 111.12 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.507 HG21 ' O ' ' A' ' 62' ' ' GLY . 10.1 m -131.68 157.32 43.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -126.77 131.79 51.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.36 0.6 . . . . 0.0 110.914 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.473 HD23 ' HA2' ' A' ' 62' ' ' GLY . 2.9 mm? -127.35 -171.55 2.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.41 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.559 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 89.5 mt-30 -129.81 136.88 50.11 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.94 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 25.8 mmtp -40.14 146.27 0.13 Allowed 'General case' 0 C--N 1.321 -0.644 0 O-C-N 124.814 1.321 . . . . 0.0 113.354 -176.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -79.55 179.6 7.38 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.382 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.85 -32.22 63.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.775 0.321 . . . . 0.0 110.691 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -92.68 16.93 11.12 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.088 0.47 . . . . 0.0 111.018 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.456 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 63.5 t30 71.75 12.54 6.27 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.765 173.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 pp -121.95 -170.31 2.03 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 121.397 -0.815 . . . . 0.0 112.091 -174.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.9 -29.6 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.881 -178.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.78 40.26 4.72 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.413 -0.898 . . . . 0.0 113.427 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 2.7 pp -123.95 177.79 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.567 0.698 . . . . 0.0 112.197 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.55 ' HG ' ' CB ' ' A' ' 127' ' ' LYS . 23.1 m -148.92 116.17 6.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.077 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 5.0 tt -105.0 125.61 59.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.449 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 125' ' ' TRP . . . -117.29 138.0 13.83 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.694 -176.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.69 159.48 13.72 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.96 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.26 96.62 0.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.896 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 44' ' ' CYS . . . -151.88 158.94 43.9 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 173.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -62.16 113.77 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.614 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.5 t80 71.21 -10.1 0.81 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.12 0.887 . . . . 0.0 111.54 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 85.6 m -147.7 75.24 11.15 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.544 -173.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 39.0 Cg_exo -63.97 -162.37 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.898 2.399 . . . . 0.0 113.205 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.477 ' SG ' ' HG ' ' A' ' 122' ' ' LEU . 56.7 m 73.48 134.79 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.966 -166.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.3 mt -145.32 -92.56 0.1 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.723 0.773 . . . . 0.0 110.972 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 49.2 p90 -142.02 175.74 9.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.555 -167.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -79.74 122.6 35.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.463 176.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.7 t -100.06 -20.55 5.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.37 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -151.15 133.11 15.12 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.356 -173.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 59' ' ' ALA . 9.8 p -135.66 159.96 39.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -90.91 -137.87 0.15 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -138.89 -38.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.733 0.697 . . . . 0.0 112.321 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -101.73 4.06 40.21 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.956 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 70.0 p -82.9 146.61 52.62 Favored Pre-proline 0 N--CA 1.433 -1.294 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 9.1 Cg_endo -50.13 -40.5 50.89 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.911 1.741 . . . . 0.0 111.204 -176.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.88 84.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.814 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.491 ' HB2' HG23 ' A' ' 52' ' ' VAL . . . -74.94 -59.02 2.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.167 0.508 . . . . 0.0 110.573 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.572 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 2.0 pp -50.03 -76.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -171.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.572 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 35.7 t70 -95.56 -19.12 20.05 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.616 1.198 . . . . 0.0 108.511 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.535 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -64.25 -32.47 84.3 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 112.512 -2.131 . . . . 0.0 114.164 -167.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 t 48.01 32.1 2.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 112.255 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.645 ' HB ' ' OH ' ' A' ' 101' ' ' TYR . 22.8 m -105.1 51.37 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-O 123.483 1.611 . . . . 0.0 109.288 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.35 166.77 18.17 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.04 -2.345 . . . . 0.0 111.242 -172.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.02 119.09 2.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.175 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.87 -28.3 3.55 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.307 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.691 ' HB3' ' CD1' ' A' ' 101' ' ' TYR . 1.1 m-20 -73.7 144.29 45.82 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 102' ' ' ASN . 17.1 tt0 -101.59 122.89 44.68 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.728 HG12 ' CE1' ' A' ' 101' ' ' TYR . 3.2 mt -108.48 101.17 12.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.329 0.585 . . . . 0.0 111.205 -170.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -92.41 -15.17 27.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.069 -175.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.03 148.73 18.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.572 -1.299 . . . . 0.0 113.847 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.402 HG11 HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -110.01 122.25 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 123.407 0.683 . . . . 0.0 109.457 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 53.2 28.36 6.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.94 -20.15 46.76 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.639 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -103.51 134.58 46.63 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 117.854 0.827 . . . . 0.0 110.52 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.2 m -66.68 152.37 45.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.692 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.404 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -88.48 6.02 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 122.396 1.093 . . . . 0.0 108.447 178.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.515 ' HE2' ' O ' ' A' ' 115' ' ' PHE . 39.3 tptt -76.05 96.19 3.77 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.254 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.49 -30.25 2.8 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.107 -1.044 . . . . 0.0 114.28 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.595 ' CG ' HG11 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -89.92 -151.32 0.23 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 117.989 0.895 . . . . 0.0 112.242 -172.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.495 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 2.7 m -132.91 141.19 48.24 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.413 ' O ' HG21 ' A' ' 86' ' ' VAL . 9.5 mtmm -37.63 -54.59 1.17 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.354 0.662 . . . . 0.0 112.715 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -51.64 -31.63 12.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.85 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 89' ' ' MET . 34.0 mt-10 -80.77 -34.92 33.85 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.849 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.595 HG11 ' CG ' ' A' ' 81' ' ' LYS . 20.3 m -73.48 -42.86 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.84 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' A' ' 91' ' ' GLN . . . -61.69 -34.65 76.13 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 171.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 38.1 ttpt -63.61 -48.33 77.79 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.727 175.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 65.6 mtt -45.38 -46.96 13.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.365 0.602 . . . . 0.0 110.275 175.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.412 HG23 ' CG2' ' A' ' 128' ' ' VAL . 34.8 mm -63.69 -54.43 32.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.973 176.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 11.9 mm-40 -61.39 -35.69 78.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -67.03 -55.16 15.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -172.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -54.42 -40.18 47.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.582 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 64.6 pttt 48.38 161.62 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.227 1.411 . . . . 0.0 113.702 -178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.67 -46.07 3.12 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.235 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.1 pt-20 -146.54 178.39 8.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.095 0.474 . . . . 0.0 110.11 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -147.48 151.04 14.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.55 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.6 m -140.35 105.49 5.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.265 0.555 . . . . 0.0 110.595 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.686 ' HB ' ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -92.61 149.67 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.077 -176.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -128.03 129.13 46.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.784 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.728 ' CE1' HG12 ' A' ' 70' ' ' ILE . 97.5 m-85 -123.46 153.61 40.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.584 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 11.1 p-10 -134.48 158.23 44.45 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.178 171.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.547 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 10.8 mptt -134.31 101.19 4.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.585 0.354 . . . . 0.0 111.178 177.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.452 HD11 ' HD3' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -164.46 160.43 20.53 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.312 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 15.1 mm-40 -121.54 80.22 1.64 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.247 0.546 . . . . 0.0 109.907 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.6 171.11 13.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.65 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 111' ' ' LEU . 12.6 m-20 -116.54 152.94 48.81 Favored Pre-proline 0 C--O 1.21 -1.013 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -32.59 -49.03 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.693 2.929 . . . . 0.0 113.743 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.471 ' O ' HG21 ' A' ' 113' ' ' VAL . 21.3 ptmt -60.7 -49.38 77.73 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.587 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.47 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.8 mm100 -90.09 -11.25 41.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.535 0.683 . . . . 0.0 111.206 -173.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.4 tm? -84.91 -40.12 17.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.493 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -66.25 -21.85 66.3 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.851 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 109' ' ' LYS . 76.0 t -64.21 -36.34 76.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.922 174.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.425 ' O ' HD22 ' A' ' 114' ' ' LEU . 7.1 tt -79.63 -30.36 41.31 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.515 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 9.8 t80 -83.7 0.07 48.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.609 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 70.13 -79.03 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.773 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.53 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . 179.72 -48.2 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.672 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 16.2 Cg_exo -30.63 136.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 124.358 3.372 . . . . 0.0 113.611 167.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -72.16 -173.68 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.971 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -132.07 168.46 17.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.991 -169.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.1 t -141.15 28.31 1.89 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.053 0.93 . . . . 0.0 108.871 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.477 ' HG ' ' SG ' ' A' ' 46' ' ' CYS . 3.3 mm? -107.36 128.9 54.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.785 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -140.18 -70.37 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.141 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -81.76 150.49 27.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.457 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 7.2 p90 -73.57 168.93 18.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.42 . . . . 0.0 111.855 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.73 168.33 17.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.467 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.55 ' CB ' ' HG ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -144.32 148.81 35.26 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.313 0.578 . . . . 0.0 111.23 -178.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 33' ' ' ILE . 4.1 p . . . . . 0 C--N 1.315 -0.899 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.904 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.1 m 68.99 127.81 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 C-N-CA 123.332 0.653 . . . . 0.0 111.054 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.72 -11.58 28.01 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.466 2.111 . . . . 0.0 112.661 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.19 145.14 3.76 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.997 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 21.4 pt -78.72 155.41 78.25 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 122.546 -0.384 . . . . 0.0 110.766 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HG3' HD12 ' A' ' 104' ' ' LEU . 35.3 Cg_endo -62.54 -86.99 0.0 OUTLIER 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.988 2.458 . . . . 0.0 112.279 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 52.9 t -112.76 128.58 25.41 Favored Pre-proline 0 N--CA 1.434 -1.233 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 19' ' ' VAL . 12.0 Cg_endo -92.42 145.93 2.76 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.771 2.981 . . . . 0.0 112.01 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.91 175.96 47.1 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.329 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 21.3 pttm -150.46 146.86 26.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.538 0.209 . . . . 0.0 110.548 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.55 141.07 43.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -109.5 119.66 40.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.808 0.814 . . . . 0.0 111.186 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 25' ' ' LEU . 2.9 mm? -124.41 -167.01 1.59 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.045 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.0 mt-30 -132.12 139.67 48.53 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.014 0.435 . . . . 0.0 109.948 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 5.3 mmtp -45.03 145.27 1.02 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.86 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.25 179.1 8.0 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.421 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.92 -21.35 64.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.169 0.509 . . . . 0.0 110.658 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.543 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 2.5 mt-30 -89.74 11.34 20.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.907 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 1.8 p-10 55.33 29.18 12.52 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.136 1.374 . . . . 0.0 112.136 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.543 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 0.9 OUTLIER -131.65 -165.74 1.62 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.639 177.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.73 -28.57 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.67 38.02 4.31 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.267 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.429 HD11 HG13 ' A' ' 37' ' ' ILE . 2.6 pp -128.82 177.51 6.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.868 0.842 . . . . 0.0 111.954 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 11.7 m -138.41 125.18 20.99 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.397 173.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 38' ' ' GLY . 22.5 mt -110.47 -168.18 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.604 ' H ' HG22 ' A' ' 37' ' ' ILE . . . 179.62 117.76 0.56 Allowed Glycine 0 C--N 1.308 -0.984 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -177.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.567 ' HA2' ' HG ' ' A' ' 47' ' ' LEU . . . -112.22 152.44 17.79 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.384 -1.388 . . . . 0.0 114.149 -172.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 44' ' ' CYS . . . -64.64 -67.46 2.03 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.399 172.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.598 ' H ' ' HA ' ' A' ' 45' ' ' PRO . . . 72.08 -63.8 0.41 Allowed 'General case' 0 C--N 1.344 0.369 0 C-N-CA 123.326 0.65 . . . . 0.0 112.215 171.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -71.49 84.22 0.83 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.702 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 72.66 -20.04 0.28 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.896 0.878 . . . . 0.0 112.472 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.673 ' O ' ' HA3' ' A' ' 40' ' ' GLY . 68.2 m -134.29 77.55 60.15 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 122.418 -0.176 . . . . 0.0 111.09 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.598 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 25.0 Cg_exo -69.15 -149.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.332 2.688 . . . . 0.0 113.738 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 45' ' ' PRO . 74.7 m 72.77 112.93 0.06 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.868 -165.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.567 ' HG ' ' HA2' ' A' ' 39' ' ' GLY . 5.7 mp -101.89 167.72 9.89 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.295 0.569 . . . . 0.0 112.497 -174.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -139.79 150.02 44.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.699 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -95.52 127.07 47.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.53 0.681 . . . . 0.0 109.285 177.518 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 125' ' ' TRP . 37.4 t -92.3 -38.32 10.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.937 -171.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.96 150.15 20.3 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.682 -174.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' A' ' 59' ' ' ALA . 8.1 p -141.33 159.98 22.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.567 173.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -95.91 -139.18 0.25 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -136.06 -33.41 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.783 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -102.38 4.49 38.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.166 0.508 . . . . 0.0 110.564 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 82.5 p -86.3 144.16 37.84 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.793 ' HA ' ' CD1' ' A' ' 60' ' ' LEU . 10.2 Cg_endo -52.25 -38.99 73.06 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.428 1.418 . . . . 0.0 111.704 -172.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.661 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.05 -45.36 87.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.543 175.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 52' ' ' VAL . . . -72.4 -60.95 1.98 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.095 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.793 ' CD1' ' HA ' ' A' ' 57' ' ' PRO 0.268 0.0 OUTLIER -61.41 -71.43 0.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -166.895 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.696 ' H ' ' CD1' ' A' ' 60' ' ' LEU . 23.7 t70 -92.84 -4.31 53.15 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -71.71 -62.28 3.48 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 112.613 -2.085 . . . . 0.0 113.648 -171.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p 74.31 23.18 2.07 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.933 1.293 . . . . 0.0 110.574 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.531 HG13 HG13 ' A' ' 99' ' ' ILE . 31.2 m -100.21 50.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.564 172.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.73 174.91 10.07 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.138 -170.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.91 132.43 52.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.607 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.15 -13.58 19.19 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.628 ' O ' HG23 ' A' ' 49' ' ' ILE . 57.8 m-20 -95.86 -175.99 3.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.026 0.441 . . . . 0.0 110.72 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . 50.9 mt-10 -132.09 154.24 49.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.101 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 47' ' ' LEU . 24.5 mm -122.83 140.29 47.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -175.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 t -131.07 -0.88 4.11 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.56 142.16 7.94 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.22 -1.467 . . . . 0.0 113.952 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.613 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -104.0 117.3 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 123.632 0.773 . . . . 0.0 109.767 -179.059 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.566 ' ND2' HG13 ' A' ' 93' ' ' VAL . 64.9 t30 53.71 29.95 10.32 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.536 0.684 . . . . 0.0 111.016 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.614 ' HA2' ' CD2' ' A' ' 100' ' ' HIS . . . 100.66 -21.52 43.61 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.917 177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 5.8 ptm180 -100.59 142.97 31.32 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 117.801 0.8 . . . . 0.0 110.529 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.7 m -59.42 149.87 28.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.188 0.518 . . . . 0.0 111.332 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.46 HD11 ' H ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -90.62 -20.96 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.166 -179.01 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.24 -25.78 68.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.123 -170.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.99 -17.71 77.24 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.863 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -135.01 -139.27 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.321 0.56 . . . . 0.0 110.215 -176.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.433 ' OG1' ' HG3' ' A' ' 85' ' ' GLU . 47.1 p -137.67 157.89 45.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.628 -172.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.465 ' O ' HG21 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -48.04 -54.94 11.38 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.774 0.671 . . . . 0.0 112.588 -178.424 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.93 -39.67 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 120.895 0.378 . . . . 0.0 111.974 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.564 ' O ' ' HG3' ' A' ' 89' ' ' MET . 39.8 mt-10 -72.7 -36.62 67.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.934 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 83' ' ' LYS . 29.1 m -72.48 -41.36 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.347 -176.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.65 -37.01 67.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.027 170.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 57.1 tttm -64.76 -48.98 72.56 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.828 173.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.564 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 58.3 mtt -54.69 -40.56 69.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.107 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.565 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 20.1 mm -61.26 -55.48 24.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.087 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.51 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 10.4 pt20 -72.34 -23.13 61.1 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -176.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -67.45 -53.75 26.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.566 HG13 ' ND2' ' A' ' 74' ' ' ASN . 33.6 m -46.59 -32.33 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 23.9 tptm 70.87 123.88 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.292 0.568 . . . . 0.0 112.073 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.514 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 105.8 -59.16 0.42 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.151 -1.024 . . . . 0.0 113.588 172.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.5 pt-20 -135.47 178.72 6.82 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.149 0.5 . . . . 0.0 110.566 -170.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 m -148.38 151.09 13.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.0 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 p -139.73 99.98 3.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.33 0.586 . . . . 0.0 109.99 170.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -86.26 115.51 27.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.82 -176.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.614 ' CD2' ' HA2' ' A' ' 75' ' ' GLY . 4.7 m-70 -91.99 119.71 31.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.533 ' CE1' ' HE2' ' A' ' 103' ' ' LYS . 5.5 p90 -132.2 -170.16 2.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.61 -170.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.536 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 4.0 p-10 -151.01 150.77 31.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.319 173.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.533 ' HE2' ' CE1' ' A' ' 101' ' ' TYR . 48.1 mmtt -127.02 118.66 24.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.841 0.353 . . . . 0.0 111.653 -164.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.503 HD12 ' HG3' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -171.15 166.31 7.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.984 177.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -134.87 85.25 2.16 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.9 -179.07 7.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.492 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -124.43 150.75 65.36 Favored Pre-proline 0 C--O 1.21 -1.013 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -177.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.543 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 36.3 Cg_exo -32.76 -52.89 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.582 2.855 . . . . 0.0 113.965 -174.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.7 ptpt -55.97 -51.06 69.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.387 0.613 . . . . 0.0 111.978 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.527 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.3 mm100 -88.16 -3.9 58.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.729 0.776 . . . . 0.0 111.343 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.72 -49.11 6.65 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.622 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 7.4 pt-20 -68.73 -23.43 64.34 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.514 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 110' ' ' GLN . 3.9 p -69.54 -31.74 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.589 0.709 . . . . 0.0 110.101 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.84 -34.02 45.49 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.283 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -78.02 -45.91 22.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.529 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 61.38 91.35 0.06 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 122.571 1.177 . . . . 0.0 110.597 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.419 ' N ' ' CD ' ' A' ' 118' ' ' PRO . . . 161.45 50.56 0.02 OUTLIER Glycine 0 C--N 1.305 -1.19 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -174.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 117' ' ' GLY . 28.3 Cg_endo -57.93 122.94 12.58 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.425 2.75 . . . . 0.0 113.1 -168.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 68.73 21.78 7.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.465 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -109.11 39.3 2.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.36 0.6 . . . . 0.0 110.141 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 122' ' ' LEU . 24.5 p -86.41 -159.88 0.52 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.159 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.417 ' H ' ' HB ' ' A' ' 121' ' ' THR . 39.6 tp 61.22 50.84 4.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.673 0.749 . . . . 0.0 110.05 -177.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -99.92 166.02 11.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.076 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -71.39 115.68 10.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.411 ' CD1' HG22 ' A' ' 50' ' ' VAL . 10.5 m-90 -83.05 176.13 9.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.781 0.801 . . . . 0.0 112.402 -170.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.613 HD21 ' N ' ' A' ' 127' ' ' LYS . 9.1 tt -105.52 156.9 17.78 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.192 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.613 ' N ' HD21 ' A' ' 126' ' ' LEU . 19.8 pttp -155.13 120.88 5.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.478 0.656 . . . . 0.0 111.575 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.605 ' O ' HG13 ' A' ' 33' ' ' ILE . 12.5 p . . . . . 0 N--CA 1.446 -0.651 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.344 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 19.8 ptpt . . . . . 0 C--O 1.232 0.16 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.67 136.42 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -110.72 129.45 55.83 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.78 0.8 . . . . 0.0 110.72 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.19 -160.2 1.03 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.01 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -140.3 149.05 42.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.117 0.484 . . . . 0.0 110.104 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 3.3 mmmm -45.39 151.45 0.37 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.578 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -84.37 172.61 11.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.169 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.02 41.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 110.828 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.47 ' OE1' HD21 ' A' ' 32' ' ' LEU . 7.8 tt0 -92.47 8.43 38.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.982 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 40.1 t30 69.35 34.75 2.8 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.901 0.858 . . . . 0.0 110.583 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.595 HD22 ' OXT' ' A' ' 128' ' ' VAL . 1.5 pp -147.07 -164.4 1.99 Allowed 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.273 -0.571 . . . . 0.0 112.002 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.695 HD11 HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -104.07 -30.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.45 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 101.56 32.52 5.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.194 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.748 HD11 HG23 ' A' ' 128' ' ' VAL . 2.8 pp -126.83 -179.48 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.613 0.721 . . . . 0.0 112.61 -175.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 39.8 m -137.6 128.73 27.64 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.506 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.535 HG12 HD13 ' A' ' 35' ' ' ILE . 48.0 mm -111.04 125.43 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.649 0.738 . . . . 0.0 111.988 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.925 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 170.563 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.303 0 CA-C-O 122.128 0.966 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -94.27 -31.78 4.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.12 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -161.0 154.15 21.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.13 0.491 . . . . 0.0 110.088 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.8 p -143.45 160.77 16.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.922 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.504 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 80.4 m-85 -112.74 124.97 53.78 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 20.6 t70 -54.19 -27.36 33.58 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -165.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -101.0 6.93 43.69 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.184 0.516 . . . . 0.0 110.492 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 30.9 p -87.55 153.9 53.32 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.32 -40.2 78.69 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.211 1.274 . . . . 0.0 110.905 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -55.68 -49.49 72.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.803 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -77.68 -56.29 4.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.848 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.621 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.3 pp -52.74 -74.12 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -170.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.621 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 37.2 t70 -94.13 -9.11 37.58 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.563 1.173 . . . . 0.0 107.938 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -82.94 -51.73 4.11 Favored Glycine 0 C--N 1.311 -0.816 0 CA-C-N 113.093 -1.867 . . . . 0.0 113.458 -171.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 p 64.57 22.55 12.68 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.699 1.2 . . . . 0.0 111.143 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 99' ' ' ILE . 9.9 m -92.1 53.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 122.959 1.361 . . . . 0.0 109.74 172.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.6 179.81 7.04 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.552 -2.113 . . . . 0.0 111.736 -171.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.37 122.71 11.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.991 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.86 1.07 34.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.71 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.698 ' O ' HG22 ' A' ' 49' ' ' ILE . 51.5 t0 -98.48 152.73 19.22 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 33.6 tt0 -101.44 82.31 2.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.896 0.379 . . . . 0.0 110.692 -174.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.477 HD13 ' HB ' ' A' ' 49' ' ' ILE . 2.0 mp -74.18 101.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.679 0.752 . . . . 0.0 109.362 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.462 HG21 HD21 ' A' ' 102' ' ' ASN . 7.5 t -100.76 -15.8 17.54 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.649 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -147.78 148.03 19.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.6 -1.285 . . . . 0.0 113.457 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -108.76 115.31 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.161 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 9.7 t-20 52.21 37.17 21.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.218 0.532 . . . . 0.0 111.311 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.69 -22.45 39.66 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.833 -0.621 . . . . 0.0 113.927 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -106.13 129.29 54.24 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 117.726 0.763 . . . . 0.0 111.245 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.54 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 46.4 m -61.63 148.67 41.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.536 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.609 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -90.68 -25.52 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.265 0.555 . . . . 0.0 109.598 177.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -73.09 86.5 1.36 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.262 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.65 -25.7 0.17 Allowed Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.07 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -111.12 -117.04 0.3 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.942 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.478 ' O ' HG13 ' A' ' 86' ' ' VAL . 4.9 m -149.61 148.93 29.91 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.236 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.598 ' O ' HG22 ' A' ' 86' ' ' VAL . 5.5 mttt -47.81 -55.69 9.12 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.253 0.549 . . . . 0.0 111.976 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.06 -36.91 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.697 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.587 ' O ' ' HG3' ' A' ' 89' ' ' MET . 37.1 mt-10 -74.36 -37.21 63.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.261 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.609 HG11 ' HB ' ' A' ' 78' ' ' ILE . 27.3 m -67.35 -43.09 88.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.888 0.375 . . . . 0.0 111.087 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.07 73.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.203 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 59.8 tttm -61.48 -45.89 92.34 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.587 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 82.5 mtp -53.7 -37.21 63.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.402 0.62 . . . . 0.0 110.723 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.695 HD13 HD11 ' A' ' 33' ' ' ILE . 97.1 mt -77.23 -38.53 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.21 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -70.68 -29.33 65.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.625 0.25 . . . . 0.0 110.86 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -62.48 -48.73 78.31 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.628 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.3 m -69.75 82.5 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 122.772 1.272 . . . . 0.0 110.08 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -67.34 123.08 19.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.407 -173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.598 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 95.9 -21.17 46.43 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.431 169.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 97' ' ' VAL . 9.2 pt-20 -124.28 169.17 12.04 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.079 0.466 . . . . 0.0 109.885 -174.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 96' ' ' GLU . 2.8 t -159.15 125.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.501 -173.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 99.5 m -141.58 131.9 25.07 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 122.171 -0.33 . . . . 0.0 110.143 172.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.712 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -120.36 132.65 69.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.429 -176.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -100.46 129.42 46.41 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 69' ' ' GLU . 27.5 p90 -136.85 165.82 25.06 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.745 0.307 . . . . 0.0 111.341 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.462 HD21 HG21 ' A' ' 71' ' ' THR . 62.1 m-20 . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 . . . . . 0 C--O 1.215 -0.73 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -31.55 -55.88 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.752 2.968 . . . . 0.0 114.138 -172.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.0 ptpt -58.0 -45.9 86.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.524 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 71.0 mm-40 -86.57 -17.63 33.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.488 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.43 HD13 ' C ' ' A' ' 111' ' ' LEU . 3.3 tm? -74.26 -44.26 53.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.161 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -70.11 -26.58 64.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.484 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.4 t -72.53 -41.72 63.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.028 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.7 tp -72.41 -23.09 61.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.822 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.8 t80 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.308 -178.546 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.507 ' CG ' ' HB ' ' A' ' 37' ' ' ILE . 1.4 pp . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 10.9 ptmm? -150.98 145.85 25.84 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.357 0.599 . . . . 0.0 110.478 176.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.748 HG23 HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 168.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 64.4 pttt . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.538 0.209 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 62' ' ' GLY . 9.7 p -142.95 138.78 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.471 ' O ' HD13 ' A' ' 25' ' ' LEU . 12.0 t -110.89 127.36 55.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.445 0.64 . . . . 0.0 110.768 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.546 HD23 HD11 ' A' ' 99' ' ' ILE . 2.6 mm? -127.51 -170.39 2.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.432 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 80.5 mt-30 -129.98 136.55 49.56 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.238 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.721 ' HZ3' ' HA ' ' A' ' 91' ' ' GLN . 22.3 mmtp -45.16 149.27 0.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.712 1.258 . . . . 0.0 112.009 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 4.5 p-10 -89.89 -162.88 0.93 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.489 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.09 65.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.755 0.312 . . . . 0.0 111.555 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.461 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 54.3 mt-30 -88.43 0.84 55.82 Favored 'General case' 0 N--CA 1.425 -1.722 0 C-N-CA 122.931 0.492 . . . . 0.0 112.245 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 50.7 t30 71.3 18.47 5.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.51 0.671 . . . . 0.0 110.943 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.457 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 2.0 pp -126.58 -165.26 1.43 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.092 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.807 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -109.03 -22.27 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.674 -177.544 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.434 ' N ' HD13 ' A' ' 32' ' ' LEU . . . 98.48 35.05 5.08 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.878 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.552 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.7 pp -123.2 171.21 12.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.463 0.649 . . . . 0.0 110.698 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 46.2 m -130.72 131.92 45.06 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.375 175.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 41.2 mm -100.44 141.29 17.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.152 -176.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.806 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.117 -176.714 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 122.468 1.127 . . . . 0.0 110.369 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 m -108.73 -19.12 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.123 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 13.9 tp60 -157.3 143.55 17.88 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-O 121.023 0.439 . . . . 0.0 110.222 -171.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.5 p -145.31 160.93 12.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.015 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -98.64 -131.15 0.21 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.119 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -138.2 -44.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.538 ' HA ' HD23 ' A' ' 60' ' ' LEU . 46.7 m-80 -100.62 8.33 43.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.334 0.588 . . . . 0.0 109.78 -170.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.428 ' CB ' ' HA3' ' A' ' 34' ' ' GLY . 31.0 p -92.19 143.66 27.85 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.507 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 3.6 Cg_endo -44.96 -41.92 15.59 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 C-N-CA 122.551 2.167 . . . . 0.0 111.776 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -58.1 -54.76 43.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.419 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.713 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -71.8 -55.0 8.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.73 0.776 . . . . 0.0 109.807 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.3 tm? -42.45 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.235 -1.802 . . . . 0.0 113.273 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -98.8 -39.54 8.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.152 0.501 . . . . 0.0 111.914 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.426 ' O ' HG11 ' A' ' 23' ' ' VAL . . . -62.89 -27.33 70.04 Favored Glycine 0 C--O 1.228 -0.226 0 CA-C-N 115.14 -0.936 . . . . 0.0 114.631 -165.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 t 50.71 35.84 12.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.312 1.053 . . . . 0.0 111.39 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.633 HG11 HG13 ' A' ' 99' ' ' ILE . 20.6 m -100.14 51.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.345 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.33 177.77 8.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.222 -168.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.26 136.21 25.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.992 -170.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.82 56.32 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.6 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.532 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -104.12 165.49 11.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.025 0.44 . . . . 0.0 110.438 176.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -108.63 99.93 9.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.173 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 49' ' ' ILE . 28.7 mm -83.66 105.43 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 77' ' ' SER . 4.2 t -101.49 -15.26 17.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.315 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -139.93 136.36 7.73 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 119.762 -1.209 . . . . 0.0 113.655 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.692 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -103.97 120.54 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 123.376 0.67 . . . . 0.0 109.379 177.645 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.523 ' ND2' HG11 ' A' ' 93' ' ' VAL . 66.0 t30 54.1 29.91 11.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.481 0.658 . . . . 0.0 110.719 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.15 -21.35 44.92 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.755 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 2.7 ptp180 -104.22 131.2 51.79 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 117.874 0.837 . . . . 0.0 110.602 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' THR . 62.6 m -47.8 136.11 11.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.201 0.525 . . . . 0.0 112.151 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.691 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -76.1 -19.75 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.76 -174.022 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.04 -12.21 59.26 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.121 -173.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.58 -20.87 61.03 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.377 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 2.6 mptp? -107.67 -131.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.845 0.831 . . . . 0.0 110.275 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 86' ' ' VAL . 5.5 m -158.13 160.12 36.95 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' VAL . 12.8 mttt -47.01 -60.8 2.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.335 0.588 . . . . 0.0 111.756 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -55.0 -34.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.076 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.591 ' O ' ' HG2' ' A' ' 89' ' ' MET . 33.2 mt-10 -77.52 -43.47 31.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.679 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.651 HG11 ' HB ' ' A' ' 78' ' ' ILE . 19.7 m -58.42 -47.6 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -57.16 -38.75 74.03 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 25.6 ttpp -60.88 -56.92 15.45 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.591 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 16.5 mmt -48.63 -43.2 36.22 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.63 0.581 . . . . 0.0 111.146 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.517 HD13 HD11 ' A' ' 33' ' ' ILE . 64.2 mt -62.45 -55.12 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.465 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.721 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 10.4 pt20 -76.94 -22.12 53.78 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.985 -0.447 . . . . 0.0 111.459 -174.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.58 -52.68 23.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.411 0.684 . . . . 0.0 111.732 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.523 HG11 ' ND2' ' A' ' 74' ' ' ASN . 31.8 m -49.42 -36.26 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.543 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 67.62 134.55 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.464 0.649 . . . . 0.0 112.493 171.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.46 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 102.27 -48.25 1.08 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.938 172.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.0 pt-20 -146.03 178.79 7.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.058 0.456 . . . . 0.0 110.144 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.522 HG11 HG23 ' A' ' 33' ' ' ILE . 5.4 m -145.39 154.69 13.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.621 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.3 m -140.71 99.78 3.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 172.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.633 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -93.45 120.63 43.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.112 -175.399 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 4.1 t-160 -94.39 129.06 41.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 171.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -139.04 163.98 30.97 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.157 0.503 . . . . 0.0 111.815 -172.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 C--N 1.32 -0.707 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 175.489 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.451 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 20.2 t70 . . . . . 0 C--O 1.21 -1.021 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 13.6 Cg_exo -29.26 -51.48 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.251 3.301 . . . . 0.0 115.16 -173.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.1 pttp -59.51 -45.63 91.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.379 0.609 . . . . 0.0 111.759 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 84.3 mm-40 -85.76 -17.81 34.79 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.838 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.422 HD13 ' C ' ' A' ' 111' ' ' LEU . 3.2 tm? -73.25 -43.73 60.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.485 -175.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -69.18 -35.47 76.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.119 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 109' ' ' LYS . 81.0 t -64.71 -41.11 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.223 0.535 . . . . 0.0 109.991 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.85 -23.79 61.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.84 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 85.4 t80 . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.041 178.701 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.516 ' HG ' ' N ' ' A' ' 127' ' ' LYS . 61.6 tp . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 120.669 0.271 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 13.8 ptmm? -169.38 151.79 4.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.696 0.398 . . . . 0.0 110.69 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.807 ' OXT' HG13 ' A' ' 33' ' ' ILE . 14.5 p . . . . . 0 C--O 1.238 0.491 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.048 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 12.0 ptmm? . . . . . 0 CA--C 1.517 -0.319 0 CA-C-O 120.82 0.343 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 62' ' ' GLY . 14.6 m -128.16 154.19 38.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.938 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.7 t -116.35 123.6 48.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.546 0.689 . . . . 0.0 110.219 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.47 HD21 ' HA2' ' A' ' 62' ' ' GLY . 7.8 mt -122.34 -168.43 1.72 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.402 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 93.6 mt-30 -133.89 140.14 46.63 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.215 0.531 . . . . 0.0 110.642 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 10.0 mmtp -45.79 144.02 1.88 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.067 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -83.63 -179.39 7.31 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.439 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.77 -24.24 61.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 118.084 0.402 . . . . 0.0 111.363 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.425 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 11.5 tt0 -96.56 21.13 9.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 110.202 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.7 p30 57.17 23.45 8.63 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.121 1.369 . . . . 0.0 113.173 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.484 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -128.72 -165.43 1.5 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.797 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.763 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.7 -26.58 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.635 -178.014 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 98.28 41.9 3.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.093 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.519 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -130.06 172.6 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.947 0.879 . . . . 0.0 111.488 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m -141.41 129.41 21.96 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.712 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.453 HG23 HD13 ' A' ' 35' ' ' ILE . 6.9 pt -119.41 137.97 51.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.896 0.855 . . . . 0.0 111.022 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.221 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.853 -179.587 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.673 ' HB ' HD13 ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.475 0.655 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 m -117.66 -22.21 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.397 -175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -155.07 138.61 15.97 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.585 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.606 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.2 p -139.91 160.89 26.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.855 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -97.93 -137.79 0.28 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.429 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.44 -34.66 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -101.72 -0.56 34.28 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.998 0.428 . . . . 0.0 110.174 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 80.2 p -84.04 148.54 53.86 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.466 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 10.2 Cg_endo -52.06 -41.16 66.04 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.484 1.456 . . . . 0.0 110.991 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.52 -45.71 88.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.827 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.606 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.38 -59.56 2.67 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.411 0.624 . . . . 0.0 110.525 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.616 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.6 pp -54.87 -75.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.616 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 31.4 t70 -94.6 -13.06 26.33 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 122.581 1.181 . . . . 0.0 108.24 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -61.55 -40.34 98.57 Favored Glycine 0 C--N 1.314 -0.687 0 CA-C-N 112.464 -2.153 . . . . 0.0 114.804 -166.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.2 p 52.31 35.29 16.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.455 1.121 . . . . 0.0 111.197 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.647 HG11 HG13 ' A' ' 99' ' ' ILE . 15.9 m -122.79 53.66 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.174 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.62 179.67 7.33 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 112.649 -2.069 . . . . 0.0 111.319 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.34 123.05 15.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.696 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.64 -18.6 8.64 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.522 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.615 ' O ' HG22 ' A' ' 49' ' ' ILE . 11.9 m-20 -83.33 144.51 29.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.524 0.662 . . . . 0.0 110.532 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 41.9 mt-10 -94.52 97.0 9.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.924 -174.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.673 HD13 ' HB ' ' A' ' 49' ' ' ILE . 2.1 mp -76.01 138.26 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -127.89 -25.03 3.13 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.963 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.15 146.81 16.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.536 -1.316 . . . . 0.0 113.772 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.691 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -117.52 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.503 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 5.4 m-20 56.24 22.17 5.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.95 0.405 . . . . 0.0 111.786 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.83 -12.21 59.25 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.451 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.691 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 9.7 ptp180 -105.76 131.72 52.76 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 117.922 0.861 . . . . 0.0 110.861 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 p -61.06 138.08 58.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.133 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.689 HG23 HG12 ' A' ' 73' ' ' VAL . 1.1 pp -77.56 -24.16 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-O 122.391 1.091 . . . . 0.0 109.883 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.614 ' H ' HD12 ' A' ' 78' ' ' ILE . 3.5 tppp? -69.63 -19.27 63.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.068 -1.878 . . . . 0.0 109.878 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.56 -15.61 75.47 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.019 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.73 -142.26 0.17 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.662 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 86' ' ' VAL . 29.7 p -136.35 169.79 17.08 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.177 -0.209 . . . . 0.0 111.105 -169.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.468 ' HB3' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -49.02 -53.99 17.7 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.81 0.693 . . . . 0.0 112.443 -176.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.06 -39.82 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.624 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.07 -35.32 66.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 82' ' ' THR . 32.3 m -68.54 -46.1 80.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.209 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' HB2' HD13 ' A' ' 126' ' ' LEU . . . -58.33 -37.82 75.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.971 0.415 . . . . 0.0 110.171 172.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 91' ' ' GLN . 60.8 tttm -63.26 -53.13 57.8 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.847 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.484 ' O ' HG13 ' A' ' 93' ' ' VAL . 24.8 mmt -51.86 -42.48 62.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.25 0.548 . . . . 0.0 111.386 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.609 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 62.5 mt -64.78 -47.96 86.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.675 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.403 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 7.1 pt20 -73.78 -35.36 64.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.159 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -58.95 -50.1 75.35 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.526 0.516 . . . . 0.0 111.981 -173.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 89' ' ' MET . 17.8 m -52.99 -35.29 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.566 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 98.5 mttt 65.16 151.32 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.824 0.821 . . . . 0.0 112.802 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 88.3 -53.52 4.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.214 168.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.1 pt-20 -137.33 178.01 7.42 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.455 HG11 HG23 ' A' ' 33' ' ' ILE . 6.8 m -147.8 150.67 14.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.846 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.503 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 34.3 m -137.97 103.61 5.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.043 0.449 . . . . 0.0 110.182 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.647 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -94.45 129.81 44.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.338 -175.382 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -114.72 119.86 38.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.258 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -142.04 154.1 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.003 0.43 . . . . 0.0 110.893 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 17.3 m120 . . . . . 0 C--N 1.323 -0.563 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.592 ' OD2' ' HG2' ' A' ' 109' ' ' LYS . 10.5 t70 . . . . . 0 C--O 1.21 -1.007 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 9.2 Cg_exo -29.9 -47.77 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.693 2.929 . . . . 0.0 114.087 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.592 ' HG2' ' OD2' ' A' ' 107' ' ' ASP . 9.2 ptpp? -58.25 -49.61 76.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.232 0.539 . . . . 0.0 111.831 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.485 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 26.3 mm-40 -85.95 -11.59 52.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.714 0.769 . . . . 0.0 110.872 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.42 -43.89 22.47 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.142 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 115' ' ' PHE . 8.2 pt-20 -69.56 -22.07 63.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.191 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 109' ' ' LYS . 82.0 t -64.02 -35.24 72.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.403 0.62 . . . . 0.0 109.583 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.07 -27.66 54.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.81 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.453 ' HB3' ' HA ' ' A' ' 112' ' ' GLU . 13.7 t80 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.149 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 87' ' ' ALA . 1.6 pp . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 121.503 0.668 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -151.43 114.55 4.75 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.634 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.763 ' OXT' HG13 ' A' ' 33' ' ' ILE . 13.8 p . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 118.011 -0.995 . . . . 0.0 108.699 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 101' ' ' TYR . 63.8 mttm . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.498 HG23 HD11 ' A' ' 99' ' ' ILE . 32.7 m -140.26 161.35 25.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.138 0.494 . . . . 0.0 112.152 -162.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 t -122.91 123.87 41.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.389 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.443 ' CD2' HD11 ' A' ' 99' ' ' ILE . 2.4 mm? -118.15 -166.68 1.24 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.805 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.652 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 93.1 mt-30 -127.67 149.67 50.1 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.908 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 23.9 mmtp -52.14 146.26 9.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.749 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.46 179.93 7.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.807 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.99 -22.2 60.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.119 0.485 . . . . 0.0 111.044 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.522 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -92.18 8.7 36.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.033 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 38.6 t30 72.61 11.72 5.52 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.335 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.577 HD22 ' OXT' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -127.13 -168.07 1.83 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.945 -0.472 . . . . 0.0 111.887 -174.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.677 HG23 HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -101.83 -26.87 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.54 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 99.08 33.41 5.49 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.144 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.71 HD11 HG23 ' A' ' 128' ' ' VAL . 2.8 pp -125.72 172.38 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.692 0.758 . . . . 0.0 112.126 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 40.0 m -139.14 127.65 23.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.24 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.559 ' HB ' ' HG ' ' A' ' 126' ' ' LEU . 66.0 mt -106.56 120.23 57.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.891 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.673 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.434 177.583 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 122.124 0.964 . . . . 0.0 110.048 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.6 t -111.79 -23.36 4.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.942 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -147.5 143.4 27.81 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.663 0.744 . . . . 0.0 112.402 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.5 p -143.05 160.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.758 -1.564 . . . . 0.0 109.395 174.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.561 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 22.8 m-85 -116.86 126.06 52.45 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 34.9 t70 -57.46 -21.99 40.69 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -164.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.492 ' HA ' HD23 ' A' ' 60' ' ' LEU . 42.5 m-80 -101.38 6.17 42.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.228 0.537 . . . . 0.0 110.23 -173.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.561 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 28.3 p -96.98 149.12 35.35 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -48.28 -40.08 35.27 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.183 1.922 . . . . 0.0 111.804 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.54 -54.16 50.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.967 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -73.95 -54.82 7.08 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.036 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -42.85 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.831 -177.199 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -95.6 -36.27 11.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.329 0.585 . . . . 0.0 111.026 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.46 -38.61 95.02 Favored Glycine 0 CA--C 1.517 0.159 0 CA-C-N 115.211 -0.904 . . . . 0.0 114.39 -167.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.11 56.19 4.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.049 0.928 . . . . 0.0 110.819 -174.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.602 HG11 HG13 ' A' ' 99' ' ' ILE . 16.3 m -128.39 49.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.581 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.92 179.28 7.58 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.295 -167.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.19 123.56 7.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.036 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.96 20.5 11.29 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.63 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.2 t0 -107.97 161.77 14.64 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 4.2 mp0 -101.98 124.51 47.73 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.031 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.407 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 10.3 mm -113.31 141.89 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.465 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.568 HG22 ' CB ' ' A' ' 101' ' ' TYR . 12.0 t -137.44 -18.57 1.27 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.706 -0.621 . . . . 0.0 112.262 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -131.9 136.68 8.91 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.032 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.736 HG12 HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -101.15 121.86 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 124.011 0.925 . . . . 0.0 109.156 175.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.502 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 9.2 t-20 57.01 25.51 10.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.542 0.687 . . . . 0.0 110.355 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.87 -21.15 43.12 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.027 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -107.45 140.31 40.6 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 118.206 1.003 . . . . 0.0 111.024 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 23.1 t -52.93 137.12 33.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 111.755 -174.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.736 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -80.94 -17.83 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 109.499 -177.023 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -64.67 -13.58 54.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.523 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.71 -19.57 78.08 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.815 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.533 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.94 -130.7 0.14 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.732 0.766 . . . . 0.0 111.653 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 86' ' ' VAL . 2.8 m -139.11 156.09 47.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.565 -168.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.5 mtpt -47.85 -49.11 30.35 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.292 0.637 . . . . 0.0 111.676 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -58.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 122.454 1.121 . . . . 0.0 110.537 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 41.2 mt-10 -61.93 -30.95 71.25 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 112.94 -1.936 . . . . 0.0 112.615 -171.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.664 HG11 ' HB ' ' A' ' 78' ' ' ILE . 30.5 m -71.17 -42.26 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 126' ' ' LEU . . . -54.17 -41.18 68.2 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 170.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 28.5 ttpp -59.38 -48.48 81.48 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.616 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 89.0 mtp -51.97 -41.16 61.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.138 0.495 . . . . 0.0 110.866 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.551 HD13 HD11 ' A' ' 33' ' ' ILE . 92.6 mt -72.21 -41.28 66.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.231 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -76.05 -25.0 55.18 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.176 -0.327 . . . . 0.0 111.792 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.03 -51.66 65.91 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.52 151.2 8.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -132.05 144.42 50.74 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.151 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.1 -47.27 1.08 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.639 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 10.5 pt-20 -138.59 176.45 8.68 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.568 0.699 . . . . 0.0 111.182 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.677 HG11 HG23 ' A' ' 33' ' ' ILE . 5.5 m -149.65 158.29 6.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.06 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.502 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 24.7 m -142.41 125.08 15.87 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 170.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.602 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -102.9 139.22 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.553 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 0.8 OUTLIER -134.56 124.42 25.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.67 -179.464 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.568 ' CB ' HG22 ' A' ' 71' ' ' THR . 1.0 OUTLIER 169.98 -130.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 O-C-N 124.426 1.079 . . . . 0.0 110.014 166.236 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.519 ' HB2' ' CD1' ' A' ' 101' ' ' TYR . 4.5 m120 . . . . . 0 N--CA 1.443 -0.812 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -158.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 111' ' ' LEU . 8.4 m-20 . . . . . 0 C--O 1.213 -0.821 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -31.36 -48.79 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.68 2.92 . . . . 0.0 114.032 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -57.08 -48.95 77.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.57 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 61.9 mm-40 -90.42 -13.42 34.96 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.677 0.751 . . . . 0.0 110.327 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.4 tm? -76.21 -38.21 56.74 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.238 -175.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.53 -25.89 63.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.394 0.616 . . . . 0.0 109.528 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 110' ' ' GLN . 96.5 t -67.02 -44.18 88.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.572 173.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.71 -21.67 62.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.758 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 77.2 t80 . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.493 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.559 ' HG ' ' HB ' ' A' ' 37' ' ' ILE . 1.2 pp . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 13.7 ptmm? -152.56 129.72 11.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.394 0.616 . . . . 0.0 110.918 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.71 HG23 HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.016 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 167.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 22' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.71 0.767 . . . . 0.0 110.007 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 HD11 ' A' ' 99' ' ' ILE . 34.8 m -122.06 145.97 27.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.306 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.1 t -117.47 110.9 18.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.721 0.772 . . . . 0.0 110.312 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.49 -164.72 0.97 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.371 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 92.3 mt-30 -131.04 144.36 51.39 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.363 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 29.5 mmtm -47.91 149.65 1.3 Allowed 'General case' 0 C--N 1.316 -0.878 0 O-C-N 124.641 1.213 . . . . 0.0 111.841 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -83.04 -178.59 7.17 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.94 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.77 -19.24 49.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.422 0.63 . . . . 0.0 110.647 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.533 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 2.5 mt-30 -92.8 11.38 27.18 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.626 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 5.0 p30 56.82 24.07 8.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.013 1.325 . . . . 0.0 112.498 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.544 HD22 ' OXT' ' A' ' 128' ' ' VAL . 1.2 pp -130.57 -165.47 1.55 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.182 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.789 HG23 HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -101.75 -29.47 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 100.36 30.86 6.07 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.221 -0.514 . . . . 0.0 113.226 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.619 HD11 HG23 ' A' ' 128' ' ' VAL . 2.8 pp -122.85 179.71 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.061 0.457 . . . . 0.0 111.592 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 51.5 m -138.16 129.67 27.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.095 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.633 ' HB ' HD12 ' A' ' 126' ' ' LEU . 61.6 mt -97.46 139.47 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.854 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.049 -179.527 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 122.083 0.944 . . . . 0.0 110.503 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.9 t -105.03 -30.26 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.258 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 3.8 pt20 -157.05 152.54 26.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.7 p -141.84 160.54 20.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.845 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 97.3 m-85 -114.51 125.92 54.35 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.675 0.75 . . . . 0.0 108.978 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -53.07 -27.59 20.84 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 125.143 1.377 . . . . 0.0 114.566 -165.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.54 ' HA ' HD23 ' A' ' 60' ' ' LEU . 4.0 m-20 -100.85 4.14 42.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.26 0.552 . . . . 0.0 110.463 -171.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.494 ' CB ' ' HA3' ' A' ' 34' ' ' GLY . 30.4 p -91.3 146.82 34.18 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -47.41 -39.11 28.07 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.255 1.97 . . . . 0.0 111.659 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.49 -54.26 49.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.256 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.575 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -75.14 -52.97 9.67 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.388 0.614 . . . . 0.0 110.138 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.1 tm? -43.09 -75.62 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.502 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -96.83 -43.95 7.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.185 0.517 . . . . 0.0 111.479 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.3 -27.75 60.86 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 115.019 -0.992 . . . . 0.0 114.822 -164.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.48 48.31 19.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.868 0.842 . . . . 0.0 111.449 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.6 HG11 HG13 ' A' ' 99' ' ' ILE . 6.1 m -123.8 53.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 CA-C-O 122.936 1.351 . . . . 0.0 109.481 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.8 173.95 10.25 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 112.485 -2.143 . . . . 0.0 111.2 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -51.25 122.36 7.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.889 -174.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.06 -4.97 16.01 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.71 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.625 ' O ' HG22 ' A' ' 49' ' ' ILE . 76.1 m-20 -98.85 172.81 7.2 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 30.7 tt0 -130.72 145.7 52.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.932 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 70' ' ' ILE . 4.2 mp -114.12 128.5 71.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.316 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.67 ' H ' ' HB2' ' A' ' 101' ' ' TYR . 7.3 t -109.03 -4.81 16.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.054 0.454 . . . . 0.0 110.586 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.76 133.43 3.41 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.459 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.694 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -103.15 120.81 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.477 HD21 ' HA ' ' A' ' 90' ' ' ILE . 96.3 m-20 53.78 29.92 10.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.238 0.542 . . . . 0.0 111.704 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.57 -21.59 41.98 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.914 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 14.7 ptm180 -101.27 137.34 39.74 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 118.061 0.93 . . . . 0.0 110.789 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m -65.91 151.39 46.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.063 0.458 . . . . 0.0 111.228 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.896 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -93.47 3.48 8.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 122.455 1.121 . . . . 0.0 108.685 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -78.94 80.88 5.26 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.549 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.59 -30.49 0.41 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.688 -1.244 . . . . 0.0 115.012 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.896 ' HE2' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -112.35 -145.05 0.39 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.844 1.322 . . . . 0.0 112.088 -172.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.548 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -134.71 151.8 51.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.14 -178.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.611 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -45.44 -54.68 7.04 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.159 0.583 . . . . 0.0 112.341 175.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 p -51.69 -31.67 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.166 0.508 . . . . 0.0 111.981 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 89' ' ' MET . 32.4 mt-10 -81.89 -40.22 22.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.005 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.611 HG22 ' HA ' ' A' ' 83' ' ' LYS . 29.9 m -70.55 -38.25 72.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.538 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.746 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -53.17 -42.37 66.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.173 169.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -64.76 -50.77 65.51 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.717 175.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 62.4 mtt -50.74 -41.31 56.28 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.569 0.543 . . . . 0.0 111.045 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.752 HD13 HD11 ' A' ' 33' ' ' ILE . 74.4 mt -65.11 -56.42 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.254 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.407 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 10.3 pt20 -73.12 -24.59 60.64 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.713 -175.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.566 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 32.2 tt0 -58.7 -53.25 60.48 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.713 0.805 . . . . 0.0 111.976 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 90' ' ' ILE . 12.4 m -56.33 -29.02 27.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.292 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 92' ' ' GLU . 57.4 mttp 61.25 148.73 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.613 0.72 . . . . 0.0 112.609 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.409 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 86.55 -53.45 4.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.407 169.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 10.0 pt-20 -129.06 175.08 8.98 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.158 0.504 . . . . 0.0 110.19 -172.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.789 HG11 HG23 ' A' ' 33' ' ' ILE . 5.7 m -151.37 151.9 11.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.648 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.8 m -141.44 117.51 10.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.798 0.332 . . . . 0.0 110.741 170.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.6 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -98.63 148.74 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.17 176.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 1.1 m-70 -143.54 116.39 8.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.67 ' HB2' ' H ' ' A' ' 71' ' ' THR . 1.3 t80 178.63 -116.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.615 0.572 . . . . 0.0 111.139 162.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.443 -0.78 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.135 -163.901 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.443 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 15.2 t70 . . . . . 0 C--O 1.205 -1.237 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 15.6 Cg_exo -29.3 -51.74 0.17 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 124.537 3.491 . . . . 0.0 115.424 -174.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.7 pttm -57.77 -48.15 80.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.356 0.598 . . . . 0.0 111.716 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.9 mm100 -83.37 -17.8 41.06 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.519 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.4 tm? -64.74 -48.36 74.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.076 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 115' ' ' PHE . 3.4 pt-20 -70.54 -25.24 63.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.794 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.8 t -69.6 -45.62 77.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.435 0.636 . . . . 0.0 109.787 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.53 -17.28 58.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.137 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 43.4 t80 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.393 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.779 HD13 ' N ' ' A' ' 127' ' ' LYS . 1.5 tm? . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.779 ' N ' HD13 ' A' ' 126' ' ' LEU . 21.8 ptmt -167.0 127.13 1.5 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.532 0.682 . . . . 0.0 111.422 176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.845 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 163.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 62' ' ' GLY . 20.7 m -126.54 146.9 31.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.864 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 t -110.95 116.04 30.52 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.726 0.774 . . . . 0.0 110.77 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.502 ' H ' HG22 ' A' ' 97' ' ' VAL . 7.3 mt -123.32 -166.89 1.52 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.646 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.659 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 16.6 pt20 -144.01 142.6 30.78 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.766 174.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HE3' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -32.87 149.74 0.01 OUTLIER 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 177.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.46 -179.25 6.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.655 -1.612 . . . . 0.0 108.385 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.58 -29.04 61.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.59 0.632 . . . . 0.0 111.499 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.558 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.2 mt-30 -88.05 5.36 41.35 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.043 0.449 . . . . 0.0 110.603 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 63.9 t30 70.28 28.22 3.92 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.349 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.683 ' HB2' ' OXT' ' A' ' 128' ' ' VAL . 1.8 pt? -128.19 -171.26 2.41 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.785 175.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.841 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -104.58 -26.21 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.715 179.091 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' N ' ' HG ' ' A' ' 32' ' ' LEU . . . 96.17 40.43 4.01 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.386 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.548 HD11 HG12 ' A' ' 128' ' ' VAL . 2.9 pp -129.64 176.74 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.968 0.89 . . . . 0.0 112.305 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 24.0 m -144.72 126.87 15.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.731 172.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.5 mt -103.32 119.9 52.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.246 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.093 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.824 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.709 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.7 m -94.31 -20.51 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.691 -170.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -157.07 136.24 11.92 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.505 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.7 p -139.88 160.28 26.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.16 -138.55 0.2 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -138.24 -39.37 0.54 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.765 0.711 . . . . 0.0 112.145 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -101.32 4.09 41.3 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.762 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 59.9 p -84.14 148.04 52.27 Favored Pre-proline 0 N--CA 1.433 -1.285 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.0 Cg_endo -49.7 -42.18 43.93 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.764 1.643 . . . . 0.0 111.22 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.576 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.6 -46.48 84.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.019 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.76 -59.13 2.87 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.346 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.6 pp -51.16 -74.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -171.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.604 ' N ' HD12 ' A' ' 60' ' ' LEU . 21.7 t70 -93.74 -15.4 25.23 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.544 1.164 . . . . 0.0 108.081 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -64.39 -48.39 74.51 Favored Glycine 0 C--N 1.313 -0.704 0 CA-C-N 112.818 -1.992 . . . . 0.0 114.524 -166.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.1 p 63.64 15.78 9.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.078 0.951 . . . . 0.0 111.006 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.588 HG11 HG13 ' A' ' 99' ' ' ILE . 16.7 m -96.92 53.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-O 123.0 1.381 . . . . 0.0 110.028 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.21 168.52 14.69 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 112.512 -2.131 . . . . 0.0 111.39 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.66 122.54 6.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.832 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.64 -14.64 11.65 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.009 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.709 ' O ' HG22 ' A' ' 49' ' ' ILE . 43.4 m-20 -90.55 146.15 24.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.2 0.5 . . . . 0.0 110.167 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -89.4 126.48 35.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.682 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.5 mm -94.42 120.27 43.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -110.97 -21.68 11.88 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.832 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.78 156.06 27.72 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.398 -1.382 . . . . 0.0 113.869 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -121.9 124.63 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 C-N-CA 123.573 0.749 . . . . 0.0 109.186 178.181 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.466 ' HA ' ' OG1' ' A' ' 98' ' ' THR . 4.7 t30 58.28 22.57 9.43 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.583 0.706 . . . . 0.0 111.192 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.44 -20.01 50.23 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.109 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 11.3 ptp180 -101.99 130.17 48.46 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 117.292 0.546 . . . . 0.0 110.619 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.6 m -63.66 153.52 35.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.021 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -93.08 -30.93 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 110.417 -178.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -71.44 91.26 1.02 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.552 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.54 -21.51 0.33 Allowed Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.799 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -125.83 -131.08 0.25 Allowed 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.245 177.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -137.48 147.36 45.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.927 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.546 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -46.32 -49.49 17.55 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.598 0.759 . . . . 0.0 112.527 176.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -57.26 -39.9 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.831 0.348 . . . . 0.0 111.623 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.46 -41.48 66.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.943 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 83' ' ' LYS . 32.8 m -67.63 -45.21 85.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.897 0.38 . . . . 0.0 110.815 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.25 -34.59 75.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.261 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.61 -51.16 68.39 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.424 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.2 mmt -53.04 -36.65 60.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.62 0.724 . . . . 0.0 111.416 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.449 HD13 HD11 ' A' ' 33' ' ' ILE . 44.6 mt -72.64 -31.86 38.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.753 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -90.37 -23.51 21.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.8 -49.45 62.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.946 0.499 . . . . 0.0 111.097 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.88 -32.32 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.718 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 62.32 119.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.659 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 96.97 -33.22 5.9 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.194 173.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.3 pt-20 -134.86 178.76 6.77 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 117.177 0.489 . . . . 0.0 110.501 -171.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.581 HG12 ' HE3' ' A' ' 27' ' ' LYS . 1.2 m -152.48 148.74 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.159 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -141.27 106.93 5.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.469 172.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.588 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -100.0 141.99 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.051 0.453 . . . . 0.0 111.705 -178.003 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -118.5 121.36 40.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -136.52 174.73 10.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.053 0.454 . . . . 0.0 111.614 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--N 1.325 -0.472 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -177.001 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 C--O 1.215 -0.761 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -30.66 -55.39 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.915 3.077 . . . . 0.0 114.721 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.54 ' O ' HG23 ' A' ' 113' ' ' VAL . 5.9 ptpp? -56.48 -47.12 79.9 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.242 0.544 . . . . 0.0 112.311 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.481 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.3 mm100 -87.84 -17.02 32.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.895 -175.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 111' ' ' LEU . 3.4 tm? -77.8 -45.32 24.79 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.021 -177.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.92 -27.27 69.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.215 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 109' ' ' LYS . 77.0 t -61.0 -41.38 88.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.14 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.79 -24.61 41.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.544 0.688 . . . . 0.0 109.802 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.9 t80 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.413 -176.899 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.463 ' HB3' ' HE3' ' A' ' 83' ' ' LYS . 1.6 pp . . . . . 0 C--O 1.227 -0.113 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.452 ' C ' ' HD2' ' A' ' 127' ' ' LYS . 0.1 OUTLIER -143.49 154.49 43.7 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.841 ' OXT' HG13 ' A' ' 33' ' ' ILE . 7.1 p . . . . . 0 C--O 1.247 0.93 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.46 ' N ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.315 0 CA-C-O 120.634 0.254 . . . . 0.0 110.352 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.466 HG23 HD11 ' A' ' 99' ' ' ILE . 27.2 m -128.71 158.65 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.152 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.9 t -132.72 117.32 17.7 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.652 0.739 . . . . 0.0 110.656 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.11 -159.25 0.9 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.875 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -122.57 158.26 30.31 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.625 0.726 . . . . 0.0 110.114 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.589 ' NZ ' ' HA ' ' A' ' 91' ' ' GLN . 11.4 mmmm -54.4 156.69 3.17 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.082 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.57 174.97 7.47 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.3 -15.56 36.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.224 0.535 . . . . 0.0 110.556 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 31' ' ' ASN . 0.9 OUTLIER -91.38 -0.49 57.65 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.746 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.508 ' C ' ' HE2' ' A' ' 27' ' ' LYS . 31.1 t30 70.06 38.05 1.59 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.427 1.108 . . . . 0.0 109.897 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -154.57 -167.35 2.59 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.572 175.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.738 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.26 -28.93 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.945 -177.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 100.4 35.11 4.52 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.608 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.505 HG22 HG23 ' A' ' 52' ' ' VAL . 2.7 pp -126.92 177.96 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.269 0.557 . . . . 0.0 111.633 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -134.76 128.19 32.39 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.626 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.772 ' HB ' HD12 ' A' ' 126' ' ' LEU . 56.2 mt -107.47 140.79 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.469 0.652 . . . . 0.0 111.912 -173.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.978 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.536 ' HB ' ' CG1' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 122.531 1.158 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -95.62 -30.55 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.206 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -155.49 139.87 16.75 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.453 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.2 p -138.33 161.2 31.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -99.33 -135.05 0.28 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 15.7 t70 -138.4 -33.41 0.68 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -101.61 1.82 38.19 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.062 0.458 . . . . 0.0 110.366 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 77.9 p -85.33 150.18 53.92 Favored Pre-proline 0 N--CA 1.44 -0.956 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.16 -40.39 77.31 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.295 1.33 . . . . 0.0 111.197 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.42 -46.28 86.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.741 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.63 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -73.62 -58.4 3.33 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.672 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 61' ' ' ASP . 2.1 pp -52.95 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -170.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.647 ' N ' HD12 ' A' ' 60' ' ' LEU . 24.0 t70 -95.99 -16.32 21.75 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.262 1.029 . . . . 0.0 108.487 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -61.21 -38.71 96.09 Favored Glycine 0 C--N 1.315 -0.586 0 CA-C-N 113.019 -1.901 . . . . 0.0 113.594 -169.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p 52.31 38.38 24.76 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.415 1.102 . . . . 0.0 111.774 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.496 HG11 HG13 ' A' ' 99' ' ' ILE . 12.4 m -118.17 54.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.832 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.514 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -84.49 168.64 15.27 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 112.716 -2.038 . . . . 0.0 111.778 -170.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.89 132.09 26.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.669 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.0 2.64 57.03 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.648 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 101' ' ' TYR . 1.7 t70 -90.77 167.89 12.14 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.97 89.52 3.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.536 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 25.0 mm -78.34 110.0 13.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.893 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -102.3 -7.57 21.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.129 -175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -151.88 135.37 4.99 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.384 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.657 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -103.57 120.83 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 123.615 0.766 . . . . 0.0 109.217 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.3 t30 55.1 32.81 19.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.952 0.882 . . . . 0.0 110.472 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.83 -21.29 44.39 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.405 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.415 ' H ' ' HG2' ' A' ' 76' ' ' ARG . 2.5 ptm180 -108.17 138.58 44.2 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 117.132 0.466 . . . . 0.0 110.484 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.487 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 17.7 t -59.58 142.51 52.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.89 0.376 . . . . 0.0 111.892 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.657 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -74.89 -22.71 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -64.38 99.35 0.29 Allowed 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.814 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.2 -30.63 1.75 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.942 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.628 ' HE3' ' SD ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -125.26 -139.27 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.795 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -141.25 159.88 41.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.896 -169.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.586 ' O ' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -49.38 -52.79 26.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.503 0.502 . . . . 0.0 110.865 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -53.94 -38.71 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.893 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 34.2 mt-10 -76.28 -39.58 53.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.567 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 83' ' ' LYS . 34.7 m -69.61 -39.31 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.299 . . . . 0.0 111.389 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.54 -43.64 62.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.326 168.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 28.5 ttpp -61.59 -46.58 89.25 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.495 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.628 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 74.1 mtp -56.3 -35.14 67.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.43 0.633 . . . . 0.0 110.482 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 93' ' ' VAL . 27.9 mm -73.7 -32.3 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.387 177.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.589 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 47.9 mt-30 -82.74 -24.67 33.44 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.754 -0.591 . . . . 0.0 111.899 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -64.25 -39.49 94.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.286 0.634 . . . . 0.0 111.895 -171.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.536 HG23 ' N ' ' A' ' 94' ' ' LYS . 3.7 m -35.48 -47.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.114 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.536 ' N ' HG23 ' A' ' 93' ' ' VAL . 55.4 mtmt 57.08 83.29 0.1 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.496 -162.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.538 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 115.47 -36.73 3.75 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 118.785 -1.674 . . . . 0.0 113.675 164.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.486 ' O ' HG21 ' A' ' 93' ' ' VAL . 11.7 pt-20 -106.13 172.35 6.86 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 117.716 0.758 . . . . 0.0 110.127 -173.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 t -153.4 127.87 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.448 -171.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.0 m -141.04 135.75 31.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.496 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -130.87 140.67 48.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.801 0.334 . . . . 0.0 111.808 -177.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -116.99 122.57 44.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.411 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 40.2 p90 -138.85 157.16 46.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.073 0.463 . . . . 0.0 111.582 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m120 . . . . . 0 C--N 1.325 -0.475 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.19 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.501 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 16.7 m-20 . . . . . 0 C--O 1.215 -0.746 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 107' ' ' ASP . 12.8 Cg_exo -31.51 -46.86 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.904 2.403 . . . . 0.0 113.959 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.1 ptpt -68.83 -48.23 64.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.511 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.492 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 74.8 mm-40 -84.92 -11.77 54.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.438 0.637 . . . . 0.0 110.968 -174.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.434 HD13 ' C ' ' A' ' 111' ' ' LEU . 3.1 tm? -70.02 -43.37 71.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.339 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.16 -30.72 63.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.271 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' LYS . 84.3 t -63.71 -36.1 75.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.473 0.654 . . . . 0.0 109.902 175.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.6 tp -77.86 -27.02 49.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.244 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.8 t80 . . . . . 0 N--CA 1.465 0.275 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.075 -177.315 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.772 HD12 ' HB ' ' A' ' 37' ' ' ILE . 2.0 mt . . . . . 0 CA--C 1.497 -1.085 0 CA-C-O 121.291 0.567 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -157.51 80.75 0.89 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.194 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.738 ' OXT' HG13 ' A' ' 33' ' ' ILE . 9.1 p . . . . . 0 N--CA 1.438 -1.068 0 CA-C-O 117.575 -1.203 . . . . 0.0 108.724 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 62' ' ' GLY . 29.8 m -128.04 152.93 36.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.5 t -118.41 123.07 44.33 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.631 0.729 . . . . 0.0 110.571 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -130.51 -165.22 1.52 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.536 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -133.28 142.93 48.75 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.326 0.584 . . . . 0.0 110.513 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.63 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 2.5 mmmm -43.09 146.95 0.37 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.487 -1.688 . . . . 0.0 112.637 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -85.09 177.8 7.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.798 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.14 -21.77 48.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.909 0.385 . . . . 0.0 111.45 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -92.88 15.11 15.56 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.123 0.487 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.473 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 1.2 p-10 54.5 35.31 23.05 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.527 1.131 . . . . 0.0 111.583 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.708 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -140.76 -171.16 3.18 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.376 174.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.827 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -97.96 -31.07 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-O 120.682 0.277 . . . . 0.0 111.039 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' N ' HD13 ' A' ' 32' ' ' LEU . . . 102.5 37.64 3.22 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.324 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 2.3 pp -126.91 173.37 12.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.131 0.491 . . . . 0.0 110.72 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.4 m -134.86 130.55 36.16 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.782 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.796 ' HB ' HD12 ' A' ' 126' ' ' LEU . 40.7 mm -114.15 128.91 70.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.73 0.776 . . . . 0.0 111.838 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.995 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.582 179.556 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.02 -34.6 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.833 -170.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -155.84 144.41 20.25 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 120.764 0.316 . . . . 0.0 110.487 -171.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.7 p -139.14 160.18 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -92.02 -136.19 0.15 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.448 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 8.6 t70 -139.73 -38.26 0.47 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.617 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -100.91 3.87 42.15 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.036 0.446 . . . . 0.0 110.324 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 61.7 p -82.62 151.26 64.62 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.5 -40.75 71.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.299 1.333 . . . . 0.0 111.269 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -59.16 -44.31 92.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.255 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.646 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -78.33 -55.94 4.85 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.836 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.7 pp -52.66 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -171.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.607 ' N ' HD12 ' A' ' 60' ' ' LEU . 29.4 t70 -95.78 -12.73 24.89 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.441 1.115 . . . . 0.0 108.12 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -65.36 -45.46 90.54 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 112.969 -1.923 . . . . 0.0 113.497 -170.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p 62.93 9.51 3.77 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.069 0.948 . . . . 0.0 111.498 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.689 HG11 HG13 ' A' ' 99' ' ' ILE . 19.1 m -89.68 53.53 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 CA-C-O 123.001 1.382 . . . . 0.0 110.166 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.441 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -84.29 169.99 14.13 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.622 -2.081 . . . . 0.0 111.459 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.48 129.87 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.143 -174.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.7 -22.24 10.11 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.673 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.493 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -80.4 161.48 24.95 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.339 -177.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -110.44 120.89 43.88 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.8 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.0 mm -89.63 123.75 41.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.588 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.6 t -103.15 -29.77 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -163.51 151.16 20.54 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.905 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.607 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -107.72 122.53 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.442 ' ND2' HG11 ' A' ' 93' ' ' VAL . 5.2 m-20 50.62 31.6 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.66 -20.66 45.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.637 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 18.8 ptp180 -100.23 124.39 45.61 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 117.502 0.651 . . . . 0.0 110.279 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.402 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 21.1 m -61.15 149.83 36.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.999 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.604 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -81.76 -17.55 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.567 0.698 . . . . 0.0 109.55 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.69 -24.14 66.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.636 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.45 -12.69 80.0 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.182 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -137.35 -131.51 0.14 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.531 0.666 . . . . 0.0 110.619 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' HG13 ' A' ' 86' ' ' VAL . 4.3 p -146.8 166.09 27.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.364 0.126 . . . . 0.0 111.046 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.522 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -49.72 -53.33 25.4 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.662 0.601 . . . . 0.0 112.406 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -56.08 -37.73 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.66 -38.86 58.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.529 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.604 HG11 ' HB ' ' A' ' 78' ' ' ILE . 26.6 m -71.13 -44.03 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.955 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.21 62.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.289 170.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.21 -52.48 63.59 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.284 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.8 mmt -54.06 -43.23 70.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 0.0 112.02 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.95 -39.59 82.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.067 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.82 -36.16 57.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 122.362 -0.211 . . . . 0.0 111.443 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.83 -44.08 90.84 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.308 0.643 . . . . 0.0 110.892 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.8 m -70.18 71.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 122.878 1.323 . . . . 0.0 110.203 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.34 126.3 26.97 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.596 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.63 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 100.66 -27.16 21.8 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.515 170.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.16 171.87 9.48 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 117.39 0.595 . . . . 0.0 110.083 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.494 HG21 HG23 ' A' ' 33' ' ' ILE . 2.1 t -157.19 128.17 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.742 -171.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.4 m -140.32 106.47 5.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.038 0.447 . . . . 0.0 110.908 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.689 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -97.18 147.81 6.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.064 -177.524 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.88 123.38 28.86 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -133.65 144.76 49.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 0.0 111.421 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.326 -0.417 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.7 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.402 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 16.5 m-20 . . . . . 0 C--O 1.216 -0.692 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.54 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 22.4 Cg_exo -31.8 -52.57 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.678 2.919 . . . . 0.0 114.07 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.0 ptmt -62.25 -48.51 79.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.015 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.474 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 71.6 mm-40 -81.4 -19.45 42.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.712 0.768 . . . . 0.0 110.153 -174.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.31 -51.17 13.86 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.204 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 4.7 pt-20 -70.77 -34.6 71.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.879 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.465 ' N ' ' HG3' ' A' ' 112' ' ' GLU . 2.9 p -65.14 -38.37 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.283 -176.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.75 -28.04 36.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.511 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 56.2 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.508 -176.839 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.796 HD12 ' HB ' ' A' ' 37' ' ' ILE . 12.2 mt . . . . . 0 CA--C 1.489 -1.388 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -165.78 85.62 0.35 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 110.996 -2.82 . . . . 0.0 109.057 175.522 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.827 ' OXT' HG13 ' A' ' 33' ' ' ILE . 6.0 p . . . . . 0 C--O 1.246 0.872 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.287 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.6 pttm . . . . . 0 CA--C 1.518 -0.264 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.492 HG23 HD11 ' A' ' 99' ' ' ILE . 29.2 m -140.53 158.72 24.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 t -124.37 125.79 44.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.163 0.506 . . . . 0.0 110.751 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.44 -169.28 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.763 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 91.0 mt-30 -132.9 149.21 52.27 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.417 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.634 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 8.6 mmtp -47.24 146.37 1.93 Allowed 'General case' 0 C--N 1.313 -1.004 0 O-C-N 124.629 1.206 . . . . 0.0 112.344 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.427 ' HB2' ' HD2' ' A' ' 57' ' ' PRO . 27.2 t70 -82.88 177.94 8.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.115 176.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.03 -19.78 61.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.185 0.517 . . . . 0.0 110.419 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.49 3.84 51.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.241 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 71.9 15.72 5.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.68 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.516 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -131.43 -163.69 1.36 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.642 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.851 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.51 -23.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.8 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.86 36.13 4.87 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.918 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.51 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.6 pp -125.91 168.53 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.903 0.859 . . . . 0.0 111.564 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 44.9 m -134.43 131.77 38.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.499 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.685 ' O ' ' HB3' ' A' ' 126' ' ' LEU . 76.3 mt -117.75 130.67 72.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.57 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.323 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.633 175.729 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.347 0 CA-C-O 122.282 1.039 . . . . 0.0 109.497 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -98.43 -25.73 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.229 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.76 145.23 12.33 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.946 -172.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 59' ' ' ALA . 7.5 p -140.25 161.12 25.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -87.81 -138.03 0.1 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -137.48 -38.94 0.59 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 119.152 0.887 . . . . 0.0 112.641 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.552 ' HA ' HD23 ' A' ' 60' ' ' LEU . 4.6 m-20 -101.45 10.86 40.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.455 0.645 . . . . 0.0 109.854 -171.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 42.9 p -93.82 147.87 34.3 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 28' ' ' ASP . 8.5 Cg_endo -48.48 -39.97 36.74 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.215 1.943 . . . . 0.0 111.631 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.8 -53.57 56.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.141 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.589 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.98 -55.04 6.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.513 0.673 . . . . 0.0 109.946 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.1 tm? -42.73 -76.22 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.171 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -96.45 -38.3 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.052 0.453 . . . . 0.0 111.514 -177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.483 ' O ' HG22 ' A' ' 63' ' ' THR . . . -66.49 -27.29 73.04 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.746 -168.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 62' ' ' GLY . 5.8 t 52.44 25.44 3.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.456 1.103 . . . . 0.0 111.645 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.572 HG11 HG13 ' A' ' 99' ' ' ILE . 29.9 m -88.93 50.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 122.068 0.937 . . . . 0.0 109.761 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.44 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.01 175.27 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.204 -171.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.43 118.53 3.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.527 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.93 5.59 8.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.82 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.707 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -107.3 161.75 14.51 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 110.431 174.665 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 18.0 mm-40 -104.05 138.24 40.87 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.6 mm -118.55 134.01 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 123.104 0.252 . . . . 0.0 110.379 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 101' ' ' TYR . 14.9 t -132.74 -18.97 2.37 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.127 -0.358 . . . . 0.0 111.844 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -139.16 138.32 9.25 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.744 -1.217 . . . . 0.0 113.635 -178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.631 HG12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -105.53 123.15 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.532 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 17.4 t-20 59.1 23.23 11.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.914 0.864 . . . . 0.0 109.965 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.93 -20.24 48.67 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.552 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -105.32 136.58 44.58 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 117.888 0.844 . . . . 0.0 111.095 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 71' ' ' THR . 19.3 t -55.88 140.63 42.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.678 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.631 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -74.68 -17.57 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.731 0.777 . . . . 0.0 109.127 -177.03 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -63.47 -20.57 65.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.633 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.4 -17.32 76.32 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.365 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.625 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 1.7 mptp? -120.42 -136.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.914 0.864 . . . . 0.0 109.635 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.9 p -151.31 163.49 38.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.525 -1.671 . . . . 0.0 107.838 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.63 ' HB3' HD22 ' A' ' 126' ' ' LEU . 1.5 mtpt -48.02 -52.75 18.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.316 0.579 . . . . 0.0 111.793 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -56.67 -35.11 44.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.362 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 89' ' ' MET . 34.1 mt-10 -77.13 -46.54 23.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.614 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.586 HG11 ' HB ' ' A' ' 78' ' ' ILE . 24.0 m -59.05 -43.7 89.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -59.51 -35.59 74.45 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 173.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 38.8 ttpt -64.34 -51.26 64.25 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.474 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 82.2 mtp -48.15 -52.24 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.737 0.648 . . . . 0.0 111.136 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.634 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 62.6 mt -61.78 -46.69 95.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.029 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.434 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 8.7 pt20 -77.39 -29.03 53.0 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.211 -0.306 . . . . 0.0 111.564 -177.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -68.23 -48.0 66.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.3 m -50.31 -33.48 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.86 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt 67.15 137.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.669 0.747 . . . . 0.0 112.282 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.565 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 90.59 -50.07 3.2 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.404 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.3 pt-20 -125.82 176.49 6.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 117.256 0.528 . . . . 0.0 110.409 -172.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.48 HG11 HG23 ' A' ' 33' ' ' ILE . 14.2 m -150.88 150.85 13.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.804 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.532 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 1.7 m -141.83 107.58 5.12 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.904 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.572 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -90.8 138.87 18.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.902 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.61 124.42 15.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.658 ' HA ' HG22 ' A' ' 71' ' ' THR . 1.0 OUTLIER -174.66 -113.17 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.168 161.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 N--CA 1.444 -0.764 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.878 -169.336 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.212 -0.883 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -32.08 -52.6 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.818 3.012 . . . . 0.0 114.443 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.2 ptmt -55.82 -46.08 78.17 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.3 mm100 -89.63 -13.41 37.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.892 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.2 tm? -70.79 -40.95 72.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.313 -177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . 5.8 pt-20 -70.7 -24.38 62.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.258 0.552 . . . . 0.0 110.46 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.08 -45.54 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.042 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.2 mt -82.61 -3.42 56.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.365 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 9.4 t80 . . . . . 0 C--N 1.321 -0.66 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.36 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 87' ' ' ALA . 40.5 tp . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 120.99 0.424 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 22.9 pttp -156.82 139.75 15.3 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.635 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.851 ' OXT' HG13 ' A' ' 33' ' ' ILE . 14.4 p . . . . . 0 C--N 1.313 -1.003 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 HD11 ' A' ' 99' ' ' ILE . 33.5 m -138.35 147.72 25.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.815 0.34 . . . . 0.0 110.195 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -110.39 101.12 9.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.279 0.561 . . . . 0.0 110.465 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.538 HD11 ' HA3' ' A' ' 62' ' ' GLY . 10.6 mt -111.88 -170.22 1.61 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.736 -174.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 88.6 mt-30 -132.54 144.38 50.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.239 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.513 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 28.5 mmtm -50.25 158.37 0.57 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.676 -175.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 5.4 p-10 -89.82 -163.64 1.04 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.92 67.24 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.477 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.456 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 19.3 tt0 -92.56 9.46 34.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.663 0.268 . . . . 0.0 111.082 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 51.9 t30 66.66 30.0 8.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.75 0.786 . . . . 0.0 110.905 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 1.3 pp -133.05 -171.24 2.63 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 121.821 -0.55 . . . . 0.0 111.202 172.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.701 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.71 -27.96 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.973 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 103.68 28.39 6.0 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.942 -0.646 . . . . 0.0 113.046 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.557 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -121.65 174.12 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.762 0.791 . . . . 0.0 112.074 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 23.0 m -137.28 126.09 24.03 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.229 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.486 ' HB ' HD12 ' A' ' 126' ' ' LEU . 68.7 mt -98.46 140.16 18.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.72 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.926 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.24 -176.952 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -97.03 -21.38 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -168.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.48 141.93 10.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.182 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.1 p -141.16 160.75 22.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.994 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.546 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 92.5 m-85 -113.96 124.67 52.73 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 30.7 t70 -58.33 -23.4 56.55 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -165.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.457 ' HA ' HD23 ' A' ' 60' ' ' LEU . 46.7 m-80 -101.77 9.84 40.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.49 0.662 . . . . 0.0 110.09 -172.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.546 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 31.6 p -98.66 149.24 35.55 Favored Pre-proline 0 CA--C 1.502 -0.877 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -48.55 -38.63 36.18 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 121.946 1.764 . . . . 0.0 111.374 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.22 5.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.065 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.496 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.15 -53.2 13.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.453 0.644 . . . . 0.0 110.227 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -45.13 -74.3 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.629 -178.298 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -95.54 -35.5 11.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.611 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.538 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -74.79 -31.49 58.2 Favored Glycine 0 C--O 1.228 -0.26 0 CA-C-N 115.523 -0.762 . . . . 0.0 114.245 -168.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p 66.05 15.38 10.05 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.851 0.86 . . . . 0.0 110.674 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.545 HG11 HG13 ' A' ' 99' ' ' ILE . 6.1 m -85.78 53.98 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 CA-C-O 122.748 1.261 . . . . 0.0 110.518 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.89 176.39 8.51 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.942 -172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.94 104.34 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.716 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.06 -10.33 3.06 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.962 -175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.4 t70 -89.32 164.95 14.69 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.735 ' HB3' ' CD2' ' A' ' 101' ' ' TYR . 5.5 mp0 -107.89 134.85 50.23 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.497 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 5.4 mm -122.97 122.29 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.708 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 7.6 t -129.85 -10.19 4.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.72 0.295 . . . . 0.0 111.699 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.3 151.52 23.1 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.711 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.714 HG11 ' HB ' ' A' ' 86' ' ' VAL . 4.4 m -117.85 147.36 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 114.355 -0.923 . . . . 0.0 109.02 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 t30 60.92 19.53 9.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.425 0.631 . . . . 0.0 110.508 171.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.01 -10.33 70.08 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.12 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 14.9 ptp180 -121.27 143.73 49.01 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 117.156 0.478 . . . . 0.0 111.238 -174.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 m -52.49 146.39 9.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.525 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.754 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -76.09 -13.19 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 121.695 0.759 . . . . 0.0 109.2 -176.458 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -58.61 -17.33 21.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.074 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.91 67.78 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.982 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -142.45 -119.73 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.966 -0.138 . . . . 0.0 111.061 178.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.458 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 14.9 t -158.1 174.77 14.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.546 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -47.32 -60.02 2.79 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -175.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 82' ' ' THR . 6.6 p -54.51 -34.62 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 121.258 0.551 . . . . 0.0 111.779 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 40.0 mt-10 -78.68 -35.08 45.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.809 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG11 ' HB ' ' A' ' 78' ' ' ILE . 34.4 m -73.42 -38.94 54.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.539 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.96 -36.41 59.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.003 169.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 60.7 tttm -64.66 -50.08 68.46 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 84.5 mtp -53.99 -44.66 71.04 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.204 0.525 . . . . 0.0 111.237 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 93' ' ' VAL . 29.6 mm -55.28 -56.87 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.631 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.516 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 8.6 pt20 -76.07 -22.86 55.16 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -58.59 -50.65 73.02 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.032 0.533 . . . . 0.0 110.959 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 90' ' ' ILE . 13.2 m -60.1 -29.66 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.941 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp 63.45 143.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.001 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.498 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 87.94 -48.81 3.72 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.876 170.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.7 pt-20 -127.24 175.65 8.0 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 117.398 0.599 . . . . 0.0 110.125 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.513 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 9.2 m -147.92 155.54 9.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.838 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -142.37 99.87 3.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.712 0.292 . . . . 0.0 111.203 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.545 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -84.95 144.6 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -147.72 131.16 16.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.735 ' CD2' ' HB3' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -177.97 -114.62 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.172 162.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 1.4 t-20 . . . . . 0 N--CA 1.442 -0.865 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.583 -171.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.445 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 9.8 m-20 . . . . . 0 C--O 1.216 -0.661 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.618 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 37.7 Cg_exo -29.09 -60.61 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.899 3.066 . . . . 0.0 115.107 -167.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.482 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.6 pttp -65.54 -50.07 66.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.238 0.542 . . . . 0.0 111.866 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.482 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 12.4 pt20 -80.11 -7.94 59.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.853 0.835 . . . . 0.0 111.827 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 111' ' ' LEU . 1.8 tm? -90.04 -48.4 7.22 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.922 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 6.0 pt-20 -71.45 -24.86 62.09 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 110.864 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.1 p -68.15 -32.64 56.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.483 0.659 . . . . 0.0 109.708 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.43 -24.9 39.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.471 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 58.7 t80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.408 -179.206 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 127' ' ' LYS . 0.4 OUTLIER . . . . . 0 CA--C 1.509 -0.604 0 CA-C-O 121.351 0.596 . . . . 0.0 111.964 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' N ' HD13 ' A' ' 126' ' ' LEU . 19.2 ptmt -167.87 111.09 0.63 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.728 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.701 ' OXT' HG13 ' A' ' 33' ' ' ILE . 12.6 p . . . . . 0 N--CA 1.441 -0.896 0 CA-C-O 118.08 -0.962 . . . . 0.0 108.909 170.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.69 157.43 42.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 t -124.58 118.61 26.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.384 0.611 . . . . 0.0 110.563 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.467 ' CD2' HD11 ' A' ' 99' ' ' ILE . 2.3 mm? -119.92 -169.6 1.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.645 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 87.8 mt-30 -129.28 140.31 51.48 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.821 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HG2' ' C ' ' A' ' 95' ' ' GLY . 25.4 mmtp -45.9 148.79 0.74 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.336 -176.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -82.7 -179.01 7.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.585 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.64 55.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.192 0.52 . . . . 0.0 110.875 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.562 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -91.12 4.1 53.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.948 -179.691 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 37.8 t30 71.04 16.71 6.35 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.036 0.922 . . . . 0.0 111.133 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.607 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -128.31 -171.1 2.37 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.769 -0.582 . . . . 0.0 111.275 -179.45 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.726 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.37 -29.23 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.604 -177.65 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.26 27.18 5.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.745 . . . . 0.0 113.125 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.442 HG22 HG23 ' A' ' 52' ' ' VAL . 2.7 pp -119.17 173.85 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.333 0.587 . . . . 0.0 111.839 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 36.3 m -134.65 129.92 35.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.517 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.524 ' H ' ' HB3' ' A' ' 126' ' ' LEU . 63.3 mt -104.03 145.07 13.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.518 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.031 -179.85 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 122.215 1.007 . . . . 0.0 109.856 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.3 -29.98 4.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.257 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 4.0 pt20 -164.31 156.29 16.43 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.3 p -141.99 161.67 20.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.263 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.554 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 89.9 m-85 -113.67 123.63 50.38 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -55.23 -25.81 35.62 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.115 -165.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.509 ' HA ' HD23 ' A' ' 60' ' ' LEU . 47.8 m-80 -102.41 8.39 40.16 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.169 0.509 . . . . 0.0 110.616 -172.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 32.0 p -96.72 150.32 36.81 Favored Pre-proline 0 CA--C 1.503 -0.844 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.51 -37.67 42.73 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 121.789 1.659 . . . . 0.0 111.396 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -57.36 -57.35 13.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.108 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.552 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -73.61 -52.6 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.451 0.643 . . . . 0.0 110.121 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -45.39 -75.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.806 -1.543 . . . . 0.0 112.743 -177.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -96.59 -33.12 11.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.157 0.503 . . . . 0.0 111.5 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.25 -28.77 63.39 Favored Glycine 0 C--O 1.228 -0.275 0 CA-C-N 115.663 -0.699 . . . . 0.0 114.236 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p 64.57 14.41 8.95 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.994 0.917 . . . . 0.0 111.403 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.73 HG11 HG13 ' A' ' 99' ' ' ILE . 6.9 m -84.98 54.56 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 CA-C-O 122.578 1.18 . . . . 0.0 111.284 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.17 173.2 10.6 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.469 -172.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -55.8 113.41 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.163 -173.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.12 -16.37 4.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.446 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.667 ' O ' HG22 ' A' ' 49' ' ' ILE . 1.7 m-20 -96.86 154.62 17.19 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 117.597 0.698 . . . . 0.0 110.746 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 38.3 tt0 -90.7 80.86 5.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.529 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.502 HD13 ' HB ' ' A' ' 49' ' ' ILE . 1.8 mp -68.85 92.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 77' ' ' SER . 9.0 t -96.08 -14.05 23.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.595 -170.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -143.83 137.27 7.35 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 119.367 -1.397 . . . . 0.0 113.629 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -104.79 119.02 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.549 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 16.9 t-20 55.03 32.18 17.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.413 0.625 . . . . 0.0 110.613 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.86 -21.28 46.73 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.643 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -102.76 126.91 50.06 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 117.725 0.762 . . . . 0.0 110.991 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.505 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 29.9 m -57.79 145.81 33.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.72 -176.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.575 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -81.32 -18.51 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.546 0.689 . . . . 0.0 109.602 -179.213 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -63.04 -24.19 67.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.877 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.44 -14.85 81.72 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.936 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.22 -132.31 0.15 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.409 0.604 . . . . 0.0 110.718 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -143.64 152.26 41.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.112 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.493 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.4 ptpt -43.43 -59.36 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.96 0.504 . . . . 0.0 112.272 176.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.5 p -53.97 -34.87 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.842 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 89' ' ' MET . 33.7 mt-10 -76.93 -42.44 39.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.557 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.555 HG11 ' HB ' ' A' ' 78' ' ' ILE . 33.6 m -66.8 -40.11 85.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.643 -175.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.596 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -52.57 -41.42 63.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.429 170.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -66.44 -45.94 78.13 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.197 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 59.4 mtt -54.62 -35.17 63.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.398 0.618 . . . . 0.0 110.765 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 33' ' ' ILE . 65.3 mt -75.33 -48.84 29.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.186 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.493 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 86.4 mt-30 -63.6 -41.06 98.36 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.03 -45.44 85.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.441 -169.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 90' ' ' ILE . 25.9 m -54.63 -31.42 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.295 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? 65.93 130.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 170.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.499 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 97.77 -47.91 1.51 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.517 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.0 pt-20 -136.48 176.83 8.34 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.188 0.518 . . . . 0.0 110.406 -172.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.6 HG11 HG23 ' A' ' 33' ' ' ILE . 5.4 m -147.43 153.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.862 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 30.8 m -142.4 115.77 9.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.73 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -111.1 123.63 67.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.269 -175.372 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -98.67 123.69 43.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 69' ' ' GLU . 17.0 p90 -141.96 139.95 32.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.577 0.703 . . . . 0.0 112.006 -173.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.469 HD21 HG21 ' A' ' 71' ' ' THR . 27.4 m-20 . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.127 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 C--O 1.211 -0.926 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 19.4 Cg_exo -29.97 -51.99 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.009 3.14 . . . . 0.0 114.958 -171.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.532 ' HG3' ' HG3' ' A' ' 110' ' ' GLN . 59.3 pttt -57.16 -44.48 83.53 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.517 0.675 . . . . 0.0 112.285 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.532 ' HG3' ' HG3' ' A' ' 109' ' ' LYS . 96.9 mt-30 -85.98 -27.74 24.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.632 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.5 tm? -66.55 -49.52 66.18 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.221 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 5.2 pt-20 -60.07 -31.68 70.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.1 0.476 . . . . 0.0 110.69 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 109' ' ' LYS . 68.8 t -64.52 -47.41 89.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.512 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.01 -13.61 57.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.496 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 20.9 t80 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.859 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.596 HD11 ' HB2' ' A' ' 87' ' ' ALA . 1.1 tm? . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.584 ' N ' HD13 ' A' ' 126' ' ' LEU . 19.8 ptmt -161.94 112.98 1.64 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.143 0.497 . . . . 0.0 110.429 -174.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.726 ' O ' HG13 ' A' ' 33' ' ' ILE . 13.1 p . . . . . 0 N--CA 1.437 -1.122 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.009 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 99' ' ' ILE . 7.7 p -147.57 158.46 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -170.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.66 HG22 HG22 ' A' ' 98' ' ' THR . 24.5 p -124.52 121.78 35.76 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 122.2 -0.313 . . . . 0.0 111.083 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.549 ' CD2' HD11 ' A' ' 99' ' ' ILE . 2.7 mm? -121.16 -165.78 1.27 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 8.4 pt20 -141.23 158.19 44.23 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.081 174.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 31' ' ' ASN . 31.1 mmtm -52.77 155.86 2.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.955 -1.02 . . . . 0.0 113.129 -172.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -85.57 -179.53 6.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.794 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.97 -21.01 60.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.619 0.645 . . . . 0.0 111.095 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.491 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -91.22 2.28 56.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.101 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.485 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 54.8 t30 70.55 35.7 1.85 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.247 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.608 HD22 ' OXT' ' A' ' 128' ' ' VAL . 2.1 pp -140.56 -170.66 3.05 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.841 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.744 HG23 HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -104.78 -25.45 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.981 -175.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 92.78 35.4 6.46 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.511 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.793 HD11 HG23 ' A' ' 128' ' ' VAL . 2.9 pp -123.01 178.96 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.738 0.304 . . . . 0.0 110.617 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 64.4 m -128.47 135.29 49.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.085 0.469 . . . . 0.0 111.135 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.442 ' HB ' HD23 ' A' ' 126' ' ' LEU . 34.9 mm -102.29 138.77 25.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.144 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.45 178.6 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 122.456 1.122 . . . . 0.0 109.615 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.0 t -86.84 -35.54 8.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.408 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.737 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 11.3 pt20 -165.57 163.53 19.36 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -173.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.5 p -141.29 159.82 22.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.132 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.521 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 50.1 m-85 -116.09 122.97 46.72 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.74 0.781 . . . . 0.0 108.907 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.47 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 7.5 m-20 -58.2 -18.94 29.57 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.324 1.45 . . . . 0.0 114.641 -164.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -102.89 6.06 38.87 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.97 0.414 . . . . 0.0 110.513 -174.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 13.1 p -102.59 151.53 38.26 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -176.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.18 -39.94 42.27 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.086 1.857 . . . . 0.0 111.779 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.02 -54.02 49.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.027 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.653 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -76.6 -53.03 8.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.497 0.665 . . . . 0.0 110.277 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER -44.22 -75.01 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.522 -176.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -96.66 -32.06 12.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.14 0.495 . . . . 0.0 111.637 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.476 ' CA ' HD21 ' A' ' 25' ' ' LEU . . . -72.84 -38.97 56.07 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.923 -0.656 . . . . 0.0 114.542 -167.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p 64.77 21.72 12.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 122.0 0.905 . . . . 0.0 110.897 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.743 HG11 HG13 ' A' ' 99' ' ' ILE . 3.8 m -88.02 56.43 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.193 176.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.64 -179.76 7.2 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.786 -168.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.737 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -57.43 139.46 53.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.722 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.89 -9.51 29.67 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.51 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -96.8 174.81 6.61 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.584 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -123.13 95.19 4.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.466 0.651 . . . . 0.0 110.377 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.9 mm -69.96 114.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.587 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 102' ' ' ASN . 6.4 t -88.11 -34.84 17.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.42 156.63 26.81 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.468 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.662 ' CG1' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -131.1 129.4 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 59.64 26.29 15.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.639 0.733 . . . . 0.0 110.037 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.55 -20.1 50.14 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.256 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -107.93 135.04 49.98 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 117.092 0.446 . . . . 0.0 111.732 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m -63.49 148.15 49.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.472 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.662 HG23 ' CG1' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -93.0 -25.67 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 CA-C-O 122.93 1.347 . . . . 0.0 109.625 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.568 ' H ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -57.88 -24.46 57.75 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.189 -2.278 . . . . 0.0 110.339 -178.415 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.8 -17.64 76.91 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.642 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.478 ' H ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -129.53 -134.87 0.22 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.062 0.931 . . . . 0.0 112.079 -176.212 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.564 ' O ' HG13 ' A' ' 86' ' ' VAL . 60.5 p -135.89 166.13 24.03 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.573 -0.079 . . . . 0.0 110.839 -169.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.625 ' HB3' HD22 ' A' ' 126' ' ' LEU . 16.6 mttt -49.1 -57.69 6.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.542 0.687 . . . . 0.0 111.919 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.47 -39.68 54.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.828 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 89' ' ' MET . 34.6 mt-10 -75.29 -37.91 60.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 82' ' ' THR . 30.0 m -67.05 -45.39 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.61 -176.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.68 ' O ' ' HG3' ' A' ' 91' ' ' GLN . . . -58.9 -43.05 90.91 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 172.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -61.63 -45.63 93.24 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.199 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 86.4 mmm -51.6 -42.33 61.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.615 HD13 HD11 ' A' ' 33' ' ' ILE . 85.9 mt -65.64 -46.89 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.609 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.68 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 59.5 mt-30 -60.45 -46.77 88.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.117 0.484 . . . . 0.0 110.979 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -61.71 -50.91 70.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.498 -167.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 89' ' ' MET . 14.8 m -52.99 -32.92 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm 61.79 137.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.442 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 95.03 -51.78 1.91 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.741 167.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.6 pt-20 -133.83 178.71 6.73 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -174.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.744 HG11 HG23 ' A' ' 33' ' ' ILE . 9.5 m -150.05 148.23 15.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.784 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.66 HG22 HG22 ' A' ' 24' ' ' THR . 12.9 p -134.51 109.46 8.72 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.743 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -102.15 126.82 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.31 0.576 . . . . 0.0 111.524 -173.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -108.17 117.16 33.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.182 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.606 ' CE1' HG12 ' A' ' 64' ' ' VAL . 1.1 m-30 -74.0 162.2 29.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.318 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.432 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 O-C-N 124.624 1.202 . . . . 0.0 108.464 175.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.483 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 10.4 t70 . . . . . 0 C--O 1.216 -0.667 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 16.6 Cg_exo -29.45 -49.84 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.902 3.068 . . . . 0.0 114.269 -176.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 19.1 ptpt -57.99 -47.65 82.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.239 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 14.9 mm100 -87.02 -19.96 27.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.449 0.642 . . . . 0.0 110.355 -176.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.416 HD13 ' C ' ' A' ' 111' ' ' LEU . 3.4 tm? -73.0 -43.12 62.54 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.276 -175.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -66.36 -31.43 72.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.889 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 109' ' ' LYS . 74.3 t -66.59 -39.77 84.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.205 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 110' ' ' GLN . 76.1 mt -70.65 -24.05 62.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.759 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 27.6 t80 . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.125 178.952 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' A' ' 83' ' ' LYS . 51.5 tp . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 4.9 pttp -166.26 161.99 17.1 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.239 0.542 . . . . 0.0 110.862 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.793 HG23 HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.778 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 165.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 25.7 pttm . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 62' ' ' GLY . 33.8 m -131.09 146.74 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.5 t -103.8 98.88 8.66 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.788 0.804 . . . . 0.0 110.378 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.493 HD11 ' HA2' ' A' ' 62' ' ' GLY . 16.6 mt -110.48 -163.83 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.753 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 18.9 pt20 -150.53 156.3 41.15 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.176 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.574 ' HE2' ' C ' ' A' ' 31' ' ' ASN . 10.0 mmmm -52.4 146.77 9.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.639 0.733 . . . . 0.0 111.938 -174.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -85.65 173.67 9.96 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.355 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.2 -20.79 56.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.118 0.485 . . . . 0.0 110.453 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -85.59 -1.26 56.94 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.032 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.574 ' C ' ' HE2' ' A' ' 27' ' ' LYS . 15.4 t30 69.01 37.52 2.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.734 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.484 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -154.22 -163.31 1.59 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.897 173.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.729 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.55 -24.27 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.494 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.44 40.71 3.6 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.761 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.531 HG22 HG23 ' A' ' 52' ' ' VAL . 2.6 pp -131.89 171.95 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.855 0.836 . . . . 0.0 111.633 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.1 m -140.59 126.5 19.41 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.161 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.922 HG22 ' H ' ' A' ' 38' ' ' GLY . 26.3 mt -122.72 -168.64 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -176.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.922 ' H ' HG22 ' A' ' 37' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.814 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 121.915 0.864 . . . . 0.0 109.27 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.18 -30.65 5.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.739 -171.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.64 142.77 15.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.976 0.417 . . . . 0.0 111.401 -172.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.4 p -140.56 160.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.011 173.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -97.34 -133.8 0.23 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.52 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 6.0 t70 -141.15 -33.3 0.53 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -101.24 0.93 38.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.971 0.415 . . . . 0.0 110.347 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 68.0 p -84.17 151.54 60.17 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 8.4 Cg_endo -53.28 -41.27 73.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.239 1.292 . . . . 0.0 111.024 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.513 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.48 -47.58 81.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.996 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.636 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.69 -56.81 4.74 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.68 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.8 pp -55.77 -75.7 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -171.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.631 ' N ' HD12 ' A' ' 60' ' ' LEU . 37.5 t70 -94.76 -13.38 25.74 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 122.546 1.165 . . . . 0.0 108.37 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -64.57 -51.16 54.54 Favored Glycine 0 C--N 1.312 -0.785 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.038 -169.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.4 p 56.95 42.76 25.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.731 1.253 . . . . 0.0 110.321 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.609 HG11 HG13 ' A' ' 99' ' ' ILE . 29.5 m -119.23 47.81 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 112.684 -2.053 . . . . 0.0 108.789 173.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.13 173.71 10.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.569 -170.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.77 108.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.674 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.92 -17.75 3.41 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.68 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 49' ' ' ILE . 18.3 m-20 -90.54 156.88 17.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.081 0.441 . . . . 0.0 110.928 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -114.9 98.26 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.365 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 70' ' ' ILE . 2.8 mp -72.82 114.67 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.076 0.465 . . . . 0.0 110.38 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -97.5 -12.42 22.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.551 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' HG23 ' A' ' 78' ' ' ILE . . . -161.17 144.75 10.15 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 119.529 -1.319 . . . . 0.0 114.143 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.823 HG13 HG22 ' A' ' 78' ' ' ILE . 5.0 m -100.79 140.56 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 CA-C-N 114.533 -0.833 . . . . 0.0 109.809 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.2 t30 53.89 29.17 9.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.826 0.822 . . . . 0.0 111.173 164.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.24 59.19 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.392 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -126.73 149.38 49.63 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.132 0.966 . . . . 0.0 111.903 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 m -57.1 148.46 21.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.454 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.823 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -85.6 -19.03 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.281 0.562 . . . . 0.0 111.076 -172.345 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -67.73 -7.53 27.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.301 -170.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.58 -27.95 73.57 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.224 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -139.14 -139.77 0.14 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 117.234 0.517 . . . . 0.0 111.847 -177.065 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.83 160.73 33.55 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -168.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HA ' HG22 ' A' ' 86' ' ' VAL . 2.5 pttt -46.87 -52.65 13.89 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.59 -35.09 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 121.047 0.451 . . . . 0.0 111.564 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 89' ' ' MET . 29.7 mt-10 -79.9 -40.33 28.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.553 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG11 ' HB ' ' A' ' 78' ' ' ILE . 27.7 m -63.41 -40.03 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.606 0.241 . . . . 0.0 111.44 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 91' ' ' GLN . . . -56.3 -45.16 80.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.437 171.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.74 -40.3 96.4 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 120.75 0.31 . . . . 0.0 110.7 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 24.9 mmt -51.22 -32.92 25.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.57 0.7 . . . . 0.0 110.927 174.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.704 HG21 HD11 ' A' ' 33' ' ' ILE . 88.6 mt -90.42 -18.44 7.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.077 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 50.4 mt-30 -87.6 -14.78 39.17 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.901 -0.499 . . . . 0.0 111.546 173.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.27 -40.53 15.44 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.12 0.962 . . . . 0.0 108.969 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -43.44 120.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.932 169.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -82.66 86.48 6.84 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.666 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 108.91 -25.16 19.72 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 118.575 -1.774 . . . . 0.0 113.923 162.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 8.6 pt-20 -125.57 173.4 8.98 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 117.947 0.874 . . . . 0.0 110.332 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.3 m -155.8 154.92 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.861 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.13 117.12 11.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.072 0.463 . . . . 0.0 110.367 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.609 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -106.25 115.49 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.902 -176.138 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -102.11 121.95 43.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.41 ' CE1' HG12 ' A' ' 64' ' ' VAL . 50.0 p90 -146.65 160.79 41.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.729 0.776 . . . . 0.0 112.595 -173.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.422 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 111' ' ' LEU . 7.5 m-20 . . . . . 0 C--O 1.207 -1.135 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -31.31 -60.33 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.955 3.103 . . . . 0.0 114.529 -171.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.514 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.2 ptmt -61.35 -44.95 96.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.676 0.75 . . . . 0.0 111.716 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.514 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 70.2 mm-40 -80.39 -9.62 59.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.844 -175.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.1 tm? -90.5 -51.74 5.25 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.471 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.5 -30.85 70.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.485 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.419 HG12 ' C ' ' A' ' 110' ' ' GLN . 4.1 p -69.1 -31.97 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.561 0.696 . . . . 0.0 109.817 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 114' ' ' LEU . 3.2 tm? -75.08 -28.73 60.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.547 176.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.6 t80 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.648 -178.983 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.641 HD13 ' HB ' ' A' ' 37' ' ' ILE . 8.6 tt . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.561 ' N ' HD23 ' A' ' 126' ' ' LEU . 22.0 ptmt -150.54 123.73 8.87 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.353 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.729 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.8 p . . . . . 0 N--CA 1.437 -1.085 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.318 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.602 HG11 ' O ' ' A' ' 62' ' ' GLY . 7.7 p -132.72 143.72 38.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.463 ' O ' HD13 ' A' ' 25' ' ' LEU . 11.6 t -113.78 130.49 56.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.437 0.637 . . . . 0.0 110.935 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.625 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.8 mm? -132.56 -167.5 1.91 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.561 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.419 ' O ' ' HG3' ' A' ' 57' ' ' PRO . 97.0 mt-30 -132.29 155.98 47.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.717 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 37.0 mmtt -46.54 145.15 1.92 Allowed 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.762 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.06 -178.87 5.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.262 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.2 -22.13 65.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.439 0.637 . . . . 0.0 110.306 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.496 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -93.12 11.22 28.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.72 0.772 . . . . 0.0 109.607 178.026 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 1.1 p-10 60.28 16.1 5.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.311 -1.768 . . . . 0.0 113.049 176.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -115.93 -159.98 0.74 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.507 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.705 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -110.93 -22.89 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 118.755 0.707 . . . . 0.0 111.596 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 96.17 38.54 4.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.744 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.511 HG22 HG23 ' A' ' 52' ' ' VAL . 2.8 pp -130.76 173.89 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.844 0.83 . . . . 0.0 112.122 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 126' ' ' LEU . 20.7 m -138.81 125.78 21.16 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.262 -1.335 . . . . 0.0 109.742 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.488 ' HB ' HD21 ' A' ' 126' ' ' LEU . 61.1 mt -124.94 131.01 73.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.504 0.668 . . . . 0.0 112.716 -173.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.05 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.572 172.603 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 122.175 0.988 . . . . 0.0 110.719 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.6 t -102.31 -30.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.305 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -150.32 138.66 20.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 120.84 0.352 . . . . 0.0 110.926 -170.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.3 p -141.34 161.24 22.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.221 174.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.57 -140.88 0.32 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.443 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 30.7 t70 -133.8 -28.52 1.39 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -101.53 -2.1 31.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.058 0.456 . . . . 0.0 110.297 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 47.9 p -84.93 146.43 45.84 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 9.8 Cg_endo -51.12 -41.83 55.8 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.729 1.619 . . . . 0.0 111.251 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.464 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.81 -43.48 85.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.799 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.646 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.85 -58.28 3.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.36 0.6 . . . . 0.0 110.902 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 61' ' ' ASP . 2.2 pp -55.02 -75.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -170.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.641 ' N ' HD12 ' A' ' 60' ' ' LEU . 32.8 t70 -95.69 -13.83 23.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 122.367 1.08 . . . . 0.0 108.702 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.625 ' HA2' HD21 ' A' ' 25' ' ' LEU . . . -65.51 -33.25 85.85 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 113.315 -1.766 . . . . 0.0 113.964 -169.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 62' ' ' GLY . 5.3 t 51.2 21.58 1.13 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.497 1.119 . . . . 0.0 112.516 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.52 HG11 HG13 ' A' ' 99' ' ' ILE . 17.9 m -101.58 54.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-O 123.001 1.381 . . . . 0.0 110.038 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.491 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -84.31 171.35 12.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 112.455 -2.157 . . . . 0.0 111.386 -171.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.49 112.02 1.15 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.175 -175.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.3 -0.24 5.97 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.574 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.661 ' O ' HG22 ' A' ' 49' ' ' ILE . 1.1 m-20 -99.35 149.16 23.44 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.216 0.532 . . . . 0.0 110.916 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -99.05 97.57 8.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.108 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.8 mm -69.72 139.43 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.888 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -124.91 -17.88 5.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.08 163.41 34.29 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.126 -1.512 . . . . 0.0 114.094 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -123.62 125.9 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 123.497 0.719 . . . . 0.0 109.267 179.03 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 54.2 30.26 11.97 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.52 -20.15 49.57 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.331 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -106.05 125.48 51.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 117.406 0.603 . . . . 0.0 111.226 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m -59.21 146.01 40.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.594 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.712 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -84.38 -25.61 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.452 0.644 . . . . 0.0 110.18 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -60.36 -24.12 64.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.536 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.97 -22.09 77.02 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.984 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -124.02 -120.43 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.287 -176.687 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 86' ' ' VAL . 7.3 m -148.91 150.08 32.33 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.49 -173.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -46.54 -56.66 5.68 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.378 0.671 . . . . 0.0 111.944 -177.623 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.84 -37.99 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.831 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 89' ' ' MET . 38.1 mt-10 -71.57 -36.4 70.89 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.712 HG11 ' HB ' ' A' ' 78' ' ' ILE . 19.9 m -71.54 -42.62 72.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.137 -175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 91' ' ' GLN . . . -51.73 -42.33 62.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.826 169.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 37.5 ttpt -60.85 -49.67 76.54 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.824 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.532 ' HE2' ' HA ' ' A' ' 86' ' ' VAL . 40.3 mtm -52.12 -39.09 59.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 110.431 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.579 HD13 HD11 ' A' ' 33' ' ' ILE . 68.1 mt -71.73 -39.17 68.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.441 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 6.7 mm-40 -71.33 -29.41 64.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.081 0.467 . . . . 0.0 110.505 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -72.15 -47.01 54.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.692 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 93' ' ' VAL . 16.8 m -71.51 51.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.793 0.806 . . . . 0.0 111.025 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -44.33 134.14 5.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.853 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.717 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 107.48 -36.88 4.11 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.438 171.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.27 147.39 32.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.737 0.779 . . . . 0.0 112.866 -168.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.463 HG12 ' NZ ' ' A' ' 27' ' ' LYS . 3.9 m -131.67 146.8 32.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.715 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.0 m -140.17 109.4 6.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 172.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -100.66 130.9 49.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.693 -174.257 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -106.1 123.11 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.917 173.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -137.14 146.19 44.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.273 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.1 m120 . . . . . 0 C--N 1.321 -0.637 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -178.866 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 21.7 Cg_exo -32.36 -48.43 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.796 2.997 . . . . 0.0 113.761 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 0.6 OUTLIER -59.04 -49.58 77.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.684 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.543 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 24.1 mm-40 -88.9 -15.82 33.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.437 0.636 . . . . 0.0 111.026 -175.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.405 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -78.7 -39.33 36.88 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.998 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 7.3 pt-20 -68.98 -31.71 70.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.176 0.512 . . . . 0.0 109.924 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.5 t -61.71 -41.18 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.982 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 98.0 mt -76.2 -22.46 55.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.806 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.5 t80 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.861 -175.142 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 37' ' ' ILE . 2.4 pp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -141.91 93.9 2.61 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.17 -172.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.705 ' OXT' HG13 ' A' ' 33' ' ' ILE . 12.0 p . . . . . 0 N--CA 1.438 -1.029 0 CA-C-O 117.853 -1.07 . . . . 0.0 109.302 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? . . . . . 0 CA--C 1.518 -0.287 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.27 152.27 35.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.839 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -122.11 126.95 49.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.461 0.648 . . . . 0.0 110.529 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 2.4 mm? -122.44 -171.13 2.2 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.084 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 87.7 mt-30 -131.97 137.58 47.96 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.642 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.697 ' HZ3' ' HA ' ' A' ' 91' ' ' GLN . 25.0 mmtp -44.11 148.0 0.46 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 124.679 1.237 . . . . 0.0 112.663 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.75 -172.19 3.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.294 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -22.02 65.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.231 0.538 . . . . 0.0 110.816 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -96.35 11.07 36.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.231 -177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.8 t30 70.26 15.23 7.49 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.389 0.614 . . . . 0.0 111.506 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.656 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.5 pp -128.57 -173.07 2.86 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 121.958 -0.464 . . . . 0.0 111.588 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.85 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.0 -24.37 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.474 -176.294 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.12 41.24 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.486 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.483 HD11 HG12 ' A' ' 128' ' ' VAL . 2.8 pp -129.24 176.6 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.403 0.62 . . . . 0.0 111.71 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 32.1 m -140.59 128.1 21.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.389 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.508 ' HB ' HD21 ' A' ' 126' ' ' LEU . 49.6 mm -114.48 143.24 24.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.421 -174.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.277 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.102 175.29 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 122.453 1.121 . . . . 0.0 109.96 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.79 -25.37 3.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.63 -171.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -155.87 144.19 20.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.908 0.385 . . . . 0.0 110.817 -175.221 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.6 p -140.43 161.11 24.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -94.43 -137.17 0.21 Allowed 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.303 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -137.27 -36.4 0.66 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.498 ' HA ' HD23 ' A' ' 60' ' ' LEU . 32.8 m-80 -100.6 -0.38 37.73 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.435 0.636 . . . . 0.0 109.495 -171.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 44.6 p -87.99 144.74 35.1 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 6.5 Cg_endo -47.04 -40.35 26.08 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.291 1.994 . . . . 0.0 111.689 -174.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.437 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -59.02 -52.26 66.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.229 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.675 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.77 -55.61 6.48 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.898 0.856 . . . . 0.0 109.524 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -43.69 -76.17 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.186 -1.825 . . . . 0.0 113.081 -178.868 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.14 -39.58 9.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.211 0.529 . . . . 0.0 111.872 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.74 -20.34 74.09 Favored Glycine 0 N--CA 1.458 0.162 0 CA-C-N 115.447 -0.797 . . . . 0.0 114.28 -166.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 t 47.23 33.48 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.194 0.998 . . . . 0.0 111.761 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.641 HG11 HG13 ' A' ' 99' ' ' ILE . 11.9 m -94.6 55.22 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 CA-C-O 122.871 1.32 . . . . 0.0 109.697 175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.45 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.77 165.36 18.91 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.42 -2.173 . . . . 0.0 111.049 -169.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -56.64 104.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.124 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.39 -8.88 2.14 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.478 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 49' ' ' ILE . 22.6 m-20 -98.69 177.05 5.42 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.706 ' HB2' ' OD1' ' A' ' 102' ' ' ASN . 41.5 mt-10 -120.97 143.02 49.24 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.039 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.2 mm -119.12 119.39 60.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.692 HG22 ' CB ' ' A' ' 101' ' ' TYR . 5.5 t -105.25 -26.85 11.86 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.533 -177.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.71 155.46 26.15 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 118.875 -1.631 . . . . 0.0 114.448 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.975 HG13 HG22 ' A' ' 78' ' ' ILE . 6.7 m -110.02 142.59 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.291 176.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.578 ' HA ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER 61.17 19.34 9.95 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.94 0.4 . . . . 0.0 110.719 171.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.17 -15.37 60.47 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 116.11 -0.495 . . . . 0.0 113.403 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 76' ' ' ARG . 5.9 ptt180 -118.56 139.18 51.87 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 117.124 0.462 . . . . 0.0 112.012 -174.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 71' ' ' THR . 35.6 m -50.15 141.6 10.96 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.975 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -83.8 -25.71 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.169 -175.301 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -63.48 -13.69 43.19 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.349 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.35 -30.08 76.47 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.636 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.664 ' HG2' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -119.33 -117.17 0.32 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.77 0.785 . . . . 0.0 112.069 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.61 ' O ' ' HB ' ' A' ' 86' ' ' VAL . 3.2 m -161.5 151.14 16.64 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -168.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.5 ' HA ' HD22 ' A' ' 126' ' ' LEU . 2.6 mttm -39.96 -57.32 1.64 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 85' ' ' GLU . 7.1 p -55.98 -32.33 32.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.456 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 89' ' ' MET . 30.9 mt-10 -90.56 -25.93 19.97 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 123.048 1.404 . . . . 0.0 108.318 -175.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.664 HG23 ' HG2' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -75.21 -42.86 44.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.797 -2.456 . . . . 0.0 110.778 -175.319 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.55 73.21 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -61.0 -52.7 63.89 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.157 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 88.2 mmm -45.44 -50.37 12.61 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.495 0.497 . . . . 0.0 112.004 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.447 ' HB ' HG21 ' A' ' 128' ' ' VAL . 25.3 mm -60.09 -53.51 47.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.236 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.697 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 7.1 pt20 -75.31 -25.34 57.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 122.205 -0.309 . . . . 0.0 111.483 -173.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.51 -52.51 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.564 0.345 . . . . 0.0 111.707 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 90' ' ' ILE . 20.5 m -49.45 -36.52 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 O-C-N 123.462 0.476 . . . . 0.0 110.95 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 95' ' ' GLY . 4.4 tmmm? 67.5 138.08 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.723 0.773 . . . . 0.0 112.196 169.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 89.71 -33.05 4.54 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.505 171.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.6 pt-20 -145.3 177.24 8.96 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.576 HG11 HG23 ' A' ' 33' ' ' ILE . 10.4 m -146.98 153.48 12.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.975 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -141.21 106.62 5.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 176.005 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.641 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -100.07 140.19 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.536 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.556 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 2.7 t-80 -135.67 127.48 29.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.187 -174.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.692 ' CB ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER 171.28 -99.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.301 1.001 . . . . 0.0 111.912 162.283 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.706 ' OD1' ' HB2' ' A' ' 69' ' ' GLU . 29.2 p-10 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.74 -162.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 . . . . . 0 CA--C 1.508 -0.671 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 17.5 Cg_exo -29.89 -52.59 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.008 3.139 . . . . 0.0 114.499 -172.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -60.32 -50.37 73.91 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.493 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 21.2 pt20 -90.7 -9.62 46.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.9 0.857 . . . . 0.0 111.911 -173.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.409 HD13 ' C ' ' A' ' 111' ' ' LEU . 1.9 tm? -86.21 -41.39 14.69 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.384 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 8.0 pt-20 -64.89 -21.05 66.74 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 110' ' ' GLN . 61.1 t -58.04 -38.53 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.436 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.5 mp -81.0 -22.74 39.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.662 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.1 t80 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -175.741 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.508 HD21 ' HB ' ' A' ' 37' ' ' ILE . 1.8 pp . . . . . 0 CA--C 1.519 -0.24 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 15.1 ptmm? -149.89 134.69 17.72 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.811 0.338 . . . . 0.0 110.221 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.85 ' OXT' HG13 ' A' ' 33' ' ' ILE . 7.7 p . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.775 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.631 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 21.2 ptmt . . . . . 0 C--O 1.231 0.103 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.44 HG23 HD11 ' A' ' 99' ' ' ILE . 24.8 m -127.64 149.21 32.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 168.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -120.98 126.31 49.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.684 0.754 . . . . 0.0 110.448 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' HB2' ' CG2' ' A' ' 97' ' ' VAL . 5.2 mt -132.64 -167.62 1.93 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.359 -175.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.1 mt-30 -134.37 142.56 47.24 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.019 0.438 . . . . 0.0 110.158 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 27.9 mmtp -48.74 152.55 0.97 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.841 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 4.0 p-10 -85.74 -164.55 1.04 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.3 -24.64 67.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.855 0.359 . . . . 0.0 111.615 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.9 mt-30 -92.21 4.65 52.8 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.104 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 36.5 t30 71.15 24.9 3.75 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.121 0.962 . . . . 0.0 110.831 176.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.549 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.7 pp -131.05 -170.15 2.3 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.721 -0.612 . . . . 0.0 111.277 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.759 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.02 -21.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.152 -176.083 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.81 30.08 6.61 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.969 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.485 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.9 pp -124.33 175.62 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.711 0.767 . . . . 0.0 112.43 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -136.25 126.42 26.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.056 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.547 ' H ' ' HB3' ' A' ' 126' ' ' LEU . 46.7 mm -97.66 146.84 7.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.404 0.621 . . . . 0.0 111.071 -176.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.781 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.635 178.002 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.83 -31.9 12.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.851 -170.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 2.9 pt20 -165.5 152.05 9.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.932 0.396 . . . . 0.0 110.213 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.481 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 9.7 p -142.02 161.66 20.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.317 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.528 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 90.5 m-85 -110.99 123.69 50.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.525 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 28.2 t70 -58.81 -19.88 45.15 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.675 -1.148 . . . . 0.0 113.869 -164.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -101.85 2.95 38.79 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.79 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 20.7 p -89.08 153.58 49.15 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 6.5 Cg_endo -49.44 -43.18 39.5 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.801 1.667 . . . . 0.0 111.532 -176.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.43 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -54.33 -50.69 66.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.029 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 54' ' ' ASP . . . -76.11 -54.01 7.46 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.067 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.608 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.7 pp -53.67 -74.68 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -170.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.608 ' N ' HD12 ' A' ' 60' ' ' LEU . 38.7 t70 -94.24 -14.62 25.32 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.405 1.097 . . . . 0.0 108.305 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -72.08 -51.55 13.84 Favored Glycine 0 C--N 1.312 -0.779 0 CA-C-N 113.259 -1.792 . . . . 0.0 113.129 -170.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.11 47.45 5.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.298 1.047 . . . . 0.0 111.119 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.504 HG11 HG13 ' A' ' 99' ' ' ILE . 19.5 m -124.86 49.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.3 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.38 -179.57 7.21 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.31 -1.313 . . . . 0.0 112.348 -169.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -47.61 118.03 2.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.568 -172.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.91 -16.97 20.47 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.384 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 49' ' ' ILE . 6.7 m-20 -81.97 157.02 24.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.949 0.404 . . . . 0.0 110.808 -178.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -101.04 124.54 46.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.037 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.418 HD13 ' HB ' ' A' ' 49' ' ' ILE . 4.2 mp -106.44 98.69 7.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -80.87 -15.01 57.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.25 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.503 ' HA2' HG23 ' A' ' 78' ' ' ILE . . . -160.77 152.27 22.91 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 119.119 -1.515 . . . . 0.0 114.562 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.873 HG13 HG22 ' A' ' 78' ' ' ILE . 5.9 m -99.81 140.76 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 114.312 -0.944 . . . . 0.0 108.803 176.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 0.2 OUTLIER 58.13 19.1 5.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.976 0.417 . . . . 0.0 111.618 170.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.36 -20.34 48.96 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.174 -0.467 . . . . 0.0 113.259 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 76' ' ' ARG . 9.8 ptm180 -105.01 134.19 48.54 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 117.143 0.472 . . . . 0.0 110.663 -176.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -52.09 138.62 25.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 0.0 111.724 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.873 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -77.7 -13.43 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.877 0.846 . . . . 0.0 109.056 -176.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -59.76 -13.42 10.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.907 -173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.76 -24.14 76.47 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.671 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -143.14 -137.89 0.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.357 0.578 . . . . 0.0 111.238 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.443 ' O ' HG13 ' A' ' 86' ' ' VAL . 26.6 p -139.86 170.83 15.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.612 0.244 . . . . 0.0 111.598 -170.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.562 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -50.19 -54.16 22.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.743 -175.737 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.73 -35.46 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.152 0.501 . . . . 0.0 111.426 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.496 ' OE2' ' HB2' ' A' ' 81' ' ' LYS . 31.8 mt-10 -80.54 -35.86 33.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.768 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.644 HG11 ' HB ' ' A' ' 78' ' ' ILE . 33.7 m -71.04 -41.38 76.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.584 0.23 . . . . 0.0 111.269 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -52.54 -39.59 61.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.027 0.441 . . . . 0.0 109.931 169.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 61.5 tttm -64.64 -49.49 70.84 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.519 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 87.6 mtp -50.37 -41.93 52.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.418 0.628 . . . . 0.0 110.473 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.544 HD13 HD11 ' A' ' 33' ' ' ILE . 63.4 mt -70.26 -47.26 67.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.389 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -65.02 -32.52 74.28 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.801 -0.562 . . . . 0.0 111.569 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.06 -46.9 88.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.706 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 93' ' ' VAL . 9.9 m -75.89 41.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.228 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -45.88 137.52 5.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.802 0.811 . . . . 0.0 111.844 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.527 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 107.61 -32.91 6.71 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.01 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.7 pt-20 -143.87 176.6 9.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.067 0.461 . . . . 0.0 110.799 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.575 HG11 HG23 ' A' ' 33' ' ' ILE . 6.1 m -152.21 150.57 12.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.043 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 40.7 m -141.29 117.6 10.74 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 170.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -104.92 129.04 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.12 -177.371 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.88 116.27 32.36 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -120.25 160.98 21.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.563 0.697 . . . . 0.0 112.486 -170.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.444 -0.755 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.502 176.633 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.578 ' OD1' ' HG2' ' A' ' 109' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.211 -0.939 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 1.4 Cg_exo -29.88 -41.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.309 2.673 . . . . 0.0 113.858 173.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.578 ' HG2' ' OD1' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -62.82 -49.76 73.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.727 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.481 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 76.3 mm-40 -87.35 -13.12 44.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.491 0.662 . . . . 0.0 110.597 -177.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 107' ' ' ASP . 2.7 tm? -75.65 -44.03 44.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.368 -176.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -68.62 -30.89 69.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.029 0.442 . . . . 0.0 109.981 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 109' ' ' LYS . 88.4 t -69.54 -29.8 42.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.59 0.709 . . . . 0.0 109.758 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 114' ' ' LEU . 8.0 tt -73.3 -27.47 61.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.1 t80 . . . . . 0 N--CA 1.446 -0.632 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.562 -179.462 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 127' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.626 ' N ' HD13 ' A' ' 126' ' ' LEU . 21.8 pttp -156.21 121.78 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.466 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.759 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.2 p . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 117.957 -1.021 . . . . 0.0 108.638 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 51.8 pttt . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.023 0.439 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -137.44 147.02 26.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.3 t -112.59 123.13 49.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.489 0.661 . . . . 0.0 110.965 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.552 HD21 ' HA2' ' A' ' 62' ' ' GLY . 9.6 mt -127.13 -168.96 1.95 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.589 -176.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.63 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.2 mt-30 -132.89 142.05 48.71 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.827 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 29.9 mmtm -48.38 153.42 0.74 Allowed 'General case' 0 C--N 1.32 -0.711 0 O-C-N 124.631 1.207 . . . . 0.0 113.013 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -86.55 -178.66 6.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.521 173.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.68 -21.76 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 111.364 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.453 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -94.64 6.5 48.69 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.307 -177.328 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.538 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 47.3 t30 67.33 32.01 6.17 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.36 1.076 . . . . 0.0 110.613 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 1.4 pp -136.93 -169.51 2.49 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.041 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.1 -26.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.685 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.2 29.18 6.15 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.299 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 2.8 pp -118.21 172.3 5.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.668 0.747 . . . . 0.0 111.555 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 60.0 m -139.1 127.31 22.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.541 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.443 HG21 HD23 ' A' ' 126' ' ' LEU . 48.3 mm -98.3 130.09 47.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.274 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.005 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.11 179.213 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.9 t -79.03 -29.36 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.018 -168.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' A' ' 36' ' ' SER . 2.6 pt20 -161.03 152.42 19.09 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.221 0.534 . . . . 0.0 110.112 -173.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 59' ' ' ALA . 8.5 p -142.13 160.94 20.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.326 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.559 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 97.8 m-85 -111.63 125.97 54.52 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.691 0.758 . . . . 0.0 109.217 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -51.36 -29.16 14.53 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.803 -1.544 . . . . 0.0 114.136 -166.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.511 ' HA ' HD23 ' A' ' 60' ' ' LEU . 51.3 m-80 -102.18 9.14 40.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.864 0.364 . . . . 0.0 110.729 -172.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.559 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 32.7 p -95.55 147.72 33.46 Favored Pre-proline 0 CA--C 1.501 -0.936 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.3 Cg_endo -47.32 -39.65 27.71 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.111 1.874 . . . . 0.0 111.235 -175.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -55.89 -57.2 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.201 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.567 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.96 -54.62 8.18 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.458 0.647 . . . . 0.0 110.026 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -44.15 -75.52 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.783 -178.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.423 ' HB3' HD22 ' A' ' 25' ' ' LEU . 22.0 t70 -97.48 -31.66 12.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.035 0.445 . . . . 0.0 111.942 -174.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.552 ' HA2' HD21 ' A' ' 25' ' ' LEU . . . -72.4 -36.67 59.22 Favored Glycine 0 C--O 1.227 -0.281 0 N-CA-C 115.127 0.811 . . . . 0.0 115.127 -166.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.9 p 65.06 24.02 12.5 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.181 0.991 . . . . 0.0 110.788 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 99' ' ' ILE . 31.2 m -94.82 49.0 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.646 174.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.74 -179.43 7.11 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.949 -170.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.0 135.18 37.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.934 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.81 -11.1 20.93 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.888 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 49' ' ' ILE . 13.8 m-20 -101.23 178.09 4.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.905 0.353 . . . . 0.0 110.515 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -120.9 143.4 48.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.1 mm -104.94 115.85 47.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -113.87 1.39 14.75 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -173.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 78' ' ' ILE . . . -163.1 145.71 10.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.208 -1.473 . . . . 0.0 114.296 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.828 HG13 HG22 ' A' ' 78' ' ' ILE . 6.0 m -110.88 143.45 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.532 -0.834 . . . . 0.0 109.73 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 55.9 26.58 9.93 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.623 0.725 . . . . 0.0 111.608 164.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.48 -14.57 64.47 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.525 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -109.46 172.42 6.87 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 123.084 0.554 . . . . 0.0 110.291 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 t -74.13 174.96 7.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.97 0.414 . . . . 0.0 110.47 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.828 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -109.15 -14.04 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.485 0.659 . . . . 0.0 109.328 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -64.25 -19.14 65.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.855 -169.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.01 -20.84 76.62 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.619 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -142.51 -145.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.275 0.538 . . . . 0.0 110.655 -178.833 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.3 t -140.78 173.38 11.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.55 0.214 . . . . 0.0 110.564 -169.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -41.14 -61.27 1.03 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.556 1.143 . . . . 0.0 113.843 -175.277 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -57.31 -36.38 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 120.976 0.417 . . . . 0.0 111.503 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 89' ' ' MET . 34.3 mt-10 -80.62 -33.11 36.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.016 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.589 HG11 ' HB ' ' A' ' 78' ' ' ILE . 35.1 m -70.09 -45.63 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.453 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.11 -37.6 83.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -61.08 -52.27 65.63 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.236 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 21.1 mmt -50.02 -40.34 44.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.23 0.538 . . . . 0.0 111.686 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.591 HD13 HD11 ' A' ' 33' ' ' ILE . 44.1 mt -65.77 -53.05 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.113 178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.538 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 4.1 pt20 -80.29 -18.54 48.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.42 -53.05 60.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.951 0.5 . . . . 0.0 111.098 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 90' ' ' ILE . 12.6 m -56.42 -27.68 25.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.978 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 pttm 48.98 157.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.113 1.365 . . . . 0.0 113.439 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.37 -50.81 4.29 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.117 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.4 pt-20 -132.9 177.2 7.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.021 0.438 . . . . 0.0 109.936 -173.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.54 HG11 HG23 ' A' ' 33' ' ' ILE . 8.8 m -151.04 153.54 9.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.685 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.5 m -140.89 100.09 3.75 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.598 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -90.64 138.07 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.71 -172.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -116.36 117.73 30.78 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -125.59 154.96 41.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.461 0.648 . . . . 0.0 111.926 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 . . . . . 0 N--CA 1.441 -0.884 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.652 -179.135 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.408 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 24.8 t70 . . . . . 0 C--O 1.214 -0.805 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 6.3 Cg_exo -29.34 -50.63 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.016 3.144 . . . . 0.0 115.073 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.0 ptpt -58.08 -49.1 78.1 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.523 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.7 pt20 -90.15 -13.53 35.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.845 0.831 . . . . 0.0 111.76 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.443 HD13 ' C ' ' A' ' 111' ' ' LEU . 1.7 tm? -79.35 -40.77 29.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.495 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 6.7 pt-20 -65.97 -29.14 69.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.204 0.526 . . . . 0.0 109.72 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.2 t -58.88 -45.46 91.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.556 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.412 ' HA ' ' CG ' ' A' ' 79' ' ' LYS . 10.9 mp -80.7 -16.68 53.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.533 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 42.4 t80 . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.706 -176.751 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 127' ' ' LYS . 35.0 tp . . . . . 0 N--CA 1.45 -0.43 0 CA-C-O 120.828 0.347 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' H ' HD12 ' A' ' 126' ' ' LEU . 10.4 ptmm? -167.27 162.74 15.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.335 173.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.731 ' O ' HG13 ' A' ' 33' ' ' ILE . 5.0 p . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 170.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.589 HG23 HD11 ' A' ' 99' ' ' ILE . 25.3 m -125.55 160.7 31.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 118.096 -1.442 . . . . 0.0 112.583 -164.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -135.6 118.05 15.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.525 0.678 . . . . 0.0 110.539 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' C ' ' HB ' ' A' ' 97' ' ' VAL . 3.3 mm? -113.58 -159.4 0.69 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.055 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 19.9 pt20 -142.39 149.31 39.18 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 31' ' ' ASN . 36.1 mmtm -37.19 151.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.407 ' HB3' HD12 ' A' ' 32' ' ' LEU . 18.3 t70 -83.67 177.67 8.29 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.034 -1.894 . . . . 0.0 109.126 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.57 -25.37 62.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.103 0.41 . . . . 0.0 111.404 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.4 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 13.7 tt0 -94.2 20.33 8.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.39 0.614 . . . . 0.0 110.336 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 2.4 p-10 54.35 30.04 11.94 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.938 1.295 . . . . 0.0 112.629 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 0.9 OUTLIER -128.05 -166.5 1.63 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.561 175.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.747 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.97 -25.98 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.545 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.469 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 97.7 39.68 3.82 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.526 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.568 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.9 pp -131.44 172.48 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.822 0.82 . . . . 0.0 111.854 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 126' ' ' LEU . 27.2 m -138.16 127.86 25.14 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.193 175.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.663 ' HB ' ' CD2' ' A' ' 126' ' ' LEU . 49.7 mm -106.44 119.87 56.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.423 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.01 178.114 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.717 HG22 ' O ' ' A' ' 68' ' ' ASP . 2.3 tt . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.558 0.694 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.25 -21.12 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.583 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.64 143.6 18.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.454 -173.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.9 p -139.1 160.35 29.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 173.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -94.73 -140.81 0.24 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -130.0 -43.05 1.22 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.937 0.79 . . . . 0.0 112.408 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.738 ' HA ' HD23 ' A' ' 60' ' ' LEU . 3.6 m-20 -99.29 13.7 32.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.387 0.613 . . . . 0.0 110.067 -172.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.583 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 65.7 p -91.95 141.1 25.02 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.7 Cg_endo -48.06 -38.22 31.67 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 121.935 1.756 . . . . 0.0 111.413 -173.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.537 ' HB1' HG12 ' A' ' 64' ' ' VAL . . . -54.33 -56.56 17.24 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.762 175.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.74 -56.95 4.25 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.472 0.653 . . . . 0.0 110.187 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.2 tm? -42.28 -76.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.675 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -96.15 -37.88 10.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.819 -171.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.568 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . -64.3 -74.55 0.45 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.261 -168.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 6.0 t 130.86 0.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.195 1.398 . . . . 0.0 108.853 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.537 HG12 ' HB1' ' A' ' 58' ' ' ALA . 0.6 OUTLIER -75.96 58.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 124.651 2.167 . . . . 0.0 111.849 -175.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.595 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -85.73 173.0 10.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 113.633 -1.622 . . . . 0.0 110.19 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.78 124.85 20.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.165 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.67 -15.99 6.25 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.923 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.717 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.2 m-20 -89.66 146.45 24.52 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.028 0.442 . . . . 0.0 110.688 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -89.58 88.76 7.54 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.507 HD11 HG13 ' A' ' 64' ' ' VAL . 40.6 mt -87.26 94.66 4.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.496 -176.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' SER . 11.1 t -102.35 1.79 35.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.545 -171.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -134.3 130.61 5.63 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.777 -1.201 . . . . 0.0 113.923 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.737 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -99.63 125.4 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 123.939 0.896 . . . . 0.0 108.938 177.423 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 59.53 21.62 10.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.075 0.464 . . . . 0.0 110.947 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' HA2' ' ND1' ' A' ' 100' ' ' HIS . . . 101.4 -19.02 52.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.562 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -112.33 141.22 46.32 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 117.656 0.728 . . . . 0.0 111.148 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.498 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 51.0 m -48.81 143.45 5.33 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.744 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -83.93 -18.3 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.266 -176.469 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -61.56 -25.36 67.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.964 -170.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.25 -15.27 78.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.782 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.631 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 5.7 mptt -108.98 -119.43 0.27 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.71 0.767 . . . . 0.0 109.882 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.53 ' O ' HG13 ' A' ' 86' ' ' VAL . 10.2 t -179.7 167.17 1.38 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.803 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.501 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -50.12 -53.03 30.27 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.8 0.687 . . . . 0.0 112.431 -171.731 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.24 -39.72 85.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.983 0.42 . . . . 0.0 111.761 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -74.19 -42.6 59.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.744 HG11 ' HB ' ' A' ' 78' ' ' ILE . 27.7 m -57.91 -43.15 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 126' ' ' LEU . . . -53.39 -42.99 67.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.832 174.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -64.59 -49.95 69.15 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.306 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.9 mmt -49.84 -46.22 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.274 0.559 . . . . 0.0 110.904 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 93' ' ' VAL . 20.4 mm -59.18 -56.9 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.873 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.67 -24.81 67.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.07 -46.18 88.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.142 0.496 . . . . 0.0 111.361 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.2 m -72.88 55.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.104 0.954 . . . . 0.0 110.581 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -43.35 131.84 4.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.677 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 107.32 -35.47 5.0 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.072 170.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 12.9 pt-20 -132.56 177.81 7.33 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.102 0.477 . . . . 0.0 110.903 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 33' ' ' ILE . 16.9 t -152.28 133.64 5.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.314 -170.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.4 m -132.45 116.25 16.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 174.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.589 HD11 HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -107.47 124.2 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 121.128 0.489 . . . . 0.0 111.602 -176.773 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.449 ' ND1' ' HA2' ' A' ' 75' ' ' GLY . 0.3 OUTLIER -112.96 103.14 11.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.734 173.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -128.55 162.9 26.17 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 . . . . . 0 C--N 1.317 -0.826 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.892 -177.196 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 C--O 1.208 -1.089 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.436 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 27.4 Cg_exo -31.45 -54.83 0.27 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.254 3.303 . . . . 0.0 114.905 -172.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 0.5 OUTLIER -57.59 -43.57 84.71 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.724 0.773 . . . . 0.0 111.884 178.795 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 90.4 mt-30 -82.33 -26.56 32.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.514 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.428 HD13 ' C ' ' A' ' 111' ' ' LEU . 3.2 tm? -69.55 -48.12 61.41 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.782 -175.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 5.1 pt-20 -64.78 -31.35 72.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.528 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 109' ' ' LYS . 75.1 t -64.55 -41.14 91.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.291 0.567 . . . . 0.0 109.797 175.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 tp -70.54 -32.71 70.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.584 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.7 t80 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.252 -178.585 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.663 ' CD2' ' HB ' ' A' ' 37' ' ' ILE . 2.1 pp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -144.98 95.6 2.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.226 0.536 . . . . 0.0 110.396 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.747 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.1 p . . . . . 0 N--CA 1.443 -0.809 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.343 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 60.7 pttt . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 120.914 0.387 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.507 HG21 ' O ' ' A' ' 62' ' ' GLY . 10.1 m -131.68 157.32 43.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -126.77 131.79 51.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.36 0.6 . . . . 0.0 110.914 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.9 mm? -127.35 -171.55 2.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.41 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 89.5 mt-30 -129.81 136.88 50.11 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.94 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 25.8 mmtp -40.14 146.27 0.13 Allowed 'General case' 0 C--N 1.321 -0.644 0 O-C-N 124.814 1.321 . . . . 0.0 113.354 -176.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -79.55 179.6 7.38 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.382 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.85 -32.22 63.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.775 0.321 . . . . 0.0 110.691 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -92.68 16.93 11.12 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.088 0.47 . . . . 0.0 111.018 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 63.5 t30 71.75 12.54 6.27 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.765 173.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 pp -121.95 -170.31 2.03 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 121.397 -0.815 . . . . 0.0 112.091 -174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.9 -29.6 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.881 -178.09 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 93.78 40.26 4.72 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.413 -0.898 . . . . 0.0 113.427 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 2.7 pp -123.95 177.79 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.567 0.698 . . . . 0.0 112.197 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 49' ' ' ILE . 23.1 m -148.92 116.17 6.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.077 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 5.0 tt -105.0 125.61 59.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.449 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.694 -176.697 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.41 0.624 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.7 t -100.06 -20.55 5.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.37 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -151.15 133.11 15.12 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.356 -173.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.8 p -135.66 159.96 39.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -90.91 -137.87 0.15 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -138.89 -38.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.733 0.697 . . . . 0.0 112.321 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -101.73 4.06 40.21 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.956 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 70.0 p -82.9 146.61 52.62 Favored Pre-proline 0 N--CA 1.433 -1.294 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 9.1 Cg_endo -50.13 -40.5 50.89 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.911 1.741 . . . . 0.0 111.204 -176.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.88 84.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.814 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.94 -59.02 2.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.167 0.508 . . . . 0.0 110.573 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 61' ' ' ASP . 2.0 pp -50.03 -76.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -171.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.64 ' N ' HD12 ' A' ' 60' ' ' LEU . 35.7 t70 -95.56 -19.12 20.05 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.616 1.198 . . . . 0.0 108.511 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.538 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -64.25 -32.47 84.3 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 112.512 -2.131 . . . . 0.0 114.164 -167.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 t 48.01 32.1 2.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 112.255 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.609 ' HB ' ' OH ' ' A' ' 101' ' ' TYR . 22.8 m -105.1 51.37 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-O 123.483 1.611 . . . . 0.0 109.288 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.481 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.35 166.77 18.17 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.04 -2.345 . . . . 0.0 111.242 -172.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.02 119.09 2.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.175 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.87 -28.3 3.55 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.307 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.703 ' HB3' ' CD1' ' A' ' 101' ' ' TYR . 1.1 m-20 -73.7 144.29 45.82 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.6 ' HB3' ' O ' ' A' ' 102' ' ' ASN . 17.1 tt0 -101.59 122.89 44.68 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.731 HG12 ' CE1' ' A' ' 101' ' ' TYR . 3.2 mt -108.48 101.17 12.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.329 0.585 . . . . 0.0 111.205 -170.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -92.41 -15.17 27.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.069 -175.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.03 148.73 18.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.572 -1.299 . . . . 0.0 113.847 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.53 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -110.01 122.25 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 123.407 0.683 . . . . 0.0 109.457 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 53.2 28.36 6.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.94 -20.15 46.76 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.639 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 17.3 ptp180 -103.51 134.58 46.63 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 117.854 0.827 . . . . 0.0 110.52 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.2 m -66.68 152.37 45.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.692 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.53 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -88.48 6.02 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 122.396 1.093 . . . . 0.0 108.447 178.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.524 ' HE2' ' O ' ' A' ' 115' ' ' PHE . 39.3 tptt -76.05 96.19 3.77 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.254 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.49 -30.25 2.8 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.107 -1.044 . . . . 0.0 114.28 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.679 ' CG ' HG13 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -89.92 -151.32 0.23 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 117.989 0.895 . . . . 0.0 112.242 -172.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.479 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 2.7 m -132.91 141.19 48.24 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HA ' HG22 ' A' ' 86' ' ' VAL . 9.5 mtmm -37.63 -54.59 1.17 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.354 0.662 . . . . 0.0 112.715 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -51.64 -31.63 12.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.85 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 89' ' ' MET . 34.0 mt-10 -80.77 -34.92 33.85 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.849 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.679 HG13 ' CG ' ' A' ' 81' ' ' LYS . 20.3 m -73.48 -42.86 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.84 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' A' ' 91' ' ' GLN . . . -61.69 -34.65 76.13 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 171.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 38.1 ttpt -63.61 -48.33 77.79 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.727 175.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 65.6 mtt -45.38 -46.96 13.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.365 0.602 . . . . 0.0 110.275 175.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.416 ' CG2' HG21 ' A' ' 128' ' ' VAL . 34.8 mm -63.69 -54.43 32.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.973 176.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.625 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 11.9 mm-40 -61.39 -35.69 78.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -67.03 -55.16 15.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -172.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -54.42 -40.18 47.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.582 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.472 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 64.6 pttt 48.38 161.62 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.227 1.411 . . . . 0.0 113.702 -178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.67 -46.07 3.12 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.235 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.1 pt-20 -146.54 178.39 8.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.095 0.474 . . . . 0.0 110.11 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.618 HG11 HG23 ' A' ' 33' ' ' ILE . 4.6 m -147.48 151.04 14.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.55 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.6 m -140.35 105.49 5.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.265 0.555 . . . . 0.0 110.595 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.702 ' HB ' ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -92.61 149.67 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.077 -176.533 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -128.03 129.13 46.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.784 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.731 ' CE1' HG12 ' A' ' 70' ' ' ILE . 97.5 m-85 -123.46 153.61 40.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.6 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 11.1 p-10 . . . . . 0 N--CA 1.44 -0.946 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.178 171.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 111' ' ' LEU . 12.6 m-20 . . . . . 0 C--O 1.21 -1.013 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -32.59 -49.03 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.693 2.929 . . . . 0.0 113.743 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 113' ' ' VAL . 21.3 ptmt -60.7 -49.38 77.73 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.587 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.475 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.8 mm100 -90.09 -11.25 41.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.535 0.683 . . . . 0.0 111.206 -173.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.4 tm? -84.91 -40.12 17.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.493 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -66.25 -21.85 66.3 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.851 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 109' ' ' LYS . 76.0 t -64.21 -36.34 76.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.922 174.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 114' ' ' LEU . 7.1 tt -79.63 -30.36 41.31 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.524 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 9.8 t80 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.609 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -144.32 148.81 35.26 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.313 0.578 . . . . 0.0 111.23 -178.36 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 33' ' ' ILE . 4.1 p . . . . . 0 C--N 1.315 -0.899 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 21.3 pttm . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.538 0.209 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.55 141.07 43.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -109.5 119.66 40.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.808 0.814 . . . . 0.0 111.186 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.54 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.9 mm? -124.41 -167.01 1.59 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.045 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.0 mt-30 -132.12 139.67 48.53 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.014 0.435 . . . . 0.0 109.948 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 5.3 mmtp -45.03 145.27 1.02 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.86 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.25 179.1 8.0 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.421 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.92 -21.35 64.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.169 0.509 . . . . 0.0 110.658 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.5 mt-30 -89.74 11.34 20.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.907 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p30 55.33 29.18 12.52 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.136 1.374 . . . . 0.0 112.136 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 0.9 OUTLIER -131.65 -165.74 1.62 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.639 177.115 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.73 -28.57 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.67 38.02 4.31 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.267 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 52' ' ' VAL . 2.6 pp -128.82 177.51 6.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.868 0.842 . . . . 0.0 111.954 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 11.7 m -138.41 125.18 20.99 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.397 173.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.923 HG22 ' H ' ' A' ' 38' ' ' GLY . 22.5 mt -110.47 -168.18 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.923 ' H ' HG22 ' A' ' 37' ' ' ILE . . . . . . . . 0 C--N 1.308 -0.984 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.31 0 CA-C-O 121.53 0.681 . . . . 0.0 109.285 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 37.4 t -92.3 -38.32 10.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.937 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.96 150.15 20.3 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.682 -174.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 59' ' ' ALA . 8.1 p -141.33 159.98 22.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.567 173.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -95.91 -139.18 0.25 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.437 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 18.9 t70 -136.06 -33.41 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.783 176.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -102.38 4.49 38.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.166 0.508 . . . . 0.0 110.564 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 82.5 p -86.3 144.16 37.84 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.815 ' HA ' ' CD1' ' A' ' 60' ' ' LEU . 10.2 Cg_endo -52.25 -38.99 73.06 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.428 1.418 . . . . 0.0 111.704 -172.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.658 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.05 -45.36 87.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.543 175.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.681 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.4 -60.95 1.98 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.095 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.011 HD13 ' H ' ' A' ' 61' ' ' ASP 0.268 0.0 OUTLIER -61.41 -71.43 0.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -166.895 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 1.011 ' H ' HD13 ' A' ' 60' ' ' LEU . 23.7 t70 -92.84 -4.31 53.15 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -71.71 -62.28 3.48 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 112.613 -2.085 . . . . 0.0 113.648 -171.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p 74.31 23.18 2.07 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.933 1.293 . . . . 0.0 110.574 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.637 HG11 HG13 ' A' ' 99' ' ' ILE . 31.2 m -100.21 50.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.564 172.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.73 174.91 10.07 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.138 -170.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.91 132.43 52.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.607 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.15 -13.58 19.19 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.638 ' O ' HG22 ' A' ' 49' ' ' ILE . 57.8 m-20 -95.86 -175.99 3.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.026 0.441 . . . . 0.0 110.72 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . 50.9 mt-10 -132.09 154.24 49.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.101 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 mm -122.83 140.29 47.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 t -131.07 -0.88 4.11 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.56 142.16 7.94 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.22 -1.467 . . . . 0.0 113.952 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.663 HG12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -104.0 117.3 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 123.632 0.773 . . . . 0.0 109.767 -179.059 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.578 ' ND2' HG11 ' A' ' 93' ' ' VAL . 64.9 t30 53.71 29.95 10.32 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.536 0.684 . . . . 0.0 111.016 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.622 ' HA2' ' CD2' ' A' ' 100' ' ' HIS . . . 100.66 -21.52 43.61 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.917 177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 5.8 ptm180 -100.59 142.97 31.32 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 117.801 0.8 . . . . 0.0 110.529 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.7 m -59.42 149.87 28.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.188 0.518 . . . . 0.0 111.332 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.663 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -90.62 -20.96 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.166 -179.01 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.24 -25.78 68.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.123 -170.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.99 -17.71 77.24 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.863 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -135.01 -139.27 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.321 0.56 . . . . 0.0 110.215 -176.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 85' ' ' GLU . 47.1 p -137.67 157.89 45.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.628 -172.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.487 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -48.04 -54.94 11.38 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.774 0.671 . . . . 0.0 112.588 -178.424 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.93 -39.67 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 120.895 0.378 . . . . 0.0 111.974 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.566 ' O ' ' HG3' ' A' ' 89' ' ' MET . 39.8 mt-10 -72.7 -36.62 67.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.934 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 83' ' ' LYS . 29.1 m -72.48 -41.36 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.347 -176.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.65 -37.01 67.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.027 170.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 57.1 tttm -64.76 -48.98 72.56 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.828 173.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.566 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 58.3 mtt -54.69 -40.56 69.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.107 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.581 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 20.1 mm -61.26 -55.48 24.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.087 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -72.34 -23.13 61.1 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -176.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -67.45 -53.75 26.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.578 HG11 ' ND2' ' A' ' 74' ' ' ASN . 33.6 m -46.59 -32.33 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 23.9 tptm 70.87 123.88 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.292 0.568 . . . . 0.0 112.073 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.566 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 105.8 -59.16 0.42 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.151 -1.024 . . . . 0.0 113.588 172.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.5 pt-20 -135.47 178.72 6.82 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.149 0.5 . . . . 0.0 110.566 -170.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.585 HG11 HG23 ' A' ' 33' ' ' ILE . 9.2 m -148.38 151.09 13.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.0 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 p -139.73 99.98 3.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.33 0.586 . . . . 0.0 109.99 170.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.637 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -86.26 115.51 27.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.82 -176.274 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.622 ' CD2' ' HA2' ' A' ' 75' ' ' GLY . 4.7 m-70 -91.99 119.71 31.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -132.2 -170.16 2.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.61 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.523 ' ND2' ' HB2' ' A' ' 69' ' ' GLU . 4.0 p-10 . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.319 173.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 C--O 1.21 -1.013 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.54 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 36.3 Cg_exo -32.76 -52.89 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.582 2.855 . . . . 0.0 113.965 -174.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.7 ptpt -55.97 -51.06 69.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.387 0.613 . . . . 0.0 111.978 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.529 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.3 mm100 -88.16 -3.9 58.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.729 0.776 . . . . 0.0 111.343 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.72 -49.11 6.65 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.622 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 7.4 pt-20 -68.73 -23.43 64.34 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.514 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 110' ' ' GLN . 3.9 p -69.54 -31.74 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.589 0.709 . . . . 0.0 110.101 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.84 -34.02 45.49 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.283 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.6 t80 . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.529 -178.27 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 127' ' ' LYS . 9.1 tt . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.62 ' N ' HD23 ' A' ' 126' ' ' LEU . 19.8 pttp -155.13 120.88 5.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.478 0.656 . . . . 0.0 111.575 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.601 ' O ' HG13 ' A' ' 33' ' ' ILE . 12.5 p . . . . . 0 N--CA 1.446 -0.651 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.344 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -147.27 102.71 3.78 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.37 5.18 6.45 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.621 2.214 . . . . 0.0 113.305 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.5 63.07 2.18 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.253 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.523 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 2.7 pt -79.07 157.09 76.36 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.523 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 36.1 Cg_endo -66.26 -87.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.377 2.051 . . . . 0.0 113.393 -171.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.11 96.09 48.44 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 120.766 0.317 . . . . 0.0 110.978 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.76 144.39 31.12 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.576 2.184 . . . . 0.0 112.487 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -154.7 172.5 33.13 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 19.8 ptpt -148.63 141.72 24.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.815 0.308 . . . . 0.0 110.558 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.67 136.42 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -110.72 129.45 55.83 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.78 0.8 . . . . 0.0 110.72 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.19 -160.2 1.03 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.01 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -140.3 149.05 42.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.117 0.484 . . . . 0.0 110.104 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 3.3 mmmm -45.39 151.45 0.37 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.578 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -84.37 172.61 11.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.169 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.02 41.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 110.828 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.47 ' OE1' HD21 ' A' ' 32' ' ' LEU . 7.8 tt0 -92.47 8.43 38.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.982 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 40.1 t30 69.35 34.75 2.8 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.901 0.858 . . . . 0.0 110.583 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.595 HD22 ' OXT' ' A' ' 128' ' ' VAL . 1.5 pp -147.07 -164.4 1.99 Allowed 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.273 -0.571 . . . . 0.0 112.002 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.695 HD11 HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -104.07 -30.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.45 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 101.56 32.52 5.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.194 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.748 HD11 HG23 ' A' ' 128' ' ' VAL . 2.8 pp -126.83 -179.48 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.613 0.721 . . . . 0.0 112.61 -175.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 39.8 m -137.6 128.73 27.64 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.506 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 48.0 mm -111.04 125.43 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.649 0.738 . . . . 0.0 111.988 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 48' ' ' TYR . . . -132.62 126.59 4.54 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 170.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.07 61.74 2.17 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.888 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.82 149.94 7.69 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.455 ' HB3' ' NE2' ' A' ' 116' ' ' GLN . . . -117.63 -76.43 0.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.798 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.552 ' NE2' ' HA ' ' A' ' 113' ' ' VAL . 18.0 pt20 -77.62 104.75 8.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.034 0.445 . . . . 0.0 109.974 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 74.17 4.79 4.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.927 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.463 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 69.1 m 57.66 58.9 7.15 Favored Pre-proline 0 C--O 1.231 0.095 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.995 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 21.8 Cg_exo -65.63 -86.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.493 2.128 . . . . 0.0 112.609 -173.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.738 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 93.8 m -151.72 -97.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 46' ' ' CYS . 0.4 OUTLIER 50.62 -66.89 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.201 1.4 . . . . 0.0 114.136 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.603 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 87.9 m-85 68.6 -57.15 0.5 Allowed 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.262 0.625 . . . . 0.0 112.515 -174.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -86.57 115.85 28.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 118.509 -1.277 . . . . 0.0 110.32 -179.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -94.27 -31.78 4.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.12 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -161.0 154.15 21.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.13 0.491 . . . . 0.0 110.088 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.8 p -143.45 160.77 16.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.922 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.504 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 80.4 m-85 -112.74 124.97 53.78 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 20.6 t70 -54.19 -27.36 33.58 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -165.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -101.0 6.93 43.69 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.184 0.516 . . . . 0.0 110.492 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 30.9 p -87.55 153.9 53.32 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.32 -40.2 78.69 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.211 1.274 . . . . 0.0 110.905 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -55.68 -49.49 72.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.803 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -77.68 -56.29 4.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.848 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.621 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.3 pp -52.74 -74.12 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -170.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.621 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 37.2 t70 -94.13 -9.11 37.58 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.563 1.173 . . . . 0.0 107.938 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -82.94 -51.73 4.11 Favored Glycine 0 C--N 1.311 -0.816 0 CA-C-N 113.093 -1.867 . . . . 0.0 113.458 -171.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 p 64.57 22.55 12.68 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.699 1.2 . . . . 0.0 111.143 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 99' ' ' ILE . 9.9 m -92.1 53.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 122.959 1.361 . . . . 0.0 109.74 172.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.6 179.81 7.04 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.552 -2.113 . . . . 0.0 111.736 -171.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.37 122.71 11.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.991 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.86 1.07 34.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.71 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.698 ' O ' HG22 ' A' ' 49' ' ' ILE . 51.5 t0 -98.48 152.73 19.22 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 33.6 tt0 -101.44 82.31 2.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.896 0.379 . . . . 0.0 110.692 -174.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.477 HD13 ' HB ' ' A' ' 49' ' ' ILE . 2.0 mp -74.18 101.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.679 0.752 . . . . 0.0 109.362 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.462 HG21 HD21 ' A' ' 102' ' ' ASN . 7.5 t -100.76 -15.8 17.54 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.649 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -147.78 148.03 19.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.6 -1.285 . . . . 0.0 113.457 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -108.76 115.31 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 9.7 t-20 52.21 37.17 21.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.218 0.532 . . . . 0.0 111.311 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.69 -22.45 39.66 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.833 -0.621 . . . . 0.0 113.927 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -106.13 129.29 54.24 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 117.726 0.763 . . . . 0.0 111.245 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.54 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 46.4 m -61.63 148.67 41.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.536 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.609 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -90.68 -25.52 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.265 0.555 . . . . 0.0 109.598 177.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -73.09 86.5 1.36 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.262 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.65 -25.7 0.17 Allowed Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.07 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -111.12 -117.04 0.3 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.942 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.478 ' O ' HG13 ' A' ' 86' ' ' VAL . 4.9 m -149.61 148.93 29.91 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.236 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.598 ' O ' HG22 ' A' ' 86' ' ' VAL . 5.5 mttt -47.81 -55.69 9.12 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.253 0.549 . . . . 0.0 111.976 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.06 -36.91 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.697 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.587 ' O ' ' HG3' ' A' ' 89' ' ' MET . 37.1 mt-10 -74.36 -37.21 63.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.261 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.609 HG11 ' HB ' ' A' ' 78' ' ' ILE . 27.3 m -67.35 -43.09 88.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.888 0.375 . . . . 0.0 111.087 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.07 73.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.203 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 59.8 tttm -61.48 -45.89 92.34 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.587 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 82.5 mtp -53.7 -37.21 63.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.402 0.62 . . . . 0.0 110.723 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.695 HD13 HD11 ' A' ' 33' ' ' ILE . 97.1 mt -77.23 -38.53 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.21 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -70.68 -29.33 65.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.625 0.25 . . . . 0.0 110.86 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -62.48 -48.73 78.31 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.628 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.3 m -69.75 82.5 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 122.772 1.272 . . . . 0.0 110.08 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -67.34 123.08 19.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.407 -173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.598 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 95.9 -21.17 46.43 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.431 169.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 97' ' ' VAL . 9.2 pt-20 -124.28 169.17 12.04 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.079 0.466 . . . . 0.0 109.885 -174.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 96' ' ' GLU . 2.8 t -159.15 125.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.501 -173.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 99.5 m -141.58 131.9 25.07 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 122.171 -0.33 . . . . 0.0 110.143 172.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.712 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -120.36 132.65 69.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.429 -176.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -100.46 129.42 46.41 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 69' ' ' GLU . 27.5 p90 -136.85 165.82 25.06 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.745 0.307 . . . . 0.0 111.341 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.603 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 62.1 m-20 -142.58 172.25 12.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.603 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 13.1 mptt -148.57 99.44 3.01 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -174.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.586 HD12 ' H ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -97.83 125.98 42.96 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.518 -171.149 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.521 ' N ' HD12 ' A' ' 104' ' ' LEU . 23.1 mp0 -81.61 -22.84 37.41 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.194 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.586 ' H ' HD12 ' A' ' 104' ' ' LEU . . . 52.31 -155.46 0.17 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.199 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.5 152.1 79.76 Favored Pre-proline 0 C--O 1.215 -0.73 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -31.55 -55.88 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.752 2.968 . . . . 0.0 114.138 -172.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.0 ptpt -58.0 -45.9 86.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.524 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 71.0 mm-40 -86.57 -17.63 33.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.488 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.43 HD13 ' C ' ' A' ' 111' ' ' LEU . 3.3 tm? -74.26 -44.26 53.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.161 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -70.11 -26.58 64.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.484 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.552 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 79.4 t -72.53 -41.72 63.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.028 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.7 tp -72.41 -23.09 61.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.822 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -61.5 -42.0 98.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.308 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.508 ' OE1' ' HG2' ' A' ' 42' ' ' GLN . 12.4 mm100 63.07 94.82 0.05 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.702 0.763 . . . . 0.0 110.778 -173.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.521 ' H ' ' HD2' ' A' ' 118' ' ' PRO . . . -126.52 -57.64 0.14 Allowed Glycine 0 C--N 1.309 -0.97 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 117' ' ' GLY . 10.3 Cg_endo -50.5 123.93 12.28 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.397 2.731 . . . . 0.0 111.311 165.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -115.86 42.87 2.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.467 0.651 . . . . 0.0 110.471 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -79.59 -24.56 41.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.884 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 p -84.76 106.76 16.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.799 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.6 tp -86.22 -71.19 0.55 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 62.01 178.41 0.13 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.436 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -118.0 103.31 9.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.485 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -92.71 -179.19 5.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.507 ' CG ' ' HB ' ' A' ' 37' ' ' ILE . 1.4 pp -117.71 168.96 9.97 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 10.9 ptmm? -150.98 145.85 25.84 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.357 0.599 . . . . 0.0 110.478 176.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.748 HG23 HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 168.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 p -76.95 129.85 77.47 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.988 0.394 . . . . 0.0 110.357 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.93 46.72 2.13 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.935 2.423 . . . . 0.0 112.359 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.3 -178.15 41.83 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.038 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.475 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 10.5 pt -106.85 156.06 37.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 29.7 Cg_endo -62.68 -91.03 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.348 2.032 . . . . 0.0 112.931 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.1 112.68 15.85 Favored Pre-proline 0 N--CA 1.438 -1.027 0 O-C-N 122.161 -0.337 . . . . 0.0 110.678 174.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.17 144.39 10.58 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.848 2.365 . . . . 0.0 112.996 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.25 -176.86 42.97 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 64.4 pttt -141.95 161.32 38.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.14 0.47 . . . . 0.0 110.633 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 62' ' ' GLY . 9.7 p -142.95 138.78 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.471 ' O ' HD13 ' A' ' 25' ' ' LEU . 12.0 t -110.89 127.36 55.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.445 0.64 . . . . 0.0 110.768 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.546 HD23 HD11 ' A' ' 99' ' ' ILE . 2.6 mm? -127.51 -170.39 2.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.432 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 80.5 mt-30 -129.98 136.55 49.56 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.238 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.721 ' HZ3' ' HA ' ' A' ' 91' ' ' GLN . 22.3 mmtp -45.16 149.27 0.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.712 1.258 . . . . 0.0 112.009 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 4.5 p-10 -89.89 -162.88 0.93 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.489 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.09 65.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.755 0.312 . . . . 0.0 111.555 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.461 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 54.3 mt-30 -88.43 0.84 55.82 Favored 'General case' 0 N--CA 1.425 -1.722 0 C-N-CA 122.931 0.492 . . . . 0.0 112.245 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 50.7 t30 71.3 18.47 5.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.51 0.671 . . . . 0.0 110.943 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.457 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 2.0 pp -126.58 -165.26 1.43 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.092 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.807 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -109.03 -22.27 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.674 -177.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.434 ' N ' HD13 ' A' ' 32' ' ' LEU . . . 98.48 35.05 5.08 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.878 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.552 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.7 pp -123.2 171.21 12.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.463 0.649 . . . . 0.0 110.698 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 46.2 m -130.72 131.92 45.06 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.375 175.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 41.2 mm -100.44 141.29 17.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.152 -176.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.29 -158.81 8.03 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.117 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.489 ' HA3' HD12 ' A' ' 47' ' ' LEU . . . -12.39 -102.15 0.0 OUTLIER Glycine 0 C--N 1.34 0.784 0 N-CA-C 115.83 1.092 . . . . 0.0 115.83 -159.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 45' ' ' PRO . . . 55.29 80.65 0.07 OUTLIER Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.769 -172.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.605 ' N ' ' HA ' ' A' ' 45' ' ' PRO . . . -173.54 -153.28 0.06 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.992 0.396 . . . . 0.0 110.808 -166.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -50.66 129.95 23.57 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.559 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 76.68 -21.53 0.32 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.949 0.9 . . . . 0.0 112.904 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 38.3 t -162.63 80.8 1.72 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.948 0.404 . . . . 0.0 111.26 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.605 ' HA ' ' N ' ' A' ' 41' ' ' ALA . 17.1 Cg_exo -75.4 23.07 0.43 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.63 2.887 . . . . 0.0 112.954 174.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 80.9 m -95.54 -141.79 0.26 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.489 HD12 ' HA3' ' A' ' 39' ' ' GLY . 40.2 mt 76.0 -103.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.377 0.608 . . . . 0.0 110.809 177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.618 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 26.6 m-85 68.75 -77.78 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.778 -176.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -82.2 109.84 16.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 118.066 -1.454 . . . . 0.0 110.369 -172.03 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 m -108.73 -19.12 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.123 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 13.9 tp60 -157.3 143.55 17.88 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-O 121.023 0.439 . . . . 0.0 110.222 -171.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.5 p -145.31 160.93 12.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.015 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -98.64 -131.15 0.21 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.119 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -138.2 -44.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.538 ' HA ' HD23 ' A' ' 60' ' ' LEU . 46.7 m-80 -100.62 8.33 43.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.334 0.588 . . . . 0.0 109.78 -170.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.428 ' CB ' ' HA3' ' A' ' 34' ' ' GLY . 31.0 p -92.19 143.66 27.85 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.507 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 3.6 Cg_endo -44.96 -41.92 15.59 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 C-N-CA 122.551 2.167 . . . . 0.0 111.776 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -58.1 -54.76 43.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.419 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.713 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -71.8 -55.0 8.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.73 0.776 . . . . 0.0 109.807 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.3 tm? -42.45 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.235 -1.802 . . . . 0.0 113.273 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -98.8 -39.54 8.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.152 0.501 . . . . 0.0 111.914 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.426 ' O ' HG11 ' A' ' 23' ' ' VAL . . . -62.89 -27.33 70.04 Favored Glycine 0 C--O 1.228 -0.226 0 CA-C-N 115.14 -0.936 . . . . 0.0 114.631 -165.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 t 50.71 35.84 12.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.312 1.053 . . . . 0.0 111.39 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.633 HG11 HG13 ' A' ' 99' ' ' ILE . 20.6 m -100.14 51.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.345 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.33 177.77 8.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.222 -168.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.26 136.21 25.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.992 -170.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.82 56.32 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.6 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.532 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -104.12 165.49 11.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.025 0.44 . . . . 0.0 110.438 176.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -108.63 99.93 9.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.173 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 49' ' ' ILE . 28.7 mm -83.66 105.43 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 77' ' ' SER . 4.2 t -101.49 -15.26 17.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.315 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -139.93 136.36 7.73 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 119.762 -1.209 . . . . 0.0 113.655 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.692 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -103.97 120.54 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 123.376 0.67 . . . . 0.0 109.379 177.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.523 ' ND2' HG11 ' A' ' 93' ' ' VAL . 66.0 t30 54.1 29.91 11.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.481 0.658 . . . . 0.0 110.719 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.15 -21.35 44.92 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.755 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 2.7 ptp180 -104.22 131.2 51.79 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 117.874 0.837 . . . . 0.0 110.602 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' THR . 62.6 m -47.8 136.11 11.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.201 0.525 . . . . 0.0 112.151 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.691 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -76.1 -19.75 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.76 -174.022 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.04 -12.21 59.26 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.121 -173.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.58 -20.87 61.03 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.377 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 2.6 mptp? -107.67 -131.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.845 0.831 . . . . 0.0 110.275 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 86' ' ' VAL . 5.5 m -158.13 160.12 36.95 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' VAL . 12.8 mttt -47.01 -60.8 2.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.335 0.588 . . . . 0.0 111.756 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -55.0 -34.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.076 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.591 ' O ' ' HG2' ' A' ' 89' ' ' MET . 33.2 mt-10 -77.52 -43.47 31.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.679 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.651 HG11 ' HB ' ' A' ' 78' ' ' ILE . 19.7 m -58.42 -47.6 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -57.16 -38.75 74.03 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 25.6 ttpp -60.88 -56.92 15.45 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.591 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 16.5 mmt -48.63 -43.2 36.22 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.63 0.581 . . . . 0.0 111.146 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.517 HD13 HD11 ' A' ' 33' ' ' ILE . 64.2 mt -62.45 -55.12 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.465 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.721 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 10.4 pt20 -76.94 -22.12 53.78 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.985 -0.447 . . . . 0.0 111.459 -174.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.58 -52.68 23.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.411 0.684 . . . . 0.0 111.732 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.523 HG11 ' ND2' ' A' ' 74' ' ' ASN . 31.8 m -49.42 -36.26 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.543 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 67.62 134.55 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.464 0.649 . . . . 0.0 112.493 171.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.46 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 102.27 -48.25 1.08 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.938 172.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.0 pt-20 -146.03 178.79 7.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.058 0.456 . . . . 0.0 110.144 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.522 HG11 HG23 ' A' ' 33' ' ' ILE . 5.4 m -145.39 154.69 13.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.621 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.3 m -140.71 99.78 3.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 172.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.633 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -93.45 120.63 43.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.112 -175.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 4.1 t-160 -94.39 129.06 41.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 171.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -139.04 163.98 30.97 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.157 0.503 . . . . 0.0 111.815 -172.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -133.75 103.13 5.73 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 18' ' ' PRO . 11.0 mtpt -93.58 139.55 30.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.28 0.562 . . . . 0.0 111.607 -165.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.594 ' HG ' ' H ' ' A' ' 106' ' ' ALA . 1.0 OUTLIER -157.99 -52.82 0.07 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.057 -175.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.444 ' O ' HD23 ' A' ' 111' ' ' LEU . 2.7 mp0 59.37 18.61 6.91 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -170.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.594 ' H ' ' HG ' ' A' ' 104' ' ' LEU . . . 58.77 -166.32 0.17 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.643 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 20.2 t70 -125.53 144.95 49.58 Favored Pre-proline 0 C--O 1.21 -1.021 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 13.6 Cg_exo -29.26 -51.48 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.251 3.301 . . . . 0.0 115.16 -173.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.1 pttp -59.51 -45.63 91.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.379 0.609 . . . . 0.0 111.759 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 84.3 mm-40 -85.76 -17.81 34.79 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.838 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 105' ' ' GLN . 3.2 tm? -73.25 -43.73 60.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.485 -175.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -69.18 -35.47 76.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.119 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 109' ' ' LYS . 81.0 t -64.71 -41.11 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.223 0.535 . . . . 0.0 109.991 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.85 -23.79 61.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.84 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -76.08 -49.64 16.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.041 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -85.09 42.43 0.94 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.208 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -122.29 -61.5 0.21 Allowed Glycine 0 C--N 1.312 -0.792 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -38.62 86.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.195 3.263 . . . . 0.0 112.752 158.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -151.73 21.81 0.7 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.845 0.831 . . . . 0.0 109.402 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -125.61 124.03 40.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.12 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.07 -20.76 17.16 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.393 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.1 mt -80.52 76.0 7.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.174 0.511 . . . . 0.0 110.597 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.2 166.79 28.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.926 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -82.39 109.34 16.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.928 0.394 . . . . 0.0 110.325 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 51.2 t90 -85.13 153.18 22.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.246 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.516 ' HG ' ' N ' ' A' ' 127' ' ' LYS . 61.6 tp -143.36 167.97 20.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.669 0.271 . . . . 0.0 111.333 -173.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 13.8 ptmm? -169.38 151.79 4.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.696 0.398 . . . . 0.0 110.69 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.807 ' OXT' HG13 ' A' ' 33' ' ' ILE . 14.5 p . . . . . 0 C--O 1.238 0.491 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.048 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -77.06 112.92 26.08 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.35 65.47 8.87 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.587 2.191 . . . . 0.0 112.409 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.65 -23.25 40.01 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.578 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 5.2 pt -113.01 166.92 10.06 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 60.0 Cg_endo -75.08 -161.71 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.523 1.482 . . . . 0.0 112.066 -177.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -41.94 113.69 1.22 Allowed Pre-proline 0 C--O 1.234 0.265 0 O-C-N 123.459 0.474 . . . . 0.0 111.485 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 19' ' ' VAL . 9.8 Cg_endo -88.27 126.22 1.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.162 2.575 . . . . 0.0 113.1 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.15 134.16 8.77 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 12.0 ptmm? -159.78 114.62 2.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.82 0.343 . . . . 0.0 110.596 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 62' ' ' GLY . 14.6 m -128.16 154.19 38.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.938 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.7 t -116.35 123.6 48.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.546 0.689 . . . . 0.0 110.219 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.47 HD21 ' HA2' ' A' ' 62' ' ' GLY . 7.8 mt -122.34 -168.43 1.72 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.402 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 93.6 mt-30 -133.89 140.14 46.63 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.215 0.531 . . . . 0.0 110.642 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 10.0 mmtp -45.79 144.02 1.88 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.067 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -83.63 -179.39 7.31 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.439 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.77 -24.24 61.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 118.084 0.402 . . . . 0.0 111.363 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.425 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 11.5 tt0 -96.56 21.13 9.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 110.202 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.7 p30 57.17 23.45 8.63 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.121 1.369 . . . . 0.0 113.173 174.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.484 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -128.72 -165.43 1.5 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.797 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.763 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.7 -26.58 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.635 -178.014 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 98.28 41.9 3.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.093 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.519 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -130.06 172.6 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.947 0.879 . . . . 0.0 111.488 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m -141.41 129.41 21.96 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.712 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.453 HG23 HD13 ' A' ' 35' ' ' ILE . 6.9 pt -119.41 137.97 51.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.896 0.855 . . . . 0.0 111.022 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' A' ' 125' ' ' TRP . . . -109.93 -157.81 16.84 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.853 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -14.09 -69.78 0.01 OUTLIER Glycine 0 C--N 1.343 0.921 0 O-C-N 124.929 1.017 . . . . 0.0 115.508 -163.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 46' ' ' CYS . . . 69.35 30.3 71.48 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.653 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 64.08 5.82 2.61 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -71.05 -28.37 64.33 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -106.44 -56.87 2.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.897 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.538 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 47.6 m -162.76 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.767 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 44' ' ' CYS . 40.3 Cg_endo -77.57 138.65 17.45 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.601 2.201 . . . . 0.0 112.934 -167.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 79.7 m -59.62 -94.98 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.275 -0.393 . . . . 0.0 111.18 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 48' ' ' TYR . 1.2 pp 47.74 -70.67 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.597 ' N ' HD12 ' A' ' 47' ' ' LEU . 49.1 m-85 70.22 -88.21 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.377 0.671 . . . . 0.0 110.592 -170.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.673 ' HB ' HD13 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -71.54 128.74 34.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 119.373 0.988 . . . . 0.0 110.647 -172.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 m -117.66 -22.21 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.397 -175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -155.07 138.61 15.97 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.585 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.606 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.2 p -139.91 160.89 26.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.855 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -97.93 -137.79 0.28 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.429 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.44 -34.66 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -101.72 -0.56 34.28 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.998 0.428 . . . . 0.0 110.174 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 80.2 p -84.04 148.54 53.86 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.466 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 10.2 Cg_endo -52.06 -41.16 66.04 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.484 1.456 . . . . 0.0 110.991 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.52 -45.71 88.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.827 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.606 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.38 -59.56 2.67 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.411 0.624 . . . . 0.0 110.525 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.616 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.6 pp -54.87 -75.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.616 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 31.4 t70 -94.6 -13.06 26.33 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 122.581 1.181 . . . . 0.0 108.24 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -61.55 -40.34 98.57 Favored Glycine 0 C--N 1.314 -0.687 0 CA-C-N 112.464 -2.153 . . . . 0.0 114.804 -166.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.2 p 52.31 35.29 16.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.455 1.121 . . . . 0.0 111.197 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.647 HG11 HG13 ' A' ' 99' ' ' ILE . 15.9 m -122.79 53.66 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.174 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.62 179.67 7.33 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 112.649 -2.069 . . . . 0.0 111.319 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.34 123.05 15.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.696 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.64 -18.6 8.64 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.522 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.615 ' O ' HG22 ' A' ' 49' ' ' ILE . 11.9 m-20 -83.33 144.51 29.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.524 0.662 . . . . 0.0 110.532 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 41.9 mt-10 -94.52 97.0 9.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.924 -174.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.673 HD13 ' HB ' ' A' ' 49' ' ' ILE . 2.1 mp -76.01 138.26 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -127.89 -25.03 3.13 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.963 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.15 146.81 16.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.536 -1.316 . . . . 0.0 113.772 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.691 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -117.52 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.503 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 5.4 m-20 56.24 22.17 5.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.95 0.405 . . . . 0.0 111.786 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.83 -12.21 59.25 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.451 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.691 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 9.7 ptp180 -105.76 131.72 52.76 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 117.922 0.861 . . . . 0.0 110.861 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 p -61.06 138.08 58.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.133 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.689 HG23 HG12 ' A' ' 73' ' ' VAL . 1.1 pp -77.56 -24.16 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-O 122.391 1.091 . . . . 0.0 109.883 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.614 ' H ' HD12 ' A' ' 78' ' ' ILE . 3.5 tppp? -69.63 -19.27 63.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.068 -1.878 . . . . 0.0 109.878 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.56 -15.61 75.47 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.019 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.73 -142.26 0.17 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.662 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 86' ' ' VAL . 29.7 p -136.35 169.79 17.08 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.177 -0.209 . . . . 0.0 111.105 -169.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.468 ' HB3' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -49.02 -53.99 17.7 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.81 0.693 . . . . 0.0 112.443 -176.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.06 -39.82 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.624 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.07 -35.32 66.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 82' ' ' THR . 32.3 m -68.54 -46.1 80.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.209 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' HB2' HD13 ' A' ' 126' ' ' LEU . . . -58.33 -37.82 75.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.971 0.415 . . . . 0.0 110.171 172.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 91' ' ' GLN . 60.8 tttm -63.26 -53.13 57.8 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.847 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.484 ' O ' HG13 ' A' ' 93' ' ' VAL . 24.8 mmt -51.86 -42.48 62.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.25 0.548 . . . . 0.0 111.386 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.609 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 62.5 mt -64.78 -47.96 86.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.675 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.403 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 7.1 pt20 -73.78 -35.36 64.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.159 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -58.95 -50.1 75.35 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.526 0.516 . . . . 0.0 111.981 -173.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 89' ' ' MET . 17.8 m -52.99 -35.29 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.566 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 98.5 mttt 65.16 151.32 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.824 0.821 . . . . 0.0 112.802 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 88.3 -53.52 4.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.214 168.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.1 pt-20 -137.33 178.01 7.42 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.455 HG11 HG23 ' A' ' 33' ' ' ILE . 6.8 m -147.8 150.67 14.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.846 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.503 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 34.3 m -137.97 103.61 5.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.043 0.449 . . . . 0.0 110.182 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.647 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -94.45 129.81 44.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.338 -175.382 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -114.72 119.86 38.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.258 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -142.04 154.1 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.003 0.43 . . . . 0.0 110.893 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 20' ' ' PRO . 17.3 m120 -141.7 -172.25 3.5 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.402 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 9.1 mptt -148.24 98.58 2.93 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -173.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 105' ' ' GLN . 0.3 OUTLIER -112.13 -178.66 3.47 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.277 -169.333 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.523 ' H ' HD12 ' A' ' 104' ' ' LEU . 14.7 mm100 -104.9 -84.33 0.49 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.981 0.42 . . . . 0.0 111.123 -173.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 58.82 -177.35 0.08 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.527 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.592 ' OD2' ' HG2' ' A' ' 109' ' ' LYS . 10.5 t70 -172.54 151.21 2.35 Favored Pre-proline 0 C--O 1.21 -1.007 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 9.2 Cg_exo -29.9 -47.77 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.693 2.929 . . . . 0.0 114.087 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.592 ' HG2' ' OD2' ' A' ' 107' ' ' ASP . 9.2 ptpp? -58.25 -49.61 76.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.232 0.539 . . . . 0.0 111.831 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.485 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 26.3 mm-40 -85.95 -11.59 52.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.714 0.769 . . . . 0.0 110.872 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.42 -43.89 22.47 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.142 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 115' ' ' PHE . 8.2 pt-20 -69.56 -22.07 63.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.191 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 109' ' ' LYS . 82.0 t -64.02 -35.24 72.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.403 0.62 . . . . 0.0 109.583 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.07 -27.66 54.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.81 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 118' ' ' PRO . 13.7 t80 -89.38 36.62 0.84 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.149 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 116' ' ' GLN . 5.8 pt20 -71.64 81.59 0.84 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.08 0.943 . . . . 0.0 111.27 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.546 ' H ' ' CD ' ' A' ' 118' ' ' PRO . . . 148.22 50.16 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.546 ' CD ' ' H ' ' A' ' 117' ' ' GLY . 11.2 Cg_endo -51.43 110.25 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.713 2.942 . . . . 0.0 113.718 -167.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -134.31 138.74 45.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.719 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -128.62 96.92 4.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.095 0.474 . . . . 0.0 110.873 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 29.0 p -97.5 92.59 6.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.67 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.5 tp -59.11 107.3 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 110.075 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.82 147.87 23.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.343 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -58.58 145.44 39.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.784 0.326 . . . . 0.0 110.415 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.483 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 11.6 m-90 -75.98 147.76 38.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 87' ' ' ALA . 1.6 pp -89.27 169.0 11.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.503 0.668 . . . . 0.0 112.069 -165.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -151.43 114.55 4.75 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.634 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.763 ' OXT' HG13 ' A' ' 33' ' ' ILE . 13.8 p . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 118.011 -0.995 . . . . 0.0 108.699 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 p -62.99 134.74 95.89 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.479 0.181 . . . . 0.0 110.537 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.66 63.88 3.04 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.959 2.439 . . . . 0.0 112.631 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.57 82.07 0.3 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.656 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.707 ' HB ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -92.39 154.93 42.79 Favored Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 122.102 0.161 . . . . 0.0 111.338 -177.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.603 ' HD3' HD11 ' A' ' 104' ' ' LEU . 38.3 Cg_endo -68.83 -86.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.457 2.105 . . . . 0.0 113.407 -172.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.86 107.4 54.65 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-O 121.392 0.615 . . . . 0.0 110.708 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.36 165.61 23.13 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 124.652 3.568 . . . . 0.0 113.257 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 100' ' ' HIS . . . 85.05 -63.54 4.37 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.578 169.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 63.8 mttm 83.03 -136.35 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.418 1.087 . . . . 0.0 111.546 -174.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.498 HG23 HD11 ' A' ' 99' ' ' ILE . 32.7 m -140.26 161.35 25.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.138 0.494 . . . . 0.0 112.152 -162.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 t -122.91 123.87 41.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.389 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.443 ' CD2' HD11 ' A' ' 99' ' ' ILE . 2.4 mm? -118.15 -166.68 1.24 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.805 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.652 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 93.1 mt-30 -127.67 149.67 50.1 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.908 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 23.9 mmtp -52.14 146.26 9.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.749 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.46 179.93 7.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.807 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.99 -22.2 60.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.119 0.485 . . . . 0.0 111.044 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.522 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -92.18 8.7 36.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.033 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 38.6 t30 72.61 11.72 5.52 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.335 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.577 HD22 ' OXT' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -127.13 -168.07 1.83 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.945 -0.472 . . . . 0.0 111.887 -174.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.677 HG23 HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -101.83 -26.87 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 99.08 33.41 5.49 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.144 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.71 HD11 HG23 ' A' ' 128' ' ' VAL . 2.8 pp -125.72 172.38 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.692 0.758 . . . . 0.0 112.126 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 40.0 m -139.14 127.65 23.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.24 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 66.0 mt -106.56 120.23 57.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.891 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.15 -160.21 9.42 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.434 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.32 143.09 17.48 Favored Glycine 0 C--N 1.319 -0.372 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.508 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 42' ' ' GLN . . . -70.86 -121.31 0.05 OUTLIER Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.621 169.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.668 ' H ' ' HA ' ' A' ' 45' ' ' PRO . . . 69.05 -18.67 0.18 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 44' ' ' CYS . 28.0 mm-40 -75.09 56.99 0.8 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 67.73 -7.01 0.62 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.726 0.81 . . . . 0.0 110.808 -174.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' A' ' 42' ' ' GLN . 59.6 m -137.78 92.24 13.04 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.345 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.668 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 52.6 Cg_exo -63.23 -153.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 123.914 3.076 . . . . 0.0 114.045 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 45' ' ' PRO . 76.5 m 70.68 122.98 0.03 OUTLIER 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -163.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -131.97 178.83 6.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.162 0.982 . . . . 0.0 113.067 -170.177 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.692 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 83.7 m-85 67.01 -80.82 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.657 -1.611 . . . . 0.0 110.71 -163.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.37 115.52 28.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.048 -177.21 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.6 t -111.79 -23.36 4.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.942 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -147.5 143.4 27.81 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.663 0.744 . . . . 0.0 112.402 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.5 p -143.05 160.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.758 -1.564 . . . . 0.0 109.395 174.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.561 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 22.8 m-85 -116.86 126.06 52.45 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 34.9 t70 -57.46 -21.99 40.69 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -164.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.492 ' HA ' HD23 ' A' ' 60' ' ' LEU . 42.5 m-80 -101.38 6.17 42.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.228 0.537 . . . . 0.0 110.23 -173.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.561 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 28.3 p -96.98 149.12 35.35 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -48.28 -40.08 35.27 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.183 1.922 . . . . 0.0 111.804 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.54 -54.16 50.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.967 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -73.95 -54.82 7.08 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.036 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -42.85 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.831 -177.199 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -95.6 -36.27 11.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.329 0.585 . . . . 0.0 111.026 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.46 -38.61 95.02 Favored Glycine 0 CA--C 1.517 0.159 0 CA-C-N 115.211 -0.904 . . . . 0.0 114.39 -167.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.11 56.19 4.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.049 0.928 . . . . 0.0 110.819 -174.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.602 HG11 HG13 ' A' ' 99' ' ' ILE . 16.3 m -128.39 49.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.581 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.92 179.28 7.58 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.295 -167.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.19 123.56 7.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.036 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.96 20.5 11.29 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.63 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.2 t0 -107.97 161.77 14.64 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 4.2 mp0 -101.98 124.51 47.73 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.031 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.414 ' H ' ' HB2' ' A' ' 48' ' ' TYR . 10.3 mm -113.31 141.89 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.465 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.568 HG22 ' CB ' ' A' ' 101' ' ' TYR . 12.0 t -137.44 -18.57 1.27 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.706 -0.621 . . . . 0.0 112.262 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -131.9 136.68 8.91 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.032 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.736 HG12 HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -101.15 121.86 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 124.011 0.925 . . . . 0.0 109.156 175.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.502 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 9.2 t-20 57.01 25.51 10.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.542 0.687 . . . . 0.0 110.355 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.87 -21.15 43.12 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.027 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -107.45 140.31 40.6 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 118.206 1.003 . . . . 0.0 111.024 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 23.1 t -52.93 137.12 33.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 111.755 -174.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.736 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -80.94 -17.83 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 109.499 -177.023 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -64.67 -13.58 54.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.523 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.71 -19.57 78.08 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.815 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.533 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.94 -130.7 0.14 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.732 0.766 . . . . 0.0 111.653 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 86' ' ' VAL . 2.8 m -139.11 156.09 47.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.565 -168.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.5 mtpt -47.85 -49.11 30.35 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.292 0.637 . . . . 0.0 111.676 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -58.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 122.454 1.121 . . . . 0.0 110.537 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 41.2 mt-10 -61.93 -30.95 71.25 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 112.94 -1.936 . . . . 0.0 112.615 -171.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.664 HG11 ' HB ' ' A' ' 78' ' ' ILE . 30.5 m -71.17 -42.26 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 126' ' ' LEU . . . -54.17 -41.18 68.2 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 170.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 28.5 ttpp -59.38 -48.48 81.48 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.616 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 89.0 mtp -51.97 -41.16 61.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.138 0.495 . . . . 0.0 110.866 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.551 HD13 HD11 ' A' ' 33' ' ' ILE . 92.6 mt -72.21 -41.28 66.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.231 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -76.05 -25.0 55.18 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.176 -0.327 . . . . 0.0 111.792 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.03 -51.66 65.91 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.52 151.2 8.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -132.05 144.42 50.74 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.151 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.1 -47.27 1.08 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.639 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 10.5 pt-20 -138.59 176.45 8.68 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.568 0.699 . . . . 0.0 111.182 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.677 HG11 HG23 ' A' ' 33' ' ' ILE . 5.5 m -149.65 158.29 6.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.06 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.502 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 24.7 m -142.41 125.08 15.87 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 170.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.602 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -102.9 139.22 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.641 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 0.8 OUTLIER -134.56 124.42 25.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.67 -179.464 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.568 ' CB ' HG22 ' A' ' 71' ' ' THR . 1.0 OUTLIER 169.98 -130.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 O-C-N 124.426 1.079 . . . . 0.0 110.014 166.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.707 ' ND2' ' HB ' ' A' ' 17' ' ' ILE . 4.5 m120 -172.66 -172.33 0.88 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -158.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.642 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 4.1 mptt -124.34 167.37 14.45 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 169.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 103' ' ' LYS . 4.1 pp 54.28 -150.12 0.41 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.112 0.883 . . . . 0.0 113.031 171.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.539 ' N ' HD12 ' A' ' 104' ' ' LEU . 23.9 tt0 80.32 71.76 0.03 OUTLIER 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.432 1.093 . . . . 0.0 109.537 -175.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.02 165.44 11.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.628 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 111' ' ' LEU . 8.4 m-20 -145.23 161.62 41.06 Favored Pre-proline 0 C--O 1.213 -0.821 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -31.36 -48.79 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.68 2.92 . . . . 0.0 114.032 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -57.08 -48.95 77.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.57 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 61.9 mm-40 -90.42 -13.42 34.96 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.677 0.751 . . . . 0.0 110.327 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.4 tm? -76.21 -38.21 56.74 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.238 -175.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.53 -25.89 63.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.394 0.616 . . . . 0.0 109.528 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 110' ' ' GLN . 96.5 t -67.02 -44.18 88.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.572 173.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 4.1 mm? -70.71 -21.67 62.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.758 176.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.9 -39.58 61.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.493 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -143.12 -65.82 0.38 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.308 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.724 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . 175.44 -46.6 0.13 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.124 -174.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.724 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 29.2 Cg_exo -9.08 77.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.297 1 C-N-CA 127.171 5.247 . . . . 0.0 116.832 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.401 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 43.4 tt0 -176.55 40.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -77.8 63.87 2.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.678 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 m -90.05 131.19 36.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.296 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.71 103.35 2.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.881 0.372 . . . . 0.0 110.417 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 123' ' ' ARG . 30.3 mmt180 -130.05 142.43 50.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.626 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.52 162.46 28.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.734 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -119.08 142.11 48.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.994 0.426 . . . . 0.0 110.366 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.559 ' HG ' ' HB ' ' A' ' 37' ' ' ILE . 1.2 pp -113.47 168.57 9.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 13.7 ptmm? -152.56 129.72 11.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.394 0.616 . . . . 0.0 110.918 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.71 HG23 HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.016 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 167.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.3 t -137.75 89.53 15.2 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.761 0.315 . . . . 0.0 110.374 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.58 -32.2 39.41 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.84 2.36 . . . . 0.0 112.618 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.38 -87.09 0.73 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.345 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 pt -71.4 150.92 94.1 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 123.107 -0.055 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.608 ' HG3' HD21 ' A' ' 104' ' ' LEU . 34.3 Cg_endo -65.15 -78.4 0.01 OUTLIER 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.313 2.009 . . . . 0.0 112.571 -172.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.09 115.02 61.88 Favored Pre-proline 0 N--CA 1.427 -1.584 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.33 130.63 30.96 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.105 2.536 . . . . 0.0 112.204 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.36 91.82 0.58 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.728 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -138.33 100.49 4.13 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.71 0.767 . . . . 0.0 110.007 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 HD11 ' A' ' 99' ' ' ILE . 34.8 m -122.06 145.97 27.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.306 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.1 t -117.47 110.9 18.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.721 0.772 . . . . 0.0 110.312 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.49 -164.72 0.97 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.371 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 92.3 mt-30 -131.04 144.36 51.39 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.363 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 29.5 mmtm -47.91 149.65 1.3 Allowed 'General case' 0 C--N 1.316 -0.878 0 O-C-N 124.641 1.213 . . . . 0.0 111.841 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -83.04 -178.59 7.17 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.94 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.77 -19.24 49.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.422 0.63 . . . . 0.0 110.647 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.533 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 2.5 mt-30 -92.8 11.38 27.18 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.626 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 5.0 p30 56.82 24.07 8.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.013 1.325 . . . . 0.0 112.498 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.544 HD22 ' OXT' ' A' ' 128' ' ' VAL . 1.2 pp -130.57 -165.47 1.55 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.182 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.789 HG23 HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -101.75 -29.47 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 100.36 30.86 6.07 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.221 -0.514 . . . . 0.0 113.226 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.619 HD11 HG23 ' A' ' 128' ' ' VAL . 2.8 pp -122.85 179.71 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.061 0.457 . . . . 0.0 111.592 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 51.5 m -138.16 129.67 27.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.095 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.834 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 61.6 mt -97.46 139.47 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.854 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.74 -175.13 41.2 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.049 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.77 108.01 2.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.311 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.603 ' H ' ' HB3' ' A' ' 47' ' ' LEU . . . 97.74 106.39 2.48 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.51 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.504 ' HB3' ' HG2' ' A' ' 45' ' ' PRO . . . -59.65 -67.07 0.42 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.661 0.267 . . . . 0.0 110.862 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -94.42 -71.33 0.67 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -107.96 -59.84 1.79 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 170.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.515 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 47.3 t -171.5 61.77 0.34 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.12 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 0.9 OUTLIER -82.96 -50.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.323 2.015 . . . . 0.0 110.246 173.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 82.5 m -144.43 173.61 11.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.762 175.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.603 ' HB3' ' H ' ' A' ' 40' ' ' GLY . 0.1 OUTLIER -140.81 -172.94 3.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.023 0.916 . . . . 0.0 112.812 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.834 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 5.3 m-85 68.48 -37.86 0.36 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.222 -1.354 . . . . 0.0 114.034 -172.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -112.44 114.69 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 118.207 -1.397 . . . . 0.0 110.503 169.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.9 t -105.03 -30.26 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.258 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 3.8 pt20 -157.05 152.54 26.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.7 p -141.84 160.54 20.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.845 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 97.3 m-85 -114.51 125.92 54.35 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.675 0.75 . . . . 0.0 108.978 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -53.07 -27.59 20.84 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 125.143 1.377 . . . . 0.0 114.566 -165.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.54 ' HA ' HD23 ' A' ' 60' ' ' LEU . 4.0 m-20 -100.85 4.14 42.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.26 0.552 . . . . 0.0 110.463 -171.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.494 ' CB ' ' HA3' ' A' ' 34' ' ' GLY . 30.4 p -91.3 146.82 34.18 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -47.41 -39.11 28.07 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.255 1.97 . . . . 0.0 111.659 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.49 -54.26 49.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.256 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.575 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -75.14 -52.97 9.67 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.388 0.614 . . . . 0.0 110.138 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.1 tm? -43.09 -75.62 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.502 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -96.83 -43.95 7.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.185 0.517 . . . . 0.0 111.479 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.3 -27.75 60.86 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 115.019 -0.992 . . . . 0.0 114.822 -164.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.48 48.31 19.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.868 0.842 . . . . 0.0 111.449 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.6 HG11 HG13 ' A' ' 99' ' ' ILE . 6.1 m -123.8 53.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 CA-C-O 122.936 1.351 . . . . 0.0 109.481 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.8 173.95 10.25 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 112.485 -2.143 . . . . 0.0 111.2 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -51.25 122.36 7.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.889 -174.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.06 -4.97 16.01 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.71 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.625 ' O ' HG22 ' A' ' 49' ' ' ILE . 76.1 m-20 -98.85 172.81 7.2 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 30.7 tt0 -130.72 145.7 52.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.932 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 70' ' ' ILE . 4.2 mp -114.12 128.5 71.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.316 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.67 ' H ' ' HB2' ' A' ' 101' ' ' TYR . 7.3 t -109.03 -4.81 16.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.054 0.454 . . . . 0.0 110.586 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.76 133.43 3.41 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.459 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.694 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -103.15 120.81 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.477 HD21 ' HA ' ' A' ' 90' ' ' ILE . 96.3 m-20 53.78 29.92 10.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.238 0.542 . . . . 0.0 111.704 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.57 -21.59 41.98 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.914 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 14.7 ptm180 -101.27 137.34 39.74 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 118.061 0.93 . . . . 0.0 110.789 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m -65.91 151.39 46.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.063 0.458 . . . . 0.0 111.228 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.896 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -93.47 3.48 8.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 122.455 1.121 . . . . 0.0 108.685 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -78.94 80.88 5.26 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.549 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.59 -30.49 0.41 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.688 -1.244 . . . . 0.0 115.012 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.896 ' HE2' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -112.35 -145.05 0.39 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.844 1.322 . . . . 0.0 112.088 -172.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.548 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -134.71 151.8 51.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.14 -178.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.611 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -45.44 -54.68 7.04 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.159 0.583 . . . . 0.0 112.341 175.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 p -51.69 -31.67 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.166 0.508 . . . . 0.0 111.981 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 89' ' ' MET . 32.4 mt-10 -81.89 -40.22 22.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.005 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.611 HG22 ' HA ' ' A' ' 83' ' ' LYS . 29.9 m -70.55 -38.25 72.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.538 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.746 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -53.17 -42.37 66.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.173 169.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -64.76 -50.77 65.51 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.717 175.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 62.4 mtt -50.74 -41.31 56.28 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.569 0.543 . . . . 0.0 111.045 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.752 HD13 HD11 ' A' ' 33' ' ' ILE . 74.4 mt -65.11 -56.42 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.254 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.407 ' HB2' ' OD1' ' A' ' 31' ' ' ASN . 10.3 pt20 -73.12 -24.59 60.64 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.713 -175.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.566 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 32.2 tt0 -58.7 -53.25 60.48 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.713 0.805 . . . . 0.0 111.976 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 90' ' ' ILE . 12.4 m -56.33 -29.02 27.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.292 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 92' ' ' GLU . 57.4 mttp 61.25 148.73 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.613 0.72 . . . . 0.0 112.609 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.409 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 86.55 -53.45 4.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.407 169.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 10.0 pt-20 -129.06 175.08 8.98 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.158 0.504 . . . . 0.0 110.19 -172.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.789 HG11 HG23 ' A' ' 33' ' ' ILE . 5.7 m -151.37 151.9 11.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.648 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.8 m -141.44 117.51 10.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.798 0.332 . . . . 0.0 110.741 170.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.6 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -98.63 148.74 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.17 176.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 1.1 m-70 -143.54 116.39 8.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.67 ' HB2' ' H ' ' A' ' 71' ' ' THR . 1.3 t80 178.63 -116.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.615 0.572 . . . . 0.0 111.139 162.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 1.1 p-10 -161.47 175.68 11.9 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.135 -163.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 102' ' ' ASN . 53.0 mmtt -120.45 35.6 4.82 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.608 HD21 ' HG3' ' A' ' 18' ' ' PRO . 4.3 pp -178.89 157.07 0.86 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.176 0.512 . . . . 0.0 111.629 175.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 15.6 mm-40 -123.54 16.45 9.62 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.66 0.743 . . . . 0.0 109.245 171.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 73.52 -101.94 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.155 -1.384 . . . . 0.0 113.265 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.443 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 15.2 t70 -154.11 146.78 17.63 Favored Pre-proline 0 C--O 1.205 -1.237 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.031 -169.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 15.6 Cg_exo -29.3 -51.74 0.17 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 124.537 3.491 . . . . 0.0 115.424 -174.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.7 pttm -57.77 -48.15 80.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.356 0.598 . . . . 0.0 111.716 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.9 mm100 -83.37 -17.8 41.06 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.519 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.4 tm? -64.74 -48.36 74.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.076 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 115' ' ' PHE . 3.4 pt-20 -70.54 -25.24 63.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.794 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.8 t -69.6 -45.62 77.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.435 0.636 . . . . 0.0 109.787 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.53 -17.28 58.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.137 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 43.4 t80 -91.74 9.36 32.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.393 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -77.78 10.53 2.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.212 0.529 . . . . 0.0 110.481 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -141.54 -63.33 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -30.16 108.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 124.579 3.519 . . . . 0.0 113.546 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -96.73 105.65 17.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.565 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.414 ' CD1' ' HZ ' ' A' ' 115' ' ' PHE . 3.1 p90 -69.58 118.78 12.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.436 0.636 . . . . 0.0 110.053 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.43 76.63 1.87 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.95 77.97 8.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 17.6 ptp180 -166.48 107.03 0.67 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.76 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 123' ' ' ARG . 63.0 m-70 70.29 143.35 0.05 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.408 0.623 . . . . 0.0 111.406 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -82.21 137.29 34.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.106 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.779 HD13 ' N ' ' A' ' 127' ' ' LYS . 1.5 tm? -111.33 161.21 16.29 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.779 ' N ' HD13 ' A' ' 126' ' ' LEU . 21.8 ptmt -167.0 127.13 1.5 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.532 0.682 . . . . 0.0 111.422 176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.845 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 163.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 112.009 -0.436 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 m 57.94 70.13 1.36 Allowed Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 122.817 0.447 . . . . 0.0 111.114 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.45 53.57 4.27 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.84 2.36 . . . . 0.0 112.465 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.63 -62.08 3.55 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.062 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.5 pt -110.36 152.71 43.44 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.556 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 51.0 Cg_endo -70.1 -61.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.714 1.609 . . . . 0.0 112.105 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.3 93.98 7.53 Favored Pre-proline 0 N--CA 1.441 -0.922 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 173.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.21 138.22 46.33 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.699 2.266 . . . . 0.0 112.557 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.93 144.82 12.06 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.274 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -157.54 129.84 7.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 62' ' ' GLY . 20.7 m -126.54 146.9 31.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.864 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 t -110.95 116.04 30.52 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.726 0.774 . . . . 0.0 110.77 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.502 ' H ' HG22 ' A' ' 97' ' ' VAL . 7.3 mt -123.32 -166.89 1.52 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.646 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.659 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 16.6 pt20 -144.01 142.6 30.78 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.766 174.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HE3' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -32.87 149.74 0.01 OUTLIER 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 177.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.46 -179.25 6.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.655 -1.612 . . . . 0.0 108.385 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.58 -29.04 61.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.59 0.632 . . . . 0.0 111.499 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.558 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.2 mt-30 -88.05 5.36 41.35 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.043 0.449 . . . . 0.0 110.603 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 63.9 t30 70.28 28.22 3.92 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.349 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.683 ' HB2' ' OXT' ' A' ' 128' ' ' VAL . 1.8 pt? -128.19 -171.26 2.41 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.785 175.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.841 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -104.58 -26.21 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.715 179.091 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' N ' ' HG ' ' A' ' 32' ' ' LEU . . . 96.17 40.43 4.01 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.386 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.548 HD11 HG12 ' A' ' 128' ' ' VAL . 2.9 pp -129.64 176.74 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.968 0.89 . . . . 0.0 112.305 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 24.0 m -144.72 126.87 15.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.731 172.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.5 mt -103.32 119.9 52.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.246 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.39 134.99 11.89 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.824 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.08 162.31 12.68 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.623 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' ' HG ' ' A' ' 47' ' ' LEU . . . -70.05 -143.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.799 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 121' ' ' THR . . . -174.71 -84.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.66 0.267 . . . . 0.0 110.596 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -97.54 -14.62 20.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 110.201 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -87.74 -73.58 0.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 p -158.05 97.72 1.85 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.177 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.571 ' HG2' ' O ' ' A' ' 119' ' ' GLN . 81.8 Cg_exo -49.57 146.62 14.52 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.221 2.614 . . . . 0.0 112.725 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 84.3 m 70.37 125.95 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 O-C-N 124.261 0.976 . . . . 0.0 109.598 -165.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.526 ' O ' ' HG3' ' A' ' 69' ' ' GLU . 13.2 mt -140.16 -93.44 0.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.652 0.739 . . . . 0.0 110.888 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 49.2 p90 -144.01 174.58 10.73 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.347 -168.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.709 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -77.63 121.01 29.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.23 178.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.7 m -94.31 -20.51 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.691 -170.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -157.07 136.24 11.92 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.505 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.7 p -139.88 160.28 26.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.16 -138.55 0.2 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -138.24 -39.37 0.54 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.765 0.711 . . . . 0.0 112.145 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -101.32 4.09 41.3 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.762 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 59.9 p -84.14 148.04 52.27 Favored Pre-proline 0 N--CA 1.433 -1.285 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.0 Cg_endo -49.7 -42.18 43.93 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.764 1.643 . . . . 0.0 111.22 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.576 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.6 -46.48 84.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.019 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.76 -59.13 2.87 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.346 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.6 pp -51.16 -74.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -171.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.604 ' N ' HD12 ' A' ' 60' ' ' LEU . 21.7 t70 -93.74 -15.4 25.23 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.544 1.164 . . . . 0.0 108.081 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -64.39 -48.39 74.51 Favored Glycine 0 C--N 1.313 -0.704 0 CA-C-N 112.818 -1.992 . . . . 0.0 114.524 -166.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.1 p 63.64 15.78 9.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.078 0.951 . . . . 0.0 111.006 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG11 HG13 ' A' ' 99' ' ' ILE . 16.7 m -96.92 53.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-O 123.0 1.381 . . . . 0.0 110.028 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.21 168.52 14.69 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 112.512 -2.131 . . . . 0.0 111.39 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.66 122.54 6.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.832 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.64 -14.64 11.65 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.009 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.709 ' O ' HG22 ' A' ' 49' ' ' ILE . 43.4 m-20 -90.55 146.15 24.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.2 0.5 . . . . 0.0 110.167 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 47' ' ' LEU . 33.1 tt0 -89.4 126.48 35.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.682 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.5 mm -94.42 120.27 43.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -110.97 -21.68 11.88 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.832 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.78 156.06 27.72 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.398 -1.382 . . . . 0.0 113.869 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -121.9 124.63 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 C-N-CA 123.573 0.749 . . . . 0.0 109.186 178.181 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.466 ' HA ' ' OG1' ' A' ' 98' ' ' THR . 4.7 t30 58.28 22.57 9.43 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.583 0.706 . . . . 0.0 111.192 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.44 -20.01 50.23 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.109 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 11.3 ptp180 -101.99 130.17 48.46 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 117.292 0.546 . . . . 0.0 110.619 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.6 m -63.66 153.52 35.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.021 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -93.08 -30.93 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 110.417 -178.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -71.44 91.26 1.02 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.552 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.54 -21.51 0.33 Allowed Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.799 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -125.83 -131.08 0.25 Allowed 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.245 177.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -137.48 147.36 45.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.927 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.546 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -46.32 -49.49 17.55 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.598 0.759 . . . . 0.0 112.527 176.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -57.26 -39.9 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.831 0.348 . . . . 0.0 111.623 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.46 -41.48 66.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.943 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 83' ' ' LYS . 32.8 m -67.63 -45.21 85.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.897 0.38 . . . . 0.0 110.815 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.25 -34.59 75.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.261 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.61 -51.16 68.39 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.424 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.2 mmt -53.04 -36.65 60.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.62 0.724 . . . . 0.0 111.416 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.449 HD13 HD11 ' A' ' 33' ' ' ILE . 44.6 mt -72.64 -31.86 38.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.753 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -90.37 -23.51 21.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.8 -49.45 62.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.946 0.499 . . . . 0.0 111.097 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.88 -32.32 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.718 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 62.32 119.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.659 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 96.97 -33.22 5.9 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.194 173.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.3 pt-20 -134.86 178.76 6.77 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 117.177 0.489 . . . . 0.0 110.501 -171.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.581 HG12 ' HE3' ' A' ' 27' ' ' LYS . 1.2 m -152.48 148.74 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.159 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -141.27 106.93 5.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.469 172.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.588 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -100.0 141.99 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.051 0.453 . . . . 0.0 111.705 -178.003 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -118.5 121.36 40.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -136.52 174.73 10.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.053 0.454 . . . . 0.0 111.614 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -166.47 -169.8 1.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HE3' ' OD1' ' A' ' 68' ' ' ASP . 10.3 mptt -144.4 97.34 3.02 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.556 ' HG ' ' HG3' ' A' ' 18' ' ' PRO . 5.7 mt -127.91 134.91 49.38 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -172.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -140.99 98.64 3.42 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.788 164.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.83 163.95 8.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.075 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -125.65 155.87 71.72 Favored Pre-proline 0 C--O 1.215 -0.761 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -30.66 -55.39 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.915 3.077 . . . . 0.0 114.721 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.54 ' O ' HG23 ' A' ' 113' ' ' VAL . 5.9 ptpp? -56.48 -47.12 79.9 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.242 0.544 . . . . 0.0 112.311 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.481 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.3 mm100 -87.84 -17.02 32.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.895 -175.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 111' ' ' LEU . 3.4 tm? -77.8 -45.32 24.79 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.021 -177.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.92 -27.27 69.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.215 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 109' ' ' LYS . 77.0 t -61.0 -41.38 88.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.14 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.79 -24.61 41.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.544 0.688 . . . . 0.0 109.802 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -92.69 30.38 1.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.413 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -89.75 11.49 19.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.017 0.437 . . . . 0.0 110.648 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.519 ' H ' ' HD3' ' A' ' 118' ' ' PRO . . . 151.5 51.87 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.519 ' HD3' ' H ' ' A' ' 117' ' ' GLY . 38.4 Cg_endo -61.64 -17.96 57.37 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.419 2.746 . . . . 0.0 113.478 -169.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.571 ' O ' ' HG2' ' A' ' 45' ' ' PRO . 35.0 tt0 67.71 87.81 0.12 Allowed 'General case' 0 N--CA 1.462 0.168 0 O-C-N 123.75 0.656 . . . . 0.0 110.131 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.79 91.79 0.2 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.964 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.696 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 3.5 p -140.61 134.73 30.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.962 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.435 HD13 ' HB1' ' A' ' 41' ' ' ALA . 3.3 mm? -71.96 106.04 4.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.395 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.459 ' HA ' ' HE ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -102.05 103.3 13.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.17 0.509 . . . . 0.0 111.166 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -71.68 168.46 17.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.898 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -80.38 115.95 20.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.463 ' HB3' ' HE3' ' A' ' 83' ' ' LYS . 1.6 pp -89.12 168.56 12.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.043 175.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.452 ' C ' ' HD2' ' A' ' 127' ' ' LYS . 0.1 OUTLIER -143.49 154.49 43.7 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.841 ' OXT' HG13 ' A' ' 33' ' ' ILE . 7.1 p . . . . . 0 C--O 1.247 0.93 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.804 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.7 t -121.44 127.47 26.09 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.08 10.31 1.78 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.714 2.276 . . . . 0.0 112.541 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.31 -61.44 4.71 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -107.01 150.95 40.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.822 0.344 . . . . 0.0 110.359 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.431 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 30.9 Cg_endo -86.7 -152.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.384 2.723 . . . . 0.0 111.843 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 1.5 t -34.08 122.55 0.51 Allowed Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.864 0.866 . . . . 0.0 112.67 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 19' ' ' VAL . 10.6 Cg_endo -90.95 128.74 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 123.528 2.819 . . . . 0.0 112.243 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.07 143.68 17.46 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.46 ' N ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -155.48 127.63 7.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.77 0.285 . . . . 0.0 110.352 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.466 HG23 HD11 ' A' ' 99' ' ' ILE . 27.2 m -128.71 158.65 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.152 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.9 t -132.72 117.32 17.7 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.652 0.739 . . . . 0.0 110.656 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.11 -159.25 0.9 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.875 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -122.57 158.26 30.31 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.625 0.726 . . . . 0.0 110.114 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.589 ' NZ ' ' HA ' ' A' ' 91' ' ' GLN . 11.4 mmmm -54.4 156.69 3.17 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.082 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.57 174.97 7.47 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.3 -15.56 36.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.224 0.535 . . . . 0.0 110.556 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 31' ' ' ASN . 0.9 OUTLIER -91.38 -0.49 57.65 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.746 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.508 ' C ' ' HE2' ' A' ' 27' ' ' LYS . 31.1 t30 70.06 38.05 1.59 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.427 1.108 . . . . 0.0 109.897 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -154.57 -167.35 2.59 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.572 175.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.738 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.26 -28.93 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.945 -177.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 100.4 35.11 4.52 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.608 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.505 HG22 HG23 ' A' ' 52' ' ' VAL . 2.7 pp -126.92 177.96 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.269 0.557 . . . . 0.0 111.633 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -134.76 128.19 32.39 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.626 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.772 ' HB ' HD12 ' A' ' 126' ' ' LEU . 56.2 mt -107.47 140.79 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.469 0.652 . . . . 0.0 111.912 -173.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 48' ' ' TYR . . . 177.94 -170.51 42.8 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.978 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.28 153.48 17.01 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.94 -72.76 0.44 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.386 -0.912 . . . . 0.0 112.697 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -83.0 81.07 8.83 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 10.5 pt20 55.84 -70.38 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.401 1.48 . . . . 0.0 113.826 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 123' ' ' ARG . 54.9 p90 -154.53 16.97 0.46 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.778 0.717 . . . . 0.0 111.595 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 56.4 m -91.07 -49.21 0.34 Allowed Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.978 -174.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 44' ' ' CYS . 94.8 Cg_endo -99.7 -163.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.09 1.86 . . . . 0.0 111.972 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.6 m -117.79 -179.74 3.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.389 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 48' ' ' TYR . 4.2 pp 149.27 -40.51 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.134 2.173 . . . . 0.0 107.262 171.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.761 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 78.8 m-85 62.69 -22.33 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 174.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.536 ' HB ' ' CG1' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -110.85 109.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 120.338 1.426 . . . . 0.0 110.218 171.319 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -95.62 -30.55 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.206 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -155.49 139.87 16.75 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.453 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.2 p -138.33 161.2 31.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -99.33 -135.05 0.28 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 15.7 t70 -138.4 -33.41 0.68 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -101.61 1.82 38.19 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.062 0.458 . . . . 0.0 110.366 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 77.9 p -85.33 150.18 53.92 Favored Pre-proline 0 N--CA 1.44 -0.956 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.16 -40.39 77.31 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.295 1.33 . . . . 0.0 111.197 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.42 -46.28 86.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.741 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.63 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -73.62 -58.4 3.33 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.672 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 61' ' ' ASP . 2.1 pp -52.95 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -170.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.647 ' N ' HD12 ' A' ' 60' ' ' LEU . 24.0 t70 -95.99 -16.32 21.75 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.262 1.029 . . . . 0.0 108.487 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -61.21 -38.71 96.09 Favored Glycine 0 C--N 1.315 -0.586 0 CA-C-N 113.019 -1.901 . . . . 0.0 113.594 -169.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p 52.31 38.38 24.76 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.415 1.102 . . . . 0.0 111.774 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.496 HG11 HG13 ' A' ' 99' ' ' ILE . 12.4 m -118.17 54.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.832 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.514 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -84.49 168.64 15.27 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 112.716 -2.038 . . . . 0.0 111.778 -170.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.89 132.09 26.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.669 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.0 2.64 57.03 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.648 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 101' ' ' TYR . 1.7 t70 -90.77 167.89 12.14 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.97 89.52 3.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.536 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 25.0 mm -78.34 110.0 13.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.893 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -102.3 -7.57 21.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.129 -175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -151.88 135.37 4.99 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.384 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.657 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -103.57 120.83 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 123.615 0.766 . . . . 0.0 109.217 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.3 t30 55.1 32.81 19.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.952 0.882 . . . . 0.0 110.472 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.83 -21.29 44.39 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.405 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.415 ' H ' ' HG2' ' A' ' 76' ' ' ARG . 2.5 ptm180 -108.17 138.58 44.2 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 117.132 0.466 . . . . 0.0 110.484 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.487 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 17.7 t -59.58 142.51 52.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.89 0.376 . . . . 0.0 111.892 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.657 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -74.89 -22.71 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -64.38 99.35 0.29 Allowed 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.814 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.2 -30.63 1.75 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.942 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.628 ' HE3' ' SD ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -125.26 -139.27 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.795 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -141.25 159.88 41.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.896 -169.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.586 ' O ' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -49.38 -52.79 26.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.503 0.502 . . . . 0.0 110.865 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -53.94 -38.71 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.893 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 34.2 mt-10 -76.28 -39.58 53.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.567 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 83' ' ' LYS . 34.7 m -69.61 -39.31 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.299 . . . . 0.0 111.389 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.54 -43.64 62.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.326 168.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 28.5 ttpp -61.59 -46.58 89.25 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.495 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.628 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 74.1 mtp -56.3 -35.14 67.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.43 0.633 . . . . 0.0 110.482 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 93' ' ' VAL . 27.9 mm -73.7 -32.3 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.387 177.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.589 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 47.9 mt-30 -82.74 -24.67 33.44 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.754 -0.591 . . . . 0.0 111.899 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -64.25 -39.49 94.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.286 0.634 . . . . 0.0 111.895 -171.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.536 HG23 ' N ' ' A' ' 94' ' ' LYS . 3.7 m -35.48 -47.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.114 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.536 ' N ' HG23 ' A' ' 93' ' ' VAL . 55.4 mtmt 57.08 83.29 0.1 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.496 -162.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.538 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 115.47 -36.73 3.75 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 118.785 -1.674 . . . . 0.0 113.675 164.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' O ' HG21 ' A' ' 93' ' ' VAL . 11.7 pt-20 -106.13 172.35 6.86 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 117.716 0.758 . . . . 0.0 110.127 -173.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 t -153.4 127.87 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.448 -171.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.0 m -141.04 135.75 31.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.496 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -130.87 140.67 48.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.801 0.334 . . . . 0.0 111.808 -177.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -116.99 122.57 44.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.411 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 40.2 p90 -138.85 157.16 46.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.073 0.463 . . . . 0.0 111.582 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -139.83 -179.23 5.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.617 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -107.69 166.96 10.3 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.0 -177.148 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 103' ' ' LYS . 4.0 pp 56.66 115.2 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.87 1.356 . . . . 0.0 114.506 170.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.49 30.37 0.75 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.019 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -100.06 148.63 24.34 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.122 0.963 . . . . 0.0 112.299 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.501 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 16.7 m-20 -151.65 168.62 10.8 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 107' ' ' ASP . 12.8 Cg_exo -31.51 -46.86 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.904 2.403 . . . . 0.0 113.959 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.1 ptpt -68.83 -48.23 64.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.511 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.492 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.5 mm100 -84.92 -11.77 54.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.438 0.637 . . . . 0.0 110.968 -174.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.434 HD13 ' C ' ' A' ' 111' ' ' LEU . 3.1 tm? -70.02 -43.37 71.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.339 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.16 -30.72 63.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.271 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 118' ' ' PRO . 84.3 t -63.71 -36.1 75.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.473 0.654 . . . . 0.0 109.902 175.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.6 tp -77.86 -27.02 49.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.244 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -58.77 -40.9 85.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.075 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -141.57 -67.57 0.4 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.222 0.534 . . . . 0.0 109.876 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.781 ' H ' ' CD ' ' A' ' 118' ' ' PRO . . . 147.06 39.3 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.246 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.781 ' CD ' ' H ' ' A' ' 117' ' ' GLY . 18.6 Cg_endo -54.65 114.35 1.8 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.964 2.443 . . . . 0.0 112.579 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -88.88 62.05 6.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.669 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -77.42 -23.39 50.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.937 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 p -99.2 129.32 45.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.124 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.4 tp -98.17 -85.2 0.38 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.391 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.585 ' HG2' ' H ' ' A' ' 124' ' ' HIS . 44.9 ttt180 60.85 179.73 0.1 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.003 0.43 . . . . 0.0 110.6 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.585 ' H ' ' HG2' ' A' ' 123' ' ' ARG . 62.9 t60 -102.36 109.68 21.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 173.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -81.23 -179.35 7.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.262 0.554 . . . . 0.0 111.139 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.772 HD12 ' HB ' ' A' ' 37' ' ' ILE . 2.0 mt -95.6 169.03 10.32 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.972 172.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -157.51 80.75 0.89 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.194 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.738 ' OXT' HG13 ' A' ' 33' ' ' ILE . 9.1 p . . . . . 0 N--CA 1.438 -1.068 0 CA-C-O 117.575 -1.203 . . . . 0.0 108.724 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.802 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.524 ' HB3' HD13 ' A' ' 17' ' ' ILE . 32.9 t -75.6 118.36 70.36 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.69 99.18 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.482 2.121 . . . . 0.0 111.792 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 151.25 -23.34 0.97 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.651 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 14' ' ' SER . 3.9 pt -90.16 151.55 44.96 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.511 ' HD3' HD11 ' A' ' 104' ' ' LEU . 46.3 Cg_endo -76.93 -75.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.973 1.782 . . . . 0.0 112.708 -171.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.7 93.9 15.49 Favored Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.293 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HB3' HD11 ' A' ' 17' ' ' ILE . 46.5 Cg_endo -83.05 130.68 5.69 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.755 2.303 . . . . 0.0 112.407 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.53 152.22 20.85 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.101 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -160.09 137.19 9.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 62' ' ' GLY . 29.8 m -128.04 152.93 36.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.5 t -118.41 123.07 44.33 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.631 0.729 . . . . 0.0 110.571 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -130.51 -165.22 1.52 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.536 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -133.28 142.93 48.75 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.326 0.584 . . . . 0.0 110.513 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.63 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 2.5 mmmm -43.09 146.95 0.37 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.487 -1.688 . . . . 0.0 112.637 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -85.09 177.8 7.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.798 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.14 -21.77 48.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.909 0.385 . . . . 0.0 111.45 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -92.88 15.11 15.56 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.123 0.487 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.473 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 1.2 p-10 54.5 35.31 23.05 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.527 1.131 . . . . 0.0 111.583 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.708 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -140.76 -171.16 3.18 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.376 174.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.827 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -97.96 -31.07 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-O 120.682 0.277 . . . . 0.0 111.039 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' N ' HD13 ' A' ' 32' ' ' LEU . . . 102.5 37.64 3.22 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.324 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 2.3 pp -126.91 173.37 12.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.131 0.491 . . . . 0.0 110.72 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.4 m -134.86 130.55 36.16 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.782 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.796 ' HB ' HD12 ' A' ' 126' ' ' LEU . 40.7 mm -114.15 128.91 70.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.73 0.776 . . . . 0.0 111.838 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 47' ' ' LEU . . . -138.42 168.27 24.72 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.582 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 47' ' ' LEU . . . -73.27 143.97 33.83 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.411 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.477 ' H ' ' HB3' ' A' ' 47' ' ' LEU . . . -60.92 -52.36 52.79 Favored Glycine 0 CA--C 1.502 -0.742 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 174.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.573 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -124.04 -163.38 1.14 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 166.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -80.9 -46.04 15.84 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.361 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -154.86 46.16 0.53 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.618 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 3.7 m -138.23 -74.03 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 44' ' ' CYS . 43.4 Cg_endo -95.42 -164.92 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.215 1.943 . . . . 0.0 113.333 -169.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.485 ' SG ' ' HG3' ' A' ' 105' ' ' GLN . 61.8 m -76.32 -175.31 3.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.954 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -134.48 179.41 6.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.568 0.699 . . . . 0.0 112.093 -174.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.501 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 48.4 p90 -145.19 174.74 10.82 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.579 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -88.03 118.83 34.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.02 -34.6 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.833 -170.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -155.84 144.41 20.25 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 120.764 0.316 . . . . 0.0 110.487 -171.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.7 p -139.14 160.18 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -92.02 -136.19 0.15 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.448 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 8.6 t70 -139.73 -38.26 0.47 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.617 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -100.91 3.87 42.15 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.036 0.446 . . . . 0.0 110.324 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 61.7 p -82.62 151.26 64.62 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.5 -40.75 71.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.299 1.333 . . . . 0.0 111.269 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -59.16 -44.31 92.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.255 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.646 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -78.33 -55.94 4.85 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.836 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.7 pp -52.66 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -171.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.607 ' N ' HD12 ' A' ' 60' ' ' LEU . 29.4 t70 -95.78 -12.73 24.89 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.441 1.115 . . . . 0.0 108.12 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -65.36 -45.46 90.54 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 112.969 -1.923 . . . . 0.0 113.497 -170.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p 62.93 9.51 3.77 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.069 0.948 . . . . 0.0 111.498 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.689 HG11 HG13 ' A' ' 99' ' ' ILE . 19.1 m -89.68 53.53 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 CA-C-O 123.001 1.382 . . . . 0.0 110.166 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.441 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -84.29 169.99 14.13 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.622 -2.081 . . . . 0.0 111.459 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.48 129.87 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.143 -174.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.7 -22.24 10.11 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.673 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -80.4 161.48 24.95 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.339 -177.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.446 ' OE2' ' HA ' ' A' ' 104' ' ' LEU . 27.4 tt0 -110.44 120.89 43.88 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.8 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.0 mm -89.63 123.75 41.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.588 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.459 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 7.6 t -103.15 -29.77 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -175.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -163.51 151.16 20.54 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.905 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.607 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -107.72 122.53 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.442 ' ND2' HG11 ' A' ' 93' ' ' VAL . 5.2 m-20 50.62 31.6 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.66 -20.66 45.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.637 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 18.8 ptp180 -100.23 124.39 45.61 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 117.502 0.651 . . . . 0.0 110.279 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.402 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 21.1 m -61.15 149.83 36.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.999 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.604 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -81.76 -17.55 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.567 0.698 . . . . 0.0 109.55 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HE2' ' SG ' ' A' ' 46' ' ' CYS . 37.9 ttmt -61.69 -24.14 66.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.636 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.45 -12.69 80.0 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.182 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -137.35 -131.51 0.14 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.531 0.666 . . . . 0.0 110.619 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' HG13 ' A' ' 86' ' ' VAL . 4.3 p -146.8 166.09 27.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.364 0.126 . . . . 0.0 111.046 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -49.72 -53.33 25.4 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.662 0.601 . . . . 0.0 112.406 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -56.08 -37.73 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.66 -38.86 58.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.529 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.604 HG11 ' HB ' ' A' ' 78' ' ' ILE . 26.6 m -71.13 -44.03 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.955 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.21 62.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.289 170.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.21 -52.48 63.59 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.284 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.8 mmt -54.06 -43.23 70.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 0.0 112.02 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.95 -39.59 82.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.067 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.82 -36.16 57.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 122.362 -0.211 . . . . 0.0 111.443 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.83 -44.08 90.84 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.308 0.643 . . . . 0.0 110.892 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.8 m -70.18 71.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 122.878 1.323 . . . . 0.0 110.203 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.34 126.3 26.97 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.596 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.63 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 100.66 -27.16 21.8 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.515 170.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.16 171.87 9.48 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 117.39 0.595 . . . . 0.0 110.083 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.494 HG21 HG23 ' A' ' 33' ' ' ILE . 2.1 t -157.19 128.17 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.742 -171.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.4 m -140.32 106.47 5.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.038 0.447 . . . . 0.0 110.908 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.689 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -97.18 147.81 6.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.064 -177.524 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.88 123.38 28.86 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -133.65 144.76 49.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 0.0 111.421 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.464 ' ND2' HD12 ' A' ' 17' ' ' ILE . 24.6 m-20 -135.26 -172.19 3.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -101.62 -4.82 25.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.239 0.542 . . . . 0.0 109.66 174.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.511 HD11 ' HD3' ' A' ' 18' ' ' PRO . 4.3 pp -177.25 163.01 2.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.873 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.485 ' HG3' ' SG ' ' A' ' 46' ' ' CYS . 13.0 pt20 -155.3 66.48 0.64 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.267 0.555 . . . . 0.0 111.498 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.45 156.59 39.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.522 0.677 . . . . 0.0 111.454 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.402 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 16.5 m-20 -133.95 158.7 74.78 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.54 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 22.4 Cg_exo -31.8 -52.57 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.678 2.919 . . . . 0.0 114.07 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.0 ptmt -62.25 -48.51 79.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.015 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.474 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 71.6 mm-40 -81.4 -19.45 42.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.712 0.768 . . . . 0.0 110.153 -174.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.31 -51.17 13.86 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.204 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 4.7 pt-20 -70.77 -34.6 71.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.879 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.525 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 2.9 p -65.14 -38.37 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.283 -176.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.75 -28.04 36.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.511 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -58.68 -45.88 88.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.508 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -67.07 -33.1 74.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.608 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.77 62.59 0.54 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 113' ' ' VAL . 18.0 Cg_endo -56.86 -69.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.418 2.745 . . . . 0.0 112.988 -173.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -144.67 -78.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.503 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.465 ' CZ ' HD22 ' A' ' 47' ' ' LEU . 8.0 t80 45.45 73.02 0.18 Allowed 'General case' 0 CA--C 1.53 0.198 0 O-C-N 124.254 0.971 . . . . 0.0 111.629 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.8 p -87.55 119.79 28.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.829 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.7 mt -94.81 138.57 32.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -146.95 111.58 5.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.759 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 76.1 t60 72.16 126.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.986 0.804 . . . . 0.0 112.164 174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -72.54 137.43 46.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.796 HD12 ' HB ' ' A' ' 37' ' ' ILE . 12.2 mt -91.21 168.75 11.38 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -167.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -165.78 85.62 0.35 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 110.996 -2.82 . . . . 0.0 109.057 175.522 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.827 ' OXT' HG13 ' A' ' 33' ' ' ILE . 6.0 p . . . . . 0 C--O 1.246 0.872 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.287 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 t -154.92 91.85 2.91 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.55 -14.46 19.98 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.586 2.191 . . . . 0.0 112.342 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.7 -90.07 0.95 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.588 HG13 ' ND2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -73.69 157.57 87.34 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.038 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.682 ' HG3' HD21 ' A' ' 104' ' ' LEU . 51.2 Cg_endo -68.5 -101.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.192 1.928 . . . . 0.0 114.528 -164.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.3 t -86.61 107.55 14.27 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 118.553 0.615 . . . . 0.0 110.422 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.486 ' HA ' ' ND2' ' A' ' 102' ' ' ASN . 9.9 Cg_endo -48.84 123.21 9.35 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 124.343 3.362 . . . . 0.0 114.549 -167.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.09 110.82 2.15 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.155 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -168.36 138.26 2.48 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.492 HG23 HD11 ' A' ' 99' ' ' ILE . 29.2 m -140.53 158.72 24.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 t -124.37 125.79 44.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.163 0.506 . . . . 0.0 110.751 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.44 -169.28 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.763 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 91.0 mt-30 -132.9 149.21 52.27 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.417 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.634 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 8.6 mmtp -47.24 146.37 1.93 Allowed 'General case' 0 C--N 1.313 -1.004 0 O-C-N 124.629 1.206 . . . . 0.0 112.344 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.427 ' HB2' ' HD2' ' A' ' 57' ' ' PRO . 27.2 t70 -82.88 177.94 8.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.115 176.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.03 -19.78 61.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.185 0.517 . . . . 0.0 110.419 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.49 3.84 51.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.241 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 71.9 15.72 5.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.68 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.516 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -131.43 -163.69 1.36 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.642 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.851 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.51 -23.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.8 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.86 36.13 4.87 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.918 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.51 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.6 pp -125.91 168.53 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.903 0.859 . . . . 0.0 111.564 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 44.9 m -134.43 131.77 38.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.499 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.685 ' O ' ' HB3' ' A' ' 126' ' ' LEU . 76.3 mt -117.75 130.67 72.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.57 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.89 125.32 3.38 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.633 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.73 116.26 4.8 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.07 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.37 -167.12 4.21 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.435 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.6 -19.15 64.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 13.4 mm-40 68.88 -46.17 0.55 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.655 0.782 . . . . 0.0 111.362 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -55.53 -16.04 3.46 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.822 0.849 . . . . 0.0 111.097 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.628 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 29.8 m -146.62 -68.05 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.628 ' HD3' ' HB2' ' A' ' 44' ' ' CYS . 66.4 Cg_endo -95.09 -37.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.698 1.599 . . . . 0.0 115.878 -165.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.727 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 64.5 m 70.51 -66.58 0.28 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.562 0.745 . . . . 0.0 112.731 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 46' ' ' CYS . 0.1 OUTLIER 55.96 -75.05 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.381 1.472 . . . . 0.0 114.511 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 30.2 m-85 70.23 -74.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -169.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -79.11 109.5 13.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 118.344 -1.342 . . . . 0.0 109.497 -176.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -98.43 -25.73 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.229 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.76 145.23 12.33 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.946 -172.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 59' ' ' ALA . 7.5 p -140.25 161.12 25.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -87.81 -138.03 0.1 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -137.48 -38.94 0.59 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 119.152 0.887 . . . . 0.0 112.641 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.552 ' HA ' HD23 ' A' ' 60' ' ' LEU . 4.6 m-20 -101.45 10.86 40.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.455 0.645 . . . . 0.0 109.854 -171.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 42.9 p -93.82 147.87 34.3 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 28' ' ' ASP . 8.5 Cg_endo -48.48 -39.97 36.74 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.215 1.943 . . . . 0.0 111.631 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.8 -53.57 56.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.141 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.589 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.98 -55.04 6.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.513 0.673 . . . . 0.0 109.946 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.1 tm? -42.73 -76.22 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.171 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -96.45 -38.3 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.052 0.453 . . . . 0.0 111.514 -177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.483 ' O ' HG22 ' A' ' 63' ' ' THR . . . -66.49 -27.29 73.04 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.746 -168.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 62' ' ' GLY . 5.8 t 52.44 25.44 3.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.456 1.103 . . . . 0.0 111.645 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.572 HG11 HG13 ' A' ' 99' ' ' ILE . 29.9 m -88.93 50.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 122.068 0.937 . . . . 0.0 109.761 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.44 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.01 175.27 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.204 -171.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.43 118.53 3.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.527 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.93 5.59 8.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.82 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.707 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -107.3 161.75 14.51 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 110.431 174.665 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 18.0 mm-40 -104.05 138.24 40.87 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.6 mm -118.55 134.01 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 123.104 0.252 . . . . 0.0 110.379 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 101' ' ' TYR . 14.9 t -132.74 -18.97 2.37 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.127 -0.358 . . . . 0.0 111.844 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -139.16 138.32 9.25 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.744 -1.217 . . . . 0.0 113.635 -178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.631 HG12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -105.53 123.15 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.532 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 17.4 t-20 59.1 23.23 11.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.914 0.864 . . . . 0.0 109.965 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.93 -20.24 48.67 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.552 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -105.32 136.58 44.58 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 117.888 0.844 . . . . 0.0 111.095 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 71' ' ' THR . 19.3 t -55.88 140.63 42.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.678 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.631 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -74.68 -17.57 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.731 0.777 . . . . 0.0 109.127 -177.03 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -63.47 -20.57 65.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.633 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.4 -17.32 76.32 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.365 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.625 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 1.7 mptp? -120.42 -136.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.914 0.864 . . . . 0.0 109.635 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.9 p -151.31 163.49 38.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.525 -1.671 . . . . 0.0 107.838 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.63 ' HB3' HD22 ' A' ' 126' ' ' LEU . 1.5 mtpt -48.02 -52.75 18.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.316 0.579 . . . . 0.0 111.793 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -56.67 -35.11 44.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.362 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 89' ' ' MET . 34.1 mt-10 -77.13 -46.54 23.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.614 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.586 HG11 ' HB ' ' A' ' 78' ' ' ILE . 24.0 m -59.05 -43.7 89.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -59.51 -35.59 74.45 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 173.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 38.8 ttpt -64.34 -51.26 64.25 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.474 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 82.2 mtp -48.15 -52.24 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.737 0.648 . . . . 0.0 111.136 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.634 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 62.6 mt -61.78 -46.69 95.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.029 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.434 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 8.7 pt20 -77.39 -29.03 53.0 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.211 -0.306 . . . . 0.0 111.564 -177.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -68.23 -48.0 66.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.3 m -50.31 -33.48 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.86 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt 67.15 137.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.669 0.747 . . . . 0.0 112.282 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.565 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 90.59 -50.07 3.2 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.404 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.3 pt-20 -125.82 176.49 6.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 117.256 0.528 . . . . 0.0 110.409 -172.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.48 HG11 HG23 ' A' ' 33' ' ' ILE . 14.2 m -150.88 150.85 13.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.804 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.532 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 1.7 m -141.83 107.58 5.12 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.904 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.572 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -90.8 138.87 18.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.902 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.61 124.42 15.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.658 ' HA ' HG22 ' A' ' 71' ' ' THR . 1.0 OUTLIER -174.66 -113.17 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.168 161.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.588 ' ND2' HG13 ' A' ' 17' ' ' ILE . 1.5 t-20 -179.03 -173.55 0.3 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.878 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.785 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 8.7 mmpt? -93.22 171.13 9.12 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 172.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 103' ' ' LYS . 3.6 pp 52.93 154.27 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 O-C-N 124.594 1.184 . . . . 0.0 112.358 -173.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 0.2 OUTLIER -91.1 -13.19 33.56 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.578 -178.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -178.85 165.12 1.57 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.394 0.616 . . . . 0.0 112.58 -173.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -125.73 148.81 63.45 Favored Pre-proline 0 C--O 1.212 -0.883 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 168.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -32.08 -52.6 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.818 3.012 . . . . 0.0 114.443 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.2 ptmt -55.82 -46.08 78.17 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.3 mm100 -89.63 -13.41 37.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.892 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.2 tm? -70.79 -40.95 72.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.313 -177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . 5.8 pt-20 -70.7 -24.38 62.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.258 0.552 . . . . 0.0 110.46 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.08 -45.54 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.042 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 116' ' ' GLN . 74.2 mt -82.61 -3.42 56.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.365 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 9.4 t80 -64.69 38.52 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.36 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 114' ' ' LEU . 41.7 mt-30 -61.26 98.4 0.08 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.567 0.698 . . . . 0.0 110.322 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.635 ' H ' ' HD2' ' A' ' 118' ' ' PRO . . . -94.5 -50.67 2.14 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.635 ' HD2' ' H ' ' A' ' 117' ' ' GLY . 5.6 Cg_exo -34.9 -53.64 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.738 3.625 . . . . 0.0 112.984 164.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -78.78 113.77 17.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.046 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -78.18 -26.54 47.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.791 0.329 . . . . 0.0 110.725 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 122' ' ' LEU . 1.1 m 60.8 -143.96 0.49 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.926 175.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 96.5 mt 62.06 -167.68 0.2 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.653 0.381 . . . . 0.0 111.347 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 122' ' ' LEU . 18.0 ptp180 57.7 165.34 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.088 1.355 . . . . 0.0 113.201 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 36.5 m80 62.69 92.88 0.06 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.628 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.462 ' CZ3' ' HD3' ' A' ' 127' ' ' LYS . 22.2 t90 -70.49 107.19 3.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.309 0.576 . . . . 0.0 109.967 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 87' ' ' ALA . 40.5 tp -93.94 142.41 27.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.243 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 22.9 pttp -156.82 139.75 15.3 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.635 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.851 ' OXT' HG13 ' A' ' 33' ' ' ILE . 14.4 p . . . . . 0 C--N 1.313 -1.003 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.8 m 59.16 87.88 0.13 Allowed Pre-proline 0 CA--C 1.532 0.26 0 O-C-N 123.751 0.324 . . . . 0.0 110.75 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.11 107.0 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.63 2.22 . . . . 0.0 112.294 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.24 69.68 2.92 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.039 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.638 HG13 ' ND2' ' A' ' 102' ' ' ASN . 1.6 pt -86.54 165.68 31.7 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.671 -0.265 . . . . 0.0 110.428 -177.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HG2' HD21 ' A' ' 104' ' ' LEU . 12.4 Cg_exo -64.48 -141.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.028 3.152 . . . . 0.0 114.433 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 19' ' ' VAL . 10.3 t -50.21 109.74 1.41 Allowed Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 123.546 0.738 . . . . 0.0 111.164 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -52.44 126.82 21.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.549 2.833 . . . . 0.0 113.501 -170.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.47 109.25 1.16 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.634 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -170.29 139.78 1.78 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 HD11 ' A' ' 99' ' ' ILE . 33.5 m -138.35 147.72 25.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.815 0.34 . . . . 0.0 110.195 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -110.39 101.12 9.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.279 0.561 . . . . 0.0 110.465 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.538 HD11 ' HA3' ' A' ' 62' ' ' GLY . 10.6 mt -111.88 -170.22 1.61 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.736 -174.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 88.6 mt-30 -132.54 144.38 50.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.239 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.513 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 28.5 mmtm -50.25 158.37 0.57 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.676 -175.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 5.4 p-10 -89.82 -163.64 1.04 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.92 67.24 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.477 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.456 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 19.3 tt0 -92.56 9.46 34.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.663 0.268 . . . . 0.0 111.082 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 51.9 t30 66.66 30.0 8.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.75 0.786 . . . . 0.0 110.905 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 1.3 pp -133.05 -171.24 2.63 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 121.821 -0.55 . . . . 0.0 111.202 172.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.701 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.71 -27.96 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.973 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 103.68 28.39 6.0 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.942 -0.646 . . . . 0.0 113.046 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.557 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -121.65 174.12 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.762 0.791 . . . . 0.0 112.074 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 23.0 m -137.28 126.09 24.03 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.229 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.486 ' HB ' HD12 ' A' ' 126' ' ' LEU . 68.7 mt -98.46 140.16 18.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.72 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.23 99.88 0.46 Allowed Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.24 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.34 124.29 6.99 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.86 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -53.56 -43.54 67.59 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 114.321 0.488 . . . . 0.0 114.321 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.567 ' H ' ' HA ' ' A' ' 45' ' ' PRO . . . 79.74 -77.11 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.308 0.643 . . . . 0.0 111.607 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -65.99 -49.98 65.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.153 0.502 . . . . 0.0 110.393 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -78.75 -40.65 32.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.951 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 53.8 t 176.89 117.84 0.16 Allowed Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.617 177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.567 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 17.0 Cg_exo -68.57 52.38 0.67 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.585 2.857 . . . . 0.0 112.914 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' A' ' 71' ' ' THR . 42.2 t -150.64 -89.61 0.07 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HB2' ' H ' ' A' ' 48' ' ' TYR . 8.1 mt 53.59 -100.72 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -172.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 54.1 p90 -148.69 -179.86 7.3 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -163.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -93.57 128.5 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.336 178.529 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -97.03 -21.38 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -168.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.48 141.93 10.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.182 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.1 p -141.16 160.75 22.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.994 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.546 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 92.5 m-85 -113.96 124.67 52.73 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 30.7 t70 -58.33 -23.4 56.55 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -165.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.457 ' HA ' HD23 ' A' ' 60' ' ' LEU . 46.7 m-80 -101.77 9.84 40.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.49 0.662 . . . . 0.0 110.09 -172.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.546 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 31.6 p -98.66 149.24 35.55 Favored Pre-proline 0 CA--C 1.502 -0.877 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -48.55 -38.63 36.18 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 121.946 1.764 . . . . 0.0 111.374 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.22 5.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.065 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.496 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.15 -53.2 13.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.453 0.644 . . . . 0.0 110.227 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -45.13 -74.3 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.629 -178.298 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -95.54 -35.5 11.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.611 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.538 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -74.79 -31.49 58.2 Favored Glycine 0 C--O 1.228 -0.26 0 CA-C-N 115.523 -0.762 . . . . 0.0 114.245 -168.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p 66.05 15.38 10.05 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.851 0.86 . . . . 0.0 110.674 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.545 HG11 HG13 ' A' ' 99' ' ' ILE . 6.1 m -85.78 53.98 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 CA-C-O 122.748 1.261 . . . . 0.0 110.518 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.89 176.39 8.51 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.942 -172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.94 104.34 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.716 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.06 -10.33 3.06 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.962 -175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.4 t70 -89.32 164.95 14.69 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.735 ' HB3' ' CD2' ' A' ' 101' ' ' TYR . 5.5 mp0 -107.89 134.85 50.23 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.497 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 5.4 mm -122.97 122.29 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.708 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 7.6 t -129.85 -10.19 4.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.72 0.295 . . . . 0.0 111.699 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.3 151.52 23.1 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.711 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.714 HG11 ' HB ' ' A' ' 86' ' ' VAL . 4.4 m -117.85 147.36 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 114.355 -0.923 . . . . 0.0 109.02 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 t30 60.92 19.53 9.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.425 0.631 . . . . 0.0 110.508 171.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.01 -10.33 70.08 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.12 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 14.9 ptp180 -121.27 143.73 49.01 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 117.156 0.478 . . . . 0.0 111.238 -174.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 m -52.49 146.39 9.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.525 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.754 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -76.09 -13.19 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 121.695 0.759 . . . . 0.0 109.2 -176.458 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -58.61 -17.33 21.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.074 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.91 67.78 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.982 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -142.45 -119.73 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.966 -0.138 . . . . 0.0 111.061 178.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.458 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 14.9 t -158.1 174.77 14.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.546 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -47.32 -60.02 2.79 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -175.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 82' ' ' THR . 6.6 p -54.51 -34.62 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 121.258 0.551 . . . . 0.0 111.779 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 40.0 mt-10 -78.68 -35.08 45.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.809 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG11 ' HB ' ' A' ' 78' ' ' ILE . 34.4 m -73.42 -38.94 54.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.539 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.96 -36.41 59.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.003 169.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 60.7 tttm -64.66 -50.08 68.46 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 84.5 mtp -53.99 -44.66 71.04 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.204 0.525 . . . . 0.0 111.237 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 93' ' ' VAL . 29.6 mm -55.28 -56.87 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.631 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.516 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 8.6 pt20 -76.07 -22.86 55.16 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -58.59 -50.65 73.02 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.032 0.533 . . . . 0.0 110.959 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 90' ' ' ILE . 13.2 m -60.1 -29.66 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.941 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp 63.45 143.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.001 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.498 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 87.94 -48.81 3.72 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.876 170.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.7 pt-20 -127.24 175.65 8.0 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 117.398 0.599 . . . . 0.0 110.125 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.513 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 9.2 m -147.92 155.54 9.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.838 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -142.37 99.87 3.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.712 0.292 . . . . 0.0 111.203 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.545 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -84.95 144.6 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -147.72 131.16 16.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.735 ' CD2' ' HB3' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -177.97 -114.62 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.172 162.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.638 ' ND2' HG13 ' A' ' 17' ' ' ILE . 1.4 t-20 -174.43 -169.17 0.43 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.583 -171.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.28 32.93 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -171.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.558 HD21 ' HG2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -164.85 157.01 15.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 0.0 111.0 175.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -97.84 25.03 6.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.714 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.561 ' HB1' ' HG3' ' A' ' 110' ' ' GLN . . . 70.78 -174.66 0.18 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.427 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.578 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 9.8 m-20 -137.06 158.36 72.86 Favored Pre-proline 0 C--O 1.216 -0.661 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.618 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 37.7 Cg_exo -29.09 -60.61 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.899 3.066 . . . . 0.0 115.107 -167.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.482 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.6 pttp -65.54 -50.07 66.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.238 0.542 . . . . 0.0 111.866 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.578 ' CG ' ' H ' ' A' ' 107' ' ' ASP . 12.4 pt20 -80.11 -7.94 59.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.853 0.835 . . . . 0.0 111.827 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 111' ' ' LEU . 1.8 tm? -90.04 -48.4 7.22 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.922 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 6.0 pt-20 -71.45 -24.86 62.09 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 110.864 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.1 p -68.15 -32.64 56.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.483 0.659 . . . . 0.0 109.708 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.43 -24.9 39.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.471 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -63.94 -47.33 80.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.408 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 70.5 -70.19 0.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.203 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.611 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . -166.34 -49.54 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.28 -175.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 1.1 Cg_endo -41.48 116.82 0.54 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.999 3.133 . . . . 0.0 113.341 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -129.66 -45.78 1.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.229 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -88.04 5.38 41.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.992 0.425 . . . . 0.0 110.728 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.4 m -78.99 69.49 5.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.754 0.788 . . . . 0.0 110.353 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.02 116.14 4.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.24 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 20.4 ptt180 -148.02 128.7 14.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.186 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.466 ' O ' ' HD3' ' A' ' 83' ' ' LYS . 12.9 m-70 73.57 139.11 0.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.146 0.904 . . . . 0.0 111.939 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -71.24 132.64 45.25 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -92.17 153.51 19.27 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.964 -167.228 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' N ' HD13 ' A' ' 126' ' ' LEU . 19.2 ptmt -167.87 111.09 0.63 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.728 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.701 ' OXT' HG13 ' A' ' 33' ' ' ILE . 12.6 p . . . . . 0 N--CA 1.441 -0.896 0 CA-C-O 118.08 -0.962 . . . . 0.0 108.909 170.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.601 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.497 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 13.4 m -71.94 -49.78 10.03 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 14' ' ' SER . 22.1 Cg_endo -61.86 156.63 47.6 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.759 1.639 . . . . 0.0 111.654 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.28 -30.08 8.23 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.631 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.542 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 5.9 pt -70.68 155.84 92.82 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 20.2 Cg_endo -59.26 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.273 1.982 . . . . 0.0 113.025 -168.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 17.6 t -116.52 106.11 49.07 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.9 141.98 67.12 Favored 'Trans proline' 0 C--N 1.329 -0.452 0 C-N-CA 123.422 2.748 . . . . 0.0 112.459 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.42 155.63 27.12 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.005 -0.616 . . . . 0.0 111.63 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -166.49 137.91 3.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.69 157.43 42.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 t -124.58 118.61 26.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.384 0.611 . . . . 0.0 110.563 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.467 ' CD2' HD11 ' A' ' 99' ' ' ILE . 2.3 mm? -119.92 -169.6 1.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.645 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 87.8 mt-30 -129.28 140.31 51.48 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.821 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HG2' ' C ' ' A' ' 95' ' ' GLY . 25.4 mmtp -45.9 148.79 0.74 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.336 -176.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -82.7 -179.01 7.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.585 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.64 55.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.192 0.52 . . . . 0.0 110.875 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.562 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -91.12 4.1 53.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.948 -179.691 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 37.8 t30 71.04 16.71 6.35 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.036 0.922 . . . . 0.0 111.133 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.607 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -128.31 -171.1 2.37 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.769 -0.582 . . . . 0.0 111.275 -179.45 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.726 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.37 -29.23 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.604 -177.65 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.26 27.18 5.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.745 . . . . 0.0 113.125 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG22 HG23 ' A' ' 52' ' ' VAL . 2.7 pp -119.17 173.85 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.333 0.587 . . . . 0.0 111.839 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 36.3 m -134.65 129.92 35.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.517 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 63.3 mt -104.03 145.07 13.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.518 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.89 150.97 11.65 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.031 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.7 109.75 3.81 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.589 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.474 ' HA2' ' HD2' ' A' ' 45' ' ' PRO . . . 96.04 129.46 6.0 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.408 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' H ' ' HD2' ' A' ' 45' ' ' PRO . . . -98.16 -87.75 0.33 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -99.02 -42.01 7.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.71 0.291 . . . . 0.0 110.342 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -88.99 -88.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.63 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 22.6 p 178.79 49.57 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.417 0 O-C-N 123.302 0.376 . . . . 0.0 111.83 173.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.63 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 4.9 Cg_exo -82.3 -179.53 4.74 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.136 1.891 . . . . 0.0 111.542 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 48' ' ' TYR . 5.7 p -74.61 -78.95 0.09 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.296 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 69' ' ' GLU . 1.5 pp 50.67 -49.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.539 1.936 . . . . 0.0 115.51 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 18.6 m-85 69.01 -51.72 0.59 Allowed 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 118.596 0.635 . . . . 0.0 112.682 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -88.13 111.72 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 119.419 1.009 . . . . 0.0 109.856 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.3 -29.98 4.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.257 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 4.0 pt20 -164.31 156.29 16.43 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.3 p -141.99 161.67 20.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.263 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.554 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 89.9 m-85 -113.67 123.63 50.38 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -55.23 -25.81 35.62 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.115 -165.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.509 ' HA ' HD23 ' A' ' 60' ' ' LEU . 47.8 m-80 -102.41 8.39 40.16 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.169 0.509 . . . . 0.0 110.616 -172.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 32.0 p -96.72 150.32 36.81 Favored Pre-proline 0 CA--C 1.503 -0.844 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.51 -37.67 42.73 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 121.789 1.659 . . . . 0.0 111.396 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -57.36 -57.35 13.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.108 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.552 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -73.61 -52.6 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.451 0.643 . . . . 0.0 110.121 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -45.39 -75.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.806 -1.543 . . . . 0.0 112.743 -177.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -96.59 -33.12 11.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.157 0.503 . . . . 0.0 111.5 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.25 -28.77 63.39 Favored Glycine 0 C--O 1.228 -0.275 0 CA-C-N 115.663 -0.699 . . . . 0.0 114.236 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p 64.57 14.41 8.95 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.994 0.917 . . . . 0.0 111.403 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.73 HG11 HG13 ' A' ' 99' ' ' ILE . 6.9 m -84.98 54.56 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 CA-C-O 122.578 1.18 . . . . 0.0 111.284 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.17 173.2 10.6 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.469 -172.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -55.8 113.41 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.163 -173.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.12 -16.37 4.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.446 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.667 ' O ' HG22 ' A' ' 49' ' ' ILE . 1.7 m-20 -96.86 154.62 17.19 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 117.597 0.698 . . . . 0.0 110.746 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 38.3 tt0 -90.7 80.86 5.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.529 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.502 HD13 ' HB ' ' A' ' 49' ' ' ILE . 1.8 mp -68.85 92.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 77' ' ' SER . 9.0 t -96.08 -14.05 23.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.595 -170.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -143.83 137.27 7.35 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 119.367 -1.397 . . . . 0.0 113.629 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -104.79 119.02 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.549 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 16.9 t-20 55.03 32.18 17.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.413 0.625 . . . . 0.0 110.613 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.86 -21.28 46.73 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.643 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -102.76 126.91 50.06 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 117.725 0.762 . . . . 0.0 110.991 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.505 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 29.9 m -57.79 145.81 33.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.72 -176.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.575 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -81.32 -18.51 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.546 0.689 . . . . 0.0 109.602 -179.213 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -63.04 -24.19 67.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.877 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.44 -14.85 81.72 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.936 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.22 -132.31 0.15 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.409 0.604 . . . . 0.0 110.718 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -143.64 152.26 41.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.112 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.493 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.4 ptpt -43.43 -59.36 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.96 0.504 . . . . 0.0 112.272 176.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.5 p -53.97 -34.87 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.842 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 89' ' ' MET . 33.7 mt-10 -76.93 -42.44 39.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.557 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.555 HG11 ' HB ' ' A' ' 78' ' ' ILE . 33.6 m -66.8 -40.11 85.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.643 -175.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.596 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -52.57 -41.42 63.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.429 170.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -66.44 -45.94 78.13 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.197 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 59.4 mtt -54.62 -35.17 63.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.398 0.618 . . . . 0.0 110.765 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 33' ' ' ILE . 65.3 mt -75.33 -48.84 29.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.186 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.493 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 86.4 mt-30 -63.6 -41.06 98.36 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.03 -45.44 85.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.441 -169.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 90' ' ' ILE . 25.9 m -54.63 -31.42 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.295 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? 65.93 130.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 170.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.499 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 97.77 -47.91 1.51 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.517 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.0 pt-20 -136.48 176.83 8.34 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.188 0.518 . . . . 0.0 110.406 -172.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.6 HG11 HG23 ' A' ' 33' ' ' ILE . 5.4 m -147.43 153.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.862 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 30.8 m -142.4 115.77 9.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.73 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -111.1 123.63 67.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.269 -175.372 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -98.67 123.69 43.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 69' ' ' GLU . 17.0 p90 -141.96 139.95 32.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.577 0.703 . . . . 0.0 112.006 -173.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.4 m-20 -115.55 169.59 9.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.127 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 103' ' ' LYS . 2.6 mptt -115.11 82.43 1.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.95 -0.7 . . . . 0.0 112.797 -168.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -178.62 167.73 1.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.772 170.171 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.431 ' O ' ' HB3' ' A' ' 45' ' ' PRO . 15.9 pt20 -107.48 13.12 27.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.834 171.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 70.51 162.68 0.24 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.152 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -134.18 156.84 78.72 Favored Pre-proline 0 C--O 1.211 -0.926 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 19.4 Cg_exo -29.97 -51.99 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.009 3.14 . . . . 0.0 114.958 -171.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.532 ' HG3' ' HG3' ' A' ' 110' ' ' GLN . 59.3 pttt -57.16 -44.48 83.53 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.517 0.675 . . . . 0.0 112.285 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.532 ' HG3' ' HG3' ' A' ' 109' ' ' LYS . 96.9 mt-30 -85.98 -27.74 24.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.632 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.5 tm? -66.55 -49.52 66.18 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.221 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 5.2 pt-20 -60.07 -31.68 70.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.1 0.476 . . . . 0.0 110.69 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 109' ' ' LYS . 68.8 t -64.52 -47.41 89.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.512 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.01 -13.61 57.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.496 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 20.9 t80 -87.66 37.91 0.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.859 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -58.65 -24.4 61.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.247 0.546 . . . . 0.0 110.185 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.636 ' H ' ' CD ' ' A' ' 118' ' ' PRO . . . 154.86 47.74 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.585 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.636 ' CD ' ' H ' ' A' ' 117' ' ' GLY . 38.0 Cg_endo -64.92 5.73 0.44 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.292 2.661 . . . . 0.0 113.15 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 117' ' ' GLY . 86.6 mm-40 -77.38 -154.76 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.686 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.3 t80 65.92 33.33 7.95 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 122.339 1.066 . . . . 0.0 108.712 -173.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 m -85.87 95.86 9.59 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.203 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 pp -80.04 9.6 5.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.431 0.634 . . . . 0.0 110.378 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 73.32 64.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.489 169.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.58 126.43 36.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.45 0.643 . . . . 0.0 109.648 166.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -83.87 158.29 21.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.709 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.596 HD11 ' HB2' ' A' ' 87' ' ' ALA . 1.1 tm? -101.08 158.84 15.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.584 ' N ' HD13 ' A' ' 126' ' ' LEU . 19.8 ptmt -161.94 112.98 1.64 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.143 0.497 . . . . 0.0 110.429 -174.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.726 ' O ' HG13 ' A' ' 33' ' ' ILE . 13.1 p . . . . . 0 N--CA 1.437 -1.122 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.726 -0.549 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -147.83 72.29 11.43 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.764 0.316 . . . . 0.0 111.405 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -92.13 -166.6 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.157 2.572 . . . . 0.0 111.763 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.58 -51.87 9.07 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.325 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.503 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 14.7 pt -113.06 159.8 33.36 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 26.7 Cg_endo -67.95 -70.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.657 1.572 . . . . 0.0 112.571 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.8 t -124.73 110.22 27.91 Favored Pre-proline 0 N--CA 1.439 -1.017 0 CA-C-O 120.982 0.42 . . . . 0.0 110.095 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.66 145.37 18.2 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 124.62 3.547 . . . . 0.0 114.486 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 100' ' ' HIS . . . 83.98 164.27 36.89 Favored Glycine 0 N--CA 1.461 0.321 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.349 168.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -160.86 -74.87 0.06 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 117.023 0.412 . . . . 0.0 111.457 174.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 99' ' ' ILE . 7.7 p -147.57 158.46 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -170.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.66 HG22 HG22 ' A' ' 98' ' ' THR . 24.5 p -124.52 121.78 35.76 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 122.2 -0.313 . . . . 0.0 111.083 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.549 ' CD2' HD11 ' A' ' 99' ' ' ILE . 2.7 mm? -121.16 -165.78 1.27 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 8.4 pt20 -141.23 158.19 44.23 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.081 174.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 31' ' ' ASN . 31.1 mmtm -52.77 155.86 2.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.955 -1.02 . . . . 0.0 113.129 -172.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -85.57 -179.53 6.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.794 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.97 -21.01 60.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.619 0.645 . . . . 0.0 111.095 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.491 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -91.22 2.28 56.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.101 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.485 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 54.8 t30 70.55 35.7 1.85 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.247 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.608 HD22 ' OXT' ' A' ' 128' ' ' VAL . 2.1 pp -140.56 -170.66 3.05 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.841 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.744 HG23 HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -104.78 -25.45 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.981 -175.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 92.78 35.4 6.46 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.511 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.793 HD11 HG23 ' A' ' 128' ' ' VAL . 2.9 pp -123.01 178.96 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.738 0.304 . . . . 0.0 110.617 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 64.4 m -128.47 135.29 49.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.085 0.469 . . . . 0.0 111.135 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 34.9 mm -102.29 138.77 25.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.144 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.74 123.97 1.22 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.45 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.66 101.6 2.81 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.638 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 45' ' ' PRO . . . 94.33 118.82 3.04 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.371 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.614 ' HB2' HD21 ' A' ' 47' ' ' LEU . . . -95.07 -78.43 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.744 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -95.33 48.63 1.16 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.198 0.523 . . . . 0.0 109.944 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.8 t80 56.91 27.1 12.54 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.438 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.479 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 32.5 m -143.28 -69.88 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.534 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 73.3 Cg_endo -73.61 124.74 9.53 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.113 1.209 . . . . 0.0 111.095 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.753 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 71.2 m -69.11 -51.63 36.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.524 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.81 ' O ' ' HA ' ' A' ' 69' ' ' GLU . 1.6 pp 56.74 -56.98 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.83 1.652 . . . . 0.0 114.648 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.712 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 17.4 m-85 71.68 -36.3 0.36 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.165 0.586 . . . . 0.0 112.505 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.94 108.18 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 122.456 1.122 . . . . 0.0 109.615 176.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.0 t -86.84 -35.54 8.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.408 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.737 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 11.3 pt20 -165.57 163.53 19.36 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -173.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.5 p -141.29 159.82 22.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.132 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.521 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 50.1 m-85 -116.09 122.97 46.72 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.74 0.781 . . . . 0.0 108.907 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.47 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 7.5 m-20 -58.2 -18.94 29.57 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.324 1.45 . . . . 0.0 114.641 -164.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -102.89 6.06 38.87 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.97 0.414 . . . . 0.0 110.513 -174.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 13.1 p -102.59 151.53 38.26 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -176.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.18 -39.94 42.27 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.086 1.857 . . . . 0.0 111.779 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.02 -54.02 49.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.027 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.653 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -76.6 -53.03 8.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.497 0.665 . . . . 0.0 110.277 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER -44.22 -75.01 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.522 -176.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -96.66 -32.06 12.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.14 0.495 . . . . 0.0 111.637 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.476 ' CA ' HD21 ' A' ' 25' ' ' LEU . . . -72.84 -38.97 56.07 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.923 -0.656 . . . . 0.0 114.542 -167.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p 64.77 21.72 12.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 122.0 0.905 . . . . 0.0 110.897 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.743 HG11 HG13 ' A' ' 99' ' ' ILE . 3.8 m -88.02 56.43 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.193 176.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.64 -179.76 7.2 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.786 -168.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.737 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -57.43 139.46 53.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.722 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.89 -9.51 29.67 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.51 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -96.8 174.81 6.61 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.584 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.81 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 25.0 tt0 -123.13 95.19 4.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.466 0.651 . . . . 0.0 110.377 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.9 mm -69.96 114.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.587 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 102' ' ' ASN . 6.4 t -88.11 -34.84 17.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.42 156.63 26.81 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.468 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.662 ' CG1' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -131.1 129.4 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 59.64 26.29 15.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.639 0.733 . . . . 0.0 110.037 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.55 -20.1 50.14 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.256 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -107.93 135.04 49.98 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 117.092 0.446 . . . . 0.0 111.732 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m -63.49 148.15 49.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.472 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.662 HG23 ' CG1' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -93.0 -25.67 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 CA-C-O 122.93 1.347 . . . . 0.0 109.625 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.568 ' H ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -57.88 -24.46 57.75 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.189 -2.278 . . . . 0.0 110.339 -178.415 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.8 -17.64 76.91 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.642 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.478 ' H ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -129.53 -134.87 0.22 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.062 0.931 . . . . 0.0 112.079 -176.212 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.564 ' O ' HG13 ' A' ' 86' ' ' VAL . 60.5 p -135.89 166.13 24.03 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.573 -0.079 . . . . 0.0 110.839 -169.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.625 ' HB3' HD22 ' A' ' 126' ' ' LEU . 16.6 mttt -49.1 -57.69 6.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.542 0.687 . . . . 0.0 111.919 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.47 -39.68 54.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.828 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 89' ' ' MET . 34.6 mt-10 -75.29 -37.91 60.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 82' ' ' THR . 30.0 m -67.05 -45.39 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.61 -176.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.68 ' O ' ' HG3' ' A' ' 91' ' ' GLN . . . -58.9 -43.05 90.91 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 172.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -61.63 -45.63 93.24 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.199 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 86.4 mmm -51.6 -42.33 61.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.615 HD13 HD11 ' A' ' 33' ' ' ILE . 85.9 mt -65.64 -46.89 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.609 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.68 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 59.5 mt-30 -60.45 -46.77 88.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.117 0.484 . . . . 0.0 110.979 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -61.71 -50.91 70.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.498 -167.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 89' ' ' MET . 14.8 m -52.99 -32.92 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm 61.79 137.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.442 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 95.03 -51.78 1.91 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.741 167.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.6 pt-20 -133.83 178.71 6.73 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -174.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.744 HG11 HG23 ' A' ' 33' ' ' ILE . 9.5 m -150.05 148.23 15.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.784 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.66 HG22 HG22 ' A' ' 24' ' ' THR . 12.9 p -134.51 109.46 8.72 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.743 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -102.15 126.82 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.31 0.576 . . . . 0.0 111.524 -173.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 35.0 m170 -108.17 117.16 33.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.182 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.606 ' CE1' HG12 ' A' ' 64' ' ' VAL . 1.1 m-30 -74.0 162.2 29.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.318 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.432 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -175.68 155.51 1.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 O-C-N 124.624 1.202 . . . . 0.0 108.464 175.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -99.16 -32.59 11.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.652 ' O ' HD22 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -152.55 134.85 15.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.738 0.78 . . . . 0.0 112.121 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -92.11 -19.47 22.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.173 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.09 159.07 42.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.994 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.483 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 10.4 t70 -135.12 149.43 70.15 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 16.6 Cg_exo -29.45 -49.84 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.902 3.068 . . . . 0.0 114.269 -176.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 19.1 ptpt -57.99 -47.65 82.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.239 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 14.9 mm100 -87.02 -19.96 27.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.449 0.642 . . . . 0.0 110.355 -176.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.416 HD13 ' C ' ' A' ' 111' ' ' LEU . 3.4 tm? -73.0 -43.12 62.54 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.276 -175.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -66.36 -31.43 72.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.889 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 109' ' ' LYS . 74.3 t -66.59 -39.77 84.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.205 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 110' ' ' GLN . 76.1 mt -70.65 -24.05 62.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.759 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.455 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 27.6 t80 -84.04 -7.56 59.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.125 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 113' ' ' VAL . 51.1 mt-30 -87.61 29.62 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.385 0.612 . . . . 0.0 110.27 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.484 ' H ' ' HD3' ' A' ' 118' ' ' PRO . . . 159.45 50.76 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.484 ' HD3' ' H ' ' A' ' 117' ' ' GLY . 28.9 Cg_endo -58.93 -56.46 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.249 2.633 . . . . 0.0 113.068 -170.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 48.27 49.91 17.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.137 0.494 . . . . 0.0 112.092 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -86.47 73.93 10.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.486 ' O ' ' HE3' ' A' ' 83' ' ' LYS . 13.5 t -84.36 175.05 9.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.83 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.4 ' HG ' HG23 ' A' ' 121' ' ' THR . 86.0 mt 64.03 60.54 1.0 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.515 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -69.78 85.3 0.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.499 0.666 . . . . 0.0 111.298 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -165.94 159.96 16.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -74.15 144.56 44.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.013 0.435 . . . . 0.0 110.59 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' A' ' 83' ' ' LYS . 51.5 tp -117.51 168.43 10.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.483 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 4.9 pttp -166.26 161.99 17.1 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.239 0.542 . . . . 0.0 110.862 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.793 HG23 HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.778 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 165.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 112.211 -0.356 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 p -142.13 87.92 9.44 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.947 0.403 . . . . 0.0 110.295 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.73 6.53 5.42 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.12 2.547 . . . . 0.0 112.859 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.69 35.71 24.63 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.62 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.561 HD12 ' ND2' ' A' ' 102' ' ' ASN . 2.9 pt -69.11 140.67 91.01 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.964 0.411 . . . . 0.0 111.26 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.52 -100.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.323 2.682 . . . . 0.0 113.826 -171.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.456 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 29.5 t -84.51 130.51 53.3 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 120.466 0.174 . . . . 0.0 111.189 -173.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 19' ' ' VAL . 6.6 Cg_endo -82.21 134.59 8.06 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.248 2.632 . . . . 0.0 111.453 -175.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.59 148.87 20.39 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.293 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 25.7 pttm -172.32 136.49 0.81 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 62' ' ' GLY . 33.8 m -131.09 146.74 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.5 t -103.8 98.88 8.66 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.788 0.804 . . . . 0.0 110.378 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.493 HD11 ' HA2' ' A' ' 62' ' ' GLY . 16.6 mt -110.48 -163.83 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.753 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 18.9 pt20 -150.53 156.3 41.15 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.176 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.574 ' HE2' ' C ' ' A' ' 31' ' ' ASN . 10.0 mmmm -52.4 146.77 9.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.639 0.733 . . . . 0.0 111.938 -174.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -85.65 173.67 9.96 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.355 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.2 -20.79 56.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.118 0.485 . . . . 0.0 110.453 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -85.59 -1.26 56.94 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.032 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.574 ' C ' ' HE2' ' A' ' 27' ' ' LYS . 15.4 t30 69.01 37.52 2.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.734 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.484 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -154.22 -163.31 1.59 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.897 173.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.729 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.55 -24.27 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.494 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.44 40.71 3.6 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.761 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.531 HG22 HG23 ' A' ' 52' ' ' VAL . 2.6 pp -131.89 171.95 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.855 0.836 . . . . 0.0 111.633 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.1 m -140.59 126.5 19.41 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.161 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.922 HG22 ' H ' ' A' ' 38' ' ' GLY . 26.3 mt -122.72 -168.64 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -176.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.922 ' H ' HG22 ' A' ' 37' ' ' ILE . . . -166.19 155.51 26.8 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' HA2' ' N ' ' A' ' 46' ' ' CYS . . . -70.12 118.5 8.1 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.928 -177.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.21 -17.0 9.13 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.93 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.36 -172.26 2.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.143 0.472 . . . . 0.0 110.314 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 84.5 mm-40 -62.08 144.01 55.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 87.4 t80 77.29 -0.33 2.89 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.772 0.796 . . . . 0.0 110.484 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 28.0 p 51.88 60.01 14.25 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.106 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 2.5 Cg_endo -78.66 -71.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 122.191 1.927 . . . . 0.0 111.968 -173.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.527 ' N ' ' HA2' ' A' ' 39' ' ' GLY . 9.3 t -177.13 157.08 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.651 HD12 ' N ' ' A' ' 48' ' ' TYR . 3.5 pp 172.3 -51.43 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.154 0.909 . . . . 0.0 112.1 162.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.651 ' N ' HD12 ' A' ' 47' ' ' LEU . 6.3 p90 -80.43 115.71 20.1 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.335 -174.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -75.74 117.5 20.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.915 0.864 . . . . 0.0 109.27 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.18 -30.65 5.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.739 -171.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.64 142.77 15.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.976 0.417 . . . . 0.0 111.401 -172.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.4 p -140.56 160.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.011 173.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -97.34 -133.8 0.23 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.52 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 6.0 t70 -141.15 -33.3 0.53 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -101.24 0.93 38.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.971 0.415 . . . . 0.0 110.347 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 68.0 p -84.17 151.54 60.17 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 8.4 Cg_endo -53.28 -41.27 73.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.239 1.292 . . . . 0.0 111.024 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.513 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.48 -47.58 81.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.996 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.636 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.69 -56.81 4.74 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.68 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.8 pp -55.77 -75.7 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -171.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.631 ' N ' HD12 ' A' ' 60' ' ' LEU . 37.5 t70 -94.76 -13.38 25.74 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 122.546 1.165 . . . . 0.0 108.37 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -64.57 -51.16 54.54 Favored Glycine 0 C--N 1.312 -0.785 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.038 -169.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.4 p 56.95 42.76 25.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.731 1.253 . . . . 0.0 110.321 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.609 HG11 HG13 ' A' ' 99' ' ' ILE . 29.5 m -119.23 47.81 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 112.684 -2.053 . . . . 0.0 108.789 173.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.13 173.71 10.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.569 -170.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.77 108.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.674 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.92 -17.75 3.41 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.68 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 49' ' ' ILE . 18.3 m-20 -90.54 156.88 17.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.081 0.441 . . . . 0.0 110.928 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -114.9 98.26 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.365 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 2.8 mp -72.82 114.67 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.076 0.465 . . . . 0.0 110.38 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -97.5 -12.42 22.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.551 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' HG23 ' A' ' 78' ' ' ILE . . . -161.17 144.75 10.15 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 119.529 -1.319 . . . . 0.0 114.143 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.823 HG13 HG22 ' A' ' 78' ' ' ILE . 5.0 m -100.79 140.56 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 CA-C-N 114.533 -0.833 . . . . 0.0 109.809 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.2 t30 53.89 29.17 9.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.826 0.822 . . . . 0.0 111.173 164.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.24 59.19 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.392 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -126.73 149.38 49.63 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.132 0.966 . . . . 0.0 111.903 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 m -57.1 148.46 21.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.454 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.823 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -85.6 -19.03 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.281 0.562 . . . . 0.0 111.076 -172.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -67.73 -7.53 27.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.301 -170.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.58 -27.95 73.57 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.224 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -139.14 -139.77 0.14 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 117.234 0.517 . . . . 0.0 111.847 -177.065 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.83 160.73 33.55 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -168.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HA ' HG22 ' A' ' 86' ' ' VAL . 2.5 pttt -46.87 -52.65 13.89 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.59 -35.09 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 121.047 0.451 . . . . 0.0 111.564 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 89' ' ' MET . 29.7 mt-10 -79.9 -40.33 28.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.553 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG11 ' HB ' ' A' ' 78' ' ' ILE . 27.7 m -63.41 -40.03 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.606 0.241 . . . . 0.0 111.44 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 91' ' ' GLN . . . -56.3 -45.16 80.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.437 171.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.74 -40.3 96.4 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 120.75 0.31 . . . . 0.0 110.7 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 24.9 mmt -51.22 -32.92 25.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.57 0.7 . . . . 0.0 110.927 174.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.704 HG21 HD11 ' A' ' 33' ' ' ILE . 88.6 mt -90.42 -18.44 7.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.077 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 50.4 mt-30 -87.6 -14.78 39.17 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.901 -0.499 . . . . 0.0 111.546 173.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.27 -40.53 15.44 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.12 0.962 . . . . 0.0 108.969 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -43.44 120.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.932 169.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -82.66 86.48 6.84 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.666 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 108.91 -25.16 19.72 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 118.575 -1.774 . . . . 0.0 113.923 162.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 8.6 pt-20 -125.57 173.4 8.98 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 117.947 0.874 . . . . 0.0 110.332 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.3 m -155.8 154.92 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.861 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.13 117.12 11.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.072 0.463 . . . . 0.0 110.367 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.609 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -106.25 115.49 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.902 -176.138 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -102.11 121.95 43.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.41 ' CE1' HG12 ' A' ' 64' ' ' VAL . 50.0 p90 -146.65 160.79 41.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.729 0.776 . . . . 0.0 112.595 -173.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.561 ' ND2' HD12 ' A' ' 17' ' ' ILE . 28.7 m-80 -137.91 -166.2 1.92 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.625 ' C ' HD13 ' A' ' 104' ' ' LEU . 1.2 mptt -123.2 143.81 49.78 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.137 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.625 HD13 ' C ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER 41.18 178.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -176.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -156.34 25.32 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.7 172.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -169.49 -165.5 0.52 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.583 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 111' ' ' LEU . 7.5 m-20 -111.24 149.91 41.25 Favored Pre-proline 0 C--O 1.207 -1.135 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -31.31 -60.33 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.955 3.103 . . . . 0.0 114.529 -171.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.514 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.2 ptmt -61.35 -44.95 96.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.676 0.75 . . . . 0.0 111.716 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.514 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 70.2 mm-40 -80.39 -9.62 59.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.844 -175.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.1 tm? -90.5 -51.74 5.25 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.471 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.5 -30.85 70.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.485 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.419 HG12 ' C ' ' A' ' 110' ' ' GLN . 4.1 p -69.1 -31.97 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.561 0.696 . . . . 0.0 109.817 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 114' ' ' LEU . 3.2 tm? -75.08 -28.73 60.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.547 176.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -75.44 -3.13 32.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.648 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -80.04 58.66 3.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.607 0.717 . . . . 0.0 110.149 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.565 ' H ' ' HD2' ' A' ' 118' ' ' PRO . . . -148.17 -53.04 0.02 OUTLIER Glycine 0 C--N 1.312 -0.755 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.29 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.565 ' HD2' ' H ' ' A' ' 117' ' ' GLY . 99.0 Cg_exo -29.66 117.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.526 3.484 . . . . 0.0 114.097 168.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 73.51 -15.59 0.55 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.466 0.706 . . . . 0.0 112.441 175.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -89.21 -71.63 0.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -85.26 -34.96 21.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.64 55.9 3.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.12 172.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -61.88 -30.41 70.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.923 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -96.63 89.93 5.14 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -82.62 173.31 12.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.839 -176.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.641 HD13 ' HB ' ' A' ' 37' ' ' ILE . 8.6 tt -90.27 146.07 24.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.497 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.561 ' N ' HD23 ' A' ' 126' ' ' LEU . 22.0 ptmt -150.54 123.73 8.87 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.353 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.729 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.8 p . . . . . 0 N--CA 1.437 -1.085 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.318 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 112.004 -0.438 . . . . 0.0 112.004 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.2 m -97.72 103.63 17.58 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 13' ' ' GLY . 37.4 Cg_exo -59.05 -38.37 87.82 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.137 2.558 . . . . 0.0 113.349 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 179.97 136.58 2.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.457 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.541 HD12 ' ND2' ' A' ' 102' ' ' ASN . 3.0 pt -114.64 151.05 44.94 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.28 -62.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.378 2.052 . . . . 0.0 113.235 -174.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.11 96.33 34.5 Favored Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 122.577 0.351 . . . . 0.0 111.101 -177.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.651 ' HA ' ' OD1' ' A' ' 102' ' ' ASN . 3.0 Cg_exo -68.35 112.81 2.9 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.416 2.077 . . . . 0.0 111.55 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -118.83 149.01 18.31 Favored Glycine 0 C--N 1.312 -0.791 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.956 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -149.71 134.32 17.6 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.209 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.602 HG11 ' O ' ' A' ' 62' ' ' GLY . 7.7 p -132.72 143.72 38.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.463 ' O ' HD13 ' A' ' 25' ' ' LEU . 11.6 t -113.78 130.49 56.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.437 0.637 . . . . 0.0 110.935 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.625 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.8 mm? -132.56 -167.5 1.91 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.561 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.419 ' O ' ' HG3' ' A' ' 57' ' ' PRO . 97.0 mt-30 -132.29 155.98 47.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.717 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 37.0 mmtt -46.54 145.15 1.92 Allowed 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.762 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.06 -178.87 5.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.262 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.2 -22.13 65.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.439 0.637 . . . . 0.0 110.306 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.496 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -93.12 11.22 28.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.72 0.772 . . . . 0.0 109.607 178.026 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 1.1 p-10 60.28 16.1 5.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.311 -1.768 . . . . 0.0 113.049 176.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -115.93 -159.98 0.74 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.507 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.705 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -110.93 -22.89 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 118.755 0.707 . . . . 0.0 111.596 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 96.17 38.54 4.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.744 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.511 HG22 HG23 ' A' ' 52' ' ' VAL . 2.8 pp -130.76 173.89 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.844 0.83 . . . . 0.0 112.122 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.502 ' HB3' ' CD1' ' A' ' 125' ' ' TRP . 20.7 m -138.81 125.78 21.16 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.262 -1.335 . . . . 0.0 109.742 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.488 ' HB ' HD21 ' A' ' 126' ' ' LEU . 61.1 mt -124.94 131.01 73.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.504 0.668 . . . . 0.0 112.716 -173.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.95 116.2 0.78 Allowed Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.572 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.68 99.7 0.62 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.655 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.568 ' H ' ' HG ' ' A' ' 47' ' ' LEU . . . 76.7 171.83 34.58 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.126 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.52 -43.48 0.07 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.515 0.674 . . . . 0.0 109.771 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.528 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 20.1 mp0 -75.59 84.85 2.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.185 175.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 73.5 t80 77.22 -0.93 2.84 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.712 0.768 . . . . 0.0 109.735 -172.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.572 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 61.5 m 71.21 56.57 0.42 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.51 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 12.6 Cg_exo -73.48 -86.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.338 2.025 . . . . 0.0 112.537 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.467 ' H ' ' HB2' ' A' ' 45' ' ' PRO . 70.9 m -158.28 168.59 26.61 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 40' ' ' GLY . 4.6 pp 154.12 -38.57 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.35 1.46 . . . . 0.0 108.281 168.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.533 ' N ' HD12 ' A' ' 47' ' ' LEU . 83.2 m-85 66.39 -85.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.219 -1.355 . . . . 0.0 113.344 176.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -75.56 116.56 18.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 120.037 1.29 . . . . 0.0 110.719 -171.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.427 HG22 HD11 ' A' ' 47' ' ' LEU . 24.6 t -102.31 -30.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.305 -174.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -150.32 138.66 20.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 120.84 0.352 . . . . 0.0 110.926 -170.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.3 p -141.34 161.24 22.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.221 174.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.57 -140.88 0.32 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.443 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 30.7 t70 -133.8 -28.52 1.39 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -101.53 -2.1 31.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.058 0.456 . . . . 0.0 110.297 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 47.9 p -84.93 146.43 45.84 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 9.8 Cg_endo -51.12 -41.83 55.8 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.729 1.619 . . . . 0.0 111.251 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.464 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.81 -43.48 85.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.799 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.646 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.85 -58.28 3.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.36 0.6 . . . . 0.0 110.902 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 61' ' ' ASP . 2.2 pp -55.02 -75.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -170.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.641 ' N ' HD12 ' A' ' 60' ' ' LEU . 32.8 t70 -95.69 -13.83 23.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 122.367 1.08 . . . . 0.0 108.702 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.625 ' HA2' HD21 ' A' ' 25' ' ' LEU . . . -65.51 -33.25 85.85 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 113.315 -1.766 . . . . 0.0 113.964 -169.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 62' ' ' GLY . 5.3 t 51.2 21.58 1.13 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.497 1.119 . . . . 0.0 112.516 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.52 HG11 HG13 ' A' ' 99' ' ' ILE . 17.9 m -101.58 54.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-O 123.001 1.381 . . . . 0.0 110.038 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.491 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -84.31 171.35 12.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 112.455 -2.157 . . . . 0.0 111.386 -171.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.49 112.02 1.15 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.175 -175.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.3 -0.24 5.97 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.574 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.661 ' O ' HG22 ' A' ' 49' ' ' ILE . 1.1 m-20 -99.35 149.16 23.44 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.216 0.532 . . . . 0.0 110.916 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 105' ' ' GLN . 5.4 mp0 -99.05 97.57 8.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.108 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.8 mm -69.72 139.43 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.888 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -124.91 -17.88 5.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.08 163.41 34.29 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.126 -1.512 . . . . 0.0 114.094 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -123.62 125.9 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 123.497 0.719 . . . . 0.0 109.267 179.03 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 54.2 30.26 11.97 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.52 -20.15 49.57 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.331 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -106.05 125.48 51.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 117.406 0.603 . . . . 0.0 111.226 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m -59.21 146.01 40.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.594 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.712 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -84.38 -25.61 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.452 0.644 . . . . 0.0 110.18 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -60.36 -24.12 64.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.536 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.97 -22.09 77.02 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.984 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -124.02 -120.43 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.287 -176.687 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 86' ' ' VAL . 7.3 m -148.91 150.08 32.33 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.49 -173.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -46.54 -56.66 5.68 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.378 0.671 . . . . 0.0 111.944 -177.623 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.84 -37.99 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.831 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 89' ' ' MET . 38.1 mt-10 -71.57 -36.4 70.89 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.712 HG11 ' HB ' ' A' ' 78' ' ' ILE . 19.9 m -71.54 -42.62 72.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.137 -175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 91' ' ' GLN . . . -51.73 -42.33 62.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.826 169.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 37.5 ttpt -60.85 -49.67 76.54 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.824 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.532 ' HE2' ' HA ' ' A' ' 86' ' ' VAL . 40.3 mtm -52.12 -39.09 59.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 110.431 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.579 HD13 HD11 ' A' ' 33' ' ' ILE . 68.1 mt -71.73 -39.17 68.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.441 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 6.7 mm-40 -71.33 -29.41 64.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.081 0.467 . . . . 0.0 110.505 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -72.15 -47.01 54.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.692 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 93' ' ' VAL . 16.8 m -71.51 51.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.793 0.806 . . . . 0.0 111.025 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -44.33 134.14 5.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.853 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.717 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 107.48 -36.88 4.11 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.438 171.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.27 147.39 32.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.737 0.779 . . . . 0.0 112.866 -168.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.463 HG12 ' NZ ' ' A' ' 27' ' ' LYS . 3.9 m -131.67 146.8 32.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.715 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.0 m -140.17 109.4 6.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 172.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -100.66 130.9 49.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.693 -174.257 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -106.1 123.11 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.917 173.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -137.14 146.19 44.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.273 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.651 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 54.2 m-20 -132.94 173.2 11.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.623 ' HB3' HD13 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -102.08 161.59 13.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 174.029 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.623 HD13 ' HB3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER 30.57 58.25 0.22 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.902 1.281 . . . . 0.0 114.246 -177.195 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.509 ' H ' ' HG2' ' A' ' 69' ' ' GLU . 58.3 tt0 -80.28 52.96 1.68 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.1 0.952 . . . . 0.0 109.703 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.45 179.06 8.91 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.078 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -133.98 155.12 80.46 Favored Pre-proline 0 CA--C 1.505 -0.769 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 21.7 Cg_exo -32.36 -48.43 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.796 2.997 . . . . 0.0 113.761 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 0.6 OUTLIER -59.04 -49.58 77.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.684 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.543 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 24.1 mm-40 -88.9 -15.82 33.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.437 0.636 . . . . 0.0 111.026 -175.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -78.7 -39.33 36.88 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.998 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 7.3 pt-20 -68.98 -31.71 70.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.176 0.512 . . . . 0.0 109.924 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.5 t -61.71 -41.18 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.982 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 98.0 mt -76.2 -22.46 55.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.806 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.7 -52.77 40.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.861 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -103.77 -61.04 1.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.98 0.419 . . . . 0.0 110.374 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.528 ' HA2' ' HG2' ' A' ' 42' ' ' GLN . . . 118.87 58.5 0.27 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 113' ' ' VAL . 11.7 Cg_endo -52.77 -40.29 74.81 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.596 2.864 . . . . 0.0 112.924 -176.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -154.3 135.59 14.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.527 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -148.02 154.26 40.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.7 t -164.99 -34.09 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.77 0.319 . . . . 0.0 111.019 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 41.1 tp -104.66 104.51 14.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.496 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -130.17 88.38 2.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.652 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -147.54 121.9 9.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 173.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.502 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 4.5 p90 -112.99 179.11 4.06 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.1 0.476 . . . . 0.0 111.581 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 37' ' ' ILE . 2.4 pp -96.18 168.81 10.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.136 175.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -141.91 93.9 2.61 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.17 -172.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.705 ' OXT' HG13 ' A' ' 33' ' ' ILE . 12.0 p . . . . . 0 N--CA 1.438 -1.029 0 CA-C-O 117.853 -1.07 . . . . 0.0 109.302 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.805 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.8 m -147.43 69.66 11.49 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.776 0.322 . . . . 0.0 110.286 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.92 66.84 7.11 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 122.781 2.321 . . . . 0.0 112.403 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.21 81.12 0.26 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.491 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 18.2 pt -64.57 154.7 83.81 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.596 ' HD2' HD22 ' A' ' 102' ' ' ASN . 20.4 Cg_endo -55.23 -84.4 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.626 2.884 . . . . 0.0 112.029 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -130.9 148.71 71.33 Favored Pre-proline 0 N--CA 1.431 -1.408 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 172.109 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.42 124.12 13.26 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.405 2.07 . . . . 0.0 111.542 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 103' ' ' LYS . . . -116.31 110.54 2.18 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.568 -176.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -143.1 110.65 5.82 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.27 152.27 35.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.839 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -122.11 126.95 49.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.461 0.648 . . . . 0.0 110.529 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 2.4 mm? -122.44 -171.13 2.2 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.084 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 87.7 mt-30 -131.97 137.58 47.96 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.642 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.697 ' HZ3' ' HA ' ' A' ' 91' ' ' GLN . 25.0 mmtp -44.11 148.0 0.46 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 124.679 1.237 . . . . 0.0 112.663 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.75 -172.19 3.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.294 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -22.02 65.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.231 0.538 . . . . 0.0 110.816 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -96.35 11.07 36.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.231 -177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.8 t30 70.26 15.23 7.49 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.389 0.614 . . . . 0.0 111.506 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.656 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.5 pp -128.57 -173.07 2.86 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 121.958 -0.464 . . . . 0.0 111.588 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.85 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.0 -24.37 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.474 -176.294 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.12 41.24 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.486 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.483 HD11 HG12 ' A' ' 128' ' ' VAL . 2.8 pp -129.24 176.6 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.403 0.62 . . . . 0.0 111.71 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 32.1 m -140.59 128.1 21.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.389 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 49.6 mm -114.48 143.24 24.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.421 -174.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' HA3' ' CE3' ' A' ' 125' ' ' TRP . . . 179.41 124.11 0.86 Allowed Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.102 175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 44' ' ' CYS . . . -78.88 149.84 33.47 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.045 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.02 44.72 0.6 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.49 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.645 ' H ' ' HD2' ' A' ' 45' ' ' PRO . . . -90.72 -20.23 22.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 109.949 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -174.49 -63.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.656 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -103.98 -71.14 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.455 173.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.724 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 83.9 m -148.33 30.79 0.06 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.724 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 6.8 Cg_endo -93.29 160.82 2.5 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.639 1.559 . . . . 0.0 112.39 174.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.725 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 69.4 m 66.95 169.62 0.25 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.327 0.651 . . . . 0.0 112.505 175.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 46' ' ' CYS . 0.1 OUTLIER 54.08 -75.86 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.175 1.39 . . . . 0.0 112.895 -178.611 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 37.7 m-85 66.05 -65.78 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -85.01 109.76 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 118.014 -1.474 . . . . 0.0 109.96 -174.354 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.79 -25.37 3.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.63 -171.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -155.87 144.19 20.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.908 0.385 . . . . 0.0 110.817 -175.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.6 p -140.43 161.11 24.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -94.43 -137.17 0.21 Allowed 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.303 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -137.27 -36.4 0.66 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.498 ' HA ' HD23 ' A' ' 60' ' ' LEU . 32.8 m-80 -100.6 -0.38 37.73 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.435 0.636 . . . . 0.0 109.495 -171.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 44.6 p -87.99 144.74 35.1 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 6.5 Cg_endo -47.04 -40.35 26.08 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.291 1.994 . . . . 0.0 111.689 -174.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.437 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -59.02 -52.26 66.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.229 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.675 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.77 -55.61 6.48 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.898 0.856 . . . . 0.0 109.524 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -43.69 -76.17 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.186 -1.825 . . . . 0.0 113.081 -178.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.14 -39.58 9.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.211 0.529 . . . . 0.0 111.872 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.74 -20.34 74.09 Favored Glycine 0 N--CA 1.458 0.162 0 CA-C-N 115.447 -0.797 . . . . 0.0 114.28 -166.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 t 47.23 33.48 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.194 0.998 . . . . 0.0 111.761 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.641 HG11 HG13 ' A' ' 99' ' ' ILE . 11.9 m -94.6 55.22 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 CA-C-O 122.871 1.32 . . . . 0.0 109.697 175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.45 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.77 165.36 18.91 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.42 -2.173 . . . . 0.0 111.049 -169.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -56.64 104.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.124 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.39 -8.88 2.14 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.478 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 49' ' ' ILE . 22.6 m-20 -98.69 177.05 5.42 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 41.5 mt-10 -120.97 143.02 49.24 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.039 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.511 ' H ' ' HB2' ' A' ' 48' ' ' TYR . 18.2 mm -119.12 119.39 60.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.692 HG22 ' CB ' ' A' ' 101' ' ' TYR . 5.5 t -105.25 -26.85 11.86 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.533 -177.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.71 155.46 26.15 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 118.875 -1.631 . . . . 0.0 114.448 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.975 HG13 HG22 ' A' ' 78' ' ' ILE . 6.7 m -110.02 142.59 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.291 176.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.578 ' HA ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER 61.17 19.34 9.95 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.94 0.4 . . . . 0.0 110.719 171.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.17 -15.37 60.47 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 116.11 -0.495 . . . . 0.0 113.403 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 76' ' ' ARG . 5.9 ptt180 -118.56 139.18 51.87 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 117.124 0.462 . . . . 0.0 112.012 -174.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 71' ' ' THR . 35.6 m -50.15 141.6 10.96 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.975 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -83.8 -25.71 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.169 -175.301 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -63.48 -13.69 43.19 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.349 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.35 -30.08 76.47 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.636 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.664 ' HG2' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -119.33 -117.17 0.32 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.77 0.785 . . . . 0.0 112.069 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.61 ' O ' ' HB ' ' A' ' 86' ' ' VAL . 3.2 m -161.5 151.14 16.64 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -168.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 123' ' ' ARG . 2.6 mttm -39.96 -57.32 1.64 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 85' ' ' GLU . 7.1 p -55.98 -32.33 32.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.456 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 89' ' ' MET . 30.9 mt-10 -90.56 -25.93 19.97 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 123.048 1.404 . . . . 0.0 108.318 -175.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.664 HG23 ' HG2' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -75.21 -42.86 44.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.797 -2.456 . . . . 0.0 110.778 -175.319 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.55 73.21 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -61.0 -52.7 63.89 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.157 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 88.2 mmm -45.44 -50.37 12.61 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.495 0.497 . . . . 0.0 112.004 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.447 ' HB ' HG21 ' A' ' 128' ' ' VAL . 25.3 mm -60.09 -53.51 47.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.236 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.697 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 7.1 pt20 -75.31 -25.34 57.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 122.205 -0.309 . . . . 0.0 111.483 -173.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.51 -52.51 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.564 0.345 . . . . 0.0 111.707 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 90' ' ' ILE . 20.5 m -49.45 -36.52 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 O-C-N 123.462 0.476 . . . . 0.0 110.95 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 95' ' ' GLY . 4.4 tmmm? 67.5 138.08 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.723 0.773 . . . . 0.0 112.196 169.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 89.71 -33.05 4.54 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.505 171.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.6 pt-20 -145.3 177.24 8.96 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.576 HG11 HG23 ' A' ' 33' ' ' ILE . 10.4 m -146.98 153.48 12.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.975 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -141.21 106.62 5.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 176.005 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.641 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -100.07 140.19 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.536 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.556 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 2.7 t-80 -135.67 127.48 29.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.187 -174.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.692 ' CB ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER 171.28 -99.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.301 1.001 . . . . 0.0 111.912 162.283 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.706 ' OD1' ' HB2' ' A' ' 69' ' ' GLU . 29.2 p-10 -155.89 159.18 39.09 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.74 -162.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 23.5 mmtt -128.0 119.54 25.69 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.425 0.631 . . . . 0.0 112.539 -170.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.492 ' N ' HD23 ' A' ' 104' ' ' LEU . 0.4 OUTLIER -168.49 36.66 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.664 -177.166 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -40.19 96.12 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 124.982 1.426 . . . . 0.0 111.994 -173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.522 ' HB1' ' HG3' ' A' ' 110' ' ' GLN . . . -75.87 172.13 13.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.974 -174.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.625 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 41.5 m-20 -127.16 152.89 76.59 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 17.5 Cg_exo -29.89 -52.59 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.008 3.139 . . . . 0.0 114.499 -172.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -60.32 -50.37 73.91 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.625 ' CG ' ' H ' ' A' ' 107' ' ' ASP . 21.2 pt20 -90.7 -9.62 46.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.9 0.857 . . . . 0.0 111.911 -173.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.409 HD13 ' C ' ' A' ' 111' ' ' LEU . 1.9 tm? -86.21 -41.39 14.69 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.384 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 8.0 pt-20 -64.89 -21.05 66.74 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 110' ' ' GLN . 61.1 t -58.04 -38.53 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.436 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.5 mp -81.0 -22.74 39.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.662 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -110.52 36.14 3.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 71.41 -79.11 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.959 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.55 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . -177.54 -55.27 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 12.1 Cg_endo -53.77 139.98 67.7 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 123.817 3.012 . . . . 0.0 112.931 171.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -108.74 118.63 37.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -160.59 168.45 24.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.126 -174.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.423 ' HB ' ' NE1' ' A' ' 125' ' ' TRP . 7.5 t -134.8 124.62 25.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.227 0.537 . . . . 0.0 110.59 174.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 98.1 mt -119.08 -39.38 2.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.148 176.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.564 ' O ' ' HE3' ' A' ' 83' ' ' LYS . 3.6 tpm_? -89.94 2.49 55.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.951 -175.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 123' ' ' ARG . 89.8 m-70 72.99 145.16 0.07 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.506 0.67 . . . . 0.0 112.222 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.454 ' CE3' ' HA3' ' A' ' 38' ' ' GLY . 7.6 m95 -104.23 154.17 20.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.712 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.508 HD21 ' HB ' ' A' ' 37' ' ' ILE . 1.8 pp -112.37 168.71 9.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 15.1 ptmm? -149.89 134.69 17.72 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.811 0.338 . . . . 0.0 110.221 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.85 ' OXT' HG13 ' A' ' 33' ' ' ILE . 7.7 p . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.775 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 112.307 -0.317 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.6 m -89.62 129.4 47.06 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.583 0.23 . . . . 0.0 110.441 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.94 63.42 6.77 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.625 2.217 . . . . 0.0 111.855 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.21 128.71 11.87 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.209 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.478 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 6.1 pt -123.04 161.06 46.75 Favored Pre-proline 0 C--N 1.321 -0.636 0 O-C-N 122.951 -0.146 . . . . 0.0 111.101 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.691 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 18.8 Cg_endo -53.63 -82.67 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.558 2.839 . . . . 0.0 112.272 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.0 t -133.6 121.2 16.06 Favored Pre-proline 0 N--CA 1.434 -1.27 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -60.47 120.78 8.72 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.977 2.451 . . . . 0.0 112.196 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' HA3' ' CE1' ' A' ' 101' ' ' TYR . . . -129.32 163.68 22.47 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.559 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.631 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 21.2 ptmt -157.27 136.84 12.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.834 0.317 . . . . 0.0 111.828 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG23 HD11 ' A' ' 99' ' ' ILE . 24.8 m -127.64 149.21 32.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 168.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -120.98 126.31 49.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.684 0.754 . . . . 0.0 110.448 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' HB2' ' CG2' ' A' ' 97' ' ' VAL . 5.2 mt -132.64 -167.62 1.93 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.359 -175.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.1 mt-30 -134.37 142.56 47.24 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.019 0.438 . . . . 0.0 110.158 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 27.9 mmtp -48.74 152.55 0.97 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.841 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 4.0 p-10 -85.74 -164.55 1.04 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.3 -24.64 67.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.855 0.359 . . . . 0.0 111.615 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.9 mt-30 -92.21 4.65 52.8 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.104 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 36.5 t30 71.15 24.9 3.75 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.121 0.962 . . . . 0.0 110.831 176.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.549 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.7 pp -131.05 -170.15 2.3 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.721 -0.612 . . . . 0.0 111.277 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.759 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.02 -21.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.152 -176.083 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.81 30.08 6.61 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.969 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.485 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.9 pp -124.33 175.62 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.711 0.767 . . . . 0.0 112.43 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -136.25 126.42 26.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.056 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.547 ' H ' ' HB3' ' A' ' 126' ' ' LEU . 46.7 mm -97.66 146.84 7.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.404 0.621 . . . . 0.0 111.071 -176.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.83 161.68 28.07 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.635 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' HA2' ' CA ' ' A' ' 46' ' ' CYS . . . -90.35 137.97 14.23 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.006 -175.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.502 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -143.93 17.57 2.17 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 119.032 -1.556 . . . . 0.0 114.235 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.409 ' H ' ' HD2' ' A' ' 45' ' ' PRO . . . -68.9 -78.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.35 0.575 . . . . 0.0 110.268 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -148.78 -46.69 0.15 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.68 0.276 . . . . 0.0 110.514 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -92.21 4.31 53.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.196 0.522 . . . . 0.0 110.266 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.512 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 46.5 t 73.79 61.66 0.32 Allowed Pre-proline 0 C--N 1.333 -0.109 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.077 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 4.7 Cg_exo -80.26 -80.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.316 2.01 . . . . 0.0 111.571 176.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.617 ' O ' HD23 ' A' ' 47' ' ' LEU . 69.3 m -157.8 156.77 32.1 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 46' ' ' CYS . 1.1 pp 160.49 -42.72 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.67 1.232 . . . . 0.0 110.734 158.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.502 ' CD2' ' HA3' ' A' ' 40' ' ' GLY . 90.5 m-85 -76.57 146.48 38.3 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.239 0.542 . . . . 0.0 111.406 176.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -96.84 120.47 46.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.868 171.434 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.83 -31.9 12.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.851 -170.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 2.9 pt20 -165.5 152.05 9.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.932 0.396 . . . . 0.0 110.213 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.481 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 9.7 p -142.02 161.66 20.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.317 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.528 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 90.5 m-85 -110.99 123.69 50.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.525 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 28.2 t70 -58.81 -19.88 45.15 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.675 -1.148 . . . . 0.0 113.869 -164.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -101.85 2.95 38.79 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.79 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 20.7 p -89.08 153.58 49.15 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 6.5 Cg_endo -49.44 -43.18 39.5 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.801 1.667 . . . . 0.0 111.532 -176.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.43 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -54.33 -50.69 66.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.029 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 54' ' ' ASP . . . -76.11 -54.01 7.46 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.067 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.608 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.7 pp -53.67 -74.68 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -170.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.608 ' N ' HD12 ' A' ' 60' ' ' LEU . 38.7 t70 -94.24 -14.62 25.32 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.405 1.097 . . . . 0.0 108.305 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -72.08 -51.55 13.84 Favored Glycine 0 C--N 1.312 -0.779 0 CA-C-N 113.259 -1.792 . . . . 0.0 113.129 -170.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.11 47.45 5.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.298 1.047 . . . . 0.0 111.119 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.504 HG11 HG13 ' A' ' 99' ' ' ILE . 19.5 m -124.86 49.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.3 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.38 -179.57 7.21 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.31 -1.313 . . . . 0.0 112.348 -169.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -47.61 118.03 2.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.568 -172.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.91 -16.97 20.47 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.384 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 49' ' ' ILE . 6.7 m-20 -81.97 157.02 24.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.949 0.404 . . . . 0.0 110.808 -178.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -101.04 124.54 46.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.037 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.418 HD13 ' HB ' ' A' ' 49' ' ' ILE . 4.2 mp -106.44 98.69 7.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -80.87 -15.01 57.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.25 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.503 ' HA2' HG23 ' A' ' 78' ' ' ILE . . . -160.77 152.27 22.91 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 119.119 -1.515 . . . . 0.0 114.562 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.873 HG13 HG22 ' A' ' 78' ' ' ILE . 5.9 m -99.81 140.76 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 114.312 -0.944 . . . . 0.0 108.803 176.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 0.2 OUTLIER 58.13 19.1 5.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.976 0.417 . . . . 0.0 111.618 170.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.36 -20.34 48.96 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.174 -0.467 . . . . 0.0 113.259 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 76' ' ' ARG . 9.8 ptm180 -105.01 134.19 48.54 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 117.143 0.472 . . . . 0.0 110.663 -176.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -52.09 138.62 25.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 0.0 111.724 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.873 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -77.7 -13.43 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.877 0.846 . . . . 0.0 109.056 -176.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -59.76 -13.42 10.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.907 -173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.76 -24.14 76.47 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.671 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -143.14 -137.89 0.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.357 0.578 . . . . 0.0 111.238 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.443 ' O ' HG13 ' A' ' 86' ' ' VAL . 26.6 p -139.86 170.83 15.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.612 0.244 . . . . 0.0 111.598 -170.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.562 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -50.19 -54.16 22.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.743 -175.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.73 -35.46 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.152 0.501 . . . . 0.0 111.426 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' OE2' ' HB2' ' A' ' 81' ' ' LYS . 31.8 mt-10 -80.54 -35.86 33.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.768 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.644 HG11 ' HB ' ' A' ' 78' ' ' ILE . 33.7 m -71.04 -41.38 76.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.584 0.23 . . . . 0.0 111.269 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -52.54 -39.59 61.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.027 0.441 . . . . 0.0 109.931 169.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 61.5 tttm -64.64 -49.49 70.84 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.519 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 87.6 mtp -50.37 -41.93 52.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.418 0.628 . . . . 0.0 110.473 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.544 HD13 HD11 ' A' ' 33' ' ' ILE . 63.4 mt -70.26 -47.26 67.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.389 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -65.02 -32.52 74.28 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.801 -0.562 . . . . 0.0 111.569 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.06 -46.9 88.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.706 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 93' ' ' VAL . 9.9 m -75.89 41.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.228 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -45.88 137.52 5.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.802 0.811 . . . . 0.0 111.844 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.527 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 107.61 -32.91 6.71 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.01 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.7 pt-20 -143.87 176.6 9.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.067 0.461 . . . . 0.0 110.799 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.575 HG11 HG23 ' A' ' 33' ' ' ILE . 6.1 m -152.21 150.57 12.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.043 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 40.7 m -141.29 117.6 10.74 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 170.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -104.92 129.04 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.12 -177.371 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.88 116.27 32.36 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.613 ' CD1' ' HE2' ' A' ' 103' ' ' LYS . 17.9 p90 -120.25 160.98 21.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.563 0.697 . . . . 0.0 112.486 -170.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.498 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . 2.1 p-10 -135.5 145.82 47.48 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.502 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.718 ' O ' HD12 ' A' ' 104' ' ' LEU . 63.4 mmtt -122.38 -62.68 1.35 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -167.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER 34.92 -98.96 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.665 0.786 . . . . 0.0 112.509 -168.46 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -166.33 72.24 0.14 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.367 0.603 . . . . 0.0 109.916 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.15 166.73 24.57 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.951 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.578 ' OD1' ' HG2' ' A' ' 109' ' ' LYS . 1.0 OUTLIER 173.27 158.78 0.28 Allowed Pre-proline 0 C--O 1.211 -0.939 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -172.234 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 1.4 Cg_exo -29.88 -41.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.309 2.673 . . . . 0.0 113.858 173.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.578 ' HG2' ' OD1' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -62.82 -49.76 73.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.727 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.481 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 76.3 mm-40 -87.35 -13.12 44.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.491 0.662 . . . . 0.0 110.597 -177.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 107' ' ' ASP . 2.7 tm? -75.65 -44.03 44.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.368 -176.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -68.62 -30.89 69.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.029 0.442 . . . . 0.0 109.981 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 109' ' ' LYS . 88.4 t -69.54 -29.8 42.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.59 0.709 . . . . 0.0 109.758 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 114' ' ' LEU . 8.0 tt -73.3 -27.47 61.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -103.44 35.45 2.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.562 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 71.48 -70.42 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.362 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.605 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . -166.41 -51.34 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 10.1 Cg_endo -48.74 108.56 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.711 2.941 . . . . 0.0 113.019 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -83.76 177.06 8.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.807 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -147.84 126.22 12.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.281 0.563 . . . . 0.0 111.297 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.2 t -160.5 87.56 0.76 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.977 0.894 . . . . 0.0 109.328 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 122' ' ' LEU . 6.2 mp -76.06 -80.02 0.1 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.677 -174.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -172.07 3.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -88.2 87.54 7.35 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.65 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -104.4 161.8 13.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.605 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -129.71 162.54 28.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.219 -177.059 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.626 ' N ' HD13 ' A' ' 126' ' ' LEU . 21.8 pttp -156.21 121.78 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.466 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.759 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.2 p . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 117.957 -1.021 . . . . 0.0 108.638 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.0 p -125.83 91.71 47.78 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.775 0.321 . . . . 0.0 110.478 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.72 -25.13 5.57 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.281 1.987 . . . . 0.0 112.35 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.75 127.43 7.69 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.469 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.527 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 16.3 pt -92.15 153.71 43.17 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 20.8 Cg_endo -57.87 -71.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.001 2.467 . . . . 0.0 112.687 -169.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.06 89.47 9.78 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 172.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.4 126.86 21.93 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.299 2.666 . . . . 0.0 113.18 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -141.21 139.78 9.81 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 51.8 pttt -159.13 130.83 6.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.023 0.439 . . . . 0.0 111.134 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -137.44 147.02 26.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.3 t -112.59 123.13 49.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.489 0.661 . . . . 0.0 110.965 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.552 HD21 ' HA2' ' A' ' 62' ' ' GLY . 9.6 mt -127.13 -168.96 1.95 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.589 -176.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.63 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.2 mt-30 -132.89 142.05 48.71 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.827 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 29.9 mmtm -48.38 153.42 0.74 Allowed 'General case' 0 C--N 1.32 -0.711 0 O-C-N 124.631 1.207 . . . . 0.0 113.013 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -86.55 -178.66 6.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.521 173.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.68 -21.76 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 111.364 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.453 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -94.64 6.5 48.69 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.307 -177.328 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.538 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 47.3 t30 67.33 32.01 6.17 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.36 1.076 . . . . 0.0 110.613 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 1.4 pp -136.93 -169.51 2.49 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.041 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.1 -26.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.685 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.2 29.18 6.15 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.299 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 2.8 pp -118.21 172.3 5.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.668 0.747 . . . . 0.0 111.555 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 60.0 m -139.1 127.31 22.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.541 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.443 HG21 HD23 ' A' ' 126' ' ' LEU . 48.3 mm -98.3 130.09 47.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.274 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.01 129.1 9.73 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.11 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' HA2' ' C ' ' A' ' 45' ' ' PRO . . . -68.3 125.5 21.15 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.093 -176.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.583 ' HA3' ' CD1' ' A' ' 47' ' ' LEU . . . -78.92 -9.95 86.63 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 119.887 -1.149 . . . . 0.0 114.477 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.553 ' H ' ' HA ' ' A' ' 45' ' ' PRO . . . -149.58 -171.54 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.121 0.96 . . . . 0.0 111.674 -174.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -90.75 -49.6 6.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.027 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 119' ' ' GLN . 83.1 m-85 -80.27 -42.74 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.187 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 118' ' ' PRO . 63.2 m -120.55 66.58 12.98 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.819 0.342 . . . . 0.0 111.22 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.555 ' HD3' ' C ' ' A' ' 43' ' ' TYR . 7.6 Cg_exo -78.69 83.05 2.32 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.813 2.342 . . . . 0.0 113.294 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.529 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 64.1 m -148.14 126.26 12.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 168.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.583 ' CD1' ' HA3' ' A' ' 40' ' ' GLY . 47.6 mt -164.64 -92.77 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.598 1.19 . . . . 0.0 111.224 172.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -59.45 150.16 27.42 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.064 -2.334 . . . . 0.0 112.208 -172.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.81 104.19 15.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 163.559 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.9 t -79.03 -29.36 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.018 -168.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' A' ' 36' ' ' SER . 2.6 pt20 -161.03 152.42 19.09 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.221 0.534 . . . . 0.0 110.112 -173.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 59' ' ' ALA . 8.5 p -142.13 160.94 20.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.326 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.559 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 97.8 m-85 -111.63 125.97 54.52 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.691 0.758 . . . . 0.0 109.217 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -51.36 -29.16 14.53 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.803 -1.544 . . . . 0.0 114.136 -166.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.511 ' HA ' HD23 ' A' ' 60' ' ' LEU . 51.3 m-80 -102.18 9.14 40.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.864 0.364 . . . . 0.0 110.729 -172.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.559 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 32.7 p -95.55 147.72 33.46 Favored Pre-proline 0 CA--C 1.501 -0.936 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.3 Cg_endo -47.32 -39.65 27.71 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.111 1.874 . . . . 0.0 111.235 -175.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -55.89 -57.2 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.201 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.567 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.96 -54.62 8.18 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.458 0.647 . . . . 0.0 110.026 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -44.15 -75.52 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.783 -178.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' HB3' HD22 ' A' ' 25' ' ' LEU . 22.0 t70 -97.48 -31.66 12.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.035 0.445 . . . . 0.0 111.942 -174.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.552 ' HA2' HD21 ' A' ' 25' ' ' LEU . . . -72.4 -36.67 59.22 Favored Glycine 0 C--O 1.227 -0.281 0 N-CA-C 115.127 0.811 . . . . 0.0 115.127 -166.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.9 p 65.06 24.02 12.5 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.181 0.991 . . . . 0.0 110.788 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 99' ' ' ILE . 31.2 m -94.82 49.0 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.646 174.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.74 -179.43 7.11 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.949 -170.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.0 135.18 37.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.934 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.81 -11.1 20.93 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.888 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 49' ' ' ILE . 13.8 m-20 -101.23 178.09 4.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.905 0.353 . . . . 0.0 110.515 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HG3' ' H ' ' A' ' 104' ' ' LEU . 15.5 mm-40 -120.9 143.4 48.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.1 mm -104.94 115.85 47.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.481 HG21 HG21 ' A' ' 17' ' ' ILE . 9.7 t -113.87 1.39 14.75 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -173.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 78' ' ' ILE . . . -163.1 145.71 10.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.208 -1.473 . . . . 0.0 114.296 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.828 HG13 HG22 ' A' ' 78' ' ' ILE . 6.0 m -110.88 143.45 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.532 -0.834 . . . . 0.0 109.73 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 55.9 26.58 9.93 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.623 0.725 . . . . 0.0 111.608 164.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.48 -14.57 64.47 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.525 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -109.46 172.42 6.87 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 123.084 0.554 . . . . 0.0 110.291 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 t -74.13 174.96 7.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.97 0.414 . . . . 0.0 110.47 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.828 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -109.15 -14.04 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.485 0.659 . . . . 0.0 109.328 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -64.25 -19.14 65.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.855 -169.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.01 -20.84 76.62 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.619 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -142.51 -145.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.275 0.538 . . . . 0.0 110.655 -178.833 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.3 t -140.78 173.38 11.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.55 0.214 . . . . 0.0 110.564 -169.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -41.14 -61.27 1.03 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.556 1.143 . . . . 0.0 113.843 -175.277 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -57.31 -36.38 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 120.976 0.417 . . . . 0.0 111.503 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 89' ' ' MET . 34.3 mt-10 -80.62 -33.11 36.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.016 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.589 HG11 ' HB ' ' A' ' 78' ' ' ILE . 35.1 m -70.09 -45.63 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.453 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.11 -37.6 83.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -61.08 -52.27 65.63 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.236 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 21.1 mmt -50.02 -40.34 44.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.23 0.538 . . . . 0.0 111.686 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.591 HD13 HD11 ' A' ' 33' ' ' ILE . 44.1 mt -65.77 -53.05 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.113 178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.538 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 4.1 pt20 -80.29 -18.54 48.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.42 -53.05 60.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.951 0.5 . . . . 0.0 111.098 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 90' ' ' ILE . 12.6 m -56.42 -27.68 25.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.978 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 pttm 48.98 157.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.113 1.365 . . . . 0.0 113.439 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.37 -50.81 4.29 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.117 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.4 pt-20 -132.9 177.2 7.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.021 0.438 . . . . 0.0 109.936 -173.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.54 HG11 HG23 ' A' ' 33' ' ' ILE . 8.8 m -151.04 153.54 9.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.685 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.5 m -140.89 100.09 3.75 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.598 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -90.64 138.07 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.71 -172.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -116.36 117.73 30.78 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -125.59 154.96 41.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.461 0.648 . . . . 0.0 111.926 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 18' ' ' PRO . 14.6 p-10 -140.05 176.84 8.42 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.652 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -132.39 80.63 1.91 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.528 ' H ' ' HG3' ' A' ' 69' ' ' GLU . 0.8 OUTLIER -176.62 157.8 1.64 Allowed 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.378 0.671 . . . . 0.0 110.52 170.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -97.1 15.03 23.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.47 ' HB1' ' HG3' ' A' ' 110' ' ' GLN . . . 68.07 -179.15 0.22 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.253 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.602 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 24.8 t70 -135.88 143.65 45.28 Favored Pre-proline 0 C--O 1.214 -0.805 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 6.3 Cg_exo -29.34 -50.63 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.016 3.144 . . . . 0.0 115.073 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.0 ptpt -58.08 -49.1 78.1 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.602 ' CG ' ' H ' ' A' ' 107' ' ' ASP . 3.7 pt20 -90.15 -13.53 35.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.845 0.831 . . . . 0.0 111.76 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.443 HD13 ' C ' ' A' ' 111' ' ' LEU . 1.7 tm? -79.35 -40.77 29.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.495 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 6.7 pt-20 -65.97 -29.14 69.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.204 0.526 . . . . 0.0 109.72 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.2 t -58.88 -45.46 91.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.556 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.412 ' HA ' ' CG ' ' A' ' 79' ' ' LYS . 10.9 mp -80.7 -16.68 53.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.533 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -74.24 -42.61 59.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.706 -176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -78.73 60.61 2.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.452 0.644 . . . . 0.0 111.747 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 79' ' ' LYS . . . -159.87 -61.8 0.01 OUTLIER Glycine 0 C--N 1.309 -0.952 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 171.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.482 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 10.4 Cg_exo -40.61 -142.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 1 C-N-CA 125.552 4.168 . . . . 0.0 115.958 164.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.693 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 57.5 tt0 70.21 -119.1 0.11 Allowed 'General case' 0 C--O 1.237 0.417 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.687 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 119' ' ' GLN . 84.3 m-85 69.29 -60.06 0.47 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.319 0.647 . . . . 0.0 110.759 -172.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.7 p -135.85 133.63 37.99 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 pp -85.32 168.5 14.62 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.708 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 124' ' ' HIS . 12.5 tpp180 69.97 -163.77 0.17 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -174.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.415 ' H ' ' HG3' ' A' ' 123' ' ' ARG . 10.7 m-70 64.52 125.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.556 0.693 . . . . 0.0 112.589 177.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -89.82 172.13 9.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.064 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 127' ' ' LYS . 35.0 tp -124.03 149.62 45.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -175.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' H ' HD12 ' A' ' 126' ' ' LEU . 10.4 ptmm? -167.27 162.74 15.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.335 173.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.731 ' O ' HG13 ' A' ' 33' ' ' ILE . 5.0 p . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 170.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.6 m -127.92 83.91 64.76 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.62 0.248 . . . . 0.0 110.581 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.46 151.0 32.72 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.393 2.062 . . . . 0.0 112.088 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.09 64.46 3.94 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.563 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.496 HD12 ' ND2' ' A' ' 102' ' ' ASN . 5.3 pt -117.21 138.8 25.23 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.692 ' HD3' HD11 ' A' ' 104' ' ' LEU . 29.3 Cg_endo -65.23 -80.91 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.932 2.421 . . . . 0.0 114.091 -163.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 76.9 t -109.89 101.35 46.74 Favored Pre-proline 0 N--CA 1.442 -0.861 0 CA-C-O 121.369 0.604 . . . . 0.0 110.475 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 18' ' ' PRO . 4.2 Cg_endo -85.78 121.1 2.09 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 124.089 3.193 . . . . 0.0 113.136 -176.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.624 ' HA2' ' CG ' ' A' ' 100' ' ' HIS . . . 126.64 -105.5 0.78 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.044 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 13.9 mmmm 99.92 -90.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.067 1.347 . . . . 0.0 113.221 174.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.589 HG23 HD11 ' A' ' 99' ' ' ILE . 25.3 m -125.55 160.7 31.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 118.096 -1.442 . . . . 0.0 112.583 -164.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -135.6 118.05 15.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.525 0.678 . . . . 0.0 110.539 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' C ' ' HB ' ' A' ' 97' ' ' VAL . 3.3 mm? -113.58 -159.4 0.69 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.055 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 19.9 pt20 -142.39 149.31 39.18 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 31' ' ' ASN . 36.1 mmtm -37.19 151.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.407 ' HB3' HD12 ' A' ' 32' ' ' LEU . 18.3 t70 -83.67 177.67 8.29 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.034 -1.894 . . . . 0.0 109.126 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.57 -25.37 62.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.103 0.41 . . . . 0.0 111.404 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.4 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 13.7 tt0 -94.2 20.33 8.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.39 0.614 . . . . 0.0 110.336 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 2.4 p-10 54.35 30.04 11.94 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.938 1.295 . . . . 0.0 112.629 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 0.9 OUTLIER -128.05 -166.5 1.63 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.561 175.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.747 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.97 -25.98 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.545 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.469 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 97.7 39.68 3.82 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.526 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.568 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.9 pp -131.44 172.48 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.822 0.82 . . . . 0.0 111.854 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 126' ' ' LEU . 27.2 m -138.16 127.86 25.14 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.193 175.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.663 ' HB ' ' CD2' ' A' ' 126' ' ' LEU . 49.7 mm -106.44 119.87 56.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.423 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.5 -163.31 9.63 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.01 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.2 125.98 7.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.428 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 45' ' ' PRO . . . -83.96 -171.27 47.64 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.958 169.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.18 -86.73 0.11 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -130.77 -67.75 0.71 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.908 0.385 . . . . 0.0 111.352 -177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -135.66 40.65 2.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.258 -175.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 2.6 m -146.78 -71.29 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 44' ' ' CYS . 39.2 Cg_endo -90.47 146.68 4.17 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.487 1.458 . . . . 0.0 111.882 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.423 ' SG ' ' HA2' ' A' ' 67' ' ' GLY . 56.3 m -80.36 150.82 29.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 0.0 110.884 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.15 130.73 34.96 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.53 1.157 . . . . 0.0 112.862 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.63 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 25.0 m-85 66.94 -78.03 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.041 -1.89 . . . . 0.0 111.183 -172.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.717 HG22 ' O ' ' A' ' 68' ' ' ASP . 2.3 tt -85.4 122.91 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 118.549 -1.261 . . . . 0.0 111.166 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.25 -21.12 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.583 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.64 143.6 18.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.454 -173.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.9 p -139.1 160.35 29.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 173.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -94.73 -140.81 0.24 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -130.0 -43.05 1.22 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.937 0.79 . . . . 0.0 112.408 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.738 ' HA ' HD23 ' A' ' 60' ' ' LEU . 3.6 m-20 -99.29 13.7 32.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.387 0.613 . . . . 0.0 110.067 -172.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.583 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 65.7 p -91.95 141.1 25.02 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.7 Cg_endo -48.06 -38.22 31.67 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 121.935 1.756 . . . . 0.0 111.413 -173.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.537 ' HB1' HG12 ' A' ' 64' ' ' VAL . . . -54.33 -56.56 17.24 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.762 175.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.74 -56.95 4.25 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.472 0.653 . . . . 0.0 110.187 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.2 tm? -42.28 -76.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.675 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -96.15 -37.88 10.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.819 -171.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.568 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . -64.3 -74.55 0.45 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.261 -168.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 6.0 t 130.86 0.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.195 1.398 . . . . 0.0 108.853 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.537 HG12 ' HB1' ' A' ' 58' ' ' ALA . 0.6 OUTLIER -75.96 58.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 124.651 2.167 . . . . 0.0 111.849 -175.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.595 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -85.73 173.0 10.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 113.633 -1.622 . . . . 0.0 110.19 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.78 124.85 20.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.165 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.423 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . 127.67 -15.99 6.25 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.923 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.717 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.2 m-20 -89.66 146.45 24.52 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.028 0.442 . . . . 0.0 110.688 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -89.58 88.76 7.54 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.507 HD11 HG13 ' A' ' 64' ' ' VAL . 40.6 mt -87.26 94.66 4.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.496 -176.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' SER . 11.1 t -102.35 1.79 35.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.545 -171.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -134.3 130.61 5.63 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.777 -1.201 . . . . 0.0 113.923 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.737 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -99.63 125.4 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 123.939 0.896 . . . . 0.0 108.938 177.423 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 59.53 21.62 10.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.075 0.464 . . . . 0.0 110.947 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' HA2' ' ND1' ' A' ' 100' ' ' HIS . . . 101.4 -19.02 52.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.562 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -112.33 141.22 46.32 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 117.656 0.728 . . . . 0.0 111.148 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.498 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 51.0 m -48.81 143.45 5.33 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.744 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -83.93 -18.3 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.266 -176.469 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -61.56 -25.36 67.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.964 -170.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.25 -15.27 78.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.782 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.631 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 5.7 mptt -108.98 -119.43 0.27 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.71 0.767 . . . . 0.0 109.882 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.53 ' O ' HG13 ' A' ' 86' ' ' VAL . 10.2 t -179.7 167.17 1.38 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.803 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.501 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -50.12 -53.03 30.27 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.8 0.687 . . . . 0.0 112.431 -171.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.24 -39.72 85.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.983 0.42 . . . . 0.0 111.761 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -74.19 -42.6 59.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.744 HG11 ' HB ' ' A' ' 78' ' ' ILE . 27.7 m -57.91 -43.15 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 126' ' ' LEU . . . -53.39 -42.99 67.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.832 174.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -64.59 -49.95 69.15 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.306 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.9 mmt -49.84 -46.22 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.274 0.559 . . . . 0.0 110.904 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 93' ' ' VAL . 20.4 mm -59.18 -56.9 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.873 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.67 -24.81 67.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.07 -46.18 88.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.142 0.496 . . . . 0.0 111.361 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.2 m -72.88 55.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.104 0.954 . . . . 0.0 110.581 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -43.35 131.84 4.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.677 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 107.32 -35.47 5.0 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.072 170.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 12.9 pt-20 -132.56 177.81 7.33 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.102 0.477 . . . . 0.0 110.903 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 33' ' ' ILE . 16.9 t -152.28 133.64 5.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.314 -170.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.4 m -132.45 116.25 16.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 174.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.589 HD11 HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -107.47 124.2 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 121.128 0.489 . . . . 0.0 111.602 -176.773 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.624 ' CG ' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -112.96 103.14 11.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.734 173.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -128.55 162.9 26.17 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.496 ' ND2' HD12 ' A' ' 17' ' ' ILE . 31.3 m-80 -136.66 163.55 30.31 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.892 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.684 ' C ' ' HG ' ' A' ' 104' ' ' LEU . 11.2 mmpt? -94.02 166.06 12.34 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.621 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.692 HD11 ' HD3' ' A' ' 18' ' ' PRO . 0.5 OUTLIER 57.16 -66.08 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 174.511 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.598 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.3 OUTLIER 56.45 56.18 5.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -166.317 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 105' ' ' GLN . . . 71.27 -150.65 0.09 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.477 -173.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -130.68 152.1 79.89 Favored Pre-proline 0 C--O 1.208 -1.089 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.436 -176.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.436 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 27.4 Cg_exo -31.45 -54.83 0.27 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.254 3.303 . . . . 0.0 114.905 -172.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 0.5 OUTLIER -57.59 -43.57 84.71 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.724 0.773 . . . . 0.0 111.884 178.795 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 90.4 mt-30 -82.33 -26.56 32.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.514 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 105' ' ' GLN . 3.2 tm? -69.55 -48.12 61.41 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.782 -175.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 5.1 pt-20 -64.78 -31.35 72.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.528 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 109' ' ' LYS . 75.1 t -64.55 -41.14 91.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.291 0.567 . . . . 0.0 109.797 175.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 tp -70.54 -32.71 70.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.584 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 116' ' ' GLN . 43.7 t80 -79.52 -10.85 59.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.252 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 115' ' ' PHE . 28.2 tt0 74.03 -66.58 0.3 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.823 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.98 59.7 0.23 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.15 134.49 56.52 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.792 2.995 . . . . 0.0 113.575 -173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -95.49 4.62 53.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.464 0.649 . . . . 0.0 109.479 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -124.67 82.33 2.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.989 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.9 m -114.64 108.69 17.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.597 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 122' ' ' LEU . 7.1 mp -107.78 122.4 46.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -81.3 90.46 6.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.3 0.571 . . . . 0.0 110.718 -177.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -144.39 123.07 12.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.274 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -115.97 148.9 39.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.898 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.663 ' CD2' ' HB ' ' A' ' 37' ' ' ILE . 2.1 pp -90.63 169.2 11.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.861 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -144.98 95.6 2.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.226 0.536 . . . . 0.0 110.396 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.747 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.1 p . . . . . 0 N--CA 1.443 -0.809 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.343 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.5 m -144.02 159.2 53.85 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.02 -46.24 33.73 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.129 1.886 . . . . 0.0 111.152 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.57 68.84 1.52 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.126 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 71' ' ' THR . 20.8 pt -80.25 150.68 71.46 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.2 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HD3' HD13 ' A' ' 104' ' ' LEU . 28.3 Cg_endo -61.27 -78.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.006 2.471 . . . . 0.0 112.18 -170.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.8 119.31 37.62 Favored Pre-proline 0 N--CA 1.432 -1.333 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.77 135.09 37.15 Favored 'Trans proline' 0 C--N 1.33 -0.4 0 C-N-CA 123.445 2.764 . . . . 0.0 112.291 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.13 143.41 11.31 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -160.85 136.96 8.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.914 0.387 . . . . 0.0 111.12 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.507 HG21 ' O ' ' A' ' 62' ' ' GLY . 10.1 m -131.68 157.32 43.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -126.77 131.79 51.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.36 0.6 . . . . 0.0 110.914 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.9 mm? -127.35 -171.55 2.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.41 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 89.5 mt-30 -129.81 136.88 50.11 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.94 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 25.8 mmtp -40.14 146.27 0.13 Allowed 'General case' 0 C--N 1.321 -0.644 0 O-C-N 124.814 1.321 . . . . 0.0 113.354 -176.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -79.55 179.6 7.38 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.382 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.85 -32.22 63.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.775 0.321 . . . . 0.0 110.691 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -92.68 16.93 11.12 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.088 0.47 . . . . 0.0 111.018 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 63.5 t30 71.75 12.54 6.27 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.765 173.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 pp -121.95 -170.31 2.03 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 121.397 -0.815 . . . . 0.0 112.091 -174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.9 -29.6 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.881 -178.09 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 93.78 40.26 4.72 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.413 -0.898 . . . . 0.0 113.427 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 2.7 pp -123.95 177.79 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.567 0.698 . . . . 0.0 112.197 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 49' ' ' ILE . 23.1 m -148.92 116.17 6.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.077 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 5.0 tt -105.0 125.61 59.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.449 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 125' ' ' TRP . . . -117.29 138.0 13.83 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.694 -176.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' HA3' ' H ' ' A' ' 46' ' ' CYS . . . -111.69 159.48 13.72 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.96 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.26 96.62 0.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.896 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 44' ' ' CYS . . . -151.88 158.94 43.9 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 173.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -62.16 113.77 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.614 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.5 t80 71.21 -10.1 0.81 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.12 0.887 . . . . 0.0 111.54 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.694 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 85.6 m -147.7 75.24 11.15 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.544 -173.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -63.97 -162.37 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.898 2.399 . . . . 0.0 113.205 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.489 ' SG ' ' HG ' ' A' ' 122' ' ' LEU . 56.7 m 73.48 134.79 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.966 -166.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HB2' ' H ' ' A' ' 48' ' ' TYR . 13.3 mt -145.32 -92.56 0.1 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.723 0.773 . . . . 0.0 110.972 174.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 49.2 p90 -142.02 175.74 9.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.555 -167.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -79.74 122.6 35.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.463 176.232 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.7 t -100.06 -20.55 5.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.37 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -151.15 133.11 15.12 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.356 -173.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.8 p -135.66 159.96 39.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -90.91 -137.87 0.15 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -138.89 -38.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.733 0.697 . . . . 0.0 112.321 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -101.73 4.06 40.21 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.956 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 70.0 p -82.9 146.61 52.62 Favored Pre-proline 0 N--CA 1.433 -1.294 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 9.1 Cg_endo -50.13 -40.5 50.89 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.911 1.741 . . . . 0.0 111.204 -176.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.88 84.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.814 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.94 -59.02 2.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.167 0.508 . . . . 0.0 110.573 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 61' ' ' ASP . 2.0 pp -50.03 -76.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -171.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.64 ' N ' HD12 ' A' ' 60' ' ' LEU . 35.7 t70 -95.56 -19.12 20.05 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.616 1.198 . . . . 0.0 108.511 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.538 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -64.25 -32.47 84.3 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 112.512 -2.131 . . . . 0.0 114.164 -167.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 t 48.01 32.1 2.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 112.255 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.609 ' HB ' ' OH ' ' A' ' 101' ' ' TYR . 22.8 m -105.1 51.37 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-O 123.483 1.611 . . . . 0.0 109.288 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.481 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.35 166.77 18.17 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.04 -2.345 . . . . 0.0 111.242 -172.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.02 119.09 2.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.175 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.87 -28.3 3.55 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.307 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.703 ' HB3' ' CD1' ' A' ' 101' ' ' TYR . 1.1 m-20 -73.7 144.29 45.82 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.6 ' HB3' ' O ' ' A' ' 102' ' ' ASN . 17.1 tt0 -101.59 122.89 44.68 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.731 HG12 ' CE1' ' A' ' 101' ' ' TYR . 3.2 mt -108.48 101.17 12.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.329 0.585 . . . . 0.0 111.205 -170.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.491 HG21 HG21 ' A' ' 17' ' ' ILE . 5.2 t -92.41 -15.17 27.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.069 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.03 148.73 18.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.572 -1.299 . . . . 0.0 113.847 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.53 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -110.01 122.25 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 123.407 0.683 . . . . 0.0 109.457 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 53.2 28.36 6.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.94 -20.15 46.76 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.639 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 17.3 ptp180 -103.51 134.58 46.63 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 117.854 0.827 . . . . 0.0 110.52 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.2 m -66.68 152.37 45.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.692 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.53 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -88.48 6.02 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 122.396 1.093 . . . . 0.0 108.447 178.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.524 ' HE2' ' O ' ' A' ' 115' ' ' PHE . 39.3 tptt -76.05 96.19 3.77 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.254 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.49 -30.25 2.8 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.107 -1.044 . . . . 0.0 114.28 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.679 ' CG ' HG13 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -89.92 -151.32 0.23 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 117.989 0.895 . . . . 0.0 112.242 -172.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.479 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 2.7 m -132.91 141.19 48.24 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HA ' HG22 ' A' ' 86' ' ' VAL . 9.5 mtmm -37.63 -54.59 1.17 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.354 0.662 . . . . 0.0 112.715 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -51.64 -31.63 12.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.85 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 89' ' ' MET . 34.0 mt-10 -80.77 -34.92 33.85 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.849 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.679 HG13 ' CG ' ' A' ' 81' ' ' LYS . 20.3 m -73.48 -42.86 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.84 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' A' ' 91' ' ' GLN . . . -61.69 -34.65 76.13 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 171.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 38.1 ttpt -63.61 -48.33 77.79 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.727 175.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 65.6 mtt -45.38 -46.96 13.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.365 0.602 . . . . 0.0 110.275 175.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.416 ' CG2' HG21 ' A' ' 128' ' ' VAL . 34.8 mm -63.69 -54.43 32.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.973 176.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.625 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 11.9 mm-40 -61.39 -35.69 78.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -67.03 -55.16 15.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -172.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -54.42 -40.18 47.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.582 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.472 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 64.6 pttt 48.38 161.62 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.227 1.411 . . . . 0.0 113.702 -178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.67 -46.07 3.12 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.235 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.1 pt-20 -146.54 178.39 8.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.095 0.474 . . . . 0.0 110.11 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.618 HG11 HG23 ' A' ' 33' ' ' ILE . 4.6 m -147.48 151.04 14.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.55 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.6 m -140.35 105.49 5.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.265 0.555 . . . . 0.0 110.595 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.702 ' HB ' ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -92.61 149.67 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.077 -176.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -128.03 129.13 46.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.784 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.731 ' CE1' HG12 ' A' ' 70' ' ' ILE . 97.5 m-85 -123.46 153.61 40.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.6 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 11.1 p-10 -134.48 158.23 44.45 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.178 171.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.553 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 10.8 mptt -134.31 101.19 4.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.585 0.354 . . . . 0.0 111.178 177.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.536 HD13 ' HD3' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -164.46 160.43 20.53 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.312 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.433 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 15.1 mm-40 -121.54 80.22 1.64 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.247 0.546 . . . . 0.0 109.907 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.6 171.11 13.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.65 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 111' ' ' LEU . 12.6 m-20 -116.54 152.94 48.81 Favored Pre-proline 0 C--O 1.21 -1.013 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -32.59 -49.03 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.693 2.929 . . . . 0.0 113.743 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 113' ' ' VAL . 21.3 ptmt -60.7 -49.38 77.73 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.587 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.475 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.8 mm100 -90.09 -11.25 41.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.535 0.683 . . . . 0.0 111.206 -173.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.4 tm? -84.91 -40.12 17.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.493 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -66.25 -21.85 66.3 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.851 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 109' ' ' LYS . 76.0 t -64.21 -36.34 76.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.922 174.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 114' ' ' LEU . 7.1 tt -79.63 -30.36 41.31 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.524 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 9.8 t80 -83.7 0.07 48.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.609 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 70.13 -79.03 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.773 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.533 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . 179.72 -48.2 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.672 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 16.2 Cg_exo -30.63 136.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 124.358 3.372 . . . . 0.0 113.611 167.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -72.16 -173.68 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.971 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -132.07 168.46 17.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.991 -169.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.1 t -141.15 28.31 1.89 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.053 0.93 . . . . 0.0 108.871 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.489 ' HG ' ' SG ' ' A' ' 46' ' ' CYS . 3.3 mm? -107.36 128.9 54.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.785 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 123' ' ' ARG . 7.1 tpm_? -140.18 -70.37 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.141 176.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -81.76 150.49 27.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.508 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 7.2 p90 -73.57 168.93 18.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.42 . . . . 0.0 111.855 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.73 168.33 17.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.467 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -144.32 148.81 35.26 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.313 0.578 . . . . 0.0 111.23 -178.36 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 33' ' ' ILE . 4.1 p . . . . . 0 C--N 1.315 -0.899 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.904 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.1 m 68.99 127.81 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 C-N-CA 123.332 0.653 . . . . 0.0 111.054 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.72 -11.58 28.01 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.466 2.111 . . . . 0.0 112.661 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.19 145.14 3.76 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.997 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.462 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 21.4 pt -78.72 155.41 78.25 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 122.546 -0.384 . . . . 0.0 110.766 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HG3' HD13 ' A' ' 104' ' ' LEU . 35.3 Cg_endo -62.54 -86.99 0.0 OUTLIER 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.988 2.458 . . . . 0.0 112.279 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 52.9 t -112.76 128.58 25.41 Favored Pre-proline 0 N--CA 1.434 -1.233 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 19' ' ' VAL . 12.0 Cg_endo -92.42 145.93 2.76 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.771 2.981 . . . . 0.0 112.01 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.91 175.96 47.1 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.329 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 21.3 pttm -150.46 146.86 26.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.538 0.209 . . . . 0.0 110.548 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.55 141.07 43.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -109.5 119.66 40.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.808 0.814 . . . . 0.0 111.186 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.54 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.9 mm? -124.41 -167.01 1.59 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.045 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.0 mt-30 -132.12 139.67 48.53 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.014 0.435 . . . . 0.0 109.948 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 5.3 mmtp -45.03 145.27 1.02 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.86 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.25 179.1 8.0 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.421 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.92 -21.35 64.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.169 0.509 . . . . 0.0 110.658 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.5 mt-30 -89.74 11.34 20.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.907 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p30 55.33 29.18 12.52 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.136 1.374 . . . . 0.0 112.136 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 0.9 OUTLIER -131.65 -165.74 1.62 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.639 177.115 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.73 -28.57 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.67 38.02 4.31 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.267 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 52' ' ' VAL . 2.6 pp -128.82 177.51 6.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.868 0.842 . . . . 0.0 111.954 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 11.7 m -138.41 125.18 20.99 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.397 173.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.923 HG22 ' H ' ' A' ' 38' ' ' GLY . 22.5 mt -110.47 -168.18 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.923 ' H ' HG22 ' A' ' 37' ' ' ILE . . . 179.62 117.76 0.56 Allowed Glycine 0 C--N 1.308 -0.984 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -177.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.614 ' HA2' ' HG ' ' A' ' 47' ' ' LEU . . . -112.22 152.44 17.79 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.384 -1.388 . . . . 0.0 114.149 -172.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.685 ' HA3' ' O ' ' A' ' 44' ' ' CYS . . . -64.64 -67.46 2.03 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.399 172.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.574 ' H ' ' HA ' ' A' ' 45' ' ' PRO . . . 72.08 -63.8 0.41 Allowed 'General case' 0 C--N 1.344 0.369 0 C-N-CA 123.326 0.65 . . . . 0.0 112.215 171.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -71.49 84.22 0.83 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.702 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 72.66 -20.04 0.28 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.896 0.878 . . . . 0.0 112.472 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.685 ' O ' ' HA3' ' A' ' 40' ' ' GLY . 68.2 m -134.29 77.55 60.15 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 122.418 -0.176 . . . . 0.0 111.09 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.574 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 25.0 Cg_exo -69.15 -149.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.332 2.688 . . . . 0.0 113.738 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 45' ' ' PRO . 74.7 m 72.77 112.93 0.06 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.868 -165.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.614 ' HG ' ' HA2' ' A' ' 39' ' ' GLY . 5.7 mp -101.89 167.72 9.89 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.295 0.569 . . . . 0.0 112.497 -174.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -139.79 150.02 44.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.699 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -95.52 127.07 47.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.53 0.681 . . . . 0.0 109.285 177.518 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG21 ' CD1' ' A' ' 125' ' ' TRP . 37.4 t -92.3 -38.32 10.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.937 -171.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.96 150.15 20.3 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.682 -174.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 59' ' ' ALA . 8.1 p -141.33 159.98 22.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.567 173.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -95.91 -139.18 0.25 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.437 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 18.9 t70 -136.06 -33.41 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.783 176.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -102.38 4.49 38.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.166 0.508 . . . . 0.0 110.564 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 82.5 p -86.3 144.16 37.84 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.815 ' HA ' ' CD1' ' A' ' 60' ' ' LEU . 10.2 Cg_endo -52.25 -38.99 73.06 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.428 1.418 . . . . 0.0 111.704 -172.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.658 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.05 -45.36 87.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.543 175.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.681 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.4 -60.95 1.98 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.095 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.011 HD13 ' H ' ' A' ' 61' ' ' ASP 0.268 0.0 OUTLIER -61.41 -71.43 0.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -166.895 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 1.011 ' H ' HD13 ' A' ' 60' ' ' LEU . 23.7 t70 -92.84 -4.31 53.15 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -71.71 -62.28 3.48 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 112.613 -2.085 . . . . 0.0 113.648 -171.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p 74.31 23.18 2.07 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.933 1.293 . . . . 0.0 110.574 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.637 HG11 HG13 ' A' ' 99' ' ' ILE . 31.2 m -100.21 50.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.564 172.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.73 174.91 10.07 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.138 -170.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.91 132.43 52.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.607 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.15 -13.58 19.19 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.638 ' O ' HG22 ' A' ' 49' ' ' ILE . 57.8 m-20 -95.86 -175.99 3.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.026 0.441 . . . . 0.0 110.72 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . 50.9 mt-10 -132.09 154.24 49.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.101 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 47' ' ' LEU . 24.5 mm -122.83 140.29 47.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -175.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 t -131.07 -0.88 4.11 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.56 142.16 7.94 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.22 -1.467 . . . . 0.0 113.952 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.663 HG12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -104.0 117.3 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 123.632 0.773 . . . . 0.0 109.767 -179.059 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.578 ' ND2' HG11 ' A' ' 93' ' ' VAL . 64.9 t30 53.71 29.95 10.32 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.536 0.684 . . . . 0.0 111.016 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.622 ' HA2' ' CD2' ' A' ' 100' ' ' HIS . . . 100.66 -21.52 43.61 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.917 177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 5.8 ptm180 -100.59 142.97 31.32 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 117.801 0.8 . . . . 0.0 110.529 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.7 m -59.42 149.87 28.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.188 0.518 . . . . 0.0 111.332 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.663 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -90.62 -20.96 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.166 -179.01 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.24 -25.78 68.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.123 -170.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.99 -17.71 77.24 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.863 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -135.01 -139.27 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.321 0.56 . . . . 0.0 110.215 -176.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 85' ' ' GLU . 47.1 p -137.67 157.89 45.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.628 -172.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.487 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -48.04 -54.94 11.38 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.774 0.671 . . . . 0.0 112.588 -178.424 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.93 -39.67 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 120.895 0.378 . . . . 0.0 111.974 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.566 ' O ' ' HG3' ' A' ' 89' ' ' MET . 39.8 mt-10 -72.7 -36.62 67.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.934 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 83' ' ' LYS . 29.1 m -72.48 -41.36 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.347 -176.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.65 -37.01 67.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.027 170.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 57.1 tttm -64.76 -48.98 72.56 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.828 173.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.566 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 58.3 mtt -54.69 -40.56 69.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.107 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.581 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 20.1 mm -61.26 -55.48 24.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.087 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -72.34 -23.13 61.1 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -176.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -67.45 -53.75 26.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.578 HG11 ' ND2' ' A' ' 74' ' ' ASN . 33.6 m -46.59 -32.33 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 23.9 tptm 70.87 123.88 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.292 0.568 . . . . 0.0 112.073 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.566 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 105.8 -59.16 0.42 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.151 -1.024 . . . . 0.0 113.588 172.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.5 pt-20 -135.47 178.72 6.82 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.149 0.5 . . . . 0.0 110.566 -170.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.585 HG11 HG23 ' A' ' 33' ' ' ILE . 9.2 m -148.38 151.09 13.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.0 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 p -139.73 99.98 3.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.33 0.586 . . . . 0.0 109.99 170.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.637 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -86.26 115.51 27.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.82 -176.274 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.622 ' CD2' ' HA2' ' A' ' 75' ' ' GLY . 4.7 m-70 -91.99 119.71 31.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.542 ' CE1' ' HE2' ' A' ' 103' ' ' LYS . 5.5 p90 -132.2 -170.16 2.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.61 -170.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 4.0 p-10 -151.01 150.77 31.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.319 173.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.542 ' HE2' ' CE1' ' A' ' 101' ' ' TYR . 48.1 mmtt -127.02 118.66 24.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.841 0.353 . . . . 0.0 111.653 -164.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.484 HD13 ' HG3' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -171.15 166.31 7.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.984 177.525 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -134.87 85.25 2.16 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.9 -179.07 7.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.492 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -124.43 150.75 65.36 Favored Pre-proline 0 C--O 1.21 -1.013 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -177.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.54 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 36.3 Cg_exo -32.76 -52.89 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.582 2.855 . . . . 0.0 113.965 -174.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.7 ptpt -55.97 -51.06 69.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.387 0.613 . . . . 0.0 111.978 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.529 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.3 mm100 -88.16 -3.9 58.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.729 0.776 . . . . 0.0 111.343 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.72 -49.11 6.65 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.622 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 7.4 pt-20 -68.73 -23.43 64.34 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.514 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 110' ' ' GLN . 3.9 p -69.54 -31.74 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.589 0.709 . . . . 0.0 110.101 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.84 -34.02 45.49 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.283 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -78.02 -45.91 22.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.529 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 61.38 91.35 0.06 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 122.571 1.177 . . . . 0.0 110.597 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.452 ' H ' ' CD ' ' A' ' 118' ' ' PRO . . . 161.45 50.56 0.02 OUTLIER Glycine 0 C--N 1.305 -1.19 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -174.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.452 ' CD ' ' H ' ' A' ' 117' ' ' GLY . 28.3 Cg_endo -57.93 122.94 12.58 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.425 2.75 . . . . 0.0 113.1 -168.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 68.73 21.78 7.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.465 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -109.11 39.3 2.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.36 0.6 . . . . 0.0 110.141 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.5 p -86.41 -159.88 0.52 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.159 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.6 tp 61.22 50.84 4.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.673 0.749 . . . . 0.0 110.05 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -99.92 166.02 11.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.076 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -71.39 115.68 10.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.418 ' CD1' HG21 ' A' ' 50' ' ' VAL . 10.5 m-90 -83.05 176.13 9.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.781 0.801 . . . . 0.0 112.402 -170.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 127' ' ' LYS . 9.1 tt -105.52 156.9 17.78 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.192 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.62 ' N ' HD23 ' A' ' 126' ' ' LEU . 19.8 pttp -155.13 120.88 5.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.478 0.656 . . . . 0.0 111.575 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.601 ' O ' HG13 ' A' ' 33' ' ' ILE . 12.5 p . . . . . 0 N--CA 1.446 -0.651 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.344 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 19.8 ptpt . . . . . 0 C--O 1.232 0.16 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.67 136.42 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -110.72 129.45 55.83 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.78 0.8 . . . . 0.0 110.72 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.19 -160.2 1.03 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.01 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -140.3 149.05 42.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.117 0.484 . . . . 0.0 110.104 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 3.3 mmmm -45.39 151.45 0.37 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.578 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -84.37 172.61 11.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.169 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.02 41.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 110.828 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.642 HE21 HD21 ' A' ' 32' ' ' LEU . 3.9 tt0 -92.47 8.43 38.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.982 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 40.1 t30 69.35 34.75 2.8 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.901 0.858 . . . . 0.0 110.583 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.642 HD21 HE21 ' A' ' 30' ' ' GLN . 1.5 pp -147.07 -164.4 1.99 Allowed 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.273 -0.571 . . . . 0.0 112.002 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.695 HD11 HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -104.07 -30.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.45 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 101.56 32.52 5.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.194 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.748 HD11 HG23 ' A' ' 128' ' ' VAL . 2.8 pp -126.83 -179.48 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.613 0.721 . . . . 0.0 112.61 -175.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 39.8 m -137.6 128.73 27.64 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.506 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.535 HG12 HD13 ' A' ' 35' ' ' ILE . 48.0 mm -111.04 125.43 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.649 0.738 . . . . 0.0 111.988 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.925 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 170.563 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.303 0 CA-C-O 122.128 0.966 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -94.27 -31.78 4.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.12 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -161.0 154.15 21.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.13 0.491 . . . . 0.0 110.088 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.8 p -143.45 160.77 16.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.922 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.504 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 80.4 m-85 -112.74 124.97 53.78 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 20.6 t70 -54.19 -27.36 33.58 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -165.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -101.0 6.93 43.69 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.184 0.516 . . . . 0.0 110.492 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 30.9 p -87.55 153.9 53.32 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.32 -40.2 78.69 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.211 1.274 . . . . 0.0 110.905 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -55.68 -49.49 72.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.803 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -77.68 -56.29 4.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.848 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.621 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.3 pp -52.74 -74.12 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -170.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.621 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 37.2 t70 -94.13 -9.11 37.58 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.563 1.173 . . . . 0.0 107.938 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -82.94 -51.73 4.11 Favored Glycine 0 C--N 1.311 -0.816 0 CA-C-N 113.093 -1.867 . . . . 0.0 113.458 -171.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 p 64.57 22.55 12.68 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.699 1.2 . . . . 0.0 111.143 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 99' ' ' ILE . 9.9 m -92.1 53.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 122.959 1.361 . . . . 0.0 109.74 172.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.6 179.81 7.04 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.552 -2.113 . . . . 0.0 111.736 -171.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.37 122.71 11.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.991 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.86 1.07 34.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.71 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.698 ' O ' HG22 ' A' ' 49' ' ' ILE . 51.5 t0 -98.48 152.73 19.22 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 33.6 tt0 -101.44 82.31 2.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.896 0.379 . . . . 0.0 110.692 -174.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.477 HD13 ' HB ' ' A' ' 49' ' ' ILE . 2.0 mp -74.18 101.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.679 0.752 . . . . 0.0 109.362 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.462 HG21 HD21 ' A' ' 102' ' ' ASN . 7.5 t -100.76 -15.8 17.54 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.649 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -147.78 148.03 19.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.6 -1.285 . . . . 0.0 113.457 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -108.76 115.31 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 9.7 t-20 52.21 37.17 21.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.218 0.532 . . . . 0.0 111.311 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.69 -22.45 39.66 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.833 -0.621 . . . . 0.0 113.927 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -106.13 129.29 54.24 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 117.726 0.763 . . . . 0.0 111.245 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.54 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 46.4 m -61.63 148.67 41.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.536 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.609 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -90.68 -25.52 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.265 0.555 . . . . 0.0 109.598 177.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -73.09 86.5 1.36 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.262 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.65 -25.7 0.17 Allowed Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.07 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -111.12 -117.04 0.3 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.942 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.478 ' O ' HG13 ' A' ' 86' ' ' VAL . 4.9 m -149.61 148.93 29.91 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.236 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.598 ' O ' HG22 ' A' ' 86' ' ' VAL . 5.5 mttt -47.81 -55.69 9.12 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.253 0.549 . . . . 0.0 111.976 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.06 -36.91 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.697 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.587 ' O ' ' HG3' ' A' ' 89' ' ' MET . 37.1 mt-10 -74.36 -37.21 63.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.261 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.609 HG11 ' HB ' ' A' ' 78' ' ' ILE . 27.3 m -67.35 -43.09 88.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.888 0.375 . . . . 0.0 111.087 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.07 73.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.203 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 59.8 tttm -61.48 -45.89 92.34 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.587 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 82.5 mtp -53.7 -37.21 63.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.402 0.62 . . . . 0.0 110.723 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.695 HD13 HD11 ' A' ' 33' ' ' ILE . 97.1 mt -77.23 -38.53 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.21 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -70.68 -29.33 65.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.625 0.25 . . . . 0.0 110.86 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -62.48 -48.73 78.31 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.628 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 93' ' ' VAL . 13.3 m -69.75 82.5 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 122.772 1.272 . . . . 0.0 110.08 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -67.34 123.08 19.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.407 -173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.598 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 95.9 -21.17 46.43 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.431 169.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 97' ' ' VAL . 9.2 pt-20 -124.28 169.17 12.04 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.079 0.466 . . . . 0.0 109.885 -174.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 96' ' ' GLU . 2.8 t -159.15 125.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.501 -173.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 99.5 m -141.58 131.9 25.07 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 122.171 -0.33 . . . . 0.0 110.143 172.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.712 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -120.36 132.65 69.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.429 -176.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -100.46 129.42 46.41 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 69' ' ' GLU . 27.5 p90 -136.85 165.82 25.06 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.745 0.307 . . . . 0.0 111.341 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.462 HD21 HG21 ' A' ' 71' ' ' THR . 62.1 m-20 . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 . . . . . 0 C--O 1.215 -0.73 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -31.55 -55.88 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.752 2.968 . . . . 0.0 114.138 -172.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.0 ptpt -58.0 -45.9 86.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.524 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 71.0 mm-40 -86.57 -17.63 33.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.488 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.43 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.3 tm? -74.26 -44.26 53.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.161 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -70.11 -26.58 64.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.484 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.4 t -72.53 -41.72 63.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.028 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.7 tp -72.41 -23.09 61.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.822 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.8 t80 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.308 -178.546 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.507 ' CG ' ' HB ' ' A' ' 37' ' ' ILE . 1.4 pp . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 10.9 ptmm? -150.98 145.85 25.84 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.357 0.599 . . . . 0.0 110.478 176.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.748 HG23 HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 168.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 64.4 pttt . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.538 0.209 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 62' ' ' GLY . 9.7 p -142.95 138.78 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.471 ' O ' HD13 ' A' ' 25' ' ' LEU . 12.0 t -110.89 127.36 55.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.445 0.64 . . . . 0.0 110.768 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.546 HD23 HD11 ' A' ' 99' ' ' ILE . 2.6 mm? -127.51 -170.39 2.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.432 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 80.5 mt-30 -129.98 136.55 49.56 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.238 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.721 ' HZ3' ' HA ' ' A' ' 91' ' ' GLN . 22.3 mmtp -45.16 149.27 0.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.712 1.258 . . . . 0.0 112.009 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 4.5 p-10 -89.89 -162.88 0.93 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.489 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.09 65.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.755 0.312 . . . . 0.0 111.555 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.461 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 36.5 mt-30 -88.43 0.84 55.82 Favored 'General case' 0 N--CA 1.425 -1.722 0 C-N-CA 122.931 0.492 . . . . 0.0 112.245 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 50.7 t30 71.3 18.47 5.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.51 0.671 . . . . 0.0 110.943 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.457 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 2.0 pp -126.58 -165.26 1.43 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.092 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.807 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -109.03 -22.27 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.674 -177.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.434 ' N ' HD13 ' A' ' 32' ' ' LEU . . . 98.48 35.05 5.08 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.878 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.552 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.7 pp -123.2 171.21 12.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.463 0.649 . . . . 0.0 110.698 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 46.2 m -130.72 131.92 45.06 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.375 175.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 41.2 mm -100.44 141.29 17.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.152 -176.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.806 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.117 -176.714 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 122.468 1.127 . . . . 0.0 110.369 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 m -108.73 -19.12 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.123 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 13.9 tp60 -157.3 143.55 17.88 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-O 121.023 0.439 . . . . 0.0 110.222 -171.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.5 p -145.31 160.93 12.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.015 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -98.64 -131.15 0.21 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.119 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -138.2 -44.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.538 ' HA ' HD23 ' A' ' 60' ' ' LEU . 46.7 m-80 -100.62 8.33 43.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.334 0.588 . . . . 0.0 109.78 -170.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.428 ' CB ' ' HA3' ' A' ' 34' ' ' GLY . 31.0 p -92.19 143.66 27.85 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.507 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 3.6 Cg_endo -44.96 -41.92 15.59 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 C-N-CA 122.551 2.167 . . . . 0.0 111.776 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -58.1 -54.76 43.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.419 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.713 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -71.8 -55.0 8.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.73 0.776 . . . . 0.0 109.807 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.3 tm? -42.45 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.235 -1.802 . . . . 0.0 113.273 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -98.8 -39.54 8.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.152 0.501 . . . . 0.0 111.914 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.426 ' O ' HG11 ' A' ' 23' ' ' VAL . . . -62.89 -27.33 70.04 Favored Glycine 0 C--O 1.228 -0.226 0 CA-C-N 115.14 -0.936 . . . . 0.0 114.631 -165.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 t 50.71 35.84 12.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.312 1.053 . . . . 0.0 111.39 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.633 HG11 HG13 ' A' ' 99' ' ' ILE . 20.6 m -100.14 51.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.345 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.33 177.77 8.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.222 -168.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.26 136.21 25.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.992 -170.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.82 56.32 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.6 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.532 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -104.12 165.49 11.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.025 0.44 . . . . 0.0 110.438 176.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -108.63 99.93 9.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.173 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 49' ' ' ILE . 28.7 mm -83.66 105.43 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 77' ' ' SER . 4.2 t -101.49 -15.26 17.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.315 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -139.93 136.36 7.73 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 119.762 -1.209 . . . . 0.0 113.655 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.692 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -103.97 120.54 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 123.376 0.67 . . . . 0.0 109.379 177.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.523 ' ND2' HG11 ' A' ' 93' ' ' VAL . 66.0 t30 54.1 29.91 11.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.481 0.658 . . . . 0.0 110.719 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.15 -21.35 44.92 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.755 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 2.7 ptp180 -104.22 131.2 51.79 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 117.874 0.837 . . . . 0.0 110.602 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' THR . 62.6 m -47.8 136.11 11.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.201 0.525 . . . . 0.0 112.151 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.691 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -76.1 -19.75 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.76 -174.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.04 -12.21 59.26 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.121 -173.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.58 -20.87 61.03 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.377 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.545 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 2.6 mptp? -107.67 -131.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.845 0.831 . . . . 0.0 110.275 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 86' ' ' VAL . 5.5 m -158.13 160.12 36.95 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' VAL . 12.8 mttt -47.01 -60.8 2.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.335 0.588 . . . . 0.0 111.756 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -55.0 -34.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.076 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.591 ' O ' ' HG2' ' A' ' 89' ' ' MET . 33.2 mt-10 -77.52 -43.47 31.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.679 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.651 HG11 ' HB ' ' A' ' 78' ' ' ILE . 19.7 m -58.42 -47.6 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -57.16 -38.75 74.03 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 25.6 ttpp -60.88 -56.92 15.45 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.591 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 16.5 mmt -48.63 -43.2 36.22 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.63 0.581 . . . . 0.0 111.146 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.517 HD13 HD11 ' A' ' 33' ' ' ILE . 64.2 mt -62.45 -55.12 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.465 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.721 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 10.4 pt20 -76.94 -22.12 53.78 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.985 -0.447 . . . . 0.0 111.459 -174.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.58 -52.68 23.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.411 0.684 . . . . 0.0 111.732 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.523 HG11 ' ND2' ' A' ' 74' ' ' ASN . 31.8 m -49.42 -36.26 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.543 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 67.62 134.55 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.464 0.649 . . . . 0.0 112.493 171.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.46 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 102.27 -48.25 1.08 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.938 172.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.0 pt-20 -146.03 178.79 7.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.058 0.456 . . . . 0.0 110.144 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.522 HG11 HG23 ' A' ' 33' ' ' ILE . 5.4 m -145.39 154.69 13.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.621 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.3 m -140.71 99.78 3.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 172.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.633 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -93.45 120.63 43.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.112 -175.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 4.1 t-160 -94.39 129.06 41.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 171.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -139.04 163.98 30.97 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.157 0.503 . . . . 0.0 111.815 -172.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 C--N 1.32 -0.707 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 175.489 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.451 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 20.2 t70 . . . . . 0 C--O 1.21 -1.021 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 13.6 Cg_exo -29.26 -51.48 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.251 3.301 . . . . 0.0 115.16 -173.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.1 pttp -59.51 -45.63 91.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.379 0.609 . . . . 0.0 111.759 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 15.1 mm100 -85.76 -17.81 34.79 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.838 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.422 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.2 tm? -73.25 -43.73 60.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.485 -175.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -69.18 -35.47 76.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.119 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 109' ' ' LYS . 81.0 t -64.71 -41.11 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.223 0.535 . . . . 0.0 109.991 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.85 -23.79 61.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.84 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 85.4 t80 . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.041 178.701 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.516 ' HG ' ' N ' ' A' ' 127' ' ' LYS . 61.6 tp . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 120.669 0.271 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 13.8 ptmm? -169.38 151.79 4.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.696 0.398 . . . . 0.0 110.69 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.807 ' OXT' HG13 ' A' ' 33' ' ' ILE . 14.5 p . . . . . 0 C--O 1.238 0.491 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.048 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 12.0 ptmm? . . . . . 0 CA--C 1.517 -0.319 0 CA-C-O 120.82 0.343 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 62' ' ' GLY . 14.6 m -128.16 154.19 38.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.938 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.7 t -116.35 123.6 48.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.546 0.689 . . . . 0.0 110.219 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.47 HD21 ' HA2' ' A' ' 62' ' ' GLY . 7.8 mt -122.34 -168.43 1.72 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.402 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 93.6 mt-30 -133.89 140.14 46.63 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.215 0.531 . . . . 0.0 110.642 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 10.0 mmtp -45.79 144.02 1.88 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.067 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -83.63 -179.39 7.31 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.439 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.77 -24.24 61.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 118.084 0.402 . . . . 0.0 111.363 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.565 HE21 HD21 ' A' ' 32' ' ' LEU . 6.1 tt0 -96.56 21.13 9.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 110.202 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.466 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 1.7 p-10 57.17 23.45 8.63 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.121 1.369 . . . . 0.0 113.173 174.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.565 HD21 HE21 ' A' ' 30' ' ' GLN . 0.8 OUTLIER -128.72 -165.43 1.5 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.797 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.763 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.7 -26.58 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.635 -178.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 98.28 41.9 3.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.093 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.519 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -130.06 172.6 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.947 0.879 . . . . 0.0 111.488 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m -141.41 129.41 21.96 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.712 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.453 HG23 HD13 ' A' ' 35' ' ' ILE . 6.9 pt -119.41 137.97 51.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.896 0.855 . . . . 0.0 111.022 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.221 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.853 -179.587 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.673 ' HB ' HD13 ' A' ' 70' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.475 0.655 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 m -117.66 -22.21 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.397 -175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -155.07 138.61 15.97 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.585 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.606 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.2 p -139.91 160.89 26.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.855 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -97.93 -137.79 0.28 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.429 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.44 -34.66 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -101.72 -0.56 34.28 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.998 0.428 . . . . 0.0 110.174 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 80.2 p -84.04 148.54 53.86 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.466 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 10.2 Cg_endo -52.06 -41.16 66.04 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.484 1.456 . . . . 0.0 110.991 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.52 -45.71 88.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.827 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.606 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.38 -59.56 2.67 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.411 0.624 . . . . 0.0 110.525 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.616 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.6 pp -54.87 -75.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.616 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 31.4 t70 -94.6 -13.06 26.33 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 122.581 1.181 . . . . 0.0 108.24 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -61.55 -40.34 98.57 Favored Glycine 0 C--N 1.314 -0.687 0 CA-C-N 112.464 -2.153 . . . . 0.0 114.804 -166.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.2 p 52.31 35.29 16.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.455 1.121 . . . . 0.0 111.197 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.647 HG11 HG13 ' A' ' 99' ' ' ILE . 15.9 m -122.79 53.66 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.174 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.62 179.67 7.33 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 112.649 -2.069 . . . . 0.0 111.319 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.34 123.05 15.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.696 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.64 -18.6 8.64 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.522 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.615 ' O ' HG22 ' A' ' 49' ' ' ILE . 11.9 m-20 -83.33 144.51 29.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.524 0.662 . . . . 0.0 110.532 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 41.9 mt-10 -94.52 97.0 9.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.924 -174.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.673 HD13 ' HB ' ' A' ' 49' ' ' ILE . 2.1 mp -76.01 138.26 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -127.89 -25.03 3.13 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.963 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.15 146.81 16.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.536 -1.316 . . . . 0.0 113.772 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.691 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -117.52 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.503 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 5.4 m-20 56.24 22.17 5.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.95 0.405 . . . . 0.0 111.786 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.83 -12.21 59.25 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.451 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.691 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 9.7 ptp180 -105.76 131.72 52.76 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 117.922 0.861 . . . . 0.0 110.861 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 p -61.06 138.08 58.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.133 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.689 HG23 HG12 ' A' ' 73' ' ' VAL . 1.1 pp -77.56 -24.16 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-O 122.391 1.091 . . . . 0.0 109.883 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.614 ' H ' HD12 ' A' ' 78' ' ' ILE . 3.5 tppp? -69.63 -19.27 63.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.068 -1.878 . . . . 0.0 109.878 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.56 -15.61 75.47 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.019 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.73 -142.26 0.17 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.662 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 86' ' ' VAL . 29.7 p -136.35 169.79 17.08 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.177 -0.209 . . . . 0.0 111.105 -169.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.468 ' HB3' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -49.02 -53.99 17.7 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.81 0.693 . . . . 0.0 112.443 -176.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.06 -39.82 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.624 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.07 -35.32 66.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 82' ' ' THR . 32.3 m -68.54 -46.1 80.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.209 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' HB2' HD13 ' A' ' 126' ' ' LEU . . . -58.33 -37.82 75.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.971 0.415 . . . . 0.0 110.171 172.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 91' ' ' GLN . 60.8 tttm -63.26 -53.13 57.8 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.847 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.484 ' O ' HG13 ' A' ' 93' ' ' VAL . 24.8 mmt -51.86 -42.48 62.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.25 0.548 . . . . 0.0 111.386 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.609 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 62.5 mt -64.78 -47.96 86.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.675 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.466 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 7.1 pt20 -73.78 -35.36 64.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.159 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -58.95 -50.1 75.35 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.526 0.516 . . . . 0.0 111.981 -173.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 89' ' ' MET . 17.8 m -52.99 -35.29 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.566 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 98.5 mttt 65.16 151.32 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.824 0.821 . . . . 0.0 112.802 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 88.3 -53.52 4.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.214 168.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.1 pt-20 -137.33 178.01 7.42 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.455 HG11 HG23 ' A' ' 33' ' ' ILE . 6.8 m -147.8 150.67 14.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.846 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.503 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 34.3 m -137.97 103.61 5.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.043 0.449 . . . . 0.0 110.182 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.647 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -94.45 129.81 44.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.338 -175.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -114.72 119.86 38.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.258 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -142.04 154.1 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.003 0.43 . . . . 0.0 110.893 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 17.3 m120 . . . . . 0 C--N 1.323 -0.563 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.592 ' OD2' ' HG2' ' A' ' 109' ' ' LYS . 10.5 t70 . . . . . 0 C--O 1.21 -1.007 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 9.2 Cg_exo -29.9 -47.77 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.693 2.929 . . . . 0.0 114.087 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.592 ' HG2' ' OD2' ' A' ' 107' ' ' ASP . 9.2 ptpp? -58.25 -49.61 76.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.232 0.539 . . . . 0.0 111.831 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.485 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 26.3 mm-40 -85.95 -11.59 52.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.714 0.769 . . . . 0.0 110.872 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.42 -43.89 22.47 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.142 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 115' ' ' PHE . 8.2 pt-20 -69.56 -22.07 63.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.191 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 109' ' ' LYS . 82.0 t -64.02 -35.24 72.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.403 0.62 . . . . 0.0 109.583 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.07 -27.66 54.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.81 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.453 ' HB3' ' HA ' ' A' ' 112' ' ' GLU . 13.7 t80 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.149 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 87' ' ' ALA . 1.6 pp . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 121.503 0.668 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -151.43 114.55 4.75 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.634 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.763 ' OXT' HG13 ' A' ' 33' ' ' ILE . 13.8 p . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 118.011 -0.995 . . . . 0.0 108.699 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 101' ' ' TYR . 63.8 mttm . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.498 HG23 HD11 ' A' ' 99' ' ' ILE . 32.7 m -140.26 161.35 25.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.138 0.494 . . . . 0.0 112.152 -162.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 t -122.91 123.87 41.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.389 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.443 ' CD2' HD11 ' A' ' 99' ' ' ILE . 2.4 mm? -118.15 -166.68 1.24 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.805 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.652 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 93.1 mt-30 -127.67 149.67 50.1 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.908 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 23.9 mmtp -52.14 146.26 9.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.749 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.46 179.93 7.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.807 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.99 -22.2 60.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.119 0.485 . . . . 0.0 111.044 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.522 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -92.18 8.7 36.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.033 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 38.6 t30 72.61 11.72 5.52 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.335 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.577 HD22 ' OXT' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -127.13 -168.07 1.83 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.945 -0.472 . . . . 0.0 111.887 -174.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.677 HG23 HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -101.83 -26.87 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 99.08 33.41 5.49 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.144 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.71 HD11 HG23 ' A' ' 128' ' ' VAL . 2.8 pp -125.72 172.38 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.692 0.758 . . . . 0.0 112.126 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 40.0 m -139.14 127.65 23.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.24 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.559 ' HB ' ' HG ' ' A' ' 126' ' ' LEU . 66.0 mt -106.56 120.23 57.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.891 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.673 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.434 177.583 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 122.124 0.964 . . . . 0.0 110.048 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.6 t -111.79 -23.36 4.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.942 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -147.5 143.4 27.81 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.663 0.744 . . . . 0.0 112.402 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.5 p -143.05 160.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.758 -1.564 . . . . 0.0 109.395 174.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.561 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 22.8 m-85 -116.86 126.06 52.45 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 34.9 t70 -57.46 -21.99 40.69 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -164.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.492 ' HA ' HD23 ' A' ' 60' ' ' LEU . 42.5 m-80 -101.38 6.17 42.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.228 0.537 . . . . 0.0 110.23 -173.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.561 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 28.3 p -96.98 149.12 35.35 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -48.28 -40.08 35.27 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.183 1.922 . . . . 0.0 111.804 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.54 -54.16 50.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.967 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -73.95 -54.82 7.08 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.036 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -42.85 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.831 -177.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -95.6 -36.27 11.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.329 0.585 . . . . 0.0 111.026 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.46 -38.61 95.02 Favored Glycine 0 CA--C 1.517 0.159 0 CA-C-N 115.211 -0.904 . . . . 0.0 114.39 -167.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.11 56.19 4.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.049 0.928 . . . . 0.0 110.819 -174.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.602 HG11 HG13 ' A' ' 99' ' ' ILE . 16.3 m -128.39 49.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.581 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.92 179.28 7.58 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.295 -167.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.19 123.56 7.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.036 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.96 20.5 11.29 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.63 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.2 t0 -107.97 161.77 14.64 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 4.2 mp0 -101.98 124.51 47.73 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.031 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.407 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 10.3 mm -113.31 141.89 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.465 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.568 HG22 ' CB ' ' A' ' 101' ' ' TYR . 12.0 t -137.44 -18.57 1.27 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.706 -0.621 . . . . 0.0 112.262 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -131.9 136.68 8.91 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.032 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.736 HG12 HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -101.15 121.86 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 124.011 0.925 . . . . 0.0 109.156 175.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.502 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 9.2 t-20 57.01 25.51 10.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.542 0.687 . . . . 0.0 110.355 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.87 -21.15 43.12 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.027 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -107.45 140.31 40.6 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 118.206 1.003 . . . . 0.0 111.024 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 23.1 t -52.93 137.12 33.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 111.755 -174.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.736 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -80.94 -17.83 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 109.499 -177.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -64.67 -13.58 54.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.523 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.71 -19.57 78.08 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.815 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.94 -130.7 0.14 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.732 0.766 . . . . 0.0 111.653 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 86' ' ' VAL . 2.8 m -139.11 156.09 47.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.565 -168.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.5 mtpt -47.85 -49.11 30.35 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.292 0.637 . . . . 0.0 111.676 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -58.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 122.454 1.121 . . . . 0.0 110.537 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 41.2 mt-10 -61.93 -30.95 71.25 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 112.94 -1.936 . . . . 0.0 112.615 -171.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.664 HG11 ' HB ' ' A' ' 78' ' ' ILE . 30.5 m -71.17 -42.26 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 126' ' ' LEU . . . -54.17 -41.18 68.2 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 170.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 28.5 ttpp -59.38 -48.48 81.48 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.616 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 89.0 mtp -51.97 -41.16 61.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.138 0.495 . . . . 0.0 110.866 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.551 HD13 HD11 ' A' ' 33' ' ' ILE . 92.6 mt -72.21 -41.28 66.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.231 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -76.05 -25.0 55.18 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.176 -0.327 . . . . 0.0 111.792 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.03 -51.66 65.91 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.52 151.2 8.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -132.05 144.42 50.74 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.151 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.1 -47.27 1.08 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.639 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 10.5 pt-20 -138.59 176.45 8.68 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.568 0.699 . . . . 0.0 111.182 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.677 HG11 HG23 ' A' ' 33' ' ' ILE . 5.5 m -149.65 158.29 6.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.06 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.502 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 24.7 m -142.41 125.08 15.87 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 170.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.602 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -102.9 139.22 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.553 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 0.7 OUTLIER -134.56 124.42 25.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.67 -179.464 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.568 ' CB ' HG22 ' A' ' 71' ' ' THR . 1.0 OUTLIER 169.98 -130.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 O-C-N 124.426 1.079 . . . . 0.0 110.014 166.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.519 ' HB2' ' CD1' ' A' ' 101' ' ' TYR . 4.5 m120 . . . . . 0 N--CA 1.443 -0.812 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -158.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 111' ' ' LEU . 8.4 m-20 . . . . . 0 C--O 1.213 -0.821 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -31.36 -48.79 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.68 2.92 . . . . 0.0 114.032 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -57.08 -48.95 77.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.57 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 61.9 mm-40 -90.42 -13.42 34.96 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.677 0.751 . . . . 0.0 110.327 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.4 tm? -76.21 -38.21 56.74 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.238 -175.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.53 -25.89 63.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.394 0.616 . . . . 0.0 109.528 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 110' ' ' GLN . 96.5 t -67.02 -44.18 88.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.572 173.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.71 -21.67 62.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.758 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 77.2 t80 . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.493 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.559 ' HG ' ' HB ' ' A' ' 37' ' ' ILE . 1.2 pp . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 13.7 ptmm? -152.56 129.72 11.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.394 0.616 . . . . 0.0 110.918 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.71 HG23 HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.016 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 167.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.71 0.767 . . . . 0.0 110.007 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 HD11 ' A' ' 99' ' ' ILE . 34.8 m -122.06 145.97 27.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.306 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.1 t -117.47 110.9 18.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.721 0.772 . . . . 0.0 110.312 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.49 -164.72 0.97 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.371 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 92.3 mt-30 -131.04 144.36 51.39 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.363 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 29.5 mmtm -47.91 149.65 1.3 Allowed 'General case' 0 C--N 1.316 -0.878 0 O-C-N 124.641 1.213 . . . . 0.0 111.841 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -83.04 -178.59 7.17 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.94 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.77 -19.24 49.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.422 0.63 . . . . 0.0 110.647 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.533 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 3.9 mt-30 -92.8 11.38 27.18 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.626 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.551 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 1.2 p-10 56.82 24.07 8.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.013 1.325 . . . . 0.0 112.498 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.544 HD22 ' OXT' ' A' ' 128' ' ' VAL . 1.2 pp -130.57 -165.47 1.55 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.182 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.789 HG23 HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -101.75 -29.47 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 100.36 30.86 6.07 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.221 -0.514 . . . . 0.0 113.226 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.619 HD11 HG23 ' A' ' 128' ' ' VAL . 2.8 pp -122.85 179.71 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.061 0.457 . . . . 0.0 111.592 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 51.5 m -138.16 129.67 27.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.095 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.633 ' HB ' HD12 ' A' ' 126' ' ' LEU . 61.6 mt -97.46 139.47 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.854 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.049 -179.527 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 122.083 0.944 . . . . 0.0 110.503 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.9 t -105.03 -30.26 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.258 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 3.8 pt20 -157.05 152.54 26.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.7 p -141.84 160.54 20.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.845 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 97.3 m-85 -114.51 125.92 54.35 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.675 0.75 . . . . 0.0 108.978 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -53.07 -27.59 20.84 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 125.143 1.377 . . . . 0.0 114.566 -165.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.54 ' HA ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -100.85 4.14 42.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.26 0.552 . . . . 0.0 110.463 -171.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.494 ' CB ' ' HA3' ' A' ' 34' ' ' GLY . 30.4 p -91.3 146.82 34.18 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -47.41 -39.11 28.07 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.255 1.97 . . . . 0.0 111.659 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.49 -54.26 49.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.256 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.575 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -75.14 -52.97 9.67 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.388 0.614 . . . . 0.0 110.138 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.1 tm? -43.09 -75.62 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.502 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -96.83 -43.95 7.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.185 0.517 . . . . 0.0 111.479 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.3 -27.75 60.86 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 115.019 -0.992 . . . . 0.0 114.822 -164.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.48 48.31 19.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.868 0.842 . . . . 0.0 111.449 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.6 HG11 HG13 ' A' ' 99' ' ' ILE . 6.1 m -123.8 53.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 CA-C-O 122.936 1.351 . . . . 0.0 109.481 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.8 173.95 10.25 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 112.485 -2.143 . . . . 0.0 111.2 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -51.25 122.36 7.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.889 -174.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.06 -4.97 16.01 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.71 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.625 ' O ' HG22 ' A' ' 49' ' ' ILE . 76.1 m-20 -98.85 172.81 7.2 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 30.7 tt0 -130.72 145.7 52.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.932 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 70' ' ' ILE . 4.2 mp -114.12 128.5 71.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.316 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.67 ' H ' ' HB2' ' A' ' 101' ' ' TYR . 7.3 t -109.03 -4.81 16.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.054 0.454 . . . . 0.0 110.586 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.76 133.43 3.41 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.459 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.694 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -103.15 120.81 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.477 HD21 ' HA ' ' A' ' 90' ' ' ILE . 96.3 m-20 53.78 29.92 10.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.238 0.542 . . . . 0.0 111.704 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.57 -21.59 41.98 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.914 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 14.7 ptm180 -101.27 137.34 39.74 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 118.061 0.93 . . . . 0.0 110.789 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m -65.91 151.39 46.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.063 0.458 . . . . 0.0 111.228 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.896 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -93.47 3.48 8.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 122.455 1.121 . . . . 0.0 108.685 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -78.94 80.88 5.26 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.549 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.59 -30.49 0.41 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.688 -1.244 . . . . 0.0 115.012 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.896 ' HE2' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -112.35 -145.05 0.39 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.844 1.322 . . . . 0.0 112.088 -172.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.548 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -134.71 151.8 51.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.14 -178.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.611 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -45.44 -54.68 7.04 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.159 0.583 . . . . 0.0 112.341 175.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 p -51.69 -31.67 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.166 0.508 . . . . 0.0 111.981 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 89' ' ' MET . 32.4 mt-10 -81.89 -40.22 22.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.005 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.611 HG22 ' HA ' ' A' ' 83' ' ' LYS . 29.9 m -70.55 -38.25 72.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.538 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.746 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -53.17 -42.37 66.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.173 169.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -64.76 -50.77 65.51 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.717 175.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 62.4 mtt -50.74 -41.31 56.28 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.569 0.543 . . . . 0.0 111.045 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.752 HD13 HD11 ' A' ' 33' ' ' ILE . 74.4 mt -65.11 -56.42 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.254 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.551 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 10.3 pt20 -73.12 -24.59 60.64 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.713 -175.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.566 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 32.2 tt0 -58.7 -53.25 60.48 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.713 0.805 . . . . 0.0 111.976 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 90' ' ' ILE . 12.4 m -56.33 -29.02 27.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.292 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 92' ' ' GLU . 57.4 mttp 61.25 148.73 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.613 0.72 . . . . 0.0 112.609 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.409 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 86.55 -53.45 4.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.407 169.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 10.0 pt-20 -129.06 175.08 8.98 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.158 0.504 . . . . 0.0 110.19 -172.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.789 HG11 HG23 ' A' ' 33' ' ' ILE . 5.7 m -151.37 151.9 11.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.648 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.8 m -141.44 117.51 10.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.798 0.332 . . . . 0.0 110.741 170.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.6 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -98.63 148.74 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.17 176.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 1.1 m-70 -143.54 116.39 8.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.67 ' HB2' ' H ' ' A' ' 71' ' ' THR . 1.3 t80 178.63 -116.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.615 0.572 . . . . 0.0 111.139 162.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.443 -0.78 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.135 -163.901 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.443 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 15.2 t70 . . . . . 0 C--O 1.205 -1.237 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 15.6 Cg_exo -29.3 -51.74 0.17 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 124.537 3.491 . . . . 0.0 115.424 -174.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.7 pttm -57.77 -48.15 80.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.356 0.598 . . . . 0.0 111.716 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.9 mm100 -83.37 -17.8 41.06 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.519 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.4 tm? -64.74 -48.36 74.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.076 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 115' ' ' PHE . 3.4 pt-20 -70.54 -25.24 63.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.794 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.8 t -69.6 -45.62 77.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.435 0.636 . . . . 0.0 109.787 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.53 -17.28 58.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.137 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 43.4 t80 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.393 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.779 HD13 ' N ' ' A' ' 127' ' ' LYS . 1.5 tm? . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.779 ' N ' HD13 ' A' ' 126' ' ' LEU . 21.8 ptmt -167.0 127.13 1.5 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.532 0.682 . . . . 0.0 111.422 176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.845 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 163.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 62' ' ' GLY . 20.7 m -126.54 146.9 31.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.864 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 t -110.95 116.04 30.52 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.726 0.774 . . . . 0.0 110.77 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.502 ' H ' HG22 ' A' ' 97' ' ' VAL . 7.3 mt -123.32 -166.89 1.52 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.646 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.659 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 2.0 pt20 -144.01 142.6 30.78 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.766 174.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HE3' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -32.87 149.74 0.01 OUTLIER 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 177.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.46 -179.25 6.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.655 -1.612 . . . . 0.0 108.385 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.58 -29.04 61.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.59 0.632 . . . . 0.0 111.499 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.558 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.2 mt-30 -88.05 5.36 41.35 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.043 0.449 . . . . 0.0 110.603 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 63.9 t30 70.28 28.22 3.92 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.349 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.683 ' HB2' ' OXT' ' A' ' 128' ' ' VAL . 1.8 pt? -128.19 -171.26 2.41 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.785 175.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.841 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -104.58 -26.21 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.715 179.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' N ' ' HG ' ' A' ' 32' ' ' LEU . . . 96.17 40.43 4.01 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.386 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.548 HD11 HG12 ' A' ' 128' ' ' VAL . 2.9 pp -129.64 176.74 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.968 0.89 . . . . 0.0 112.305 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 24.0 m -144.72 126.87 15.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.731 172.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.5 mt -103.32 119.9 52.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.246 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.093 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.824 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.709 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.7 m -94.31 -20.51 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.691 -170.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -157.07 136.24 11.92 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.505 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.7 p -139.88 160.28 26.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.16 -138.55 0.2 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -138.24 -39.37 0.54 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.765 0.711 . . . . 0.0 112.145 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -101.32 4.09 41.3 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.762 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 59.9 p -84.14 148.04 52.27 Favored Pre-proline 0 N--CA 1.433 -1.285 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.0 Cg_endo -49.7 -42.18 43.93 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.764 1.643 . . . . 0.0 111.22 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.576 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.6 -46.48 84.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.019 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.76 -59.13 2.87 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.346 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.6 pp -51.16 -74.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -171.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.604 ' N ' HD12 ' A' ' 60' ' ' LEU . 21.7 t70 -93.74 -15.4 25.23 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.544 1.164 . . . . 0.0 108.081 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -64.39 -48.39 74.51 Favored Glycine 0 C--N 1.313 -0.704 0 CA-C-N 112.818 -1.992 . . . . 0.0 114.524 -166.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.1 p 63.64 15.78 9.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.078 0.951 . . . . 0.0 111.006 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.588 HG11 HG13 ' A' ' 99' ' ' ILE . 16.7 m -96.92 53.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-O 123.0 1.381 . . . . 0.0 110.028 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.21 168.52 14.69 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 112.512 -2.131 . . . . 0.0 111.39 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.66 122.54 6.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.832 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.64 -14.64 11.65 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.009 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.709 ' O ' HG22 ' A' ' 49' ' ' ILE . 43.4 m-20 -90.55 146.15 24.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.2 0.5 . . . . 0.0 110.167 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -89.4 126.48 35.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.682 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.5 mm -94.42 120.27 43.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -110.97 -21.68 11.88 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.832 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.78 156.06 27.72 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.398 -1.382 . . . . 0.0 113.869 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -121.9 124.63 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 C-N-CA 123.573 0.749 . . . . 0.0 109.186 178.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.466 ' HA ' ' OG1' ' A' ' 98' ' ' THR . 6.9 t-20 58.28 22.57 9.43 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.583 0.706 . . . . 0.0 111.192 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.44 -20.01 50.23 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.109 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 11.3 ptp180 -101.99 130.17 48.46 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 117.292 0.546 . . . . 0.0 110.619 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.6 m -63.66 153.52 35.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.021 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -93.08 -30.93 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 110.417 -178.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -71.44 91.26 1.02 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.552 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.54 -21.51 0.33 Allowed Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.799 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -125.83 -131.08 0.25 Allowed 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.245 177.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -137.48 147.36 45.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.927 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.546 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -46.32 -49.49 17.55 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.598 0.759 . . . . 0.0 112.527 176.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -57.26 -39.9 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.831 0.348 . . . . 0.0 111.623 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.46 -41.48 66.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.943 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 83' ' ' LYS . 32.8 m -67.63 -45.21 85.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.897 0.38 . . . . 0.0 110.815 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.25 -34.59 75.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.261 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.61 -51.16 68.39 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.424 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.2 mmt -53.04 -36.65 60.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.62 0.724 . . . . 0.0 111.416 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.449 HD13 HD11 ' A' ' 33' ' ' ILE . 44.6 mt -72.64 -31.86 38.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.753 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -90.37 -23.51 21.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.8 -49.45 62.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.946 0.499 . . . . 0.0 111.097 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.88 -32.32 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.718 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 62.32 119.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.659 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 96.97 -33.22 5.9 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.194 173.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.3 pt-20 -134.86 178.76 6.77 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 117.177 0.489 . . . . 0.0 110.501 -171.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.581 HG12 ' HE3' ' A' ' 27' ' ' LYS . 1.2 m -152.48 148.74 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.159 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -141.27 106.93 5.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.469 172.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.588 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -100.0 141.99 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.051 0.453 . . . . 0.0 111.705 -178.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -118.5 121.36 40.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -136.52 174.73 10.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.053 0.454 . . . . 0.0 111.614 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--N 1.325 -0.472 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -177.001 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 C--O 1.215 -0.761 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -30.66 -55.39 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.915 3.077 . . . . 0.0 114.721 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.54 ' O ' HG23 ' A' ' 113' ' ' VAL . 5.9 ptpp? -56.48 -47.12 79.9 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.242 0.544 . . . . 0.0 112.311 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.481 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.3 mm100 -87.84 -17.02 32.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.895 -175.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.425 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -77.8 -45.32 24.79 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.021 -177.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.92 -27.27 69.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.215 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 109' ' ' LYS . 77.0 t -61.0 -41.38 88.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.14 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.79 -24.61 41.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.544 0.688 . . . . 0.0 109.802 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.9 t80 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.413 -176.899 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.463 ' HB3' ' HE3' ' A' ' 83' ' ' LYS . 1.6 pp . . . . . 0 C--O 1.227 -0.113 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.452 ' C ' ' HD2' ' A' ' 127' ' ' LYS . 0.1 OUTLIER -143.49 154.49 43.7 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.841 ' OXT' HG13 ' A' ' 33' ' ' ILE . 7.1 p . . . . . 0 C--O 1.247 0.93 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.315 0 CA-C-O 120.634 0.254 . . . . 0.0 110.352 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.466 HG23 HD11 ' A' ' 99' ' ' ILE . 27.2 m -128.71 158.65 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.152 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.9 t -132.72 117.32 17.7 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.652 0.739 . . . . 0.0 110.656 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.11 -159.25 0.9 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.875 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 96' ' ' GLU . 31.9 mm-40 -122.57 158.26 30.31 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.625 0.726 . . . . 0.0 110.114 175.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.589 ' NZ ' ' HA ' ' A' ' 91' ' ' GLN . 11.4 mmmm -54.4 156.69 3.17 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.082 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.57 174.97 7.47 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.3 -15.56 36.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.224 0.535 . . . . 0.0 110.556 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.479 ' NE2' HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -91.38 -0.49 57.65 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.746 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.508 ' C ' ' HE2' ' A' ' 27' ' ' LYS . 31.1 t30 70.06 38.05 1.59 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.427 1.108 . . . . 0.0 109.897 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -154.57 -167.35 2.59 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.572 175.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.738 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.26 -28.93 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.945 -177.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 100.4 35.11 4.52 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.608 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.505 HG22 HG23 ' A' ' 52' ' ' VAL . 2.7 pp -126.92 177.96 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.269 0.557 . . . . 0.0 111.633 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -134.76 128.19 32.39 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.626 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.772 ' HB ' HD12 ' A' ' 126' ' ' LEU . 56.2 mt -107.47 140.79 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.469 0.652 . . . . 0.0 111.912 -173.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.978 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.536 ' HB ' ' CG1' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 122.531 1.158 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -95.62 -30.55 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.206 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -155.49 139.87 16.75 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.453 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.2 p -138.33 161.2 31.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -99.33 -135.05 0.28 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 15.7 t70 -138.4 -33.41 0.68 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -101.61 1.82 38.19 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.062 0.458 . . . . 0.0 110.366 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 77.9 p -85.33 150.18 53.92 Favored Pre-proline 0 N--CA 1.44 -0.956 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.16 -40.39 77.31 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.295 1.33 . . . . 0.0 111.197 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.42 -46.28 86.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.741 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.63 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -73.62 -58.4 3.33 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.672 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 61' ' ' ASP . 2.1 pp -52.95 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -170.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.647 ' N ' HD12 ' A' ' 60' ' ' LEU . 24.0 t70 -95.99 -16.32 21.75 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.262 1.029 . . . . 0.0 108.487 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -61.21 -38.71 96.09 Favored Glycine 0 C--N 1.315 -0.586 0 CA-C-N 113.019 -1.901 . . . . 0.0 113.594 -169.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p 52.31 38.38 24.76 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.415 1.102 . . . . 0.0 111.774 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.496 HG11 HG13 ' A' ' 99' ' ' ILE . 12.4 m -118.17 54.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.832 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.514 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -84.49 168.64 15.27 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 112.716 -2.038 . . . . 0.0 111.778 -170.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.89 132.09 26.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.669 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.0 2.64 57.03 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.648 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 101' ' ' TYR . 1.7 t70 -90.77 167.89 12.14 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.97 89.52 3.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.536 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 25.0 mm -78.34 110.0 13.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.893 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -102.3 -7.57 21.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.129 -175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -151.88 135.37 4.99 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.384 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.657 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -103.57 120.83 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 123.615 0.766 . . . . 0.0 109.217 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.3 t30 55.1 32.81 19.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.952 0.882 . . . . 0.0 110.472 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.83 -21.29 44.39 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.405 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.415 ' H ' ' HG2' ' A' ' 76' ' ' ARG . 2.5 ptm180 -108.17 138.58 44.2 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 117.132 0.466 . . . . 0.0 110.484 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.487 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 17.7 t -59.58 142.51 52.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.89 0.376 . . . . 0.0 111.892 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.657 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -74.89 -22.71 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -64.38 99.35 0.29 Allowed 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.814 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.2 -30.63 1.75 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.942 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.628 ' HE3' ' SD ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -125.26 -139.27 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.795 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -141.25 159.88 41.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.896 -169.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.586 ' O ' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -49.38 -52.79 26.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.503 0.502 . . . . 0.0 110.865 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -53.94 -38.71 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.893 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 34.2 mt-10 -76.28 -39.58 53.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.567 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 83' ' ' LYS . 34.7 m -69.61 -39.31 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.299 . . . . 0.0 111.389 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.54 -43.64 62.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.326 168.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 28.5 ttpp -61.59 -46.58 89.25 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.495 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.628 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 74.1 mtp -56.3 -35.14 67.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.43 0.633 . . . . 0.0 110.482 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 93' ' ' VAL . 27.9 mm -73.7 -32.3 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.387 177.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.589 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 56.0 mt-30 -82.74 -24.67 33.44 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.754 -0.591 . . . . 0.0 111.899 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -64.25 -39.49 94.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.286 0.634 . . . . 0.0 111.895 -171.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.536 HG23 ' N ' ' A' ' 94' ' ' LYS . 3.7 m -35.48 -47.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.114 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.536 ' N ' HG23 ' A' ' 93' ' ' VAL . 55.4 mtmt 57.08 83.29 0.1 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.496 -162.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.538 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 115.47 -36.73 3.75 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 118.785 -1.674 . . . . 0.0 113.675 164.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.506 ' HA ' ' NE2' ' A' ' 26' ' ' GLN . 11.7 pt-20 -106.13 172.35 6.86 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 117.716 0.758 . . . . 0.0 110.127 -173.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 t -153.4 127.87 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.448 -171.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.0 m -141.04 135.75 31.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.496 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -130.87 140.67 48.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.801 0.334 . . . . 0.0 111.808 -177.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -116.99 122.57 44.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.411 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 40.2 p90 -138.85 157.16 46.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.073 0.463 . . . . 0.0 111.582 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m120 . . . . . 0 C--N 1.325 -0.475 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.19 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.501 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 16.7 m-20 . . . . . 0 C--O 1.215 -0.746 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 107' ' ' ASP . 12.8 Cg_exo -31.51 -46.86 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.904 2.403 . . . . 0.0 113.959 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.1 ptpt -68.83 -48.23 64.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.511 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.492 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.5 mm100 -84.92 -11.77 54.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.438 0.637 . . . . 0.0 110.968 -174.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.434 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.1 tm? -70.02 -43.37 71.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.339 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.16 -30.72 63.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.271 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' LYS . 84.3 t -63.71 -36.1 75.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.473 0.654 . . . . 0.0 109.902 175.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.6 tp -77.86 -27.02 49.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.244 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.8 t80 . . . . . 0 N--CA 1.465 0.275 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.075 -177.315 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.772 HD12 ' HB ' ' A' ' 37' ' ' ILE . 2.0 mt . . . . . 0 CA--C 1.497 -1.085 0 CA-C-O 121.291 0.567 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -157.51 80.75 0.89 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.194 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.738 ' OXT' HG13 ' A' ' 33' ' ' ILE . 9.1 p . . . . . 0 N--CA 1.438 -1.068 0 CA-C-O 117.575 -1.203 . . . . 0.0 108.724 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 62' ' ' GLY . 29.8 m -128.04 152.93 36.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.5 t -118.41 123.07 44.33 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.631 0.729 . . . . 0.0 110.571 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -130.51 -165.22 1.52 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.536 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -133.28 142.93 48.75 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.326 0.584 . . . . 0.0 110.513 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.63 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 2.5 mmmm -43.09 146.95 0.37 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.487 -1.688 . . . . 0.0 112.637 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -85.09 177.8 7.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.798 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.14 -21.77 48.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.909 0.385 . . . . 0.0 111.45 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.55 ' NE2' HD21 ' A' ' 32' ' ' LEU . 5.0 tt0 -92.88 15.11 15.56 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.123 0.487 . . . . 0.0 110.231 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.473 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 1.2 p-10 54.5 35.31 23.05 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.527 1.131 . . . . 0.0 111.583 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.708 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -140.76 -171.16 3.18 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.376 174.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.827 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -97.96 -31.07 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-O 120.682 0.277 . . . . 0.0 111.039 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' N ' HD13 ' A' ' 32' ' ' LEU . . . 102.5 37.64 3.22 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.324 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 2.3 pp -126.91 173.37 12.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.131 0.491 . . . . 0.0 110.72 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.4 m -134.86 130.55 36.16 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.782 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.796 ' HB ' HD12 ' A' ' 126' ' ' LEU . 40.7 mm -114.15 128.91 70.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.73 0.776 . . . . 0.0 111.838 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.995 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.582 179.556 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.02 -34.6 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.833 -170.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -155.84 144.41 20.25 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 120.764 0.316 . . . . 0.0 110.487 -171.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.7 p -139.14 160.18 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -92.02 -136.19 0.15 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.448 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 8.6 t70 -139.73 -38.26 0.47 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.617 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -100.91 3.87 42.15 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.036 0.446 . . . . 0.0 110.324 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 61.7 p -82.62 151.26 64.62 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.5 -40.75 71.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.299 1.333 . . . . 0.0 111.269 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -59.16 -44.31 92.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.255 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.646 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -78.33 -55.94 4.85 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.836 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.7 pp -52.66 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -171.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.607 ' N ' HD12 ' A' ' 60' ' ' LEU . 29.4 t70 -95.78 -12.73 24.89 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.441 1.115 . . . . 0.0 108.12 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -65.36 -45.46 90.54 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 112.969 -1.923 . . . . 0.0 113.497 -170.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p 62.93 9.51 3.77 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.069 0.948 . . . . 0.0 111.498 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.689 HG11 HG13 ' A' ' 99' ' ' ILE . 19.1 m -89.68 53.53 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 CA-C-O 123.001 1.382 . . . . 0.0 110.166 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.441 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -84.29 169.99 14.13 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.622 -2.081 . . . . 0.0 111.459 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.48 129.87 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.143 -174.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.7 -22.24 10.11 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.673 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.493 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -80.4 161.48 24.95 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.339 -177.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -110.44 120.89 43.88 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.8 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.0 mm -89.63 123.75 41.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.588 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.6 t -103.15 -29.77 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -163.51 151.16 20.54 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.905 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.607 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -107.72 122.53 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.442 ' ND2' HG11 ' A' ' 93' ' ' VAL . 5.2 m-20 50.62 31.6 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.66 -20.66 45.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.637 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 18.8 ptp180 -100.23 124.39 45.61 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 117.502 0.651 . . . . 0.0 110.279 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.402 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 21.1 m -61.15 149.83 36.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.999 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.604 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -81.76 -17.55 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.567 0.698 . . . . 0.0 109.55 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.69 -24.14 66.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.636 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.45 -12.69 80.0 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.182 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -137.35 -131.51 0.14 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.531 0.666 . . . . 0.0 110.619 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' HG13 ' A' ' 86' ' ' VAL . 4.3 p -146.8 166.09 27.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.364 0.126 . . . . 0.0 111.046 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.522 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -49.72 -53.33 25.4 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.662 0.601 . . . . 0.0 112.406 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -56.08 -37.73 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.66 -38.86 58.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.529 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.604 HG11 ' HB ' ' A' ' 78' ' ' ILE . 26.6 m -71.13 -44.03 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.955 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.21 62.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.289 170.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.21 -52.48 63.59 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.284 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.8 mmt -54.06 -43.23 70.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 0.0 112.02 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.95 -39.59 82.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.067 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.82 -36.16 57.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 122.362 -0.211 . . . . 0.0 111.443 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.83 -44.08 90.84 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.308 0.643 . . . . 0.0 110.892 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 93' ' ' VAL . 13.8 m -70.18 71.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 122.878 1.323 . . . . 0.0 110.203 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.34 126.3 26.97 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.596 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.63 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 100.66 -27.16 21.8 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.515 170.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.16 171.87 9.48 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 117.39 0.595 . . . . 0.0 110.083 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.494 HG21 HG23 ' A' ' 33' ' ' ILE . 2.1 t -157.19 128.17 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.742 -171.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.4 m -140.32 106.47 5.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.038 0.447 . . . . 0.0 110.908 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.689 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -97.18 147.81 6.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.064 -177.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -130.88 123.38 28.86 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -133.65 144.76 49.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 0.0 111.421 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 . . . . . 0 C--N 1.326 -0.417 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.402 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 16.5 m-20 . . . . . 0 C--O 1.216 -0.692 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.54 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 22.4 Cg_exo -31.8 -52.57 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.678 2.919 . . . . 0.0 114.07 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.0 ptmt -62.25 -48.51 79.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.015 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.474 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 71.6 mm-40 -81.4 -19.45 42.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.712 0.768 . . . . 0.0 110.153 -174.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.31 -51.17 13.86 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.204 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 4.7 pt-20 -70.77 -34.6 71.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.879 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.465 ' N ' ' HG3' ' A' ' 112' ' ' GLU . 2.9 p -65.14 -38.37 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.283 -176.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.75 -28.04 36.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.511 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 56.2 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.508 -176.839 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.796 HD12 ' HB ' ' A' ' 37' ' ' ILE . 12.2 mt . . . . . 0 CA--C 1.489 -1.388 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -165.78 85.62 0.35 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 110.996 -2.82 . . . . 0.0 109.057 175.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.827 ' OXT' HG13 ' A' ' 33' ' ' ILE . 6.0 p . . . . . 0 C--O 1.246 0.872 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.287 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.6 pttm . . . . . 0 CA--C 1.518 -0.264 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.492 HG23 HD11 ' A' ' 99' ' ' ILE . 29.2 m -140.53 158.72 24.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 t -124.37 125.79 44.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.163 0.506 . . . . 0.0 110.751 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.44 -169.28 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.763 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 91.0 mt-30 -132.9 149.21 52.27 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.417 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.634 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 8.6 mmtp -47.24 146.37 1.93 Allowed 'General case' 0 C--N 1.313 -1.004 0 O-C-N 124.629 1.206 . . . . 0.0 112.344 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.427 ' HB2' ' HD2' ' A' ' 57' ' ' PRO . 27.2 t70 -82.88 177.94 8.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.115 176.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.03 -19.78 61.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.185 0.517 . . . . 0.0 110.419 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.449 ' NE2' HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -89.49 3.84 51.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.241 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.9 15.72 5.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.68 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.516 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -131.43 -163.69 1.36 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.642 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.851 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.51 -23.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.8 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.86 36.13 4.87 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.918 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.51 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.6 pp -125.91 168.53 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.903 0.859 . . . . 0.0 111.564 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 44.9 m -134.43 131.77 38.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.499 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.685 ' O ' ' HB3' ' A' ' 126' ' ' LEU . 76.3 mt -117.75 130.67 72.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.57 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.323 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.633 175.729 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.347 0 CA-C-O 122.282 1.039 . . . . 0.0 109.497 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -98.43 -25.73 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.229 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.76 145.23 12.33 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.946 -172.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 59' ' ' ALA . 7.5 p -140.25 161.12 25.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -87.81 -138.03 0.1 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -137.48 -38.94 0.59 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 119.152 0.887 . . . . 0.0 112.641 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.552 ' HA ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -101.45 10.86 40.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.455 0.645 . . . . 0.0 109.854 -171.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 42.9 p -93.82 147.87 34.3 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 28' ' ' ASP . 8.5 Cg_endo -48.48 -39.97 36.74 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.215 1.943 . . . . 0.0 111.631 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.8 -53.57 56.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.141 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.589 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.98 -55.04 6.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.513 0.673 . . . . 0.0 109.946 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.1 tm? -42.73 -76.22 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.171 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -96.45 -38.3 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.052 0.453 . . . . 0.0 111.514 -177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.483 ' O ' HG22 ' A' ' 63' ' ' THR . . . -66.49 -27.29 73.04 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.746 -168.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 62' ' ' GLY . 5.8 t 52.44 25.44 3.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.456 1.103 . . . . 0.0 111.645 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.572 HG11 HG13 ' A' ' 99' ' ' ILE . 29.9 m -88.93 50.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 122.068 0.937 . . . . 0.0 109.761 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.44 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.01 175.27 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.204 -171.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.43 118.53 3.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.527 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.93 5.59 8.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.82 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.707 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -107.3 161.75 14.51 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 110.431 174.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 18.0 mm-40 -104.05 138.24 40.87 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.6 mm -118.55 134.01 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 123.104 0.252 . . . . 0.0 110.379 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 101' ' ' TYR . 14.9 t -132.74 -18.97 2.37 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.127 -0.358 . . . . 0.0 111.844 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -139.16 138.32 9.25 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.744 -1.217 . . . . 0.0 113.635 -178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.631 HG12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -105.53 123.15 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.532 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 17.4 t-20 59.1 23.23 11.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.914 0.864 . . . . 0.0 109.965 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.93 -20.24 48.67 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.552 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -105.32 136.58 44.58 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 117.888 0.844 . . . . 0.0 111.095 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 71' ' ' THR . 19.3 t -55.88 140.63 42.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.678 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.631 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -74.68 -17.57 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.731 0.777 . . . . 0.0 109.127 -177.03 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -63.47 -20.57 65.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.633 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.4 -17.32 76.32 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.365 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.625 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 1.7 mptp? -120.42 -136.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.914 0.864 . . . . 0.0 109.635 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.9 p -151.31 163.49 38.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.525 -1.671 . . . . 0.0 107.838 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.63 ' HB3' HD22 ' A' ' 126' ' ' LEU . 1.5 mtpt -48.02 -52.75 18.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.316 0.579 . . . . 0.0 111.793 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -56.67 -35.11 44.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.362 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 89' ' ' MET . 34.1 mt-10 -77.13 -46.54 23.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.614 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.586 HG11 ' HB ' ' A' ' 78' ' ' ILE . 24.0 m -59.05 -43.7 89.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -59.51 -35.59 74.45 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 173.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 38.8 ttpt -64.34 -51.26 64.25 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.474 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 82.2 mtp -48.15 -52.24 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.737 0.648 . . . . 0.0 111.136 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.634 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 62.6 mt -61.78 -46.69 95.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.029 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.434 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 8.7 pt20 -77.39 -29.03 53.0 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.211 -0.306 . . . . 0.0 111.564 -177.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -68.23 -48.0 66.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.3 m -50.31 -33.48 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.86 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt 67.15 137.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.669 0.747 . . . . 0.0 112.282 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.565 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 90.59 -50.07 3.2 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.404 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.3 pt-20 -125.82 176.49 6.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 117.256 0.528 . . . . 0.0 110.409 -172.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.48 HG11 HG23 ' A' ' 33' ' ' ILE . 14.2 m -150.88 150.85 13.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.804 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.532 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 1.7 m -141.83 107.58 5.12 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.904 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.572 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -90.8 138.87 18.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.902 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.61 124.42 15.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.658 ' HA ' HG22 ' A' ' 71' ' ' THR . 1.0 OUTLIER -174.66 -113.17 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.168 161.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 N--CA 1.444 -0.764 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.878 -169.336 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.212 -0.883 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -32.08 -52.6 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.818 3.012 . . . . 0.0 114.443 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.2 ptmt -55.82 -46.08 78.17 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.3 mm100 -89.63 -13.41 37.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.892 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.2 tm? -70.79 -40.95 72.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.313 -177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . 5.8 pt-20 -70.7 -24.38 62.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.258 0.552 . . . . 0.0 110.46 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.08 -45.54 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.042 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.2 mt -82.61 -3.42 56.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.365 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 9.4 t80 . . . . . 0 C--N 1.321 -0.66 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.36 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 87' ' ' ALA . 40.5 tp . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 120.99 0.424 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 22.9 pttp -156.82 139.75 15.3 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.635 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.851 ' OXT' HG13 ' A' ' 33' ' ' ILE . 14.4 p . . . . . 0 C--N 1.313 -1.003 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 HD11 ' A' ' 99' ' ' ILE . 33.5 m -138.35 147.72 25.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.815 0.34 . . . . 0.0 110.195 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -110.39 101.12 9.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.279 0.561 . . . . 0.0 110.465 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.538 HD11 ' HA3' ' A' ' 62' ' ' GLY . 10.6 mt -111.88 -170.22 1.61 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.736 -174.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 88.6 mt-30 -132.54 144.38 50.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.239 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.513 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 28.5 mmtm -50.25 158.37 0.57 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.676 -175.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 5.4 p-10 -89.82 -163.64 1.04 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.92 67.24 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.477 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.518 HE21 HD21 ' A' ' 32' ' ' LEU . 9.2 tt0 -92.56 9.46 34.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.663 0.268 . . . . 0.0 111.082 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 51.9 t30 66.66 30.0 8.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.75 0.786 . . . . 0.0 110.905 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 1.3 pp -133.05 -171.24 2.63 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 121.821 -0.55 . . . . 0.0 111.202 172.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.701 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.71 -27.96 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.973 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 103.68 28.39 6.0 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.942 -0.646 . . . . 0.0 113.046 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.557 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -121.65 174.12 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.762 0.791 . . . . 0.0 112.074 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 23.0 m -137.28 126.09 24.03 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.229 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.486 ' HB ' HD12 ' A' ' 126' ' ' LEU . 68.7 mt -98.46 140.16 18.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.72 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.926 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.24 -176.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -97.03 -21.38 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -168.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.48 141.93 10.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.182 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.1 p -141.16 160.75 22.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.994 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.546 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 92.5 m-85 -113.96 124.67 52.73 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 30.7 t70 -58.33 -23.4 56.55 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -165.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.457 ' HA ' HD23 ' A' ' 60' ' ' LEU . 46.7 m-80 -101.77 9.84 40.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.49 0.662 . . . . 0.0 110.09 -172.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.546 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 31.6 p -98.66 149.24 35.55 Favored Pre-proline 0 CA--C 1.502 -0.877 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -48.55 -38.63 36.18 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 121.946 1.764 . . . . 0.0 111.374 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.22 5.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.065 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.496 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.15 -53.2 13.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.453 0.644 . . . . 0.0 110.227 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -45.13 -74.3 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.629 -178.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -95.54 -35.5 11.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.611 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.538 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -74.79 -31.49 58.2 Favored Glycine 0 C--O 1.228 -0.26 0 CA-C-N 115.523 -0.762 . . . . 0.0 114.245 -168.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p 66.05 15.38 10.05 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.851 0.86 . . . . 0.0 110.674 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.545 HG11 HG13 ' A' ' 99' ' ' ILE . 6.1 m -85.78 53.98 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 CA-C-O 122.748 1.261 . . . . 0.0 110.518 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.89 176.39 8.51 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.942 -172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.94 104.34 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.716 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.06 -10.33 3.06 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.962 -175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.4 t70 -89.32 164.95 14.69 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.735 ' HB3' ' CD2' ' A' ' 101' ' ' TYR . 5.5 mp0 -107.89 134.85 50.23 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.497 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 5.4 mm -122.97 122.29 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.708 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 7.6 t -129.85 -10.19 4.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.72 0.295 . . . . 0.0 111.699 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.3 151.52 23.1 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.711 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.714 HG11 ' HB ' ' A' ' 86' ' ' VAL . 4.4 m -117.85 147.36 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 114.355 -0.923 . . . . 0.0 109.02 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.416 ' ND2' HG11 ' A' ' 93' ' ' VAL . 5.5 t-20 60.92 19.53 9.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.425 0.631 . . . . 0.0 110.508 171.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.01 -10.33 70.08 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.12 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 14.9 ptp180 -121.27 143.73 49.01 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 117.156 0.478 . . . . 0.0 111.238 -174.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 m -52.49 146.39 9.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.525 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.754 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -76.09 -13.19 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 121.695 0.759 . . . . 0.0 109.2 -176.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -58.61 -17.33 21.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.074 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.91 67.78 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.982 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -142.45 -119.73 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.966 -0.138 . . . . 0.0 111.061 178.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.458 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 14.9 t -158.1 174.77 14.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.546 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -47.32 -60.02 2.79 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -175.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 82' ' ' THR . 6.6 p -54.51 -34.62 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 121.258 0.551 . . . . 0.0 111.779 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 40.0 mt-10 -78.68 -35.08 45.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.809 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG11 ' HB ' ' A' ' 78' ' ' ILE . 34.4 m -73.42 -38.94 54.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.539 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.96 -36.41 59.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.003 169.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 60.7 tttm -64.66 -50.08 68.46 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 84.5 mtp -53.99 -44.66 71.04 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.204 0.525 . . . . 0.0 111.237 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 93' ' ' VAL . 29.6 mm -55.28 -56.87 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.631 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.516 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 8.6 pt20 -76.07 -22.86 55.16 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -58.59 -50.65 73.02 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.032 0.533 . . . . 0.0 110.959 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 90' ' ' ILE . 13.2 m -60.1 -29.66 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.941 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp 63.45 143.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.001 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.498 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 87.94 -48.81 3.72 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.876 170.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.7 pt-20 -127.24 175.65 8.0 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 117.398 0.599 . . . . 0.0 110.125 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.513 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 9.2 m -147.92 155.54 9.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.838 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -142.37 99.87 3.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.712 0.292 . . . . 0.0 111.203 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.545 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -84.95 144.6 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -147.72 131.16 16.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.735 ' CD2' ' HB3' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -177.97 -114.62 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.172 162.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 1.4 t-20 . . . . . 0 N--CA 1.442 -0.865 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.583 -171.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.445 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 9.8 m-20 . . . . . 0 C--O 1.216 -0.661 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.618 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 37.7 Cg_exo -29.09 -60.61 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.899 3.066 . . . . 0.0 115.107 -167.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.482 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.6 pttp -65.54 -50.07 66.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.238 0.542 . . . . 0.0 111.866 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.482 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 12.4 pt20 -80.11 -7.94 59.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.853 0.835 . . . . 0.0 111.827 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.439 ' C ' HD13 ' A' ' 111' ' ' LEU . 1.8 tm? -90.04 -48.4 7.22 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.922 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 6.0 pt-20 -71.45 -24.86 62.09 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 110.864 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.1 p -68.15 -32.64 56.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.483 0.659 . . . . 0.0 109.708 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.43 -24.9 39.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.471 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 58.7 t80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.408 -179.206 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 127' ' ' LYS . 0.4 OUTLIER . . . . . 0 CA--C 1.509 -0.604 0 CA-C-O 121.351 0.596 . . . . 0.0 111.964 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' N ' HD13 ' A' ' 126' ' ' LEU . 19.2 ptmt -167.87 111.09 0.63 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.728 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.701 ' OXT' HG13 ' A' ' 33' ' ' ILE . 12.6 p . . . . . 0 N--CA 1.441 -0.896 0 CA-C-O 118.08 -0.962 . . . . 0.0 108.909 170.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.69 157.43 42.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 t -124.58 118.61 26.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.384 0.611 . . . . 0.0 110.563 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.467 ' CD2' HD11 ' A' ' 99' ' ' ILE . 2.3 mm? -119.92 -169.6 1.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.645 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 87.8 mt-30 -129.28 140.31 51.48 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.821 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HG2' ' C ' ' A' ' 95' ' ' GLY . 25.4 mmtp -45.9 148.79 0.74 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.336 -176.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -82.7 -179.01 7.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.585 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.64 55.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.192 0.52 . . . . 0.0 110.875 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.562 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.7 mt-30 -91.12 4.1 53.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.948 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 37.8 t30 71.04 16.71 6.35 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.036 0.922 . . . . 0.0 111.133 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.607 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -128.31 -171.1 2.37 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.769 -0.582 . . . . 0.0 111.275 -179.45 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.726 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.37 -29.23 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.604 -177.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.26 27.18 5.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.745 . . . . 0.0 113.125 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.442 HG22 HG23 ' A' ' 52' ' ' VAL . 2.7 pp -119.17 173.85 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.333 0.587 . . . . 0.0 111.839 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 36.3 m -134.65 129.92 35.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.517 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.524 ' H ' ' HB3' ' A' ' 126' ' ' LEU . 63.3 mt -104.03 145.07 13.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.518 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.031 -179.85 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 122.215 1.007 . . . . 0.0 109.856 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.3 -29.98 4.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.257 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 4.0 pt20 -164.31 156.29 16.43 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.3 p -141.99 161.67 20.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.263 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.554 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 89.9 m-85 -113.67 123.63 50.38 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -55.23 -25.81 35.62 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.115 -165.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.509 ' HA ' HD23 ' A' ' 60' ' ' LEU . 47.8 m-80 -102.41 8.39 40.16 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.169 0.509 . . . . 0.0 110.616 -172.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 32.0 p -96.72 150.32 36.81 Favored Pre-proline 0 CA--C 1.503 -0.844 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.51 -37.67 42.73 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 121.789 1.659 . . . . 0.0 111.396 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -57.36 -57.35 13.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.108 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.552 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -73.61 -52.6 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.451 0.643 . . . . 0.0 110.121 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -45.39 -75.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.806 -1.543 . . . . 0.0 112.743 -177.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -96.59 -33.12 11.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.157 0.503 . . . . 0.0 111.5 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.25 -28.77 63.39 Favored Glycine 0 C--O 1.228 -0.275 0 CA-C-N 115.663 -0.699 . . . . 0.0 114.236 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p 64.57 14.41 8.95 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.994 0.917 . . . . 0.0 111.403 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.73 HG11 HG13 ' A' ' 99' ' ' ILE . 6.9 m -84.98 54.56 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 CA-C-O 122.578 1.18 . . . . 0.0 111.284 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.17 173.2 10.6 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.469 -172.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -55.8 113.41 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.163 -173.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.12 -16.37 4.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.446 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.667 ' O ' HG22 ' A' ' 49' ' ' ILE . 1.7 m-20 -96.86 154.62 17.19 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 117.597 0.698 . . . . 0.0 110.746 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 38.3 tt0 -90.7 80.86 5.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.529 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.502 HD13 ' HB ' ' A' ' 49' ' ' ILE . 1.8 mp -68.85 92.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 77' ' ' SER . 9.0 t -96.08 -14.05 23.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.595 -170.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -143.83 137.27 7.35 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 119.367 -1.397 . . . . 0.0 113.629 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -104.79 119.02 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.549 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 16.9 t-20 55.03 32.18 17.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.413 0.625 . . . . 0.0 110.613 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.86 -21.28 46.73 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.643 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -102.76 126.91 50.06 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 117.725 0.762 . . . . 0.0 110.991 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.505 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 29.9 m -57.79 145.81 33.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.72 -176.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.575 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -81.32 -18.51 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.546 0.689 . . . . 0.0 109.602 -179.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -63.04 -24.19 67.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.877 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.44 -14.85 81.72 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.936 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.593 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.22 -132.31 0.15 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.409 0.604 . . . . 0.0 110.718 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -143.64 152.26 41.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.112 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.493 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.4 ptpt -43.43 -59.36 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.96 0.504 . . . . 0.0 112.272 176.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.5 p -53.97 -34.87 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.842 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 89' ' ' MET . 33.7 mt-10 -76.93 -42.44 39.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.557 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.555 HG11 ' HB ' ' A' ' 78' ' ' ILE . 33.6 m -66.8 -40.11 85.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.643 -175.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.596 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -52.57 -41.42 63.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.429 170.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -66.44 -45.94 78.13 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.197 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 59.4 mtt -54.62 -35.17 63.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.398 0.618 . . . . 0.0 110.765 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 33' ' ' ILE . 65.3 mt -75.33 -48.84 29.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.186 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.493 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 86.4 mt-30 -63.6 -41.06 98.36 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.03 -45.44 85.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.441 -169.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 90' ' ' ILE . 25.9 m -54.63 -31.42 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.295 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? 65.93 130.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 170.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.499 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 97.77 -47.91 1.51 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.517 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.0 pt-20 -136.48 176.83 8.34 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.188 0.518 . . . . 0.0 110.406 -172.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.6 HG11 HG23 ' A' ' 33' ' ' ILE . 5.4 m -147.43 153.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.862 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 30.8 m -142.4 115.77 9.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.73 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -111.1 123.63 67.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.269 -175.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -98.67 123.69 43.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 69' ' ' GLU . 17.0 p90 -141.96 139.95 32.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.577 0.703 . . . . 0.0 112.006 -173.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.469 HD21 HG21 ' A' ' 71' ' ' THR . 27.4 m-20 . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.127 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 C--O 1.211 -0.926 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 19.4 Cg_exo -29.97 -51.99 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.009 3.14 . . . . 0.0 114.958 -171.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.532 ' HG3' ' HG3' ' A' ' 110' ' ' GLN . 59.3 pttt -57.16 -44.48 83.53 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.517 0.675 . . . . 0.0 112.285 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.532 ' HG3' ' HG3' ' A' ' 109' ' ' LYS . 96.9 mt-30 -85.98 -27.74 24.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.632 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.5 tm? -66.55 -49.52 66.18 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.221 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 5.2 pt-20 -60.07 -31.68 70.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.1 0.476 . . . . 0.0 110.69 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 109' ' ' LYS . 68.8 t -64.52 -47.41 89.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.512 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.01 -13.61 57.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.496 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 20.9 t80 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.859 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.596 HD11 ' HB2' ' A' ' 87' ' ' ALA . 1.1 tm? . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.584 ' N ' HD13 ' A' ' 126' ' ' LEU . 19.8 ptmt -161.94 112.98 1.64 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.143 0.497 . . . . 0.0 110.429 -174.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.726 ' O ' HG13 ' A' ' 33' ' ' ILE . 13.1 p . . . . . 0 N--CA 1.437 -1.122 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.009 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 99' ' ' ILE . 7.7 p -147.57 158.46 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -170.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.66 HG22 HG22 ' A' ' 98' ' ' THR . 24.5 p -124.52 121.78 35.76 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 122.2 -0.313 . . . . 0.0 111.083 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.549 ' CD2' HD11 ' A' ' 99' ' ' ILE . 2.7 mm? -121.16 -165.78 1.27 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.7 pt20 -141.23 158.19 44.23 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.081 174.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 31' ' ' ASN . 31.1 mmtm -52.77 155.86 2.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.955 -1.02 . . . . 0.0 113.129 -172.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -85.57 -179.53 6.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.794 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.97 -21.01 60.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.619 0.645 . . . . 0.0 111.095 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.491 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -91.22 2.28 56.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.101 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.485 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 54.8 t30 70.55 35.7 1.85 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.247 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.608 HD22 ' OXT' ' A' ' 128' ' ' VAL . 2.1 pp -140.56 -170.66 3.05 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.841 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.744 HG23 HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -104.78 -25.45 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.981 -175.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 92.78 35.4 6.46 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.511 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.793 HD11 HG23 ' A' ' 128' ' ' VAL . 2.9 pp -123.01 178.96 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.738 0.304 . . . . 0.0 110.617 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 64.4 m -128.47 135.29 49.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.085 0.469 . . . . 0.0 111.135 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.442 ' HB ' HD23 ' A' ' 126' ' ' LEU . 34.9 mm -102.29 138.77 25.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.144 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.45 178.6 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 122.456 1.122 . . . . 0.0 109.615 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.0 t -86.84 -35.54 8.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.408 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.737 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 11.3 pt20 -165.57 163.53 19.36 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -173.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.5 p -141.29 159.82 22.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.132 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.521 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 50.1 m-85 -116.09 122.97 46.72 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.74 0.781 . . . . 0.0 108.907 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.47 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 7.5 m-20 -58.2 -18.94 29.57 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.324 1.45 . . . . 0.0 114.641 -164.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -102.89 6.06 38.87 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.97 0.414 . . . . 0.0 110.513 -174.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 13.1 p -102.59 151.53 38.26 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -176.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.18 -39.94 42.27 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.086 1.857 . . . . 0.0 111.779 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.02 -54.02 49.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.027 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.653 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -76.6 -53.03 8.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.497 0.665 . . . . 0.0 110.277 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER -44.22 -75.01 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.522 -176.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -96.66 -32.06 12.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.14 0.495 . . . . 0.0 111.637 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.476 ' CA ' HD21 ' A' ' 25' ' ' LEU . . . -72.84 -38.97 56.07 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.923 -0.656 . . . . 0.0 114.542 -167.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p 64.77 21.72 12.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 122.0 0.905 . . . . 0.0 110.897 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.743 HG11 HG13 ' A' ' 99' ' ' ILE . 3.8 m -88.02 56.43 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.193 176.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.64 -179.76 7.2 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.786 -168.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.737 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -57.43 139.46 53.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.722 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.89 -9.51 29.67 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.51 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -96.8 174.81 6.61 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.584 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -123.13 95.19 4.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.466 0.651 . . . . 0.0 110.377 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.9 mm -69.96 114.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.587 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 102' ' ' ASN . 6.4 t -88.11 -34.84 17.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.42 156.63 26.81 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.468 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.662 ' CG1' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -131.1 129.4 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 59.64 26.29 15.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.639 0.733 . . . . 0.0 110.037 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.55 -20.1 50.14 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.256 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -107.93 135.04 49.98 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 117.092 0.446 . . . . 0.0 111.732 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m -63.49 148.15 49.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.472 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.662 HG23 ' CG1' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -93.0 -25.67 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 CA-C-O 122.93 1.347 . . . . 0.0 109.625 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.568 ' H ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -57.88 -24.46 57.75 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.189 -2.278 . . . . 0.0 110.339 -178.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.8 -17.64 76.91 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.642 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.478 ' H ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -129.53 -134.87 0.22 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.062 0.931 . . . . 0.0 112.079 -176.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.564 ' O ' HG13 ' A' ' 86' ' ' VAL . 60.5 p -135.89 166.13 24.03 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.573 -0.079 . . . . 0.0 110.839 -169.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.625 ' HB3' HD22 ' A' ' 126' ' ' LEU . 16.6 mttt -49.1 -57.69 6.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.542 0.687 . . . . 0.0 111.919 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.47 -39.68 54.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.828 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 89' ' ' MET . 34.6 mt-10 -75.29 -37.91 60.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 82' ' ' THR . 30.0 m -67.05 -45.39 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.61 -176.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.68 ' O ' ' HG3' ' A' ' 91' ' ' GLN . . . -58.9 -43.05 90.91 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 172.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -61.63 -45.63 93.24 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.199 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 86.4 mmm -51.6 -42.33 61.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.615 HD13 HD11 ' A' ' 33' ' ' ILE . 85.9 mt -65.64 -46.89 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.609 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.68 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 59.5 mt-30 -60.45 -46.77 88.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.117 0.484 . . . . 0.0 110.979 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -61.71 -50.91 70.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.498 -167.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 89' ' ' MET . 14.8 m -52.99 -32.92 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm 61.79 137.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.442 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 95.03 -51.78 1.91 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.741 167.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.6 pt-20 -133.83 178.71 6.73 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -174.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.744 HG11 HG23 ' A' ' 33' ' ' ILE . 9.5 m -150.05 148.23 15.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.784 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.66 HG22 HG22 ' A' ' 24' ' ' THR . 12.9 p -134.51 109.46 8.72 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.743 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -102.15 126.82 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.31 0.576 . . . . 0.0 111.524 -173.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -108.17 117.16 33.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.182 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.606 ' CE1' HG12 ' A' ' 64' ' ' VAL . 1.1 m-30 -74.0 162.2 29.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.318 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.432 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 O-C-N 124.624 1.202 . . . . 0.0 108.464 175.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.483 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 10.4 t70 . . . . . 0 C--O 1.216 -0.667 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 16.6 Cg_exo -29.45 -49.84 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.902 3.068 . . . . 0.0 114.269 -176.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 19.1 ptpt -57.99 -47.65 82.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.239 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 14.9 mm100 -87.02 -19.96 27.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.449 0.642 . . . . 0.0 110.355 -176.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -73.0 -43.12 62.54 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.276 -175.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -66.36 -31.43 72.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.889 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 109' ' ' LYS . 74.3 t -66.59 -39.77 84.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.205 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 110' ' ' GLN . 76.1 mt -70.65 -24.05 62.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.759 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 27.6 t80 . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.125 178.952 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' A' ' 83' ' ' LYS . 51.5 tp . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 4.9 pttp -166.26 161.99 17.1 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.239 0.542 . . . . 0.0 110.862 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.793 HG23 HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.778 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 165.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 25.7 pttm . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 62' ' ' GLY . 33.8 m -131.09 146.74 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.5 t -103.8 98.88 8.66 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.788 0.804 . . . . 0.0 110.378 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.493 HD11 ' HA2' ' A' ' 62' ' ' GLY . 16.6 mt -110.48 -163.83 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.753 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 2.2 pt20 -150.53 156.3 41.15 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.176 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.574 ' HE2' ' C ' ' A' ' 31' ' ' ASN . 10.0 mmmm -52.4 146.77 9.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.639 0.733 . . . . 0.0 111.938 -174.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -85.65 173.67 9.96 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.355 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.2 -20.79 56.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.118 0.485 . . . . 0.0 110.453 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.477 ' NE2' HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -85.59 -1.26 56.94 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.032 -177.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.574 ' C ' ' HE2' ' A' ' 27' ' ' LYS . 15.4 t30 69.01 37.52 2.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.734 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.484 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -154.22 -163.31 1.59 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.897 173.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.729 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.55 -24.27 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.494 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.44 40.71 3.6 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.761 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.531 HG22 HG23 ' A' ' 52' ' ' VAL . 2.6 pp -131.89 171.95 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.855 0.836 . . . . 0.0 111.633 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.1 m -140.59 126.5 19.41 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.161 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.922 HG22 ' H ' ' A' ' 38' ' ' GLY . 26.3 mt -122.72 -168.64 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -176.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.922 ' H ' HG22 ' A' ' 37' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.814 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 121.915 0.864 . . . . 0.0 109.27 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.18 -30.65 5.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.739 -171.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.64 142.77 15.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.976 0.417 . . . . 0.0 111.401 -172.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.4 p -140.56 160.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.011 173.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -97.34 -133.8 0.23 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.52 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 6.0 t70 -141.15 -33.3 0.53 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -101.24 0.93 38.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.971 0.415 . . . . 0.0 110.347 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 68.0 p -84.17 151.54 60.17 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 8.4 Cg_endo -53.28 -41.27 73.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.239 1.292 . . . . 0.0 111.024 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.513 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.48 -47.58 81.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.996 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.636 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.69 -56.81 4.74 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.68 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.8 pp -55.77 -75.7 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -171.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.631 ' N ' HD12 ' A' ' 60' ' ' LEU . 37.5 t70 -94.76 -13.38 25.74 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 122.546 1.165 . . . . 0.0 108.37 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -64.57 -51.16 54.54 Favored Glycine 0 C--N 1.312 -0.785 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.038 -169.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.4 p 56.95 42.76 25.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.731 1.253 . . . . 0.0 110.321 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.609 HG11 HG13 ' A' ' 99' ' ' ILE . 29.5 m -119.23 47.81 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 112.684 -2.053 . . . . 0.0 108.789 173.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.13 173.71 10.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.569 -170.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.77 108.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.674 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.92 -17.75 3.41 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.68 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 49' ' ' ILE . 18.3 m-20 -90.54 156.88 17.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.081 0.441 . . . . 0.0 110.928 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -114.9 98.26 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.365 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 70' ' ' ILE . 2.8 mp -72.82 114.67 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.076 0.465 . . . . 0.0 110.38 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -97.5 -12.42 22.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.551 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' HG23 ' A' ' 78' ' ' ILE . . . -161.17 144.75 10.15 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 119.529 -1.319 . . . . 0.0 114.143 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.823 HG13 HG22 ' A' ' 78' ' ' ILE . 5.0 m -100.79 140.56 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 CA-C-N 114.533 -0.833 . . . . 0.0 109.809 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.2 t30 53.89 29.17 9.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.826 0.822 . . . . 0.0 111.173 164.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.24 59.19 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.392 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -126.73 149.38 49.63 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.132 0.966 . . . . 0.0 111.903 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 m -57.1 148.46 21.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.454 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.823 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -85.6 -19.03 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.281 0.562 . . . . 0.0 111.076 -172.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -67.73 -7.53 27.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.301 -170.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.58 -27.95 73.57 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.224 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -139.14 -139.77 0.14 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 117.234 0.517 . . . . 0.0 111.847 -177.065 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.83 160.73 33.55 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -168.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HA ' HG22 ' A' ' 86' ' ' VAL . 2.5 pttt -46.87 -52.65 13.89 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.59 -35.09 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 121.047 0.451 . . . . 0.0 111.564 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 89' ' ' MET . 29.7 mt-10 -79.9 -40.33 28.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.553 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG11 ' HB ' ' A' ' 78' ' ' ILE . 27.7 m -63.41 -40.03 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.606 0.241 . . . . 0.0 111.44 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 91' ' ' GLN . . . -56.3 -45.16 80.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.437 171.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.74 -40.3 96.4 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 120.75 0.31 . . . . 0.0 110.7 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 24.9 mmt -51.22 -32.92 25.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.57 0.7 . . . . 0.0 110.927 174.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.704 HG21 HD11 ' A' ' 33' ' ' ILE . 88.6 mt -90.42 -18.44 7.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.077 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 50.4 mt-30 -87.6 -14.78 39.17 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.901 -0.499 . . . . 0.0 111.546 173.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.27 -40.53 15.44 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.12 0.962 . . . . 0.0 108.969 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -43.44 120.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.932 169.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -82.66 86.48 6.84 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.666 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 108.91 -25.16 19.72 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 118.575 -1.774 . . . . 0.0 113.923 162.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 8.6 pt-20 -125.57 173.4 8.98 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 117.947 0.874 . . . . 0.0 110.332 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.3 m -155.8 154.92 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.861 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.13 117.12 11.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.072 0.463 . . . . 0.0 110.367 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.609 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -106.25 115.49 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.902 -176.138 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -102.11 121.95 43.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.41 ' CE1' HG12 ' A' ' 64' ' ' VAL . 50.0 p90 -146.65 160.79 41.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.729 0.776 . . . . 0.0 112.595 -173.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.422 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 111' ' ' LEU . 7.5 m-20 . . . . . 0 C--O 1.207 -1.135 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -31.31 -60.33 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.955 3.103 . . . . 0.0 114.529 -171.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.514 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.2 ptmt -61.35 -44.95 96.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.676 0.75 . . . . 0.0 111.716 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.514 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 70.2 mm-40 -80.39 -9.62 59.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.844 -175.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.1 tm? -90.5 -51.74 5.25 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.471 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.5 -30.85 70.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.485 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.419 HG12 ' C ' ' A' ' 110' ' ' GLN . 4.1 p -69.1 -31.97 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.561 0.696 . . . . 0.0 109.817 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 114' ' ' LEU . 3.2 tm? -75.08 -28.73 60.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.547 176.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.6 t80 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.648 -178.983 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.641 HD13 ' HB ' ' A' ' 37' ' ' ILE . 8.6 tt . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.561 ' N ' HD23 ' A' ' 126' ' ' LEU . 22.0 ptmt -150.54 123.73 8.87 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.353 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.729 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.8 p . . . . . 0 N--CA 1.437 -1.085 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.318 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.602 HG11 ' O ' ' A' ' 62' ' ' GLY . 7.7 p -132.72 143.72 38.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.463 ' O ' HD13 ' A' ' 25' ' ' LEU . 11.6 t -113.78 130.49 56.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.437 0.637 . . . . 0.0 110.935 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.625 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.8 mm? -132.56 -167.5 1.91 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.561 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.419 ' O ' ' HG3' ' A' ' 57' ' ' PRO . 97.0 mt-30 -132.29 155.98 47.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.717 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 37.0 mmtt -46.54 145.15 1.92 Allowed 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.762 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.06 -178.87 5.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.262 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.2 -22.13 65.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.439 0.637 . . . . 0.0 110.306 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.496 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -93.12 11.22 28.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.72 0.772 . . . . 0.0 109.607 178.026 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 1.1 p-10 60.28 16.1 5.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.311 -1.768 . . . . 0.0 113.049 176.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -115.93 -159.98 0.74 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.507 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.705 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -110.93 -22.89 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 118.755 0.707 . . . . 0.0 111.596 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 96.17 38.54 4.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.744 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.511 HG22 HG23 ' A' ' 52' ' ' VAL . 2.8 pp -130.76 173.89 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.844 0.83 . . . . 0.0 112.122 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 126' ' ' LEU . 20.7 m -138.81 125.78 21.16 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.262 -1.335 . . . . 0.0 109.742 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.488 ' HB ' HD21 ' A' ' 126' ' ' LEU . 61.1 mt -124.94 131.01 73.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.504 0.668 . . . . 0.0 112.716 -173.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.05 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.572 172.603 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 122.175 0.988 . . . . 0.0 110.719 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.6 t -102.31 -30.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.305 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -150.32 138.66 20.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 120.84 0.352 . . . . 0.0 110.926 -170.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.3 p -141.34 161.24 22.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.221 174.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.57 -140.88 0.32 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.443 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 30.7 t70 -133.8 -28.52 1.39 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -101.53 -2.1 31.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.058 0.456 . . . . 0.0 110.297 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 47.9 p -84.93 146.43 45.84 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 9.8 Cg_endo -51.12 -41.83 55.8 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.729 1.619 . . . . 0.0 111.251 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.464 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.81 -43.48 85.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.799 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.646 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.85 -58.28 3.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.36 0.6 . . . . 0.0 110.902 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 61' ' ' ASP . 2.2 pp -55.02 -75.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -170.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.641 ' N ' HD12 ' A' ' 60' ' ' LEU . 32.8 t70 -95.69 -13.83 23.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 122.367 1.08 . . . . 0.0 108.702 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.625 ' HA2' HD21 ' A' ' 25' ' ' LEU . . . -65.51 -33.25 85.85 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 113.315 -1.766 . . . . 0.0 113.964 -169.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 62' ' ' GLY . 5.3 t 51.2 21.58 1.13 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.497 1.119 . . . . 0.0 112.516 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.52 HG11 HG13 ' A' ' 99' ' ' ILE . 17.9 m -101.58 54.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-O 123.001 1.381 . . . . 0.0 110.038 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.491 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -84.31 171.35 12.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 112.455 -2.157 . . . . 0.0 111.386 -171.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.49 112.02 1.15 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.175 -175.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.3 -0.24 5.97 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.574 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.661 ' O ' HG22 ' A' ' 49' ' ' ILE . 1.1 m-20 -99.35 149.16 23.44 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.216 0.532 . . . . 0.0 110.916 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -99.05 97.57 8.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.108 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.8 mm -69.72 139.43 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.888 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -124.91 -17.88 5.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.08 163.41 34.29 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.126 -1.512 . . . . 0.0 114.094 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -123.62 125.9 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 123.497 0.719 . . . . 0.0 109.267 179.03 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 54.2 30.26 11.97 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.52 -20.15 49.57 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.331 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -106.05 125.48 51.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 117.406 0.603 . . . . 0.0 111.226 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m -59.21 146.01 40.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.594 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.712 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -84.38 -25.61 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.452 0.644 . . . . 0.0 110.18 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -60.36 -24.12 64.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.536 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.97 -22.09 77.02 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.984 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -124.02 -120.43 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.287 -176.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 86' ' ' VAL . 7.3 m -148.91 150.08 32.33 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.49 -173.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -46.54 -56.66 5.68 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.378 0.671 . . . . 0.0 111.944 -177.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.84 -37.99 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.831 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 89' ' ' MET . 38.1 mt-10 -71.57 -36.4 70.89 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.712 HG11 ' HB ' ' A' ' 78' ' ' ILE . 19.9 m -71.54 -42.62 72.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.137 -175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 91' ' ' GLN . . . -51.73 -42.33 62.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.826 169.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 37.5 ttpt -60.85 -49.67 76.54 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.824 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.532 ' HE2' ' HA ' ' A' ' 86' ' ' VAL . 40.3 mtm -52.12 -39.09 59.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 110.431 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.579 HD13 HD11 ' A' ' 33' ' ' ILE . 68.1 mt -71.73 -39.17 68.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.441 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 6.7 mm-40 -71.33 -29.41 64.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.081 0.467 . . . . 0.0 110.505 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -72.15 -47.01 54.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.692 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 93' ' ' VAL . 16.8 m -71.51 51.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.793 0.806 . . . . 0.0 111.025 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -44.33 134.14 5.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.853 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.717 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 107.48 -36.88 4.11 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.438 171.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.27 147.39 32.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.737 0.779 . . . . 0.0 112.866 -168.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.463 HG12 ' NZ ' ' A' ' 27' ' ' LYS . 3.9 m -131.67 146.8 32.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.715 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.0 m -140.17 109.4 6.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 172.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -100.66 130.9 49.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.693 -174.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -106.1 123.11 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.917 173.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -137.14 146.19 44.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.273 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 . . . . . 0 C--N 1.321 -0.637 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -178.866 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 21.7 Cg_exo -32.36 -48.43 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.796 2.997 . . . . 0.0 113.761 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 0.6 OUTLIER -59.04 -49.58 77.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.684 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.543 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 24.1 mm-40 -88.9 -15.82 33.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.437 0.636 . . . . 0.0 111.026 -175.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.405 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -78.7 -39.33 36.88 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.998 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 7.3 pt-20 -68.98 -31.71 70.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.176 0.512 . . . . 0.0 109.924 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.5 t -61.71 -41.18 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.982 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 98.0 mt -76.2 -22.46 55.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.806 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.5 t80 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.861 -175.142 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 37' ' ' ILE . 2.4 pp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -141.91 93.9 2.61 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.17 -172.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.705 ' OXT' HG13 ' A' ' 33' ' ' ILE . 12.0 p . . . . . 0 N--CA 1.438 -1.029 0 CA-C-O 117.853 -1.07 . . . . 0.0 109.302 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 100' ' ' HIS . 2.3 mppt? . . . . . 0 CA--C 1.518 -0.287 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.27 152.27 35.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.839 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -122.11 126.95 49.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.461 0.648 . . . . 0.0 110.529 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 2.4 mm? -122.44 -171.13 2.2 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.084 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 87.7 mt-30 -131.97 137.58 47.96 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.642 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.697 ' HZ3' ' HA ' ' A' ' 91' ' ' GLN . 25.0 mmtp -44.11 148.0 0.46 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 124.679 1.237 . . . . 0.0 112.663 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.75 -172.19 3.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.294 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -22.02 65.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.231 0.538 . . . . 0.0 110.816 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.451 ' NE2' HD21 ' A' ' 32' ' ' LEU . 7.1 tt0 -96.35 11.07 36.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.231 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.8 t30 70.26 15.23 7.49 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.389 0.614 . . . . 0.0 111.506 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.656 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.5 pp -128.57 -173.07 2.86 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 121.958 -0.464 . . . . 0.0 111.588 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.85 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.0 -24.37 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.474 -176.294 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.12 41.24 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.486 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.483 HD11 HG12 ' A' ' 128' ' ' VAL . 2.8 pp -129.24 176.6 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.403 0.62 . . . . 0.0 111.71 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 32.1 m -140.59 128.1 21.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.389 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.508 ' HB ' HD21 ' A' ' 126' ' ' LEU . 49.6 mm -114.48 143.24 24.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.421 -174.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.277 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.102 175.29 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 122.453 1.121 . . . . 0.0 109.96 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.79 -25.37 3.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.63 -171.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -155.87 144.19 20.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.908 0.385 . . . . 0.0 110.817 -175.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.6 p -140.43 161.11 24.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -94.43 -137.17 0.21 Allowed 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.303 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -137.27 -36.4 0.66 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.498 ' HA ' HD23 ' A' ' 60' ' ' LEU . 32.8 m-80 -100.6 -0.38 37.73 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.435 0.636 . . . . 0.0 109.495 -171.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 44.6 p -87.99 144.74 35.1 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 6.5 Cg_endo -47.04 -40.35 26.08 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.291 1.994 . . . . 0.0 111.689 -174.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.437 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -59.02 -52.26 66.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.229 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.675 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.77 -55.61 6.48 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.898 0.856 . . . . 0.0 109.524 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -43.69 -76.17 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.186 -1.825 . . . . 0.0 113.081 -178.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.14 -39.58 9.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.211 0.529 . . . . 0.0 111.872 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.74 -20.34 74.09 Favored Glycine 0 N--CA 1.458 0.162 0 CA-C-N 115.447 -0.797 . . . . 0.0 114.28 -166.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 t 47.23 33.48 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.194 0.998 . . . . 0.0 111.761 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.641 HG11 HG13 ' A' ' 99' ' ' ILE . 11.9 m -94.6 55.22 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 CA-C-O 122.871 1.32 . . . . 0.0 109.697 175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.45 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.77 165.36 18.91 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.42 -2.173 . . . . 0.0 111.049 -169.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -56.64 104.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.124 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.39 -8.88 2.14 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.478 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 49' ' ' ILE . 22.6 m-20 -98.69 177.05 5.42 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.706 ' HB2' ' OD1' ' A' ' 102' ' ' ASN . 41.5 mt-10 -120.97 143.02 49.24 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.039 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.2 mm -119.12 119.39 60.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.692 HG22 ' CB ' ' A' ' 101' ' ' TYR . 5.5 t -105.25 -26.85 11.86 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.533 -177.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.71 155.46 26.15 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 118.875 -1.631 . . . . 0.0 114.448 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.975 HG13 HG22 ' A' ' 78' ' ' ILE . 6.7 m -110.02 142.59 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.291 176.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.578 ' HA ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER 61.17 19.34 9.95 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.94 0.4 . . . . 0.0 110.719 171.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.17 -15.37 60.47 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 116.11 -0.495 . . . . 0.0 113.403 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 76' ' ' ARG . 5.9 ptt180 -118.56 139.18 51.87 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 117.124 0.462 . . . . 0.0 112.012 -174.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 71' ' ' THR . 35.6 m -50.15 141.6 10.96 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.975 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -83.8 -25.71 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.169 -175.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -63.48 -13.69 43.19 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.349 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.35 -30.08 76.47 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.636 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.664 ' HG2' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -119.33 -117.17 0.32 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.77 0.785 . . . . 0.0 112.069 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.61 ' O ' ' HB ' ' A' ' 86' ' ' VAL . 3.2 m -161.5 151.14 16.64 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -168.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.5 ' HA ' HD22 ' A' ' 126' ' ' LEU . 2.6 mttm -39.96 -57.32 1.64 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 85' ' ' GLU . 7.1 p -55.98 -32.33 32.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.456 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 89' ' ' MET . 30.9 mt-10 -90.56 -25.93 19.97 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 123.048 1.404 . . . . 0.0 108.318 -175.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.664 HG23 ' HG2' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -75.21 -42.86 44.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.797 -2.456 . . . . 0.0 110.778 -175.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.55 73.21 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -61.0 -52.7 63.89 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.157 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 88.2 mmm -45.44 -50.37 12.61 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.495 0.497 . . . . 0.0 112.004 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.447 ' HB ' HG21 ' A' ' 128' ' ' VAL . 25.3 mm -60.09 -53.51 47.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.236 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.697 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -75.31 -25.34 57.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 122.205 -0.309 . . . . 0.0 111.483 -173.034 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.51 -52.51 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.564 0.345 . . . . 0.0 111.707 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 90' ' ' ILE . 20.5 m -49.45 -36.52 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 O-C-N 123.462 0.476 . . . . 0.0 110.95 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 95' ' ' GLY . 4.4 tmmm? 67.5 138.08 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.723 0.773 . . . . 0.0 112.196 169.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 89.71 -33.05 4.54 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.505 171.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.6 pt-20 -145.3 177.24 8.96 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.576 HG11 HG23 ' A' ' 33' ' ' ILE . 10.4 m -146.98 153.48 12.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.975 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -141.21 106.62 5.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 176.005 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.641 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -100.07 140.19 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.536 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.556 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 1.3 t60 -135.67 127.48 29.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.187 -174.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.692 ' CB ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER 171.28 -99.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.301 1.001 . . . . 0.0 111.912 162.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.706 ' OD1' ' HB2' ' A' ' 69' ' ' GLU . 29.2 p-10 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.74 -162.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 . . . . . 0 CA--C 1.508 -0.671 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 17.5 Cg_exo -29.89 -52.59 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.008 3.139 . . . . 0.0 114.499 -172.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -60.32 -50.37 73.91 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.493 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 21.2 pt20 -90.7 -9.62 46.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.9 0.857 . . . . 0.0 111.911 -173.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 111' ' ' LEU . 1.9 tm? -86.21 -41.39 14.69 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.384 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 8.0 pt-20 -64.89 -21.05 66.74 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 110' ' ' GLN . 61.1 t -58.04 -38.53 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.436 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.5 mp -81.0 -22.74 39.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.662 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.1 t80 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -175.741 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.508 HD21 ' HB ' ' A' ' 37' ' ' ILE . 1.8 pp . . . . . 0 CA--C 1.519 -0.24 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 15.1 ptmm? -149.89 134.69 17.72 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.811 0.338 . . . . 0.0 110.221 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.85 ' OXT' HG13 ' A' ' 33' ' ' ILE . 7.7 p . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.775 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.631 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 21.2 ptmt . . . . . 0 C--O 1.231 0.103 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.44 HG23 HD11 ' A' ' 99' ' ' ILE . 24.8 m -127.64 149.21 32.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 168.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -120.98 126.31 49.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.684 0.754 . . . . 0.0 110.448 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' HB2' ' CG2' ' A' ' 97' ' ' VAL . 5.2 mt -132.64 -167.62 1.93 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.359 -175.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.1 mt-30 -134.37 142.56 47.24 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.019 0.438 . . . . 0.0 110.158 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 27.9 mmtp -48.74 152.55 0.97 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.841 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 4.0 p-10 -85.74 -164.55 1.04 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.3 -24.64 67.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.855 0.359 . . . . 0.0 111.615 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.9 mt-30 -92.21 4.65 52.8 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.104 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 36.5 t30 71.15 24.9 3.75 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.121 0.962 . . . . 0.0 110.831 176.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.549 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.7 pp -131.05 -170.15 2.3 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.721 -0.612 . . . . 0.0 111.277 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.759 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.02 -21.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.152 -176.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.81 30.08 6.61 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.969 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.485 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.9 pp -124.33 175.62 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.711 0.767 . . . . 0.0 112.43 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -136.25 126.42 26.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.056 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.547 ' H ' ' HB3' ' A' ' 126' ' ' LEU . 46.7 mm -97.66 146.84 7.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.404 0.621 . . . . 0.0 111.071 -176.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.781 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.635 178.002 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.83 -31.9 12.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.851 -170.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 2.9 pt20 -165.5 152.05 9.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.932 0.396 . . . . 0.0 110.213 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.481 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 9.7 p -142.02 161.66 20.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.317 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.528 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 90.5 m-85 -110.99 123.69 50.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.525 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 28.2 t70 -58.81 -19.88 45.15 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.675 -1.148 . . . . 0.0 113.869 -164.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.85 2.95 38.79 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.79 -175.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 20.7 p -89.08 153.58 49.15 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 6.5 Cg_endo -49.44 -43.18 39.5 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.801 1.667 . . . . 0.0 111.532 -176.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.43 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -54.33 -50.69 66.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.029 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 54' ' ' ASP . . . -76.11 -54.01 7.46 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.067 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.608 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.7 pp -53.67 -74.68 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -170.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.608 ' N ' HD12 ' A' ' 60' ' ' LEU . 38.7 t70 -94.24 -14.62 25.32 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.405 1.097 . . . . 0.0 108.305 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -72.08 -51.55 13.84 Favored Glycine 0 C--N 1.312 -0.779 0 CA-C-N 113.259 -1.792 . . . . 0.0 113.129 -170.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.11 47.45 5.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.298 1.047 . . . . 0.0 111.119 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.504 HG11 HG13 ' A' ' 99' ' ' ILE . 19.5 m -124.86 49.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.3 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.38 -179.57 7.21 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.31 -1.313 . . . . 0.0 112.348 -169.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -47.61 118.03 2.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.568 -172.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.91 -16.97 20.47 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.384 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 49' ' ' ILE . 6.7 m-20 -81.97 157.02 24.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.949 0.404 . . . . 0.0 110.808 -178.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -101.04 124.54 46.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.037 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.418 HD13 ' HB ' ' A' ' 49' ' ' ILE . 4.2 mp -106.44 98.69 7.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -80.87 -15.01 57.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.25 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.503 ' HA2' HG23 ' A' ' 78' ' ' ILE . . . -160.77 152.27 22.91 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 119.119 -1.515 . . . . 0.0 114.562 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.873 HG13 HG22 ' A' ' 78' ' ' ILE . 5.9 m -99.81 140.76 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 114.312 -0.944 . . . . 0.0 108.803 176.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.506 ' ND2' HG11 ' A' ' 93' ' ' VAL . 4.9 t-20 58.13 19.1 5.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.976 0.417 . . . . 0.0 111.618 170.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.36 -20.34 48.96 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.174 -0.467 . . . . 0.0 113.259 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 76' ' ' ARG . 9.8 ptm180 -105.01 134.19 48.54 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 117.143 0.472 . . . . 0.0 110.663 -176.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -52.09 138.62 25.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 0.0 111.724 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.873 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -77.7 -13.43 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.877 0.846 . . . . 0.0 109.056 -176.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -59.76 -13.42 10.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.907 -173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.76 -24.14 76.47 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.671 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -143.14 -137.89 0.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.357 0.578 . . . . 0.0 111.238 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.443 ' O ' HG13 ' A' ' 86' ' ' VAL . 26.6 p -139.86 170.83 15.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.612 0.244 . . . . 0.0 111.598 -170.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.562 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -50.19 -54.16 22.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.743 -175.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.73 -35.46 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.152 0.501 . . . . 0.0 111.426 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.496 ' OE2' ' HB2' ' A' ' 81' ' ' LYS . 31.8 mt-10 -80.54 -35.86 33.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.768 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.644 HG11 ' HB ' ' A' ' 78' ' ' ILE . 33.7 m -71.04 -41.38 76.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.584 0.23 . . . . 0.0 111.269 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -52.54 -39.59 61.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.027 0.441 . . . . 0.0 109.931 169.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 61.5 tttm -64.64 -49.49 70.84 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.519 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 87.6 mtp -50.37 -41.93 52.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.418 0.628 . . . . 0.0 110.473 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.544 HD13 HD11 ' A' ' 33' ' ' ILE . 63.4 mt -70.26 -47.26 67.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.389 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -65.02 -32.52 74.28 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.801 -0.562 . . . . 0.0 111.569 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.06 -46.9 88.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.706 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.506 HG11 ' ND2' ' A' ' 74' ' ' ASN . 9.9 m -75.89 41.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.228 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -45.88 137.52 5.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.802 0.811 . . . . 0.0 111.844 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.527 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 107.61 -32.91 6.71 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.01 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.7 pt-20 -143.87 176.6 9.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.067 0.461 . . . . 0.0 110.799 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.575 HG11 HG23 ' A' ' 33' ' ' ILE . 6.1 m -152.21 150.57 12.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.043 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 40.7 m -141.29 117.6 10.74 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 170.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -104.92 129.04 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.12 -177.371 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.88 116.27 32.36 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -120.25 160.98 21.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.563 0.697 . . . . 0.0 112.486 -170.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.444 -0.755 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.502 176.633 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.578 ' OD1' ' HG2' ' A' ' 109' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.211 -0.939 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 1.4 Cg_exo -29.88 -41.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.309 2.673 . . . . 0.0 113.858 173.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.578 ' HG2' ' OD1' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -62.82 -49.76 73.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.727 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.481 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 76.3 mm-40 -87.35 -13.12 44.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.491 0.662 . . . . 0.0 110.597 -177.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 107' ' ' ASP . 2.7 tm? -75.65 -44.03 44.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.368 -176.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -68.62 -30.89 69.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.029 0.442 . . . . 0.0 109.981 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 109' ' ' LYS . 88.4 t -69.54 -29.8 42.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.59 0.709 . . . . 0.0 109.758 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 114' ' ' LEU . 8.0 tt -73.3 -27.47 61.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.1 t80 . . . . . 0 N--CA 1.446 -0.632 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.562 -179.462 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 127' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.626 ' N ' HD13 ' A' ' 126' ' ' LEU . 21.8 pttp -156.21 121.78 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.466 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.759 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.2 p . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 117.957 -1.021 . . . . 0.0 108.638 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 51.8 pttt . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.023 0.439 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -137.44 147.02 26.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.3 t -112.59 123.13 49.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.489 0.661 . . . . 0.0 110.965 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.552 HD21 ' HA2' ' A' ' 62' ' ' GLY . 9.6 mt -127.13 -168.96 1.95 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.589 -176.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.63 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.2 mt-30 -132.89 142.05 48.71 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.827 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 29.9 mmtm -48.38 153.42 0.74 Allowed 'General case' 0 C--N 1.32 -0.711 0 O-C-N 124.631 1.207 . . . . 0.0 113.013 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -86.55 -178.66 6.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.521 173.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.68 -21.76 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 111.364 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.453 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -94.64 6.5 48.69 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.307 -177.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.538 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 47.3 t30 67.33 32.01 6.17 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.36 1.076 . . . . 0.0 110.613 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 1.4 pp -136.93 -169.51 2.49 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.041 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.1 -26.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.685 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.2 29.18 6.15 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.299 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 2.8 pp -118.21 172.3 5.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.668 0.747 . . . . 0.0 111.555 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 60.0 m -139.1 127.31 22.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.541 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.443 HG21 HD23 ' A' ' 126' ' ' LEU . 48.3 mm -98.3 130.09 47.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.274 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.005 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.11 179.213 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.9 t -79.03 -29.36 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.018 -168.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' A' ' 36' ' ' SER . 2.6 pt20 -161.03 152.42 19.09 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.221 0.534 . . . . 0.0 110.112 -173.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 59' ' ' ALA . 8.5 p -142.13 160.94 20.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.326 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.559 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 97.8 m-85 -111.63 125.97 54.52 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.691 0.758 . . . . 0.0 109.217 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -51.36 -29.16 14.53 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.803 -1.544 . . . . 0.0 114.136 -166.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.511 ' HA ' HD23 ' A' ' 60' ' ' LEU . 51.3 m-80 -102.18 9.14 40.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.864 0.364 . . . . 0.0 110.729 -172.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.559 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 32.7 p -95.55 147.72 33.46 Favored Pre-proline 0 CA--C 1.501 -0.936 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.3 Cg_endo -47.32 -39.65 27.71 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.111 1.874 . . . . 0.0 111.235 -175.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -55.89 -57.2 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.201 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.567 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.96 -54.62 8.18 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.458 0.647 . . . . 0.0 110.026 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -44.15 -75.52 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.783 -178.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.423 ' HB3' HD22 ' A' ' 25' ' ' LEU . 22.0 t70 -97.48 -31.66 12.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.035 0.445 . . . . 0.0 111.942 -174.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.552 ' HA2' HD21 ' A' ' 25' ' ' LEU . . . -72.4 -36.67 59.22 Favored Glycine 0 C--O 1.227 -0.281 0 N-CA-C 115.127 0.811 . . . . 0.0 115.127 -166.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.9 p 65.06 24.02 12.5 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.181 0.991 . . . . 0.0 110.788 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 99' ' ' ILE . 31.2 m -94.82 49.0 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.646 174.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.74 -179.43 7.11 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.949 -170.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.0 135.18 37.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.934 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.81 -11.1 20.93 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.888 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 49' ' ' ILE . 13.8 m-20 -101.23 178.09 4.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.905 0.353 . . . . 0.0 110.515 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -120.9 143.4 48.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.1 mm -104.94 115.85 47.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -113.87 1.39 14.75 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -173.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 78' ' ' ILE . . . -163.1 145.71 10.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.208 -1.473 . . . . 0.0 114.296 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.828 HG13 HG22 ' A' ' 78' ' ' ILE . 6.0 m -110.88 143.45 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.532 -0.834 . . . . 0.0 109.73 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 55.9 26.58 9.93 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.623 0.725 . . . . 0.0 111.608 164.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.48 -14.57 64.47 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.525 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -109.46 172.42 6.87 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 123.084 0.554 . . . . 0.0 110.291 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 t -74.13 174.96 7.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.97 0.414 . . . . 0.0 110.47 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.828 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -109.15 -14.04 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.485 0.659 . . . . 0.0 109.328 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.646 ' HD2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -64.25 -19.14 65.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.855 -169.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.01 -20.84 76.62 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.619 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -142.51 -145.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.275 0.538 . . . . 0.0 110.655 -178.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.3 t -140.78 173.38 11.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.55 0.214 . . . . 0.0 110.564 -169.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -41.14 -61.27 1.03 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.556 1.143 . . . . 0.0 113.843 -175.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -57.31 -36.38 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 120.976 0.417 . . . . 0.0 111.503 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 89' ' ' MET . 34.3 mt-10 -80.62 -33.11 36.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.016 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.589 HG11 ' HB ' ' A' ' 78' ' ' ILE . 35.1 m -70.09 -45.63 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.453 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.11 -37.6 83.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -61.08 -52.27 65.63 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.236 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 21.1 mmt -50.02 -40.34 44.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.23 0.538 . . . . 0.0 111.686 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.591 HD13 HD11 ' A' ' 33' ' ' ILE . 44.1 mt -65.77 -53.05 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.113 178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.538 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 4.1 pt20 -80.29 -18.54 48.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.42 -53.05 60.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.951 0.5 . . . . 0.0 111.098 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 90' ' ' ILE . 12.6 m -56.42 -27.68 25.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.978 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 pttm 48.98 157.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.113 1.365 . . . . 0.0 113.439 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.37 -50.81 4.29 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.117 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.4 pt-20 -132.9 177.2 7.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.021 0.438 . . . . 0.0 109.936 -173.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.54 HG11 HG23 ' A' ' 33' ' ' ILE . 8.8 m -151.04 153.54 9.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.685 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.5 m -140.89 100.09 3.75 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.598 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -90.64 138.07 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.71 -172.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -116.36 117.73 30.78 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -125.59 154.96 41.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.461 0.648 . . . . 0.0 111.926 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 . . . . . 0 N--CA 1.441 -0.884 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.652 -179.135 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.408 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 24.8 t70 . . . . . 0 C--O 1.214 -0.805 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 6.3 Cg_exo -29.34 -50.63 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.016 3.144 . . . . 0.0 115.073 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.0 ptpt -58.08 -49.1 78.1 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.523 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 3.7 pt20 -90.15 -13.53 35.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.845 0.831 . . . . 0.0 111.76 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.443 ' C ' HD13 ' A' ' 111' ' ' LEU . 1.7 tm? -79.35 -40.77 29.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.495 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 6.7 pt-20 -65.97 -29.14 69.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.204 0.526 . . . . 0.0 109.72 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.2 t -58.88 -45.46 91.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.556 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.412 ' HA ' ' CG ' ' A' ' 79' ' ' LYS . 10.9 mp -80.7 -16.68 53.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.533 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 42.4 t80 . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.706 -176.751 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 127' ' ' LYS . 35.0 tp . . . . . 0 N--CA 1.45 -0.43 0 CA-C-O 120.828 0.347 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' H ' HD12 ' A' ' 126' ' ' LEU . 10.4 ptmm? -167.27 162.74 15.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.335 173.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.731 ' O ' HG13 ' A' ' 33' ' ' ILE . 5.0 p . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 170.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.589 HG23 HD11 ' A' ' 99' ' ' ILE . 25.3 m -125.55 160.7 31.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 118.096 -1.442 . . . . 0.0 112.583 -164.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -135.6 118.05 15.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.525 0.678 . . . . 0.0 110.539 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' C ' ' HB ' ' A' ' 97' ' ' VAL . 3.3 mm? -113.58 -159.4 0.69 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.055 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 2.0 pt20 -142.39 149.31 39.18 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 31' ' ' ASN . 36.1 mmtm -37.19 151.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.407 ' HB3' HD12 ' A' ' 32' ' ' LEU . 18.3 t70 -83.67 177.67 8.29 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.034 -1.894 . . . . 0.0 109.126 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.57 -25.37 62.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.103 0.41 . . . . 0.0 111.404 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.495 HE21 HD21 ' A' ' 32' ' ' LEU . 7.2 tt0 -94.2 20.33 8.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.39 0.614 . . . . 0.0 110.336 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 2.4 p-10 54.35 30.04 11.94 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.938 1.295 . . . . 0.0 112.629 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 0.9 OUTLIER -128.05 -166.5 1.63 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.561 175.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.747 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.97 -25.98 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.545 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.469 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 97.7 39.68 3.82 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.526 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.568 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.9 pp -131.44 172.48 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.822 0.82 . . . . 0.0 111.854 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 126' ' ' LEU . 27.2 m -138.16 127.86 25.14 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.193 175.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.663 ' HB ' ' CD2' ' A' ' 126' ' ' LEU . 49.7 mm -106.44 119.87 56.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.423 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.01 178.114 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.717 HG22 ' O ' ' A' ' 68' ' ' ASP . 2.3 tt . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.558 0.694 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.25 -21.12 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.583 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.64 143.6 18.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.454 -173.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.9 p -139.1 160.35 29.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 173.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -94.73 -140.81 0.24 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -130.0 -43.05 1.22 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.937 0.79 . . . . 0.0 112.408 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.738 ' HA ' HD23 ' A' ' 60' ' ' LEU . 1.0 OUTLIER -99.29 13.7 32.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.387 0.613 . . . . 0.0 110.067 -172.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.583 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 65.7 p -91.95 141.1 25.02 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.7 Cg_endo -48.06 -38.22 31.67 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 121.935 1.756 . . . . 0.0 111.413 -173.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.537 ' HB1' HG12 ' A' ' 64' ' ' VAL . . . -54.33 -56.56 17.24 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.762 175.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.74 -56.95 4.25 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.472 0.653 . . . . 0.0 110.187 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.2 tm? -42.28 -76.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.675 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -96.15 -37.88 10.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.819 -171.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.568 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . -64.3 -74.55 0.45 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.261 -168.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 6.0 t 130.86 0.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.195 1.398 . . . . 0.0 108.853 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.537 HG12 ' HB1' ' A' ' 58' ' ' ALA . 0.6 OUTLIER -75.96 58.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 124.651 2.167 . . . . 0.0 111.849 -175.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.595 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -85.73 173.0 10.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 113.633 -1.622 . . . . 0.0 110.19 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.78 124.85 20.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.165 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.67 -15.99 6.25 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.923 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.717 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.2 m-20 -89.66 146.45 24.52 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.028 0.442 . . . . 0.0 110.688 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -89.58 88.76 7.54 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.507 HD11 HG13 ' A' ' 64' ' ' VAL . 40.6 mt -87.26 94.66 4.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.496 -176.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' SER . 11.1 t -102.35 1.79 35.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.545 -171.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -134.3 130.61 5.63 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.777 -1.201 . . . . 0.0 113.923 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.737 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -99.63 125.4 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 123.939 0.896 . . . . 0.0 108.938 177.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 59.53 21.62 10.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.075 0.464 . . . . 0.0 110.947 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' HA2' ' ND1' ' A' ' 100' ' ' HIS . . . 101.4 -19.02 52.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.562 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -112.33 141.22 46.32 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 117.656 0.728 . . . . 0.0 111.148 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.498 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 51.0 m -48.81 143.45 5.33 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.744 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -83.93 -18.3 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.266 -176.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -61.56 -25.36 67.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.964 -170.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.25 -15.27 78.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.782 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.631 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 5.7 mptt -108.98 -119.43 0.27 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.71 0.767 . . . . 0.0 109.882 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.53 ' O ' HG13 ' A' ' 86' ' ' VAL . 10.2 t -179.7 167.17 1.38 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.803 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.501 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -50.12 -53.03 30.27 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.8 0.687 . . . . 0.0 112.431 -171.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.24 -39.72 85.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.983 0.42 . . . . 0.0 111.761 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -74.19 -42.6 59.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.744 HG11 ' HB ' ' A' ' 78' ' ' ILE . 27.7 m -57.91 -43.15 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 126' ' ' LEU . . . -53.39 -42.99 67.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.832 174.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -64.59 -49.95 69.15 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.306 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.9 mmt -49.84 -46.22 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.274 0.559 . . . . 0.0 110.904 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 93' ' ' VAL . 20.4 mm -59.18 -56.9 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.873 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.67 -24.81 67.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.07 -46.18 88.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.142 0.496 . . . . 0.0 111.361 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 93' ' ' VAL . 13.2 m -72.88 55.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.104 0.954 . . . . 0.0 110.581 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -43.35 131.84 4.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.677 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 107.32 -35.47 5.0 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.072 170.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 12.9 pt-20 -132.56 177.81 7.33 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.102 0.477 . . . . 0.0 110.903 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 33' ' ' ILE . 16.9 t -152.28 133.64 5.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.314 -170.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.4 m -132.45 116.25 16.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 174.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.589 HD11 HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -107.47 124.2 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 121.128 0.489 . . . . 0.0 111.602 -176.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.449 ' ND1' ' HA2' ' A' ' 75' ' ' GLY . 0.3 OUTLIER -112.96 103.14 11.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.734 173.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -128.55 162.9 26.17 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 . . . . . 0 C--N 1.317 -0.826 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.892 -177.196 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 C--O 1.208 -1.089 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.436 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 27.4 Cg_exo -31.45 -54.83 0.27 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.254 3.303 . . . . 0.0 114.905 -172.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 0.5 OUTLIER -57.59 -43.57 84.71 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.724 0.773 . . . . 0.0 111.884 178.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 19.9 mt-30 -82.33 -26.56 32.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.514 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.428 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.2 tm? -69.55 -48.12 61.41 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.782 -175.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 5.1 pt-20 -64.78 -31.35 72.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.528 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 109' ' ' LYS . 75.1 t -64.55 -41.14 91.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.291 0.567 . . . . 0.0 109.797 175.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 tp -70.54 -32.71 70.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.584 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.7 t80 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.252 -178.585 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.663 ' CD2' ' HB ' ' A' ' 37' ' ' ILE . 2.1 pp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -144.98 95.6 2.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.226 0.536 . . . . 0.0 110.396 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.747 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.1 p . . . . . 0 N--CA 1.443 -0.809 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.343 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 60.7 pttt . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 120.914 0.387 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.507 HG21 ' O ' ' A' ' 62' ' ' GLY . 10.1 m -131.68 157.32 43.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -126.77 131.79 51.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.36 0.6 . . . . 0.0 110.914 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.9 mm? -127.35 -171.55 2.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.41 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 89.5 mt-30 -129.81 136.88 50.11 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.94 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 25.8 mmtp -40.14 146.27 0.13 Allowed 'General case' 0 C--N 1.321 -0.644 0 O-C-N 124.814 1.321 . . . . 0.0 113.354 -176.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -79.55 179.6 7.38 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.382 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.85 -32.22 63.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.775 0.321 . . . . 0.0 110.691 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -92.68 16.93 11.12 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.088 0.47 . . . . 0.0 111.018 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 63.5 t30 71.75 12.54 6.27 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.765 173.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 pp -121.95 -170.31 2.03 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 121.397 -0.815 . . . . 0.0 112.091 -174.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.9 -29.6 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.881 -178.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 93.78 40.26 4.72 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.413 -0.898 . . . . 0.0 113.427 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 2.7 pp -123.95 177.79 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.567 0.698 . . . . 0.0 112.197 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 49' ' ' ILE . 23.1 m -148.92 116.17 6.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.077 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 5.0 tt -105.0 125.61 59.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.449 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.694 -176.697 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.41 0.624 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.7 t -100.06 -20.55 5.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.37 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -151.15 133.11 15.12 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.356 -173.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.8 p -135.66 159.96 39.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -90.91 -137.87 0.15 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -138.89 -38.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.733 0.697 . . . . 0.0 112.321 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -101.73 4.06 40.21 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.956 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 70.0 p -82.9 146.61 52.62 Favored Pre-proline 0 N--CA 1.433 -1.294 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 9.1 Cg_endo -50.13 -40.5 50.89 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.911 1.741 . . . . 0.0 111.204 -176.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.88 84.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.814 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.94 -59.02 2.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.167 0.508 . . . . 0.0 110.573 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 61' ' ' ASP . 2.0 pp -50.03 -76.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -171.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.64 ' N ' HD12 ' A' ' 60' ' ' LEU . 35.7 t70 -95.56 -19.12 20.05 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.616 1.198 . . . . 0.0 108.511 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.538 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -64.25 -32.47 84.3 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 112.512 -2.131 . . . . 0.0 114.164 -167.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 t 48.01 32.1 2.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 112.255 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.609 ' HB ' ' OH ' ' A' ' 101' ' ' TYR . 22.8 m -105.1 51.37 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-O 123.483 1.611 . . . . 0.0 109.288 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.481 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.35 166.77 18.17 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.04 -2.345 . . . . 0.0 111.242 -172.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.02 119.09 2.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.175 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.87 -28.3 3.55 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.307 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.703 ' HB3' ' CD1' ' A' ' 101' ' ' TYR . 1.1 m-20 -73.7 144.29 45.82 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.6 ' HB3' ' O ' ' A' ' 102' ' ' ASN . 17.1 tt0 -101.59 122.89 44.68 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.731 HG12 ' CE1' ' A' ' 101' ' ' TYR . 3.2 mt -108.48 101.17 12.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.329 0.585 . . . . 0.0 111.205 -170.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -92.41 -15.17 27.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.069 -175.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.03 148.73 18.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.572 -1.299 . . . . 0.0 113.847 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.53 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -110.01 122.25 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 123.407 0.683 . . . . 0.0 109.457 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 53.2 28.36 6.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.94 -20.15 46.76 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.639 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 17.3 ptp180 -103.51 134.58 46.63 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 117.854 0.827 . . . . 0.0 110.52 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.2 m -66.68 152.37 45.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.692 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.53 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -88.48 6.02 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 122.396 1.093 . . . . 0.0 108.447 178.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.524 ' HE2' ' O ' ' A' ' 115' ' ' PHE . 39.3 tptt -76.05 96.19 3.77 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.254 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.49 -30.25 2.8 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.107 -1.044 . . . . 0.0 114.28 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.679 ' CG ' HG13 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -89.92 -151.32 0.23 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 117.989 0.895 . . . . 0.0 112.242 -172.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.479 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 2.7 m -132.91 141.19 48.24 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HA ' HG22 ' A' ' 86' ' ' VAL . 9.5 mtmm -37.63 -54.59 1.17 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.354 0.662 . . . . 0.0 112.715 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -51.64 -31.63 12.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.85 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 89' ' ' MET . 34.0 mt-10 -80.77 -34.92 33.85 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.849 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.679 HG13 ' CG ' ' A' ' 81' ' ' LYS . 20.3 m -73.48 -42.86 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.84 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' A' ' 91' ' ' GLN . . . -61.69 -34.65 76.13 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 171.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 38.1 ttpt -63.61 -48.33 77.79 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.727 175.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 65.6 mtt -45.38 -46.96 13.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.365 0.602 . . . . 0.0 110.275 175.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.416 ' CG2' HG21 ' A' ' 128' ' ' VAL . 34.8 mm -63.69 -54.43 32.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.973 176.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.625 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 11.9 mm-40 -61.39 -35.69 78.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -67.03 -55.16 15.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -172.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -54.42 -40.18 47.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.582 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.472 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 64.6 pttt 48.38 161.62 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.227 1.411 . . . . 0.0 113.702 -178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.67 -46.07 3.12 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.235 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.1 pt-20 -146.54 178.39 8.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.095 0.474 . . . . 0.0 110.11 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.618 HG11 HG23 ' A' ' 33' ' ' ILE . 4.6 m -147.48 151.04 14.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.55 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.6 m -140.35 105.49 5.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.265 0.555 . . . . 0.0 110.595 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.702 ' HB ' ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -92.61 149.67 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.077 -176.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -128.03 129.13 46.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.784 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.731 ' CE1' HG12 ' A' ' 70' ' ' ILE . 97.5 m-85 -123.46 153.61 40.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.6 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 11.1 p-10 . . . . . 0 N--CA 1.44 -0.946 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.178 171.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 111' ' ' LEU . 12.6 m-20 . . . . . 0 C--O 1.21 -1.013 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -32.59 -49.03 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.693 2.929 . . . . 0.0 113.743 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 113' ' ' VAL . 21.3 ptmt -60.7 -49.38 77.73 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.587 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.475 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.8 mm100 -90.09 -11.25 41.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.535 0.683 . . . . 0.0 111.206 -173.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.4 tm? -84.91 -40.12 17.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.493 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -66.25 -21.85 66.3 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.851 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 109' ' ' LYS . 76.0 t -64.21 -36.34 76.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.922 174.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 114' ' ' LEU . 7.1 tt -79.63 -30.36 41.31 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.524 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 9.8 t80 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.609 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -144.32 148.81 35.26 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.313 0.578 . . . . 0.0 111.23 -178.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 33' ' ' ILE . 4.1 p . . . . . 0 C--N 1.315 -0.899 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 21.3 pttm . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.538 0.209 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.55 141.07 43.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -109.5 119.66 40.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.808 0.814 . . . . 0.0 111.186 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.54 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.9 mm? -124.41 -167.01 1.59 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.045 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.0 mt-30 -132.12 139.67 48.53 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.014 0.435 . . . . 0.0 109.948 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 5.3 mmtp -45.03 145.27 1.02 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.86 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.25 179.1 8.0 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.421 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.92 -21.35 64.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.169 0.509 . . . . 0.0 110.658 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 2.5 mt-30 -89.74 11.34 20.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.907 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 1.8 p-10 55.33 29.18 12.52 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.136 1.374 . . . . 0.0 112.136 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 0.9 OUTLIER -131.65 -165.74 1.62 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.639 177.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.73 -28.57 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.67 38.02 4.31 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.267 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 52' ' ' VAL . 2.6 pp -128.82 177.51 6.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.868 0.842 . . . . 0.0 111.954 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 11.7 m -138.41 125.18 20.99 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.397 173.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.923 HG22 ' H ' ' A' ' 38' ' ' GLY . 22.5 mt -110.47 -168.18 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.923 ' H ' HG22 ' A' ' 37' ' ' ILE . . . . . . . . 0 C--N 1.308 -0.984 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.31 0 CA-C-O 121.53 0.681 . . . . 0.0 109.285 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 37.4 t -92.3 -38.32 10.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.937 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.96 150.15 20.3 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.682 -174.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 59' ' ' ALA . 8.1 p -141.33 159.98 22.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.567 173.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -95.91 -139.18 0.25 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.437 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 18.9 t70 -136.06 -33.41 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.783 176.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -102.38 4.49 38.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.166 0.508 . . . . 0.0 110.564 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 82.5 p -86.3 144.16 37.84 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.815 ' HA ' ' CD1' ' A' ' 60' ' ' LEU . 10.2 Cg_endo -52.25 -38.99 73.06 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.428 1.418 . . . . 0.0 111.704 -172.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.658 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.05 -45.36 87.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.543 175.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.681 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.4 -60.95 1.98 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.095 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.011 HD13 ' H ' ' A' ' 61' ' ' ASP 0.268 0.0 OUTLIER -61.41 -71.43 0.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -166.895 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 1.011 ' H ' HD13 ' A' ' 60' ' ' LEU . 23.7 t70 -92.84 -4.31 53.15 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -71.71 -62.28 3.48 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 112.613 -2.085 . . . . 0.0 113.648 -171.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p 74.31 23.18 2.07 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.933 1.293 . . . . 0.0 110.574 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.637 HG11 HG13 ' A' ' 99' ' ' ILE . 31.2 m -100.21 50.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.564 172.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.73 174.91 10.07 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.138 -170.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.91 132.43 52.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.607 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.15 -13.58 19.19 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.638 ' O ' HG22 ' A' ' 49' ' ' ILE . 57.8 m-20 -95.86 -175.99 3.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.026 0.441 . . . . 0.0 110.72 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . 50.9 mt-10 -132.09 154.24 49.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.101 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 mm -122.83 140.29 47.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 t -131.07 -0.88 4.11 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.56 142.16 7.94 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.22 -1.467 . . . . 0.0 113.952 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.663 HG12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -104.0 117.3 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 123.632 0.773 . . . . 0.0 109.767 -179.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.578 ' ND2' HG11 ' A' ' 93' ' ' VAL . 64.9 t30 53.71 29.95 10.32 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.536 0.684 . . . . 0.0 111.016 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.622 ' HA2' ' CD2' ' A' ' 100' ' ' HIS . . . 100.66 -21.52 43.61 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.917 177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 5.8 ptm180 -100.59 142.97 31.32 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 117.801 0.8 . . . . 0.0 110.529 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.7 m -59.42 149.87 28.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.188 0.518 . . . . 0.0 111.332 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.663 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -90.62 -20.96 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.166 -179.01 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.24 -25.78 68.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.123 -170.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.99 -17.71 77.24 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.863 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -135.01 -139.27 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.321 0.56 . . . . 0.0 110.215 -176.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 85' ' ' GLU . 47.1 p -137.67 157.89 45.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.628 -172.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.487 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -48.04 -54.94 11.38 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.774 0.671 . . . . 0.0 112.588 -178.424 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.93 -39.67 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 120.895 0.378 . . . . 0.0 111.974 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.566 ' O ' ' HG3' ' A' ' 89' ' ' MET . 39.8 mt-10 -72.7 -36.62 67.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.934 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 83' ' ' LYS . 29.1 m -72.48 -41.36 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.347 -176.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.65 -37.01 67.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.027 170.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 57.1 tttm -64.76 -48.98 72.56 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.828 173.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.566 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 58.3 mtt -54.69 -40.56 69.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.107 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.581 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 20.1 mm -61.26 -55.48 24.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.087 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.527 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 10.4 pt20 -72.34 -23.13 61.1 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -176.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -67.45 -53.75 26.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.578 HG11 ' ND2' ' A' ' 74' ' ' ASN . 33.6 m -46.59 -32.33 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 23.9 tptm 70.87 123.88 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.292 0.568 . . . . 0.0 112.073 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.566 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 105.8 -59.16 0.42 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.151 -1.024 . . . . 0.0 113.588 172.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.5 pt-20 -135.47 178.72 6.82 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.149 0.5 . . . . 0.0 110.566 -170.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.585 HG11 HG23 ' A' ' 33' ' ' ILE . 9.2 m -148.38 151.09 13.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.0 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 p -139.73 99.98 3.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.33 0.586 . . . . 0.0 109.99 170.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.637 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -86.26 115.51 27.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.82 -176.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.622 ' CD2' ' HA2' ' A' ' 75' ' ' GLY . 4.7 m-70 -91.99 119.71 31.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -132.2 -170.16 2.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.61 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.523 ' ND2' ' HB2' ' A' ' 69' ' ' GLU . 4.0 p-10 . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.319 173.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 C--O 1.21 -1.013 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.54 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 36.3 Cg_exo -32.76 -52.89 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.582 2.855 . . . . 0.0 113.965 -174.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.7 ptpt -55.97 -51.06 69.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.387 0.613 . . . . 0.0 111.978 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.529 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.3 mm100 -88.16 -3.9 58.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.729 0.776 . . . . 0.0 111.343 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.72 -49.11 6.65 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.622 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 7.4 pt-20 -68.73 -23.43 64.34 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.514 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 110' ' ' GLN . 3.9 p -69.54 -31.74 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.589 0.709 . . . . 0.0 110.101 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.84 -34.02 45.49 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.283 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.6 t80 . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.529 -178.27 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 127' ' ' LYS . 9.1 tt . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.62 ' N ' HD23 ' A' ' 126' ' ' LEU . 19.8 pttp -155.13 120.88 5.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.478 0.656 . . . . 0.0 111.575 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.601 ' O ' HG13 ' A' ' 33' ' ' ILE . 12.5 p . . . . . 0 N--CA 1.446 -0.651 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.344 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -147.27 102.71 3.78 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.37 5.18 6.45 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.621 2.214 . . . . 0.0 113.305 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.5 63.07 2.18 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.253 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.523 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 2.7 pt -79.07 157.09 76.36 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.523 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 36.1 Cg_endo -66.26 -87.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.377 2.051 . . . . 0.0 113.393 -171.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.11 96.09 48.44 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 120.766 0.317 . . . . 0.0 110.978 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.76 144.39 31.12 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.576 2.184 . . . . 0.0 112.487 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -154.7 172.5 33.13 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 19.8 ptpt -148.63 141.72 24.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.815 0.308 . . . . 0.0 110.558 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.67 136.42 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -110.72 129.45 55.83 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.78 0.8 . . . . 0.0 110.72 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.19 -160.2 1.03 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.01 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -140.3 149.05 42.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.117 0.484 . . . . 0.0 110.104 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 3.3 mmmm -45.39 151.45 0.37 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.578 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -84.37 172.61 11.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.169 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.02 41.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 110.828 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.642 HE21 HD21 ' A' ' 32' ' ' LEU . 3.9 tt0 -92.47 8.43 38.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.982 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 40.1 t30 69.35 34.75 2.8 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.901 0.858 . . . . 0.0 110.583 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.642 HD21 HE21 ' A' ' 30' ' ' GLN . 1.5 pp -147.07 -164.4 1.99 Allowed 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.273 -0.571 . . . . 0.0 112.002 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.695 HD11 HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -104.07 -30.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.45 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 101.56 32.52 5.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.194 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.748 HD11 HG23 ' A' ' 128' ' ' VAL . 2.8 pp -126.83 -179.48 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.613 0.721 . . . . 0.0 112.61 -175.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 39.8 m -137.6 128.73 27.64 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.506 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 48.0 mm -111.04 125.43 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.649 0.738 . . . . 0.0 111.988 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 48' ' ' TYR . . . -132.62 126.59 4.54 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 170.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.07 61.74 2.17 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.888 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.82 149.94 7.69 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.455 ' HB3' ' NE2' ' A' ' 116' ' ' GLN . . . -117.63 -76.43 0.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.798 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.552 ' NE2' ' HA ' ' A' ' 113' ' ' VAL . 18.0 pt20 -77.62 104.75 8.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.034 0.445 . . . . 0.0 109.974 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 74.17 4.79 4.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.927 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.463 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 69.1 m 57.66 58.9 7.15 Favored Pre-proline 0 C--O 1.231 0.095 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.995 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 21.8 Cg_exo -65.63 -86.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.493 2.128 . . . . 0.0 112.609 -173.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.738 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 93.8 m -151.72 -97.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 46' ' ' CYS . 0.4 OUTLIER 50.62 -66.89 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.201 1.4 . . . . 0.0 114.136 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.603 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 87.9 m-85 68.6 -57.15 0.5 Allowed 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.262 0.625 . . . . 0.0 112.515 -174.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -86.57 115.85 28.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 118.509 -1.277 . . . . 0.0 110.32 -179.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -94.27 -31.78 4.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.12 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -161.0 154.15 21.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.13 0.491 . . . . 0.0 110.088 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.8 p -143.45 160.77 16.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.922 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.504 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 80.4 m-85 -112.74 124.97 53.78 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 20.6 t70 -54.19 -27.36 33.58 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -165.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -101.0 6.93 43.69 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.184 0.516 . . . . 0.0 110.492 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 30.9 p -87.55 153.9 53.32 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.32 -40.2 78.69 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.211 1.274 . . . . 0.0 110.905 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -55.68 -49.49 72.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.803 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -77.68 -56.29 4.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.848 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.621 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.3 pp -52.74 -74.12 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -170.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.621 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 37.2 t70 -94.13 -9.11 37.58 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.563 1.173 . . . . 0.0 107.938 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -82.94 -51.73 4.11 Favored Glycine 0 C--N 1.311 -0.816 0 CA-C-N 113.093 -1.867 . . . . 0.0 113.458 -171.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 p 64.57 22.55 12.68 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.699 1.2 . . . . 0.0 111.143 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 99' ' ' ILE . 9.9 m -92.1 53.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 122.959 1.361 . . . . 0.0 109.74 172.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.6 179.81 7.04 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.552 -2.113 . . . . 0.0 111.736 -171.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.37 122.71 11.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.991 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.86 1.07 34.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.71 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.698 ' O ' HG22 ' A' ' 49' ' ' ILE . 51.5 t0 -98.48 152.73 19.22 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 33.6 tt0 -101.44 82.31 2.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.896 0.379 . . . . 0.0 110.692 -174.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.477 HD13 ' HB ' ' A' ' 49' ' ' ILE . 2.0 mp -74.18 101.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.679 0.752 . . . . 0.0 109.362 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.462 HG21 HD21 ' A' ' 102' ' ' ASN . 7.5 t -100.76 -15.8 17.54 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.649 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -147.78 148.03 19.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.6 -1.285 . . . . 0.0 113.457 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -108.76 115.31 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 9.7 t-20 52.21 37.17 21.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.218 0.532 . . . . 0.0 111.311 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.69 -22.45 39.66 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.833 -0.621 . . . . 0.0 113.927 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -106.13 129.29 54.24 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 117.726 0.763 . . . . 0.0 111.245 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.54 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 46.4 m -61.63 148.67 41.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.536 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.609 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -90.68 -25.52 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.265 0.555 . . . . 0.0 109.598 177.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -73.09 86.5 1.36 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.262 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.65 -25.7 0.17 Allowed Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.07 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -111.12 -117.04 0.3 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.942 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.478 ' O ' HG13 ' A' ' 86' ' ' VAL . 4.9 m -149.61 148.93 29.91 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.236 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.598 ' O ' HG22 ' A' ' 86' ' ' VAL . 5.5 mttt -47.81 -55.69 9.12 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.253 0.549 . . . . 0.0 111.976 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.06 -36.91 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.697 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.587 ' O ' ' HG3' ' A' ' 89' ' ' MET . 37.1 mt-10 -74.36 -37.21 63.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.261 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.609 HG11 ' HB ' ' A' ' 78' ' ' ILE . 27.3 m -67.35 -43.09 88.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.888 0.375 . . . . 0.0 111.087 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.07 73.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.203 171.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 59.8 tttm -61.48 -45.89 92.34 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.587 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 82.5 mtp -53.7 -37.21 63.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.402 0.62 . . . . 0.0 110.723 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.695 HD13 HD11 ' A' ' 33' ' ' ILE . 97.1 mt -77.23 -38.53 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.21 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -70.68 -29.33 65.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.625 0.25 . . . . 0.0 110.86 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -62.48 -48.73 78.31 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.628 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 93' ' ' VAL . 13.3 m -69.75 82.5 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 122.772 1.272 . . . . 0.0 110.08 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -67.34 123.08 19.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.407 -173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.598 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 95.9 -21.17 46.43 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.431 169.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 97' ' ' VAL . 9.2 pt-20 -124.28 169.17 12.04 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.079 0.466 . . . . 0.0 109.885 -174.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 96' ' ' GLU . 2.8 t -159.15 125.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.501 -173.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 99.5 m -141.58 131.9 25.07 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 122.171 -0.33 . . . . 0.0 110.143 172.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.712 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -120.36 132.65 69.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.429 -176.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -100.46 129.42 46.41 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 69' ' ' GLU . 27.5 p90 -136.85 165.82 25.06 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.745 0.307 . . . . 0.0 111.341 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.603 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 62.1 m-20 -142.58 172.25 12.95 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.603 ' HD2' ' O ' ' A' ' 102' ' ' ASN . 13.1 mptt -148.57 99.44 3.01 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -174.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.586 HD12 ' H ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -97.83 125.98 42.96 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.518 -171.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.521 ' N ' HD12 ' A' ' 104' ' ' LEU . 23.1 mp0 -81.61 -22.84 37.41 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.194 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.586 ' H ' HD12 ' A' ' 104' ' ' LEU . . . 52.31 -155.46 0.17 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.199 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.5 152.1 79.76 Favored Pre-proline 0 C--O 1.215 -0.73 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -31.55 -55.88 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.752 2.968 . . . . 0.0 114.138 -172.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.0 ptpt -58.0 -45.9 86.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.524 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 71.0 mm-40 -86.57 -17.63 33.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.488 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.43 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.3 tm? -74.26 -44.26 53.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.161 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -70.11 -26.58 64.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.484 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.552 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 79.4 t -72.53 -41.72 63.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.028 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.7 tp -72.41 -23.09 61.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.822 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -61.5 -42.0 98.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.308 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.508 ' OE1' ' HG2' ' A' ' 42' ' ' GLN . 12.4 mm100 63.07 94.82 0.05 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.702 0.763 . . . . 0.0 110.778 -173.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.521 ' H ' ' HD2' ' A' ' 118' ' ' PRO . . . -126.52 -57.64 0.14 Allowed Glycine 0 C--N 1.309 -0.97 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 117' ' ' GLY . 10.3 Cg_endo -50.5 123.93 12.28 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.397 2.731 . . . . 0.0 111.311 165.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -115.86 42.87 2.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.467 0.651 . . . . 0.0 110.471 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -79.59 -24.56 41.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.884 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 p -84.76 106.76 16.54 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.799 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.6 tp -86.22 -71.19 0.55 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 62.01 178.41 0.13 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.436 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -118.0 103.31 9.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.485 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -92.71 -179.19 5.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.507 ' CG ' ' HB ' ' A' ' 37' ' ' ILE . 1.4 pp -117.71 168.96 9.97 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 10.9 ptmm? -150.98 145.85 25.84 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.357 0.599 . . . . 0.0 110.478 176.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.748 HG23 HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 168.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 p -76.95 129.85 77.47 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.988 0.394 . . . . 0.0 110.357 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.93 46.72 2.13 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.935 2.423 . . . . 0.0 112.359 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.3 -178.15 41.83 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.038 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.475 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 10.5 pt -106.85 156.06 37.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 29.7 Cg_endo -62.68 -91.03 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.348 2.032 . . . . 0.0 112.931 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.1 112.68 15.85 Favored Pre-proline 0 N--CA 1.438 -1.027 0 O-C-N 122.161 -0.337 . . . . 0.0 110.678 174.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.17 144.39 10.58 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.848 2.365 . . . . 0.0 112.996 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.25 -176.86 42.97 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 64.4 pttt -141.95 161.32 38.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.14 0.47 . . . . 0.0 110.633 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 62' ' ' GLY . 9.7 p -142.95 138.78 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.471 ' O ' HD13 ' A' ' 25' ' ' LEU . 12.0 t -110.89 127.36 55.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.445 0.64 . . . . 0.0 110.768 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.546 HD23 HD11 ' A' ' 99' ' ' ILE . 2.6 mm? -127.51 -170.39 2.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.432 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 80.5 mt-30 -129.98 136.55 49.56 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.238 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.721 ' HZ3' ' HA ' ' A' ' 91' ' ' GLN . 22.3 mmtp -45.16 149.27 0.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.712 1.258 . . . . 0.0 112.009 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 4.5 p-10 -89.89 -162.88 0.93 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.489 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.09 65.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.755 0.312 . . . . 0.0 111.555 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.461 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 36.5 mt-30 -88.43 0.84 55.82 Favored 'General case' 0 N--CA 1.425 -1.722 0 C-N-CA 122.931 0.492 . . . . 0.0 112.245 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 50.7 t30 71.3 18.47 5.63 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.51 0.671 . . . . 0.0 110.943 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.457 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 2.0 pp -126.58 -165.26 1.43 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.092 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.807 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -109.03 -22.27 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.674 -177.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.434 ' N ' HD13 ' A' ' 32' ' ' LEU . . . 98.48 35.05 5.08 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.878 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.552 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.7 pp -123.2 171.21 12.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.463 0.649 . . . . 0.0 110.698 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 46.2 m -130.72 131.92 45.06 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.375 175.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 41.2 mm -100.44 141.29 17.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.152 -176.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.29 -158.81 8.03 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.117 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.489 ' HA3' HD12 ' A' ' 47' ' ' LEU . . . -12.39 -102.15 0.0 OUTLIER Glycine 0 C--N 1.34 0.784 0 N-CA-C 115.83 1.092 . . . . 0.0 115.83 -159.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 45' ' ' PRO . . . 55.29 80.65 0.07 OUTLIER Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.769 -172.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.605 ' N ' ' HA ' ' A' ' 45' ' ' PRO . . . -173.54 -153.28 0.06 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.992 0.396 . . . . 0.0 110.808 -166.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -50.66 129.95 23.57 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.559 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 76.68 -21.53 0.32 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.949 0.9 . . . . 0.0 112.904 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 38.3 t -162.63 80.8 1.72 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.948 0.404 . . . . 0.0 111.26 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.605 ' HA ' ' N ' ' A' ' 41' ' ' ALA . 17.1 Cg_exo -75.4 23.07 0.43 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.63 2.887 . . . . 0.0 112.954 174.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 80.9 m -95.54 -141.79 0.26 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.489 HD12 ' HA3' ' A' ' 39' ' ' GLY . 40.2 mt 76.0 -103.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.377 0.608 . . . . 0.0 110.809 177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.618 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 26.6 m-85 68.75 -77.78 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.778 -176.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -82.2 109.84 16.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 118.066 -1.454 . . . . 0.0 110.369 -172.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 m -108.73 -19.12 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.123 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 13.9 tp60 -157.3 143.55 17.88 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-O 121.023 0.439 . . . . 0.0 110.222 -171.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.5 p -145.31 160.93 12.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.015 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -98.64 -131.15 0.21 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.119 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -138.2 -44.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.538 ' HA ' HD23 ' A' ' 60' ' ' LEU . 46.7 m-80 -100.62 8.33 43.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.334 0.588 . . . . 0.0 109.78 -170.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.428 ' CB ' ' HA3' ' A' ' 34' ' ' GLY . 31.0 p -92.19 143.66 27.85 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.507 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 3.6 Cg_endo -44.96 -41.92 15.59 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 C-N-CA 122.551 2.167 . . . . 0.0 111.776 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -58.1 -54.76 43.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.419 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.713 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -71.8 -55.0 8.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.73 0.776 . . . . 0.0 109.807 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.3 tm? -42.45 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.235 -1.802 . . . . 0.0 113.273 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -98.8 -39.54 8.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.152 0.501 . . . . 0.0 111.914 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.426 ' O ' HG11 ' A' ' 23' ' ' VAL . . . -62.89 -27.33 70.04 Favored Glycine 0 C--O 1.228 -0.226 0 CA-C-N 115.14 -0.936 . . . . 0.0 114.631 -165.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 t 50.71 35.84 12.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.312 1.053 . . . . 0.0 111.39 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.633 HG11 HG13 ' A' ' 99' ' ' ILE . 20.6 m -100.14 51.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.345 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.33 177.77 8.59 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.222 -168.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.26 136.21 25.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.992 -170.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.82 56.32 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.6 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.532 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -104.12 165.49 11.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.025 0.44 . . . . 0.0 110.438 176.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -108.63 99.93 9.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.173 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 49' ' ' ILE . 28.7 mm -83.66 105.43 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 77' ' ' SER . 4.2 t -101.49 -15.26 17.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.315 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -139.93 136.36 7.73 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 119.762 -1.209 . . . . 0.0 113.655 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.692 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -103.97 120.54 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 123.376 0.67 . . . . 0.0 109.379 177.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.523 ' ND2' HG11 ' A' ' 93' ' ' VAL . 66.0 t30 54.1 29.91 11.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.481 0.658 . . . . 0.0 110.719 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.15 -21.35 44.92 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.755 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 2.7 ptp180 -104.22 131.2 51.79 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 117.874 0.837 . . . . 0.0 110.602 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' THR . 62.6 m -47.8 136.11 11.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.201 0.525 . . . . 0.0 112.151 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.691 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -76.1 -19.75 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.76 -174.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.04 -12.21 59.26 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.121 -173.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.58 -20.87 61.03 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.377 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.545 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 2.6 mptp? -107.67 -131.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.845 0.831 . . . . 0.0 110.275 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 86' ' ' VAL . 5.5 m -158.13 160.12 36.95 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' VAL . 12.8 mttt -47.01 -60.8 2.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.335 0.588 . . . . 0.0 111.756 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.7 p -55.0 -34.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.076 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.591 ' O ' ' HG2' ' A' ' 89' ' ' MET . 33.2 mt-10 -77.52 -43.47 31.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.679 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.651 HG11 ' HB ' ' A' ' 78' ' ' ILE . 19.7 m -58.42 -47.6 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -57.16 -38.75 74.03 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 25.6 ttpp -60.88 -56.92 15.45 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.591 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 16.5 mmt -48.63 -43.2 36.22 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.63 0.581 . . . . 0.0 111.146 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.517 HD13 HD11 ' A' ' 33' ' ' ILE . 64.2 mt -62.45 -55.12 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.465 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.721 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 10.4 pt20 -76.94 -22.12 53.78 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.985 -0.447 . . . . 0.0 111.459 -174.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.58 -52.68 23.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.411 0.684 . . . . 0.0 111.732 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.523 HG11 ' ND2' ' A' ' 74' ' ' ASN . 31.8 m -49.42 -36.26 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.543 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 67.62 134.55 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.464 0.649 . . . . 0.0 112.493 171.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.46 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 102.27 -48.25 1.08 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.938 172.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.0 pt-20 -146.03 178.79 7.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.058 0.456 . . . . 0.0 110.144 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.522 HG11 HG23 ' A' ' 33' ' ' ILE . 5.4 m -145.39 154.69 13.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.621 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.3 m -140.71 99.78 3.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 172.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.633 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -93.45 120.63 43.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.112 -175.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.433 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 4.1 t-160 -94.39 129.06 41.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 171.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -139.04 163.98 30.97 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.157 0.503 . . . . 0.0 111.815 -172.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -133.75 103.13 5.73 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 18' ' ' PRO . 11.0 mtpt -93.58 139.55 30.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.28 0.562 . . . . 0.0 111.607 -165.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.594 ' HG ' ' H ' ' A' ' 106' ' ' ALA . 1.0 OUTLIER -157.99 -52.82 0.07 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.057 -175.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.444 ' O ' HD23 ' A' ' 111' ' ' LEU . 2.7 mp0 59.37 18.61 6.91 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -170.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.594 ' H ' ' HG ' ' A' ' 104' ' ' LEU . . . 58.77 -166.32 0.17 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.643 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 20.2 t70 -125.53 144.95 49.58 Favored Pre-proline 0 C--O 1.21 -1.021 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 13.6 Cg_exo -29.26 -51.48 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.251 3.301 . . . . 0.0 115.16 -173.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.1 pttp -59.51 -45.63 91.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.379 0.609 . . . . 0.0 111.759 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 15.1 mm100 -85.76 -17.81 34.79 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.838 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 105' ' ' GLN . 3.2 tm? -73.25 -43.73 60.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.485 -175.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -69.18 -35.47 76.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.119 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 109' ' ' LYS . 81.0 t -64.71 -41.11 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.223 0.535 . . . . 0.0 109.991 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.85 -23.79 61.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.84 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -76.08 -49.64 16.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.041 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -85.09 42.43 0.94 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.208 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -122.29 -61.5 0.21 Allowed Glycine 0 C--N 1.312 -0.792 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -38.62 86.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.195 3.263 . . . . 0.0 112.752 158.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -151.73 21.81 0.7 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.845 0.831 . . . . 0.0 109.402 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -125.61 124.03 40.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.12 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.07 -20.76 17.16 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.393 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.1 mt -80.52 76.0 7.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.174 0.511 . . . . 0.0 110.597 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.2 166.79 28.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.926 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -82.39 109.34 16.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.928 0.394 . . . . 0.0 110.325 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 51.2 t90 -85.13 153.18 22.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.246 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.516 ' HG ' ' N ' ' A' ' 127' ' ' LYS . 61.6 tp -143.36 167.97 20.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.669 0.271 . . . . 0.0 111.333 -173.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 13.8 ptmm? -169.38 151.79 4.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.696 0.398 . . . . 0.0 110.69 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.807 ' OXT' HG13 ' A' ' 33' ' ' ILE . 14.5 p . . . . . 0 C--O 1.238 0.491 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.048 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -77.06 112.92 26.08 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.35 65.47 8.87 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.587 2.191 . . . . 0.0 112.409 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.65 -23.25 40.01 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.578 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 5.2 pt -113.01 166.92 10.06 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 60.0 Cg_endo -75.08 -161.71 0.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.523 1.482 . . . . 0.0 112.066 -177.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -41.94 113.69 1.22 Allowed Pre-proline 0 C--O 1.234 0.265 0 O-C-N 123.459 0.474 . . . . 0.0 111.485 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 19' ' ' VAL . 9.8 Cg_endo -88.27 126.22 1.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.162 2.575 . . . . 0.0 113.1 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.15 134.16 8.77 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 12.0 ptmm? -159.78 114.62 2.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.82 0.343 . . . . 0.0 110.596 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 62' ' ' GLY . 14.6 m -128.16 154.19 38.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.938 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.7 t -116.35 123.6 48.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.546 0.689 . . . . 0.0 110.219 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.47 HD21 ' HA2' ' A' ' 62' ' ' GLY . 7.8 mt -122.34 -168.43 1.72 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.402 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 93.6 mt-30 -133.89 140.14 46.63 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.215 0.531 . . . . 0.0 110.642 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 10.0 mmtp -45.79 144.02 1.88 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.067 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -83.63 -179.39 7.31 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.439 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.77 -24.24 61.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 118.084 0.402 . . . . 0.0 111.363 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.565 HE21 HD21 ' A' ' 32' ' ' LEU . 6.1 tt0 -96.56 21.13 9.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 110.202 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.466 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 1.7 p-10 57.17 23.45 8.63 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.121 1.369 . . . . 0.0 113.173 174.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.565 HD21 HE21 ' A' ' 30' ' ' GLN . 0.8 OUTLIER -128.72 -165.43 1.5 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.797 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.763 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.7 -26.58 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.635 -178.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 98.28 41.9 3.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.093 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.519 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -130.06 172.6 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.947 0.879 . . . . 0.0 111.488 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m -141.41 129.41 21.96 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.712 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.453 HG23 HD13 ' A' ' 35' ' ' ILE . 6.9 pt -119.41 137.97 51.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.896 0.855 . . . . 0.0 111.022 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' A' ' 125' ' ' TRP . . . -109.93 -157.81 16.84 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.853 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -14.09 -69.78 0.01 OUTLIER Glycine 0 C--N 1.343 0.921 0 O-C-N 124.929 1.017 . . . . 0.0 115.508 -163.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 46' ' ' CYS . . . 69.35 30.3 71.48 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.653 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 64.08 5.82 2.61 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -71.05 -28.37 64.33 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -106.44 -56.87 2.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.897 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.538 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 47.6 m -162.76 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.767 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 44' ' ' CYS . 40.3 Cg_endo -77.57 138.65 17.45 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.601 2.201 . . . . 0.0 112.934 -167.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 79.7 m -59.62 -94.98 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.275 -0.393 . . . . 0.0 111.18 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 48' ' ' TYR . 1.2 pp 47.74 -70.67 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.597 ' N ' HD12 ' A' ' 47' ' ' LEU . 49.1 m-85 70.22 -88.21 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.377 0.671 . . . . 0.0 110.592 -170.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.673 ' HB ' HD13 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -71.54 128.74 34.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 119.373 0.988 . . . . 0.0 110.647 -172.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 m -117.66 -22.21 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.397 -175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -155.07 138.61 15.97 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.585 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.606 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.2 p -139.91 160.89 26.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.855 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -97.93 -137.79 0.28 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.429 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.44 -34.66 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -101.72 -0.56 34.28 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.998 0.428 . . . . 0.0 110.174 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 80.2 p -84.04 148.54 53.86 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.466 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 10.2 Cg_endo -52.06 -41.16 66.04 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.484 1.456 . . . . 0.0 110.991 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.52 -45.71 88.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.827 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.606 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.38 -59.56 2.67 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.411 0.624 . . . . 0.0 110.525 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.616 ' HG ' ' H ' ' A' ' 61' ' ' ASP . 1.6 pp -54.87 -75.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.616 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 31.4 t70 -94.6 -13.06 26.33 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 122.581 1.181 . . . . 0.0 108.24 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -61.55 -40.34 98.57 Favored Glycine 0 C--N 1.314 -0.687 0 CA-C-N 112.464 -2.153 . . . . 0.0 114.804 -166.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.2 p 52.31 35.29 16.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.455 1.121 . . . . 0.0 111.197 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.647 HG11 HG13 ' A' ' 99' ' ' ILE . 15.9 m -122.79 53.66 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.174 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.62 179.67 7.33 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 112.649 -2.069 . . . . 0.0 111.319 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.34 123.05 15.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.696 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.64 -18.6 8.64 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.522 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.615 ' O ' HG22 ' A' ' 49' ' ' ILE . 11.9 m-20 -83.33 144.51 29.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.524 0.662 . . . . 0.0 110.532 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 41.9 mt-10 -94.52 97.0 9.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.924 -174.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.673 HD13 ' HB ' ' A' ' 49' ' ' ILE . 2.1 mp -76.01 138.26 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.483 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -127.89 -25.03 3.13 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.963 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.15 146.81 16.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.536 -1.316 . . . . 0.0 113.772 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.691 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -117.52 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.503 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 5.4 m-20 56.24 22.17 5.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.95 0.405 . . . . 0.0 111.786 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.83 -12.21 59.25 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.451 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.691 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 9.7 ptp180 -105.76 131.72 52.76 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 117.922 0.861 . . . . 0.0 110.861 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 p -61.06 138.08 58.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.133 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.689 HG23 HG12 ' A' ' 73' ' ' VAL . 1.1 pp -77.56 -24.16 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-O 122.391 1.091 . . . . 0.0 109.883 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.614 ' H ' HD12 ' A' ' 78' ' ' ILE . 3.5 tppp? -69.63 -19.27 63.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.068 -1.878 . . . . 0.0 109.878 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.56 -15.61 75.47 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.019 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.73 -142.26 0.17 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.662 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 86' ' ' VAL . 29.7 p -136.35 169.79 17.08 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.177 -0.209 . . . . 0.0 111.105 -169.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.468 ' HB3' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -49.02 -53.99 17.7 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.81 0.693 . . . . 0.0 112.443 -176.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.06 -39.82 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.624 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.07 -35.32 66.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 82' ' ' THR . 32.3 m -68.54 -46.1 80.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.209 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' HB2' HD13 ' A' ' 126' ' ' LEU . . . -58.33 -37.82 75.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.971 0.415 . . . . 0.0 110.171 172.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 91' ' ' GLN . 60.8 tttm -63.26 -53.13 57.8 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.847 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.484 ' O ' HG13 ' A' ' 93' ' ' VAL . 24.8 mmt -51.86 -42.48 62.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.25 0.548 . . . . 0.0 111.386 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.609 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 62.5 mt -64.78 -47.96 86.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.675 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.466 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 7.1 pt20 -73.78 -35.36 64.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.159 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -58.95 -50.1 75.35 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.526 0.516 . . . . 0.0 111.981 -173.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 89' ' ' MET . 17.8 m -52.99 -35.29 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.566 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 98.5 mttt 65.16 151.32 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.824 0.821 . . . . 0.0 112.802 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 88.3 -53.52 4.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.214 168.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.1 pt-20 -137.33 178.01 7.42 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.455 HG11 HG23 ' A' ' 33' ' ' ILE . 6.8 m -147.8 150.67 14.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.846 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.503 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 34.3 m -137.97 103.61 5.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.043 0.449 . . . . 0.0 110.182 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.647 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -94.45 129.81 44.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.338 -175.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -114.72 119.86 38.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.258 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -142.04 154.1 44.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.003 0.43 . . . . 0.0 110.893 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 20' ' ' PRO . 17.3 m120 -141.7 -172.25 3.5 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.402 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 9.1 mptt -148.24 98.58 2.93 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -173.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 105' ' ' GLN . 0.3 OUTLIER -112.13 -178.66 3.47 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.277 -169.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.523 ' H ' HD12 ' A' ' 104' ' ' LEU . 14.7 mm100 -104.9 -84.33 0.49 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.981 0.42 . . . . 0.0 111.123 -173.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 58.82 -177.35 0.08 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.527 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.592 ' OD2' ' HG2' ' A' ' 109' ' ' LYS . 10.5 t70 -172.54 151.21 2.35 Favored Pre-proline 0 C--O 1.21 -1.007 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 9.2 Cg_exo -29.9 -47.77 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.693 2.929 . . . . 0.0 114.087 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.592 ' HG2' ' OD2' ' A' ' 107' ' ' ASP . 9.2 ptpp? -58.25 -49.61 76.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.232 0.539 . . . . 0.0 111.831 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.485 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 26.3 mm-40 -85.95 -11.59 52.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.714 0.769 . . . . 0.0 110.872 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.42 -43.89 22.47 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.142 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 115' ' ' PHE . 8.2 pt-20 -69.56 -22.07 63.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.191 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 109' ' ' LYS . 82.0 t -64.02 -35.24 72.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.403 0.62 . . . . 0.0 109.583 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.07 -27.66 54.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.81 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 118' ' ' PRO . 13.7 t80 -89.38 36.62 0.84 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.149 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 116' ' ' GLN . 5.8 pt20 -71.64 81.59 0.84 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.08 0.943 . . . . 0.0 111.27 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.546 ' H ' ' CD ' ' A' ' 118' ' ' PRO . . . 148.22 50.16 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.546 ' CD ' ' H ' ' A' ' 117' ' ' GLY . 11.2 Cg_endo -51.43 110.25 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.713 2.942 . . . . 0.0 113.718 -167.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -134.31 138.74 45.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.719 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -128.62 96.92 4.53 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.095 0.474 . . . . 0.0 110.873 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 29.0 p -97.5 92.59 6.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.67 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.5 tp -59.11 107.3 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 110.075 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.82 147.87 23.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.343 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -58.58 145.44 39.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.784 0.326 . . . . 0.0 110.415 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.483 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 11.6 m-90 -75.98 147.76 38.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 87' ' ' ALA . 1.6 pp -89.27 169.0 11.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.503 0.668 . . . . 0.0 112.069 -165.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -151.43 114.55 4.75 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.634 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.763 ' OXT' HG13 ' A' ' 33' ' ' ILE . 13.8 p . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 118.011 -0.995 . . . . 0.0 108.699 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 p -62.99 134.74 95.89 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.479 0.181 . . . . 0.0 110.537 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.66 63.88 3.04 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.959 2.439 . . . . 0.0 112.631 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.57 82.07 0.3 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.656 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.707 ' HB ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -92.39 154.93 42.79 Favored Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 122.102 0.161 . . . . 0.0 111.338 -177.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.603 ' HD3' HD11 ' A' ' 104' ' ' LEU . 38.3 Cg_endo -68.83 -86.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.457 2.105 . . . . 0.0 113.407 -172.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.86 107.4 54.65 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-O 121.392 0.615 . . . . 0.0 110.708 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.36 165.61 23.13 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 124.652 3.568 . . . . 0.0 113.257 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 100' ' ' HIS . . . 85.05 -63.54 4.37 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.578 169.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 63.8 mttm 83.03 -136.35 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.418 1.087 . . . . 0.0 111.546 -174.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.498 HG23 HD11 ' A' ' 99' ' ' ILE . 32.7 m -140.26 161.35 25.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.138 0.494 . . . . 0.0 112.152 -162.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 t -122.91 123.87 41.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.389 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.443 ' CD2' HD11 ' A' ' 99' ' ' ILE . 2.4 mm? -118.15 -166.68 1.24 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.805 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.652 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 93.1 mt-30 -127.67 149.67 50.1 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.908 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 23.9 mmtp -52.14 146.26 9.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.749 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.46 179.93 7.52 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.807 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.99 -22.2 60.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.119 0.485 . . . . 0.0 111.044 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.522 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -92.18 8.7 36.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.033 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 38.6 t30 72.61 11.72 5.52 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.335 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.577 HD22 ' OXT' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -127.13 -168.07 1.83 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.945 -0.472 . . . . 0.0 111.887 -174.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.677 HG23 HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -101.83 -26.87 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 99.08 33.41 5.49 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.144 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.71 HD11 HG23 ' A' ' 128' ' ' VAL . 2.8 pp -125.72 172.38 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.692 0.758 . . . . 0.0 112.126 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 40.0 m -139.14 127.65 23.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.24 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 66.0 mt -106.56 120.23 57.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.891 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.15 -160.21 9.42 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.434 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.32 143.09 17.48 Favored Glycine 0 C--N 1.319 -0.372 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.508 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 42' ' ' GLN . . . -70.86 -121.31 0.05 OUTLIER Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.621 169.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.668 ' H ' ' HA ' ' A' ' 45' ' ' PRO . . . 69.05 -18.67 0.18 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 44' ' ' CYS . 28.0 mm-40 -75.09 56.99 0.8 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 67.73 -7.01 0.62 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.726 0.81 . . . . 0.0 110.808 -174.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' A' ' 42' ' ' GLN . 59.6 m -137.78 92.24 13.04 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.345 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.668 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 52.6 Cg_exo -63.23 -153.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 123.914 3.076 . . . . 0.0 114.045 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 45' ' ' PRO . 76.5 m 70.68 122.98 0.03 OUTLIER 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -163.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -131.97 178.83 6.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.162 0.982 . . . . 0.0 113.067 -170.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.692 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 83.7 m-85 67.01 -80.82 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.657 -1.611 . . . . 0.0 110.71 -163.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.37 115.52 28.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.048 -177.21 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.6 t -111.79 -23.36 4.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.942 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -147.5 143.4 27.81 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.663 0.744 . . . . 0.0 112.402 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.5 p -143.05 160.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.758 -1.564 . . . . 0.0 109.395 174.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.561 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 22.8 m-85 -116.86 126.06 52.45 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 34.9 t70 -57.46 -21.99 40.69 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -164.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.492 ' HA ' HD23 ' A' ' 60' ' ' LEU . 42.5 m-80 -101.38 6.17 42.5 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.228 0.537 . . . . 0.0 110.23 -173.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.561 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 28.3 p -96.98 149.12 35.35 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -48.28 -40.08 35.27 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.183 1.922 . . . . 0.0 111.804 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.54 -54.16 50.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.967 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -73.95 -54.82 7.08 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.036 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -42.85 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.831 -177.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -95.6 -36.27 11.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.329 0.585 . . . . 0.0 111.026 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.46 -38.61 95.02 Favored Glycine 0 CA--C 1.517 0.159 0 CA-C-N 115.211 -0.904 . . . . 0.0 114.39 -167.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.11 56.19 4.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.049 0.928 . . . . 0.0 110.819 -174.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.602 HG11 HG13 ' A' ' 99' ' ' ILE . 16.3 m -128.39 49.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.581 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.92 179.28 7.58 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.295 -167.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.19 123.56 7.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.036 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.96 20.5 11.29 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.63 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.2 t0 -107.97 161.77 14.64 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 4.2 mp0 -101.98 124.51 47.73 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.031 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.414 ' H ' ' HB2' ' A' ' 48' ' ' TYR . 10.3 mm -113.31 141.89 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.465 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.568 HG22 ' CB ' ' A' ' 101' ' ' TYR . 12.0 t -137.44 -18.57 1.27 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.706 -0.621 . . . . 0.0 112.262 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -131.9 136.68 8.91 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.032 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.736 HG12 HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -101.15 121.86 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 124.011 0.925 . . . . 0.0 109.156 175.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.502 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 9.2 t-20 57.01 25.51 10.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.542 0.687 . . . . 0.0 110.355 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.87 -21.15 43.12 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.027 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -107.45 140.31 40.6 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 118.206 1.003 . . . . 0.0 111.024 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 23.1 t -52.93 137.12 33.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 111.755 -174.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.736 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -80.94 -17.83 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 109.499 -177.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -64.67 -13.58 54.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.523 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.71 -19.57 78.08 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.815 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.94 -130.7 0.14 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.732 0.766 . . . . 0.0 111.653 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 86' ' ' VAL . 2.8 m -139.11 156.09 47.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.565 -168.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.5 mtpt -47.85 -49.11 30.35 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.292 0.637 . . . . 0.0 111.676 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -58.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 122.454 1.121 . . . . 0.0 110.537 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 41.2 mt-10 -61.93 -30.95 71.25 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 112.94 -1.936 . . . . 0.0 112.615 -171.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.664 HG11 ' HB ' ' A' ' 78' ' ' ILE . 30.5 m -71.17 -42.26 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 126' ' ' LEU . . . -54.17 -41.18 68.2 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 170.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 28.5 ttpp -59.38 -48.48 81.48 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.616 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 89.0 mtp -51.97 -41.16 61.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.138 0.495 . . . . 0.0 110.866 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.551 HD13 HD11 ' A' ' 33' ' ' ILE . 92.6 mt -72.21 -41.28 66.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.231 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -76.05 -25.0 55.18 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.176 -0.327 . . . . 0.0 111.792 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.03 -51.66 65.91 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.52 151.2 8.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -132.05 144.42 50.74 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.151 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.1 -47.27 1.08 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.639 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 10.5 pt-20 -138.59 176.45 8.68 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.568 0.699 . . . . 0.0 111.182 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.677 HG11 HG23 ' A' ' 33' ' ' ILE . 5.5 m -149.65 158.29 6.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.06 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.502 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 24.7 m -142.41 125.08 15.87 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 170.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.602 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -102.9 139.22 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.641 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 0.7 OUTLIER -134.56 124.42 25.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.67 -179.464 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.568 ' CB ' HG22 ' A' ' 71' ' ' THR . 1.0 OUTLIER 169.98 -130.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 O-C-N 124.426 1.079 . . . . 0.0 110.014 166.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.707 ' ND2' ' HB ' ' A' ' 17' ' ' ILE . 4.5 m120 -172.66 -172.33 0.88 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -158.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.642 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 4.1 mptt -124.34 167.37 14.45 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 169.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 103' ' ' LYS . 4.1 pp 54.28 -150.12 0.41 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.112 0.883 . . . . 0.0 113.031 171.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.539 ' N ' HD12 ' A' ' 104' ' ' LEU . 35.3 tt0 80.32 71.76 0.03 OUTLIER 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.432 1.093 . . . . 0.0 109.537 -175.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.02 165.44 11.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.628 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 111' ' ' LEU . 8.4 m-20 -145.23 161.62 41.06 Favored Pre-proline 0 C--O 1.213 -0.821 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -31.36 -48.79 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.68 2.92 . . . . 0.0 114.032 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -57.08 -48.95 77.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.57 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 61.9 mm-40 -90.42 -13.42 34.96 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.677 0.751 . . . . 0.0 110.327 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.4 tm? -76.21 -38.21 56.74 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.238 -175.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -70.53 -25.89 63.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.394 0.616 . . . . 0.0 109.528 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 110' ' ' GLN . 96.5 t -67.02 -44.18 88.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.572 173.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 4.1 mm? -70.71 -21.67 62.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.758 176.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.9 -39.58 61.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.493 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -143.12 -65.82 0.38 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.308 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.724 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . 175.44 -46.6 0.13 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.124 -174.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.724 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 29.2 Cg_exo -9.08 77.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.297 1 C-N-CA 127.171 5.247 . . . . 0.0 116.832 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.468 HE21 HG21 ' A' ' 113' ' ' VAL . 8.0 tt0 -176.55 40.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -77.8 63.87 2.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.678 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 m -90.05 131.19 36.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.296 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.71 103.35 2.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.881 0.372 . . . . 0.0 110.417 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 123' ' ' ARG . 30.3 mmt180 -130.05 142.43 50.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.626 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.52 162.46 28.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.734 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -119.08 142.11 48.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.994 0.426 . . . . 0.0 110.366 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.559 ' HG ' ' HB ' ' A' ' 37' ' ' ILE . 1.2 pp -113.47 168.57 9.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 13.7 ptmm? -152.56 129.72 11.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.394 0.616 . . . . 0.0 110.918 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.71 HG23 HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.016 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 167.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.3 t -137.75 89.53 15.2 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.761 0.315 . . . . 0.0 110.374 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.58 -32.2 39.41 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.84 2.36 . . . . 0.0 112.618 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.38 -87.09 0.73 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.345 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 pt -71.4 150.92 94.1 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 123.107 -0.055 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.608 ' HG3' HD21 ' A' ' 104' ' ' LEU . 34.3 Cg_endo -65.15 -78.4 0.01 OUTLIER 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.313 2.009 . . . . 0.0 112.571 -172.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.09 115.02 61.88 Favored Pre-proline 0 N--CA 1.427 -1.584 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.33 130.63 30.96 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.105 2.536 . . . . 0.0 112.204 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.36 91.82 0.58 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.728 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -138.33 100.49 4.13 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.71 0.767 . . . . 0.0 110.007 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 HD11 ' A' ' 99' ' ' ILE . 34.8 m -122.06 145.97 27.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.306 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.1 t -117.47 110.9 18.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.721 0.772 . . . . 0.0 110.312 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.49 -164.72 0.97 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.371 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 92.3 mt-30 -131.04 144.36 51.39 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.363 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 29.5 mmtm -47.91 149.65 1.3 Allowed 'General case' 0 C--N 1.316 -0.878 0 O-C-N 124.641 1.213 . . . . 0.0 111.841 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -83.04 -178.59 7.17 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.94 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.77 -19.24 49.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.422 0.63 . . . . 0.0 110.647 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.533 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 3.9 mt-30 -92.8 11.38 27.18 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.626 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.551 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 1.2 p-10 56.82 24.07 8.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.013 1.325 . . . . 0.0 112.498 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.544 HD22 ' OXT' ' A' ' 128' ' ' VAL . 1.2 pp -130.57 -165.47 1.55 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.182 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.789 HG23 HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -101.75 -29.47 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 100.36 30.86 6.07 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.221 -0.514 . . . . 0.0 113.226 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.619 HD11 HG23 ' A' ' 128' ' ' VAL . 2.8 pp -122.85 179.71 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.061 0.457 . . . . 0.0 111.592 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 51.5 m -138.16 129.67 27.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.095 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.834 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 61.6 mt -97.46 139.47 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.854 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.74 -175.13 41.2 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.049 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.77 108.01 2.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.311 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.603 ' H ' ' HB3' ' A' ' 47' ' ' LEU . . . 97.74 106.39 2.48 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.51 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.504 ' HB3' ' HG2' ' A' ' 45' ' ' PRO . . . -59.65 -67.07 0.42 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.661 0.267 . . . . 0.0 110.862 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -94.42 -71.33 0.67 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -107.96 -59.84 1.79 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 170.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.515 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 47.3 t -171.5 61.77 0.34 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.12 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 0.9 OUTLIER -82.96 -50.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.323 2.015 . . . . 0.0 110.246 173.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 82.5 m -144.43 173.61 11.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.762 175.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.603 ' HB3' ' H ' ' A' ' 40' ' ' GLY . 0.1 OUTLIER -140.81 -172.94 3.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.023 0.916 . . . . 0.0 112.812 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.834 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 5.3 m-85 68.48 -37.86 0.36 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.222 -1.354 . . . . 0.0 114.034 -172.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -112.44 114.69 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 118.207 -1.397 . . . . 0.0 110.503 169.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.9 t -105.03 -30.26 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.258 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 3.8 pt20 -157.05 152.54 26.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.7 p -141.84 160.54 20.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.845 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 97.3 m-85 -114.51 125.92 54.35 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.675 0.75 . . . . 0.0 108.978 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -53.07 -27.59 20.84 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 125.143 1.377 . . . . 0.0 114.566 -165.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.54 ' HA ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -100.85 4.14 42.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.26 0.552 . . . . 0.0 110.463 -171.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.494 ' CB ' ' HA3' ' A' ' 34' ' ' GLY . 30.4 p -91.3 146.82 34.18 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -47.41 -39.11 28.07 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.255 1.97 . . . . 0.0 111.659 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.49 -54.26 49.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.744 -1.116 . . . . 0.0 112.256 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.575 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -75.14 -52.97 9.67 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.388 0.614 . . . . 0.0 110.138 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.1 tm? -43.09 -75.62 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.502 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -96.83 -43.95 7.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.185 0.517 . . . . 0.0 111.479 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.3 -27.75 60.86 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-N 115.019 -0.992 . . . . 0.0 114.822 -164.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.48 48.31 19.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.868 0.842 . . . . 0.0 111.449 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.6 HG11 HG13 ' A' ' 99' ' ' ILE . 6.1 m -123.8 53.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 CA-C-O 122.936 1.351 . . . . 0.0 109.481 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.8 173.95 10.25 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 112.485 -2.143 . . . . 0.0 111.2 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -51.25 122.36 7.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.889 -174.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.06 -4.97 16.01 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.71 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.625 ' O ' HG22 ' A' ' 49' ' ' ILE . 76.1 m-20 -98.85 172.81 7.2 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 30.7 tt0 -130.72 145.7 52.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.932 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 70' ' ' ILE . 4.2 mp -114.12 128.5 71.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.316 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.67 ' H ' ' HB2' ' A' ' 101' ' ' TYR . 7.3 t -109.03 -4.81 16.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.054 0.454 . . . . 0.0 110.586 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.76 133.43 3.41 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.459 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.694 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -103.15 120.81 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.477 HD21 ' HA ' ' A' ' 90' ' ' ILE . 96.3 m-20 53.78 29.92 10.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.238 0.542 . . . . 0.0 111.704 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.57 -21.59 41.98 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.914 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 14.7 ptm180 -101.27 137.34 39.74 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 118.061 0.93 . . . . 0.0 110.789 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m -65.91 151.39 46.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.063 0.458 . . . . 0.0 111.228 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.896 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -93.47 3.48 8.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 122.455 1.121 . . . . 0.0 108.685 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -78.94 80.88 5.26 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.549 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.59 -30.49 0.41 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.688 -1.244 . . . . 0.0 115.012 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.896 ' HE2' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -112.35 -145.05 0.39 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.844 1.322 . . . . 0.0 112.088 -172.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.548 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -134.71 151.8 51.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.14 -178.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.611 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -45.44 -54.68 7.04 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.159 0.583 . . . . 0.0 112.341 175.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 p -51.69 -31.67 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.166 0.508 . . . . 0.0 111.981 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 89' ' ' MET . 32.4 mt-10 -81.89 -40.22 22.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.005 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.611 HG22 ' HA ' ' A' ' 83' ' ' LYS . 29.9 m -70.55 -38.25 72.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.538 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.746 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -53.17 -42.37 66.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.173 169.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -64.76 -50.77 65.51 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.717 175.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 62.4 mtt -50.74 -41.31 56.28 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.569 0.543 . . . . 0.0 111.045 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.752 HD13 HD11 ' A' ' 33' ' ' ILE . 74.4 mt -65.11 -56.42 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.254 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.551 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 10.3 pt20 -73.12 -24.59 60.64 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.713 -175.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.566 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 32.2 tt0 -58.7 -53.25 60.48 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.713 0.805 . . . . 0.0 111.976 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 90' ' ' ILE . 12.4 m -56.33 -29.02 27.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.292 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 92' ' ' GLU . 57.4 mttp 61.25 148.73 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.613 0.72 . . . . 0.0 112.609 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.409 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 86.55 -53.45 4.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.407 169.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 10.0 pt-20 -129.06 175.08 8.98 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.158 0.504 . . . . 0.0 110.19 -172.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.789 HG11 HG23 ' A' ' 33' ' ' ILE . 5.7 m -151.37 151.9 11.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.648 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.8 m -141.44 117.51 10.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.798 0.332 . . . . 0.0 110.741 170.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.6 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -98.63 148.74 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.17 176.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 1.1 m-70 -143.54 116.39 8.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.67 ' HB2' ' H ' ' A' ' 71' ' ' THR . 1.3 t80 178.63 -116.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.615 0.572 . . . . 0.0 111.139 162.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 1.1 p-10 -161.47 175.68 11.9 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.135 -163.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 102' ' ' ASN . 53.0 mmtt -120.45 35.6 4.82 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -171.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.608 HD21 ' HG3' ' A' ' 18' ' ' PRO . 4.3 pp -178.89 157.07 0.86 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.176 0.512 . . . . 0.0 111.629 175.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 15.6 mm-40 -123.54 16.45 9.62 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.66 0.743 . . . . 0.0 109.245 171.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 73.52 -101.94 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.155 -1.384 . . . . 0.0 113.265 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.443 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 15.2 t70 -154.11 146.78 17.63 Favored Pre-proline 0 C--O 1.205 -1.237 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.031 -169.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 15.6 Cg_exo -29.3 -51.74 0.17 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 124.537 3.491 . . . . 0.0 115.424 -174.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.7 pttm -57.77 -48.15 80.49 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.356 0.598 . . . . 0.0 111.716 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.9 mm100 -83.37 -17.8 41.06 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.519 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.4 tm? -64.74 -48.36 74.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.076 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 115' ' ' PHE . 3.4 pt-20 -70.54 -25.24 63.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.794 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.8 t -69.6 -45.62 77.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.435 0.636 . . . . 0.0 109.787 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.53 -17.28 58.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.137 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 43.4 t80 -91.74 9.36 32.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.393 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -77.78 10.53 2.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.212 0.529 . . . . 0.0 110.481 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -141.54 -63.33 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -30.16 108.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 124.579 3.519 . . . . 0.0 113.546 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -96.73 105.65 17.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.565 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.414 ' CD1' ' HZ ' ' A' ' 115' ' ' PHE . 3.1 p90 -69.58 118.78 12.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.436 0.636 . . . . 0.0 110.053 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.43 76.63 1.87 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.95 77.97 8.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 17.6 ptp180 -166.48 107.03 0.67 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.76 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 123' ' ' ARG . 63.0 m-70 70.29 143.35 0.05 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.408 0.623 . . . . 0.0 111.406 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -82.21 137.29 34.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.106 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.779 HD13 ' N ' ' A' ' 127' ' ' LYS . 1.5 tm? -111.33 161.21 16.29 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.779 ' N ' HD13 ' A' ' 126' ' ' LEU . 21.8 ptmt -167.0 127.13 1.5 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.532 0.682 . . . . 0.0 111.422 176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.845 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 163.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 112.009 -0.436 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 m 57.94 70.13 1.36 Allowed Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 122.817 0.447 . . . . 0.0 111.114 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.45 53.57 4.27 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.84 2.36 . . . . 0.0 112.465 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.63 -62.08 3.55 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.062 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.5 pt -110.36 152.71 43.44 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.556 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 51.0 Cg_endo -70.1 -61.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.714 1.609 . . . . 0.0 112.105 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.3 93.98 7.53 Favored Pre-proline 0 N--CA 1.441 -0.922 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 173.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.21 138.22 46.33 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.699 2.266 . . . . 0.0 112.557 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.93 144.82 12.06 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.274 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -157.54 129.84 7.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 62' ' ' GLY . 20.7 m -126.54 146.9 31.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.864 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 t -110.95 116.04 30.52 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.726 0.774 . . . . 0.0 110.77 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.502 ' H ' HG22 ' A' ' 97' ' ' VAL . 7.3 mt -123.32 -166.89 1.52 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.646 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.659 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 2.0 pt20 -144.01 142.6 30.78 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.766 174.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HE3' HG12 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -32.87 149.74 0.01 OUTLIER 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 177.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -87.46 -179.25 6.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.655 -1.612 . . . . 0.0 108.385 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.58 -29.04 61.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.59 0.632 . . . . 0.0 111.499 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.558 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.2 mt-30 -88.05 5.36 41.35 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.043 0.449 . . . . 0.0 110.603 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 63.9 t30 70.28 28.22 3.92 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.349 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.683 ' HB2' ' OXT' ' A' ' 128' ' ' VAL . 1.8 pt? -128.19 -171.26 2.41 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.785 175.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.841 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -104.58 -26.21 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.715 179.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' N ' ' HG ' ' A' ' 32' ' ' LEU . . . 96.17 40.43 4.01 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.386 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.548 HD11 HG12 ' A' ' 128' ' ' VAL . 2.9 pp -129.64 176.74 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.968 0.89 . . . . 0.0 112.305 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 24.0 m -144.72 126.87 15.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.731 172.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.5 mt -103.32 119.9 52.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.246 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.39 134.99 11.89 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.824 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.08 162.31 12.68 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.623 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' ' HG ' ' A' ' 47' ' ' LEU . . . -70.05 -143.41 0.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.799 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 121' ' ' THR . . . -174.71 -84.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.66 0.267 . . . . 0.0 110.596 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -97.54 -14.62 20.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 110.201 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -87.74 -73.58 0.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 p -158.05 97.72 1.85 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.177 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.571 ' HG2' ' O ' ' A' ' 119' ' ' GLN . 81.8 Cg_exo -49.57 146.62 14.52 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.221 2.614 . . . . 0.0 112.725 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 84.3 m 70.37 125.95 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 O-C-N 124.261 0.976 . . . . 0.0 109.598 -165.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.526 ' O ' ' HG3' ' A' ' 69' ' ' GLU . 13.2 mt -140.16 -93.44 0.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.652 0.739 . . . . 0.0 110.888 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 49.2 p90 -144.01 174.58 10.73 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.347 -168.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.709 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -77.63 121.01 29.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.23 178.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.7 m -94.31 -20.51 6.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.691 -170.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -157.07 136.24 11.92 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.505 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.7 p -139.88 160.28 26.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.16 -138.55 0.2 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -138.24 -39.37 0.54 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.765 0.711 . . . . 0.0 112.145 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -101.32 4.09 41.3 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.762 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 59.9 p -84.14 148.04 52.27 Favored Pre-proline 0 N--CA 1.433 -1.285 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.0 Cg_endo -49.7 -42.18 43.93 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.764 1.643 . . . . 0.0 111.22 -176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.576 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.6 -46.48 84.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.019 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.76 -59.13 2.87 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.346 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.6 pp -51.16 -74.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -171.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.604 ' N ' HD12 ' A' ' 60' ' ' LEU . 21.7 t70 -93.74 -15.4 25.23 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.544 1.164 . . . . 0.0 108.081 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -64.39 -48.39 74.51 Favored Glycine 0 C--N 1.313 -0.704 0 CA-C-N 112.818 -1.992 . . . . 0.0 114.524 -166.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.1 p 63.64 15.78 9.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.078 0.951 . . . . 0.0 111.006 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG11 HG13 ' A' ' 99' ' ' ILE . 16.7 m -96.92 53.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-O 123.0 1.381 . . . . 0.0 110.028 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.21 168.52 14.69 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 112.512 -2.131 . . . . 0.0 111.39 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.66 122.54 6.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.832 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.64 -14.64 11.65 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.009 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.709 ' O ' HG22 ' A' ' 49' ' ' ILE . 43.4 m-20 -90.55 146.15 24.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.2 0.5 . . . . 0.0 110.167 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 47' ' ' LEU . 33.1 tt0 -89.4 126.48 35.57 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.682 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.5 mm -94.42 120.27 43.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -110.97 -21.68 11.88 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.832 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.78 156.06 27.72 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.398 -1.382 . . . . 0.0 113.869 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -121.9 124.63 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 C-N-CA 123.573 0.749 . . . . 0.0 109.186 178.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.466 ' HA ' ' OG1' ' A' ' 98' ' ' THR . 6.9 t-20 58.28 22.57 9.43 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.583 0.706 . . . . 0.0 111.192 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.44 -20.01 50.23 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.109 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 11.3 ptp180 -101.99 130.17 48.46 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 117.292 0.546 . . . . 0.0 110.619 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.6 m -63.66 153.52 35.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.021 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -93.08 -30.93 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 110.417 -178.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -71.44 91.26 1.02 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.552 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.54 -21.51 0.33 Allowed Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.799 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -125.83 -131.08 0.25 Allowed 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.245 177.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -137.48 147.36 45.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.927 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.546 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -46.32 -49.49 17.55 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.598 0.759 . . . . 0.0 112.527 176.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -57.26 -39.9 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.831 0.348 . . . . 0.0 111.623 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.46 -41.48 66.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.943 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 83' ' ' LYS . 32.8 m -67.63 -45.21 85.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.897 0.38 . . . . 0.0 110.815 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.25 -34.59 75.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.261 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.61 -51.16 68.39 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.424 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.2 mmt -53.04 -36.65 60.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.62 0.724 . . . . 0.0 111.416 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.449 HD13 HD11 ' A' ' 33' ' ' ILE . 44.6 mt -72.64 -31.86 38.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.753 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -90.37 -23.51 21.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.8 -49.45 62.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.946 0.499 . . . . 0.0 111.097 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.88 -32.32 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.718 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 62.32 119.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.659 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 96.97 -33.22 5.9 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.194 173.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.3 pt-20 -134.86 178.76 6.77 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 117.177 0.489 . . . . 0.0 110.501 -171.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.581 HG12 ' HE3' ' A' ' 27' ' ' LYS . 1.2 m -152.48 148.74 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.159 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -141.27 106.93 5.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.469 172.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.588 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -100.0 141.99 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.051 0.453 . . . . 0.0 111.705 -178.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -118.5 121.36 40.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -136.52 174.73 10.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.053 0.454 . . . . 0.0 111.614 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -166.47 -169.8 1.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HE3' ' OD1' ' A' ' 68' ' ' ASP . 10.3 mptt -144.4 97.34 3.02 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.556 ' HG ' ' HG3' ' A' ' 18' ' ' PRO . 5.7 mt -127.91 134.91 49.38 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -172.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -140.99 98.64 3.42 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.788 164.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.83 163.95 8.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.075 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -125.65 155.87 71.72 Favored Pre-proline 0 C--O 1.215 -0.761 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -30.66 -55.39 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.915 3.077 . . . . 0.0 114.721 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.54 ' O ' HG23 ' A' ' 113' ' ' VAL . 5.9 ptpp? -56.48 -47.12 79.9 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.242 0.544 . . . . 0.0 112.311 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.481 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.3 mm100 -87.84 -17.02 32.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.895 -175.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.425 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -77.8 -45.32 24.79 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.021 -177.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -63.92 -27.27 69.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.215 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 109' ' ' LYS . 77.0 t -61.0 -41.38 88.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.14 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.79 -24.61 41.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.544 0.688 . . . . 0.0 109.802 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -92.69 30.38 1.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.413 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -89.75 11.49 19.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.017 0.437 . . . . 0.0 110.648 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.519 ' H ' ' HD3' ' A' ' 118' ' ' PRO . . . 151.5 51.87 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.519 ' HD3' ' H ' ' A' ' 117' ' ' GLY . 38.4 Cg_endo -61.64 -17.96 57.37 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.419 2.746 . . . . 0.0 113.478 -169.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.571 ' O ' ' HG2' ' A' ' 45' ' ' PRO . 35.0 tt0 67.71 87.81 0.12 Allowed 'General case' 0 N--CA 1.462 0.168 0 O-C-N 123.75 0.656 . . . . 0.0 110.131 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.79 91.79 0.2 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.964 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.696 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 3.5 p -140.61 134.73 30.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.962 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.435 HD13 ' HB1' ' A' ' 41' ' ' ALA . 3.3 mm? -71.96 106.04 4.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.395 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.459 ' HE ' ' HA ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -102.05 103.3 13.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.17 0.509 . . . . 0.0 111.166 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -71.68 168.46 17.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.898 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -80.38 115.95 20.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.463 ' HB3' ' HE3' ' A' ' 83' ' ' LYS . 1.6 pp -89.12 168.56 12.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.043 175.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.452 ' C ' ' HD2' ' A' ' 127' ' ' LYS . 0.1 OUTLIER -143.49 154.49 43.7 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.841 ' OXT' HG13 ' A' ' 33' ' ' ILE . 7.1 p . . . . . 0 C--O 1.247 0.93 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.804 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.7 t -121.44 127.47 26.09 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.08 10.31 1.78 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.714 2.276 . . . . 0.0 112.541 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.31 -61.44 4.71 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -107.01 150.95 40.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.822 0.344 . . . . 0.0 110.359 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.431 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 30.9 Cg_endo -86.7 -152.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.384 2.723 . . . . 0.0 111.843 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 1.5 t -34.08 122.55 0.51 Allowed Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.864 0.866 . . . . 0.0 112.67 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 19' ' ' VAL . 10.6 Cg_endo -90.95 128.74 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 123.528 2.819 . . . . 0.0 112.243 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.07 143.68 17.46 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -155.48 127.63 7.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.77 0.285 . . . . 0.0 110.352 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.466 HG23 HD11 ' A' ' 99' ' ' ILE . 27.2 m -128.71 158.65 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.152 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.9 t -132.72 117.32 17.7 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.652 0.739 . . . . 0.0 110.656 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.11 -159.25 0.9 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.875 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 96' ' ' GLU . 31.9 mm-40 -122.57 158.26 30.31 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.625 0.726 . . . . 0.0 110.114 175.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.589 ' NZ ' ' HA ' ' A' ' 91' ' ' GLN . 11.4 mmmm -54.4 156.69 3.17 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.082 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.57 174.97 7.47 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.3 -15.56 36.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.224 0.535 . . . . 0.0 110.556 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.479 ' NE2' HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -91.38 -0.49 57.65 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.746 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.508 ' C ' ' HE2' ' A' ' 27' ' ' LYS . 31.1 t30 70.06 38.05 1.59 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.427 1.108 . . . . 0.0 109.897 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -154.57 -167.35 2.59 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.572 175.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.738 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.26 -28.93 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.945 -177.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 100.4 35.11 4.52 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.608 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.505 HG22 HG23 ' A' ' 52' ' ' VAL . 2.7 pp -126.92 177.96 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.269 0.557 . . . . 0.0 111.633 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -134.76 128.19 32.39 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.626 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.772 ' HB ' HD12 ' A' ' 126' ' ' LEU . 56.2 mt -107.47 140.79 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.469 0.652 . . . . 0.0 111.912 -173.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 48' ' ' TYR . . . 177.94 -170.51 42.8 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.978 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.28 153.48 17.01 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.94 -72.76 0.44 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.386 -0.912 . . . . 0.0 112.697 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -83.0 81.07 8.83 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 10.5 pt20 55.84 -70.38 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.401 1.48 . . . . 0.0 113.826 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 123' ' ' ARG . 54.9 p90 -154.53 16.97 0.46 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.778 0.717 . . . . 0.0 111.595 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 56.4 m -91.07 -49.21 0.34 Allowed Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.978 -174.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 44' ' ' CYS . 94.8 Cg_endo -99.7 -163.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.09 1.86 . . . . 0.0 111.972 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.6 m -117.79 -179.74 3.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.389 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 48' ' ' TYR . 4.2 pp 149.27 -40.51 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.134 2.173 . . . . 0.0 107.262 171.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.761 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 78.8 m-85 62.69 -22.33 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 174.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.536 ' HB ' ' CG1' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -110.85 109.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 120.338 1.426 . . . . 0.0 110.218 171.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -95.62 -30.55 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.206 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -155.49 139.87 16.75 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.453 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.2 p -138.33 161.2 31.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -99.33 -135.05 0.28 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 15.7 t70 -138.4 -33.41 0.68 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -101.61 1.82 38.19 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.062 0.458 . . . . 0.0 110.366 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 77.9 p -85.33 150.18 53.92 Favored Pre-proline 0 N--CA 1.44 -0.956 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.16 -40.39 77.31 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.295 1.33 . . . . 0.0 111.197 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.42 -46.28 86.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.741 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.63 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -73.62 -58.4 3.33 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.672 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 61' ' ' ASP . 2.1 pp -52.95 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -170.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.647 ' N ' HD12 ' A' ' 60' ' ' LEU . 24.0 t70 -95.99 -16.32 21.75 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.262 1.029 . . . . 0.0 108.487 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -61.21 -38.71 96.09 Favored Glycine 0 C--N 1.315 -0.586 0 CA-C-N 113.019 -1.901 . . . . 0.0 113.594 -169.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p 52.31 38.38 24.76 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.415 1.102 . . . . 0.0 111.774 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.496 HG11 HG13 ' A' ' 99' ' ' ILE . 12.4 m -118.17 54.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.832 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.514 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -84.49 168.64 15.27 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 112.716 -2.038 . . . . 0.0 111.778 -170.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.89 132.09 26.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.669 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.0 2.64 57.03 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.648 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 101' ' ' TYR . 1.7 t70 -90.77 167.89 12.14 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.97 89.52 3.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.536 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 25.0 mm -78.34 110.0 13.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.893 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -102.3 -7.57 21.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.129 -175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -151.88 135.37 4.99 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.384 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.657 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -103.57 120.83 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 123.615 0.766 . . . . 0.0 109.217 179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.3 t30 55.1 32.81 19.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.952 0.882 . . . . 0.0 110.472 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.83 -21.29 44.39 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.405 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.415 ' H ' ' HG2' ' A' ' 76' ' ' ARG . 2.5 ptm180 -108.17 138.58 44.2 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 117.132 0.466 . . . . 0.0 110.484 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.487 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 17.7 t -59.58 142.51 52.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.89 0.376 . . . . 0.0 111.892 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.657 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -74.89 -22.71 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -64.38 99.35 0.29 Allowed 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.814 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.2 -30.63 1.75 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.942 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.628 ' HE3' ' SD ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -125.26 -139.27 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.795 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -141.25 159.88 41.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.896 -169.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.586 ' O ' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -49.38 -52.79 26.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.503 0.502 . . . . 0.0 110.865 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -53.94 -38.71 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.893 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 34.2 mt-10 -76.28 -39.58 53.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.567 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 83' ' ' LYS . 34.7 m -69.61 -39.31 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.299 . . . . 0.0 111.389 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.54 -43.64 62.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.326 168.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 28.5 ttpp -61.59 -46.58 89.25 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.495 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.628 ' SD ' ' HE3' ' A' ' 81' ' ' LYS . 74.1 mtp -56.3 -35.14 67.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.43 0.633 . . . . 0.0 110.482 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 93' ' ' VAL . 27.9 mm -73.7 -32.3 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.387 177.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.589 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 56.0 mt-30 -82.74 -24.67 33.44 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.754 -0.591 . . . . 0.0 111.899 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -64.25 -39.49 94.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.286 0.634 . . . . 0.0 111.895 -171.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.536 HG23 ' N ' ' A' ' 94' ' ' LYS . 3.7 m -35.48 -47.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.114 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.536 ' N ' HG23 ' A' ' 93' ' ' VAL . 55.4 mtmt 57.08 83.29 0.1 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.496 -162.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.538 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 115.47 -36.73 3.75 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 118.785 -1.674 . . . . 0.0 113.675 164.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.506 ' HA ' ' NE2' ' A' ' 26' ' ' GLN . 11.7 pt-20 -106.13 172.35 6.86 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 117.716 0.758 . . . . 0.0 110.127 -173.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 t -153.4 127.87 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.448 -171.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.0 m -141.04 135.75 31.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.496 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -130.87 140.67 48.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.801 0.334 . . . . 0.0 111.808 -177.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -116.99 122.57 44.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.411 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 40.2 p90 -138.85 157.16 46.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.073 0.463 . . . . 0.0 111.582 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -139.83 -179.23 5.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.617 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -107.69 166.96 10.3 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.0 -177.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 103' ' ' LYS . 4.0 pp 56.66 115.2 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.87 1.356 . . . . 0.0 114.506 170.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.49 30.37 0.75 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.019 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -100.06 148.63 24.34 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.122 0.963 . . . . 0.0 112.299 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.501 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 16.7 m-20 -151.65 168.62 10.8 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 107' ' ' ASP . 12.8 Cg_exo -31.51 -46.86 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.904 2.403 . . . . 0.0 113.959 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.1 ptpt -68.83 -48.23 64.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.511 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.492 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.5 mm100 -84.92 -11.77 54.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.438 0.637 . . . . 0.0 110.968 -174.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.434 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.1 tm? -70.02 -43.37 71.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.339 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -73.16 -30.72 63.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.271 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 118' ' ' PRO . 84.3 t -63.71 -36.1 75.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.473 0.654 . . . . 0.0 109.902 175.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.6 tp -77.86 -27.02 49.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.244 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -58.77 -40.9 85.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.075 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -141.57 -67.57 0.4 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.222 0.534 . . . . 0.0 109.876 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.781 ' H ' ' CD ' ' A' ' 118' ' ' PRO . . . 147.06 39.3 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.246 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.781 ' CD ' ' H ' ' A' ' 117' ' ' GLY . 18.6 Cg_endo -54.65 114.35 1.8 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.964 2.443 . . . . 0.0 112.579 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -88.88 62.05 6.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.669 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -77.42 -23.39 50.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.937 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 p -99.2 129.32 45.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.124 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.4 tp -98.17 -85.2 0.38 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.391 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.585 ' HG2' ' H ' ' A' ' 124' ' ' HIS . 44.9 ttt180 60.85 179.73 0.1 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.003 0.43 . . . . 0.0 110.6 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.585 ' H ' ' HG2' ' A' ' 123' ' ' ARG . 62.9 t60 -102.36 109.68 21.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 173.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -81.23 -179.35 7.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.262 0.554 . . . . 0.0 111.139 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.772 HD12 ' HB ' ' A' ' 37' ' ' ILE . 2.0 mt -95.6 169.03 10.32 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.972 172.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -157.51 80.75 0.89 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.194 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.738 ' OXT' HG13 ' A' ' 33' ' ' ILE . 9.1 p . . . . . 0 N--CA 1.438 -1.068 0 CA-C-O 117.575 -1.203 . . . . 0.0 108.724 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.802 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.524 ' HB3' HD13 ' A' ' 17' ' ' ILE . 32.9 t -75.6 118.36 70.36 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.69 99.18 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.482 2.121 . . . . 0.0 111.792 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 151.25 -23.34 0.97 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.651 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 14' ' ' SER . 3.9 pt -90.16 151.55 44.96 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.511 ' HD3' HD11 ' A' ' 104' ' ' LEU . 46.3 Cg_endo -76.93 -75.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.973 1.782 . . . . 0.0 112.708 -171.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.7 93.9 15.49 Favored Pre-proline 0 N--CA 1.439 -0.994 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.293 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HB3' HD11 ' A' ' 17' ' ' ILE . 46.5 Cg_endo -83.05 130.68 5.69 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.755 2.303 . . . . 0.0 112.407 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.53 152.22 20.85 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.101 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -160.09 137.19 9.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 62' ' ' GLY . 29.8 m -128.04 152.93 36.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.5 t -118.41 123.07 44.33 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.631 0.729 . . . . 0.0 110.571 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -130.51 -165.22 1.52 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.536 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -133.28 142.93 48.75 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.326 0.584 . . . . 0.0 110.513 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.63 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 2.5 mmmm -43.09 146.95 0.37 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.487 -1.688 . . . . 0.0 112.637 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -85.09 177.8 7.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.798 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.14 -21.77 48.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.909 0.385 . . . . 0.0 111.45 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.55 ' NE2' HD21 ' A' ' 32' ' ' LEU . 5.0 tt0 -92.88 15.11 15.56 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.123 0.487 . . . . 0.0 110.231 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.473 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 1.2 p-10 54.5 35.31 23.05 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.527 1.131 . . . . 0.0 111.583 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.708 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -140.76 -171.16 3.18 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.376 174.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.827 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -97.96 -31.07 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-O 120.682 0.277 . . . . 0.0 111.039 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' N ' HD13 ' A' ' 32' ' ' LEU . . . 102.5 37.64 3.22 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.324 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 2.3 pp -126.91 173.37 12.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.131 0.491 . . . . 0.0 110.72 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.4 m -134.86 130.55 36.16 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.782 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.796 ' HB ' HD12 ' A' ' 126' ' ' LEU . 40.7 mm -114.15 128.91 70.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.73 0.776 . . . . 0.0 111.838 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 47' ' ' LEU . . . -138.42 168.27 24.72 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.582 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 47' ' ' LEU . . . -73.27 143.97 33.83 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.411 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.477 ' H ' ' HB3' ' A' ' 47' ' ' LEU . . . -60.92 -52.36 52.79 Favored Glycine 0 CA--C 1.502 -0.742 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 174.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.573 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -124.04 -163.38 1.14 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 166.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -80.9 -46.04 15.84 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.361 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -154.86 46.16 0.53 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.618 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 3.7 m -138.23 -74.03 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 44' ' ' CYS . 43.4 Cg_endo -95.42 -164.92 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.215 1.943 . . . . 0.0 113.333 -169.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.485 ' SG ' ' HG3' ' A' ' 105' ' ' GLN . 61.8 m -76.32 -175.31 3.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.954 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -134.48 179.41 6.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.568 0.699 . . . . 0.0 112.093 -174.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.501 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 48.4 p90 -145.19 174.74 10.82 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.579 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -88.03 118.83 34.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.02 -34.6 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.833 -170.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -155.84 144.41 20.25 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 120.764 0.316 . . . . 0.0 110.487 -171.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.7 p -139.14 160.18 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -92.02 -136.19 0.15 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.448 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 8.6 t70 -139.73 -38.26 0.47 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.617 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -100.91 3.87 42.15 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.036 0.446 . . . . 0.0 110.324 -173.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 61.7 p -82.62 151.26 64.62 Favored Pre-proline 0 N--CA 1.439 -0.988 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.5 -40.75 71.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.299 1.333 . . . . 0.0 111.269 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -59.16 -44.31 92.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.255 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.646 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -78.33 -55.94 4.85 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.836 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.7 pp -52.66 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -171.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.607 ' N ' HD12 ' A' ' 60' ' ' LEU . 29.4 t70 -95.78 -12.73 24.89 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.441 1.115 . . . . 0.0 108.12 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -65.36 -45.46 90.54 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 112.969 -1.923 . . . . 0.0 113.497 -170.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p 62.93 9.51 3.77 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.069 0.948 . . . . 0.0 111.498 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.689 HG11 HG13 ' A' ' 99' ' ' ILE . 19.1 m -89.68 53.53 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 CA-C-O 123.001 1.382 . . . . 0.0 110.166 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.441 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -84.29 169.99 14.13 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.622 -2.081 . . . . 0.0 111.459 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.48 129.87 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.143 -174.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.7 -22.24 10.11 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.673 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -80.4 161.48 24.95 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.339 -177.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.446 ' OE2' ' HA ' ' A' ' 104' ' ' LEU . 27.4 tt0 -110.44 120.89 43.88 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.8 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.0 mm -89.63 123.75 41.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.588 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.459 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 7.6 t -103.15 -29.77 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -175.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -163.51 151.16 20.54 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.905 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.607 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -107.72 122.53 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.442 ' ND2' HG11 ' A' ' 93' ' ' VAL . 5.2 m-20 50.62 31.6 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.66 -20.66 45.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.637 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 18.8 ptp180 -100.23 124.39 45.61 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 117.502 0.651 . . . . 0.0 110.279 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.402 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 21.1 m -61.15 149.83 36.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.999 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.604 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -81.76 -17.55 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.567 0.698 . . . . 0.0 109.55 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HE2' ' SG ' ' A' ' 46' ' ' CYS . 37.9 ttmt -61.69 -24.14 66.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.636 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.45 -12.69 80.0 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.182 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -137.35 -131.51 0.14 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.531 0.666 . . . . 0.0 110.619 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' HG13 ' A' ' 86' ' ' VAL . 4.3 p -146.8 166.09 27.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.364 0.126 . . . . 0.0 111.046 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -49.72 -53.33 25.4 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.662 0.601 . . . . 0.0 112.406 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -56.08 -37.73 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.66 -38.86 58.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.529 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.604 HG11 ' HB ' ' A' ' 78' ' ' ILE . 26.6 m -71.13 -44.03 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.955 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.21 62.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.289 170.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.21 -52.48 63.59 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.284 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.8 mmt -54.06 -43.23 70.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 0.0 112.02 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.95 -39.59 82.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.067 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.82 -36.16 57.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 122.362 -0.211 . . . . 0.0 111.443 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.83 -44.08 90.84 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.308 0.643 . . . . 0.0 110.892 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 93' ' ' VAL . 13.8 m -70.18 71.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 122.878 1.323 . . . . 0.0 110.203 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.34 126.3 26.97 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.596 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.63 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 100.66 -27.16 21.8 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.515 170.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.16 171.87 9.48 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 117.39 0.595 . . . . 0.0 110.083 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.494 HG21 HG23 ' A' ' 33' ' ' ILE . 2.1 t -157.19 128.17 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.742 -171.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.4 m -140.32 106.47 5.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.038 0.447 . . . . 0.0 110.908 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.689 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -97.18 147.81 6.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.064 -177.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -130.88 123.38 28.86 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -133.65 144.76 49.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 0.0 111.421 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.464 ' ND2' HD12 ' A' ' 17' ' ' ILE . 24.6 m-20 -135.26 -172.19 3.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -101.62 -4.82 25.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.239 0.542 . . . . 0.0 109.66 174.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.511 HD11 ' HD3' ' A' ' 18' ' ' PRO . 4.3 pp -177.25 163.01 2.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.873 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.485 ' HG3' ' SG ' ' A' ' 46' ' ' CYS . 13.0 pt20 -155.3 66.48 0.64 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.267 0.555 . . . . 0.0 111.498 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.45 156.59 39.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.522 0.677 . . . . 0.0 111.454 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.402 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 16.5 m-20 -133.95 158.7 74.78 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.54 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 22.4 Cg_exo -31.8 -52.57 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.678 2.919 . . . . 0.0 114.07 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.0 ptmt -62.25 -48.51 79.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.015 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.474 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 71.6 mm-40 -81.4 -19.45 42.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.712 0.768 . . . . 0.0 110.153 -174.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.31 -51.17 13.86 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.204 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 4.7 pt-20 -70.77 -34.6 71.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.879 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.525 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 2.9 p -65.14 -38.37 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.283 -176.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.75 -28.04 36.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.511 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -58.68 -45.88 88.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.508 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -67.07 -33.1 74.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.608 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.77 62.59 0.54 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 113' ' ' VAL . 18.0 Cg_endo -56.86 -69.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.418 2.745 . . . . 0.0 112.988 -173.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -144.67 -78.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.503 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.465 ' CZ ' HD22 ' A' ' 47' ' ' LEU . 8.0 t80 45.45 73.02 0.18 Allowed 'General case' 0 CA--C 1.53 0.198 0 O-C-N 124.254 0.971 . . . . 0.0 111.629 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.8 p -87.55 119.79 28.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.829 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.7 mt -94.81 138.57 32.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -146.95 111.58 5.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.759 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 76.1 t60 72.16 126.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.986 0.804 . . . . 0.0 112.164 174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -72.54 137.43 46.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.796 HD12 ' HB ' ' A' ' 37' ' ' ILE . 12.2 mt -91.21 168.75 11.38 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -167.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -165.78 85.62 0.35 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 110.996 -2.82 . . . . 0.0 109.057 175.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.827 ' OXT' HG13 ' A' ' 33' ' ' ILE . 6.0 p . . . . . 0 C--O 1.246 0.872 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.287 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 t -154.92 91.85 2.91 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.55 -14.46 19.98 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.586 2.191 . . . . 0.0 112.342 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.7 -90.07 0.95 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.456 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -73.69 157.57 87.34 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.682 ' HG3' HD21 ' A' ' 104' ' ' LEU . 51.2 Cg_endo -68.5 -101.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.192 1.928 . . . . 0.0 114.528 -164.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.504 ' N ' HD21 ' A' ' 102' ' ' ASN . 49.3 t -86.61 107.55 14.27 Favored Pre-proline 0 N--CA 1.446 -0.645 0 CA-C-N 118.553 0.615 . . . . 0.0 110.422 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -48.84 123.21 9.35 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 124.343 3.362 . . . . 0.0 114.549 -167.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.09 110.82 2.15 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.155 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -168.36 138.26 2.48 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.492 HG23 HD11 ' A' ' 99' ' ' ILE . 29.2 m -140.53 158.72 24.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 t -124.37 125.79 44.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.163 0.506 . . . . 0.0 110.751 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.44 -169.28 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.763 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 91.0 mt-30 -132.9 149.21 52.27 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.417 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.634 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 8.6 mmtp -47.24 146.37 1.93 Allowed 'General case' 0 C--N 1.313 -1.004 0 O-C-N 124.629 1.206 . . . . 0.0 112.344 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.427 ' HB2' ' HD2' ' A' ' 57' ' ' PRO . 27.2 t70 -82.88 177.94 8.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.115 176.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.03 -19.78 61.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.185 0.517 . . . . 0.0 110.419 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.449 ' NE2' HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -89.49 3.84 51.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.241 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.9 15.72 5.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.68 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.516 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -131.43 -163.69 1.36 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.642 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.851 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.51 -23.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.8 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.86 36.13 4.87 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.918 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.51 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.6 pp -125.91 168.53 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.903 0.859 . . . . 0.0 111.564 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 44.9 m -134.43 131.77 38.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.499 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.685 ' O ' ' HB3' ' A' ' 126' ' ' LEU . 76.3 mt -117.75 130.67 72.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.57 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.89 125.32 3.38 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.633 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.73 116.26 4.8 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.07 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.37 -167.12 4.21 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.435 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.6 -19.15 64.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 13.4 mm-40 68.88 -46.17 0.55 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.655 0.782 . . . . 0.0 111.362 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -55.53 -16.04 3.46 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.822 0.849 . . . . 0.0 111.097 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.628 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 29.8 m -146.62 -68.05 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.628 ' HD3' ' HB2' ' A' ' 44' ' ' CYS . 66.4 Cg_endo -95.09 -37.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.698 1.599 . . . . 0.0 115.878 -165.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.727 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 64.5 m 70.51 -66.58 0.28 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.562 0.745 . . . . 0.0 112.731 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 46' ' ' CYS . 0.1 OUTLIER 55.96 -75.05 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.381 1.472 . . . . 0.0 114.511 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 30.2 m-85 70.23 -74.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -169.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -79.11 109.5 13.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 118.344 -1.342 . . . . 0.0 109.497 -176.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -98.43 -25.73 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.229 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.76 145.23 12.33 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.946 -172.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 59' ' ' ALA . 7.5 p -140.25 161.12 25.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -87.81 -138.03 0.1 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -137.48 -38.94 0.59 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 119.152 0.887 . . . . 0.0 112.641 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.552 ' HA ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -101.45 10.86 40.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.455 0.645 . . . . 0.0 109.854 -171.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 42.9 p -93.82 147.87 34.3 Favored Pre-proline 0 N--CA 1.441 -0.879 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 28' ' ' ASP . 8.5 Cg_endo -48.48 -39.97 36.74 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.215 1.943 . . . . 0.0 111.631 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.8 -53.57 56.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.141 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.589 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.98 -55.04 6.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.513 0.673 . . . . 0.0 109.946 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.1 tm? -42.73 -76.22 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.171 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -96.45 -38.3 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.052 0.453 . . . . 0.0 111.514 -177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.483 ' O ' HG22 ' A' ' 63' ' ' THR . . . -66.49 -27.29 73.04 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.746 -168.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 62' ' ' GLY . 5.8 t 52.44 25.44 3.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.456 1.103 . . . . 0.0 111.645 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.572 HG11 HG13 ' A' ' 99' ' ' ILE . 29.9 m -88.93 50.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 122.068 0.937 . . . . 0.0 109.761 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.44 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.01 175.27 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.204 -171.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.43 118.53 3.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.527 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.93 5.59 8.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.82 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.707 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -107.3 161.75 14.51 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 110.431 174.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 18.0 mm-40 -104.05 138.24 40.87 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.6 mm -118.55 134.01 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 123.104 0.252 . . . . 0.0 110.379 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 101' ' ' TYR . 14.9 t -132.74 -18.97 2.37 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.127 -0.358 . . . . 0.0 111.844 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -139.16 138.32 9.25 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.744 -1.217 . . . . 0.0 113.635 -178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.631 HG12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -105.53 123.15 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.532 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 17.4 t-20 59.1 23.23 11.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.914 0.864 . . . . 0.0 109.965 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.93 -20.24 48.67 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.552 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -105.32 136.58 44.58 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 117.888 0.844 . . . . 0.0 111.095 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 71' ' ' THR . 19.3 t -55.88 140.63 42.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.678 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.631 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -74.68 -17.57 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.731 0.777 . . . . 0.0 109.127 -177.03 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -63.47 -20.57 65.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.633 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.4 -17.32 76.32 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.365 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.625 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 1.7 mptp? -120.42 -136.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.914 0.864 . . . . 0.0 109.635 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.9 p -151.31 163.49 38.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.525 -1.671 . . . . 0.0 107.838 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.63 ' HB3' HD22 ' A' ' 126' ' ' LEU . 1.5 mtpt -48.02 -52.75 18.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.316 0.579 . . . . 0.0 111.793 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -56.67 -35.11 44.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.362 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 89' ' ' MET . 34.1 mt-10 -77.13 -46.54 23.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.614 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.586 HG11 ' HB ' ' A' ' 78' ' ' ILE . 24.0 m -59.05 -43.7 89.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -59.51 -35.59 74.45 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 173.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 38.8 ttpt -64.34 -51.26 64.25 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.474 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 82.2 mtp -48.15 -52.24 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.737 0.648 . . . . 0.0 111.136 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.634 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 62.6 mt -61.78 -46.69 95.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.029 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.434 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 8.7 pt20 -77.39 -29.03 53.0 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.211 -0.306 . . . . 0.0 111.564 -177.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -68.23 -48.0 66.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.3 m -50.31 -33.48 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.86 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt 67.15 137.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.669 0.747 . . . . 0.0 112.282 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.565 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 90.59 -50.07 3.2 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.404 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.3 pt-20 -125.82 176.49 6.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 117.256 0.528 . . . . 0.0 110.409 -172.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.48 HG11 HG23 ' A' ' 33' ' ' ILE . 14.2 m -150.88 150.85 13.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.804 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.532 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 1.7 m -141.83 107.58 5.12 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.904 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.572 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -90.8 138.87 18.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.902 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.61 124.42 15.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.658 ' HA ' HG22 ' A' ' 71' ' ' THR . 1.0 OUTLIER -174.66 -113.17 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.168 161.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.553 ' ND2' ' HG2' ' A' ' 18' ' ' PRO . 1.5 t30 -179.03 -173.55 0.3 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.878 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.785 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 8.7 mmpt? -93.22 171.13 9.12 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 172.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 103' ' ' LYS . 3.6 pp 52.93 154.27 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 O-C-N 124.594 1.184 . . . . 0.0 112.358 -173.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.485 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 0.2 OUTLIER -91.1 -13.19 33.56 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.578 -178.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -178.85 165.12 1.57 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.394 0.616 . . . . 0.0 112.58 -173.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -125.73 148.81 63.45 Favored Pre-proline 0 C--O 1.212 -0.883 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 168.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -32.08 -52.6 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.818 3.012 . . . . 0.0 114.443 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.2 ptmt -55.82 -46.08 78.17 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.3 mm100 -89.63 -13.41 37.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.892 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.2 tm? -70.79 -40.95 72.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.313 -177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . 5.8 pt-20 -70.7 -24.38 62.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.258 0.552 . . . . 0.0 110.46 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.08 -45.54 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.042 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 116' ' ' GLN . 74.2 mt -82.61 -3.42 56.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.365 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 9.4 t80 -64.69 38.52 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.36 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 114' ' ' LEU . 41.7 mt-30 -61.26 98.4 0.08 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.567 0.698 . . . . 0.0 110.322 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.635 ' H ' ' HD2' ' A' ' 118' ' ' PRO . . . -94.5 -50.67 2.14 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.635 ' HD2' ' H ' ' A' ' 117' ' ' GLY . 5.6 Cg_exo -34.9 -53.64 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.738 3.625 . . . . 0.0 112.984 164.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -78.78 113.77 17.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.046 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -78.18 -26.54 47.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.791 0.329 . . . . 0.0 110.725 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 122' ' ' LEU . 1.1 m 60.8 -143.96 0.49 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.926 175.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 96.5 mt 62.06 -167.68 0.2 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.653 0.381 . . . . 0.0 111.347 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 122' ' ' LEU . 18.0 ptp180 57.7 165.34 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.088 1.355 . . . . 0.0 113.201 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 36.5 m80 62.69 92.88 0.06 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.628 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.462 ' CZ3' ' HD3' ' A' ' 127' ' ' LYS . 22.2 t90 -70.49 107.19 3.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.309 0.576 . . . . 0.0 109.967 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 87' ' ' ALA . 40.5 tp -93.94 142.41 27.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.243 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 22.9 pttp -156.82 139.75 15.3 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.635 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.851 ' OXT' HG13 ' A' ' 33' ' ' ILE . 14.4 p . . . . . 0 C--N 1.313 -1.003 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.8 m 59.16 87.88 0.13 Allowed Pre-proline 0 CA--C 1.532 0.26 0 O-C-N 123.751 0.324 . . . . 0.0 110.75 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.11 107.0 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.63 2.22 . . . . 0.0 112.294 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.24 69.68 2.92 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.039 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.638 HG13 ' ND2' ' A' ' 102' ' ' ASN . 1.6 pt -86.54 165.68 31.7 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.671 -0.265 . . . . 0.0 110.428 -177.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HG2' HD21 ' A' ' 104' ' ' LEU . 12.4 Cg_exo -64.48 -141.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 124.028 3.152 . . . . 0.0 114.433 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 19' ' ' VAL . 10.3 t -50.21 109.74 1.41 Allowed Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 123.546 0.738 . . . . 0.0 111.164 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -52.44 126.82 21.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.549 2.833 . . . . 0.0 113.501 -170.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.47 109.25 1.16 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.634 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -170.29 139.78 1.78 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 HD11 ' A' ' 99' ' ' ILE . 33.5 m -138.35 147.72 25.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.815 0.34 . . . . 0.0 110.195 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -110.39 101.12 9.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.279 0.561 . . . . 0.0 110.465 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.538 HD11 ' HA3' ' A' ' 62' ' ' GLY . 10.6 mt -111.88 -170.22 1.61 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.736 -174.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 88.6 mt-30 -132.54 144.38 50.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.239 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.513 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 28.5 mmtm -50.25 158.37 0.57 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.676 -175.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 5.4 p-10 -89.82 -163.64 1.04 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.92 67.24 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.477 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.518 HE21 HD21 ' A' ' 32' ' ' LEU . 9.2 tt0 -92.56 9.46 34.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.663 0.268 . . . . 0.0 111.082 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 51.9 t30 66.66 30.0 8.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.75 0.786 . . . . 0.0 110.905 176.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 1.3 pp -133.05 -171.24 2.63 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 121.821 -0.55 . . . . 0.0 111.202 172.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.701 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.71 -27.96 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.973 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 103.68 28.39 6.0 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.942 -0.646 . . . . 0.0 113.046 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.557 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.8 pp -121.65 174.12 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.762 0.791 . . . . 0.0 112.074 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 23.0 m -137.28 126.09 24.03 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.229 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.486 ' HB ' HD12 ' A' ' 126' ' ' LEU . 68.7 mt -98.46 140.16 18.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.72 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.23 99.88 0.46 Allowed Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.24 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.34 124.29 6.99 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.86 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -53.56 -43.54 67.59 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 114.321 0.488 . . . . 0.0 114.321 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.567 ' H ' ' HA ' ' A' ' 45' ' ' PRO . . . 79.74 -77.11 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.308 0.643 . . . . 0.0 111.607 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.99 -49.98 65.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.153 0.502 . . . . 0.0 110.393 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -78.75 -40.65 32.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.951 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 53.8 t 176.89 117.84 0.16 Allowed Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.617 177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.567 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 17.0 Cg_exo -68.57 52.38 0.67 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.585 2.857 . . . . 0.0 112.914 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' A' ' 71' ' ' THR . 42.2 t -150.64 -89.61 0.07 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HB2' ' H ' ' A' ' 48' ' ' TYR . 8.1 mt 53.59 -100.72 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -172.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 54.1 p90 -148.69 -179.86 7.3 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -163.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -93.57 128.5 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.336 178.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -97.03 -21.38 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -168.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.48 141.93 10.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.182 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.1 p -141.16 160.75 22.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.994 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.546 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 92.5 m-85 -113.96 124.67 52.73 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 30.7 t70 -58.33 -23.4 56.55 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -165.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.457 ' HA ' HD23 ' A' ' 60' ' ' LEU . 46.7 m-80 -101.77 9.84 40.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.49 0.662 . . . . 0.0 110.09 -172.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.546 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 31.6 p -98.66 149.24 35.55 Favored Pre-proline 0 CA--C 1.502 -0.877 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -48.55 -38.63 36.18 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 121.946 1.764 . . . . 0.0 111.374 -175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.22 5.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.065 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.496 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.15 -53.2 13.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.453 0.644 . . . . 0.0 110.227 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -45.13 -74.3 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.629 -178.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -95.54 -35.5 11.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.611 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.538 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -74.79 -31.49 58.2 Favored Glycine 0 C--O 1.228 -0.26 0 CA-C-N 115.523 -0.762 . . . . 0.0 114.245 -168.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p 66.05 15.38 10.05 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.851 0.86 . . . . 0.0 110.674 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.545 HG11 HG13 ' A' ' 99' ' ' ILE . 6.1 m -85.78 53.98 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 CA-C-O 122.748 1.261 . . . . 0.0 110.518 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.89 176.39 8.51 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.942 -172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.94 104.34 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.716 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.06 -10.33 3.06 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.962 -175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.4 t70 -89.32 164.95 14.69 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.735 ' HB3' ' CD2' ' A' ' 101' ' ' TYR . 5.5 mp0 -107.89 134.85 50.23 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.497 ' CG1' ' HB ' ' A' ' 49' ' ' ILE . 5.4 mm -122.97 122.29 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.708 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 7.6 t -129.85 -10.19 4.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.72 0.295 . . . . 0.0 111.699 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.3 151.52 23.1 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.434 -1.365 . . . . 0.0 113.711 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.714 HG11 ' HB ' ' A' ' 86' ' ' VAL . 4.4 m -117.85 147.36 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 114.355 -0.923 . . . . 0.0 109.02 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.416 ' ND2' HG11 ' A' ' 93' ' ' VAL . 5.5 t-20 60.92 19.53 9.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.425 0.631 . . . . 0.0 110.508 171.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.01 -10.33 70.08 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.12 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 14.9 ptp180 -121.27 143.73 49.01 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 117.156 0.478 . . . . 0.0 111.238 -174.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 m -52.49 146.39 9.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.525 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.754 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -76.09 -13.19 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 121.695 0.759 . . . . 0.0 109.2 -176.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -58.61 -17.33 21.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.074 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.91 -26.91 67.78 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.982 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -142.45 -119.73 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.966 -0.138 . . . . 0.0 111.061 178.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.458 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 14.9 t -158.1 174.77 14.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.546 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -47.32 -60.02 2.79 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -175.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 82' ' ' THR . 6.6 p -54.51 -34.62 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 121.258 0.551 . . . . 0.0 111.779 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 40.0 mt-10 -78.68 -35.08 45.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.809 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG11 ' HB ' ' A' ' 78' ' ' ILE . 34.4 m -73.42 -38.94 54.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.539 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.96 -36.41 59.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.003 169.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 60.7 tttm -64.66 -50.08 68.46 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 84.5 mtp -53.99 -44.66 71.04 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.204 0.525 . . . . 0.0 111.237 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 93' ' ' VAL . 29.6 mm -55.28 -56.87 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.631 177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.516 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 8.6 pt20 -76.07 -22.86 55.16 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -58.59 -50.65 73.02 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.032 0.533 . . . . 0.0 110.959 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 90' ' ' ILE . 13.2 m -60.1 -29.66 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.941 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp 63.45 143.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.001 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.498 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 87.94 -48.81 3.72 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.876 170.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.7 pt-20 -127.24 175.65 8.0 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 117.398 0.599 . . . . 0.0 110.125 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.513 ' CG1' ' HD3' ' A' ' 27' ' ' LYS . 9.2 m -147.92 155.54 9.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.838 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -142.37 99.87 3.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.712 0.292 . . . . 0.0 111.203 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.545 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -84.95 144.6 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -147.72 131.16 16.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.735 ' CD2' ' HB3' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -177.97 -114.62 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.172 162.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.638 ' ND2' HG13 ' A' ' 17' ' ' ILE . 1.4 t-20 -174.43 -169.17 0.43 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.583 -171.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.28 32.93 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -171.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.558 HD21 ' HG2' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -164.85 157.01 15.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 0.0 111.0 175.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -97.84 25.03 6.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.714 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.561 ' HB1' ' HG3' ' A' ' 110' ' ' GLN . . . 70.78 -174.66 0.18 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.427 173.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.578 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 9.8 m-20 -137.06 158.36 72.86 Favored Pre-proline 0 C--O 1.216 -0.661 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.618 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 37.7 Cg_exo -29.09 -60.61 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.899 3.066 . . . . 0.0 115.107 -167.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.482 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 21.6 pttp -65.54 -50.07 66.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.238 0.542 . . . . 0.0 111.866 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.578 ' CG ' ' H ' ' A' ' 107' ' ' ASP . 12.4 pt20 -80.11 -7.94 59.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.853 0.835 . . . . 0.0 111.827 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.439 ' C ' HD13 ' A' ' 111' ' ' LEU . 1.8 tm? -90.04 -48.4 7.22 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.922 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 6.0 pt-20 -71.45 -24.86 62.09 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 110.864 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.1 p -68.15 -32.64 56.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.483 0.659 . . . . 0.0 109.708 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.43 -24.9 39.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.471 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -63.94 -47.33 80.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.408 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 70.5 -70.19 0.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.203 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.611 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . -166.34 -49.54 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.28 -175.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 1.1 Cg_endo -41.48 116.82 0.54 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.999 3.133 . . . . 0.0 113.341 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -129.66 -45.78 1.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.229 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -88.04 5.38 41.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.992 0.425 . . . . 0.0 110.728 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.4 m -78.99 69.49 5.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.754 0.788 . . . . 0.0 110.353 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.02 116.14 4.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.24 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 20.4 ptt180 -148.02 128.7 14.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.186 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.466 ' O ' ' HD3' ' A' ' 83' ' ' LYS . 12.9 m-70 73.57 139.11 0.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.146 0.904 . . . . 0.0 111.939 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -71.24 132.64 45.25 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -92.17 153.51 19.27 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.964 -167.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' N ' HD13 ' A' ' 126' ' ' LEU . 19.2 ptmt -167.87 111.09 0.63 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.728 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.701 ' OXT' HG13 ' A' ' 33' ' ' ILE . 12.6 p . . . . . 0 N--CA 1.441 -0.896 0 CA-C-O 118.08 -0.962 . . . . 0.0 108.909 170.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.601 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.497 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 13.4 m -71.94 -49.78 10.03 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 14' ' ' SER . 22.1 Cg_endo -61.86 156.63 47.6 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.759 1.639 . . . . 0.0 111.654 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.28 -30.08 8.23 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.631 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.542 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 5.9 pt -70.68 155.84 92.82 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 20.2 Cg_endo -59.26 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.273 1.982 . . . . 0.0 113.025 -168.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 17.6 t -116.52 106.11 49.07 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.9 141.98 67.12 Favored 'Trans proline' 0 C--N 1.329 -0.452 0 C-N-CA 123.422 2.748 . . . . 0.0 112.459 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.42 155.63 27.12 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.005 -0.616 . . . . 0.0 111.63 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -166.49 137.91 3.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.69 157.43 42.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 t -124.58 118.61 26.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.384 0.611 . . . . 0.0 110.563 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.467 ' CD2' HD11 ' A' ' 99' ' ' ILE . 2.3 mm? -119.92 -169.6 1.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.645 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 87.8 mt-30 -129.28 140.31 51.48 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.821 177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HG2' ' C ' ' A' ' 95' ' ' GLY . 25.4 mmtp -45.9 148.79 0.74 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.336 -176.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -82.7 -179.01 7.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.585 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.64 55.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.192 0.52 . . . . 0.0 110.875 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.562 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.7 mt-30 -91.12 4.1 53.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.948 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 37.8 t30 71.04 16.71 6.35 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.036 0.922 . . . . 0.0 111.133 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.607 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -128.31 -171.1 2.37 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.769 -0.582 . . . . 0.0 111.275 -179.45 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.726 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -101.37 -29.23 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.604 -177.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.26 27.18 5.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.745 . . . . 0.0 113.125 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG22 HG23 ' A' ' 52' ' ' VAL . 2.7 pp -119.17 173.85 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.333 0.587 . . . . 0.0 111.839 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 36.3 m -134.65 129.92 35.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.517 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 63.3 mt -104.03 145.07 13.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.518 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.89 150.97 11.65 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.031 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.7 109.75 3.81 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.589 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.474 ' HA2' ' HD2' ' A' ' 45' ' ' PRO . . . 96.04 129.46 6.0 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.408 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' H ' ' HD2' ' A' ' 45' ' ' PRO . . . -98.16 -87.75 0.33 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -99.02 -42.01 7.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.71 0.291 . . . . 0.0 110.342 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -88.99 -88.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.63 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 22.6 p 178.79 49.57 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.417 0 O-C-N 123.302 0.376 . . . . 0.0 111.83 173.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.63 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 4.9 Cg_exo -82.3 -179.53 4.74 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.136 1.891 . . . . 0.0 111.542 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 48' ' ' TYR . 5.7 p -74.61 -78.95 0.09 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.296 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 69' ' ' GLU . 1.5 pp 50.67 -49.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.539 1.936 . . . . 0.0 115.51 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 18.6 m-85 69.01 -51.72 0.59 Allowed 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 118.596 0.635 . . . . 0.0 112.682 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -88.13 111.72 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 119.419 1.009 . . . . 0.0 109.856 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.3 -29.98 4.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.257 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 4.0 pt20 -164.31 156.29 16.43 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.3 p -141.99 161.67 20.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.263 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.554 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 89.9 m-85 -113.67 123.63 50.38 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -55.23 -25.81 35.62 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.115 -165.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.509 ' HA ' HD23 ' A' ' 60' ' ' LEU . 47.8 m-80 -102.41 8.39 40.16 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.169 0.509 . . . . 0.0 110.616 -172.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 32.0 p -96.72 150.32 36.81 Favored Pre-proline 0 CA--C 1.503 -0.844 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.51 -37.67 42.73 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 121.789 1.659 . . . . 0.0 111.396 -174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -57.36 -57.35 13.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.108 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.552 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -73.61 -52.6 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.451 0.643 . . . . 0.0 110.121 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -45.39 -75.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.806 -1.543 . . . . 0.0 112.743 -177.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -96.59 -33.12 11.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.157 0.503 . . . . 0.0 111.5 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.25 -28.77 63.39 Favored Glycine 0 C--O 1.228 -0.275 0 CA-C-N 115.663 -0.699 . . . . 0.0 114.236 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p 64.57 14.41 8.95 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.994 0.917 . . . . 0.0 111.403 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.73 HG11 HG13 ' A' ' 99' ' ' ILE . 6.9 m -84.98 54.56 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 CA-C-O 122.578 1.18 . . . . 0.0 111.284 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.17 173.2 10.6 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.469 -172.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -55.8 113.41 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.163 -173.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.12 -16.37 4.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.446 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.667 ' O ' HG22 ' A' ' 49' ' ' ILE . 1.7 m-20 -96.86 154.62 17.19 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 117.597 0.698 . . . . 0.0 110.746 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 38.3 tt0 -90.7 80.86 5.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.529 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.502 HD13 ' HB ' ' A' ' 49' ' ' ILE . 1.8 mp -68.85 92.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 77' ' ' SER . 9.0 t -96.08 -14.05 23.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.595 -170.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -143.83 137.27 7.35 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 119.367 -1.397 . . . . 0.0 113.629 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -104.79 119.02 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.549 ' HA ' ' HB ' ' A' ' 98' ' ' THR . 16.9 t-20 55.03 32.18 17.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.413 0.625 . . . . 0.0 110.613 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.86 -21.28 46.73 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.643 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -102.76 126.91 50.06 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 117.725 0.762 . . . . 0.0 110.991 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.505 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 29.9 m -57.79 145.81 33.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.72 -176.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.575 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -81.32 -18.51 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 121.546 0.689 . . . . 0.0 109.602 -179.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -63.04 -24.19 67.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.877 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.44 -14.85 81.72 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.936 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.593 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -136.22 -132.31 0.15 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.409 0.604 . . . . 0.0 110.718 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -143.64 152.26 41.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.112 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.493 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.4 ptpt -43.43 -59.36 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.96 0.504 . . . . 0.0 112.272 176.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.5 p -53.97 -34.87 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.842 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 89' ' ' MET . 33.7 mt-10 -76.93 -42.44 39.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.557 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.555 HG11 ' HB ' ' A' ' 78' ' ' ILE . 33.6 m -66.8 -40.11 85.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.643 -175.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.596 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -52.57 -41.42 63.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.429 170.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -66.44 -45.94 78.13 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.197 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 59.4 mtt -54.62 -35.17 63.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.398 0.618 . . . . 0.0 110.765 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 33' ' ' ILE . 65.3 mt -75.33 -48.84 29.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.186 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.493 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 86.4 mt-30 -63.6 -41.06 98.36 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.03 -45.44 85.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.441 -169.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 90' ' ' ILE . 25.9 m -54.63 -31.42 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.295 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? 65.93 130.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 170.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.499 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 97.77 -47.91 1.51 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.517 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.0 pt-20 -136.48 176.83 8.34 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.188 0.518 . . . . 0.0 110.406 -172.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.6 HG11 HG23 ' A' ' 33' ' ' ILE . 5.4 m -147.43 153.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.862 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 30.8 m -142.4 115.77 9.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.73 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -111.1 123.63 67.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.269 -175.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -98.67 123.69 43.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 69' ' ' GLU . 17.0 p90 -141.96 139.95 32.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.577 0.703 . . . . 0.0 112.006 -173.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.4 m-20 -115.55 169.59 9.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.127 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 103' ' ' LYS . 2.6 mptt -115.11 82.43 1.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.95 -0.7 . . . . 0.0 112.797 -168.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 18' ' ' PRO . 0.8 OUTLIER -178.62 167.73 1.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.772 170.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.431 ' O ' ' HB3' ' A' ' 45' ' ' PRO . 15.9 pt20 -107.48 13.12 27.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.834 171.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 70.51 162.68 0.24 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.152 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -134.18 156.84 78.72 Favored Pre-proline 0 C--O 1.211 -0.926 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 19.4 Cg_exo -29.97 -51.99 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.009 3.14 . . . . 0.0 114.958 -171.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.532 ' HG3' ' HG3' ' A' ' 110' ' ' GLN . 59.3 pttt -57.16 -44.48 83.53 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.517 0.675 . . . . 0.0 112.285 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.532 ' HG3' ' HG3' ' A' ' 109' ' ' LYS . 96.9 mt-30 -85.98 -27.74 24.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.632 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.5 tm? -66.55 -49.52 66.18 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.221 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 5.2 pt-20 -60.07 -31.68 70.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.1 0.476 . . . . 0.0 110.69 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 109' ' ' LYS . 68.8 t -64.52 -47.41 89.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.512 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.01 -13.61 57.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.496 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 20.9 t80 -87.66 37.91 0.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.859 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -58.65 -24.4 61.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.247 0.546 . . . . 0.0 110.185 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.636 ' H ' ' CD ' ' A' ' 118' ' ' PRO . . . 154.86 47.74 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.585 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.636 ' CD ' ' H ' ' A' ' 117' ' ' GLY . 38.0 Cg_endo -64.92 5.73 0.44 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.292 2.661 . . . . 0.0 113.15 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 117' ' ' GLY . 16.0 mm100 -77.38 -154.76 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.686 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.3 t80 65.92 33.33 7.95 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 122.339 1.066 . . . . 0.0 108.712 -173.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 m -85.87 95.86 9.59 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.203 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 pp -80.04 9.6 5.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.431 0.634 . . . . 0.0 110.378 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 73.32 64.57 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.489 169.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -130.58 126.43 36.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.45 0.643 . . . . 0.0 109.648 166.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -83.87 158.29 21.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.709 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.596 HD11 ' HB2' ' A' ' 87' ' ' ALA . 1.1 tm? -101.08 158.84 15.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.584 ' N ' HD13 ' A' ' 126' ' ' LEU . 19.8 ptmt -161.94 112.98 1.64 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.143 0.497 . . . . 0.0 110.429 -174.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.726 ' O ' HG13 ' A' ' 33' ' ' ILE . 13.1 p . . . . . 0 N--CA 1.437 -1.122 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.726 -0.549 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -147.83 72.29 11.43 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.764 0.316 . . . . 0.0 111.405 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -92.13 -166.6 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.157 2.572 . . . . 0.0 111.763 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.58 -51.87 9.07 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.325 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.503 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 14.7 pt -113.06 159.8 33.36 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 26.7 Cg_endo -67.95 -70.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.657 1.572 . . . . 0.0 112.571 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.8 t -124.73 110.22 27.91 Favored Pre-proline 0 N--CA 1.439 -1.017 0 CA-C-O 120.982 0.42 . . . . 0.0 110.095 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.66 145.37 18.2 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 124.62 3.547 . . . . 0.0 114.486 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 100' ' ' HIS . . . 83.98 164.27 36.89 Favored Glycine 0 N--CA 1.461 0.321 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.349 168.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -160.86 -74.87 0.06 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 117.023 0.412 . . . . 0.0 111.457 174.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 99' ' ' ILE . 7.7 p -147.57 158.46 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -170.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.66 HG22 HG22 ' A' ' 98' ' ' THR . 24.5 p -124.52 121.78 35.76 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 122.2 -0.313 . . . . 0.0 111.083 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.549 ' CD2' HD11 ' A' ' 99' ' ' ILE . 2.7 mm? -121.16 -165.78 1.27 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.7 pt20 -141.23 158.19 44.23 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.081 174.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 31' ' ' ASN . 31.1 mmtm -52.77 155.86 2.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.955 -1.02 . . . . 0.0 113.129 -172.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -85.57 -179.53 6.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.794 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.97 -21.01 60.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.619 0.645 . . . . 0.0 111.095 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.491 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -91.22 2.28 56.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.101 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.485 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 54.8 t30 70.55 35.7 1.85 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.247 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.608 HD22 ' OXT' ' A' ' 128' ' ' VAL . 2.1 pp -140.56 -170.66 3.05 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.841 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.744 HG23 HG11 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -104.78 -25.45 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.981 -175.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 92.78 35.4 6.46 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.511 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.793 HD11 HG23 ' A' ' 128' ' ' VAL . 2.9 pp -123.01 178.96 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.738 0.304 . . . . 0.0 110.617 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 64.4 m -128.47 135.29 49.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.085 0.469 . . . . 0.0 111.135 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 34.9 mm -102.29 138.77 25.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.144 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.74 123.97 1.22 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.45 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.66 101.6 2.81 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.638 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 45' ' ' PRO . . . 94.33 118.82 3.04 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.371 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.614 ' HB2' HD21 ' A' ' 47' ' ' LEU . . . -95.07 -78.43 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.744 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -95.33 48.63 1.16 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.198 0.523 . . . . 0.0 109.944 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.8 t80 56.91 27.1 12.54 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.438 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.479 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 32.5 m -143.28 -69.88 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.534 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 73.3 Cg_endo -73.61 124.74 9.53 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.113 1.209 . . . . 0.0 111.095 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.753 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 71.2 m -69.11 -51.63 36.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.524 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.81 ' O ' ' HA ' ' A' ' 69' ' ' GLU . 1.6 pp 56.74 -56.98 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.83 1.652 . . . . 0.0 114.648 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.712 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 17.4 m-85 71.68 -36.3 0.36 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.165 0.586 . . . . 0.0 112.505 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.94 108.18 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 122.456 1.122 . . . . 0.0 109.615 176.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.0 t -86.84 -35.54 8.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.408 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.737 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 11.3 pt20 -165.57 163.53 19.36 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -173.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.5 p -141.29 159.82 22.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.132 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.521 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 50.1 m-85 -116.09 122.97 46.72 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.74 0.781 . . . . 0.0 108.907 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.47 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 7.5 m-20 -58.2 -18.94 29.57 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.324 1.45 . . . . 0.0 114.641 -164.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -102.89 6.06 38.87 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.97 0.414 . . . . 0.0 110.513 -174.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 13.1 p -102.59 151.53 38.26 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -176.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.18 -39.94 42.27 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.086 1.857 . . . . 0.0 111.779 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.02 -54.02 49.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.027 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.653 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -76.6 -53.03 8.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.497 0.665 . . . . 0.0 110.277 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER -44.22 -75.01 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.879 -1.51 . . . . 0.0 112.522 -176.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -96.66 -32.06 12.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.14 0.495 . . . . 0.0 111.637 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.476 ' CA ' HD21 ' A' ' 25' ' ' LEU . . . -72.84 -38.97 56.07 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.923 -0.656 . . . . 0.0 114.542 -167.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p 64.77 21.72 12.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 122.0 0.905 . . . . 0.0 110.897 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.743 HG11 HG13 ' A' ' 99' ' ' ILE . 3.8 m -88.02 56.43 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.193 176.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.64 -179.76 7.2 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.786 -168.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.737 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -57.43 139.46 53.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.722 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.89 -9.51 29.67 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.51 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -96.8 174.81 6.61 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.584 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.81 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 25.0 tt0 -123.13 95.19 4.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.466 0.651 . . . . 0.0 110.377 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.9 mm -69.96 114.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.587 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 102' ' ' ASN . 6.4 t -88.11 -34.84 17.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.42 156.63 26.81 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.468 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.662 ' CG1' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -131.1 129.4 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 59.64 26.29 15.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.639 0.733 . . . . 0.0 110.037 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.55 -20.1 50.14 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.256 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -107.93 135.04 49.98 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 117.092 0.446 . . . . 0.0 111.732 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m -63.49 148.15 49.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.472 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.662 HG23 ' CG1' ' A' ' 73' ' ' VAL . 1.0 OUTLIER -93.0 -25.67 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 CA-C-O 122.93 1.347 . . . . 0.0 109.625 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.568 ' H ' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -57.88 -24.46 57.75 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.189 -2.278 . . . . 0.0 110.339 -178.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.8 -17.64 76.91 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.642 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.478 ' H ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -129.53 -134.87 0.22 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.062 0.931 . . . . 0.0 112.079 -176.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.564 ' O ' HG13 ' A' ' 86' ' ' VAL . 60.5 p -135.89 166.13 24.03 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.573 -0.079 . . . . 0.0 110.839 -169.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.625 ' HB3' HD22 ' A' ' 126' ' ' LEU . 16.6 mttt -49.1 -57.69 6.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.542 0.687 . . . . 0.0 111.919 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.47 -39.68 54.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.828 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 89' ' ' MET . 34.6 mt-10 -75.29 -37.91 60.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 82' ' ' THR . 30.0 m -67.05 -45.39 86.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.61 -176.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.68 ' O ' ' HG3' ' A' ' 91' ' ' GLN . . . -58.9 -43.05 90.91 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 172.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -61.63 -45.63 93.24 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.199 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 86.4 mmm -51.6 -42.33 61.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.615 HD13 HD11 ' A' ' 33' ' ' ILE . 85.9 mt -65.64 -46.89 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.609 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.68 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 59.5 mt-30 -60.45 -46.77 88.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.117 0.484 . . . . 0.0 110.979 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -61.71 -50.91 70.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.498 -167.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 89' ' ' MET . 14.8 m -52.99 -32.92 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm 61.79 137.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.442 ' C ' ' HG2' ' A' ' 27' ' ' LYS . . . 95.03 -51.78 1.91 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.741 167.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.6 pt-20 -133.83 178.71 6.73 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -174.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.744 HG11 HG23 ' A' ' 33' ' ' ILE . 9.5 m -150.05 148.23 15.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.784 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.66 HG22 HG22 ' A' ' 24' ' ' THR . 12.9 p -134.51 109.46 8.72 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.743 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -102.15 126.82 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.31 0.576 . . . . 0.0 111.524 -173.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 35.0 m170 -108.17 117.16 33.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.182 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.606 ' CE1' HG12 ' A' ' 64' ' ' VAL . 1.1 m-30 -74.0 162.2 29.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.318 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.432 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -175.68 155.51 1.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 O-C-N 124.624 1.202 . . . . 0.0 108.464 175.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.447 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -99.16 -32.59 11.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.652 HD22 ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -152.55 134.85 15.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.738 0.78 . . . . 0.0 112.121 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.41 HE22 ' CG2' ' A' ' 17' ' ' ILE . 26.4 mm-40 -92.11 -19.47 22.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.173 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.09 159.07 42.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.994 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.483 ' CG ' ' HD2' ' A' ' 108' ' ' PRO . 10.4 t70 -135.12 149.43 70.15 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 16.6 Cg_exo -29.45 -49.84 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.902 3.068 . . . . 0.0 114.269 -176.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 19.1 ptpt -57.99 -47.65 82.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.239 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 14.9 mm100 -87.02 -19.96 27.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.449 0.642 . . . . 0.0 110.355 -176.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -73.0 -43.12 62.54 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.276 -175.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -66.36 -31.43 72.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.889 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 109' ' ' LYS . 74.3 t -66.59 -39.77 84.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.205 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 110' ' ' GLN . 76.1 mt -70.65 -24.05 62.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.759 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.455 ' O ' ' HD3' ' A' ' 118' ' ' PRO . 27.6 t80 -84.04 -7.56 59.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.125 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 113' ' ' VAL . 51.1 mt-30 -87.61 29.62 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.385 0.612 . . . . 0.0 110.27 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.484 ' H ' ' HD3' ' A' ' 118' ' ' PRO . . . 159.45 50.76 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.484 ' HD3' ' H ' ' A' ' 117' ' ' GLY . 28.9 Cg_endo -58.93 -56.46 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.249 2.633 . . . . 0.0 113.068 -170.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 48.27 49.91 17.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.137 0.494 . . . . 0.0 112.092 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -86.47 73.93 10.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.486 ' O ' ' HE3' ' A' ' 83' ' ' LYS . 13.5 t -84.36 175.05 9.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.83 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.4 ' HG ' HG23 ' A' ' 121' ' ' THR . 86.0 mt 64.03 60.54 1.0 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.515 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -69.78 85.3 0.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.499 0.666 . . . . 0.0 111.298 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -165.94 159.96 16.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -74.15 144.56 44.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.013 0.435 . . . . 0.0 110.59 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' A' ' 83' ' ' LYS . 51.5 tp -117.51 168.43 10.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.483 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 4.9 pttp -166.26 161.99 17.1 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.239 0.542 . . . . 0.0 110.862 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.793 HG23 HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.778 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 165.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 112.211 -0.356 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 p -142.13 87.92 9.44 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.947 0.403 . . . . 0.0 110.295 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.73 6.53 5.42 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.12 2.547 . . . . 0.0 112.859 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.69 35.71 24.63 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.62 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.561 HD12 ' ND2' ' A' ' 102' ' ' ASN . 2.9 pt -69.11 140.67 91.01 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.964 0.411 . . . . 0.0 111.26 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.52 -100.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.323 2.682 . . . . 0.0 113.826 -171.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.456 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 29.5 t -84.51 130.51 53.3 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 120.466 0.174 . . . . 0.0 111.189 -173.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 19' ' ' VAL . 6.6 Cg_endo -82.21 134.59 8.06 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.248 2.632 . . . . 0.0 111.453 -175.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.59 148.87 20.39 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.293 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 25.7 pttm -172.32 136.49 0.81 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 62' ' ' GLY . 33.8 m -131.09 146.74 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.5 t -103.8 98.88 8.66 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.788 0.804 . . . . 0.0 110.378 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.493 HD11 ' HA2' ' A' ' 62' ' ' GLY . 16.6 mt -110.48 -163.83 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.753 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 2.2 pt20 -150.53 156.3 41.15 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.176 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.574 ' HE2' ' C ' ' A' ' 31' ' ' ASN . 10.0 mmmm -52.4 146.77 9.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.639 0.733 . . . . 0.0 111.938 -174.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -85.65 173.67 9.96 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.355 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.2 -20.79 56.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.118 0.485 . . . . 0.0 110.453 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.477 ' NE2' HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -85.59 -1.26 56.94 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.032 -177.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.574 ' C ' ' HE2' ' A' ' 27' ' ' LYS . 15.4 t30 69.01 37.52 2.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.734 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.484 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -154.22 -163.31 1.59 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.897 173.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.729 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.55 -24.27 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.494 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.44 40.71 3.6 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.761 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.531 HG22 HG23 ' A' ' 52' ' ' VAL . 2.6 pp -131.89 171.95 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.855 0.836 . . . . 0.0 111.633 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.1 m -140.59 126.5 19.41 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.161 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.922 HG22 ' H ' ' A' ' 38' ' ' GLY . 26.3 mt -122.72 -168.64 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -176.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.922 ' H ' HG22 ' A' ' 37' ' ' ILE . . . -166.19 155.51 26.8 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' HA2' ' N ' ' A' ' 46' ' ' CYS . . . -70.12 118.5 8.1 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.928 -177.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.21 -17.0 9.13 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.93 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.36 -172.26 2.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.143 0.472 . . . . 0.0 110.314 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 14.9 mm100 -62.08 144.01 55.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 87.4 t80 77.29 -0.33 2.89 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.772 0.796 . . . . 0.0 110.484 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 28.0 p 51.88 60.01 14.25 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.106 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 2.5 Cg_endo -78.66 -71.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 122.191 1.927 . . . . 0.0 111.968 -173.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.527 ' N ' ' HA2' ' A' ' 39' ' ' GLY . 9.3 t -177.13 157.08 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.651 HD12 ' N ' ' A' ' 48' ' ' TYR . 3.5 pp 172.3 -51.43 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.154 0.909 . . . . 0.0 112.1 162.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.651 ' N ' HD12 ' A' ' 47' ' ' LEU . 6.3 p90 -80.43 115.71 20.1 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.335 -174.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -75.74 117.5 20.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.915 0.864 . . . . 0.0 109.27 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.18 -30.65 5.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.739 -171.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.64 142.77 15.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.976 0.417 . . . . 0.0 111.401 -172.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.4 p -140.56 160.73 24.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.011 173.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -97.34 -133.8 0.23 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.52 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 6.0 t70 -141.15 -33.3 0.53 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -101.24 0.93 38.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.971 0.415 . . . . 0.0 110.347 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 68.0 p -84.17 151.54 60.17 Favored Pre-proline 0 N--CA 1.44 -0.94 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 8.4 Cg_endo -53.28 -41.27 73.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.239 1.292 . . . . 0.0 111.024 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.513 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.48 -47.58 81.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.996 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.636 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.69 -56.81 4.74 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.68 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.8 pp -55.77 -75.7 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -171.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.631 ' N ' HD12 ' A' ' 60' ' ' LEU . 37.5 t70 -94.76 -13.38 25.74 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 122.546 1.165 . . . . 0.0 108.37 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -64.57 -51.16 54.54 Favored Glycine 0 C--N 1.312 -0.785 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.038 -169.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.4 p 56.95 42.76 25.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 122.731 1.253 . . . . 0.0 110.321 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.609 HG11 HG13 ' A' ' 99' ' ' ILE . 29.5 m -119.23 47.81 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 112.684 -2.053 . . . . 0.0 108.789 173.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.13 173.71 10.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.569 -170.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.77 108.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.674 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.92 -17.75 3.41 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.68 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 49' ' ' ILE . 18.3 m-20 -90.54 156.88 17.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.081 0.441 . . . . 0.0 110.928 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -114.9 98.26 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.365 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 2.8 mp -72.82 114.67 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.076 0.465 . . . . 0.0 110.38 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -97.5 -12.42 22.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.551 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' HG23 ' A' ' 78' ' ' ILE . . . -161.17 144.75 10.15 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 119.529 -1.319 . . . . 0.0 114.143 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.823 HG13 HG22 ' A' ' 78' ' ' ILE . 5.0 m -100.79 140.56 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.75 0 CA-C-N 114.533 -0.833 . . . . 0.0 109.809 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.2 t30 53.89 29.17 9.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.826 0.822 . . . . 0.0 111.173 164.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.24 59.19 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.392 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -126.73 149.38 49.63 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.132 0.966 . . . . 0.0 111.903 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 m -57.1 148.46 21.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.454 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.823 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -85.6 -19.03 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.281 0.562 . . . . 0.0 111.076 -172.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -67.73 -7.53 27.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.301 -170.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.58 -27.95 73.57 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.224 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -139.14 -139.77 0.14 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 117.234 0.517 . . . . 0.0 111.847 -177.065 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.83 160.73 33.55 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -168.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HA ' HG22 ' A' ' 86' ' ' VAL . 2.5 pttt -46.87 -52.65 13.89 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -59.59 -35.09 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 121.047 0.451 . . . . 0.0 111.564 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 89' ' ' MET . 29.7 mt-10 -79.9 -40.33 28.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.553 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG11 ' HB ' ' A' ' 78' ' ' ILE . 27.7 m -63.41 -40.03 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.606 0.241 . . . . 0.0 111.44 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 91' ' ' GLN . . . -56.3 -45.16 80.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.437 171.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.74 -40.3 96.4 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 120.75 0.31 . . . . 0.0 110.7 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 24.9 mmt -51.22 -32.92 25.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.57 0.7 . . . . 0.0 110.927 174.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.704 HG21 HD11 ' A' ' 33' ' ' ILE . 88.6 mt -90.42 -18.44 7.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.077 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 50.4 mt-30 -87.6 -14.78 39.17 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.901 -0.499 . . . . 0.0 111.546 173.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.27 -40.53 15.44 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.12 0.962 . . . . 0.0 108.969 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -43.44 120.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.932 169.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -82.66 86.48 6.84 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.666 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 108.91 -25.16 19.72 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 118.575 -1.774 . . . . 0.0 113.923 162.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 8.6 pt-20 -125.57 173.4 8.98 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 117.947 0.874 . . . . 0.0 110.332 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.3 m -155.8 154.92 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.861 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.13 117.12 11.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.072 0.463 . . . . 0.0 110.367 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.609 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -106.25 115.49 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.902 -176.138 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -102.11 121.95 43.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.41 ' CE1' HG12 ' A' ' 64' ' ' VAL . 50.0 p90 -146.65 160.79 41.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.729 0.776 . . . . 0.0 112.595 -173.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.561 ' ND2' HD12 ' A' ' 17' ' ' ILE . 28.7 m-80 -137.91 -166.2 1.92 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.625 ' C ' HD13 ' A' ' 104' ' ' LEU . 1.2 mptt -123.2 143.81 49.78 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.137 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.625 HD13 ' C ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER 41.18 178.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -176.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -156.34 25.32 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.7 172.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -169.49 -165.5 0.52 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.583 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 111' ' ' LEU . 7.5 m-20 -111.24 149.91 41.25 Favored Pre-proline 0 C--O 1.207 -1.135 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -31.31 -60.33 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.955 3.103 . . . . 0.0 114.529 -171.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.514 ' HG3' ' HG2' ' A' ' 110' ' ' GLN . 21.2 ptmt -61.35 -44.95 96.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.676 0.75 . . . . 0.0 111.716 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.514 ' HG2' ' HG3' ' A' ' 109' ' ' LYS . 70.2 mm-40 -80.39 -9.62 59.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.844 -175.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.1 tm? -90.5 -51.74 5.25 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.471 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.5 -30.85 70.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.485 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.419 HG12 ' C ' ' A' ' 110' ' ' GLN . 4.1 p -69.1 -31.97 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.561 0.696 . . . . 0.0 109.817 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 114' ' ' LEU . 3.2 tm? -75.08 -28.73 60.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.547 176.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -75.44 -3.13 32.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.648 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -80.04 58.66 3.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.607 0.717 . . . . 0.0 110.149 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.565 ' H ' ' HD2' ' A' ' 118' ' ' PRO . . . -148.17 -53.04 0.02 OUTLIER Glycine 0 C--N 1.312 -0.755 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.29 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.565 ' HD2' ' H ' ' A' ' 117' ' ' GLY . 99.0 Cg_exo -29.66 117.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.526 3.484 . . . . 0.0 114.097 168.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 73.51 -15.59 0.55 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.466 0.706 . . . . 0.0 112.441 175.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -89.21 -71.63 0.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -85.26 -34.96 21.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.64 55.9 3.72 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.12 172.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -61.88 -30.41 70.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.923 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -96.63 89.93 5.14 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -82.62 173.31 12.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.839 -176.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.641 HD13 ' HB ' ' A' ' 37' ' ' ILE . 8.6 tt -90.27 146.07 24.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.497 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.561 ' N ' HD23 ' A' ' 126' ' ' LEU . 22.0 ptmt -150.54 123.73 8.87 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.353 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.729 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.8 p . . . . . 0 N--CA 1.437 -1.085 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.318 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 112.004 -0.438 . . . . 0.0 112.004 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.2 m -97.72 103.63 17.58 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 13' ' ' GLY . 37.4 Cg_exo -59.05 -38.37 87.82 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.137 2.558 . . . . 0.0 113.349 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 179.97 136.58 2.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.457 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.541 HD12 ' ND2' ' A' ' 102' ' ' ASN . 3.0 pt -114.64 151.05 44.94 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.28 -62.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.378 2.052 . . . . 0.0 113.235 -174.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.11 96.33 34.5 Favored Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 122.577 0.351 . . . . 0.0 111.101 -177.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.651 ' HA ' ' OD1' ' A' ' 102' ' ' ASN . 3.0 Cg_exo -68.35 112.81 2.9 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.416 2.077 . . . . 0.0 111.55 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -118.83 149.01 18.31 Favored Glycine 0 C--N 1.312 -0.791 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.956 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -149.71 134.32 17.6 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.209 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.602 HG11 ' O ' ' A' ' 62' ' ' GLY . 7.7 p -132.72 143.72 38.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.463 ' O ' HD13 ' A' ' 25' ' ' LEU . 11.6 t -113.78 130.49 56.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.437 0.637 . . . . 0.0 110.935 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.625 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.8 mm? -132.56 -167.5 1.91 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.561 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.419 ' O ' ' HG3' ' A' ' 57' ' ' PRO . 97.0 mt-30 -132.29 155.98 47.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.717 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 37.0 mmtt -46.54 145.15 1.92 Allowed 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.762 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.06 -178.87 5.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.262 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.2 -22.13 65.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.439 0.637 . . . . 0.0 110.306 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.496 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -93.12 11.22 28.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.72 0.772 . . . . 0.0 109.607 178.026 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 1.1 p-10 60.28 16.1 5.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.311 -1.768 . . . . 0.0 113.049 176.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -115.93 -159.98 0.74 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.507 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.705 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -110.93 -22.89 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 118.755 0.707 . . . . 0.0 111.596 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 96.17 38.54 4.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.744 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.511 HG22 HG23 ' A' ' 52' ' ' VAL . 2.8 pp -130.76 173.89 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.844 0.83 . . . . 0.0 112.122 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.502 ' HB3' ' CD1' ' A' ' 125' ' ' TRP . 20.7 m -138.81 125.78 21.16 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.262 -1.335 . . . . 0.0 109.742 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.488 ' HB ' HD21 ' A' ' 126' ' ' LEU . 61.1 mt -124.94 131.01 73.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.504 0.668 . . . . 0.0 112.716 -173.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.95 116.2 0.78 Allowed Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.572 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.68 99.7 0.62 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.655 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.568 ' H ' ' HG ' ' A' ' 47' ' ' LEU . . . 76.7 171.83 34.58 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.126 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.52 -43.48 0.07 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.515 0.674 . . . . 0.0 109.771 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.528 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 20.1 mp0 -75.59 84.85 2.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.185 175.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 73.5 t80 77.22 -0.93 2.84 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.712 0.768 . . . . 0.0 109.735 -172.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.572 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 61.5 m 71.21 56.57 0.42 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.51 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 12.6 Cg_exo -73.48 -86.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.338 2.025 . . . . 0.0 112.537 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.467 ' H ' ' HB2' ' A' ' 45' ' ' PRO . 70.9 m -158.28 168.59 26.61 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 40' ' ' GLY . 4.6 pp 154.12 -38.57 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.35 1.46 . . . . 0.0 108.281 168.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.533 ' N ' HD12 ' A' ' 47' ' ' LEU . 83.2 m-85 66.39 -85.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.219 -1.355 . . . . 0.0 113.344 176.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -75.56 116.56 18.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 120.037 1.29 . . . . 0.0 110.719 -171.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.427 HG22 HD11 ' A' ' 47' ' ' LEU . 24.6 t -102.31 -30.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.305 -174.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -150.32 138.66 20.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 120.84 0.352 . . . . 0.0 110.926 -170.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.3 p -141.34 161.24 22.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.221 174.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.57 -140.88 0.32 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.443 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 30.7 t70 -133.8 -28.52 1.39 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -101.53 -2.1 31.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.058 0.456 . . . . 0.0 110.297 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 47.9 p -84.93 146.43 45.84 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 9.8 Cg_endo -51.12 -41.83 55.8 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.729 1.619 . . . . 0.0 111.251 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.464 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -57.81 -43.48 85.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.799 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.646 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.85 -58.28 3.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.36 0.6 . . . . 0.0 110.902 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 61' ' ' ASP . 2.2 pp -55.02 -75.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -170.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.641 ' N ' HD12 ' A' ' 60' ' ' LEU . 32.8 t70 -95.69 -13.83 23.92 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 122.367 1.08 . . . . 0.0 108.702 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.625 ' HA2' HD21 ' A' ' 25' ' ' LEU . . . -65.51 -33.25 85.85 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 113.315 -1.766 . . . . 0.0 113.964 -169.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 62' ' ' GLY . 5.3 t 51.2 21.58 1.13 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.497 1.119 . . . . 0.0 112.516 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.52 HG11 HG13 ' A' ' 99' ' ' ILE . 17.9 m -101.58 54.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 CA-C-O 123.001 1.381 . . . . 0.0 110.038 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.491 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -84.31 171.35 12.77 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 112.455 -2.157 . . . . 0.0 111.386 -171.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.49 112.02 1.15 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.175 -175.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.3 -0.24 5.97 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.574 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.661 ' O ' HG22 ' A' ' 49' ' ' ILE . 1.1 m-20 -99.35 149.16 23.44 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.216 0.532 . . . . 0.0 110.916 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 105' ' ' GLN . 5.4 mp0 -99.05 97.57 8.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.108 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.8 mm -69.72 139.43 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.888 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -124.91 -17.88 5.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.08 163.41 34.29 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.126 -1.512 . . . . 0.0 114.094 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -123.62 125.9 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 123.497 0.719 . . . . 0.0 109.267 179.03 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 54.2 30.26 11.97 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.52 -20.15 49.57 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.331 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -106.05 125.48 51.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 117.406 0.603 . . . . 0.0 111.226 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m -59.21 146.01 40.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.594 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.712 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -84.38 -25.61 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.452 0.644 . . . . 0.0 110.18 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -60.36 -24.12 64.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.536 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.97 -22.09 77.02 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.984 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -124.02 -120.43 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.287 -176.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 86' ' ' VAL . 7.3 m -148.91 150.08 32.33 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.49 -173.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -46.54 -56.66 5.68 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.378 0.671 . . . . 0.0 111.944 -177.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.84 -37.99 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.831 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 89' ' ' MET . 38.1 mt-10 -71.57 -36.4 70.89 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.712 HG11 ' HB ' ' A' ' 78' ' ' ILE . 19.9 m -71.54 -42.62 72.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.137 -175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 91' ' ' GLN . . . -51.73 -42.33 62.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.826 169.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 37.5 ttpt -60.85 -49.67 76.54 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.824 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.532 ' HE2' ' HA ' ' A' ' 86' ' ' VAL . 40.3 mtm -52.12 -39.09 59.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 110.431 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.579 HD13 HD11 ' A' ' 33' ' ' ILE . 68.1 mt -71.73 -39.17 68.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.441 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 6.7 mm-40 -71.33 -29.41 64.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.081 0.467 . . . . 0.0 110.505 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -72.15 -47.01 54.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.692 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 93' ' ' VAL . 16.8 m -71.51 51.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.793 0.806 . . . . 0.0 111.025 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -44.33 134.14 5.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.853 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.717 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 107.48 -36.88 4.11 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.438 171.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.27 147.39 32.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.737 0.779 . . . . 0.0 112.866 -168.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.463 HG12 ' NZ ' ' A' ' 27' ' ' LYS . 3.9 m -131.67 146.8 32.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.715 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.0 m -140.17 109.4 6.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 172.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -100.66 130.9 49.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.693 -174.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -106.1 123.11 47.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.917 173.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -137.14 146.19 44.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.273 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.651 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 54.2 m-20 -132.94 173.2 11.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.623 ' HB3' HD13 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -102.08 161.59 13.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 174.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.623 HD13 ' HB3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER 30.57 58.25 0.22 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.902 1.281 . . . . 0.0 114.246 -177.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.509 ' H ' ' HG2' ' A' ' 69' ' ' GLU . 9.4 tt0 -80.28 52.96 1.68 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.1 0.952 . . . . 0.0 109.703 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.45 179.06 8.91 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.078 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -133.98 155.12 80.46 Favored Pre-proline 0 CA--C 1.505 -0.769 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 21.7 Cg_exo -32.36 -48.43 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.796 2.997 . . . . 0.0 113.761 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 0.6 OUTLIER -59.04 -49.58 77.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.684 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.543 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 24.1 mm-40 -88.9 -15.82 33.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.437 0.636 . . . . 0.0 111.026 -175.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' C ' HD13 ' A' ' 111' ' ' LEU . 3.4 tm? -78.7 -39.33 36.88 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.998 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 7.3 pt-20 -68.98 -31.71 70.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.176 0.512 . . . . 0.0 109.924 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.5 t -61.71 -41.18 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.982 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 98.0 mt -76.2 -22.46 55.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.806 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.7 -52.77 40.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.861 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -103.77 -61.04 1.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.98 0.419 . . . . 0.0 110.374 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.528 ' HA2' ' HG2' ' A' ' 42' ' ' GLN . . . 118.87 58.5 0.27 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 113' ' ' VAL . 11.7 Cg_endo -52.77 -40.29 74.81 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.596 2.864 . . . . 0.0 112.924 -176.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -154.3 135.59 14.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.527 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -148.02 154.26 40.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.7 t -164.99 -34.09 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.77 0.319 . . . . 0.0 111.019 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 41.1 tp -104.66 104.51 14.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.496 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -130.17 88.38 2.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.652 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -147.54 121.9 9.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 173.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.502 ' CD1' ' HB3' ' A' ' 36' ' ' SER . 4.5 p90 -112.99 179.11 4.06 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.1 0.476 . . . . 0.0 111.581 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 37' ' ' ILE . 2.4 pp -96.18 168.81 10.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.136 175.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -141.91 93.9 2.61 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.17 -172.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.705 ' OXT' HG13 ' A' ' 33' ' ' ILE . 12.0 p . . . . . 0 N--CA 1.438 -1.029 0 CA-C-O 117.853 -1.07 . . . . 0.0 109.302 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.805 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.8 m -147.43 69.66 11.49 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.776 0.322 . . . . 0.0 110.286 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.92 66.84 7.11 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 122.781 2.321 . . . . 0.0 112.403 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.21 81.12 0.26 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.491 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 18.2 pt -64.57 154.7 83.81 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.596 ' HD2' HD22 ' A' ' 102' ' ' ASN . 20.4 Cg_endo -55.23 -84.4 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.626 2.884 . . . . 0.0 112.029 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -130.9 148.71 71.33 Favored Pre-proline 0 N--CA 1.431 -1.408 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 172.109 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.42 124.12 13.26 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.405 2.07 . . . . 0.0 111.542 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 103' ' ' LYS . . . -116.31 110.54 2.18 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.568 -176.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 100' ' ' HIS . 2.3 mppt? -143.1 110.65 5.82 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.27 152.27 35.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.839 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -122.11 126.95 49.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.461 0.648 . . . . 0.0 110.529 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 57' ' ' PRO . 2.4 mm? -122.44 -171.13 2.2 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.084 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 87.7 mt-30 -131.97 137.58 47.96 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.642 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.697 ' HZ3' ' HA ' ' A' ' 91' ' ' GLN . 25.0 mmtp -44.11 148.0 0.46 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 124.679 1.237 . . . . 0.0 112.663 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.75 -172.19 3.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.294 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.17 -22.02 65.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.231 0.538 . . . . 0.0 110.816 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.451 ' NE2' HD21 ' A' ' 32' ' ' LEU . 7.1 tt0 -96.35 11.07 36.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.231 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.8 t30 70.26 15.23 7.49 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.389 0.614 . . . . 0.0 111.506 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.656 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.5 pp -128.57 -173.07 2.86 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 121.958 -0.464 . . . . 0.0 111.588 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.85 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.0 -24.37 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.474 -176.294 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.12 41.24 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.486 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.483 HD11 HG12 ' A' ' 128' ' ' VAL . 2.8 pp -129.24 176.6 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.403 0.62 . . . . 0.0 111.71 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 32.1 m -140.59 128.1 21.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.389 174.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 49.6 mm -114.48 143.24 24.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.421 -174.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' HA3' ' CE3' ' A' ' 125' ' ' TRP . . . 179.41 124.11 0.86 Allowed Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.102 175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 44' ' ' CYS . . . -78.88 149.84 33.47 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.045 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.02 44.72 0.6 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.977 -1.106 . . . . 0.0 113.49 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.645 ' H ' ' HD2' ' A' ' 45' ' ' PRO . . . -90.72 -20.23 22.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 109.949 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -174.49 -63.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.656 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -103.98 -71.14 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.455 173.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.724 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 83.9 m -148.33 30.79 0.06 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.724 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 6.8 Cg_endo -93.29 160.82 2.5 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.639 1.559 . . . . 0.0 112.39 174.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.725 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 69.4 m 66.95 169.62 0.25 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.327 0.651 . . . . 0.0 112.505 175.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 46' ' ' CYS . 0.1 OUTLIER 54.08 -75.86 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.175 1.39 . . . . 0.0 112.895 -178.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 37.7 m-85 66.05 -65.78 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -85.01 109.76 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 118.014 -1.474 . . . . 0.0 109.96 -174.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.79 -25.37 3.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.63 -171.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -155.87 144.19 20.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.908 0.385 . . . . 0.0 110.817 -175.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 59' ' ' ALA . 5.6 p -140.43 161.11 24.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -94.43 -137.17 0.21 Allowed 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.303 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -137.27 -36.4 0.66 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.498 ' HA ' HD23 ' A' ' 60' ' ' LEU . 32.8 m-80 -100.6 -0.38 37.73 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.435 0.636 . . . . 0.0 109.495 -171.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 44.6 p -87.99 144.74 35.1 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 6.5 Cg_endo -47.04 -40.35 26.08 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.291 1.994 . . . . 0.0 111.689 -174.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.437 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -59.02 -52.26 66.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.229 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.675 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.77 -55.61 6.48 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.898 0.856 . . . . 0.0 109.524 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.9 OUTLIER -43.69 -76.17 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.186 -1.825 . . . . 0.0 113.081 -178.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.14 -39.58 9.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.211 0.529 . . . . 0.0 111.872 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.74 -20.34 74.09 Favored Glycine 0 N--CA 1.458 0.162 0 CA-C-N 115.447 -0.797 . . . . 0.0 114.28 -166.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 t 47.23 33.48 2.57 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.194 0.998 . . . . 0.0 111.761 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.641 HG11 HG13 ' A' ' 99' ' ' ILE . 11.9 m -94.6 55.22 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 CA-C-O 122.871 1.32 . . . . 0.0 109.697 175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.45 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.77 165.36 18.91 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.42 -2.173 . . . . 0.0 111.049 -169.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -56.64 104.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.124 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.39 -8.88 2.14 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.478 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 49' ' ' ILE . 22.6 m-20 -98.69 177.05 5.42 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 41.5 mt-10 -120.97 143.02 49.24 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.039 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.511 ' H ' ' HB2' ' A' ' 48' ' ' TYR . 18.2 mm -119.12 119.39 60.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.692 HG22 ' CB ' ' A' ' 101' ' ' TYR . 5.5 t -105.25 -26.85 11.86 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.533 -177.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.71 155.46 26.15 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 118.875 -1.631 . . . . 0.0 114.448 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.975 HG13 HG22 ' A' ' 78' ' ' ILE . 6.7 m -110.02 142.59 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.291 176.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.578 ' HA ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER 61.17 19.34 9.95 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.94 0.4 . . . . 0.0 110.719 171.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.17 -15.37 60.47 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 116.11 -0.495 . . . . 0.0 113.403 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 76' ' ' ARG . 5.9 ptt180 -118.56 139.18 51.87 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 117.124 0.462 . . . . 0.0 112.012 -174.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 71' ' ' THR . 35.6 m -50.15 141.6 10.96 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.975 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -83.8 -25.71 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.169 -175.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -63.48 -13.69 43.19 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.349 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.35 -30.08 76.47 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.636 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.664 ' HG2' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -119.33 -117.17 0.32 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.77 0.785 . . . . 0.0 112.069 -179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.61 ' O ' ' HB ' ' A' ' 86' ' ' VAL . 3.2 m -161.5 151.14 16.64 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -168.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 123' ' ' ARG . 2.6 mttm -39.96 -57.32 1.64 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 85' ' ' GLU . 7.1 p -55.98 -32.33 32.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.456 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 89' ' ' MET . 30.9 mt-10 -90.56 -25.93 19.97 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 123.048 1.404 . . . . 0.0 108.318 -175.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.664 HG23 ' HG2' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -75.21 -42.86 44.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 111.797 -2.456 . . . . 0.0 110.778 -175.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.55 73.21 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -61.0 -52.7 63.89 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.157 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 88.2 mmm -45.44 -50.37 12.61 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.495 0.497 . . . . 0.0 112.004 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.447 ' HB ' HG21 ' A' ' 128' ' ' VAL . 25.3 mm -60.09 -53.51 47.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.236 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.697 ' HA ' ' HZ3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -75.31 -25.34 57.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 122.205 -0.309 . . . . 0.0 111.483 -173.034 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.51 -52.51 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.564 0.345 . . . . 0.0 111.707 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 90' ' ' ILE . 20.5 m -49.45 -36.52 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 O-C-N 123.462 0.476 . . . . 0.0 110.95 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 95' ' ' GLY . 4.4 tmmm? 67.5 138.08 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.723 0.773 . . . . 0.0 112.196 169.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 89.71 -33.05 4.54 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.505 171.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 13.6 pt-20 -145.3 177.24 8.96 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.576 HG11 HG23 ' A' ' 33' ' ' ILE . 10.4 m -146.98 153.48 12.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.975 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -141.21 106.62 5.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 176.005 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.641 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -100.07 140.19 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.536 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.556 ' O ' ' HB2' ' A' ' 101' ' ' TYR . 1.3 t60 -135.67 127.48 29.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.187 -174.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.692 ' CB ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER 171.28 -99.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.301 1.001 . . . . 0.0 111.912 162.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.706 ' OD1' ' HB2' ' A' ' 69' ' ' GLU . 29.2 p-10 -155.89 159.18 39.09 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.74 -162.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 23.5 mmtt -128.0 119.54 25.69 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.425 0.631 . . . . 0.0 112.539 -170.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -168.49 36.66 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.664 -177.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -40.19 96.12 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 124.982 1.426 . . . . 0.0 111.994 -173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.522 ' HB1' ' HG3' ' A' ' 110' ' ' GLN . . . -75.87 172.13 13.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.974 -174.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.625 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 41.5 m-20 -127.16 152.89 76.59 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 17.5 Cg_exo -29.89 -52.59 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.008 3.139 . . . . 0.0 114.499 -172.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -60.32 -50.37 73.91 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.625 ' CG ' ' H ' ' A' ' 107' ' ' ASP . 21.2 pt20 -90.7 -9.62 46.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.9 0.857 . . . . 0.0 111.911 -173.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 111' ' ' LEU . 1.9 tm? -86.21 -41.39 14.69 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.384 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 8.0 pt-20 -64.89 -21.05 66.74 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 110' ' ' GLN . 61.1 t -58.04 -38.53 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.436 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.5 mp -81.0 -22.74 39.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.662 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -110.52 36.14 3.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 71.41 -79.11 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.959 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.55 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . -177.54 -55.27 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 12.1 Cg_endo -53.77 139.98 67.7 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 123.817 3.012 . . . . 0.0 112.931 171.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -108.74 118.63 37.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -160.59 168.45 24.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.126 -174.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.423 ' HB ' ' NE1' ' A' ' 125' ' ' TRP . 7.5 t -134.8 124.62 25.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.227 0.537 . . . . 0.0 110.59 174.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 98.1 mt -119.08 -39.38 2.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.148 176.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.564 ' O ' ' HE3' ' A' ' 83' ' ' LYS . 3.6 tpm_? -89.94 2.49 55.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.951 -175.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 123' ' ' ARG . 89.8 m-70 72.99 145.16 0.07 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.506 0.67 . . . . 0.0 112.222 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.454 ' CE3' ' HA3' ' A' ' 38' ' ' GLY . 7.6 m95 -104.23 154.17 20.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.712 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.508 HD21 ' HB ' ' A' ' 37' ' ' ILE . 1.8 pp -112.37 168.71 9.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 15.1 ptmm? -149.89 134.69 17.72 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.811 0.338 . . . . 0.0 110.221 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.85 ' OXT' HG13 ' A' ' 33' ' ' ILE . 7.7 p . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.775 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 112.307 -0.317 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.6 m -89.62 129.4 47.06 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.583 0.23 . . . . 0.0 110.441 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.94 63.42 6.77 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.625 2.217 . . . . 0.0 111.855 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.21 128.71 11.87 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.209 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.478 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 6.1 pt -123.04 161.06 46.75 Favored Pre-proline 0 C--N 1.321 -0.636 0 O-C-N 122.951 -0.146 . . . . 0.0 111.101 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.691 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 18.8 Cg_endo -53.63 -82.67 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.558 2.839 . . . . 0.0 112.272 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.0 t -133.6 121.2 16.06 Favored Pre-proline 0 N--CA 1.434 -1.27 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -60.47 120.78 8.72 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.977 2.451 . . . . 0.0 112.196 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' HA3' ' CE1' ' A' ' 101' ' ' TYR . . . -129.32 163.68 22.47 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.559 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.631 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 21.2 ptmt -157.27 136.84 12.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.834 0.317 . . . . 0.0 111.828 -178.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG23 HD11 ' A' ' 99' ' ' ILE . 24.8 m -127.64 149.21 32.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 168.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -120.98 126.31 49.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.684 0.754 . . . . 0.0 110.448 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' HB2' ' CG2' ' A' ' 97' ' ' VAL . 5.2 mt -132.64 -167.62 1.93 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.359 -175.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.1 mt-30 -134.37 142.56 47.24 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.019 0.438 . . . . 0.0 110.158 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HG3' ' H ' ' A' ' 95' ' ' GLY . 27.9 mmtp -48.74 152.55 0.97 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.841 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 30' ' ' GLN . 4.0 p-10 -85.74 -164.55 1.04 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.3 -24.64 67.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.855 0.359 . . . . 0.0 111.615 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 1.9 mt-30 -92.21 4.65 52.8 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.104 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 36.5 t30 71.15 24.9 3.75 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.121 0.962 . . . . 0.0 110.831 176.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.549 ' HB2' ' C ' ' A' ' 128' ' ' VAL . 1.7 pp -131.05 -170.15 2.3 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.721 -0.612 . . . . 0.0 111.277 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.759 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.02 -21.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.152 -176.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.81 30.08 6.61 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.969 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.485 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.9 pp -124.33 175.62 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.711 0.767 . . . . 0.0 112.43 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -136.25 126.42 26.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.056 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.547 ' H ' ' HB3' ' A' ' 126' ' ' LEU . 46.7 mm -97.66 146.84 7.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.404 0.621 . . . . 0.0 111.071 -176.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.83 161.68 28.07 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.635 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' HA2' ' CA ' ' A' ' 46' ' ' CYS . . . -90.35 137.97 14.23 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.006 -175.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.502 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -143.93 17.57 2.17 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 119.032 -1.556 . . . . 0.0 114.235 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.409 ' H ' ' HD2' ' A' ' 45' ' ' PRO . . . -68.9 -78.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.35 0.575 . . . . 0.0 110.268 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -148.78 -46.69 0.15 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.68 0.276 . . . . 0.0 110.514 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -92.21 4.31 53.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.196 0.522 . . . . 0.0 110.266 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.512 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 46.5 t 73.79 61.66 0.32 Allowed Pre-proline 0 C--N 1.333 -0.109 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.077 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 4.7 Cg_exo -80.26 -80.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.316 2.01 . . . . 0.0 111.571 176.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.617 ' O ' HD23 ' A' ' 47' ' ' LEU . 69.3 m -157.8 156.77 32.1 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 46' ' ' CYS . 1.1 pp 160.49 -42.72 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.67 1.232 . . . . 0.0 110.734 158.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.502 ' CD2' ' HA3' ' A' ' 40' ' ' GLY . 90.5 m-85 -76.57 146.48 38.3 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.239 0.542 . . . . 0.0 111.406 176.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -96.84 120.47 46.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.868 171.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.83 -31.9 12.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.851 -170.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 2.9 pt20 -165.5 152.05 9.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.932 0.396 . . . . 0.0 110.213 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.481 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 9.7 p -142.02 161.66 20.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.317 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.528 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 90.5 m-85 -110.99 123.69 50.68 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.525 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 28.2 t70 -58.81 -19.88 45.15 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.675 -1.148 . . . . 0.0 113.869 -164.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.85 2.95 38.79 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.79 -175.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 20.7 p -89.08 153.58 49.15 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 6.5 Cg_endo -49.44 -43.18 39.5 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.801 1.667 . . . . 0.0 111.532 -176.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.43 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -54.33 -50.69 66.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.029 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 54' ' ' ASP . . . -76.11 -54.01 7.46 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.067 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.608 HD12 ' N ' ' A' ' 61' ' ' ASP . 1.7 pp -53.67 -74.68 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -170.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.608 ' N ' HD12 ' A' ' 60' ' ' LEU . 38.7 t70 -94.24 -14.62 25.32 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.405 1.097 . . . . 0.0 108.305 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -72.08 -51.55 13.84 Favored Glycine 0 C--N 1.312 -0.779 0 CA-C-N 113.259 -1.792 . . . . 0.0 113.129 -170.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.11 47.45 5.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.298 1.047 . . . . 0.0 111.119 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.504 HG11 HG13 ' A' ' 99' ' ' ILE . 19.5 m -124.86 49.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.3 176.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.38 -179.57 7.21 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.31 -1.313 . . . . 0.0 112.348 -169.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -47.61 118.03 2.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.568 -172.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.91 -16.97 20.47 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.384 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 49' ' ' ILE . 6.7 m-20 -81.97 157.02 24.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.949 0.404 . . . . 0.0 110.808 -178.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -101.04 124.54 46.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.037 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.418 HD13 ' HB ' ' A' ' 49' ' ' ILE . 4.2 mp -106.44 98.69 7.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -80.87 -15.01 57.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.25 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.503 ' HA2' HG23 ' A' ' 78' ' ' ILE . . . -160.77 152.27 22.91 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 119.119 -1.515 . . . . 0.0 114.562 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.873 HG13 HG22 ' A' ' 78' ' ' ILE . 5.9 m -99.81 140.76 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 114.312 -0.944 . . . . 0.0 108.803 176.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.506 ' ND2' HG11 ' A' ' 93' ' ' VAL . 4.9 t-20 58.13 19.1 5.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.976 0.417 . . . . 0.0 111.618 170.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.36 -20.34 48.96 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.174 -0.467 . . . . 0.0 113.259 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 76' ' ' ARG . 9.8 ptm180 -105.01 134.19 48.54 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 117.143 0.472 . . . . 0.0 110.663 -176.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -52.09 138.62 25.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 0.0 111.724 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.873 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -77.7 -13.43 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.877 0.846 . . . . 0.0 109.056 -176.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -59.76 -13.42 10.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.907 -173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.76 -24.14 76.47 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.671 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -143.14 -137.89 0.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.357 0.578 . . . . 0.0 111.238 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.443 ' O ' HG13 ' A' ' 86' ' ' VAL . 26.6 p -139.86 170.83 15.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.612 0.244 . . . . 0.0 111.598 -170.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.562 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -50.19 -54.16 22.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.743 -175.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.73 -35.46 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.152 0.501 . . . . 0.0 111.426 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' OE2' ' HB2' ' A' ' 81' ' ' LYS . 31.8 mt-10 -80.54 -35.86 33.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.768 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.644 HG11 ' HB ' ' A' ' 78' ' ' ILE . 33.7 m -71.04 -41.38 76.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.584 0.23 . . . . 0.0 111.269 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 126' ' ' LEU . . . -52.54 -39.59 61.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.027 0.441 . . . . 0.0 109.931 169.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 61.5 tttm -64.64 -49.49 70.84 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.519 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 87.6 mtp -50.37 -41.93 52.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.418 0.628 . . . . 0.0 110.473 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.544 HD13 HD11 ' A' ' 33' ' ' ILE . 63.4 mt -70.26 -47.26 67.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.389 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -65.02 -32.52 74.28 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.801 -0.562 . . . . 0.0 111.569 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.06 -46.9 88.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.706 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.506 HG11 ' ND2' ' A' ' 74' ' ' ASN . 9.9 m -75.89 41.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.228 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -45.88 137.52 5.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.802 0.811 . . . . 0.0 111.844 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.527 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 107.61 -32.91 6.71 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.01 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.7 pt-20 -143.87 176.6 9.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.067 0.461 . . . . 0.0 110.799 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.575 HG11 HG23 ' A' ' 33' ' ' ILE . 6.1 m -152.21 150.57 12.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.043 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 40.7 m -141.29 117.6 10.74 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 170.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -104.92 129.04 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.12 -177.371 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.88 116.27 32.36 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.613 ' CD1' ' HE2' ' A' ' 103' ' ' LYS . 17.9 p90 -120.25 160.98 21.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.563 0.697 . . . . 0.0 112.486 -170.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.498 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . 2.1 p-10 -135.5 145.82 47.48 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.502 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.718 ' O ' HD12 ' A' ' 104' ' ' LEU . 63.4 mmtt -122.38 -62.68 1.35 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -167.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER 34.92 -98.96 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.665 0.786 . . . . 0.0 112.509 -168.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -166.33 72.24 0.14 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.367 0.603 . . . . 0.0 109.916 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.15 166.73 24.57 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.951 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.578 ' OD1' ' HG2' ' A' ' 109' ' ' LYS . 1.0 OUTLIER 173.27 158.78 0.28 Allowed Pre-proline 0 C--O 1.211 -0.939 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -172.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 107' ' ' ASP . 1.4 Cg_exo -29.88 -41.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.309 2.673 . . . . 0.0 113.858 173.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.578 ' HG2' ' OD1' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -62.82 -49.76 73.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.727 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.481 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 76.3 mm-40 -87.35 -13.12 44.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.491 0.662 . . . . 0.0 110.597 -177.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 107' ' ' ASP . 2.7 tm? -75.65 -44.03 44.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.368 -176.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -68.62 -30.89 69.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.029 0.442 . . . . 0.0 109.981 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 109' ' ' LYS . 88.4 t -69.54 -29.8 42.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.59 0.709 . . . . 0.0 109.758 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 114' ' ' LEU . 8.0 tt -73.3 -27.47 61.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -103.44 35.45 2.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.562 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 71.48 -70.42 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.362 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.605 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . -166.41 -51.34 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 10.1 Cg_endo -48.74 108.56 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.711 2.941 . . . . 0.0 113.019 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -83.76 177.06 8.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.807 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -147.84 126.22 12.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.281 0.563 . . . . 0.0 111.297 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.2 t -160.5 87.56 0.76 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.977 0.894 . . . . 0.0 109.328 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 122' ' ' LEU . 6.2 mp -76.06 -80.02 0.1 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.677 -174.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -172.07 3.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -88.2 87.54 7.35 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.65 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -104.4 161.8 13.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.605 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -129.71 162.54 28.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.219 -177.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.626 ' N ' HD13 ' A' ' 126' ' ' LEU . 21.8 pttp -156.21 121.78 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.466 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.759 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.2 p . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 117.957 -1.021 . . . . 0.0 108.638 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.0 p -125.83 91.71 47.78 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.775 0.321 . . . . 0.0 110.478 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.72 -25.13 5.57 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.281 1.987 . . . . 0.0 112.35 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.75 127.43 7.69 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.469 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.527 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 16.3 pt -92.15 153.71 43.17 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 17' ' ' ILE . 20.8 Cg_endo -57.87 -71.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.001 2.467 . . . . 0.0 112.687 -169.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.06 89.47 9.78 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 172.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.4 126.86 21.93 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.299 2.666 . . . . 0.0 113.18 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -141.21 139.78 9.81 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 51.8 pttt -159.13 130.83 6.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.023 0.439 . . . . 0.0 111.134 -175.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -137.44 147.02 26.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.93 -0.766 . . . . 0.0 108.93 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.3 t -112.59 123.13 49.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.489 0.661 . . . . 0.0 110.965 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.552 HD21 ' HA2' ' A' ' 62' ' ' GLY . 9.6 mt -127.13 -168.96 1.95 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.589 -176.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.63 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.2 mt-30 -132.89 142.05 48.71 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.827 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HD3' ' CG1' ' A' ' 97' ' ' VAL . 29.9 mmtm -48.38 153.42 0.74 Allowed 'General case' 0 C--N 1.32 -0.711 0 O-C-N 124.631 1.207 . . . . 0.0 113.013 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -86.55 -178.66 6.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.521 173.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.68 -21.76 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.267 0.556 . . . . 0.0 111.364 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.453 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -94.64 6.5 48.69 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.307 -177.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.538 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 47.3 t30 67.33 32.01 6.17 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.36 1.076 . . . . 0.0 110.613 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 1.4 pp -136.93 -169.51 2.49 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.041 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.1 -26.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.685 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.2 29.18 6.15 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.299 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 2.8 pp -118.21 172.3 5.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.668 0.747 . . . . 0.0 111.555 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 60.0 m -139.1 127.31 22.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.541 175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.443 HG21 HD23 ' A' ' 126' ' ' LEU . 48.3 mm -98.3 130.09 47.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.274 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.01 129.1 9.73 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.11 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' HA2' ' C ' ' A' ' 45' ' ' PRO . . . -68.3 125.5 21.15 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.093 -176.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.583 ' HA3' ' CD1' ' A' ' 47' ' ' LEU . . . -78.92 -9.95 86.63 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 119.887 -1.149 . . . . 0.0 114.477 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.553 ' H ' ' HA ' ' A' ' 45' ' ' PRO . . . -149.58 -171.54 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.121 0.96 . . . . 0.0 111.674 -174.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -90.75 -49.6 6.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.027 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 119' ' ' GLN . 83.1 m-85 -80.27 -42.74 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.187 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 118' ' ' PRO . 63.2 m -120.55 66.58 12.98 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.819 0.342 . . . . 0.0 111.22 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.555 ' HD3' ' C ' ' A' ' 43' ' ' TYR . 7.6 Cg_exo -78.69 83.05 2.32 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.813 2.342 . . . . 0.0 113.294 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.529 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 64.1 m -148.14 126.26 12.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 168.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.583 ' CD1' ' HA3' ' A' ' 40' ' ' GLY . 47.6 mt -164.64 -92.77 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.598 1.19 . . . . 0.0 111.224 172.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -59.45 150.16 27.42 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 112.064 -2.334 . . . . 0.0 112.208 -172.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.81 104.19 15.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 163.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.9 t -79.03 -29.36 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.018 -168.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' A' ' 36' ' ' SER . 2.6 pt20 -161.03 152.42 19.09 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.221 0.534 . . . . 0.0 110.112 -173.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 59' ' ' ALA . 8.5 p -142.13 160.94 20.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.326 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.559 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 97.8 m-85 -111.63 125.97 54.52 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.691 0.758 . . . . 0.0 109.217 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -51.36 -29.16 14.53 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.803 -1.544 . . . . 0.0 114.136 -166.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.511 ' HA ' HD23 ' A' ' 60' ' ' LEU . 51.3 m-80 -102.18 9.14 40.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.864 0.364 . . . . 0.0 110.729 -172.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.559 ' CG2' ' HB2' ' A' ' 53' ' ' PHE . 32.7 p -95.55 147.72 33.46 Favored Pre-proline 0 CA--C 1.501 -0.936 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.3 Cg_endo -47.32 -39.65 27.71 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.111 1.874 . . . . 0.0 111.235 -175.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . . . -55.89 -57.2 13.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.201 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.567 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.96 -54.62 8.18 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.458 0.647 . . . . 0.0 110.026 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -44.15 -75.52 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.783 -178.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' HB3' HD22 ' A' ' 25' ' ' LEU . 22.0 t70 -97.48 -31.66 12.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.035 0.445 . . . . 0.0 111.942 -174.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.552 ' HA2' HD21 ' A' ' 25' ' ' LEU . . . -72.4 -36.67 59.22 Favored Glycine 0 C--O 1.227 -0.281 0 N-CA-C 115.127 0.811 . . . . 0.0 115.127 -166.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.9 p 65.06 24.02 12.5 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.181 0.991 . . . . 0.0 110.788 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 99' ' ' ILE . 31.2 m -94.82 49.0 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.646 174.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.74 -179.43 7.11 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.949 -170.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.0 135.18 37.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.934 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.81 -11.1 20.93 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.888 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 49' ' ' ILE . 13.8 m-20 -101.23 178.09 4.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.905 0.353 . . . . 0.0 110.515 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HG3' ' H ' ' A' ' 104' ' ' LEU . 15.5 mm-40 -120.9 143.4 48.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.1 mm -104.94 115.85 47.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.481 HG21 HG21 ' A' ' 17' ' ' ILE . 9.7 t -113.87 1.39 14.75 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -173.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 78' ' ' ILE . . . -163.1 145.71 10.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.208 -1.473 . . . . 0.0 114.296 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.828 HG13 HG22 ' A' ' 78' ' ' ILE . 6.0 m -110.88 143.45 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.532 -0.834 . . . . 0.0 109.73 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 55.9 26.58 9.93 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.623 0.725 . . . . 0.0 111.608 164.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.48 -14.57 64.47 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.525 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -109.46 172.42 6.87 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 123.084 0.554 . . . . 0.0 110.291 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 t -74.13 174.96 7.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.97 0.414 . . . . 0.0 110.47 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.828 HG22 HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -109.15 -14.04 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.485 0.659 . . . . 0.0 109.328 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.646 ' HD2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -64.25 -19.14 65.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.855 -169.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.01 -20.84 76.62 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.619 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -142.51 -145.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.275 0.538 . . . . 0.0 110.655 -178.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.3 t -140.78 173.38 11.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.55 0.214 . . . . 0.0 110.564 -169.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' HA ' HG22 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -41.14 -61.27 1.03 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.556 1.143 . . . . 0.0 113.843 -175.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -57.31 -36.38 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 120.976 0.417 . . . . 0.0 111.503 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 89' ' ' MET . 34.3 mt-10 -80.62 -33.11 36.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.016 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.589 HG11 ' HB ' ' A' ' 78' ' ' ILE . 35.1 m -70.09 -45.63 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.453 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.11 -37.6 83.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -61.08 -52.27 65.63 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.236 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 21.1 mmt -50.02 -40.34 44.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.23 0.538 . . . . 0.0 111.686 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.591 HD13 HD11 ' A' ' 33' ' ' ILE . 44.1 mt -65.77 -53.05 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.113 178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.538 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 4.1 pt20 -80.29 -18.54 48.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.42 -53.05 60.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.951 0.5 . . . . 0.0 111.098 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 90' ' ' ILE . 12.6 m -56.42 -27.68 25.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.978 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 pttm 48.98 157.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.113 1.365 . . . . 0.0 113.439 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.37 -50.81 4.29 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.117 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 9.4 pt-20 -132.9 177.2 7.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.021 0.438 . . . . 0.0 109.936 -173.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.54 HG11 HG23 ' A' ' 33' ' ' ILE . 8.8 m -151.04 153.54 9.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.685 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.5 m -140.89 100.09 3.75 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.598 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -90.64 138.07 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.71 -172.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -116.36 117.73 30.78 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -125.59 154.96 41.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.461 0.648 . . . . 0.0 111.926 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 18' ' ' PRO . 14.6 p-10 -140.05 176.84 8.42 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.652 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -132.39 80.63 1.91 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.528 ' H ' ' HG3' ' A' ' 69' ' ' GLU . 0.8 OUTLIER -176.62 157.8 1.64 Allowed 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.378 0.671 . . . . 0.0 110.52 170.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -97.1 15.03 23.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.47 ' HB1' ' HG3' ' A' ' 110' ' ' GLN . . . 68.07 -179.15 0.22 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.253 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.602 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 24.8 t70 -135.88 143.65 45.28 Favored Pre-proline 0 C--O 1.214 -0.805 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 6.3 Cg_exo -29.34 -50.63 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.016 3.144 . . . . 0.0 115.073 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.0 ptpt -58.08 -49.1 78.1 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.602 ' CG ' ' H ' ' A' ' 107' ' ' ASP . 3.7 pt20 -90.15 -13.53 35.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.845 0.831 . . . . 0.0 111.76 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.443 ' C ' HD13 ' A' ' 111' ' ' LEU . 1.7 tm? -79.35 -40.77 29.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.495 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 6.7 pt-20 -65.97 -29.14 69.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.204 0.526 . . . . 0.0 109.72 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 109' ' ' LYS . 79.2 t -58.88 -45.46 91.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.556 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.412 ' HA ' ' CG ' ' A' ' 79' ' ' LYS . 10.9 mp -80.7 -16.68 53.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.533 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -74.24 -42.61 59.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.706 -176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -78.73 60.61 2.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.452 0.644 . . . . 0.0 111.747 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 79' ' ' LYS . . . -159.87 -61.8 0.01 OUTLIER Glycine 0 C--N 1.309 -0.952 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 171.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.482 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 10.4 Cg_exo -40.61 -142.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 1 C-N-CA 125.552 4.168 . . . . 0.0 115.958 164.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.693 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 9.3 tt0 70.21 -119.1 0.11 Allowed 'General case' 0 C--O 1.237 0.417 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.687 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 119' ' ' GLN . 84.3 m-85 69.29 -60.06 0.47 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.319 0.647 . . . . 0.0 110.759 -172.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.7 p -135.85 133.63 37.99 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 pp -85.32 168.5 14.62 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.708 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 124' ' ' HIS . 12.5 tpp180 69.97 -163.77 0.17 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -174.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.415 ' H ' ' HG3' ' A' ' 123' ' ' ARG . 10.7 m-70 64.52 125.2 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.556 0.693 . . . . 0.0 112.589 177.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -89.82 172.13 9.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.064 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 127' ' ' LYS . 35.0 tp -124.03 149.62 45.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -175.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' H ' HD12 ' A' ' 126' ' ' LEU . 10.4 ptmm? -167.27 162.74 15.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.335 173.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.731 ' O ' HG13 ' A' ' 33' ' ' ILE . 5.0 p . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 170.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.6 m -127.92 83.91 64.76 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.62 0.248 . . . . 0.0 110.581 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.46 151.0 32.72 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.393 2.062 . . . . 0.0 112.088 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.09 64.46 3.94 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.563 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.496 HD12 ' ND2' ' A' ' 102' ' ' ASN . 5.3 pt -117.21 138.8 25.23 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.692 ' HD3' HD11 ' A' ' 104' ' ' LEU . 29.3 Cg_endo -65.23 -80.91 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.932 2.421 . . . . 0.0 114.091 -163.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 76.9 t -109.89 101.35 46.74 Favored Pre-proline 0 N--CA 1.442 -0.861 0 CA-C-O 121.369 0.604 . . . . 0.0 110.475 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 18' ' ' PRO . 4.2 Cg_endo -85.78 121.1 2.09 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 124.089 3.193 . . . . 0.0 113.136 -176.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.624 ' HA2' ' CG ' ' A' ' 100' ' ' HIS . . . 126.64 -105.5 0.78 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.044 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 13.9 mmmm 99.92 -90.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.067 1.347 . . . . 0.0 113.221 174.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.589 HG23 HD11 ' A' ' 99' ' ' ILE . 25.3 m -125.55 160.7 31.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 118.096 -1.442 . . . . 0.0 112.583 -164.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -135.6 118.05 15.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.525 0.678 . . . . 0.0 110.539 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' C ' ' HB ' ' A' ' 97' ' ' VAL . 3.3 mm? -113.58 -159.4 0.69 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.055 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 95' ' ' GLY . 2.0 pt20 -142.39 149.31 39.18 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 31' ' ' ASN . 36.1 mmtm -37.19 151.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.407 ' HB3' HD12 ' A' ' 32' ' ' LEU . 18.3 t70 -83.67 177.67 8.29 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.034 -1.894 . . . . 0.0 109.126 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.57 -25.37 62.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.103 0.41 . . . . 0.0 111.404 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.495 HE21 HD21 ' A' ' 32' ' ' LEU . 7.2 tt0 -94.2 20.33 8.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.39 0.614 . . . . 0.0 110.336 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 2.4 p-10 54.35 30.04 11.94 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.938 1.295 . . . . 0.0 112.629 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 0.9 OUTLIER -128.05 -166.5 1.63 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.561 175.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.747 HG13 ' OXT' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -105.97 -25.98 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.545 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.469 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 97.7 39.68 3.82 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.526 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.568 HG13 ' OXT' ' A' ' 128' ' ' VAL . 2.9 pp -131.44 172.48 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.822 0.82 . . . . 0.0 111.854 -177.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 126' ' ' LEU . 27.2 m -138.16 127.86 25.14 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.193 175.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.663 ' HB ' ' CD2' ' A' ' 126' ' ' LEU . 49.7 mm -106.44 119.87 56.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.423 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -137.5 -163.31 9.63 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.01 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.2 125.98 7.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.428 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 45' ' ' PRO . . . -83.96 -171.27 47.64 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.958 169.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.18 -86.73 0.11 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -130.77 -67.75 0.71 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.908 0.385 . . . . 0.0 111.352 -177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -135.66 40.65 2.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.258 -175.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 2.6 m -146.78 -71.29 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 44' ' ' CYS . 39.2 Cg_endo -90.47 146.68 4.17 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.487 1.458 . . . . 0.0 111.882 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.423 ' SG ' ' HA2' ' A' ' 67' ' ' GLY . 56.3 m -80.36 150.82 29.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 0.0 110.884 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.15 130.73 34.96 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.53 1.157 . . . . 0.0 112.862 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.63 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 25.0 m-85 66.94 -78.03 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.041 -1.89 . . . . 0.0 111.183 -172.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.717 HG22 ' O ' ' A' ' 68' ' ' ASP . 2.3 tt -85.4 122.91 38.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 118.549 -1.261 . . . . 0.0 111.166 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.25 -21.12 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.583 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.64 143.6 18.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.454 -173.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.9 p -139.1 160.35 29.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 173.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -94.73 -140.81 0.24 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -130.0 -43.05 1.22 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.937 0.79 . . . . 0.0 112.408 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.738 ' HA ' HD23 ' A' ' 60' ' ' LEU . 1.0 OUTLIER -99.29 13.7 32.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.387 0.613 . . . . 0.0 110.067 -172.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.583 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 65.7 p -91.95 141.1 25.02 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 7.7 Cg_endo -48.06 -38.22 31.67 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 121.935 1.756 . . . . 0.0 111.413 -173.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.537 ' HB1' HG12 ' A' ' 64' ' ' VAL . . . -54.33 -56.56 17.24 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.762 175.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.74 -56.95 4.25 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.472 0.653 . . . . 0.0 110.187 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 55' ' ' ASN . 1.2 tm? -42.28 -76.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.675 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -96.15 -37.88 10.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.819 -171.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.568 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . -64.3 -74.55 0.45 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.261 -168.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 6.0 t 130.86 0.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.195 1.398 . . . . 0.0 108.853 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.537 HG12 ' HB1' ' A' ' 58' ' ' ALA . 0.6 OUTLIER -75.96 58.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 124.651 2.167 . . . . 0.0 111.849 -175.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.595 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -85.73 173.0 10.4 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 113.633 -1.622 . . . . 0.0 110.19 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.78 124.85 20.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.165 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.423 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . 127.67 -15.99 6.25 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.923 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.717 ' O ' HG22 ' A' ' 49' ' ' ILE . 2.2 m-20 -89.66 146.45 24.52 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.028 0.442 . . . . 0.0 110.688 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -89.58 88.76 7.54 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.507 HD11 HG13 ' A' ' 64' ' ' VAL . 40.6 mt -87.26 94.66 4.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.496 -176.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' SER . 11.1 t -102.35 1.79 35.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.545 -171.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 77' ' ' SER . . . -134.3 130.61 5.63 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.777 -1.201 . . . . 0.0 113.923 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.737 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -99.63 125.4 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 C-N-CA 123.939 0.896 . . . . 0.0 108.938 177.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 59.53 21.62 10.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.075 0.464 . . . . 0.0 110.947 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' HA2' ' ND1' ' A' ' 100' ' ' HIS . . . 101.4 -19.02 52.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.562 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -112.33 141.22 46.32 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 117.656 0.728 . . . . 0.0 111.148 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.498 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 51.0 m -48.81 143.45 5.33 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.744 ' HB ' HG11 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -83.93 -18.3 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.266 -176.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -61.56 -25.36 67.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.964 -170.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.25 -15.27 78.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.782 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.631 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 5.7 mptt -108.98 -119.43 0.27 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.71 0.767 . . . . 0.0 109.882 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.53 ' O ' HG13 ' A' ' 86' ' ' VAL . 10.2 t -179.7 167.17 1.38 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.803 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.501 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -50.12 -53.03 30.27 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.8 0.687 . . . . 0.0 112.431 -171.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.24 -39.72 85.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.983 0.42 . . . . 0.0 111.761 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -74.19 -42.6 59.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.744 HG11 ' HB ' ' A' ' 78' ' ' ILE . 27.7 m -57.91 -43.15 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 126' ' ' LEU . . . -53.39 -42.99 67.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.832 174.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -64.59 -49.95 69.15 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.306 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.9 mmt -49.84 -46.22 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.274 0.559 . . . . 0.0 110.904 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 93' ' ' VAL . 20.4 mm -59.18 -56.9 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.873 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.67 -24.81 67.1 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.07 -46.18 88.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.142 0.496 . . . . 0.0 111.361 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 93' ' ' VAL . 13.2 m -72.88 55.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.104 0.954 . . . . 0.0 110.581 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -43.35 131.84 4.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.677 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 26' ' ' GLN . . . 107.32 -35.47 5.0 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.072 170.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 12.9 pt-20 -132.56 177.81 7.33 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.102 0.477 . . . . 0.0 110.903 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 33' ' ' ILE . 16.9 t -152.28 133.64 5.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.314 -170.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.4 m -132.45 116.25 16.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 174.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.589 HD11 HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -107.47 124.2 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 121.128 0.489 . . . . 0.0 111.602 -176.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.624 ' CG ' ' HA2' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -112.96 103.14 11.1 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.734 173.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -128.55 162.9 26.17 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.496 ' ND2' HD12 ' A' ' 17' ' ' ILE . 31.3 m-80 -136.66 163.55 30.31 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.892 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.684 ' C ' ' HG ' ' A' ' 104' ' ' LEU . 11.2 mmpt? -94.02 166.06 12.34 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.621 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.692 HD11 ' HD3' ' A' ' 18' ' ' PRO . 0.5 OUTLIER 57.16 -66.08 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 174.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.598 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.3 OUTLIER 56.45 56.18 5.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -166.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 105' ' ' GLN . . . 71.27 -150.65 0.09 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.477 -173.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -130.68 152.1 79.89 Favored Pre-proline 0 C--O 1.208 -1.089 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.436 -176.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.436 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 27.4 Cg_exo -31.45 -54.83 0.27 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.254 3.303 . . . . 0.0 114.905 -172.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 0.5 OUTLIER -57.59 -43.57 84.71 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.724 0.773 . . . . 0.0 111.884 178.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 19.9 mt-30 -82.33 -26.56 32.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.514 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 105' ' ' GLN . 3.2 tm? -69.55 -48.12 61.41 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.782 -175.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 5.1 pt-20 -64.78 -31.35 72.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.528 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 109' ' ' LYS . 75.1 t -64.55 -41.14 91.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.291 0.567 . . . . 0.0 109.797 175.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 tp -70.54 -32.71 70.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.584 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 116' ' ' GLN . 43.7 t80 -79.52 -10.85 59.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.252 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 115' ' ' PHE . 28.2 tt0 74.03 -66.58 0.3 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.823 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.98 59.7 0.23 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.15 134.49 56.52 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.792 2.995 . . . . 0.0 113.575 -173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -95.49 4.62 53.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.464 0.649 . . . . 0.0 109.479 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -124.67 82.33 2.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.989 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.9 m -114.64 108.69 17.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.597 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 122' ' ' LEU . 7.1 mp -107.78 122.4 46.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -81.3 90.46 6.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.3 0.571 . . . . 0.0 110.718 -177.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -144.39 123.07 12.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.274 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -115.97 148.9 39.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.898 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.663 ' CD2' ' HB ' ' A' ' 37' ' ' ILE . 2.1 pp -90.63 169.2 11.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.861 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -144.98 95.6 2.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.226 0.536 . . . . 0.0 110.396 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.747 ' OXT' HG13 ' A' ' 33' ' ' ILE . 11.1 p . . . . . 0 N--CA 1.443 -0.809 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.343 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.5 m -144.02 159.2 53.85 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.02 -46.24 33.73 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.129 1.886 . . . . 0.0 111.152 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.57 68.84 1.52 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.126 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 71' ' ' THR . 20.8 pt -80.25 150.68 71.46 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.2 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HD3' HD13 ' A' ' 104' ' ' LEU . 28.3 Cg_endo -61.27 -78.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.006 2.471 . . . . 0.0 112.18 -170.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.8 119.31 37.62 Favored Pre-proline 0 N--CA 1.432 -1.333 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.77 135.09 37.15 Favored 'Trans proline' 0 C--N 1.33 -0.4 0 C-N-CA 123.445 2.764 . . . . 0.0 112.291 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.13 143.41 11.31 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -160.85 136.96 8.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.914 0.387 . . . . 0.0 111.12 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.507 HG21 ' O ' ' A' ' 62' ' ' GLY . 10.1 m -131.68 157.32 43.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -126.77 131.79 51.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.36 0.6 . . . . 0.0 110.914 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.9 mm? -127.35 -171.55 2.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.41 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 89.5 mt-30 -129.81 136.88 50.11 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.94 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 25.8 mmtp -40.14 146.27 0.13 Allowed 'General case' 0 C--N 1.321 -0.644 0 O-C-N 124.814 1.321 . . . . 0.0 113.354 -176.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -79.55 179.6 7.38 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.382 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.85 -32.22 63.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.775 0.321 . . . . 0.0 110.691 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -92.68 16.93 11.12 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.088 0.47 . . . . 0.0 111.018 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 63.5 t30 71.75 12.54 6.27 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.765 173.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 pp -121.95 -170.31 2.03 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 121.397 -0.815 . . . . 0.0 112.091 -174.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -106.9 -29.6 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.881 -178.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA3' HG21 ' A' ' 56' ' ' THR . . . 93.78 40.26 4.72 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.413 -0.898 . . . . 0.0 113.427 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 2.7 pp -123.95 177.79 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.567 0.698 . . . . 0.0 112.197 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 49' ' ' ILE . 23.1 m -148.92 116.17 6.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.077 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 5.0 tt -105.0 125.61 59.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.449 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 125' ' ' TRP . . . -117.29 138.0 13.83 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.694 -176.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' HA3' ' H ' ' A' ' 46' ' ' CYS . . . -111.69 159.48 13.72 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.96 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.26 96.62 0.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.896 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 44' ' ' CYS . . . -151.88 158.94 43.9 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 173.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -62.16 113.77 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.614 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.5 t80 71.21 -10.1 0.81 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.12 0.887 . . . . 0.0 111.54 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.694 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 85.6 m -147.7 75.24 11.15 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.544 -173.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -63.97 -162.37 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.898 2.399 . . . . 0.0 113.205 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.489 ' SG ' ' HG ' ' A' ' 122' ' ' LEU . 56.7 m 73.48 134.79 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.966 -166.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HB2' ' H ' ' A' ' 48' ' ' TYR . 13.3 mt -145.32 -92.56 0.1 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.723 0.773 . . . . 0.0 110.972 174.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 49.2 p90 -142.02 175.74 9.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.555 -167.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -79.74 122.6 35.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.463 176.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.7 t -100.06 -20.55 5.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.37 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -151.15 133.11 15.12 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.356 -173.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' A' ' 59' ' ' ALA . 9.8 p -135.66 159.96 39.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -90.91 -137.87 0.15 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -138.89 -38.89 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.733 0.697 . . . . 0.0 112.321 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -101.73 4.06 40.21 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.956 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 70.0 p -82.9 146.61 52.62 Favored Pre-proline 0 N--CA 1.433 -1.294 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 9.1 Cg_endo -50.13 -40.5 50.89 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.911 1.741 . . . . 0.0 111.204 -176.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.88 84.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.814 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -74.94 -59.02 2.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.167 0.508 . . . . 0.0 110.573 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 61' ' ' ASP . 2.0 pp -50.03 -76.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -171.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.64 ' N ' HD12 ' A' ' 60' ' ' LEU . 35.7 t70 -95.56 -19.12 20.05 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.616 1.198 . . . . 0.0 108.511 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.538 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -64.25 -32.47 84.3 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 112.512 -2.131 . . . . 0.0 114.164 -167.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.6 t 48.01 32.1 2.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 112.255 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.609 ' HB ' ' OH ' ' A' ' 101' ' ' TYR . 22.8 m -105.1 51.37 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-O 123.483 1.611 . . . . 0.0 109.288 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.481 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.35 166.77 18.17 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 112.04 -2.345 . . . . 0.0 111.242 -172.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.02 119.09 2.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.175 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.87 -28.3 3.55 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.307 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.703 ' HB3' ' CD1' ' A' ' 101' ' ' TYR . 1.1 m-20 -73.7 144.29 45.82 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.6 ' HB3' ' O ' ' A' ' 102' ' ' ASN . 17.1 tt0 -101.59 122.89 44.68 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.731 HG12 ' CE1' ' A' ' 101' ' ' TYR . 3.2 mt -108.48 101.17 12.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.329 0.585 . . . . 0.0 111.205 -170.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.491 HG21 HG21 ' A' ' 17' ' ' ILE . 5.2 t -92.41 -15.17 27.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.069 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.03 148.73 18.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.572 -1.299 . . . . 0.0 113.847 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.53 HG12 HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -110.01 122.25 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 123.407 0.683 . . . . 0.0 109.457 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 53.2 28.36 6.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.94 -20.15 46.76 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.639 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 17.3 ptp180 -103.51 134.58 46.63 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 117.854 0.827 . . . . 0.0 110.52 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.2 m -66.68 152.37 45.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.692 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.53 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -88.48 6.02 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 122.396 1.093 . . . . 0.0 108.447 178.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.524 ' HE2' ' O ' ' A' ' 115' ' ' PHE . 39.3 tptt -76.05 96.19 3.77 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.254 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.49 -30.25 2.8 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.107 -1.044 . . . . 0.0 114.28 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.679 ' CG ' HG13 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -89.92 -151.32 0.23 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 117.989 0.895 . . . . 0.0 112.242 -172.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.479 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 2.7 m -132.91 141.19 48.24 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HA ' HG22 ' A' ' 86' ' ' VAL . 9.5 mtmm -37.63 -54.59 1.17 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.354 0.662 . . . . 0.0 112.715 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -51.64 -31.63 12.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.85 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 89' ' ' MET . 34.0 mt-10 -80.77 -34.92 33.85 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.849 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.679 HG13 ' CG ' ' A' ' 81' ' ' LYS . 20.3 m -73.48 -42.86 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.84 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' A' ' 91' ' ' GLN . . . -61.69 -34.65 76.13 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 171.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 38.1 ttpt -63.61 -48.33 77.79 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.727 175.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 65.6 mtt -45.38 -46.96 13.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.365 0.602 . . . . 0.0 110.275 175.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.416 ' CG2' HG21 ' A' ' 128' ' ' VAL . 34.8 mm -63.69 -54.43 32.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.973 176.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.625 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 11.9 mm-40 -61.39 -35.69 78.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -67.03 -55.16 15.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -172.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -54.42 -40.18 47.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.582 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.472 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 64.6 pttt 48.38 161.62 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.227 1.411 . . . . 0.0 113.702 -178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.67 -46.07 3.12 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.235 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.1 pt-20 -146.54 178.39 8.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.095 0.474 . . . . 0.0 110.11 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.618 HG11 HG23 ' A' ' 33' ' ' ILE . 4.6 m -147.48 151.04 14.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.55 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.6 m -140.35 105.49 5.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.265 0.555 . . . . 0.0 110.595 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.702 ' HB ' ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -92.61 149.67 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.077 -176.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.1 m-70 -128.03 129.13 46.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.784 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.731 ' CE1' HG12 ' A' ' 70' ' ' ILE . 97.5 m-85 -123.46 153.61 40.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.6 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 11.1 p-10 -134.48 158.23 44.45 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.178 171.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.553 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 10.8 mptt -134.31 101.19 4.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.585 0.354 . . . . 0.0 111.178 177.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.536 HD13 ' HD3' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -164.46 160.43 20.53 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.312 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.433 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 15.1 mm-40 -121.54 80.22 1.64 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.247 0.546 . . . . 0.0 109.907 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.6 171.11 13.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.65 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 111' ' ' LEU . 12.6 m-20 -116.54 152.94 48.81 Favored Pre-proline 0 C--O 1.21 -1.013 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -32.59 -49.03 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.693 2.929 . . . . 0.0 113.743 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 113' ' ' VAL . 21.3 ptmt -60.7 -49.38 77.73 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.587 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.475 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 14.8 mm100 -90.09 -11.25 41.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.535 0.683 . . . . 0.0 111.206 -173.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 107' ' ' ASP . 3.4 tm? -84.91 -40.12 17.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.493 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -66.25 -21.85 66.3 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.851 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 109' ' ' LYS . 76.0 t -64.21 -36.34 76.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.922 174.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 114' ' ' LEU . 7.1 tt -79.63 -30.36 41.31 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.524 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 9.8 t80 -83.7 0.07 48.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.609 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 70.13 -79.03 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.773 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.533 ' N ' ' HD2' ' A' ' 118' ' ' PRO . . . 179.72 -48.2 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.672 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 117' ' ' GLY . 16.2 Cg_exo -30.63 136.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 124.358 3.372 . . . . 0.0 113.611 167.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -72.16 -173.68 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.971 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -132.07 168.46 17.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.991 -169.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.1 t -141.15 28.31 1.89 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.053 0.93 . . . . 0.0 108.871 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.489 ' HG ' ' SG ' ' A' ' 46' ' ' CYS . 3.3 mm? -107.36 128.9 54.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.785 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' A' ' 123' ' ' ARG . 7.1 tpm_? -140.18 -70.37 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.141 176.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -81.76 150.49 27.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.508 ' HB3' ' HA2' ' A' ' 38' ' ' GLY . 7.2 p90 -73.57 168.93 18.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.42 . . . . 0.0 111.855 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 pp -131.73 168.33 17.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.467 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -144.32 148.81 35.26 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.313 0.578 . . . . 0.0 111.23 -178.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 33' ' ' ILE . 4.1 p . . . . . 0 C--N 1.315 -0.899 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.904 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.1 m 68.99 127.81 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 C-N-CA 123.332 0.653 . . . . 0.0 111.054 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.72 -11.58 28.01 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.466 2.111 . . . . 0.0 112.661 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.19 145.14 3.76 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.997 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.462 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 21.4 pt -78.72 155.41 78.25 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 122.546 -0.384 . . . . 0.0 110.766 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HG3' HD13 ' A' ' 104' ' ' LEU . 35.3 Cg_endo -62.54 -86.99 0.0 OUTLIER 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.988 2.458 . . . . 0.0 112.279 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 52.9 t -112.76 128.58 25.41 Favored Pre-proline 0 N--CA 1.434 -1.233 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 19' ' ' VAL . 12.0 Cg_endo -92.42 145.93 2.76 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.771 2.981 . . . . 0.0 112.01 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.91 175.96 47.1 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.329 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 21.3 pttm -150.46 146.86 26.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.538 0.209 . . . . 0.0 110.548 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.55 141.07 43.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -109.5 119.66 40.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.808 0.814 . . . . 0.0 111.186 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.54 HD21 ' HA2' ' A' ' 62' ' ' GLY . 2.9 mm? -124.41 -167.01 1.59 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.045 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 94.0 mt-30 -132.12 139.67 48.53 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.014 0.435 . . . . 0.0 109.948 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HE2' ' O ' ' A' ' 90' ' ' ILE . 5.3 mmtp -45.03 145.27 1.02 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.86 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.25 179.1 8.0 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.421 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.92 -21.35 64.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.169 0.509 . . . . 0.0 110.658 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 2.5 mt-30 -89.74 11.34 20.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.907 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' ' 91' ' ' GLN . 1.8 p-10 55.33 29.18 12.52 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.136 1.374 . . . . 0.0 112.136 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 30' ' ' GLN . 0.9 OUTLIER -131.65 -165.74 1.62 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.639 177.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -103.73 -28.57 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 56' ' ' THR . . . 97.67 38.02 4.31 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.267 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 52' ' ' VAL . 2.6 pp -128.82 177.51 6.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.868 0.842 . . . . 0.0 111.954 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 11.7 m -138.41 125.18 20.99 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.397 173.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.923 HG22 ' H ' ' A' ' 38' ' ' GLY . 22.5 mt -110.47 -168.18 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.923 ' H ' HG22 ' A' ' 37' ' ' ILE . . . 179.62 117.76 0.56 Allowed Glycine 0 C--N 1.308 -0.984 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -177.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.614 ' HA2' ' HG ' ' A' ' 47' ' ' LEU . . . -112.22 152.44 17.79 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.384 -1.388 . . . . 0.0 114.149 -172.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.685 ' HA3' ' O ' ' A' ' 44' ' ' CYS . . . -64.64 -67.46 2.03 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.399 172.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.574 ' H ' ' HA ' ' A' ' 45' ' ' PRO . . . 72.08 -63.8 0.41 Allowed 'General case' 0 C--N 1.344 0.369 0 C-N-CA 123.326 0.65 . . . . 0.0 112.215 171.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -71.49 84.22 0.83 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.702 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 72.66 -20.04 0.28 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.896 0.878 . . . . 0.0 112.472 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.685 ' O ' ' HA3' ' A' ' 40' ' ' GLY . 68.2 m -134.29 77.55 60.15 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 122.418 -0.176 . . . . 0.0 111.09 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.574 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 25.0 Cg_exo -69.15 -149.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.332 2.688 . . . . 0.0 113.738 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 45' ' ' PRO . 74.7 m 72.77 112.93 0.06 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.868 -165.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.614 ' HG ' ' HA2' ' A' ' 39' ' ' GLY . 5.7 mp -101.89 167.72 9.89 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.295 0.569 . . . . 0.0 112.497 -174.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -139.79 150.02 44.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.699 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -95.52 127.07 47.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.53 0.681 . . . . 0.0 109.285 177.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG21 ' CD1' ' A' ' 125' ' ' TRP . 37.4 t -92.3 -38.32 10.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.937 -171.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.96 150.15 20.3 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.682 -174.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 59' ' ' ALA . 8.1 p -141.33 159.98 22.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.567 173.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -95.91 -139.18 0.25 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.437 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 18.9 t70 -136.06 -33.41 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.783 176.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -102.38 4.49 38.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.166 0.508 . . . . 0.0 110.564 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 82.5 p -86.3 144.16 37.84 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.815 ' HA ' ' CD1' ' A' ' 60' ' ' LEU . 10.2 Cg_endo -52.25 -38.99 73.06 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.428 1.418 . . . . 0.0 111.704 -172.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.658 ' O ' ' HA3' ' A' ' 62' ' ' GLY . . . -58.05 -45.36 87.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.543 175.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.681 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -72.4 -60.95 1.98 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.095 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.011 HD13 ' H ' ' A' ' 61' ' ' ASP 0.268 0.0 OUTLIER -61.41 -71.43 0.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -166.895 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 1.011 ' H ' HD13 ' A' ' 60' ' ' LEU . 23.7 t70 -92.84 -4.31 53.15 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 58' ' ' ALA . . . -71.71 -62.28 3.48 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 112.613 -2.085 . . . . 0.0 113.648 -171.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 p 74.31 23.18 2.07 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.933 1.293 . . . . 0.0 110.574 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.637 HG11 HG13 ' A' ' 99' ' ' ILE . 31.2 m -100.21 50.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.564 172.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -83.73 174.91 10.07 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.138 -170.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.91 132.43 52.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.607 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.15 -13.58 19.19 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.638 ' O ' HG22 ' A' ' 49' ' ' ILE . 57.8 m-20 -95.86 -175.99 3.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.026 0.441 . . . . 0.0 110.72 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . 50.9 mt-10 -132.09 154.24 49.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.101 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 47' ' ' LEU . 24.5 mm -122.83 140.29 47.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -175.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 t -131.07 -0.88 4.11 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -160.56 142.16 7.94 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.22 -1.467 . . . . 0.0 113.952 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.663 HG12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -104.0 117.3 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 123.632 0.773 . . . . 0.0 109.767 -179.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.578 ' ND2' HG11 ' A' ' 93' ' ' VAL . 64.9 t30 53.71 29.95 10.32 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.536 0.684 . . . . 0.0 111.016 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.622 ' HA2' ' CD2' ' A' ' 100' ' ' HIS . . . 100.66 -21.52 43.61 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.917 177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 73' ' ' VAL . 5.8 ptm180 -100.59 142.97 31.32 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 117.801 0.8 . . . . 0.0 110.529 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.7 m -59.42 149.87 28.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.188 0.518 . . . . 0.0 111.332 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.663 HG22 HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -90.62 -20.96 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.166 -179.01 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.24 -25.78 68.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.123 -170.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.99 -17.71 77.24 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.863 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -135.01 -139.27 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.321 0.56 . . . . 0.0 110.215 -176.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 85' ' ' GLU . 47.1 p -137.67 157.89 45.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.628 -172.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.487 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -48.04 -54.94 11.38 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.774 0.671 . . . . 0.0 112.588 -178.424 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.93 -39.67 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 120.895 0.378 . . . . 0.0 111.974 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.566 ' O ' ' HG3' ' A' ' 89' ' ' MET . 39.8 mt-10 -72.7 -36.62 67.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.934 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 83' ' ' LYS . 29.1 m -72.48 -41.36 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.347 -176.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.65 -37.01 67.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.027 170.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 57.1 tttm -64.76 -48.98 72.56 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.828 173.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.566 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 58.3 mtt -54.69 -40.56 69.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.107 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.581 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 20.1 mm -61.26 -55.48 24.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.087 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.527 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 10.4 pt20 -72.34 -23.13 61.1 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -176.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -67.45 -53.75 26.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.578 HG11 ' ND2' ' A' ' 74' ' ' ASN . 33.6 m -46.59 -32.33 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 23.9 tptm 70.87 123.88 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.292 0.568 . . . . 0.0 112.073 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.566 ' H ' ' HG3' ' A' ' 27' ' ' LYS . . . 105.8 -59.16 0.42 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.151 -1.024 . . . . 0.0 113.588 172.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 11.5 pt-20 -135.47 178.72 6.82 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.149 0.5 . . . . 0.0 110.566 -170.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.585 HG11 HG23 ' A' ' 33' ' ' ILE . 9.2 m -148.38 151.09 13.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.0 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 p -139.73 99.98 3.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.33 0.586 . . . . 0.0 109.99 170.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.637 HG13 HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -86.26 115.51 27.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.82 -176.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.622 ' CD2' ' HA2' ' A' ' 75' ' ' GLY . 4.7 m-70 -91.99 119.71 31.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.542 ' CE1' ' HE2' ' A' ' 103' ' ' LYS . 5.5 p90 -132.2 -170.16 2.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.61 -170.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 4.0 p-10 -151.01 150.77 31.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.319 173.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.542 ' HE2' ' CE1' ' A' ' 101' ' ' TYR . 48.1 mmtt -127.02 118.66 24.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.841 0.353 . . . . 0.0 111.653 -164.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.484 HD13 ' HG3' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -171.15 166.31 7.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.984 177.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -134.87 85.25 2.16 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.9 -179.07 7.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.492 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -124.43 150.75 65.36 Favored Pre-proline 0 C--O 1.21 -1.013 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -177.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.54 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 36.3 Cg_exo -32.76 -52.89 0.39 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.582 2.855 . . . . 0.0 113.965 -174.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 110' ' ' GLN . 19.7 ptpt -55.97 -51.06 69.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.387 0.613 . . . . 0.0 111.978 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.529 ' N ' ' HG3' ' A' ' 109' ' ' LYS . 13.3 mm100 -88.16 -3.9 58.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.729 0.776 . . . . 0.0 111.343 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.72 -49.11 6.65 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.622 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 108' ' ' PRO . 7.4 pt-20 -68.73 -23.43 64.34 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.514 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 110' ' ' GLN . 3.9 p -69.54 -31.74 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.589 0.709 . . . . 0.0 110.101 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.84 -34.02 45.49 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.283 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -78.02 -45.91 22.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.529 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 61.38 91.35 0.06 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 122.571 1.177 . . . . 0.0 110.597 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.452 ' H ' ' CD ' ' A' ' 118' ' ' PRO . . . 161.45 50.56 0.02 OUTLIER Glycine 0 C--N 1.305 -1.19 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -174.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.452 ' CD ' ' H ' ' A' ' 117' ' ' GLY . 28.3 Cg_endo -57.93 122.94 12.58 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.425 2.75 . . . . 0.0 113.1 -168.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 68.73 21.78 7.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.465 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -109.11 39.3 2.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.36 0.6 . . . . 0.0 110.141 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.5 p -86.41 -159.88 0.52 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.159 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.6 tp 61.22 50.84 4.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.673 0.749 . . . . 0.0 110.05 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -99.92 166.02 11.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.076 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -71.39 115.68 10.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.418 ' CD1' HG21 ' A' ' 50' ' ' VAL . 10.5 m-90 -83.05 176.13 9.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.781 0.801 . . . . 0.0 112.402 -170.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 127' ' ' LYS . 9.1 tt -105.52 156.9 17.78 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.192 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.62 ' N ' HD23 ' A' ' 126' ' ' LEU . 19.8 pttp -155.13 120.88 5.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.478 0.656 . . . . 0.0 111.575 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.601 ' O ' HG13 ' A' ' 33' ' ' ILE . 12.5 p . . . . . 0 N--CA 1.446 -0.651 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.344 171.348 . . . . . . . . 1 1 . 1 stop_ save_